Citrus Sinensis ID: 043586

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------
Protein Sequence
EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Secondary Structure (PSIPRED)
cccccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEEccccccccccccccccccccccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEcccccccHHHHHHHHcccccccEEEEcccccEEEEEcccccEEEEEEEcccccccccHHHHHHHHHHHHHcccccccccEEEEEEcccccEEEEcccccccHHHHcccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEccccHHccccccccccEEEccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEcEEccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEEccccccccccHHHcccccccEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccHHccccccEcHHHHHHHHcccccccEEccccccEEEEEEcccccEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHHHHccccccccEEEEEEccccccHHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEcccHHccEEcccHccEEEccHcHHHHcccccccEEEEEEccccccHHHcc
Coil and Loop (DISEMBL)
eignlknlieldvgsnsligpipstlglltdlsyldlsrnqfnssipnELTWLTGLLglnlssnklsgkipsqiasmknltwldisnnkiegsipgeitelsrldylnlssnklsgpvpfsneqlSSMYIVrlspnkglcgnfsalpscdatkpaTLFVEIFLPLAIVPSVIVFACLLVVKrkykkpklkanatnsigvfsiwnydgrivyEDLIeategfdikycigtggygsvykaqlpngkvfaLKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFcnlhnnedavELDWAKRVNIVKAMAHALAYlhhdcspsiihrdissnnillnskFEAFVADFGtarllhadssnrtllagtygyiapglpl
Flexible Loop (DISEMBL)
EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRkykkpklkanatnsigvfsiwnyDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHadssnrtllagtygyiapglpl
Low Complexity Region (SEG)
EIGNLKNLIELDVGSNSLIGPIPstlglltdlsyldlsRNQFNSSIPNEltwltgllglnlssnklsgkIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACllvvkrkykkpklkANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Disordered region (IsUnstruct)
******NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLS*************QLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA*****
Disordered Region (DISOPRED)
EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC*********************FLPLAIVPSVIVFACLLVVKR*******************IWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE********SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Disordered Region (DISEMBL)
EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Disordered Region (DISPRO)
*IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	397	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.979	0.372	0.432	4e-88
Q9LP24	1120	Probable leucine-rich rep	no	no	0.979	0.347	0.423	6e-83
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.969	0.349	0.398	3e-65
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.972	0.308	0.369	6e-64
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.972	0.323	0.368	1e-61
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.984	0.355	0.372	4e-61
O49545	1003	Leucine-rich repeat recep	no	no	0.957	0.378	0.373	1e-59
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.969	0.308	0.348	2e-59
O49318	1124	Probable leucine-rich rep	no	no	0.987	0.348	0.352	4e-59
Q6XAT2	967	LRR receptor-like serine/	no	no	0.957	0.392	0.358	7e-59

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  325 bits (833), Expect = 4e-88,   Method: Compositional matrix adjust.
 Identities = 175/405 (43%), Positives = 257/405 (63%), Gaps = 16/405 (3%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
           L NL  LD+ SN     IP TL  L  L Y++LSRN  + +IP  LT L+ L  L+LS N
Sbjct: 549 LTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYN 608

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
           +L G+I SQ  S++NL  LD+S+N + G IP    ++  L ++++S N L GP+P  N  
Sbjct: 609 QLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP-DNAA 667

Query: 125 LSSMYIVRLSPNKGLCGNFS---ALPSCDAT------KPATLFVEIFLPL--AIVPSVIV 173
             +        NK LCG+ +    L  C  T      K   L + I +P+  AI+   + 
Sbjct: 668 FRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVC 727

Query: 174 FACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYG 233
               +  +++ K+ +   ++ +     SI+++DG++ Y+++I+AT  FD KY IGTGG+G
Sbjct: 728 AGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHG 787

Query: 234 SVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 290
            VYKA+LPN  + A+KKL+ +    ++     + F NE + L+++ HRN+VKL+GFC HR
Sbjct: 788 KVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHR 846

Query: 291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI 350
           +  FL+YEYMERGSL   L N+++A +LDW KR+N+VK +AHAL+Y+HHD SP+I+HRDI
Sbjct: 847 RNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDI 906

Query: 351 SSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           SS NILL   +EA ++DFGTA+LL  DSSN + +AGTYGY+AP L
Sbjct: 907 SSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPEL 951

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  308 bits (788), Expect = 6e-83,   Method: Compositional matrix adjust.
 Identities = 181/427 (42%), Positives = 253/427 (59%), Gaps = 38/427 (8%)

Query: 2    IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
            IGNL NL  L +  N L G +P+ L  LT+L  LDLS N F+S IP        L  +NL
Sbjct: 602  IGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNL 661

Query: 62   SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            S NK  G IP +++ +  LT LD+S+N+++G IP +++ L  LD L+LS N LSG +P +
Sbjct: 662  SRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTT 720

Query: 122  NEQLSSMYIVRLSPNK-----------------------GLCGNFSAL---PSCDATKP- 154
             E + ++  V +S NK                       GLC N       P  +  KP 
Sbjct: 721  FEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPK 780

Query: 155  --ATLFVEIFLPLAIVPSVIVFACLLVVKRKYKKPKLK--ANATNSIGV-FSIWNYDGRI 209
                L V I +P+  V  VI+  C        +K KL+   N     G   SI++ DG+ 
Sbjct: 781  KNGNLVVWILVPILGV-LVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKF 839

Query: 210  VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA---FIKSFR 266
             Y+D+IE+T  FD  + IGTGGY  VY+A L +  + A+K+LH +  EE++     + F 
Sbjct: 840  KYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFL 898

Query: 267  NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 326
            NE + L+++ HRN+VKL+GFC HR+  FLIYEYME+GSL   L N+E+A  L W KR+N+
Sbjct: 899  NEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINV 958

Query: 327  VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAG 386
            VK +AHAL+Y+HHD    I+HRDISS NILL++ + A ++DFGTA+LL  DSSN + +AG
Sbjct: 959  VKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAG 1018

Query: 387  TYGYIAP 393
            TYGY+AP
Sbjct: 1019 TYGYVAP 1025

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  249 bits (636), Expect = 3e-65,   Method: Compositional matrix adjust.
 Identities = 165/414 (39%), Positives = 228/414 (55%), Gaps = 29/414 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL-LGL 59
           E+G+L  L  L + +N+L G IP  LG L+ L+ L +  N FN SIP EL  LTGL + L
Sbjct: 572 EVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIAL 631

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           NLS NKL+G+IP +++++  L +L ++NN + G IP     LS L   N S N L+GP+P
Sbjct: 632 NLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP 691

Query: 120 FSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLP--------LAIVPSV 171
                L ++ +     N+GLCG    L  C  T+P         P        +AI  +V
Sbjct: 692 L----LRNISMSSFIGNEGLCG--PPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAV 745

Query: 172 IVFACLLVVK---RKYKKPKLKANATNSIGVFSIWNYD------GRIVYEDLIEATEGFD 222
           I    L+++       ++P     ++   G  S  + D          ++DL+ AT+ FD
Sbjct: 746 IGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFD 805

Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNI 280
             + +G G  G+VYKA LP G   A+KKL ++           SFR E   L  + HRNI
Sbjct: 806 ESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNI 865

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           VKL+GFC H+    L+YEYM +GSL   LH  + +  LDW+KR  I    A  LAYLHHD
Sbjct: 866 VKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHD 923

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH-ADSSNRTLLAGTYGYIAP 393
           C P I HRDI SNNILL+ KFEA V DFG A+++    S + + +AG+YGYIAP
Sbjct: 924 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP 977

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  244 bits (624), Expect = 6e-64,   Method: Compositional matrix adjust.
 Identities = 155/420 (36%), Positives = 235/420 (55%), Gaps = 34/420 (8%)

Query: 1    EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLL-GL 59
            EIGNL+ L  L++  N L GP+PST+G L+ L  L LSRN     IP E+  L  L   L
Sbjct: 715  EIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSAL 774

Query: 60   NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            +LS N  +G+IPS I+++  L  LD+S+N++ G +PG+I ++  L YLNLS N L G + 
Sbjct: 775  DLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL- 833

Query: 120  FSNEQLSSMYIVRLSPNKGLCGNFSALPSCD--------ATKPATLFVEIFLPLAIVPSV 171
               +Q S         N GLCG  S L  C+        +  P T+ +   +      ++
Sbjct: 834  --KKQFSRWQADAFVGNAGLCG--SPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIAL 889

Query: 172  IVFACLLVVKRK---YKKPK------LKANATNSIGVFSIWNYDGRIVYEDLIEATEGFD 222
            +V   +L  K+    +KK +         ++++   +FS       I ++D++EAT   +
Sbjct: 890  MVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLN 949

Query: 223  IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
             ++ IG+GG G VYKA+L NG+  A+KK+   +  +L   KSF  E + L  + HR++VK
Sbjct: 950  EEFMIGSGGSGKVYKAELKNGETIAVKKILWKD--DLMSNKSFNREVKTLGTIRHRHLVK 1007

Query: 283  LYGFCLHRK--CMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYL 337
            L G+C  +      LIYEYM  GS++  LH NE+  +   L W  R+ I   +A  + YL
Sbjct: 1008 LMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYL 1067

Query: 338  HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL----HADSSNRTLLAGTYGYIAP 393
            H+DC P I+HRDI S+N+LL+S  EA + DFG A++L      ++ + T+ AG+YGYIAP
Sbjct: 1068 HYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAP 1127

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  237 bits (604), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 155/421 (36%), Positives = 230/421 (54%), Gaps = 35/421 (8%)

Query: 3    GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            G L +L++L++  N L GP+P++LG L +L+++DLS N  +  + +EL+ +  L+GL + 
Sbjct: 673  GLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIE 732

Query: 63   SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
             NK +G+IPS++ ++  L +LD+S N + G IP +I  L  L++LNL+ N L G VP S+
Sbjct: 733  QNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVP-SD 791

Query: 123  EQLSSMYIVRLSPNKGLCGNFSALPSC--DATK--PATLFVEIFLPLAIVPSVIVF---- 174
                      LS NK LCG       C  + TK   A     + L   I+  V VF    
Sbjct: 792  GVCQDPSKALLSGNKELCGRVVG-SDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRR 850

Query: 175  -ACLLVVKRKYKKPKLKANATNSIGVFSIWNYDG-------------------RIVYEDL 214
             A    VK++    +++ +        +++   G                   ++   D+
Sbjct: 851  WAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDI 910

Query: 215  IEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
            +EAT+ F  K  IG GG+G+VYKA LP  K  A+KKL  ++T+     + F  E + L +
Sbjct: 911  VEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQG---NREFMAEMETLGK 967

Query: 275  VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHA 333
            V H N+V L G+C   +   L+YEYM  GSL   L N    +E LDW+KR+ I    A  
Sbjct: 968  VKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARG 1027

Query: 334  LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA-DSSNRTLLAGTYGYIA 392
            LA+LHH   P IIHRDI ++NILL+  FE  VADFG ARL+ A +S   T++AGT+GYI 
Sbjct: 1028 LAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIP 1087

Query: 393  P 393
            P
Sbjct: 1088 P 1088

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  235 bits (600), Expect = 4e-61,   Method: Compositional matrix adjust.
 Identities = 152/408 (37%), Positives = 213/408 (52%), Gaps = 17/408 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL-LGL 59
           E+G L  L  L +  N L G IP + G LT L  L L  N  + +IP EL  LT L + L
Sbjct: 566 ELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISL 625

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           N+S N LSG IP  + +++ L  L +++NK+ G IP  I  L  L   N+S+N L G VP
Sbjct: 626 NISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVP 685

Query: 120 FSNEQLSSMYIVRLSPNKGLCGNFSA-----LPSCDATKPATLFVEIFLPLAIVPSVIVF 174
                   M     + N GLC +  +     +P  D+     +       +  +  +++ 
Sbjct: 686 -DTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIG 744

Query: 175 ACLLVV------KRKYKKPKLKA--NATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYC 226
           +  L+         K ++P   A  + T    + S +       Y+ L++AT  F     
Sbjct: 745 SVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVV 804

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G  G+VYKA++  G+V A+KKL+ S  E  +   SFR E   L ++ HRNIVKLYGF
Sbjct: 805 LGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEISTLGKIRHRNIVKLYGF 863

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C H+    L+YEYM +GSL   L   E    LDW  R  I    A  L YLHHDC P I+
Sbjct: 864 CYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIV 923

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAP 393
           HRDI SNNILL+ +F+A V DFG A+L+    S + + +AG+YGYIAP
Sbjct: 924 HRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAP 971

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  230 bits (587), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 151/404 (37%), Positives = 221/404 (54%), Gaps = 24/404 (5%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           IGN   + +L +  N   GPIPS +G L  LS +D S N F+  I  E++    L  ++L
Sbjct: 475 IGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDL 534

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S N+LSG+IP++I +MK L +L++S N + GSIPG I+ +  L  L+ S N LSG VP +
Sbjct: 535 SRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGT 594

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPSCDATK----------PATLFVEIFLPLAIVPSV 171
             Q S         N  LCG +   P  D             P +  +++ L L ++   
Sbjct: 595 G-QFSYFNYTSFLGNPDLCGPYLG-PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCS 652

Query: 172 IVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGG 231
           I FA + ++K +  K   KA+ + +  + +    D     +D++++ +  +I   IG GG
Sbjct: 653 IAFAVVAIIKARSLK---KASESRAWRLTAFQRLD--FTCDDVLDSLKEDNI---IGKGG 704

Query: 232 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 291
            G VYK  +PNG + A+K+L  + +   +    F  E Q L ++ HR+IV+L GFC + +
Sbjct: 705 AGIVYKGVMPNGDLVAVKRL-AAMSRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 763

Query: 292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS 351
              L+YEYM  GSL   LH  +    L W  R  I    A  L YLHHDCSP I+HRD+ 
Sbjct: 764 TNLLVYEYMPNGSLGEVLHGKKGG-HLHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVK 822

Query: 352 SNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
           SNNILL+S FEA VADFG A+ L    ++  +  +AG+YGYIAP
Sbjct: 823 SNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  229 bits (585), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 149/427 (34%), Positives = 221/427 (51%), Gaps = 42/427 (9%)

Query: 1    EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLL-GL 59
            EIGNL  L  L++  N   G +P  +G L+ L  L LSRN     IP E+  L  L   L
Sbjct: 714  EIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSAL 773

Query: 60   NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            +LS N  +G IPS I ++  L  LD+S+N++ G +PG + ++  L YLN+S N L G + 
Sbjct: 774  DLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL- 832

Query: 120  FSNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKP----------ATLFVEIFLPLAIVP 169
               +Q S         N GLCG  S L  C+  +           + + +     L  + 
Sbjct: 833  --KKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIG 888

Query: 170  SVIVFACLLVVKRK------------YKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEA 217
             +I+   L   +R             Y      + AT+   +F        I +ED++EA
Sbjct: 889  LMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHK-PLFRNGASKSDIRWEDIMEA 947

Query: 218  TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
            T     ++ IG+GG G VYKA+L NG+  A+KK+   +  +L   KSF  E + L ++ H
Sbjct: 948  THNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD--DLMSNKSFSREVKTLGRIRH 1005

Query: 278  RNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNLHNNEDAVE-----LDWAKRVNIVKAM 330
            R++VKL G+C  +      LIYEYM+ GS++  LH ++  +E     LDW  R+ I   +
Sbjct: 1006 RHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGL 1065

Query: 331  AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL----HADSSNRTLLAG 386
            A  + YLHHDC P I+HRDI S+N+LL+S  EA + DFG A++L      ++ + T  A 
Sbjct: 1066 AQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFAC 1125

Query: 387  TYGYIAP 393
            +YGYIAP
Sbjct: 1126 SYGYIAP 1132

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  229 bits (583), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 163/463 (35%), Positives = 221/463 (47%), Gaps = 71/463 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EI  L NL+  +V SNSL GPIPS +     L  LDLSRN F  S+P EL  L  L  L 
Sbjct: 536 EISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILR 595

Query: 61  LSSNKLSGKIPSQIASMKNLTWL-------------------------DISNNKIEGSIP 95
           LS N+ SG IP  I ++ +LT L                         ++S N   G IP
Sbjct: 596 LSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIP 655

Query: 96  GEITELSRLDYLNLSSNKLSGPVPFSNEQLSS-----------------------MYIVR 132
            EI  L  L YL+L++N LSG +P + E LSS                       M +  
Sbjct: 656 PEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTS 715

Query: 133 LSPNKGLCG--------NFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVKRKY 184
              NKGLCG        + S+ P   + K  +      + +       +   L+ +   +
Sbjct: 716 FLGNKGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHF 775

Query: 185 KKPKLKANATNSIGVFSIWNYDG-------RIVYEDLIEATEGFDIKYCIGTGGYGSVYK 237
            +  ++  A         +           R   +D++EAT+GF   Y +G G  G+VYK
Sbjct: 776 LRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYK 835

Query: 238 AQLPNGKVFALKKLHTSETEELAFIKS----FRNEAQVLSQVLHRNIVKLYGFCLHR--K 291
           A +P+GK  A+KKL ++         +    FR E   L ++ HRNIV+LY FC H+   
Sbjct: 836 AVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSN 895

Query: 292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS 351
              L+YEYM RGSL   LH  +    +DW  R  I    A  LAYLHHDC P IIHRDI 
Sbjct: 896 SNLLLYEYMSRGSLGELLHGGKSH-SMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIK 954

Query: 352 SNNILLNSKFEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAP 393
           SNNIL++  FEA V DFG A+++    S + + +AG+YGYIAP
Sbjct: 955 SNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAP 997

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6XAT2|ERL2_ARATH LRR receptor-like serine/threonine-protein kinase ERL2 OS=Arabidopsis thaliana GN=ERL2 PE=2 SV=1

 Score =  228 bits (581), Expect = 7e-59,   Method: Compositional matrix adjust.
 Identities = 155/432 (35%), Positives = 220/432 (50%), Gaps = 52/432 (12%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E  NL +L  L++ SNS  G IP+ LG + +L  LDLS N F+ SIP  L  L  LL LN
Sbjct: 403 EFRNLGSLTYLNLSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILN 462

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNN------------------------KIEGSIPG 96
           LS N L+G +P++  +++++  +D+S N                        KI G IP 
Sbjct: 463 LSRNHLNGTLPAEFGNLRSIQIIDVSFNFLAGVIPTELGQLQNINSLILNNNKIHGKIPD 522

Query: 97  EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSP-----NKGLCGNFSALPSCDA 151
           ++T    L  LN+S N LSG +P            R SP     N  LCGN+     C  
Sbjct: 523 QLTNCFSLANLNISFNNLSGIIP------PMKNFTRFSPASFFGNPFLCGNWVG-SICGP 575

Query: 152 TKPATLFVEIFLPLAIVPSVIVFACLL------VVKRKYKKPKLKANATNSIGV--FSIW 203
           + P +   ++F  +A++  V+ F  L+      V K K +KP LK ++    G     I 
Sbjct: 576 SLPKS---QVFTRVAVICMVLGFITLICMIFIAVYKSKQQKPVLKGSSKQPEGSTKLVIL 632

Query: 204 NYDGRI-VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFI 262
           + D  I  ++D++  TE  D KY IG G   +VYK      +  A+K+++          
Sbjct: 633 HMDMAIHTFDDIMRVTENLDEKYIIGYGASSTVYKCTSKTSRPIAIKRIYNQYPSNF--- 689

Query: 263 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 322
           + F  E + +  + HRNIV L+G+ L      L Y+YME GSL+  LH     V+LDW  
Sbjct: 690 REFETELETIGSIRHRNIVSLHGYALSPFGNLLFYDYMENGSLWDLLHGPGKKVKLDWET 749

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS-NR 381
           R+ I    A  LAYLHHDC+P IIHRDI S+NILL+  FEA ++DFG A+ + A  +   
Sbjct: 750 RLKIAVGAAQGLAYLHHDCTPRIIHRDIKSSNILLDGNFEARLSDFGIAKSIPATKTYAS 809

Query: 382 TLLAGTYGYIAP 393
           T + GT GYI P
Sbjct: 810 TYVLGTIGYIDP 821

Receptor kinase that regulates inflorescence architecture and organ shape as well as stomatal patterning, including density and clustering, together with ERL1 and ER.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
296085303	789	unnamed protein product [Vitis vinifera]	0.984	0.495	0.553	1e-117
359484066	843	PREDICTED: probable LRR receptor-like se	0.984	0.463	0.553	1e-117
359488983	758	PREDICTED: probable LRR receptor-like se	0.994	0.521	0.519	1e-116
359488981	757	PREDICTED: probable LRR receptor-like se	0.994	0.521	0.520	1e-116
359484068	868	PREDICTED: probable leucine-rich repeat	0.987	0.451	0.489	1e-115
296085307	874	unnamed protein product [Vitis vinifera]	0.987	0.448	0.489	1e-114
225452698	727	PREDICTED: probable LRR receptor-like se	0.992	0.541	0.519	1e-113
225465647	820	PREDICTED: probable LRR receptor-like se	0.934	0.452	0.483	1e-113
225452749	783	PREDICTED: probable LRR receptor-like se	0.992	0.503	0.529	1e-112
359484063	1003	PREDICTED: probable LRR receptor-like se	0.992	0.392	0.521	1e-111

>gi|296085303|emb|CBI29035.3| unnamed protein product [Vitis vinifera]

 Score =  429 bits (1102), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 218/394 (55%), Positives = 278/394 (70%), Gaps = 3/394 (0%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I NLKNLI L +  N+L G IPS+LG L  L+  ++S N+ N  IP+ +  L  L  L+L
Sbjct: 283 IWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDL 342

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S+N + GKIPSQ+ ++K LT+L++S+NK+ GSIP  +        L+LS N L G +PF 
Sbjct: 343 SANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPF- 401

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVK 181
            E  S         NKGLCG+   LP C      T  + I L   +    +V   LL+  
Sbjct: 402 -ELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLL-S 459

Query: 182 RKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP 241
           RK +K + K   T +  +FS+WNYDG+I YED+I+ATE FDIKYCIGTGGYGSVYKAQLP
Sbjct: 460 RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLP 519

Query: 242 NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME 301
            G V ALKKLH  E +E  ++KSF+NE Q+LS++ HRNIVKL G+CLH++CMFLIY YM 
Sbjct: 520 TGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMG 579

Query: 302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF 361
           RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNNILL+SK 
Sbjct: 580 RGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKL 639

Query: 362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           +AF++DFGTARLLH DSSN+TLLAGTYGYIAP L
Sbjct: 640 DAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPEL 673

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484066|ref|XP_002271307.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  428 bits (1101), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 218/394 (55%), Positives = 278/394 (70%), Gaps = 3/394 (0%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I NLKNLI L +  N+L G IPS+LG L  L+  ++S N+ N  IP+ +  L  L  L+L
Sbjct: 337 IWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLNEFNISGNRINGHIPSTIGNLNNLTRLDL 396

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S+N + GKIPSQ+ ++K LT+L++S+NK+ GSIP  +        L+LS N L G +PF 
Sbjct: 397 SANLIHGKIPSQVQNLKRLTYLNLSHNKLSGSIPTLLIYDHIKPSLDLSHNDLEGHIPF- 455

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSVIVFACLLVVK 181
            E  S         NKGLCG+   LP C      T  + I L   +    +V   LL+  
Sbjct: 456 -ELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIVISLSTTLFLFFVVLGFLLL-S 513

Query: 182 RKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP 241
           RK +K + K   T +  +FS+WNYDG+I YED+I+ATE FDIKYCIGTGGYGSVYKAQLP
Sbjct: 514 RKTRKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTGGYGSVYKAQLP 573

Query: 242 NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME 301
            G V ALKKLH  E +E  ++KSF+NE Q+LS++ HRNIVKL G+CLH++CMFLIY YM 
Sbjct: 574 TGNVVALKKLHGWERDEAIYLKSFQNEVQILSKIRHRNIVKLQGYCLHKRCMFLIYNYMG 633

Query: 302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF 361
           RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDISSNNILL+SK 
Sbjct: 634 RGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDISSNNILLDSKL 693

Query: 362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           +AF++DFGTARLLH DSSN+TLLAGTYGYIAP L
Sbjct: 694 DAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPEL 727

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488983|ref|XP_002277433.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  425 bits (1092), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 214/412 (51%), Positives = 281/412 (68%), Gaps = 17/412 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EIG +KNL +L++G N+L G IPS+ G LT+++ L    NQ +  IP E+ +L  L  L+
Sbjct: 231 EIGGMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPLEIWYLLNLSYLD 290

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS N++SG IP +I ++K L+ LD+SNN I G IP ++  L  + Y NLS N LSG +P+
Sbjct: 291 LSENQISGFIPEEIVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPY 350

Query: 121 S--------------NEQLSSMY---IVRLSPNKGLCGNFSALPSCDATKPATLFVEIFL 163
           S              N +L       +     NKGLCG     P C      TL + + L
Sbjct: 351 SISSNYNKWTLIDLSNNRLEGQTRAPVEAFGHNKGLCGEIKGRPRCKKRHQITLIIVVSL 410

Query: 164 PLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDI 223
              ++ S+ +   L   +R  K   L+     +  +FSIW+YDG I Y+D+I+ATE FDI
Sbjct: 411 STTLLLSIAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDYDGVIAYQDIIQATEDFDI 470

Query: 224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           KYCIGTGGYGSVY+AQLP+GKV ALKKLH  E  +  ++KSF NE Q+L+++ HRNIVKL
Sbjct: 471 KYCIGTGGYGSVYRAQLPSGKVVALKKLHGWERGDPTYLKSFENEVQMLTRIRHRNIVKL 530

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           +GFCLH++CMFL+Y+YME+GSL+C L +  +AVELDW KRVN+VK++A+AL+Y+HHDC  
Sbjct: 531 HGFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDL 590

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            IIHRDISSNNILL+SK EAFV+DFGTARLL  DSSNRTLL GTYGYIAP L
Sbjct: 591 PIIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLVGTYGYIAPEL 642

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359488981|ref|XP_002275364.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  424 bits (1090), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 214/411 (52%), Positives = 281/411 (68%), Gaps = 16/411 (3%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EIG +KNL +L++G N+L G IPS+ G LT+++ L    NQ +  IP E+  L  L  L+
Sbjct: 231 EIGKMKNLNKLNLGYNNLTGVIPSSFGNLTNMNSLSFRGNQISGFIPPEIGHLLNLSYLD 290

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS N++SG IP ++ ++K L+ LD+SNN I G IP ++  L  + Y NLS N LSG +P+
Sbjct: 291 LSENQISGFIPEEMVNLKKLSHLDMSNNLISGKIPSQLGNLKEVKYFNLSHNNLSGTIPY 350

Query: 121 SNEQLSSMYIVRLS----------------PNKGLCGNFSALPSCDATKPATLFVEIFLP 164
           S        ++ LS                 NKGLCG       C      TL + + L 
Sbjct: 351 SISSNYRWTLIDLSNNRLEGQARAPVEAFGHNKGLCGEIKGWARCKKRHQITLIIVVSLS 410

Query: 165 LAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIK 224
             ++ SV +   L   +R  K   L+     +  +FSIW++DG I Y+D+I+ATE FDIK
Sbjct: 411 TTLLLSVAILGFLFHKRRIRKNQLLETTKVKNGDLFSIWDFDGVIAYQDIIQATEDFDIK 470

Query: 225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           YCIGTGGYGSVY+AQLP+GKV ALKKLH  E E+  ++KSF NE Q+L+++ HRNIVKL+
Sbjct: 471 YCIGTGGYGSVYRAQLPSGKVVALKKLHGWEREDPTYLKSFENEVQMLTRIRHRNIVKLH 530

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           GFCLH++CMFL+Y+YME+GSL+C L +  +AVELDW KRVN+VK++A+AL+Y+HHDC   
Sbjct: 531 GFCLHKRCMFLVYKYMEKGSLYCMLRDEVEAVELDWIKRVNVVKSIANALSYMHHDCDLP 590

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           IIHRDISSNNILL+SK EAFV+DFGTARLL  DSSNRTLLAGTYGYIAP L
Sbjct: 591 IIHRDISSNNILLDSKLEAFVSDFGTARLLDNDSSNRTLLAGTYGYIAPEL 641

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484068|ref|XP_002271708.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At1g35710-like [Vitis vinifera]

 Score =  419 bits (1078), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 227/464 (48%), Positives = 296/464 (63%), Gaps = 72/464 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLL------------------------TDLSYLD 36
           EIGNLKNL++L +  N+L+G IPS+LG L                        T+L++L 
Sbjct: 292 EIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPLSFGNLTNLTHLY 351

Query: 37  LSRNQFNSSIP----------------NELTWLTGLLG-------LNLSSNKLSGKIPSQ 73
           L  NQ N SIP                N LT +   LG        N+  N++ G IPS+
Sbjct: 352 LRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIPSLGYLIHLNVFNIRRNRIRGHIPSK 411

Query: 74  IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-------------F 120
           I ++ NLT LD+S+N I+G IP ++  L  L+ LNLS NKLSG +P             F
Sbjct: 412 IGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDF 471

Query: 121 SN--------EQLSSMYIVRL-SPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSV 171
           S+         +L  +Y  R+   NKGLCG    LP C       L + +     I+   
Sbjct: 472 SHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLS---TILFLS 528

Query: 172 IVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGG 231
            V   +L++ RK ++ + KA +T +  +FS+WNYDG+I YED+IEATE FDIKYCIGTGG
Sbjct: 529 FVALGILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGG 588

Query: 232 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 291
           YGSVYKAQLP G V ALKKLH  E +E  ++KSF+NE QVLS++ HRNI+KL+G+CLH++
Sbjct: 589 YGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKR 648

Query: 292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS 351
           CMFLIY+YMERGSL+C L N  +A+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+S
Sbjct: 649 CMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVS 708

Query: 352 SNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           SNNILL+ K +AF++DFGTARLLH DSSN+TLLAGTYGYIAP L
Sbjct: 709 SNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPEL 752

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296085307|emb|CBI29039.3| unnamed protein product [Vitis vinifera]

 Score =  419 bits (1076), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 227/464 (48%), Positives = 296/464 (63%), Gaps = 72/464 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLL------------------------TDLSYLD 36
           EIGNLKNL++L +  N+L+G IPS+LG L                        T+L++L 
Sbjct: 298 EIGNLKNLVQLSLSHNALLGTIPSSLGNLINLTYFHLIDNQIQGLIPLSFGNLTNLTHLY 357

Query: 37  LSRNQFNSSIP----------------NELTWLTGLLG-------LNLSSNKLSGKIPSQ 73
           L  NQ N SIP                N LT +   LG        N+  N++ G IPS+
Sbjct: 358 LRYNQINGSIPPVIWNLKNLIHLRLDHNNLTGVIPSLGYLIHLNVFNIRRNRIRGHIPSK 417

Query: 74  IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-------------F 120
           I ++ NLT LD+S+N I+G IP ++  L  L+ LNLS NKLSG +P             F
Sbjct: 418 IGNLNNLTSLDLSDNLIDGKIPSQLQNLKSLESLNLSHNKLSGHIPPLSIYIHKGSSIDF 477

Query: 121 SN--------EQLSSMYIVRL-SPNKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPSV 171
           S+         +L  +Y  R+   NKGLCG    LP C       L + +     I+   
Sbjct: 478 SHNDFEGHIPHELQFVYPPRVFGHNKGLCGEREGLPHCKRGHKTILIISLS---TILFLS 534

Query: 172 IVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGG 231
            V   +L++ RK ++ + KA +T +  +FS+WNYDG+I YED+IEATE FDIKYCIGTGG
Sbjct: 535 FVALGILLLSRKTRRNQTKATSTKNGDIFSVWNYDGKIAYEDIIEATEDFDIKYCIGTGG 594

Query: 232 YGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK 291
           YGSVYKAQLP G V ALKKLH  E +E  ++KSF+NE QVLS++ HRNI+KL+G+CLH++
Sbjct: 595 YGSVYKAQLPTGNVVALKKLHGWERDEATYLKSFQNEVQVLSKIQHRNIIKLHGYCLHKR 654

Query: 292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS 351
           CMFLIY+YMERGSL+C L N  +A+ELDW KRVN++K++ HAL Y+HHD +P IIHRD+S
Sbjct: 655 CMFLIYKYMERGSLYCVLSNEVEALELDWIKRVNVIKSIVHALCYMHHDSTPPIIHRDVS 714

Query: 352 SNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           SNNILL+ K +AF++DFGTARLLH DSSN+TLLAGTYGYIAP L
Sbjct: 715 SNNILLDFKLDAFLSDFGTARLLHPDSSNQTLLAGTYGYIAPEL 758

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452698|ref|XP_002276923.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  414 bits (1064), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 218/420 (51%), Positives = 279/420 (66%), Gaps = 26/420 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EI  L  L  LD+ +N L G IP  LG L  L+Y DLS N+ +  IP+    L+ L+ L 
Sbjct: 190 EIDTLTELAYLDLSNNVLNGSIPHQLGALAKLTYFDLSWNELSGDIPSSFGHLSNLISLC 249

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP- 119
           L++N+++G IP  I ++++L  LD+S+N I G IP +I  L RL+ LNLS NKLSG +P 
Sbjct: 250 LNNNQINGPIPEDIGNLEDLVDLDLSSNSISGKIPSQIQNLKRLENLNLSRNKLSGAIPP 309

Query: 120 ------------FSNEQLSSMYIVRL---SP------NKGLCGNFSALPSCDATKPATLF 158
                        S   L       L   SP      NK LCG     P C   +  TL 
Sbjct: 310 SLTYDYKWTSIDLSYNDLEGHIPFELQFESPPGVFEHNKHLCGEIRHWPHCKKGQKITLI 369

Query: 159 VEIFLPLAIVPSVIVFACLLVVKRKYKKPK---LKANATNSIGVFSIWNYDGRIVYEDLI 215
           + I L LA +     F   L++ RK +K +     A  T    +FS+W+YDG I Y+D+I
Sbjct: 370 LVISL-LATLCIAFAFLKFLLLPRKMRKMRHMSASAAETRRGDLFSVWDYDGTIAYQDII 428

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           ++TE FDIKYC+G GGYGSVY+AQLP GKV ALKKLH  E EE  ++KSF NEAQ+LS++
Sbjct: 429 QSTENFDIKYCVGVGGYGSVYRAQLPCGKVVALKKLHGWEREEPTYLKSFENEAQILSKI 488

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            HRNIVKL+GFCLHR+ MFL+Y++MERGSLFC L +  +A+ELDW KR+N+VK++AHAL+
Sbjct: 489 RHRNIVKLHGFCLHRRSMFLVYQFMERGSLFCMLSHEVEALELDWTKRLNVVKSIAHALS 548

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y+HHDCSP IIHRDISSNN+LLNS+ EAFV+DFGTARLL  DSS +TLL GTYGYIAP L
Sbjct: 549 YMHHDCSPPIIHRDISSNNVLLNSQLEAFVSDFGTARLLDPDSSIQTLLVGTYGYIAPEL 608

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225465647|ref|XP_002270862.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  413 bits (1062), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 225/465 (48%), Positives = 279/465 (60%), Gaps = 94/465 (20%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP------------- 47
           EIGNLKNL++L +  NSLIG IPS+LG LT+L+YL L  NQ    IP             
Sbjct: 264 EIGNLKNLVQLCLSHNSLIGAIPSSLGHLTNLTYLHLFNNQIQGGIPLSFGHLTNLTDLY 323

Query: 48  ---------------------------NELT--------WLTGLLGLNLSSNKLSGKIPS 72
                                      N LT        +L  L   N+S N++SG+IPS
Sbjct: 324 LCYNQINGSIPPIIWNLKNLIHLRLDHNNLTGVIPSSLGYLIHLHEFNISGNQISGQIPS 383

Query: 73  QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP------------- 119
            I ++ NLT LD+S+N I G IP ++  L RL YLNLS NKLSG +P             
Sbjct: 384 SIGNLNNLTRLDLSDNLIHGKIPSQVQNLKRLVYLNLSHNKLSGSIPTLLIYDHIRPSLD 443

Query: 120 FSNEQLSSMYIVRLSP---------NKGLCGNFSALPSCDATKPATLFVEIFLPLAIVPS 170
            S   L       L           NKGLCG+   LP C      T  +           
Sbjct: 444 LSYNDLEGHIPFELQSKFSQGSFDNNKGLCGDIKGLPHCKEEYKTTRIIT---------- 493

Query: 171 VIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTG 230
                         +K + K   T +  +FS+WNYDG+I YED+I+ATE FDIKYCIGTG
Sbjct: 494 --------------RKIQTKEIPTKNGDIFSVWNYDGKIAYEDIIKATEDFDIKYCIGTG 539

Query: 231 GYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR 290
           GYGSVYKAQLP G V ALKKLH  ET+E  ++KSF+NE Q+LS++ HRNIVKL G+CLH+
Sbjct: 540 GYGSVYKAQLPTGNVVALKKLHGWETDEATYLKSFQNEVQILSKIRHRNIVKLQGYCLHK 599

Query: 291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI 350
           +CMFLIY YM RGSL+C L N  +A+ELDW KRVN+VK++ HA+ Y+HHDC+P IIHRDI
Sbjct: 600 RCMFLIYNYMGRGSLYCVLSNEVEALELDWIKRVNVVKSIVHAVCYMHHDCTPPIIHRDI 659

Query: 351 SSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           SSNNILL+SK +AF++DFGT+RLLH DSSN+TLL+GTYGYIAP L
Sbjct: 660 SSNNILLDSKLDAFLSDFGTSRLLHPDSSNQTLLSGTYGYIAPEL 704

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452749|ref|XP_002277477.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  410 bits (1053), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 218/412 (52%), Positives = 278/412 (67%), Gaps = 18/412 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EIGN+K LI L++ SN+L G IPS+ G LT+L+ L L  NQ +  IP E+ +L  L  L+
Sbjct: 257 EIGNMKKLIFLNLRSNNLTGVIPSSFGNLTNLNSLTLRGNQISGFIPPEIGYLLNLSYLD 316

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP- 119
           LS N++SG IP +I ++K L  LD+SNN I G IP ++  L  ++Y NLS N LSG +P 
Sbjct: 317 LSENQISGFIPEEIVNLKKLGHLDMSNNLIRGKIPSQLGYLKEVEYFNLSHNNLSGTIPH 376

Query: 120 ------------FSNEQLSSMYIV---RLSPNKGLCGNFSALPSCDATKPATLFVEIFLP 164
                        S+ QL S           +KGLCG  + L  C       L V I L 
Sbjct: 377 SISNNYMWTSIDLSHNQLESQSTTPHEAFGHDKGLCGGINGLSHCKKRHQIVLIVVISLS 436

Query: 165 LAIVPSVIVFACLLVVKRKYKKPKL-KANATNSIGVFSIWNYDGRIVYEDLIEATEGFDI 223
             ++ SV      L  K+K +K +L K     +  +FSIW+YDG I Y+D+I+ATE FDI
Sbjct: 437 ATLLLSVTALG-FLFHKQKIRKNQLSKTTKAKNGDLFSIWDYDGTIAYDDIIQATEDFDI 495

Query: 224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           KYCIGTGGYGSVY+AQLP+GKV ALKKLH+ E E+  ++KSF NE Q+LS + HRNIVKL
Sbjct: 496 KYCIGTGGYGSVYRAQLPSGKVVALKKLHSWEREDPTYLKSFENEVQMLSTIQHRNIVKL 555

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           +GFCLH +CMFL+Y+YME+GSL+C L +  + VELDW KRVN+VK++A AL+Y+HHD   
Sbjct: 556 HGFCLHNRCMFLVYKYMEKGSLYCMLRDEVEVVELDWIKRVNVVKSIASALSYMHHDYVM 615

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            IIHRDISSNNILL+SK EA V+DFGTARLL   SSN+TLL GTYGYIAP L
Sbjct: 616 PIIHRDISSNNILLDSKLEACVSDFGTARLLDPYSSNQTLLVGTYGYIAPEL 667

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484063|ref|XP_002270651.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  407 bits (1047), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 218/418 (52%), Positives = 275/418 (65%), Gaps = 24/418 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EIGNLKNL  L++ SN L   IPS+LG LT+L  L L+ N    +IP+ +  L  L   N
Sbjct: 471 EIGNLKNLAALNLSSNYLSSVIPSSLGNLTNLVTLSLTLNSLVGAIPSSVGNLINLTEFN 530

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP- 119
           +  N++ G IP +I ++KN+  LD+S+N I   IP ++  L  L+ LNLS NKLSG +P 
Sbjct: 531 ICGNQIRGCIPFEIGNLKNMASLDLSDNLINVKIPSQLQNLESLENLNLSHNKLSGHIPT 590

Query: 120 ----------FSNEQLSSMYIVRL---------SPNKGLCGNFSALPSCDATKPATLFVE 160
                      S   L     + L         S NKGLCG     P C       L   
Sbjct: 591 LPKYGWLSIDLSYNDLEGHIPIELQLEHSPEVFSYNKGLCGEIKGWPHCKRGHKTMLITT 650

Query: 161 IFLPLAIVPSVIVFACLLV---VKRKYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEA 217
           I +   +     VF  LL+   +++   K  LK N  N   +FSIWNYDG+I YED+IEA
Sbjct: 651 IAISTILFLLFAVFGFLLLSRKMRQNQTKTPLKKNEKNG-DIFSIWNYDGKIAYEDIIEA 709

Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           TE FDIKYCIGTGGYG+VYKAQLP G V ALKKLH  E +E  + KSF+NE QVLS++ H
Sbjct: 710 TEDFDIKYCIGTGGYGTVYKAQLPTGNVVALKKLHGWERDEATYFKSFQNEVQVLSKIQH 769

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           RNI+KL+G+CLH++CMFLIY+YMERGSLF  L N  +A+ELDW KRVN+VK++ HAL Y+
Sbjct: 770 RNIIKLHGYCLHKRCMFLIYKYMERGSLFGVLSNEVEALELDWIKRVNVVKSIVHALCYM 829

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           HHD +  IIHRDISS+NILL+SK +AF++DFGTARLLH DSSN+T+LAGTYGYIAP L
Sbjct: 830 HHDYTLPIIHRDISSSNILLDSKLDAFLSDFGTARLLHHDSSNQTVLAGTYGYIAPEL 887

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	397
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.972	0.369	0.392	4.5e-71
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.969	0.343	0.399	5.1e-67
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.465	0.164	0.466	3.2e-55
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.458	0.165	0.483	5.6e-55
TAIR|locus:2207056	1095	PSY1R "PSY1 receptor" [Arabido	0.448	0.162	0.469	7.3e-54
TAIR|locus:2058759	589	FEI2 "FEI 2" [Arabidopsis thal	0.481	0.324	0.442	3.7e-52
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.969	0.349	0.352	4.1e-52
UNIPROTKB|Q942F3	1121	P0480C01.18-1 "cDNA clone:J033	0.445	0.157	0.443	7.6e-52
TAIR|locus:2092810	1164	BRL3 "BRI1-like 3" [Arabidopsi	0.455	0.155	0.421	2.1e-51
TAIR|locus:2020457	1166	BRL1 "BRI1 like" [Arabidopsis	0.455	0.155	0.424	1.3e-50

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 4.5e-71, P = 4.5e-71
 Identities = 160/408 (39%), Positives = 229/408 (56%)

Query:     5 LKNLIELDVGSNSLIGPIPXXXXXXXXXXXXXXXRNQFNSSIPNEXXXXXXXXXXXXXXX 64
             L NL  LD+ SN     IP               RN  + +IP                 
Sbjct:   549 LTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYN 608

Query:    65 XXXXXIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
                  I SQ  S++NL  LD+S+N + G IP    ++  L ++++S N L GP+P  N  
Sbjct:   609 QLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIP-DNAA 667

Query:   125 LSSMYIVRLSPNKGLCGNFSA---LPSCDAT------KPATLFVEIFLPLA---IVPSVI 172
               +        NK LCG+ +    L  C  T      K   L + I +P+    I+ SV 
Sbjct:   668 FRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVC 727

Query:   173 --VFACXXXXXXXXXXXXXXANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTG 230
               +F C               +   ++ +FS   +DG++ Y+++I+AT  FD KY IGTG
Sbjct:   728 AGIFICFRKRTKQIEEHTDSESGGETLSIFS---FDGKVRYQEIIKATGEFDPKYLIGTG 784

Query:   231 GYGSVYKAQLPNGKVFALKKLHTSETEELA---FIKSFRNEAQVLSQVLHRNIVKLYGFC 287
             G+G VYKA+LPN  + A+KKL+ +    ++     + F NE + L+++ HRN+VKL+GFC
Sbjct:   785 GHGKVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFC 843

Query:   288 LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH 347
              HR+  FL+YEYMERGSL   L N+++A +LDW KR+N+VK +AHAL+Y+HHD SP+I+H
Sbjct:   844 SHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVH 903

Query:   348 RDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
             RDISS NILL   +EA ++DFGTA+LL  DSSN + +AGTYGY+AP L
Sbjct:   904 RDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPEL 951

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 688 (247.2 bits), Expect = 5.1e-67, P = 5.1e-67
 Identities = 160/401 (39%), Positives = 223/401 (55%)

Query:     5 LKNLIELDVGSNSLIGPIPXXXXXXXXXXXXXXXRNQFNSSIPNEXXXXXXXXXXXXXXX 64
             L NL  LD+ SN+    IP               RN+F+ SIP                 
Sbjct:   629 LTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLTQLDLSHN 687

Query:    65 XXXXXIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
                  IPSQ++S+++L  LD+S+N + G IP     +  L  +++S+NKL GP+P     
Sbjct:   688 QLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLP-DTPT 746

Query:   125 LSSMYIVRLSPNKGLCGNF--SALPSC-DATKP---ATLFVEIFLPLAIVPSVIVFACXX 178
                     L  N GLC N     L  C +  KP     L V I +P+  V  VI+  C  
Sbjct:   747 FRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILVPILGV-LVILSICAN 805

Query:   179 XXXX--XXXXXXXXANATNSIGV-FSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSV 235
                            N     G   SI++ DG+  Y+D+IE+T  FD  + IGTGGY  V
Sbjct:   806 TFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKV 865

Query:   236 YKAQLPNGKVFALKKLHTSETEELA--FIKS-FRNEAQVLSQVLHRNIVKLYGFCLHRKC 292
             Y+A L +  + A+K+LH +  EE++   +K  F NE + L+++ HRN+VKL+GFC HR+ 
Sbjct:   866 YRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRH 924

Query:   293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 352
              FLIYEYME+GSL   L N+E+A  L W KR+N+VK +AHAL+Y+HHD    I+HRDISS
Sbjct:   925 TFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISS 984

Query:   353 NNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              NILL++ + A ++DFGTA+LL  DSSN + +AGTYGY+AP
Sbjct:   985 GNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAP 1025

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 3.2e-55, Sum P(2) = 3.2e-55
 Identities = 90/193 (46%), Positives = 117/193 (60%)

Query:   208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE----TEELAFIK 263
             R   +D++EAT+GF   Y +G G  G+VYKA +P+GK  A+KKL ++             
Sbjct:   806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865

Query:   264 SFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWA 321
             SFR E   L ++ HRNIV+LY FC H+      L+YEYM RGSL   LH  +    +DW 
Sbjct:   866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSH-SMDWP 924

Query:   322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-SSN 380
              R  I    A  LAYLHHDC P IIHRDI SNNIL++  FEA V DFG A+++    S +
Sbjct:   925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKS 984

Query:   381 RTLLAGTYGYIAP 393
              + +AG+YGYIAP
Sbjct:   985 VSAVAGSYGYIAP 997

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 446 (162.1 bits), Expect = 5.6e-55, Sum P(2) = 5.6e-55
 Identities = 89/184 (48%), Positives = 115/184 (62%)

Query:   211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 270
             Y+ L++AT  F     +G G  G+VYKA++  G+V A+KKL+ S  E  +   SFR E  
Sbjct:   789 YQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLN-SRGEGASSDNSFRAEIS 847

Query:   271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
              L ++ HRNIVKLYGFC H+    L+YEYM +GSL   L   E    LDW  R  I    
Sbjct:   848 TLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGA 907

Query:   331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-SSNRTLLAGTYG 389
             A  L YLHHDC P I+HRDI SNNILL+ +F+A V DFG A+L+    S + + +AG+YG
Sbjct:   908 AEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYG 967

Query:   390 YIAP 393
             YIAP
Sbjct:   968 YIAP 971

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 409 (149.0 bits), Expect = 7.3e-54, Sum P(3) = 7.3e-54
 Identities = 86/183 (46%), Positives = 116/183 (63%)

Query:   213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 272
             +L++AT+ F     IG GG+G VYKA L NG   A+KKL T +   +   K F+ E +VL
Sbjct:   795 ELLKATDNFSQANIIGCGGFGLVYKATLDNGTKLAVKKL-TGDYGMME--KEFKAEVEVL 851

Query:   273 SQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMA 331
             S+  H N+V L G+C+H     LIY +ME GSL   LH N E   +LDW KR+NI++  +
Sbjct:   852 SRAKHENLVALQGYCVHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIMRGAS 911

Query:   332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
               LAY+H  C P I+HRDI S+NILL+  F+A+VADFG +RL+    ++ T  L GT GY
Sbjct:   912 SGLAYMHQICEPHIVHRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGY 971

Query:   391 IAP 393
             I P
Sbjct:   972 IPP 974

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP

GO:0004888 "transmembrane signaling receptor activity" evidence=IMP

GO:0009611 "response to wounding" evidence=IGI

GO:0031347 "regulation of defense response" evidence=IGI

TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 411 (149.7 bits), Expect = 3.7e-52, Sum P(2) = 3.7e-52
 Identities = 88/199 (44%), Positives = 125/199 (62%)

Query:   198 GVFSIWNYDGRIVY--EDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE 255
             G  SI  + G + Y  +D+I+  E  + ++ IG GG+G+VYK  + +G VFALK++   +
Sbjct:   279 GGASIVMFHGDLPYASKDIIKKLESLNEEHIIGCGGFGTVYKLSMDDGNVFALKRI--VK 336

Query:   256 TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDA 315
               E  F + F  E ++L  + HR +V L G+C       L+Y+Y+  GSL   LH   + 
Sbjct:   337 LNE-GFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLLLYDYLPGGSLDEALHKRGE- 394

Query:   316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
              +LDW  RVNI+   A  LAYLHHDCSP IIHRDI S+NILL+   EA V+DFG A+LL 
Sbjct:   395 -QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSNILLDGNLEARVSDFGLAKLLE 453

Query:   376 ADSSN-RTLLAGTYGYIAP 393
              + S+  T++AGT+GY+AP
Sbjct:   454 DEESHITTIVAGTFGYLAP 472

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009664 "plant-type cell wall organization" evidence=RCA;IMP

GO:0009826 "unidimensional cell growth" evidence=IMP

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 550 (198.7 bits), Expect = 4.1e-52, P = 4.1e-52
 Identities = 146/414 (35%), Positives = 200/414 (48%)

Query:     1 EIGNLKNLIELDVGSNSLIGPIPXXXXXXXXXXXXXXXRNQFNSSIPNEXXXXXXXXXXX 60
             E+G+L  L  L + +N+L G IP                N FN SIP E           
Sbjct:   572 EVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIAL 631

Query:    61 XXXXXXXXX-IPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
                       IP +++++  L +L ++NN + G IP     LS L   N S N L+GP+P
Sbjct:   632 NLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP 691

Query:   120 FSNEQLSSMYIVRLSPNKGLCG---NFSA-----LPSCDATKPATLFVE--IFLPLAIVP 169
                    S +I     N+GLCG   N         PS    KP  +     I +  A++ 
Sbjct:   692 LLRNISMSSFI----GNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIG 747

Query:   170 SV-------IVFACXXXXXXXXXXXXXXANATNSIGVFSIWNYDGRIVYEDLIEATEGFD 222
              V       IV+                  +  S+ ++     +G   ++DL+ AT+ FD
Sbjct:   748 GVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIY-FPPKEG-FTFQDLVAATDNFD 805

Query:   223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNI 280
               + +G G  G+VYKA LP G   A+KKL ++           SFR E   L  + HRNI
Sbjct:   806 ESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNI 865

Query:   281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
             VKL+GFC H+    L+YEYM +GSL   LH  + +  LDW+KR  I    A  LAYLHHD
Sbjct:   866 VKLHGFCNHQGSNLLLYEYMPKGSLGEILH--DPSCNLDWSKRFKIALGAAQGLAYLHHD 923

Query:   341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAP 393
             C P I HRDI SNNILL+ KFEA V DFG A+++    S + + +AG+YGYIAP
Sbjct:   924 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAP 977

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 384 (140.2 bits), Expect = 7.6e-52, Sum P(3) = 7.6e-52
 Identities = 82/185 (44%), Positives = 118/185 (63%)

Query:   213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKL-HTSETEELAFIKSFRNEAQV 271
             DL+EAT GF I   IG+GG+G VYKAQL +GKV A+KKL H S   +    + F  E + 
Sbjct:   799 DLVEATNGFHIACQIGSGGFGDVYKAQLKDGKVVAIKKLIHVSGQGD----REFTAEMET 854

Query:   272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAM 330
             + ++ HRN+V L G+C   +   L+Y+YM+ GSL   LH+ +    +L+W  R  I    
Sbjct:   855 IGKIKHRNLVPLLGYCKAGEERLLVYDYMKFGSLEDVLHDRKKIGKKLNWEARRKIAVGA 914

Query:   331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTY 388
             A  LA+LHH+C P IIHRD+ S+N+L++ + EA V+DFG ARL+    ++ ++  LAGT 
Sbjct:   915 ARGLAFLHHNCIPHIIHRDMKSSNVLIDEQLEARVSDFGMARLMSVVDTHLSVSTLAGTP 974

Query:   389 GYIAP 393
             GY+ P
Sbjct:   975 GYVPP 979

GO:0001578 "microtubule bundle formation" evidence=IMP

GO:0009647 "skotomorphogenesis" evidence=IMP

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 372 (136.0 bits), Expect = 2.1e-51, Sum P(3) = 2.1e-51
 Identities = 81/192 (42%), Positives = 117/192 (60%)

Query:   208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSETEELAFIKSF 265
             ++ +  L+EAT GF     IG+GG+G VYKA+L +G V A+KKL   T + +     + F
Sbjct:   845 KLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLADGSVVAIKKLIQVTGQGD-----REF 899

Query:   266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN--EDAVELDWAKR 323
               E + + ++ HRN+V L G+C   +   L+YEYM+ GSL   LH    +  + LDW+ R
Sbjct:   900 MAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSAR 959

Query:   324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
               I    A  LA+LHH C P IIHRD+ S+N+LL+  F A V+DFG ARL+ A  ++ ++
Sbjct:   960 KKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSV 1019

Query:   384 --LAGTYGYIAP 393
               LAGT GY+ P
Sbjct:  1020 STLAGTPGYVPP 1031

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)]

 Score = 380 (138.8 bits), Expect = 1.3e-50, Sum P(3) = 1.3e-50
 Identities = 82/193 (42%), Positives = 120/193 (62%)

Query:   208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSETEELAFIKSF 265
             ++ +  L+EAT GF  +  +G+GG+G VYKAQL +G V A+KKL   T + +     + F
Sbjct:   846 KLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGD-----REF 900

Query:   266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH---NNEDAVELDWAK 322
               E + + ++ HRN+V L G+C   +   L+YEYM+ GSL   LH   + +  + L+WA 
Sbjct:   901 MAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIYLNWAA 960

Query:   323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
             R  I    A  LA+LHH C P IIHRD+ S+N+LL+  FEA V+DFG ARL+ A  ++ +
Sbjct:   961 RKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLS 1020

Query:   383 L--LAGTYGYIAP 393
             +  LAGT GY+ P
Sbjct:  1021 VSTLAGTPGYVPP 1033

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0009691 "cytokinin biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00031862001 SubName- Full=Chromosome undetermined scaffold_60, whole genome shotgun sequence; (722 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	397
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-40
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-40
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-37
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-30
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-30
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-30
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-28
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-24
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-23
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-22
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-20
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-19
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-19
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-18
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-18
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-18
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-18
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-17
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-17
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	9e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-16
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	6e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-14
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-14
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-14
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-14
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-13
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	8e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	9e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-12
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-11
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	6e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	9e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	9e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-10
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-10
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-10
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	7e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	7e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-10
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-09
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-09
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-08
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-08
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-08
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-08
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-07
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-07
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-07
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-06
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	7e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-06
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-05
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	8e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	7e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	8e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	8e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.001
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.002
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  142 bits (360), Expect = 6e-40
 Identities = 56/174 (32%), Positives = 87/174 (50%), Gaps = 10/174 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           ++I   +G G +G VY A+    GK+ A+K +   + ++    +    E ++L ++ H N
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK--DRERILREIKILKKLKHPN 58

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IV+LY        ++L+ EY E G LF +L      +  D A+    ++ +  AL YLH 
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLF-DLLKKRGRLSEDEARF--YLRQILSALEYLH- 114

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  I+HRD+   NILL+      +ADFG AR L       T   GT  Y+AP
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAP 165

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  151 bits (382), Expect = 8e-40
 Identities = 113/385 (29%), Positives = 182/385 (47%), Gaps = 53/385 (13%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI 70
           L +  N   G +P + G    L  LDLSRNQF+ ++P +L  L+ L+ L LS NKLSG+I
Sbjct: 457 LSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEI 515

Query: 71  PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYI 130
           P +++S K L  LD+S+N++ G IP   +E+  L  L+LS N+LSG +P +   + S+  
Sbjct: 516 PDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ 575

Query: 131 VRLSP-----------------------NKGLCG--NFSALPSC---DATKPATLFVEIF 162
           V +S                        N  LCG    S LP C     T     ++   
Sbjct: 576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCT 635

Query: 163 LPLAIVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIWNYDGR----IVYEDLIEAT 218
           L   +V +++ F    V  R     +LK    N  G + +  +D +    I   D++ + 
Sbjct: 636 LGAFLVLALVAFG--FVFIRGRNNLELK-RVENEDGTWELQFFDSKVSKSITINDILSSL 692

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           +  ++   I  G  G+ YK +     + F +K+++   +   + I           ++ H
Sbjct: 693 KEENV---ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMG-------KLQH 742

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NIVKL G C   K  +LI+EY+E  +L   L N      L W +R  I   +A AL +L
Sbjct: 743 PNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFL 796

Query: 338 HHDCSPSIIHRDISSNNILLNSKFE 362
           H  CSP+++  ++S   I+++ K E
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDE 821

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  135 bits (343), Expect = 2e-37
 Identities = 58/174 (33%), Positives = 87/174 (50%), Gaps = 8/174 (4%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +++   +G+G +G+VYKA+    GK+ A+K L     +      + R E ++L ++ H N
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IV+L      +  ++L+ EY E G LF  L        L   +   I   +   L YLH 
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLH- 115

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  IIHRD+   NILL+      +ADFG A+ L   SS+ T   GT  Y+AP
Sbjct: 116 --SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  134 bits (339), Expect = 2e-37
 Identities = 61/169 (36%), Positives = 92/169 (54%), Gaps = 9/169 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G+VY A+    GK  A+K +   ++     ++    E ++L ++ H NIVKLYG
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYG 58

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                  ++L+ EY E GSL   L  NE   +L   + + I+  +   L YLH   S  I
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGI 113

Query: 346 IHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   NILL+S   +  +ADFG ++LL +D S    + GT  Y+AP
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  121 bits (306), Expect = 3e-32
 Identities = 62/180 (34%), Positives = 90/180 (50%), Gaps = 22/180 (12%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+I   IG GG+G VYKA     GK  A+K +     E+   I    NE Q+L +  H N
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII---NEIQILKKCKHPN 58

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHA 333
           IVK YG  L +  ++++ E+   GSL       +D ++    + +       + K +   
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSL-------KDLLK-STNQTLTESQIAYVCKELLKG 110

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L YLH   S  IIHRDI + NILL S  E  + DFG +  L +D+  R  + GT  ++AP
Sbjct: 111 LEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNTMVGTPYWMAP 166

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (294), Expect = 2e-30
 Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 16/162 (9%)

Query: 227 IGTGGYGSVYKAQLPNGKVF-----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G VYK +L           A+K L    +E+   I+ F  EA+++ ++ H N+V
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNVV 64

Query: 282 KLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           KL G C   + ++++ EYME G L  +  L  N    +L  +  ++    +A  + YL  
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSY--LRKNRP--KLSLSDLLSFALQIARGMEYLE- 119

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
             S + IHRD+++ N L+       ++DFG +R L+ D   R
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYR 159

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  116 bits (293), Expect = 3e-30
 Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 15/162 (9%)

Query: 227 IGTGGYGSVYKAQL----PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G VYK  L       +V  A+K L    +E+   I+ F  EA+++ ++ H NIV
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQ--IEEFLREARIMRKLDHPNIV 64

Query: 282 KLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           KL G C   + + ++ EYM  G L  +  L  N    EL  +  ++    +A  + YL  
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDY--LRKNRPK-ELSLSDLLSFALQIARGMEYLE- 120

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
             S + IHRD+++ N L+       ++DFG +R L+ D   +
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  116 bits (292), Expect = 5e-30
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 18/164 (10%)

Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +G VYK  L         KV A+K L    +EE    + F  EA ++ ++ H NI
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEEE--REEFLEEASIMKKLSHPNI 63

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           V+L G C   + ++++ EYM  G L  F  L  + + + L     + +   +A  + YL 
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDF--LRKHGEKLTLKD--LLQMALQIAKGMEYLE 119

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
              S + +HRD+++ N L+       ++DFG +R ++ D   R 
Sbjct: 120 ---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK 160

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 7e-28
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 15/166 (9%)

Query: 227 IGTGGYGSVYKAQL---PNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VYK +L          A+K L    +EE    K F  EA+V+ ++ H N+V+
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVR 60

Query: 283 LYGFCLHRKCMFLIYEYMERGSL------FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           L G C   + ++L+ EYME G L         +  + +   L     ++    +A  + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           L    S   +HRD+++ N L+       ++DFG +R ++ D   R 
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRK 163

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  109 bits (275), Expect = 1e-27
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 20/177 (11%)

Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +GSVY A     G++ A+K +  S   E   +++   E ++LS + H NIV+ Y
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRYY 65

Query: 285 GFCLHR-KCMFLIY-EYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH 338
           G      K    I+ EY+  GSL   L       E  +     ++    + +   LAYLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-----RKY--TRQILEGLAYLH 118

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
              S  I+HRDI   NIL++S     +ADFG A+ L           + GT  ++AP
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (279), Expect = 2e-26
 Identities = 63/155 (40%), Positives = 90/155 (58%), Gaps = 9/155 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           EIG L +L  LD+  N+L GPIPS+LG L +L YL L +N+ +  IP  +  L  L+ L+
Sbjct: 231 EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS N LSG+IP  +  ++NL  L + +N   G IP  +T L RL  L L SNK SG +P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 121 SNEQLSSMYIVRLSPN-------KGLC--GNFSAL 146
           +  + +++ ++ LS N       +GLC  GN   L
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (258), Expect = 3e-25
 Identities = 59/174 (33%), Positives = 82/174 (47%), Gaps = 8/174 (4%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
            +    +G G  G VYK +  P GK++ALKK+H    EE  F K    E + L       
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE--FRKQLLRELKTLRSCESPY 60

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           +VK YG       + ++ EYM+ GSL   L       E   A    I + +   L YLH 
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY---IARQILKGLDYLHT 117

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                IIHRDI  +N+L+NSK E  +ADFG +++L           GT  Y++P
Sbjct: 118 K--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 3e-24
 Identities = 54/161 (33%), Positives = 82/161 (50%), Gaps = 16/161 (9%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF-IKSFRNEAQVLSQVLHRNIVKLY 284
           IG G YG VYKA+    G++ ALKK+   E E+  F I + R E ++L ++ H NIV+L 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRM-ENEKEGFPITAIR-EIKLLQKLRHPNIVRLK 64

Query: 285 GFCLHRKC--MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
                +    +++++EYM+     L   L + E        K    +K +   L YLH +
Sbjct: 65  EIVTSKGKGSIYMVFEYMDHDLTGL---LDSPEVKFTESQIKC--YMKQLLEGLQYLHSN 119

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
               I+HRDI  +NIL+N+     +ADFG AR     +S  
Sbjct: 120 ---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  101 bits (252), Expect = 7e-24
 Identities = 63/182 (34%), Positives = 90/182 (49%), Gaps = 13/182 (7%)

Query: 220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 278
            + I   +G G +G VY A+    K+ ALK L      +   ++ F  E Q+L+ + H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NIVKLY F      ++L+ EY++ GSL   L        L  ++ + I+  +  AL YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 339 HDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLA------GTYGYI 391
              S  IIHRDI   NILL+       + DFG A+LL    S  ++ A      GT GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 392 AP 393
           AP
Sbjct: 176 AP 177

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 56/174 (32%), Positives = 80/174 (45%), Gaps = 8/174 (4%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + +   IG G +G VYK   L  G   A+K++   + +E   +KS   E  +L  + H N
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPN 60

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IVK  G       +++I EY E GSL   +       E   A     V  +   LAYLH 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV---YVYQVLQGLAYLH- 116

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                +IHRDI + NIL        +ADFG A  L+  S +   + GT  ++AP
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.3 bits (246), Expect = 1e-23
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 20/182 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           ++I   IG G +G VY  +   +GK++ LK++  S   E    +   NE ++L ++ H N
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHPN 60

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLF--------CNLHNNEDAVELDWAKRVNIVKAMA 331
           I+K Y     +  + ++ EY + G L               E+ + LDW   V +  A  
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI-LDWF--VQLCLA-- 115

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
             L YLH   S  I+HRDI   NI L S     + DFG +++L +       + GT  Y+
Sbjct: 116 --LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYL 170

Query: 392 AP 393
           +P
Sbjct: 171 SP 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (255), Expect = 2e-23
 Identities = 56/135 (41%), Positives = 81/135 (60%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           G++ NL  LD+ +N L G IP+ +G  + L  LDL  N     IPN LT LT L  L L+
Sbjct: 137 GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLA 196

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           SN+L G+IP ++  MK+L W+ +  N + G IP EI  L+ L++L+L  N L+GP+P S 
Sbjct: 197 SNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256

Query: 123 EQLSSMYIVRLSPNK 137
             L ++  + L  NK
Sbjct: 257 GNLKNLQYLFLYQNK 271

Length = 968

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 98.1 bits (245), Expect = 3e-23
 Identities = 58/174 (33%), Positives = 83/174 (47%), Gaps = 22/174 (12%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G  G VYKA     GK  A+KK+    + +EL       NE  ++    H NIV  Y
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-----NEILIMKDCKHPNIVDYY 81

Query: 285 GFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
              L    ++++ EYM+ GSL        +  NE  +         + + +   L YLH 
Sbjct: 82  DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQI-------AYVCREVLQGLEYLH- 133

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S ++IHRDI S+NILL+      +ADFG A  L  + S R  + GT  ++AP
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 18/180 (10%)

Query: 220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
            F++   IG G +G V   Q     K+FA+K ++  +  E   +++  NE ++L ++ H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 279 NIVKL-YGFCLHRKCMFLIYEYMERGSLFCNL----HNNEDAVELDWAKRVNIVKAMAHA 333
            +V L Y F    + M+L+ + +  G L  +L      +E+ V+         +  +  A
Sbjct: 61  FLVNLWYSFQ-DEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-------WICEIVLA 112

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L YLH   S  IIHRDI  +NILL+ +    + DF  A  +  D +  T  +GT GY+AP
Sbjct: 113 LEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTSGTPGYMAP 168

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 58/179 (32%), Positives = 87/179 (48%), Gaps = 26/179 (14%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G VY A  L  G++ A+K++   +  +   IK   +E +VL  + H N+VK YG
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRI-QDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLHHDC 341
             +HR+ +++  EY   G+L       E+ +E       ++++         LAYLH   
Sbjct: 67  VEVHREKVYIFMEYCSGGTL-------EELLEHGRILDEHVIRVYTLQLLEGLAYLH--- 116

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-------LAGTYGYIAP 393
           S  I+HRDI   NI L+      + DFG A  L    +N T        LAGT  Y+AP
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL---KNNTTTMGEEVQSLAGTPAYMAP 172

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 96.0 bits (240), Expect = 7e-23
 Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 9/169 (5%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G G +G V   +  + GK++A+K L   +  +   ++    E  +LS++ H  IVKL Y
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F    K ++L+ EY   G LF +  + E     + A+       +  AL YLH   S  
Sbjct: 61  AFQTEEK-LYLVLEYAPGGELF-SHLSKEGRFSEERARF--YAAEIVLALEYLH---SLG 113

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           II+RD+   NILL++     + DFG A+ L ++ S      GT  Y+AP
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =   99 bits (249), Expect = 1e-22
 Identities = 56/136 (41%), Positives = 77/136 (56%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           +IG+  +L  LD+G N L+G IP++L  LT L +L L+ NQ    IP EL  +  L  + 
Sbjct: 159 DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L  N LSG+IP +I  + +L  LD+  N + G IP  +  L  L YL L  NKLSGP+P 
Sbjct: 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP 278

Query: 121 SNEQLSSMYIVRLSPN 136
           S   L  +  + LS N
Sbjct: 279 SIFSLQKLISLDLSDN 294

Length = 968

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 50/148 (33%), Positives = 73/148 (49%), Gaps = 8/148 (5%)

Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G YG VYKA+    G++ ALKK+     EE     + R E  +L ++ H NIVKL 
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALR-EISLLKELKHPNIVKLL 64

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 + ++L++EY +   L   L      +  +  K   I+  +   LAY H   S  
Sbjct: 65  DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKS--IMYQLLRGLAYCH---SHR 118

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTAR 372
           I+HRD+   NIL+N      +ADFG AR
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 58/179 (32%), Positives = 82/179 (45%), Gaps = 21/179 (11%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FDI   +G G YGSVYKA     G+V A+K +   E      ++    E  +L Q     
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPY 59

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           IVK YG       ++++ EY   GS+       N    E+ +         I+      L
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGL 112

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S   IHRDI + NILLN + +A +ADFG +  L    + R  + GT  ++AP
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.2 bits (235), Expect = 5e-22
 Identities = 49/189 (25%), Positives = 90/189 (47%), Gaps = 27/189 (14%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVL 276
           +++   IG G +G+V K +   +GK+   K++     +E E+   +    +E  +L ++ 
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV----SEVNILRELK 57

Query: 277 HRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHN--------NEDAVELDWAKRVNI 326
           H NIV+ Y   + R  + ++++ EY E G L   +           E+ +   W     I
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI---W----RI 110

Query: 327 VKAMAHALAYLHH--DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL 384
           +  +  AL   H+  D   +++HRD+   NI L++     + DFG A++L  DSS     
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170

Query: 385 AGTYGYIAP 393
            GT  Y++P
Sbjct: 171 VGTPYYMSP 179

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.5 bits (233), Expect = 8e-22
 Identities = 51/168 (30%), Positives = 78/168 (46%), Gaps = 9/168 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G  G V K    P GK+ A+K +     E +   K    E  +L +     IV  YG
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKCNSPYIVGFYG 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
              +   + +  EYM+ GSL   L   +  +      ++ +  A+   L YLH      I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHEKHK--I 122

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+  +NIL+NS+ +  + DFG +  L  +S  +T   GT  Y+AP
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKT-FVGTSSYMAP 168

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 54/137 (39%), Positives = 80/137 (58%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E+G +K+L  + +G N+L G IP  +G LT L++LDL  N     IP+ L  L  L  L 
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L  NKLSG IP  I S++ L  LD+S+N + G IP  + +L  L+ L+L SN  +G +P 
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Query: 121 SNEQLSSMYIVRLSPNK 137
           +   L  + +++L  NK
Sbjct: 327 ALTSLPRLQVLQLWSNK 343

Length = 968

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 23/183 (12%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++   IG+G YG VYKA+ +  G++ A+K +     ++   I   + E  +L +  H
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEII---QQEISMLKECRH 59

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----- 332
            NIV  +G  L R  ++++ EY   GSL          +             +A+     
Sbjct: 60  PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---------QIAYVCRET 110

Query: 333 --ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
              LAYLH       IHRDI   NILL    +  +ADFG +  L A  + R    GT  +
Sbjct: 111 LKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167

Query: 391 IAP 393
           +AP
Sbjct: 168 MAP 170

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.4 bits (232), Expect = 2e-20
 Identities = 64/161 (39%), Positives = 80/161 (49%), Gaps = 6/161 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I +L+ LI LD+  NSL G IP  +  L +L  L L  N F   IP  LT L  L  L L
Sbjct: 280 IFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            SNK SG+IP  +    NLT LD+S N + G IP  +     L  L L SN L G +P S
Sbjct: 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS 399

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPSCDATK-PATLFVEI 161
                S+  VRL  N     +FS     + TK P   F++I
Sbjct: 400 LGACRSLRRVRLQDN-----SFSGELPSEFTKLPLVYFLDI 435

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 93.0 bits (231), Expect = 2e-20
 Identities = 54/136 (39%), Positives = 77/136 (56%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + NL +L  L + SN L+G IP  LG +  L ++ L  N  +  IP E+  LT L  L+L
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             N L+G IPS + ++KNL +L +  NK+ G IP  I  L +L  L+LS N LSG +P  
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303

Query: 122 NEQLSSMYIVRLSPNK 137
             QL ++ I+ L  N 
Sbjct: 304 VIQLQNLEILHLFSNN 319

Length = 968

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 87.9 bits (218), Expect = 9e-20
 Identities = 57/172 (33%), Positives = 91/172 (52%), Gaps = 15/172 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLH---RNIV 281
           IG G YG+VY+   +P G+V ALK ++  +  ++++ I+    E  +LSQ+      NI 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ---REVALLSQLRQSQPPNIT 65

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           K YG  L    +++I EY E GS+   +     A  +       I++ +  AL Y+H   
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKV- 120

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              +IHRDI + NIL+ +     + DFG A LL+ +SS R+   GT  ++AP
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 54/193 (27%), Positives = 88/193 (45%), Gaps = 20/193 (10%)

Query: 220 GFDIKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            ++I+ CIG G YG VYKA+  N   GK +A+KK    + +     +S   E  +L ++ 
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 277 HRNIVKLYGFCLHR--KCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           H N+V L    L    K ++L+++Y E         H     V +  +   +++  + + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAG--- 386
           + YLH   S  ++HRD+   NIL+  +        + D G ARL +A    + L      
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL--KPLADLDPV 175

Query: 387 --TYGYIAPGLPL 397
             T  Y AP L L
Sbjct: 176 VVTIWYRAPELLL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 11/152 (7%)

Query: 227 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V +   +LP  K    A+K L    +++      F  EA ++ Q  H NI++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNIIR 69

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L G     + + +I EYME GSL   L  N+   +    + V +++ +A  + YL     
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMNY 127

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              +HRD+++ NIL+NS     V+DFG +R L
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 8/162 (4%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHR 278
           F     IG G + +V  A+     K +A+K L   +  +   +K  + E +VL+++  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            I+KLY      + ++ + EY   G L   +        LD          +  AL YLH
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS---LDEKCTRFYAAEILLALEYLH 119

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
              S  IIHRD+   NILL+      + DFGTA++L  +SS 
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 84.4 bits (209), Expect = 1e-18
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 9/151 (5%)

Query: 222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
            +   IG G +G V        KV A+K L     ++    ++F  EA V++ + H N+V
Sbjct: 9   KLGATIGKGEFGDVMLGDYRGQKV-AVKCLK----DDSTAAQAFLAEASVMTTLRHPNLV 63

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           +L G  L    ++++ EYM +GSL   L +   AV +  A+++     +   + YL    
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE--- 119

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             + +HRD+++ N+L++    A V+DFG A+
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 62/174 (35%), Positives = 91/174 (52%), Gaps = 26/174 (14%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FDI   IG G YG VYKA+    G++ ALKK+     +E   I + R E ++L Q+ HRN
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67

Query: 280 IVKLY----------GFCLHRKCMFLIYEYMER---GSLFCNL-HNNEDAVELDWAKRVN 325
           IV L            F   +   +L++EYM+    G L   L H +ED ++       +
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------S 120

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +K +   L Y H     + +HRDI  +NILLN+K +  +ADFG ARL +++ S
Sbjct: 121 FMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 54/173 (31%), Positives = 78/173 (45%), Gaps = 12/173 (6%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G    VY A  LPN +  A+K++   + +    +   R E Q +SQ  H N+VK Y 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             +    ++L+  Y+  GSL   +  +      LD A    ++K +   L YLH   S  
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLH---SNG 122

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN----RTLLAGTYGYIAP 393
            IHRDI + NILL       +ADFG +  L          R    GT  ++AP
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 58/171 (33%), Positives = 86/171 (50%), Gaps = 9/171 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V K +    G++ A+KK   SE +E     + R E +VL Q+ H NIV L  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKE 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  ++L++EY+ER +L   L  +   +  D  +    +  +  A+AY H   S +I
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRS--YIWQLLQAIAYCH---SHNI 121

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPGL 395
           IHRDI   NIL++      + DFG AR L A  ++  T    T  Y AP L
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.2 bits (209), Expect = 2e-18
 Identities = 58/175 (33%), Positives = 80/175 (45%), Gaps = 22/175 (12%)

Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKL 283
           CIG G +G VYKA      +V A+K +   E E E+  I+    E Q LSQ     I K 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ---QEIQFLSQCRSPYITKY 64

Query: 284 YGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           YG  L    +++I EY   GS         L     A          I++ +   L YLH
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF---------ILREVLLGLEYLH 115

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +     IHRDI + NILL+ + +  +ADFG +  L +  S R    GT  ++AP
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAP 167

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 50/164 (30%), Positives = 83/164 (50%), Gaps = 25/164 (15%)

Query: 227 IGTGGYGSVYKAQ-LPNG---KV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G+G +G+VYK   +P G   K+  A+K L    + +    K   +EA V++ V H ++V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKA--NKEILDEAYVMASVDHPHVV 72

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 337
           +L G CL  +   LI + M  G L   + N++D +     L+W   V I K M+    YL
Sbjct: 73  RLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKDNIGSQYLLNWC--VQIAKGMS----YL 125

Query: 338 --HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
                    ++HRD+++ N+L+ +     + DFG A+LL  D  
Sbjct: 126 EEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 51/155 (32%), Positives = 84/155 (54%), Gaps = 11/155 (7%)

Query: 227 IGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V++   ++P  K    A+K L    TE+    + F +EA ++ Q  H NI++
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHHNIIR 70

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L G     K   +I EYME G+L   L +++   E    + V +++ +A  + YL     
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYL---SD 125

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            + +HRD+++ NIL+NS  E  V+DFG +R+L  D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 42/146 (28%), Positives = 75/146 (51%), Gaps = 9/146 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G+G +G V+  +       A+K +      E  FI+    EA+V+ ++ H N+V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIE----EAKVMMKLSHPNLVQLYGV 67

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F++ EYM  G L   L   +  +  +W   +++   +  A+ YL  +     I
Sbjct: 68  CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---FI 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+++ N L+       V+DFG AR
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 5e-18
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 28/187 (14%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQ 274
           F+I   IG G +G V+K  +  + +V+A+K     K++  E EE        +EA+VL++
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI------DEARVLAK 55

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVK 328
           +    I++ Y   L +  + ++ EY E G L   L         ED V   W   + I+ 
Sbjct: 56  LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQV---WRFFIQILL 112

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
                LA+LH   S  I+HRDI S N+ L++     + D G A+LL  +++    + GT 
Sbjct: 113 G----LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP 165

Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 166 YYLSPEL 172

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 16/177 (9%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +GTG +G V   +   +GK +ALK L  ++  +L  ++   NE ++L  + H  
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAMAHALAYL 337
           +V LYG       ++L+ EY+  G LF +            A+     +V     AL YL
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELF-SHLRKSGRFPEPVARFYAAQVVL----ALEYL 117

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIAP 393
           H      I++RD+   N+LL+S     + DFG A+ +      RT  L GT  Y+AP
Sbjct: 118 HSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYTLCGTPEYLAP 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 17/177 (9%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           I  G YG V+ A+  + G ++A+K +  ++      +     E  +LSQ     +VKLY 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +K ++L+ EY+  G L   L  N  +++ D A+    +  +  AL YLH   S  I
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVAR--IYIAEIVLALEYLH---SNGI 114

Query: 346 IHRDISSNNILLNSKFEAFVADFG---------TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+  +NIL++S     + DFG            L   +  ++ ++ GT  YIAP
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAP 170

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 11/173 (6%)

Query: 223 IKYCIGTGGYGSVYKAQL-PNGK---VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V + +L   GK     A+K L +  TE+    + F +EA ++ Q  H 
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NI+ L G     + + +I E+ME G+L   L  N+   +    + V +++ +A  + YL 
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYL- 122

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
                + +HRD+++ NIL+NS     V+DFG +R L  D+S+ T  +   G I
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 16/172 (9%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G GG+G V   ++    + FALK   K H  ET +   I    +E ++L +  H  IVK
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIF---SEKEILEECNHPFIVK 57

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LY     +K ++++ EY   G L+  L    D    D       +  +  A  YLH+   
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILR---DRGLFDEYTARFYIACVVLAFEYLHNR-- 112

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAP 393
             II+RD+   N+LL+S     + DFG A+ L   S  +T    GT  Y+AP
Sbjct: 113 -GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK--SGQKTWTFCGTPEYVAP 161

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 9/171 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+KA+    G+  ALKK+     E          E + L    H  +VKL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
              H     L+ EYM    L   L + E  +     K    ++ +   +AY+H   +  I
Sbjct: 67  VFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMH---ANGI 120

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPGL 395
           +HRD+   N+L+++     +ADFG ARL   +     +    T  Y AP L
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 54/179 (30%), Positives = 88/179 (49%), Gaps = 22/179 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVK 282
           IG G YG+VYKA+ L  G+  ALKK+    +EE   + + R E  +L Q+    H NIV+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVR 65

Query: 283 LYGFC----LHRKC-MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHAL 334
           L   C      R+  + L++E+++      +L           L      ++++ +   +
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH   S  I+HRD+   NIL+ S  +  +ADFG AR+   + +  T +  T  Y AP
Sbjct: 121 DFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.6 bits (204), Expect = 2e-17
 Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 17/170 (10%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G  G+VYK    P G+++ALK ++ +  +     +    E ++L  V H N+VK + 
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHD 139

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
              H   + ++ E+M+ GSL    H  ++    D A+++         +AYLH      I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLE-GTHIADEQFLADVARQI------LSGIAYLH---RRHI 189

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHA--DSSNRTLLAGTYGYIAP 393
           +HRDI  +N+L+NS     +ADFG +R+L    D  N ++  GT  Y++P
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV--GTIAYMSP 237

Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 19/160 (11%)

Query: 227 IGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +GSV K    + +GK    A+K L   +    A  K F  EA V++Q+ H  IV+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLHH 339
           L G C     M L+ E    G L   L    +    D    A +V      A  +AYL  
Sbjct: 61  LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE- 112

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             S   +HRD+++ N+LL ++ +A ++DFG +R L A S 
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 58/193 (30%), Positives = 84/193 (43%), Gaps = 24/193 (12%)

Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 272
           L + T  F++   IG G YG VYKA     G++ A+K +   E EE    +  + E  +L
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE----EEIKEEYNIL 56

Query: 273 ---SQVLHRNIVKLYGFCL------HRKCMFLIYEYMERGS---LFCNLHNNEDAVELDW 320
              S   H NI   YG  +      +   ++L+ E    GS   L   L      ++ +W
Sbjct: 57  RKYSN--HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114

Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
                I++     LAYLH      +IHRDI   NILL    E  + DFG +  L +    
Sbjct: 115 IAY--ILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 381 RTLLAGTYGYIAP 393
           R    GT  ++AP
Sbjct: 170 RNTFIGTPYWMAP 182

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 80.1 bits (198), Expect = 4e-17
 Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 21/157 (13%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +     GKV   A+K L + +  ++  +  F  EA ++  + H N+++
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDA-----VELDWAKRVNIVKAMAHALAYL 337
           LYG  L    M ++ E    GSL   L  +           D+A  V I   M     YL
Sbjct: 61  LYGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYA--VQIANGMR----YL 113

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
               S   IHRD+++ NILL S  +  + DFG  R L
Sbjct: 114 E---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 16/163 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G VYKA Q+  G+V ALKK+     ++   I + R E ++L ++ H N+V L  
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLID 74

Query: 286 FCLHR--------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             + R          ++++  YM+       L  N   V+L  ++    +  +   + YL
Sbjct: 75  MAVERPDKSKRKRGSVYMVTPYMD--HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYL 131

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           H      I+HRDI + NIL++++    +ADFG AR       N
Sbjct: 132 H---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 60/178 (33%), Positives = 86/178 (48%), Gaps = 18/178 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VY+A+   +G++ ALKK+      +   I S R E  +L  + H NIV+L  
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKE 73

Query: 286 FCL--HRKCMFLIYEYMER--GSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHH 339
             +  H   +FL+ EY E+   SL  N+    +E  V+        ++  +   L YLH 
Sbjct: 74  VVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKC-------LMLQLLRGLQYLHE 126

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +    IIHRD+  +N+LL  K    +ADFG AR     +   T    T  Y AP L L
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 8/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L        AF++    EAQ++ ++ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQ----EAQIMKKLRHDKLVQLYAV 69

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C   + ++++ EYM +GSL   L + E   +L   + V++   +A  +AYL    S + I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLE---SRNYI 125

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ NIL+       +ADFG ARL+  D
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD 156

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 22/163 (13%)

Query: 227 IGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +G V+  +  + +      + A+K L  + + +    K F  EA++L+   H NI
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHENI 70

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSL--FCNLH---------NNEDAVELDWAKRVNIVKA 329
           VK YG C       +++EYME G L  F   H          +    EL  ++ + I   
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +A  + YL    S   +HRD+++ N L+       + DFG +R
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 24/181 (13%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
            +    +GTG +G V+  +   +   +ALK +   E   L   +   NE +VL +V H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH------A 333
           I++L+     ++ ++++ EY+  G LF  L N         + R +    + +      A
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN---------SGRFSNSTGLFYASEIVCA 113

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIA 392
           L YLH   S  I++RD+   NILL+ +    + DFG A+ L     +RT  L GT  Y+A
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR----DRTWTLCGTPEYLA 166

Query: 393 P 393
           P
Sbjct: 167 P 167

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 14/159 (8%)

Query: 227 IGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V   +        G+  A+K L+ S  E       F  E ++L  + H NIV
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIV 69

Query: 282 KLYGFC--LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C     + + LI EY+  GSL   L  + D  +++  + +     +   + YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG- 126

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
             S   IHRD+++ NIL+ S+    ++DFG A++L  D 
Sbjct: 127 --SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 10/165 (6%)

Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           +E T+   +K+ +G G YG VY+          A+K L     E+   ++ F  EA V+ 
Sbjct: 3   MERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMK 57

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           ++ H N+V+L G C      ++I E+M  G+L   L    +  E++    + +   ++ A
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSA 116

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           + YL      + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 12/170 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYKA+    G++ A+KK+      E     + R E ++L ++ H NI+KL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
              H+  ++L++E+M+      +L+    +    L  +   + +  +   LA+ H   S 
Sbjct: 66  VFRHKGDLYLVFEFMDT-----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SH 117

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            I+HRD+   N+L+N++    +ADFG AR   +     T    T  Y AP
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAP 167

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 21/174 (12%)

Query: 227 IGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G VYKAQ     +F A K +     EEL   + F  E  +LS+  H NIV LY 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHH 339
              +   ++++ E+ + G+L        D++ L+  + +       + + M  AL +LH 
Sbjct: 70  AYFYENKLWILIEFCDGGAL--------DSIMLELERGLTEPQIRYVCRQMLEALNFLH- 120

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  +IHRD+ + NILL    +  +ADFG +    +    R    GT  ++AP
Sbjct: 121 --SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 76.9 bits (189), Expect = 7e-16
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)

Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V   + +LP  +    A+K L    TE+    + F +EA ++ Q  H 
Sbjct: 8   IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI+ L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 66  NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV----IQLVGMLRGIASGMKY 121

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 122 L---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 7/146 (4%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G VYK  L      A+K   ++   +L   + F  EA++L Q  H NIVKL G 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK--RKFLQEAEILKQYDHPNIVKLIGV 60

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C+ ++ ++++ E +  GSL   L   ++ + +   K + +    A  + YL    S + I
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLE---SKNCI 115

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+++ N L+       ++DFG +R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 8e-16
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 8/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V++    N    A+K L     +   F+     EAQ++ ++ H  +++LY  
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLA----EAQIMKKLRHPKLIQLYAV 69

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C   + ++++ E M+ GSL   L        L   + +++   +A  +AYL    + + I
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLE---AQNYI 125

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N+L+       VADFG AR++  D
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKED 156

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 15/158 (9%)

Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFEREIEILKSLQHDNIV 68

Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + L+ EY+  GSL   L  + +   LD  K +     +   + YL  
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLG- 125

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             S   +HRD+++ NIL+ S+    + DFG  ++L  D
Sbjct: 126 --SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 47/150 (31%), Positives = 71/150 (47%), Gaps = 2/150 (1%)

Query: 35  LDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSI 94
           L L        IPN+++ L  L  +NLS N + G IP  + S+ +L  LD+S N   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 95  PGEITELSRLDYLNLSSNKLSGPVPFS-NEQLSSMYIVRLSPNKGLCGNFSALPSCDATK 153
           P  + +L+ L  LNL+ N LSG VP +   +L        + N GLCG    L +C    
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG-IPGLRACGPHL 541

Query: 154 PATLFVEIFLPLAIVPSVIVFACLLVVKRK 183
                + I   +++    +V   +   KR+
Sbjct: 542 SVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571

Length = 623

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 59/195 (30%), Positives = 88/195 (45%), Gaps = 52/195 (26%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETE------ELAFIKSFRNEAQ 270
           ++I   +G G YG V+KA      +V ALKK+  +    T+      E+ F++   +   
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD--- 65

Query: 271 VLSQVLHRNIVKLYGFCLHR----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 326
                 H NIVKL    + +    K ++L++EYME      +LH            R NI
Sbjct: 66  ------HPNIVKLLN--VIKAENDKDIYLVFEYME-----TDLHA---------VIRANI 103

Query: 327 VKAMAH---------ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           ++ +           AL Y+H   S ++IHRD+  +NILLNS     +ADFG AR L   
Sbjct: 104 LEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 378 SSNRTLLAGTYGYIA 392
             N      T  Y+A
Sbjct: 161 EENPENPVLTD-YVA 174

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 49/159 (30%), Positives = 86/159 (54%), Gaps = 7/159 (4%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E F ++  +G+G +G V++    N    A+K L + +  +    + F+ E Q L ++ H+
Sbjct: 6   EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHK 62

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +++ L+  C   + +++I E ME+GSL   L + E  V L  A  +++   +A  +AYL 
Sbjct: 63  HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLE 121

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                + IHRD+++ NIL+       VADFG ARL+  D
Sbjct: 122 ---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.6 bits (191), Expect = 3e-15
 Identities = 46/135 (34%), Positives = 74/135 (54%), Gaps = 3/135 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLT-GLLGLNLS 62
           N   ++ +D+   ++ G I S +  L  +  ++LS NQ +  IP+++   +  L  LNLS
Sbjct: 67  NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           +N  +G IP    S+ NL  LD+SNN + G IP +I   S L  L+L  N L G +P S 
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 123 EQLSSMYIVRLSPNK 137
             L+S+  + L+ N+
Sbjct: 185 TNLTSLEFLTLASNQ 199

Length = 968

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.8 bits (184), Expect = 4e-15
 Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 34/174 (19%)

Query: 227 IGTGGYGSVYKAQL--PNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           +G G +G VYK +L  PN +       +  LK+    + ++      FR EA+++S + H
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-----EFRQEAELMSDLQH 67

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVE-----------LDWAKRV 324
            NIV L G C   +   +++EY+  G L  F   ++    V            LD +  +
Sbjct: 68  PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127

Query: 325 NIVKAMAHALAYL--HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           +I   +A  + YL  HH      +HRD+++ N L+       ++DFG +R +++
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 27/158 (17%)

Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKL-----HTSETEELAFIKSFR--NEAQVLSQVLH 277
            +G G +GSVY A+    G++ A+KK+        E   L  +KS R  NE        H
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE--------H 57

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHAL 334
            NIVKL         ++ ++EYME      NL+    +        +   +I+  +   L
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-----GNLYQLMKDRKGKPFSESVIRSIIYQILQGL 112

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           A++H        HRD+   N+L++      +ADFG AR
Sbjct: 113 AHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 74.4 bits (183), Expect = 5e-15
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 21/173 (12%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A     G+  A+KK  L   +  EL F     NE  ++    H NIV++
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHPNIVEM 81

Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL++LH  
Sbjct: 82  YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLAVLKALSFLH-- 132

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +  +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++AP
Sbjct: 133 -AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 57/179 (31%), Positives = 78/179 (43%), Gaps = 27/179 (15%)

Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G  GSV K +L N   +FALK + T    +L   K    E ++        IVK YG
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ--KQILRELEINKSCKSPYIVKYYG 66

Query: 286 FCL--HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN---------IVKAMAHAL 334
             L      + +  EY E GSL        D++     KR           I +++   L
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGKIAESVLKGL 118

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +YLH   S  IIHRDI  +NILL  K +  + DFG +      +S      GT  Y+AP
Sbjct: 119 SYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSFYMAP 172

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 49/143 (34%), Positives = 71/143 (49%), Gaps = 1/143 (0%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  L+NL  L + SN+  G IP  L  L  L  L L  N+F+  IP  L     L  L+L
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S+N L+G+IP  + S  NL  L + +N +EG IP  +     L  + L  N  SG +P  
Sbjct: 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423

Query: 122 NEQLSSMYIVRLSPNKGLCGNFS 144
             +L  +Y + +S N  L G  +
Sbjct: 424 FTKLPLVYFLDISNNN-LQGRIN 445

Length = 968

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 55/168 (32%), Positives = 83/168 (49%), Gaps = 10/168 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YG VYKA+ L  G++ A+K +     ++ + I+    E  ++ +  H NIV  +G
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ---QEIFMVKECKHCNIVAYFG 73

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L R+ +++  EY   GSL    H      EL  A    + +     LAYLH   S   
Sbjct: 74  SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY---VCRETLQGLAYLH---SKGK 127

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +HRDI   NILL    +  +ADFG A  + A  + R    GT  ++AP
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 48/179 (26%), Positives = 91/179 (50%), Gaps = 21/179 (11%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +GTG + S Y+A+ +  G + A+K++     + +E+   +++ R E ++++++ H +I++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHH 339
           + G         L  E+M  GS+   L      ++AV       +N  + +   L+YLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI------INYTEQLLRGLSYLHE 121

Query: 340 DCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTL----LAGTYGYIAP 393
           +    IIHRD+   N+L++S  +   +ADFG A  L A  +        L GT  ++AP
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 16/152 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYKA+     +  ALKK+   + +E     + R E  +L ++ H NIV+L  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQHGNIVRLQD 68

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDC 341
                K ++L++EY++      +L  + D+   D+AK   ++K     +   +AY H   
Sbjct: 69  VVHSEKRLYLVFEYLD-----LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCH--- 119

Query: 342 SPSIIHRDISSNNILLNSKFEAF-VADFGTAR 372
           S  ++HRD+   N+L++ +  A  +ADFG AR
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 71.6 bits (175), Expect = 3e-14
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 7/146 (4%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+K  L +    A+K       +EL     F +EA++L Q  H NIVKL G 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIGV 60

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  R+ ++++ E +  G     L   +D  EL   + V      A  +AYL    S + I
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLE---SKNCI 115

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+++ N L+       ++DFG +R
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+       +  A+K +      E  FI+    EAQV+ ++ H  +V+LYG 
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIE----EAQVMMKLSHPKLVQLYGV 67

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  R  + L++E+ME G L   L              + +   +   +AYL       +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYLRAQRGK--FSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N L+       V+DFG  R +  D
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 12/172 (6%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V K +    G++ A+KK   SE +++    + R E ++L Q+ H N+V L  
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDCSP 343
               +K ++L++E+++  ++  +L    + ++    ++    I++     + + H   S 
Sbjct: 68  VFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILR----GIEFCH---SH 119

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           +IIHRDI   NIL++      + DFG AR L A     T    T  Y AP L
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 45/170 (26%), Positives = 81/170 (47%), Gaps = 10/170 (5%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELA--FIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G +GSVY+   L +G  FA+K++  ++  +     +K    E  +LS++ H NIV+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            G       +++  E +  GSL   L     +            + +   L YLH     
Sbjct: 68  LGTEREEDNLYIFLELVPGGSL-AKLLKKYGS--FPEPVIRLYTRQILLGLEYLH---DR 121

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           + +HRDI   NIL+++     +ADFG A+ +   S  ++   G+  ++AP
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS-FKGSPYWMAP 170

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 19/175 (10%)

Query: 223 IKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +K  +G G +G V+ A+  N    K   L  +   +   LA  K F+ EA++L+ + H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAV-----------ELDWAKRVNI 326
           IVK YG C     + +++EYM+ G L  F   H  +  +           EL  ++ ++I
Sbjct: 69  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128

Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
              +A  + YL    S   +HRD+++ N L+ +     + DFG +R +++    R
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 180

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 70.3 bits (172), Expect = 9e-14
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G+G +G V+  +       A+K ++     E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYGV 67

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  +K ++++ E+ME G L   L   +  +  D    +++ + +   + YL  +   S I
Sbjct: 68  CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SFI 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N L++S     V+DFG  R +  D
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 5/139 (3%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +G   NL  LD+ +N+L G IP  L    +L  L L  N     IP  L     L  + 
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP- 119
           L  N  SG++PS+   +  + +LDISNN ++G I     ++  L  L+L+ NK  G +P 
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470

Query: 120 -FSNEQLSSMYIVRLSPNK 137
            F +++L ++    LS N+
Sbjct: 471 SFGSKRLENL---DLSRNQ 486

Length = 968

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.5 bits (173), Expect = 1e-13
 Identities = 54/173 (31%), Positives = 86/173 (49%), Gaps = 14/173 (8%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIK--SFRNEAQVLSQVLHRNIVKL 283
           IG G YG V+K +    G++ A+KK    E+E+   IK  + R E ++L Q+ H N+V L
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALR-EIRMLKQLKHPNLVNL 65

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HDCS 342
                 ++ + L++EY +  ++   L  N   V     K+  I+     A+ + H H+C 
Sbjct: 66  IEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKK--IIWQTLQAVNFCHKHNC- 121

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              IHRD+   NIL+  + +  + DFG AR+L     + T    T  Y AP L
Sbjct: 122 ---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.5 bits (172), Expect = 1e-13
 Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 24/176 (13%)

Query: 223 IKYCIGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +K  +G G +G V+ A+  N      K+  A+K L  +        K F  EA++L+ + 
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 65

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAV---------ELDWAKRVN 325
           H +IVK YG C+    + +++EYM+ G L  F   H   DAV         EL  ++ ++
Sbjct: 66  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNRPAELTQSQMLH 124

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
           I + +A  + YL    S   +HRD+++ N L+       + DFG +R +++    R
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYR 177

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F++   IG+G YG VYKA+ +  G++ A+K +     E+ A ++    E  ++    H
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ---QEIIMMKDCKH 65

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NIV  +G  L R  +++  E+   GSL    H      E   A    + +     L YL
Sbjct: 66  SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY---VSRETLQGLYYL 122

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S   +HRDI   NILL       +ADFG +  + A  + R    GT  ++AP
Sbjct: 123 H---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAP 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 71.8 bits (176), Expect = 2e-13
 Identities = 44/136 (32%), Positives = 70/136 (51%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + +L  L  L + SN   G IP  LG   +L+ LDLS N     IP  L     L  L L
Sbjct: 328 LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            SN L G+IP  + + ++L  + + +N   G +P E T+L  + +L++S+N L G +   
Sbjct: 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSR 447

Query: 122 NEQLSSMYIVRLSPNK 137
              + S+ ++ L+ NK
Sbjct: 448 KWDMPSLQMLSLARNK 463

Length = 968

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 54/182 (29%), Positives = 89/182 (48%), Gaps = 18/182 (9%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 278
           F++   +G G YG VYK + +  G++ A+K +  +E EE    +  + E  +L +  H R
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE----EEIKLEINMLKKYSHHR 73

Query: 279 NIVKLYGFCL------HRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMA 331
           NI   YG  +      H   ++L+ E+   GS+   + N + +A++ DW     I + + 
Sbjct: 74  NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--AYICREIL 131

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
             LA+LH   +  +IHRDI   N+LL    E  + DFG +  L      R    GT  ++
Sbjct: 132 RGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 392 AP 393
           AP
Sbjct: 189 AP 190

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 54/189 (28%), Positives = 93/189 (49%), Gaps = 24/189 (12%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + ++    I  G YG VY+A+    G++ ALKKL   + +E   I S R E  +L ++ H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63

Query: 278 RNIVKL----YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE-----LDWAKRVNIVK 328
            NIV +     G  L +  ++++ EY+E        H+ +  +E        ++   ++ 
Sbjct: 64  PNIVTVKEVVVGSNLDK--IYMVMEYVE--------HDLKSLMETMKQPFLQSEVKCLML 113

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
            +   +A+LH +    I+HRD+ ++N+LLN++    + DFG AR   +     T L  T 
Sbjct: 114 QLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170

Query: 389 GYIAPGLPL 397
            Y AP L L
Sbjct: 171 WYRAPELLL 179

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 57/171 (33%), Positives = 80/171 (46%), Gaps = 16/171 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       KV A+K +   E E+   I+  + E  VLSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    +++I EY+  GS         D +E   LD  +   I++ +   L YLH   S
Sbjct: 70  SYLKDTKLWIIMEYLGGGSAL-------DLLEPGPLDETQIATILREILKGLDYLH---S 119

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.1 bits (169), Expect = 2e-13
 Identities = 41/146 (28%), Positives = 75/146 (51%), Gaps = 9/146 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMKLSHEKLVQLYGV 67

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ ++++ EYM  G L   L  +    +   ++ + + K +   +AYL    S   I
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLE---SKQFI 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+++ N L++ +    V+DFG +R
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L        AF+     EA ++ Q+ H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRLYA- 68

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            + ++ +++I EYME GSL   L    + ++L   K +++   +A  +A++      + I
Sbjct: 69  VVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+ + NIL++      +ADFG ARL+  +
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDN 155

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 13/139 (9%)

Query: 246 FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL 305
            A+K L    ++     + F  E ++LS++   NI +L G C     + +I EYME G L
Sbjct: 49  VAVKVLRPDASDNAR--EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106

Query: 306 --FCNLHNNEDAVELDWAKR------VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 357
             F   H  E +     +K       + +   +A  + YL    S + +HRD+++ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLV 163

Query: 358 NSKFEAFVADFGTARLLHA 376
              +   +ADFG +R L++
Sbjct: 164 GKNYTIKIADFGMSRNLYS 182

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 17/182 (9%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+I   IG G +G V   ++ N G+V+A+K L+  E  + A    FR E  VL     
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 278 RNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AH 332
           R I  L Y F      ++L+ +Y   G L   L   ED +  D A+     +V A+   H
Sbjct: 61  RWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYI 391
            L Y         +HRDI  +N+LL+      +ADFG+   L AD + ++ +A GT  YI
Sbjct: 120 QLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYI 170

Query: 392 AP 393
           +P
Sbjct: 171 SP 172

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 4e-13
 Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 13/151 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRNIV 281
           +G G Y  VYKA     G++ A+KK+   E +E    + F  + R E ++L ++ H NI+
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINF-TALR-EIKLLQELKHPNII 65

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
            L     H+  + L++E+ME   L   + +    + L  A   + +      L YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH--- 119

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           S  I+HRD+  NN+L+ S     +ADFG AR
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 46/178 (25%), Positives = 79/178 (44%), Gaps = 20/178 (11%)

Query: 226 CIGTGGYGSVYKA-QLPNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
            +G G +G VY    +  G+  A+K++       E    + +   E Q+L  + H  IV+
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLH 338
            YG     + + +  EYM  GS+       +D ++   A    + +     +   + YLH
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSV-------KDQLKAYGALTETVTRKYTRQILEGVEYLH 121

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAP 393
              S  I+HRDI   NIL +S     + DFG ++ L    S+ T +    GT  +++P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 21/174 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+   H  IVKL G
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHH 339
                  ++++ E+   G++        DA+ L+  + +       I + M  AL YLH 
Sbjct: 77  AFYWDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVICRQMLEALQYLH- 127

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  IIHRD+ + N+LL    +  +ADFG +         R    GT  ++AP
Sbjct: 128 --SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 15/151 (9%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYKA+    G++ ALKK+     +E     + R E  +L ++ H NIV+L  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR-EISLLKELNHPNIVRLLD 65

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDC 341
                  ++L++E+++      +L    D+  L       ++K+    +   +AY H   
Sbjct: 66  VVHSENKLYLVFEFLDL-----DLKKYMDSSPLT-GLDPPLIKSYLYQLLQGIAYCH--- 116

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           S  ++HRD+   N+L++ +    +ADFG AR
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 19/180 (10%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHT------SETEELAFIKSFRNEAQVLSQVLHRN 279
           IG+G +GSVY      +G++ A+K++        S+  + + + +   E  +L ++ H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IV+  G  L    + +  EY+  GS+   L NN  A E    +  N V+ +   L YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVR--NFVRQILKGLNYLH- 123

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS------SNRTLLAGTYGYIAP 393
             +  IIHRDI   NIL+++K    ++DFG ++ L A+S        R  L G+  ++AP
Sbjct: 124 --NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 67.7 bits (165), Expect = 8e-13
 Identities = 40/151 (26%), Positives = 76/151 (50%), Gaps = 8/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               + +++I EYM +GSL   L ++E   ++   K ++    +A  +AY+      + I
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERK---NYI 125

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+ + N+L++      +ADFG AR++  +
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDN 156

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 67.6 bits (165), Expect = 8e-13
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN---EAQVLSQVLHRNIVKL 283
           +G G YG+VY      G++ A+K++    +  LA  K +     E  +L  + H NIV+ 
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            G CL    + +  E++  GS+   L+      E  + K     K +   +AYLH++C  
Sbjct: 68  LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            ++HRDI  NN++L       + DFG AR L
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 68.0 bits (166), Expect = 9e-13
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 7/168 (4%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YGSVYK    P G   A+K++   E +E  F      E  +L + +   IV  YG
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKF-NQIIMELDILHKAVSPYIVDFYG 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                  +++  EYM+ GSL            +       I  A+   L +L  +   +I
Sbjct: 67  AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+L+N   +  + DFG +  L A  +   +  G   Y+AP
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI--GCQSYMAP 170

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 15/151 (9%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H NIVKL  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNHPNIVKLLD 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDC 341
                  ++L++E++ +     +L    DA  L     + ++K+    +   LA+ H   
Sbjct: 67  VIHTENKLYLVFEFLHQ-----DLKKFMDASPLSGIP-LPLIKSYLFQLLQGLAFCH--- 117

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 9/156 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 61

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 62  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
                + +HRD+ + NIL+       VADFG ARL+
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 10/168 (5%)

Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G VYK      K V A+K +   E E+   I+  + E  VLSQ     I + YG
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYITRYYG 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L        L+      I++ +   L YLH   S   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYLH---SERK 122

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+ + +  +ADFG A  L      R    GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 54/168 (32%), Positives = 79/168 (47%), Gaps = 10/168 (5%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       +V A+K +   E E+   I+  + E  VLSQ     + K YG
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE--IEDIQQEITVLSQCDSPYVTKYYG 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L     A   D  +   ++K +   L YLH   S   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKK 122

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+ + +  +ADFG A  L      R    GT  ++AP
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 34/74 (45%), Positives = 48/74 (64%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           +I  L++L  +++  NS+ G IP +LG +T L  LDLS N FN SIP  L  LT L  LN
Sbjct: 437 DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILN 496

Query: 61  LSSNKLSGKIPSQI 74
           L+ N LSG++P+ +
Sbjct: 497 LNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 32/178 (17%)

Query: 222 DIKYC--IGTGGYGSVYKAQLPN---GKVF---ALKKLHTSETEELAFIKSFRNEAQVLS 273
           +I+Y   IG G +G V++A+ P     + F   A+K L   E         F+ EA +++
Sbjct: 6   NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMA 63

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN-------------------ED 314
           +  H NIVKL G C   K M L++EYM  G L   L +                     +
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            + L   +++ I K +A  +AYL        +HRD+++ N L+       +ADFG +R
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 9/148 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L        +F++    EAQ++ ++ H  +V+LY  
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE----EAQIMKKLRHDKLVQLYA- 68

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            +  + ++++ EYM +GSL   L +  +   L     V++   +A  +AY+      + I
Sbjct: 69  VVSEEPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLL 374
           HRD+ S NIL+       +ADFG ARL+
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 45/149 (30%), Positives = 80/149 (53%), Gaps = 12/149 (8%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H+NIV+LY 
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLHHDCSP 343
                K + L++EY ++     +L    D+   ++D     + +  +   LA+ H   S 
Sbjct: 67  VLHSDKKLTLVFEYCDQ-----DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SH 118

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +++HRD+   N+L+N   E  +ADFG AR
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 9/148 (6%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +    G++ ALK++H  + EE     + R E  ++ ++ H NIV+L+ 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHL-DAEEGTPSTAIR-EISLMKELKHENIVRLHD 65

Query: 286 FCLHRKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                  + L++EYM++    + + H    A++ +  K  +    +   +A+ H +    
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN---R 120

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTAR 372
           ++HRD+   N+L+N + E  +ADFG AR
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 49/170 (28%), Positives = 84/170 (49%), Gaps = 15/170 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +G+  A+K   L   +  EL F     NE  ++    H+N+V++
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHQNVVEM 83

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           Y   L  + ++++ E+++ G+L     +      L+  +   + +++  AL YLH   S 
Sbjct: 84  YKSYLVGEELWVLMEFLQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLH---SQ 136

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++AP
Sbjct: 137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 19/158 (12%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLSQVLHRNIVKL 283
           IG G YG+VYKA+ P+ G   ALK +     E+   + + R  A  + L    H NIV+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 284 YGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALA 335
              C   +      + L++E++++     +L    D V    L      ++++     L 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +LH +C   I+HRD+   NIL+ S  +  +ADFG AR+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 51/171 (29%), Positives = 81/171 (47%), Gaps = 17/171 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+K+++  +  +   I    NE  V+ +  H NIV    
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII---NEILVMRENKHPNIVNYLD 83

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 84  SYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---S 133

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 65.6 bits (160), Expect = 3e-12
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 24/177 (13%)

Query: 227 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G   KA L     +GK + +K+++ S+       +S R E  VLS + H NIV+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQ 63

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAY 336
                     ++++ +Y E G L+  ++        ED + LDW   V I  A+ H    
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWF--VQICLALKHV--- 117

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             HD    I+HRDI S NI L       + DFG AR+L++         GT  Y++P
Sbjct: 118 --HD--RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/181 (31%), Positives = 84/181 (46%), Gaps = 15/181 (8%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+I   IG G +G V   +L N  KVFA+K L+  E  + A    FR E  VL    +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK----RVNIVKAMAHA 333
           + I  L+        ++L+ +Y   G L   L   ED +  D A+     + I     H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 392
           L Y         +HRDI  +NIL++      +ADFG+   L  D + ++ +A GT  YI+
Sbjct: 121 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 393 P 393
           P
Sbjct: 172 P 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 30/185 (16%)

Query: 223 IKYCIGTGGYGSVYKAQ----LPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +K+ +G G +G V+ A+    LP     + A+K L   E  E A  + F+ EA++L+ + 
Sbjct: 9   LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--KEASESAR-QDFQREAELLTVLQ 65

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRV---------- 324
           H++IV+ YG C   + + +++EYM  G L  F   H   DA  L   + V          
Sbjct: 66  HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSH-GPDAKILAGGEDVAPGQLTLGQM 124

Query: 325 -NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS----S 379
             I   +A  + YL    S   +HRD+++ N L+       + DFG +R +++       
Sbjct: 125 LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 380 NRTLL 384
            RT+L
Sbjct: 182 GRTML 186

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 19/159 (11%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA +++ + H ++V+
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLVR 73

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLH 338
           L G CL    + L+ + M  G L   +H ++D +     L+W   V I K M     YL 
Sbjct: 74  LLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQIAKGMM----YLE 126

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                 ++HRD+++ N+L+ S     + DFG ARLL  D
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 24/181 (13%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F++   +GTG +G V  A+    G+ +A+K L   E  ++  ++    E  +L ++ H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 280 IVKLY-GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---LA 335
           IV +   F    +  FL+ E++  G LF +L            +  N V    HA   LA
Sbjct: 80  IVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKA--------GRFPNDVAKFYHAELVLA 130

Query: 336 --YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIA 392
             YLH   S  II+RD+   N+LL++K    V DFG A+ +     +RT  L GT  Y+A
Sbjct: 131 FEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLA 183

Query: 393 P 393
           P
Sbjct: 184 P 184

Length = 329

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 65.4 bits (160), Expect = 6e-12
 Identities = 34/167 (20%), Positives = 65/167 (38%), Gaps = 30/167 (17%)

Query: 227 IGTGGYGSVYK---AQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +G VY+     +  G+     A+K ++  E   +     F NEA V+ +    ++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN--ENASMRERIEFLNEASVMKEFNCHHV 71

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSL------------FCNLHNNEDAVE-LDWAKRVNIV 327
           V+L G     +   ++ E M +G L                       + +  A  +   
Sbjct: 72  VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEI--- 128

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              A  +AYL    +   +HRD+++ N ++       + DFG  R +
Sbjct: 129 ---ADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 52/180 (28%), Positives = 86/180 (47%), Gaps = 26/180 (14%)

Query: 227 IGTGGYGSVYKAQLPNG-KVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V+  +     K+  +K++     ++ E L    + +NE QVL  + H NI++
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL----AAQNECQVLKLLSHPNIIE 63

Query: 283 LYGFCLHRKCMFLIYEYMERGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
            Y   L  K + ++ EY   G+L       CN   +ED           I+      L  
Sbjct: 64  YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDED----------TILHFFVQILLA 113

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           LHH  +  I+HRD+ + NILL+       + DFG +++L + S   T++ GT  YI+P L
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV-GTPCYISPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 12/160 (7%)

Query: 223 IKYCIGTGGYGSVYKA--QLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           +  CIG G +G VY+     P  +    A+K      +  +   + F  EA ++ Q  H 
Sbjct: 10  LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHP 67

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +IVKL G       ++++ E    G L   L  N+    LD A  +     ++ ALAYL 
Sbjct: 68  HIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE 124

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
              S   +HRDI++ N+L++S     + DFG +R L  +S
Sbjct: 125 ---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 65.1 bits (158), Expect = 7e-12
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 278
           F++   +G G YG VYK + +  G++ A+K +  +  EE    +  + E  +L +  H R
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 63

Query: 279 NIVKLYGFCLHRKC------MFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMA 331
           NI   YG  + +        ++L+ E+   GS+   + N + + ++ +W     I + + 
Sbjct: 64  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 121

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
             L++LH      +IHRDI   N+LL    E  + DFG +  L      R    GT  ++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 178

Query: 392 AP 393
           AP
Sbjct: 179 AP 180

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 59/182 (32%), Positives = 86/182 (47%), Gaps = 17/182 (9%)

Query: 221 FDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELA-FIKSFRNEAQVLSQV 275
           F++   +GTG YG V+  +      +GK++A+K L  +   + A   +  R E QVL  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 276 LHRN-IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI-VKAMAH 332
                +V L Y F    K + LI +Y+  G LF +L   E   E    + V I    +  
Sbjct: 62  RQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVL 116

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYI 391
           AL +LH      II+RDI   NILL+S     + DFG ++  H D   R     GT  Y+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 392 AP 393
           AP
Sbjct: 174 AP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 64.6 bits (157), Expect = 8e-12
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 8/147 (5%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+  +L  +    A+K    +   +L     F  EA++L Q  H NIV+L G
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            C  ++ ++++ E ++ G     L    +   L   + + +V+  A  + YL        
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKHC--- 115

Query: 346 IHRDISSNNILLNSKFEAFVADFGTAR 372
           IHRD+++ N L+  K    ++DFG +R
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 19/173 (10%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H NIVKL   
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 70

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLHHD 340
             +   ++++ E+   G++        DAV L+  + +       + K    AL YLH +
Sbjct: 71  FYYENNLWILIEFCAGGAV--------DAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 123 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 5/178 (2%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
              F I+  IG G +  VYKA  L +G+V ALKK+   E  +    +    E  +L Q+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALA 335
           H N++K     +    + ++ E  + G L   + H  +    +           +  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++H   S  I+HRDI   N+ + +     + D G  R   + ++    L GT  Y++P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 58/181 (32%), Positives = 86/181 (47%), Gaps = 29/181 (16%)

Query: 227 IGTGGYGSVYKAQL----PNGKVFALKKLHTS----ETEELAFIKSFRNEAQVLSQVLHR 278
           +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   +L  V H 
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN---ILEAVKHP 60

Query: 279 NIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHA 333
            IV L Y F    K ++LI EY+  G LF +L       ED      ++   I  A+ H 
Sbjct: 61  FIVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLSE---ISLALEH- 115

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR-LLHADSSNRTLLAGTYGYIA 392
              LH      II+RD+   NILL+++    + DFG  +  +H  +   T   GT  Y+A
Sbjct: 116 ---LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMA 168

Query: 393 P 393
           P
Sbjct: 169 P 169

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 17/180 (9%)

Query: 225 YC----IGTGGYGSVYKAQ-LPNGKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVL 276
           YC    +G G YG V   +   +GK + +KKL   + S  E     K+   EAQ+LSQ+ 
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRER----KAAEQEAQLLSQLK 57

Query: 277 HRNIVKLYGFCLHRKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
           H NIV           + +++  + E G L+  L   +  +  +  + V     +A AL 
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVVEWFVQIAMALQ 116

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           YLH      I+HRD+ + N+ L       V D G AR+L       + L GT  Y++P L
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 20/181 (11%)

Query: 227 IGTGGYGSVYKAQLPNG--KVFALKKLH-------TSETEELAFIKSFRNEAQVLSQVL- 276
           +G+G +G VYK +  N    + ALK+++         + E    I    +E  ++ + L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRV-NIVKAMAH 332
           H NIV+ Y   L    ++++ + +E   L   F +L   +        +R+ NI   M  
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           AL YLH +    I+HRD++ NNI+L    +  + DFG A+      S  T + GT  Y  
Sbjct: 125 ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181

Query: 393 P 393
           P
Sbjct: 182 P 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 54/181 (29%), Positives = 85/181 (46%), Gaps = 21/181 (11%)

Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQV 275
           E  D    IG G  G V  A +   GK  A+KK  L   +  EL F     NE  ++   
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDY 76

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAH 332
            H N+V +Y   L    ++++ E++E G+L     +   NE+ +         +  ++  
Sbjct: 77  HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLSVLR 129

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           AL+YLH   +  +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++A
Sbjct: 130 ALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 393 P 393
           P
Sbjct: 187 P 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 22/161 (13%)

Query: 227 IGTGGYGSVYKAQ---LPNGKV---FALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+          V    A+K L    SE +E  F+     EA ++S+  H+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFL----MEALIMSKFNHQ 69

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHAL 334
           NIV+L G    R   F++ E M  G L   L  N    E    L     +   + +A   
Sbjct: 70  NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFE---AFVADFGTAR 372
            YL        IHRDI++ N LL  K     A +ADFG AR
Sbjct: 130 KYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 11/147 (7%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T + AF+     EA V++Q+ H N+V+L G 
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHSNLVQLLGV 67

Query: 287 CLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL    + + 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE---ANNF 123

Query: 346 IHRDISSNNILLNSKFEAFVADFGTAR 372
           +HRD+++ N+L++    A V+DFG  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82

Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLKALSVLH-- 133

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 47/124 (37%), Positives = 66/124 (53%), Gaps = 5/124 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + NL NL  LD+ S + I  +P  + LL+ L  LDLS N     + + L+ L  L GL 
Sbjct: 181 LLSNLSNLNNLDL-SGNKISDLPPEIELLSALEELDLSNNS-IIELLSSLSNLKNLSGLE 238

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS+NKL   +P  I ++ NL  LD+SNN+I  S    +  L+ L  L+LS N LS  +P 
Sbjct: 239 LSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPL 295

Query: 121 SNEQ 124
               
Sbjct: 296 IALL 299

Length = 394

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 49/115 (42%), Positives = 69/115 (60%), Gaps = 5/115 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTD-LSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           E+  L NL  LD+ +N+ I  IP  +GLL   L  LDLS N+   S+P+ L  L  L  L
Sbjct: 111 ELLELTNLTSLDLDNNN-ITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNL 168

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           +LS N LS  +P  ++++ NL  LD+S NKI   +P EI  LS L+ L+LS+N +
Sbjct: 169 DLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI 221

Length = 394

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.8 bits (152), Expect = 3e-11
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 9/156 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   +   +G G +G V+          A+K L        AF++    EAQ++ ++ H 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQ----EAQIMKKLRHD 61

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V LY   +  + ++++ E+M +GSL  +     D   L   + V++   +A  +AY+ 
Sbjct: 62  KLVPLYA-VVSEEPIYIVTEFMGKGSLL-DFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
                + IHRD+ + NIL+       +ADFG ARL+
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 37/148 (25%), Positives = 77/148 (52%), Gaps = 9/148 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+ A        A+K +          +++F  EA V+  + H  +VKL+  
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHA- 68

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            + ++ +++I E+M +GSL  +   +++  +    K ++    +A  +A++      + I
Sbjct: 69  VVTKEPIYIITEFMAKGSLL-DFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 124

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLL 374
           HRD+ + NIL+++     +ADFG AR++
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 12/169 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNE-AQVLSQVLHRNIVKLY 284
           I  G +GSVY A+    G  FA+K L  S+      + + + E A ++ Q     + KLY
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                +  ++L+ EY+  G    +L      +  DWAK    +  +   +  LH      
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDC-ASLIKTLGGLPEDWAK--QYIAEVVLGVEDLHQR---G 117

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IIHRDI   N+L++      + DFG +R    +        GT  Y+AP
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK----FVGTPDYLAP 162

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 52/181 (28%), Positives = 86/181 (47%), Gaps = 29/181 (16%)

Query: 222 DIKY--CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           DI+Y   +G G  G+VYKA  L   ++ A+K +    T EL   K   +E ++L +    
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ--KQIMSELEILYKCDSP 59

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAH 332
            I+  YG       + +  E+M+ GSL             D  +++       I  A+  
Sbjct: 60  YIIGFYGAFFVENRISICTEFMDGGSL-------------DVYRKIPEHVLGRIAVAVVK 106

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
            L YL    S  I+HRD+  +N+L+N++ +  + DFG +  L  +S  +T + GT  Y+A
Sbjct: 107 GLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL-VNSIAKTYV-GTNAYMA 161

Query: 393 P 393
           P
Sbjct: 162 P 162

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 14/151 (9%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYK +    G++ A+KK+   E+EE     +   E  +L ++ H NIV L  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRL-ESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHALAYLHHDC 341
             +    ++LI+E+     L  +L    D++         +VK+    +   + + H   
Sbjct: 67  VLMQESRLYLIFEF-----LSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           S  ++HRD+   N+L+++K    +ADFG AR
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 50/169 (29%), Positives = 74/169 (43%), Gaps = 13/169 (7%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G+VY A      +V A+KK+  S  +     +    E + L Q+ H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 286 FCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             L     +L+ EY +   S    +H       L   +   I       LAYLH      
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLHSHN--- 141

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +IHRDI + NILL    +  +ADFG+A      +S      GT  ++AP
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAP 186

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 23/183 (12%)

Query: 221 FDIKYCIGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           FD+K  +G G +G V     KA    G ++A+K +  S       +  F  E  +LS   
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM--A 331
              I +L Y F   +  ++L+ EY   G L   L+  ED  + D A+     +V A+   
Sbjct: 60  SPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS-NRTLLAGTYGY 390
           H + Y         +HRDI   N+L++      +ADFG+A  L A+   N  L  GT  Y
Sbjct: 119 HQMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169

Query: 391 IAP 393
           IAP
Sbjct: 170 IAP 172

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.3 bits (151), Expect = 8e-11
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 24/170 (14%)

Query: 222 DIKY--CIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQV- 275
           DIK+   IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 8   DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 65

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAK 322
            H NI+ L G C HR  ++L  EY   G+L   L               N  A  L   +
Sbjct: 66  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            ++    +A  + YL        IHRD+++ NIL+   + A +ADFG +R
Sbjct: 126 LLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 17/171 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+V+ A  +  G+  A+K+++  +  +   I    NE  V+ ++ + NIV    
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII---NEILVMKELKNPNIVNFLD 83

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    +F++ EY+  GSL        D V    +D A+   + +    AL +LH +  
Sbjct: 84  SFLVGDELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+N+LL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 61.7 bits (150), Expect = 8e-11
 Identities = 48/182 (26%), Positives = 88/182 (48%), Gaps = 26/182 (14%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQVLHR 278
           IG G YG VY A  +  G++ A+K++    T        +   +K+ R+E + L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHAL 334
           NIV+  GF    + + +  EY+  GS+   L       E  V           + +   L
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVR-------FFTEQVLEGL 121

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL---LHADSSNRTLLAGTYGYI 391
           AYLH   S  I+HRD+ ++N+L+++     ++DFG ++    ++ +  N + + G+  ++
Sbjct: 122 AYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWM 177

Query: 392 AP 393
           AP
Sbjct: 178 AP 179

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 63.3 bits (154), Expect = 9e-11
 Identities = 29/79 (36%), Positives = 50/79 (63%)

Query: 58  GLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
           GL L +  L G IP+ I+ +++L  +++S N I G+IP  +  ++ L+ L+LS N  +G 
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 118 VPFSNEQLSSMYIVRLSPN 136
           +P S  QL+S+ I+ L+ N
Sbjct: 482 IPESLGQLTSLRILNLNGN 500

Length = 623

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 13/169 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G+VY A+ +   +V A+KK+  S  +     +    E + L ++ H N ++  G
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 286 FCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             L     +L+ EY +   S    +H       L   +   I       LAYLH   S +
Sbjct: 93  CYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAITHGALQGLAYLH---SHN 145

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +IHRDI + NILL    +  +ADFG+A +    +S      GT  ++AP
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAP 190

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 62.0 bits (151), Expect = 9e-11
 Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 22/158 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKK-LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G V+KA+     ++ ALKK L  +E E    I + R E ++L  + H N+V L 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFP-ITALR-EIKILQLLKHENVVNLI 77

Query: 285 GFCLHRKCMF-----LIYEYMERGSLFCN-----LHNNEDAVELDWAKRVNIVKAMAHAL 334
             C  +   +       Y   E    FC      L +N+  V+   ++   ++K + + L
Sbjct: 78  EICRTKATPYNRYKGSFYLVFE----FCEHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGL 132

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            Y+H      I+HRD+ + NIL+       +ADFG AR
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 45/155 (29%), Positives = 83/155 (53%), Gaps = 13/155 (8%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G+V + +    KV A+K +    T +     +F  E  V++++ H+N+V+L G 
Sbjct: 14  IGEGEFGAVLQGEYTGQKV-AVKNIKCDVTAQ-----AFLEETAVMTKLHHKNLVRLLGV 67

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            LH   ++++ E M +G+L   L     A+ +   + +     +A  + YL    S  ++
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTARL--LHADSS 379
           HRD+++ NIL++    A V+DFG AR+  +  D+S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 36/155 (23%), Positives = 72/155 (46%), Gaps = 11/155 (7%)

Query: 227 IGTGGYGSVYKAQLPNG------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +G V+ A+           +  +K L  ++ E L     FR E  +  ++ H+N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENL--QSEFRRELDMFRKLSHKNV 70

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK--AMAHALAY-L 337
           V+L G C   +  ++I EY + G L   L   +   E      ++  +  A+   +A  +
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            H  +   +HRD+++ N L++S+ E  V+    ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 61.5 bits (149), Expect = 1e-10
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 22/173 (12%)

Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 3   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 59

Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL      LI + M  G L   +  ++D +     L+W   V
Sbjct: 60  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 116

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL AD
Sbjct: 117 QIAKGMN----YLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 227 IGTGGYGSVYKAQL-------PNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQV 275
           +G G +G V +A            KV A+K L    H+SE E L       +E +++S +
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALM------SELKIMSHL 95

Query: 276 -LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
             H NIV L G C     + +I EY   G L   L    ++  L     ++    +A  +
Sbjct: 96  GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGM 154

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           A+L    S + IHRD+++ N+LL       + DFG AR +  DS+
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN 196

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 22/176 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG VY A+ L      A+K++   ++     ++    E  + S + HRNIV+  G
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLG 72

Query: 286 FCLHRKCMFLIYEYMERGSL-------FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                    +  E +  GSL       +  L +NE  +           K +   L YLH
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIF-------YTKQILEGLKYLH 125

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +    I+HRDI  +N+L+N+      ++DFGT++ L   +       GT  Y+AP
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 9/178 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+I   IG G +G V   ++ +  +++A+K L+  E  + A    FR E  VL     
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA-HALAY 336
           + I  L+        ++L+ +Y   G L   L   ED +  D A+       +A H++  
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
           LH+      +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+P
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 58/196 (29%), Positives = 85/196 (43%), Gaps = 31/196 (15%)

Query: 204 NYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFI 262
             D   ++ DL E          IG G +G+VY A+ +   +V A+KK+  S  +     
Sbjct: 10  KDDPEKLFTDLRE----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 59

Query: 263 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----- 317
           +    E + L Q+ H N ++  G  L     +L+ EY       C L +  D +E     
Sbjct: 60  QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-------C-LGSASDILEVHKKP 111

Query: 318 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L   +   I       LAYLH   S   IHRDI + NILL       +ADFG+A L+   
Sbjct: 112 LQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168

Query: 378 SSNRTLLAGTYGYIAP 393
           +S      GT  ++AP
Sbjct: 169 NS----FVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 46/154 (29%), Positives = 74/154 (48%), Gaps = 7/154 (4%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F++   IG G +G V+  +    G+V+A+K L  S+  +   I   R E  +L+    
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             IVKLY      + ++L+ EYM  G L  NL   +D    + A+    +  +  AL  +
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEETARF--YIAELVLALDSV 117

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
           H       IHRDI  +NIL+++     +ADFG  
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 54/178 (30%), Positives = 89/178 (50%), Gaps = 19/178 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIV 281
           IG G YG V+KA+ L NG  F ALK++     EE   + + R E  VL  +    H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67

Query: 282 KLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALA 335
           +L+  C   +      + L++E++++  L   L    +  V  +  K  +++  +   L 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +LH   S  ++HRD+   NIL+ S  +  +ADFG AR +++     T +  T  Y AP
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAP 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 17/171 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+K+++  +  +   I    NE  V+ +  + NIV    
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 83

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 84  SYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLH---S 133

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 134 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 29/157 (18%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +V+K +      + ALK++   E EE A   + R E  +L  + H NIV L+ 
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70

Query: 286 FCLHRKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVK-AMAHALA 335
                +C+ L++EY++          G+L   +HN            V I    +   L+
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMS-MHN------------VKIFMFQLLRGLS 117

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           Y H      I+HRD+   N+L+N K E  +ADFG AR
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 13/169 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 286 FCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             L     +L+ EY +   S    +H  +   E++ A    +       LAYLH   S +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAA---VTHGALQGLAYLH---SHN 135

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +IHRD+ + NILL+      + DFG+A ++   +       GT  ++AP
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAP 180

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 59/183 (32%), Positives = 88/183 (48%), Gaps = 19/183 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQV 275
           F++   +GTG YG V+  +       GK++A+K L   +  ++    +  R E QVL  V
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 276 LHRN--IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MA 331
             R   +V L Y F    K + LI +Y+  G LF +L+  E   E      V +  A + 
Sbjct: 62  -RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTE----SEVRVYIAEIV 115

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
            AL +LH      II+RDI   NILL+S+    + DFG ++   A+   R     GT  Y
Sbjct: 116 LALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172

Query: 391 IAP 393
           +AP
Sbjct: 173 MAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 57/173 (32%), Positives = 82/173 (47%), Gaps = 16/173 (9%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V  A+   +GK +A+K   K    + +E   I + RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERN--VLLKNVKHPFLVG 60

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 340
           L Y F    K  F++ +Y+  G LF +L       E     R     A +A AL YLH  
Sbjct: 61  LHYSFQTADKLYFVL-DYVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH-- 113

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S +II+RD+   NILL+S+    + DFG  +     S   +   GT  Y+AP
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 33/129 (25%), Positives = 61/129 (47%), Gaps = 4/129 (3%)

Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 326
           NE  +LS + H NI+  Y   +    + +  EY   G+L+  +   +     +    +  
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWY 106

Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAG 386
           +  +  A++Y+H      I+HRDI + NI L       + DFG +++L ++ S    + G
Sbjct: 107 LFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG 163

Query: 387 TYGYIAPGL 395
           T  Y++P L
Sbjct: 164 TPYYMSPEL 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 59.8 bits (145), Expect = 4e-10
 Identities = 53/176 (30%), Positives = 80/176 (45%), Gaps = 26/176 (14%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G  GSV K + +P G V A K +H      +   K    E Q++ +     IV  YG
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSFYG 70

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-RVNIV----KAMAHALAYL--- 337
             L+   + +  E+M+ GSL        D +        V I+     A+   L YL   
Sbjct: 71  AFLNENNICMCMEFMDCGSL--------DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H      I+HRDI  +NIL+NS+ +  + DFG +  L  +S   T + GT  Y++P
Sbjct: 123 HR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGEL-INSIADTFV-GTSTYMSP 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 23/185 (12%)

Query: 221 FDIKYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQV 275
           F++   +GTG YG V+   K    + GK++A+K L  +   ++   ++  R E  VL  V
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 276 LHRN-IVKL-YGFCLHRKCMFLIYEYMERGSLFCNL----HNNEDAVELDWAKRVNIVKA 329
                +V L Y F    K + LI +Y+  G +F +L    + +ED V             
Sbjct: 62  RQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSEDEVRF-------YSGE 113

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTY 388
           +  AL +LH      I++RDI   NILL+S+    + DFG ++   ++   RT    GT 
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 389 GYIAP 393
            Y+AP
Sbjct: 171 EYMAP 175

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 24/208 (11%)

Query: 199 VFSIWNYDGRIV-YEDLIEATEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLH-TSE 255
           ++ ++ Y+  ++  E L + T+ ++I   IG G YG VYK     +G + A+K L   S+
Sbjct: 1   LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60

Query: 256 TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF-----CNLH 310
            +E   I++  N  Q L    H N+VK YG       MF   + +  G L+     CN  
Sbjct: 61  VDEE--IEAEYNILQSLPN--HPNVVKFYG-------MFYKADKLVGGQLWLVLELCNGG 109

Query: 311 NNEDAVE--LDWAKRVN---IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV 365
           +  + V+  L   +R++   I   +  AL  L H  +  IIHRD+  NNILL ++    +
Sbjct: 110 SVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169

Query: 366 ADFGTARLLHADSSNRTLLAGTYGYIAP 393
            DFG +  L +    R    GT  ++AP
Sbjct: 170 VDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 48/169 (28%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKL-HTSETE--------ELAFIKSFRNEAQVLSQVL 276
           IG+G YG V  A     G+  A+KK+ +  +          E+  ++  R          
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR---------- 57

Query: 277 HRNIVKLYGFCLHRKCM-----FLIYEYMERGSLFCNLHN--------NEDAVELDWAKR 323
           H NI+ L               +++ E ME      +LH          +D ++      
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME-----TDLHKVIKSPQPLTDDHIQY----- 107

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
              +  +   L YLH   S ++IHRD+  +NIL+NS  +  + DFG AR
Sbjct: 108 --FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 10/170 (5%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G GG+G V   Q+   GK++A KKL     ++    +   NE ++L +V  R IV L Y
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 285 GFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            F    K  + L+   M  G L  +++N  +      A+ +     +   L +LH     
Sbjct: 61  AF--ETKDDLCLVMTLMNGGDLKYHIYNVGEPG-FPEARAIFYAAQIICGLEHLHQR--- 114

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            I++RD+   N+LL+      ++D G A  L          AGT GY+AP
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.1 bits (143), Expect = 6e-10
 Identities = 37/128 (28%), Positives = 68/128 (53%), Gaps = 14/128 (10%)

Query: 230 GGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH 289
           G YG ++K ++   KV  L K H + +E      SF   A ++SQ+ H+++V  YG C+ 
Sbjct: 20  GDYGELHKTEVLL-KV--LDKSHRNYSE------SFFEAASMMSQLSHKHLVLNYGVCVC 70

Query: 290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 349
                ++ EY++ GSL   L  N++ + + W  ++ + K +A AL +L       + H +
Sbjct: 71  GDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK---GLTHGN 125

Query: 350 ISSNNILL 357
           + + N+LL
Sbjct: 126 VCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 59.5 bits (144), Expect = 7e-10
 Identities = 48/167 (28%), Positives = 72/167 (43%), Gaps = 35/167 (20%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-- 283
           +G+G YGSV  A     G+  A+KKL      E+   +++R E  +L  + H N++ L  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81

Query: 284 -----------YGFCLHRKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMA 331
                        F       +L+  YM+           +ED V+        +V  M 
Sbjct: 82  VFTSAVSGDEFQDF-------YLVMPYMQTDLQKIMGHPLSEDKVQY-------LVYQML 127

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
             L Y+H   S  IIHRD+   N+ +N   E  + DFG AR  HAD+
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADA 169

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 19/152 (12%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +    G++ ALK++   E EE A   + R EA +L  + H NIV L+ 
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRL-EHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70

Query: 286 FCLHRKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVK----AMAHALAYLHHD 340
               +K + L++EY++     + +               ++ V+     +   LAY H  
Sbjct: 71  IIHTKKTLTLVFEYLDTDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCHQR 122

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
               ++HRD+   N+L++ + E  +ADFG AR
Sbjct: 123 ---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 54/185 (29%), Positives = 88/185 (47%), Gaps = 25/185 (13%)

Query: 219 EGFDIKYCIGTGGYGSV----YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E +D+   IG G +G V    +K+   + KV+A+K L   E  + +    F  E  +++ 
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
                +V+L+      K ++++ EYM  G L  NL +N D  E  WAK       +  AL
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPE-KWAKFYT--AEVVLAL 155

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR------LLHADSSNRTLLAGTY 388
             +H   S  +IHRD+  +N+LL+      +ADFGT        ++  D++      GT 
Sbjct: 156 DAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-----VGTP 207

Query: 389 GYIAP 393
            YI+P
Sbjct: 208 DYISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.0 bits (142), Expect = 8e-10
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 85  SYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLH---S 134

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 56/173 (32%), Positives = 82/173 (47%), Gaps = 16/173 (9%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V  A+   +GK +A+K L        +E   I + RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVG 60

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 340
           L Y F    K ++ + +++  G LF +L       E     R     A +A AL YLH  
Sbjct: 61  LHYSFQTTEK-LYFVLDFVNGGELFFHLQRERSFPE----PRARFYAAEIASALGYLH-- 113

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S +I++RD+   NILL+S+    + DFG  +   A S   T   GT  Y+AP
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 9e-10
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 22/180 (12%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F I   +G GGYG V+ A+  + G++ ALK++  S   +L  ++    E  +L+      
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 280 IVKLYGFCLHRKCMFLIYEYMERG---SLFCNLHN-NEDAVELDWAKRVNIVKAMAHALA 335
           +VKL       + ++L  EY+  G   +L  NL   +ED      A+    V A+ H L 
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDAL-HELG 121

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR--LLHADSSNRTLLAGTYGYIAP 393
           Y+H D  P          N L+++     + DFG ++  + +A+S     + G+  Y+AP
Sbjct: 122 YIHRDLKPE---------NFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAP 167

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 30/178 (16%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V K    P+G + A K +H      L    + RN+     +VLH      IV
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKLIH------LEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHALA 335
             YG       + +  E+M+ GSL        D V L  A R+       I  A+   L 
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSL--------DQV-LKKAGRIPENILGKISIAVLRGLT 113

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 114 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 167

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 55/191 (28%), Positives = 82/191 (42%), Gaps = 39/191 (20%)

Query: 221 FDIKYCIGTGGYGSVY--KAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           ++I   IG G +G +Y  KA+  +     K   L K+   E E      + + E  +L++
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE------ASKKEVILLAK 55

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEY-----------MERGSLFCNLHNNEDAVELDWAKR 323
           + H NIV  +        +F++ EY            +RG LF     +ED + L W   
Sbjct: 56  MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLF-----SEDQI-LSWF-- 107

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRT 382
           V I   + H      HD    I+HRDI S NI L+     A + DFG AR L+       
Sbjct: 108 VQISLGLKHI-----HD--RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160

Query: 383 LLAGTYGYIAP 393
              GT  Y++P
Sbjct: 161 TCVGTPYYLSP 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 28/186 (15%)

Query: 220 GFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQV 275
            F +   +G G YGSVYK + L + + +ALK++     S+ E    +    NE ++L+ V
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV----NEIRILASV 56

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN--------EDAVELDWAKRVNIV 327
            H NI+      L    + ++ EY   G L   +           E  +   W     I 
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEI---W----RIF 109

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGT 387
             +   L  LH      I+HRD+ S NILL +     + D G +++L  + +   +  GT
Sbjct: 110 IQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI--GT 164

Query: 388 YGYIAP 393
             Y+AP
Sbjct: 165 PHYMAP 170

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 21/162 (12%)

Query: 227 IGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G+G +G+VYK   +P+G+      A+K L  + + +    K   +EA V++ V    + 
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSPYVC 72

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 337
           +L G CL      L+ + M  G L   +  N+D +     L+W   V I K M+    YL
Sbjct: 73  RLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQIAKGMS----YL 125

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
                  ++HRD+++ N+L+ S     + DFG ARLL  D +
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 1e-09
 Identities = 34/118 (28%), Positives = 54/118 (45%), Gaps = 11/118 (9%)

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           + N +KLY      K   LI +Y++ G LF  L        L  A+   I++ +  AL  
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---LSEAEVKKIIRQLVEALND 124

Query: 337 LHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH     +IIH DI   N+L + +K   ++ D+G  +++   S       GT  Y +P
Sbjct: 125 LH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSP 175

Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 46/169 (27%), Positives = 74/169 (43%), Gaps = 43/169 (25%)

Query: 226 CIGTGGYGSVYKA-QLPNGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
            IG+G YG V  A    +GK  A+KK+ H  +   LA  ++ R E ++L    H NI+ +
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLA-KRTLR-ELKILRHFKHDNIIAI 69

Query: 284 YGFCL----HRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA-- 333
                      K ++++ + ME      +LH+    ++   E              H   
Sbjct: 70  RDILRPPGADFKDVYVVMDLME-----SDLHHIIHSDQPLTE-------------EHIRY 111

Query: 334 --------LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
                   L Y+H   S ++IHRD+  +N+L+N   E  + DFG AR L
Sbjct: 112 FLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 7/172 (4%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G GG+G V   Q+   GK++A KKL+    ++    +    E ++L++V  R IV L Y
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            F   +  + L+   M  G L  +++N +E+       +       +   L +LH     
Sbjct: 61  AF-QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            II+RD+   N+LL++     ++D G A  L    S     AGT G++AP L
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +   NGK+ ALK +   E E   F      EA +L  + H NIV L+ 
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI--REASLLKGLKHANIVLLHD 70

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHH 339
               ++ + L++EY+   +  C   +        + V+L        +  +   L+Y+H 
Sbjct: 71  IIHTKETLTLVFEYVH--TDLCQYMDKHPGGLHPENVKL-------FLFQLLRGLSYIHQ 121

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
                I+HRD+   N+L++   E  +ADFG AR
Sbjct: 122 R---YILHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 227 IGTGGYGSV--YKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V  Y     N   G++ A+K L     ++      ++ E  +L  + H NIV
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHENIV 69

Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C  +  K + LI EY+  GSL   L  ++    L+ A+ +   + +   +AYLH 
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLH- 124

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             S   IHRD+++ N+LL++     + DFG A+
Sbjct: 125 --SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 27/156 (17%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H NIV L+ 
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 286 FCLHRKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
                K + L++EY+++         G+   N+HN    V+L        +  +   L Y
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSI-NMHN----VKL-------FLFQLLRGLNY 119

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            H      ++HRD+   N+L+N + E  +ADFG AR
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 53/183 (28%), Positives = 86/183 (46%), Gaps = 9/183 (4%)

Query: 213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV 271
           DL    E +++   IG G +G V   +     KV+A+K L   E  + +    F  E  +
Sbjct: 37  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
           ++      +V+L+      + ++++ EYM  G L  NL +N D  E  WA+       + 
Sbjct: 97  MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPE-KWARFYT--AEVV 152

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGY 390
            AL  +H   S   IHRD+  +N+LL+      +ADFGT   ++ +   R   A GT  Y
Sbjct: 153 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 391 IAP 393
           I+P
Sbjct: 210 ISP 212

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 19/159 (11%)

Query: 227 IGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G+G +G+V+K   +P G   K+    K     +    F +   +    +  + H  IV+
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF-QEITDHMLAMGSLDHAYIVR 73

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLH 338
           L G C     + L+ +    GSL  ++  + D+++    L+W   V I K M     YL 
Sbjct: 74  LLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--VQIAKGMY----YLE 126

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                 ++HR++++ NILL S     +ADFG A LL+ D
Sbjct: 127 EHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 64/212 (30%), Positives = 97/212 (45%), Gaps = 38/212 (17%)

Query: 201 SIWNYDGRIVYEDLIEA-------TEGFDIKYCIGTGGYGSVYKAQL----PNGKVFALK 249
           +I N+  R  YE   E         E FD+   IG G +G V   QL     + +V+A+K
Sbjct: 20  NIDNFLSR--YEKAAEKITKLRMKAEDFDVIKVIGRGAFGEV---QLVRHKSSKQVYAMK 74

Query: 250 KLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF 306
            L   E     + AF   F  E  +++      IV+L+      K ++++ EYM  G L 
Sbjct: 75  LLSKFEMIKRSDSAF---FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDL- 130

Query: 307 CNLHNNEDAVELDWAK--RVNIVKAMA--HALAYLHHDCSPSIIHRDISSNNILLNSKFE 362
            NL +N D  E  WA+     +V A+   H++ +         IHRD+  +N+LL+    
Sbjct: 131 VNLMSNYDIPE-KWARFYTAEVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGH 180

Query: 363 AFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
             +ADFGT   + A+   R   A GT  YI+P
Sbjct: 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 53/180 (29%), Positives = 83/180 (46%), Gaps = 11/180 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F++   +G G YG V K +    K + A+KK   SE  E     + R E ++L  +   N
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQEN 61

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IV+L      R  ++L++EY+E+  L       E   E+        V++  + L    H
Sbjct: 62  IVELKEAFRRRGKLYLVFEYVEKNML-------ELLEEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 340 DCSPS-IIHRDISSNNILLNSKFEAFVADFGTAR-LLHADSSNRTLLAGTYGYIAPGLPL 397
            C  + I+HRDI   N+L++      + DFG AR L    ++N T    T  Y +P L L
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 27/199 (13%)

Query: 209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKL---HTSETEELAFIKS 264
           I+++   + ++ ++I   IG G YG V+K     NG   A+K L   H  + E    I++
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEE----IEA 63

Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE-- 317
             N  + LS   H N+VK YG    +       ++L+ E        CN  +  D V+  
Sbjct: 64  EYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLE-------LCNGGSVTDLVKGF 114

Query: 318 LDWAKRVN--IVKAMAH-ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
           L   +R+   I+  + H AL  L H      IHRD+  NNILL ++    + DFG +  L
Sbjct: 115 LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174

Query: 375 HADSSNRTLLAGTYGYIAP 393
            +    R    GT  ++AP
Sbjct: 175 TSTRLRRNTSVGTPFWMAP 193

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 8/171 (4%)

Query: 227 IGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G+VY    K  +   ++  LK++   E      +++   EAQ+LS++ H  IVK
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQA-NQEAQLLSKLDHPAIVK 66

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
            +   L R    +I EY E   L C L   +   +        + +     L  +H+   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT--LSENQVCEWFIQLLLGVHYMHQ 124

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             I+HRD+ + NI L +     + DFG +RLL       T   GT  Y++P
Sbjct: 125 RRILHRDLKAKNIFLKNNLLK-IGDFGVSRLLMGSCDLATTFTGTPYYMSP 174

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 50/187 (26%), Positives = 78/187 (41%), Gaps = 34/187 (18%)

Query: 201 SIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEEL 259
           +IW       Y DL +          +G+G YG+V        G   A+KKL+     EL
Sbjct: 9   TIWEV--PDRYRDLKQ----------VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL 56

Query: 260 AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYM--ERGSLFCNLHN 311
            F K    E ++L  + H N++ L         +      +L+  +M  + G L  +   
Sbjct: 57  -FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115

Query: 312 NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
           +ED ++        +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG A
Sbjct: 116 SEDRIQF-------LVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA 165

Query: 372 RLLHADS 378
           R    DS
Sbjct: 166 R--QTDS 170

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 36/128 (28%), Positives = 65/128 (50%), Gaps = 19/128 (14%)

Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVE----- 317
           F  E ++LS++   NI++L G C+    + +I EYME G L  F + H+ +D  E     
Sbjct: 66  FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 318 ---------LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF 368
                    + ++  +++   +A  + YL    S + +HRD+++ N L+       +ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182

Query: 369 GTARLLHA 376
           G +R L+A
Sbjct: 183 GMSRNLYA 190

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 21/162 (12%)

Query: 227 IGTGGYGSVYKAQLPN------GKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G+G +G VY+    +      G +  A+K L    T++    K F  EA ++S   H N
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           IVKL G CL  +  ++I E ME G L   L +          L   + ++I   +A    
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF-----VADFGTAR 372
           YL        IHRD+++ N L++ K         + DFG AR
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 43/182 (23%), Positives = 78/182 (42%), Gaps = 36/182 (19%)

Query: 227 IGTGGYGSVYKAQ------LPNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G V KA              A+K L  + S +E    +  F     +L QV H 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEF----NLLKQVNHP 63

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAKR 323
           +++KLYG C     + LI EY + GSL   L               + N   ++    + 
Sbjct: 64  HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123

Query: 324 VNIVKAMAHA------LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           + +   ++ A      + YL       ++HRD+++ N+L+    +  ++DFG +R ++ +
Sbjct: 124 LTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180

Query: 378 SS 379
            S
Sbjct: 181 DS 182

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 57/178 (32%), Positives = 80/178 (44%), Gaps = 30/178 (16%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V K Q  P+G + A K +H      L    + RN+     QVLH      IV
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHALA 335
             YG       + +  E+M+ GSL        D V L  AKR+       +  A+   LA
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSL--------DQV-LKEAKRIPEEILGKVSIAVLRGLA 117

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 118 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 10/125 (8%)

Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           F  E +++S++ + NI++L G C+    + +I EYME G L  N   ++  +E  +    
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL--NQFLSQREIESTFTHAN 121

Query: 325 NIVKAMAHALAY--------LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           NI       L Y        + +  S + +HRD+++ N L+ + +   +ADFG +R L++
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 377 DSSNR 381
               R
Sbjct: 182 GDYYR 186

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.9 bits (135), Expect = 7e-09
 Identities = 35/110 (31%), Positives = 64/110 (58%), Gaps = 10/110 (9%)

Query: 248 LKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFC 307
           LK L +   + LAF ++    A ++SQ+ H+++VKLYG C+  + + ++ EY++ G L  
Sbjct: 35  LKVLGSDHRDSLAFFET----ASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDV 89

Query: 308 NLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 357
            LH  ++ V L W  ++++ K +A AL YL       ++H ++   NIL+
Sbjct: 90  FLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 31/158 (19%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK     NG++ ALK +   +TEE     + R EA +L  + H NIV L+ 
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISM-KTEEGVPFTAIR-EASLLKGLKHANIVLLHD 70

Query: 286 FCLHRKCMFLIYEYMER----------GSLF-CNLHNNEDAVELDWAKRVNIVKAMAHAL 334
               ++ +  ++EYM            G L   N+             R+ + + +   L
Sbjct: 71  IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV-------------RLFMFQ-LLRGL 116

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           AY+H      I+HRD+   N+L++   E  +ADFG AR
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.7 bits (134), Expect = 8e-09
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 17/169 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F +   +G G +GSV +AQL     + +  A+K L   +    + I+ F  EA  + +  
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59

Query: 277 HRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNL---HNNEDAVELDWAKRVNIV 327
           H N++KL G  L  +         +I  +M+ G L   L      E+   L     V  +
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
             +A  + YL    S + IHRD+++ N +LN      VADFG ++ +++
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 16/173 (9%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V  A+   +G  +A+K L      + +E   I + RN   +L  + H  +V 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVG 60

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 340
           L Y F    K ++ + +Y+  G LF +L      +E     R     A +A A+ YLH  
Sbjct: 61  LHYSFQTAEK-LYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLH-- 113

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S +II+RD+   NILL+S+    + DFG  +         +   GT  Y+AP
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 21/190 (11%)

Query: 210 VYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNE 268
             EDL +  E       IG G +G+V K    P+G + A+K++  S  +E    +   + 
Sbjct: 2   TAEDLKDLGE-------IGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDL 53

Query: 269 AQVLSQVLHRNIVKLYGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAK-R 323
             V+       IVK YG          CM L+   +++   +          E    K  
Sbjct: 54  DVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
           V  VKA+ +    L       IIHRD+  +NILL+      + DFG +  L  DS  +T 
Sbjct: 114 VATVKALNYLKEELK------IIHRDVKPSNILLDRNGNIKLCDFGISGQL-VDSIAKTR 166

Query: 384 LAGTYGYIAP 393
            AG   Y+AP
Sbjct: 167 DAGCRPYMAP 176

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 6/168 (3%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+   M  G L  ++++  +A   +  + V     +   L  LH +    I
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQE---RI 123

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++RD+   NILL+      ++D G A  +    + +  + GT GY+AP
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 33/119 (27%), Positives = 61/119 (51%), Gaps = 11/119 (9%)

Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHN------NEDAV 316
           F  E +++S++   NI++L   C+    + +I EYME G L  F + H         D V
Sbjct: 66  FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            + ++  + +   +A  + YL    S + +HRD+++ N L+   +   +ADFG +R L+
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 10/111 (9%)

Query: 248 LKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF 306
           LK L  S  +  LAF ++    A ++ QV H++IV LYG C+      ++ E++E G L 
Sbjct: 37  LKVLDPSHRDISLAFFET----ASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD 92

Query: 307 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 357
             +H   D +   W  +  + K +A AL+YL       ++H ++ + NILL
Sbjct: 93  LFMHRKSDVLTTPW--KFKVAKQLASALSYLE---DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 45/162 (27%), Positives = 77/162 (47%), Gaps = 21/162 (12%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V   Q  + G ++A+KKL  S   E E++A +++ R+   +L++  +  +VK
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERD---ILAEADNPWVVK 65

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLH 338
           LY        ++LI EY+  G +   L       E+      A+ +  + ++ H L Y  
Sbjct: 66  LYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI-HKLGY-- 122

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
                  IHRDI  +N+LL++K    ++DFG    L      
Sbjct: 123 -------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 27/170 (15%)

Query: 227 IGTGGYGSVYKAQL-----PNGKV-FALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHR 278
           +G G +G V KA+      PN     A+K L    TE +L+ + S   E +++  +  H+
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS---EMEMMKMIGKHK 76

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL------------FCNLHNNEDAVE-LDWAKRVN 325
           NI+ L G C     ++++ EY   G+L            + +  +     E L     V+
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
               +A  + +L    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 21/176 (11%)

Query: 227 IGTGGYGSVY---KAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V+   K   P+ G+++A+K L  +  +    +++ + E  +L++V H  IVK
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVK 62

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYL 337
           L Y F    K ++LI +++  G LF  L       E+ V+   A+       +A AL +L
Sbjct: 63  LHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE-------LALALDHL 114

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  II+RD+   NILL+ +    + DFG ++             GT  Y+AP
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 55/182 (30%), Positives = 79/182 (43%), Gaps = 36/182 (19%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG+G  G VYK +    G V A+K++  T   EE   I    +   VL       IVK Y
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI--LMDLDVVLKSHDCPYIVKCY 80

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN----------IVKAMAHAL 334
           G+ +    +F+  E M   +    L            KR+           +  A+  AL
Sbjct: 81  GYFITDSDVFICMELM--STCLDKL-----------LKRIQGPIPEDILGKMTVAIVKAL 127

Query: 335 AYL--HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA-RLLHADSSNRTLLAGTYGYI 391
            YL   H     +IHRD+  +NILL++     + DFG + RL+  DS  +T  AG   Y+
Sbjct: 128 HYLKEKH----GVIHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYM 181

Query: 392 AP 393
           AP
Sbjct: 182 AP 183

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 27/156 (17%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +V+K +      + ALK++   E EE A   + R E  +L  + H NIV L+ 
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71

Query: 286 FCLHRKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
                K + L++EY+++         G++  ++HN    V++        +  +   LAY
Sbjct: 72  IVHTDKSLTLVFEYLDKDLKQYMDDCGNIM-SMHN----VKI-------FLYQILRGLAY 119

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            H      ++HRD+   N+L+N + E  +ADFG AR
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEA--QVLSQVLHRNIVKL 283
           IG G YG VYKA+    GK+ ALKK      EE     + R  +  Q+LS+ ++  IV+L
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY--IVRL 66

Query: 284 YGFCLH-------RKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
               +        +  ++L++EY++     F + +       L      + +  +   +A
Sbjct: 67  --LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTAR 372
           + H      ++HRD+   N+L++ +     +AD G  R
Sbjct: 125 HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 16/173 (9%)

Query: 227 IGTGGYGSVYKAQLPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V  A+    + F     L+K    + +E   I S RN   +L  V H  +V 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNVKHPFLVG 60

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHD 340
           L + F    K ++ + +Y+  G LF +L      +E     R     A +A AL YLH  
Sbjct: 61  LHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASALGYLH-- 113

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S +I++RD+   NILL+S+    + DFG  +     +   +   GT  Y+AP
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 11/154 (7%)

Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G +G+V K       + K  A+K L  ++  + A       EA V+ Q+ +  IV++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            G C     M L+ E  E G L   L  N+   E +      +V  ++  + YL      
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMGMKYLEET--- 114

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           + +HRD+++ N+LL ++  A ++DFG ++ L AD
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 43/171 (25%), Positives = 79/171 (46%), Gaps = 28/171 (16%)

Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G   +G VYK  L         +  A+K L   +  E    + F++EA + S++ H NI
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNL-----HNNEDAVE--------LDWAKRVNIV 327
           V L G     + + +I+ Y     L   L     H++  + +        L+ A  V+IV
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 328 KAMAHALAYL--HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
             +A  + +L  HH     ++H+D+++ N+L+  K    ++D G  R ++A
Sbjct: 131 TQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 18/166 (10%)

Query: 227 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H NIV
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 69

Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR--VNIVKAMAHALAYL 337
           K  G C       + LI E++  GSL   L  N++ + L    +  V I K M     YL
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD----YL 125

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
               S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+
Sbjct: 126 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 12/160 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +DI   IG GG G VY A  P   +  ALKK+    +E     K F  EA++ + ++H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN--NEDAVELDWAKR------VNIVKAMA 331
           IV +Y  C     ++    Y+E  +L   L +   ++++  + A++      ++I   + 
Sbjct: 64  IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
             + Y+H   S  ++HRD+  +NILL    E  + D+G A
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 26/171 (15%)

Query: 222 DIKY--CIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           DIK+   IG G +G V +A +       N  +  LK+   SE +     + F  E +VL 
Sbjct: 3   DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDH----RDFAGELEVLC 57

Query: 274 QV-LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWA----------- 321
           ++  H NI+ L G C +R  +++  EY   G+L   L  +   +E D A           
Sbjct: 58  KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSR-VLETDPAFAKEHGTASTL 116

Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
               +++  +     + +      IHRD+++ N+L+     + +ADFG +R
Sbjct: 117 TSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 21/159 (13%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G G +G VY       G+  A+K++       E    + +   E Q+L  +LH  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 284 YGFCLH---RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHALAY 336
           YG CL     + + +  E+M  GS+       +D ++   A   N+ +     +   ++Y
Sbjct: 70  YG-CLRDPMERTLSIFMEHMPGGSI-------KDQLKSYGALTENVTRKYTRQILEGVSY 121

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           LH   S  I+HRDI   NIL +S     + DFG ++ L 
Sbjct: 122 LH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 9e-08
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 14/168 (8%)

Query: 234 SVYKAQLPNGKVFALKKLHTSETEELAFIKSFR-----NEAQVLSQVLHRNIVKLYGFCL 288
           S+ +   P  + FA   +  ++T E   IK+ +      EA +L  + H +I++L G   
Sbjct: 95  SILETFTPGAEGFAFACID-NKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFT 153

Query: 289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 348
           + K   LI     +  L+C L        +     + I +++  A+ YLH +    IIHR
Sbjct: 154 YNKFTCLILPRY-KTDLYCYL---AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHR 206

Query: 349 DISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPGL 395
           DI + NI +N   +  + DFG A      ++N+    AGT    AP L
Sbjct: 207 DIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPEL 254

Length = 391

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.5 bits (126), Expect = 9e-08
 Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 26/158 (16%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY   L   +G+    A+K L  +   +L  ++ F  E  ++    H N++ 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 283 LYGFCLHRKCMFLI-YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM-------AHAL 334
           L G CL  +   L+   YM+ G L  N   +E             VK +       A  +
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLR-NFIRSE--------THNPTVKDLIGFGLQVAKGM 111

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            YL    S   +HRD+++ N +L+  F   VADFG AR
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 51/137 (37%), Positives = 74/137 (54%), Gaps = 6/137 (4%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLG-LNLS 62
           NL  L  LD+  N L   I S L  LT+L+ LDL  N     IP  +  L   L  L+LS
Sbjct: 91  NLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDLDNNNITD-IPPLIGLLKSNLKELDLS 148

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
            NK+   +PS + ++ NL  LD+S N +   +P  ++ LS L+ L+LS NK+S  +P   
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205

Query: 123 EQLSSMYIVRLSPNKGL 139
           E LS++  + LS N  +
Sbjct: 206 ELLSALEELDLSNNSII 222

Length = 394

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 36/170 (21%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK--- 282
           IG G +G V+    P +GK  ALKK+  +  + L   K    E ++L    H N++    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSALD 66

Query: 283 -----LYGFCLHRKCMFLIYEYMERGSLFCNLHN--------NEDAVELDWAKRVNIVKA 329
                          ++++ E M+      +LH         + D V++        +  
Sbjct: 67  ILQPPHIDPFEE---IYVVTELMQ-----SDLHKIIVSPQPLSSDHVKV-------FLYQ 111

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           +   L YLH   S  I+HRDI   N+L+NS     + DFG AR+   D S
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 24/199 (12%)

Query: 204 NYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKV--FALKKLHTSETEELAF 261
               ++ YED       F+    +GTG +G V  A   N      A+K+   S+  +   
Sbjct: 22  KRKNKMKYED-------FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ 74

Query: 262 IKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE---DAVEL 318
           +    +E ++L+ + H   V LYG       ++L+ E++  G  F  L  N+   + V  
Sbjct: 75  VDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
            +A ++ ++        YL    S +I++RD+   N+LL+      + DFG A+++  D+
Sbjct: 135 FYAAQIVLI------FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DT 183

Query: 379 SNRTLLAGTYGYIAPGLPL 397
              T L GT  YIAP + L
Sbjct: 184 RTYT-LCGTPEYIAPEILL 201

Length = 340

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 29/161 (18%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS----QVL----- 276
           IG G +  V KAQ    GK +A+K +           K F++  QV +    Q L     
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM----------KKHFKSLEQVNNLREIQALRRLSP 56

Query: 277 HRNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           H NI++L      RK   + L++E M+  +L+  +   +    L   +  + +  +  +L
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRP--LPEKRVKSYMYQLLKSL 113

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            ++H +    I HRDI   NIL+       +ADFG+ R ++
Sbjct: 114 DHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIY 150

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 21/165 (12%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQ 274
           E F     IG G +G V   Q    GK++A+K L  SE    ++LA +K+ R+   VL++
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERD---VLAE 57

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
                +V LY      + ++LI E++  G L   L      +ED      A+ V  ++A+
Sbjct: 58  SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            H L +         IHRDI  +NIL++      ++DFG +   H
Sbjct: 118 -HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 28/166 (16%)

Query: 227 IGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-N 279
           IG G +G V KA++       +  +  +K+ + S+ +     + F  E +VL ++ H  N
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDH----RDFAGELEVLCKLGHHPN 57

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNI 326
           I+ L G C HR  ++L  EY   G+L   L  +               A  L   + ++ 
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
              +A  + YL        IHRD+++ NIL+   + A +ADFG +R
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 47.9 bits (115), Expect = 1e-07
 Identities = 19/56 (33%), Positives = 28/56 (50%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           L+LS+N+L+         + NL  LD+S N +    P   + L  L  L+LS N L
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G GG+G V   Q+ N GK++A KKL     ++ +  K    E ++L +V    IV L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +  + L+   M  G L  +++N      L+  + ++    +   + +LH   S  
Sbjct: 61  AF-ESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLH---SMD 115

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I++RD+   N+LL+ +    ++D G A  L  D    T  AGT GY+AP
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAP 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 23/160 (14%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN-------------EAQVL 272
           +G G YG V KA     GK+ A+KK+   E      +   R              E +++
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEIS--NDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 273 SQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           +++ H NI+ L    +    + L+ + M    L   +      + L  ++   I+  + +
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILN 130

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            L  LH       +HRD+S  NI +NSK    +ADFG AR
Sbjct: 131 GLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 3/174 (1%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           ++K Y   +    + ++ E  + G L   + + +    L   K V   K      + L H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTV--WKYFVQLCSALEH 121

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++P
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 51/200 (25%), Positives = 82/200 (41%), Gaps = 39/200 (19%)

Query: 213 DLIEATEGFDIKY----CIGTGGYGSVYKAQLPNGKV-FALKKLHTS-ETEELAFIKSFR 266
           +L +       +Y     +G+G YG V  A         A+KKL    ++   A  +++R
Sbjct: 5   ELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHA-KRTYR 63

Query: 267 NEAQVLSQVLHRNIVKLYG-FCLHRKCM-----FLIYEYMERGSLFCNLHN-------NE 313
            E ++L  + H N++ L   F            +L+   M       +L+N       ++
Sbjct: 64  -ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-----DLNNIVKCQKLSD 117

Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           D ++        +V  +   L Y+H   S  IIHRD+  +NI +N   E  + DFG AR 
Sbjct: 118 DHIQF-------LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR- 166

Query: 374 LHADSSNRTLLAGTYGYIAP 393
            H D    T    T  Y AP
Sbjct: 167 -HTD-DEMTGYVATRWYRAP 184

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 39/174 (22%), Positives = 79/174 (45%), Gaps = 24/174 (13%)

Query: 227 IGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G   +G +YK  L      + ++ A+K L      +      F+ EA +++++ H NIV
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQ--QWGEFQQEASLMAELHHPNIV 70

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLF-----------CNLHNNEDAV---ELDWAKRVNIV 327
            L G     + + +++EY+ +G L                ++ED      LD    ++I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
             +A  + YL    S   +H+D+++ NIL+  +    ++D G +R +++    R
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 47/183 (25%), Positives = 78/183 (42%), Gaps = 21/183 (11%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +     IG G YG V  A   P G   A+KK+   E +     ++ R E ++L +  H N
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFC-QRTLR-EIKILRRFKHEN 64

Query: 280 IVKLY------GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           I+ +        F      ++++ E ME      +L+       L        +  +   
Sbjct: 65  IIGILDIIRPPSFESFND-VYIVQELME-----TDLYKLIKTQHLSNDHIQYFLYQILRG 118

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL---LHADSSNRTLLAGTYGY 390
           L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+    H  +   T    T  Y
Sbjct: 119 LKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWY 175

Query: 391 IAP 393
            AP
Sbjct: 176 RAP 178

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 6/168 (3%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V   Q+   GK++A K+L     ++        NE Q+L +V  + +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+   M  G L  +++N  +    +  + +     +   L  LH +   + 
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHRE---NT 123

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++RD+   NILL+      ++D G A  +    S R  + GT GY+AP
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 6/168 (3%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V   Q+   GK++A KKL     ++        NE ++L +V  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+   M  G L  +++N  +    D  + +     +   L  L  +    I
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++RD+   NILL+ +    ++D G A  +    + R  + GT GY+AP
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 24/162 (14%)

Query: 227 IGTGGYGSVYKA-------QLPNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLH 277
           +G G +G VY+          P  +V A+K ++ + +  E + F+    NEA V+ +   
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----NEASVMKEFNC 68

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRVNIVKAM 330
            ++V+L G     +   +I E M RG       SL   + NN         K + +   +
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           A  +AYL+ +     +HRD+++ N ++   F   + DFG  R
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 35/128 (27%), Positives = 55/128 (42%), Gaps = 11/128 (8%)

Query: 268 EAQVLSQVLHRNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
           EA +L  V H +++++    +     CM L +       L+  L      + +D A  + 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY---SSDLYTYLTKRSRPLPIDQA--LI 161

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA 385
           I K +   L YLH   +  IIHRD+ + NI +N   +  + D G A+           LA
Sbjct: 162 IEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLA 217

Query: 386 GTYGYIAP 393
           GT    AP
Sbjct: 218 GTVETNAP 225

Length = 357

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 15/156 (9%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+    IG G +G V   Q  + G V+A+K L  ++  E   +   R E  +L +   
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
             +VK++     +  ++LI E++  G +   L       E+  +   A+ V  + ++ H 
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI-HQ 119

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
           L +         IHRDI  +N+LL+SK    ++DFG
Sbjct: 120 LGF---------IHRDIKPDNLLLDSKGHVKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 43/161 (26%), Positives = 74/161 (45%), Gaps = 17/161 (10%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F I   I  G +G VY  +   N K++A+K +  ++      +   + E   L+    
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRVNIVKAMAH 332
             IV LY        ++L+ EY+  G +   LH     + E AV+         +  +A 
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVAL 115

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           AL YLH      IIHRD+  +N+L++++    + DFG +++
Sbjct: 116 ALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 35/183 (19%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLSQVLH-RNIVKL 283
           +G G YG V K + +P G + A+K++  +  ++E    K    +  +  + +     V  
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDLDISMRSVDCPYTVTF 65

Query: 284 YGFCLHRK-----CMFLIYEYME-------RGSLFCNLHNNEDAVELDWAK-RVNIVKAM 330
           YG  L R+     CM    E M+       +      L   ED +     K  V+IVKA 
Sbjct: 66  YG-ALFREGDVWICM----EVMDTSLDKFYKKVYDKGLTIPEDIL----GKIAVSIVKA- 115

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
              L YLH   S  +IHRD+  +N+L+N   +  + DFG +  L  DS  +T+ AG   Y
Sbjct: 116 ---LEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTIDAGCKPY 169

Query: 391 IAP 393
           +AP
Sbjct: 170 MAP 172

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 13/179 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F I+  IG G +  VY+A  L + K  ALKK+   E  +    +    E  +L Q+ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELD-----WAKRVNIVKAMAHAL 334
           ++K     +    + ++ E  + G L   +   +    L      W   V +  A+ H  
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH-- 121

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++P
Sbjct: 122 --MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 14/160 (8%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAF-----IKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV + QL N     LK     +T ++A      ++ F +EA  + +  H N++
Sbjct: 7   LGEGEFGSVMEGQL-NQDDSILKV--AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 282 KLYGFCLHRK------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
           +L G CL            +I  +M+ G L   L  +       +     +VK M    +
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            + +  S S IHRD+++ N +LN      VADFG ++ ++
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIY 163

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 41/163 (25%), Positives = 75/163 (46%), Gaps = 25/163 (15%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHT-------SETEELAFIKSFRNEAQVLSQVLHRN 279
           +G+G +G V K       V+ ++K              E +       EA+++ Q+ +  
Sbjct: 3   LGSGNFGCVKKG------VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPY 56

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM---AHALAY 336
           IV++ G C     M L+ E    G L   L   +D + +      N+V+ M   +  + Y
Sbjct: 57  IVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVS-----NVVELMHQVSMGMKY 110

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           L      + +HRD+++ N+LL ++  A ++DFG ++ L AD S
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 15/148 (10%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V   Q  + G ++A+K L  ++  E   +   R E  +L +     +VK++ 
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
               ++ ++LI E++  G +   L      +E+A +   A+ V  + A+ H L +     
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI-HQLGF----- 122

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFG 369
               IHRDI  +N+LL++K    ++DFG
Sbjct: 123 ----IHRDIKPDNLLLDAKGHVKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 30/150 (20%), Positives = 54/150 (36%), Gaps = 20/150 (13%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV---KL 283
           +  G    VY     +   + LK   + E            E  +L Q+L R  +   K+
Sbjct: 6   LKGGLTNRVYLLGTKDED-YVLKINPSREKGAD-----REREVAIL-QLLARKGLPVPKV 58

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
                     +L+ E++E           E   E+   ++ +I + +A  LA LH     
Sbjct: 59  LASGESDGWSYLLMEWIE----------GETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARL 373
            + H D+   NIL++      + D+  A  
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 45/155 (29%), Positives = 68/155 (43%), Gaps = 13/155 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G G +G VY    +  G+  A K++       E    + +   E Q+L  + H  IV+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 284 YGFCLH---RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           YG CL     K + +  EYM  GS+   L       E    K     + +   ++YLH  
Sbjct: 70  YG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRK---YTRQILEGMSYLH-- 123

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            S  I+HRDI   NIL +S     + DFG ++ L 
Sbjct: 124 -SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 18/154 (11%)

Query: 227 IGTGGYGSVYKAQLPNGKVFA---LKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G V   +   G   A   +K+L  S T  E+L F++    E Q   ++ H N++
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ----EVQPYRELNHPNVL 58

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYL 337
           +  G C+      L+ E+   G L   L +N   V     K V  ++ MA      L +L
Sbjct: 59  QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV--LQRMACEVASGLLWL 116

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
           H       IH D++  N  L +     + D+G A
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 23/171 (13%)

Query: 227 IGTGGYGSVYKAQLPN-----GKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +GSV + QL        KV A+K  KL      E   I+ F +EA  +    H N
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSE---IEEFLSEAACMKDFDHPN 62

Query: 280 IVKLYGFCLHRKCM------FLIYEYMERGSLFCNL---HNNEDAVELDWAKRVNIVKAM 330
           ++KL G C     +       +I  +M+ G L   L          +L     +  +  +
Sbjct: 63  VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
           A  + YL    + + IHRD+++ N +L       VADFG ++ +++    R
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYR 170

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 11/151 (7%)

Query: 223 IKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  +GTG +G + +   +LP+ +    A+  L    +++    + F  EA  L Q  H 
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHS 66

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NIV+L G       M ++ EYM  G+L   L  +E   +L   + + ++  +A  + YL 
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYL- 123

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
                  +H+ ++++ +L+NS     ++ F 
Sbjct: 124 --SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 54/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)

Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G + A K +H      L    + RN+     QVLH      IV
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 121

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 171

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 8/173 (4%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G +G V+ A+L    + FA+K L          ++    E +VLS    H  +  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                ++ +F + EY+  G L  ++ +     + D  +       +   L +LH   S  
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKG 116

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           I++RD+  +NILL++     +ADFG  +      +      GT  YIAP + L
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILL 169

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 16/173 (9%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G GG+G V   Q+   GK++A KKL        + E +A      NE Q+L +V  R +
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL-----NEKQILEKVNSRFV 62

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V L      +  + L+   M  G L  +++N  +    D  + V     +   L  LH  
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-GFDEERAVFYAAEITCGLEDLH-- 119

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               I++RD+   NILL+      ++D G A  +    + R  + GT GY+AP
Sbjct: 120 -RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-GTVGYMAP 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 44/180 (24%), Positives = 82/180 (45%), Gaps = 19/180 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +++   +G G +G     Q  N  + +A+K++   ++   + ++  R EA +L+++ H N
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPN 59

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHA 333
           IV           ++++ EY + G L   +         ED + L W  +      M   
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQ------MCLG 112

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           + ++H      ++HRDI S NI L    +  + DFG+ARLL +  +      GT  Y+ P
Sbjct: 113 VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.8 bits (121), Expect = 7e-07
 Identities = 33/113 (29%), Positives = 52/113 (46%), Gaps = 18/113 (15%)

Query: 267 NEAQVLSQVLHRNIVKL--------YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVEL 318
           NE   L ++ H NI+K+          + + +K  F +Y +M   +      + +D   L
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-----DWKDRPLL 266

Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
               R  I+K +  A+ Y+H      +IHRDI   NI LN   +  + DFGTA
Sbjct: 267 -KQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 29/172 (16%)

Query: 227 IGTGGYGSVYKAQL-------PN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-L 276
           +G G +G V  A+        PN   KV A+K L +  TE+   +    +E +++  +  
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKV-AVKMLKSDATEK--DLSDLISEMEMMKMIGK 82

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKR 323
           H+NI+ L G C     +++I EY  +G+L             +C         +L +   
Sbjct: 83  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 50/173 (28%), Positives = 80/173 (46%), Gaps = 14/173 (8%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSE---TEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY+ +  +  +++A+K L   E    +E+A     RN            IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH-HD 340
           L + F      ++L+ +YM  G LF +L   E     D AK    +  +  AL +LH +D
Sbjct: 61  LKFSFQTDSD-LYLVTDYMSGGELFWHLQK-EGRFSEDRAKFY--IAELVLALEHLHKYD 116

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               I++RD+   NILL++     + DFG ++    D+       GT  Y+AP
Sbjct: 117 ----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 25/158 (15%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKL----HTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G VY       G+  A+K++     + ET +   + +   E Q+L  + H  IV
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE--VNALECEIQLLKNLRHDRIV 67

Query: 282 KLYGFCLH---RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHAL 334
           + YG CL     K + +  EYM  GS+       +D ++   A   N+ +     +   +
Sbjct: 68  QYYG-CLRDPEEKKLSIFVEYMPGGSI-------KDQLKAYGALTENVTRRYTRQILQGV 119

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +YLH   S  I+HRDI   NIL +S     + DFG ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 45/171 (26%), Positives = 78/171 (45%), Gaps = 27/171 (15%)

Query: 227 IGTGGYGSVYKA-------QLPNGKV-FALKKLHTSETE-ELAFIKSFRNEAQVLSQVLH 277
           +G G +G V +A         P+  V  A+K L  + T+ +LA + S     +++ +  H
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN-----EDAVE--------LDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L        +   +        L +   V
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 138 SCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVH 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 16/139 (11%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           C        + K + P   + A+KK  L +   E+L  ++    E     Q+ H NI+  
Sbjct: 9   CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQ---QEIITSRQLQHPNILPY 64

Query: 284 YGFCLHRKCMFLIYEYMERGS---LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
               +    ++++   M  GS   L    H  E   EL  A    I+K + +AL Y+H  
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIA---FILKDVLNALDYIHSK 120

Query: 341 CSPSIIHRDISSNNILLNS 359
                IHR + +++ILL+ 
Sbjct: 121 ---GFIHRSVKASHILLSG 136

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 15/176 (8%)

Query: 227 IGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           IG G +G V + +  +  +++ALK +  +     + +     E  VL+QV    IV L +
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA---MAHALAYLHHDC 341
            F    K ++L+  ++  G LF +L             R ++ +A    A  L  L +  
Sbjct: 61  SFQSPEK-LYLVLAFINGGELFHHLQRE---------GRFDLSRARFYTAELLCALENLH 110

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             ++I+RD+   NILL+ +    + DFG  +L   D        GT  Y+AP L L
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 47/173 (27%), Positives = 76/173 (43%), Gaps = 17/173 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G G +G V    +  +GK +A+K L          +     E++VL    H  +  L Y
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            F    +  F++ EY+  G LF +L      +ED      A+ V+       AL YLH  
Sbjct: 63  SFQTKDRLCFVM-EYVNGGELFFHLSRERVFSEDRTRFYGAEIVS-------ALDYLH-- 112

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S  I++RD+   N++L+      + DFG  +    D++      GT  Y+AP
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 23/176 (13%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V    +   G+ +A+K L        +E+A   +   E++VL    H  +  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTRHPFLTA 59

Query: 283 L-YGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYL 337
           L Y F  H +  F++ EY   G LF +L       E+      A+ V+       AL YL
Sbjct: 60  LKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTEERARFYGAEIVS-------ALEYL 111

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 35/167 (20%)

Query: 247 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KC----MFLIYEYME 301
           A+K L T   EE      FR E  + +++ H NIV L    L   +     +F ++EY+ 
Sbjct: 7   AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVAL----LDSGEAPPGLLFAVFEYVP 62

Query: 302 RGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL 356
             +L   L  +      +   L     + ++ A+A A     H+    I+HRD+   NI+
Sbjct: 63  GRTLREVLAADGALPAGETGRL----MLQVLDALACA-----HN--QGIVHRDLKPQNIM 111

Query: 357 LNS---KFEAFVADFGTARLL----HADSSNRTL---LAGTYGYIAP 393
           ++    +  A V DFG   LL     AD +  T    + GT  Y AP
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 42/171 (24%), Positives = 74/171 (43%), Gaps = 27/171 (15%)

Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 80

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L                    ++ +   V
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 10/170 (5%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G +G V  A+L  +G+++A+K L      +   ++    E ++LS    H  + +LY
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 285 GFCLHR-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
             C      +F + E++  G L  ++  +      D A+       +  AL +LH     
Sbjct: 63  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DK 115

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            II+RD+  +N+LL+ +    +ADFG  +    +    +   GT  YIAP
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 40/139 (28%), Positives = 61/139 (43%), Gaps = 17/139 (12%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G  G V+  +L   GK+FALK L   E  +   +K    E ++L+ + H  +  LY 
Sbjct: 9   LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHH 339
                  + L+ +Y   G LF  L         E+     +A  V +      AL YLH 
Sbjct: 69  SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF-YAAEVLL------ALEYLH- 120

Query: 340 DCSPSIIHRDISSNNILLN 358
                I++RD+   NILL+
Sbjct: 121 --LLGIVYRDLKPENILLH 137

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.8 bits (111), Expect = 7e-06
 Identities = 25/94 (26%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 264 SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
           +F   A ++SQV H ++  ++G C+      ++ E++E G L   L   +  V + W  +
Sbjct: 62  AFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 357
           + + + +A AL+YL      +++H ++ + NILL
Sbjct: 120 ITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 42/171 (24%), Positives = 79/171 (46%), Gaps = 12/171 (7%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLY 284
           +G G +G V  A+L    +++A+K L      +   ++    E +VL+    H  + +L+
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                +  +F + EY+  G L  ++  +      D  +       +   L +LH      
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERG 116

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTAR--LLHADSSNRTLLAGTYGYIAP 393
           II+RD+  +N+LL+S+    +ADFG  +  +L   +++     GT  YIAP
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST--FCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 10/170 (5%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   H  +V L+
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHDCSP 343
                   +F + EY+  G L  ++       E    +      A ++ AL YLH     
Sbjct: 63  SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALNYLHER--- 115

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAP
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 22/191 (11%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+    I  G YG+VY  +    +  FA+KK++         I+    E  +L+   +
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +V ++     ++ + ++ EY+E G     L  N  A+ +D A R+   + +  AL YL
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDC-ATLLKNIGALPVDMA-RMYFAETVL-ALEYL 117

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFG---------TARLL--HADSSNRTLL-- 384
           H   +  I+HRD+  +N+L+ S     + DFG         T  L   H +   R  L  
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 385 --AGTYGYIAP 393
              GT  YIAP
Sbjct: 175 QVCGTPEYIAP 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 35/175 (20%)

Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN  V  A+K L    T++   +    +E +++  +  H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK--DLSDLVSEMEMMKMIGKH 77

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL-----------------FCNLHNNEDAVELDW 320
           +NI+ L G C     ++++ EY  +G+L                  C L   +    L +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ----LTF 133

Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
              V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 134 KDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVH 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 25/188 (13%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + I+  IG G YG V  A     G+  A+KK++    E ++       E ++L  + H +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDV-FEHVSDATRILREIKLLRLLRHPD 60

Query: 280 IVKLYGFCL-----HRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           IV++    L       K +++++E ME      +LH     N+D   L        +  +
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMES-----DLHQVIKANDD---LTPEHHQFFLYQL 112

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL---LAGT 387
             AL Y+H   + ++ HRD+   NIL N+  +  + DFG AR+   D+           T
Sbjct: 113 LRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 388 YGYIAPGL 395
             Y AP L
Sbjct: 170 RWYRAPEL 177

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 29/179 (16%)

Query: 227 IGTGGYGSVY----KAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +G V     KA    GK +A+K L        +E+A   +   E++VL    H  
Sbjct: 3   LGKGTFGKVILVREKA---TGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRHPF 56

Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHAL 334
           +  L Y F  H +  F++ EY   G LF +L      +ED      A+ V+       AL
Sbjct: 57  LTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSEDRARFYGAEIVS-------AL 108

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S  +++RD+   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 45/172 (26%), Positives = 80/172 (46%), Gaps = 25/172 (14%)

Query: 221 FDIKYC-IGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+ + C +G G YG VYKA+  +G   + +ALK++     E      S   E  +L ++ 
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-----EGTGISMSACREIALLRELK 56

Query: 277 HRNIVKLYGFCLHR--KCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           H N++ L    L    + ++L+++Y E         H    A +    K V + + M  +
Sbjct: 57  HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK----KPVQLPRGMVKS 112

Query: 334 LAY-----LHHDCSPSIIHRDISSNNILL----NSKFEAFVADFGTARLLHA 376
           L Y     +H+  +  ++HRD+   NIL+      +    +AD G ARL ++
Sbjct: 113 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 33/176 (18%)

Query: 221 FDIKYC-IGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+ + C +G G YG VYKA+  +G   K +ALK++     E      S   E  +L ++ 
Sbjct: 2   FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-----EGTGISMSACREIALLRELK 56

Query: 277 HRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN-----IVKA 329
           H N++ L    L    + ++L+++Y E        H+    ++   A + N     + ++
Sbjct: 57  HPNVIALQKVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRS 108

Query: 330 MAHALAY-----LHHDCSPSIIHRDISSNNILL----NSKFEAFVADFGTARLLHA 376
           M  +L Y     +H+  +  ++HRD+   NIL+      +    +AD G ARL ++
Sbjct: 109 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 45.1 bits (107), Expect = 4e-05
 Identities = 36/154 (23%), Positives = 70/154 (45%), Gaps = 25/154 (16%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIVK 282
           +G G +G V  A+    G+++A+K L   +      ++S   E ++    +   H  +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 283 LYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LA 335
           L+  C   +  +  + EY   G L  ++H              +  +A+ +A      L 
Sbjct: 67  LFA-CFQTEDHVCFVMEYAAGGDLMMHIH----------TDVFSEPRAVFYAACVVLGLQ 115

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
           YLH +    I++RD+  +N+LL+++    +ADFG
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFG 146

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 42/169 (24%), Positives = 76/169 (44%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRNIVKLY 284
           +G G +G V  A+L    +V+A+K L      +   +     E ++L+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                +  +F + EY+  G L   +   + + + D  +       +  AL +LH      
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQI---QRSRKFDEPRSRFYAAEVTLALMFLHRH---G 116

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +I+RD+  +NILL+++    +ADFG  +    +    T   GT  YIAP
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 44.7 bits (106), Expect = 4e-05
 Identities = 52/195 (26%), Positives = 85/195 (43%), Gaps = 36/195 (18%)

Query: 222 DIKY----CIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           D KY     IG G YG V  A     N KV A+KK+  +    +   ++ R E ++L  +
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKV-AIKKIANAFDNRIDAKRTLR-EIKLLRHL 61

Query: 276 LHRNIVKLYGFCL--HR---KCMFLIYEYMERGSLFCNLHN--------NEDAVELDWAK 322
            H N++ +       HR     ++++YE M+      +LH         ++D  +     
Sbjct: 62  DHENVIAIKDIMPPPHREAFNDVYIVYELMD-----TDLHQIIRSSQTLSDDHCQY---- 112

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
               +  +   L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR         T
Sbjct: 113 ---FLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMT 166

Query: 383 LLAGTYGYIAPGLPL 397
               T  Y AP L L
Sbjct: 167 EYVVTRWYRAPELLL 181

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 10/170 (5%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL-Y 284
           +G G +G V    +   G+ +A+K L          +     E +VL    H  +  L Y
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLHHDCSP 343
            F  H +  F++ EY   G LF +L       E     R     A +  AL YLH +   
Sbjct: 63  SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--K 115

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 7e-05
 Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 31/121 (25%)

Query: 263 KSFRNEAQVLSQVLHRNIVKLYGFCLHRK------CMFL------IYEYMERGSLFCNLH 310
           K+   E  +L  + HR I+ L    +H        CM +      ++ Y++R        
Sbjct: 131 KTPGREIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFTYVDRSG------ 180

Query: 311 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT 370
                  L   + + I + +  ALAYLH      IIHRD+ + NI L+    A + DFG 
Sbjct: 181 ------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGA 231

Query: 371 A 371
           A
Sbjct: 232 A 232

Length = 392

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 52/203 (25%)

Query: 221 FDI--KYC----IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           FD+  +Y     +G G  G V+ A      K  A+KK+  ++ + +   K    E +++ 
Sbjct: 1   FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV---KHALREIKIIR 57

Query: 274 QVLHRNIVKLY--------------GFCLHRKCMFLIYEYMERGSLFCNLHNN----EDA 315
           ++ H NIVK+Y              G       ++++ EYME  +   N+       E+ 
Sbjct: 58  RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME--TDLANVLEQGPLSEEH 115

Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV---ADFGTAR 372
             L        +  +   L Y+H   S +++HRD+   N+ +N+  E  V    DFG AR
Sbjct: 116 ARL-------FMYQLLRGLKYIH---SANVLHRDLKPANVFINT--EDLVLKIGDFGLAR 163

Query: 373 LLHADSSNRTLLAGTYGYIAPGL 395
           ++    S++       GY++ GL
Sbjct: 164 IVDPHYSHK-------GYLSEGL 179

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 27/63 (42%), Positives = 34/63 (53%), Gaps = 4/63 (6%)

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA---DSSNRTLLAGTYGY 390
           L  +HH  S  +IHRDI S NILL S     + DFG +++  A   D   RT   GT  Y
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYY 211

Query: 391 IAP 393
           +AP
Sbjct: 212 VAP 214

Length = 496

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 32/167 (19%)

Query: 227 IGTGGYGSVYKAQ--------------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 272
           +G G YG V  A+              + N  VF+ K L      EL  ++ FR      
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITN--VFSKKILAKRALRELKLLRHFRG----- 60

Query: 273 SQVLHRNIVKLYGFCLHRKCMF-LIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAM 330
               H+NI  LY   +     F  +Y Y E   +  +LH        L  A   + +  +
Sbjct: 61  ----HKNITCLYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQI 114

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
              L Y+H   S +++HRD+   N+L+N+  E  + DFG AR    +
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81

Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 135

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 42/172 (24%), Positives = 69/172 (40%), Gaps = 14/172 (8%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G Y  V   +L  N +++A+K +      +   I   + E  V  Q      +    
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62

Query: 286 FCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLHHDC 341
            C      +FL+ EY+  G L  ++       E     +A  + I      AL +LH   
Sbjct: 63  SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI------ALNFLHER- 115

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              II+RD+  +N+LL++     + D+G  +         +   GT  YIAP
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 43.9 bits (103), Expect = 9e-05
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 17/153 (11%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H+NI+ L  
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87

Query: 286 FCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH 
Sbjct: 88  VFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 140

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 141 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 1e-04
 Identities = 19/59 (32%), Positives = 27/59 (45%)

Query: 32 LSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI 90
          L  LDLS N+           L  L  L+LS N L+   P   + + +L  LD+S N +
Sbjct: 2  LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 43.2 bits (102), Expect = 1e-04
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G +G V  A+L    + FA+K L      E   ++    E +VL+    H  +  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                ++ +F + EY+  G L   + + + +   D A+       +   L +LH      
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLH---KKG 116

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           II+RD+  +N+LL+      +ADFG  +         +   GT  YIAP
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 47/174 (27%), Positives = 75/174 (43%), Gaps = 18/174 (10%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  ++V   G
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLSLVST-G 54

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM----AHALAYLHHDC 341
            C    CM   +   ++     +L N  D         V   K M       +  L H  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGYIAP 393
           +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+AP
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83

Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 140

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVA-TRWYRAPEIML 190

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 24/162 (14%)

Query: 227 IGTGGYGSVYKAQL-------PNGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLH 277
           +G G +G VY+             +V A+K ++ S +  E + F+    NEA V+     
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRV-AVKTVNESASLRERIEFL----NEASVMKGFTC 68

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDWAKRVNIVKAM 330
            ++V+L G     +   ++ E M  G       SL     NN         + + +   +
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           A  +AYL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 28/179 (15%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRN- 279
           IG GG+G VY  +  + GK++A+K     ++   + E LA      NE  +LS V   + 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLAL-----NERIMLSLVSTGDC 56

Query: 280 --IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
             IV + Y F    K  F I + M  G L  +L  +    E +      +    A  +  
Sbjct: 57  PFIVCMSYAFHTPDKLSF-ILDLMNGGDLHYHLSQHGVFSEAE------MRFYAAEIILG 109

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGYIAP 393
           L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY+AP
Sbjct: 110 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAP 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLY 284
           +G G +G V  A+L   G+ FA+K L          ++    E +VL+       +  LY
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                ++ +F + E++  G L  ++   +D    D  +       +   L +LH   S  
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDLYRATFYAAEIVCGLQFLH---SKG 116

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           II+RD+  +N++L+      +ADFG  +      +  +   GT  YIAP
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAP 165

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 39/150 (26%), Positives = 71/150 (47%), Gaps = 13/150 (8%)

Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G G +G V  A  QL    V A+KK+    +  +   +++R E ++L  + H NI+ L 
Sbjct: 18  VGMGAFGLVCSARDQLTGQNV-AIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75

Query: 285 G-FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
             F    + ++ + E +       +LH    +  L+       +  +   L Y+H   S 
Sbjct: 76  DIFISPLEDIYFVTELLG-----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SA 127

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARL 373
            ++HRD+  +NIL+N   +  + DFG AR+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 21/155 (13%)

Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88

Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.0 bits (98), Expect = 5e-04
 Identities = 48/217 (22%), Positives = 93/217 (42%), Gaps = 37/217 (17%)

Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVF------ALKKLHTSETEELAFIKS 264
           Y+D       +++   IG G +G V+  +    + F      + + L   E  +L     
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI--- 61

Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAV-ELDWA 321
              E  V+ ++ H+NIV+     L++  + ++++ E+ + G L  N+        +++  
Sbjct: 62  ---EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEH 118

Query: 322 KRVNIVKAMAHALAYLHH----DCSPSIIHRDISSNNIL-----------------LNSK 360
             V+I + + HALAY H+         ++HRD+   NI                  LN +
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 361 FEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             A + DFG ++ +  +S   + + GT  Y +P L L
Sbjct: 179 PIAKIGDFGLSKNIGIESMAHSCV-GTPYYWSPELLL 214

Length = 1021

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 26/101 (25%), Positives = 48/101 (47%), Gaps = 6/101 (5%)

Query: 293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 352
           ++ + EY+  G L   +++ +   +    + V     ++  L +LH      II+RD+  
Sbjct: 76  LYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKL 129

Query: 353 NNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +N++L+S+    +ADFG  +    D        GT  YIAP
Sbjct: 130 DNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAP 170

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 6/103 (5%)

Query: 293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 352
           ++ + EY+  G L   ++  +          V     +A  L +LH   S  II+RD+  
Sbjct: 76  LYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKL 129

Query: 353 NNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           +N++L+S+    +ADFG  +    D        GT  YIAP +
Sbjct: 130 DNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 36.7 bits (86), Expect = 8e-04
 Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 2/45 (4%)

Query: 78  KNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
            NL  LD+SNN+I   +P  ++ L  L+ L+LS NK++   P SN
Sbjct: 1   TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKITDLSPLSN 43

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 40.5 bits (95), Expect = 8e-04
 Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 5/65 (7%)

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTY 388
           +A  L +LH   S  II+RD+  +N++L+++    +ADFG  +  +    + RT   GT 
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 389 GYIAP 393
            YIAP
Sbjct: 166 DYIAP 170

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 50/175 (28%), Positives = 80/175 (45%), Gaps = 13/175 (7%)

Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G YGSV   Y  +L   KV A+KKL       +   +++R E ++L  + H N++ L
Sbjct: 23  VGSGAYGSVCSAYDTRLRQ-KV-AVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGL 79

Query: 284 YGFCLHRKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                    +    E Y+    +  +L+N     +L       ++  +   L Y+H   S
Sbjct: 80  LDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIH---S 136

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y AP + L
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVA-TRWYRAPEIML 188

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 13/147 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G V    ++    ++A+K L  ++     + A +K+ R+   +L++  +  +VK
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERD---ILAEADNEWVVK 65

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LY     +  ++ + +Y+  G +   L       E D A R  I + +  A+  +H    
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLA-RFYIAE-LTCAIESVH---K 119

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFG 369
              IHRDI  +NIL++      + DFG
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 35.6 bits (83), Expect = 0.002
 Identities = 22/60 (36%), Positives = 27/60 (45%)

Query: 7  NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
          NL  LD+ +N L          L +L  LDLS N   S  P   + L  L  L+LS N L
Sbjct: 1  NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 40/176 (22%), Positives = 79/176 (44%), Gaps = 22/176 (12%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVL-HRNIV 281
           IG G Y  V   +L    +++A+K   K   ++ E++ ++++   E  V      H  +V
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQT---EKHVFETASNHPFLV 59

Query: 282 KLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYL 337
            L+  C   +  +F + E++  G L  ++       E     ++  +++      AL +L
Sbjct: 60  GLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISL------ALNFL 112

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H      II+RD+  +N+LL+++    + D+G  +         +   GT  YIAP
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 14/86 (16%)

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCN----LHNNEDAVELDWAKRVNIVKAMAHAL 334
           N+V L+ + +    +FL+ ++ E G L+ +    L+  E+ V+  WA        M  AL
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK-RWAAE------MVVAL 98

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSK 360
             LH +    I+ RD++ NNILL+ +
Sbjct: 99  DALHRE---GIVCRDLNPNNILLDDR 121

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 3/68 (4%)

Query: 312 NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
            ED + LD    ++    +A  +++L    S + IHRD+++ NILL       + DFG A
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 261

Query: 372 RLLHADSS 379
           R +  DS+
Sbjct: 262 RDIRNDSN 269

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	397
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.98
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.97
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.97
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.97
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.97
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.97
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.97
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.97
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.97
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.97
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.97
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.96
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.96
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.96
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.96
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.96
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.95
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.95
PTZ00036	440	glycogen synthase kinase; Provisional	99.95
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
KOG0584	632	consensus Serine/threonine protein kinase [General	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.95
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.95
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.95
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.95
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.95
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.95
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.95
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.95
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.95
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
PHA03209	357	serine/threonine kinase US3; Provisional	99.95
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.95
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.95
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.95
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.95
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.94
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.94
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.94
PHA03210	501	serine/threonine kinase US3; Provisional	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.94
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.94
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.94
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.94
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.94
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.94
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.94
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.94
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.94
PLN00009	294	cyclin-dependent kinase A; Provisional	99.93
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.93
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.93
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.93
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.93
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.93
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.93
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.93
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.93
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.93
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.93
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.93
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.93
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.93
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.92
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.92
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.92
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.92
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.92
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.92
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.92
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.92
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.92
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.92
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.92
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.92
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.92
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.92
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.91
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
PHA02882	294	putative serine/threonine kinase; Provisional	99.91
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.91
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.91
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.91
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.91
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.9
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.9
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.9
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.9
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.88
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.88
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.87
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.86
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.86
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
PRK10345	210	hypothetical protein; Provisional	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.84
smart00090	237	RIO RIO-like kinase.	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.79
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.76
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.75
PLN03150	623	hypothetical protein; Provisional	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.69
PLN00181	793	protein SPA1-RELATED; Provisional	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.64
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.63
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.62
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.59
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.59
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.59
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.55
PLN03150	623	hypothetical protein; Provisional	99.54
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.51
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.49
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.46
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.43
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.41
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.4
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.39
KOG3087	229	consensus Serine/threonine protein kinase [General	99.38
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.36
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.35
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.31
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.25
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.22
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.22
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.2
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.19
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.11
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.1
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.08
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.08
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.08
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.99
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.98
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.97
KOG1243	690	consensus Protein kinase [General function predict	98.97
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.97
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.97
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.96
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.96
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.91
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.91
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.9
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.87
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.84
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.79
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.74
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.74
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.66
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.65
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.6
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.57
PRK09902	216	hypothetical protein; Provisional	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.56
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.55
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.5
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.48
PF01636	239	APH: Phosphotransferase enzyme family This family	98.46
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.39
PLN02876	822	acyl-CoA dehydrogenase	98.39
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.38
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.37
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.35
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.34

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.4e-49  Score=420.38  Aligned_cols=372  Identities=31%  Similarity=0.504  Sum_probs=244.5

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ..+++|+.|+|++|++.+.+|..+ .+++|+.|++++|++++.+|..+.++++|+.|+|++|++++.+|..+..+++|+.
T Consensus       449 ~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  527 (968)
T PLN00113        449 WDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVS  527 (968)
T ss_pred             ccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCE
Confidence            346677777777777776666654 3466777777777777667766777777777777777777667777777777777


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC-----------------------Cc
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK-----------------------GL  139 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~-----------------------~~  139 (397)
                      |++++|.+++.+|..+..+++|+.|++++|++++.+|..+..+++|+.+++++|+                       ..
T Consensus       528 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~l  607 (968)
T PLN00113        528 LDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDL  607 (968)
T ss_pred             EECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccc
Confidence            7777777777777777777777777777777776666666666666666666554                       34


Q ss_pred             CCCC--cCCCCCCCCCCCcch-hhhhhhhh-hHhhHhhhhhhhhhhhhcccccccccccCCcceeeee--ccCCcccHHH
Q 043586          140 CGNF--SALPSCDATKPATLF-VEIFLPLA-IVPSVIVFACLLVVKRKYKKPKLKANATNSIGVFSIW--NYDGRIVYED  213 (397)
Q Consensus       140 c~~~--~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  213 (397)
                      |+..  ...++|......... ..++++++ ++++++++++++++++++++...+.............  .....+.+++
T Consensus       608 c~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  687 (968)
T PLN00113        608 CGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND  687 (968)
T ss_pred             cCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH
Confidence            5432  123344322111111 11111222 1222222222222222221111110000000000000  0011223333


Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                         ..+.|...+.||+|+||.||+|+. .++..||||++......       ..+|++.+++++||||+++++++.+++.
T Consensus       688 ---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~  757 (968)
T PLN00113        688 ---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKG  757 (968)
T ss_pred             ---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCC
Confidence               345677888999999999999986 57899999998754322       1246888999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .|+||||+++|+|.++++.      ++|.++.+++.|+++|++|||+.++++|+||||||+||+++.++.+++. ||.+.
T Consensus       758 ~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~  830 (968)
T PLN00113        758 AYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG  830 (968)
T ss_pred             CEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence            9999999999999999852      7889999999999999999998777899999999999999999988875 66655


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .....    ....||+.|||||++
T Consensus       831 ~~~~~----~~~~~t~~y~aPE~~  850 (968)
T PLN00113        831 LLCTD----TKCFISSAYVAPETR  850 (968)
T ss_pred             ccccC----CCccccccccCcccc
Confidence            43221    123689999999975

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=312.26  Aligned_cols=187  Identities=44%  Similarity=0.770  Sum_probs=165.3

Q ss_pred             CCcccHHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceee
Q 043586          206 DGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG  285 (397)
Q Consensus       206 ~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  285 (397)
                      ...++++++..+|++|...+.||+|+||.||+|...++..||||++.......   .++|.+|+.++.+++|||+|+++|
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlG  138 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLG  138 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEE
Confidence            34588999999999999999999999999999999999999999887765432   256999999999999999999999


Q ss_pred             EEeeCC-EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeE
Q 043586          286 FCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF  364 (397)
Q Consensus       286 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  364 (397)
                      ||.+.+ ..++|+|||++|+|.++++..... .++|.++++|+.++|+||+|||+.+.++|+||||||+|||+|+++++|
T Consensus       139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK  217 (361)
T KOG1187|consen  139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK  217 (361)
T ss_pred             EEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence            999988 599999999999999999976554 689999999999999999999998888999999999999999999999


Q ss_pred             EeccccccccCC-CCCCeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHA-DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~-~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+|||+|+.... .....+...||.+|+||||.
T Consensus       218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~  250 (361)
T KOG1187|consen  218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYA  250 (361)
T ss_pred             ccCccCcccCCccccceeeecCCCCccCChhhh
Confidence            999999976544 22222211799999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=298.48  Aligned_cols=171  Identities=29%  Similarity=0.484  Sum_probs=150.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..+|.+.+.||+|+||+||+|+++ ++..||||.+...... ...++.+..|+++|+.++|||||+++++++.++..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            467888899999999999999865 6799999999876532 22357788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC------CCeEEecccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK------FEAFVADFGT  370 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~DFG~  370 (397)
                      ||||+||+|.++++.++   .+++..+..++.|+|.||++||   +++||||||||.|||++..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999998764   4889999999999999999999   6799999999999999764      4689999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+.+....- ..+.+|+|.|||||++
T Consensus       162 AR~L~~~~~-a~tlcGSplYMAPEV~  186 (429)
T KOG0595|consen  162 ARFLQPGSM-AETLCGSPLYMAPEVI  186 (429)
T ss_pred             hhhCCchhH-HHHhhCCccccCHHHH
Confidence            998874433 3457899999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=285.62  Aligned_cols=174  Identities=29%  Similarity=0.495  Sum_probs=157.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||+||.++.. +++.||+|++++.........+....|..+|.+++||+||.++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            357999999999999999999754 6899999999987766555567888999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +||+.||.|..+|.+..   .+++..+.-++..|+.||.|||   +.+||||||||+|||+|.+|.++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999998654   4788889999999999999999   67999999999999999999999999999997766


Q ss_pred             CCCCeeeccccccccCCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~l  397 (397)
                      ......+++||+.|||||+++
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~  198 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILL  198 (357)
T ss_pred             CCCccccccCCccccChHHHh
Confidence            666667789999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-38  Score=284.77  Aligned_cols=173  Identities=31%  Similarity=0.476  Sum_probs=148.6

Q ss_pred             HhcCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHH----HHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ..+.|.+.+.+|+|+||.|-+|. .++|+.||||++.......    .......++|+++|++++|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45678889999999999999996 4589999999998765433    112244579999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC---CCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---FEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DF  368 (397)
                      ..|+||||++||+|.+.+-.++.   +.+.....+++|++.|+.|||   ++||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999876543   566677889999999999999   6799999999999999765   78999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+|+... ..+...+++|||.|.|||++
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl  350 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVL  350 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhhe
Confidence            9999876 44455678999999999986

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-37  Score=293.77  Aligned_cols=172  Identities=29%  Similarity=0.476  Sum_probs=159.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ..|...+.||+|+|+.||.++. .+|+.||+|++.+.........+...+|+++.++++|||||+++++|++.++.|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999987 789999999998866655556688999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |+|+.++|..+++.+   ..+++.++..+++||+.||.|||   +.+|+|||||..|+|++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999988744   35899999999999999999999   679999999999999999999999999999999888


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .....+.+|||-|+|||++
T Consensus       172 ~Erk~TlCGTPNYIAPEVl  190 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVL  190 (592)
T ss_pred             ccccceecCCCcccChhHh
Confidence            7777888999999999986

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=273.97  Aligned_cols=167  Identities=31%  Similarity=0.446  Sum_probs=146.2

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-EeeEEEe
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLIYE  298 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  298 (397)
                      .+....||+|..|+||+++++ +++.+|+|.+......  ...+++.+|+++++.++||+||.++|+|..++ ..+++||
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~--~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDP--ALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCH--HHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            344567999999999999875 7889999999544333  34588999999999999999999999999998 5999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||++|+|.+.+...   ..+++...-+|+.+|++||.|||+.  ++||||||||+|||++..|++||||||.++.+... 
T Consensus       159 YMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            99999999988754   2488899999999999999999963  58999999999999999999999999999987655 


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                       ...+++||..|||||.+
T Consensus       233 -~a~tfvGT~~YMsPERi  249 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERI  249 (364)
T ss_pred             -hcccccccccccChhhh
Confidence             34568899999999975

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=283.98  Aligned_cols=171  Identities=36%  Similarity=0.596  Sum_probs=148.1

Q ss_pred             CCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-EeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  299 (397)
                      ..+.+.+|+|+||+||+|.+.....||||++......... .++|.+|+.+|++++|||||+++|+|.++. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            4445569999999999999976555999999887655444 689999999999999999999999999987 79999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCCCCEEeCCCC-CeEEeccccccccCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISSNNILLNSKF-EAFVADFGTARLLHAD  377 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~DFG~a~~~~~~  377 (397)
                      +++|+|.++++.. ....+++..+++++.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999874 3346899999999999999999999   456 99999999999999998 9999999999876654


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ....+...||+.|||||++
T Consensus       198 ~~~~~~~~GT~~wMAPEv~  216 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVL  216 (362)
T ss_pred             cccccCCCCCccccChhhh
Confidence            3333446799999999986

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=272.88  Aligned_cols=175  Identities=27%  Similarity=0.396  Sum_probs=151.0

Q ss_pred             CCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceee-EEeeCCE-eeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG-FCLHRKC-MFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  296 (397)
                      +|++.++||+|+||.||++. ..+|..+|.|.++-... +...++....|+.+|++++|||||++++ .+.++.. +++|
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            47888999999999999996 46899999999985443 3444678899999999999999999998 4555444 8999


Q ss_pred             EeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ||||.+|+|.+.++..+ ....+++..+++++.|++.||..+|... +.  |+||||||.||+++.+|.+||+|||++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            99999999999887533 3456899999999999999999999642 34  89999999999999999999999999999


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +..........+|||.||+||.+
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i  200 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERI  200 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHH
Confidence            98877777778999999999975

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.6e-37  Score=264.73  Aligned_cols=172  Identities=28%  Similarity=0.414  Sum_probs=149.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|+....+|+|+||+||+|+.+ +|+.||||++..+..+ +...+-..+|+++|++++|||+|.++++|.....+++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            35777889999999999999976 6999999999876533 344566788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+. ++.+-+.....  .++...+.+++.|++.|+.|+|   +++++||||||+|||++..|.+||||||+|+.+..+
T Consensus        81 E~~dh-TvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPN--GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecch-HHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99986 55555554433  4788889999999999999999   779999999999999999999999999999998866


Q ss_pred             CCCeeeccccccccCCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~l  397 (397)
                      ....+..+.|.+|+|||+++
T Consensus       155 gd~YTDYVATRWYRaPELLv  174 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLV  174 (396)
T ss_pred             cchhhhhhhhhhccChhhhc
Confidence            66677788999999999874

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-36  Score=258.18  Aligned_cols=169  Identities=30%  Similarity=0.481  Sum_probs=153.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|+....+|.|+||.|..++.+ +|..+|+|++.....-+....+...+|..+|+.+.||+++++++.+.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46889999999999999999865 68899999999887766666788899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++||.|..++++.+   +++++.++-++.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999998654   4888999999999999999999   779999999999999999999999999999976433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         ..+.+|||.|+|||++
T Consensus       198 ---T~TlCGTPeYLAPEii  213 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEII  213 (355)
T ss_pred             ---EEEecCCccccChHHh
Confidence               4567899999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-35  Score=273.44  Aligned_cols=172  Identities=33%  Similarity=0.489  Sum_probs=147.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  295 (397)
                      +.|+..++||+|+||.||+|+. .+|+.||+|+++...... ....-..+|+.+|++++||||+++.+...+.  +.+|+
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4577778899999999999975 579999999998765332 2345677899999999999999999998876  68999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |+|||+. +|.-++...  ...+++.++..+++|++.||+|+|   ++||+|||||.+|||||.+|.+||+|||+|+++.
T Consensus       196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999986 777666643  345899999999999999999999   7799999999999999999999999999999887


Q ss_pred             CCCCC-eeeccccccccCCCCCC
Q 043586          376 ADSSN-RTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       376 ~~~~~-~~~~~gt~~y~APE~~l  397 (397)
                      ..... .+..+-|.+|.|||++|
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLL  292 (560)
T ss_pred             CCCCcccccceEEeeccChHHhc
Confidence            65543 55667899999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=5.7e-35  Score=249.51  Aligned_cols=172  Identities=30%  Similarity=0.431  Sum_probs=149.7

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|...+.+|+|.||+||+|++ .+|+.||||+++.....+.- -....+|++.|+.++|+||+.++++|...+...+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            3577788999999999999975 57999999999887554321 245668999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+. +|...++..  ...++..++..++.++++|++|||   .+.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus        81 Efm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99974 898888754  345889999999999999999999   678999999999999999999999999999998877


Q ss_pred             CCCeeeccccccccCCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~l  397 (397)
                      ....+..+-|.+|.|||+++
T Consensus       155 ~~~~~~~V~TRWYRAPELLf  174 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLF  174 (318)
T ss_pred             CcccccceeeeeccChHHhc
Confidence            66665557899999999763

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=269.95  Aligned_cols=170  Identities=32%  Similarity=0.470  Sum_probs=151.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+....+. ..+.+++|+++++.++||||+.++++|+...+.|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46888889999999999999876 678999999987654432 3578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.| +|..++....   .+++..+..++.+++.||.|||   +.+|.|||+||.|||++..|.+|+||||+|+.+...
T Consensus        81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99976 9999997654   4889999999999999999999   779999999999999999999999999999988776


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ....+...|||.|||||++
T Consensus       154 t~vltsikGtPlYmAPElv  172 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELV  172 (808)
T ss_pred             ceeeeeccCcccccCHHHH
Confidence            6656667799999999974

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=260.48  Aligned_cols=171  Identities=23%  Similarity=0.434  Sum_probs=156.1

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|++.+.+|+|.||.|-+|.. ..|+.||||.+++....+.+..-.+++|+++|+.++||||++++++|+..+...+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4688889999999999999964 689999999999988887777788999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||..+|.|.+++.+.+   .+++.++..+++||..|+.|+|   .++++|||||.+|||+|.++++||+|||++-.+..+
T Consensus       133 EYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  133 EYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             EecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            9999999999998754   4899999999999999999999   779999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                       ...++++|+|-|.+||++
T Consensus       207 -kfLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  207 -KFLQTFCGSPLYASPEIV  224 (668)
T ss_pred             -cHHHHhcCCcccCCcccc
Confidence             345678999999999986

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-35  Score=268.79  Aligned_cols=172  Identities=26%  Similarity=0.385  Sum_probs=148.8

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCC-Ee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK-CM  293 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~  293 (397)
                      .-++|.+.++||.|+||.||+|+. .++..||||+++.......+. - =.+|+..|+++. ||||+++.+++.+.+ .+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            346789999999999999999975 478999999998765543322 2 246999999998 999999999999988 89


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+|||||+ .+|.++++.+  ...+++..+..|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+||.
T Consensus        86 ~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence            99999996 5999999876  346999999999999999999999   77999999999999999989999999999998


Q ss_pred             cCCCCCCeeeccccccccCCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      +..... .+..+.|.+|+|||++|
T Consensus       160 v~SkpP-YTeYVSTRWYRAPEvLL  182 (538)
T KOG0661|consen  160 VRSKPP-YTEYVSTRWYRAPEVLL  182 (538)
T ss_pred             cccCCC-cchhhhcccccchHHhh
Confidence            765443 35567999999999976

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=267.25  Aligned_cols=174  Identities=30%  Similarity=0.467  Sum_probs=153.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      -..+|.+++.||+|+|++|++|+. .+++.||||++.+.........+....|-.+|.++ .||.|++++-.|++...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346799999999999999999975 47899999999887666555556777899999999 7999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|+||+++|+|.++|++.+   .+++..++.++.+|+.||+|||   ++|||||||||+|||+|.||.+||+|||.|+.+
T Consensus       151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999998764   4788889999999999999999   779999999999999999999999999999987


Q ss_pred             CCCCC-----------C--eeeccccccccCCCCC
Q 043586          375 HADSS-----------N--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~-----------~--~~~~~gt~~y~APE~~  396 (397)
                      .+...           .  ...++||..|.+||++
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL  259 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL  259 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHh
Confidence            54221           1  1458999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=266.63  Aligned_cols=174  Identities=24%  Similarity=0.428  Sum_probs=149.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchH-H-HHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETE-E-LAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKC  292 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  292 (397)
                      ..+.|.+.+.||+|+||.|+.|+. .+++.||+|++...... . ....+.+.+|+.++++++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            346799999999999999999965 46899999977664211 1 122355668999999999 9999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEeccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTA  371 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG~a  371 (397)
                      .|+||||+.||+|.+++....   .+.+..+.+++.|++.|++|+|   ++||+||||||+|||+|.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999998733   4777899999999999999999   7799999999999999999 99999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .............+||+.|+|||++
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl  193 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVL  193 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHh
Confidence            9874333445667899999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.6e-34  Score=263.54  Aligned_cols=150  Identities=27%  Similarity=0.435  Sum_probs=138.9

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|+++..||+|+||.||.|+- .+|+.+|+|++++........++..+.|-++|...++|.||+++..|++.+++|+|
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            46899999999999999999975 47999999999998887777788899999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |||++||++..+|....   .+++..+..++.+++.|++.+|   ..|+|||||||+|+|||..|.+||+|||++.-
T Consensus       220 MEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccch
Confidence            99999999999997653   4788889999999999999999   67999999999999999999999999999863

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-34  Score=253.42  Aligned_cols=172  Identities=29%  Similarity=0.371  Sum_probs=148.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  295 (397)
                      +.|+.++.|++|+||.||+|+++ +++.||+|+++....... +--.-.+|+.+|.+++|||||.+..+...  -+..|+
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~G-FPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEG-FPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCC-CcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            45888899999999999999875 678999999987653321 11234579999999999999999998775  357999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |||||+. +|...++...  .++...++..++.|+++|++|||   .+.|+||||||+|+|+...|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999975 8888888654  35888999999999999999999   6689999999999999999999999999999998


Q ss_pred             CCCCCeeeccccccccCCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      ......+..+-|.+|.|||++|
T Consensus       229 sp~k~~T~lVVTLWYRaPELLL  250 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLL  250 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhc
Confidence            8877777788999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=267.95  Aligned_cols=173  Identities=23%  Similarity=0.417  Sum_probs=153.9

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  294 (397)
                      ..++|.+..+||+|+||+|+++..+ +++.||||.+++...-..+.++....|.+++.... ||.++.++.+|++.+++|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3467999999999999999999876 57899999999887666666788889999988885 999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+.||++..+.+.    ..++++.+.-++..|+.||+|||   .++||+||||.+|||+|.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999996554442    24899999999999999999999   679999999999999999999999999999987


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+++|||.|||||++
T Consensus       519 m~~g~~TsTfCGTpey~aPEil  540 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVL  540 (694)
T ss_pred             CCCCCccccccCChhhcChhhh
Confidence            6556667789999999999986

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=264.40  Aligned_cols=169  Identities=28%  Similarity=0.431  Sum_probs=152.8

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ...|....+||+|+.|.||.|+. .+++.||||.+........   +-+.+|+.+|+..+|+|||.+++.|...+..|+|
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            45677788999999999999964 4788999999988776543   5678999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||||+||+|.+.+...    .+++.++..|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||+|.++..
T Consensus       349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            9999999999988754    3889999999999999999999   67999999999999999999999999999999988


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+|||+|||||++
T Consensus       422 ~~~KR~TmVGTPYWMAPEVv  441 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVV  441 (550)
T ss_pred             ccCccccccCCCCccchhhh
Confidence            88777778899999999985

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=255.10  Aligned_cols=174  Identities=30%  Similarity=0.444  Sum_probs=143.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHH-----------HHHHHHHHHHHHhhcccCCcccee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELA-----------FIKSFRNEAQVLSQVLHRNIVKLY  284 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~  284 (397)
                      ..++|++.+.||+|.||.|-+|+.. +++.||||++.+.......           ..+...+|+.+|+++.|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999999865 7899999999765432211           135788999999999999999999


Q ss_pred             eEEeeC--CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          285 GFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       285 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                      ++..++  +.+|||+|||..|.+...-   .....+++.++++++++++.||+|||   .+||+||||||+|+|++.+|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence            999875  5799999999988875322   22333889999999999999999999   669999999999999999999


Q ss_pred             eEEeccccccccCCCCC-----CeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSS-----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~-----~~~~~~gt~~y~APE~~  396 (397)
                      +||+|||.+.....+..     .....+|||.|||||+.
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c  287 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELC  287 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhh
Confidence            99999999986633221     12235799999999974

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-33  Score=250.84  Aligned_cols=170  Identities=31%  Similarity=0.469  Sum_probs=145.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC--EeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  295 (397)
                      .++...+.||+|+||.||++... +|...|||.+.......   .+.+.+|+.+|++++|||||+++|......  ..++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            34677788999999999999865 48999999988764332   467889999999999999999999855544  6899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEecccccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLL  374 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~~  374 (397)
                      .|||+++|+|.+++...+.  .+++..++.+.+||++||+|||   ++||+||||||+|||++. ++.+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999987654  4899999999999999999999   779999999999999999 799999999999977


Q ss_pred             CC---CCCCeeeccccccccCCCCC
Q 043586          375 HA---DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~---~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..   .........||+.|||||++
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi  193 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVI  193 (313)
T ss_pred             ccccccccccccccCCccccCchhh
Confidence            63   11223346799999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=255.53  Aligned_cols=167  Identities=33%  Similarity=0.541  Sum_probs=142.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc--ccCCccceeeEEeeCC----E
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRNIVKLYGFCLHRK----C  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~  292 (397)
                      ...++.+.||+|+||.||+|.+. ++.||||++.....      +.|..|-++++..  +|+||++++++-....    .
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~k------qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~e  282 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQEK------QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRME  282 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHHH------HHHHhHHHHHhccCccchhHHHhhchhccCCccccc
Confidence            34566678999999999999985 58999999976442      5677888887765  7999999999876554    7


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD------CSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      +|+|+||.+.|+|.++++.+    .++|....+|+..+++||+|||+.      ++++|+|||||+.||||..|+++.|+
T Consensus       283 ywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  283 YWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            99999999999999999875    489999999999999999999974      46789999999999999999999999


Q ss_pred             ccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |||+|..+..+...  ....+||.+|||||++
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvL  390 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVL  390 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHH
Confidence            99999988754432  2235799999999985

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-32  Score=249.41  Aligned_cols=172  Identities=28%  Similarity=0.443  Sum_probs=151.4

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||.|..++||+|+. +.+..||||++........  .+.+++|+..++.++||||++++..|..+..+|+||
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            5799999999999999999974 5679999999987766543  578999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      .||.+|++.++++..-. ..+++..+..|.+++++||.|||   .+|-||||||+.||||+.+|.+||+|||.+..+...
T Consensus       104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999986433 34889999999999999999999   669999999999999999999999999987766543


Q ss_pred             CCC---e-eeccccccccCCCCC
Q 043586          378 SSN---R-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~---~-~~~~gt~~y~APE~~  396 (397)
                      ...   . ..++|||+|||||++
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl  202 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVL  202 (516)
T ss_pred             CceeeEeeccccCcccccChHHh
Confidence            332   2 456899999999984

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=2.9e-33  Score=235.71  Aligned_cols=172  Identities=34%  Similarity=0.549  Sum_probs=153.2

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++++.+|+|.||.||.|+. +++..||+|++.+......+..+++++|+++-+.++||||++++++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            5699999999999999999975 468899999998877666666688999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||...|++...++.... ..+++.....++.|+|.|+.|+|   .++|+||||||+|+|++.++..||+|||-+..-.  
T Consensus       102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            99999999999985433 34788888999999999999999   7799999999999999999999999999986433  


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .....+.+||..|.|||++
T Consensus       176 ~~kR~tlcgt~dyl~pEmv  194 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMV  194 (281)
T ss_pred             CCCceeeecccccCCHhhc
Confidence            4556678999999999975

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.98  E-value=7.5e-33  Score=247.32  Aligned_cols=174  Identities=29%  Similarity=0.388  Sum_probs=146.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC-ccceeeEEeeCC-----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRK-----  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  291 (397)
                      ..|+..++||+|+||+||+|+.. +|+.||+|+++.....+. .-....+|+.++++++|+| |+++++++....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG-~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEG-VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccC-CCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            44666778999999999999854 789999999987654211 1244568999999999999 999999998876     


Q ss_pred             -EeeEEEeeccCCCchhhcccCCCc-cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          292 -CMFLIYEYMERGSLFCNLHNNEDA-VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       292 -~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                       ..++|+||++ .+|..++...... ..++...+..+++|+++||+|||   +++|+||||||.|||++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             8999999996 4898888765432 34666789999999999999999   6799999999999999999999999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      +|+....+....+..++|.+|.|||++|
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLl  193 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLL  193 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhc
Confidence            9997765555566678999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.8e-32  Score=244.91  Aligned_cols=168  Identities=27%  Similarity=0.448  Sum_probs=143.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc--ccCCccceeeEEeeCC----
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRNIVKLYGFCLHRK----  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----  291 (397)
                      ..+..+.+.||+|.||.||+|+|. |+.||||++...+.      +.+.+|.++++.+  +|+||+.+++.-..+.    
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-CCceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            356778899999999999999995 88999999976553      4567799998875  8999999998765433    


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-----DCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      .+|+|++|.+.|+|.|++...    .++....++++..+|.||++||.     +..+.|.|||||+.||||..++.+.|+
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            589999999999999999864    47888999999999999999995     457789999999999999999999999


Q ss_pred             ccccccccCCCCC----CeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      |+|+|-....+..    .....+||.+|||||++
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvL  392 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVL  392 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHh
Confidence            9999987655432    23456899999999985

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=9.4e-32  Score=256.54  Aligned_cols=150  Identities=27%  Similarity=0.417  Sum_probs=133.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++............+.+|+.++.+++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999764 68899999997654444444567888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            9999999999987543   4788999999999999999999   679999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=254.74  Aligned_cols=169  Identities=27%  Similarity=0.511  Sum_probs=143.2

Q ss_pred             CCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      .+...+.||+|.||.||.|++.....||+|.++......    +.|.+|+++|++++|++||+++++|..++.+||||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            345567799999999999999888899999998875443    6788999999999999999999999999899999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      |+.|+|.++++.. ....+...+.+.++.|||+||+||+   ++++|||||.+.||||+++..+||+|||+|+...++..
T Consensus       283 m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  283 MPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             cccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            9999999999873 2345788999999999999999999   67999999999999999999999999999995443332


Q ss_pred             Ceeecc-ccccccCCCCC
Q 043586          380 NRTLLA-GTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~-gt~~y~APE~~  396 (397)
                      ..+.-. -...|.|||.+
T Consensus       359 ~~~~~~kfPIkWtAPEa~  376 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEAL  376 (468)
T ss_pred             eecCCCCCCceecCHHHH
Confidence            222111 13359999975

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=2.9e-31  Score=249.18  Aligned_cols=166  Identities=23%  Similarity=0.338  Sum_probs=142.2

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.||+|+||.||+|+.. +++.||+|+++............+.+|++++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            35999999999999764 78999999998654333334467788999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9998886543   4788899999999999999999   669999999999999999999999999999865433333445


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..||+.|+|||++
T Consensus       155 ~~gt~~y~aPE~~  167 (323)
T cd05571         155 FCGTPEYLAPEVL  167 (323)
T ss_pred             eecCccccChhhh
Confidence            6799999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.6e-33  Score=259.18  Aligned_cols=167  Identities=32%  Similarity=0.426  Sum_probs=144.8

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |...+.||.|+||.||.|++. +.+.||||++............++.+|++.|.+++|||++.+.|+|......|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            555677999999999999864 6789999999876655555567889999999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      |- |+-.+++.-.+  .++.+.++..|+.+.+.||+|||   +.+.||||||..|||+++.|.|||+|||.|....+.. 
T Consensus       108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn-  180 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN-  180 (948)
T ss_pred             Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence            95 57777776443  24778888999999999999999   7799999999999999999999999999998765433 


Q ss_pred             CeeeccccccccCCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~l  397 (397)
                         .++|||+|||||+||
T Consensus       181 ---sFvGTPywMAPEVIL  195 (948)
T KOG0577|consen  181 ---SFVGTPYWMAPEVIL  195 (948)
T ss_pred             ---cccCCccccchhHhe
Confidence               479999999999986

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.4e-31  Score=255.57  Aligned_cols=173  Identities=26%  Similarity=0.373  Sum_probs=147.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3568999999999999999999865 578999999875433333334567889999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999988643    3678888999999999999999   6699999999999999999999999999998764


Q ss_pred             CCCC-CeeeccccccccCCCCC
Q 043586          376 ADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      .... ......||+.|+|||++
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             cCCceecccCCCCcccCCHHHH
Confidence            3322 22345799999999964

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.8e-31  Score=254.65  Aligned_cols=149  Identities=27%  Similarity=0.380  Sum_probs=132.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999754 78999999987654434444577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999887542   4778888999999999999999   67999999999999999999999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-31  Score=254.27  Aligned_cols=151  Identities=28%  Similarity=0.442  Sum_probs=134.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...........+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999999865 68899999998654433344567888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            9999999999887543   4788999999999999999999   6699999999999999999999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2e-33  Score=237.38  Aligned_cols=172  Identities=28%  Similarity=0.443  Sum_probs=147.3

Q ss_pred             HhcCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..+.|++.+.||+|+|+.||++. .++|+.+|+|++........ ..+++.+|+++.+.++||||+++.+.+.+....|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            34678888999999999999985 45799999999876654433 35778899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~  372 (397)
                      |+|+|.|++|..-+-.+   ...++..+-..++||++||.|+|   .++|||||+||+|+++..   ...+||+|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999997655433   34778888899999999999999   779999999999999953   4568999999999


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+. +......++|||+|||||++
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvv  184 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVL  184 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHh
Confidence            887 55556678899999999975

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=2.7e-31  Score=249.96  Aligned_cols=169  Identities=27%  Similarity=0.435  Sum_probs=146.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++..++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56899999999999999999875 68899999997654443344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999887543   4678888899999999999999   669999999999999999999999999999866432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .   ....||+.|+|||++
T Consensus       172 ~---~~~~gt~~y~aPE~~  187 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVI  187 (329)
T ss_pred             c---ceecCChhhcCHHHH
Confidence            2   235799999999974

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.5e-32  Score=255.66  Aligned_cols=172  Identities=24%  Similarity=0.385  Sum_probs=149.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +-|++++.||.|+.|.|..|++ .+|+.+|||++.............+.+|+-+|+-+.|||++++++++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477889999999999999986 489999999998763322222356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|.|++++-..+   .+++.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-. +
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-P  164 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence            9999999999997654   4788999999999999999999   5689999999999999999999999999998543 3


Q ss_pred             CCCeeeccccccccCCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~l  397 (397)
                      ..-..+.||+|.|+|||++.
T Consensus       165 gklLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             CccccccCCCcccCCchhhc
Confidence            33445578999999999873

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=4.7e-31  Score=253.34  Aligned_cols=149  Identities=21%  Similarity=0.331  Sum_probs=132.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999999754 688999999987554444445778899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999887543   3778888999999999999999   669999999999999999999999999998643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=3.3e-31  Score=250.17  Aligned_cols=169  Identities=27%  Similarity=0.411  Sum_probs=145.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCC--CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|.+.+  +..||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            469999999999999999997543  468999998765443333456788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            99999999999987543   4788889999999999999999   66999999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .   .....||+.|+|||++
T Consensus       184 ~---~~~~~gt~~y~aPE~~  200 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEIL  200 (340)
T ss_pred             C---cceecCChhhcCHHHH
Confidence            2   2345799999999974

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=7.4e-32  Score=231.21  Aligned_cols=177  Identities=29%  Similarity=0.448  Sum_probs=152.1

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccch-----HHHHHHHHHHHHHHHHhhc-ccCCccceee
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQV-LHRNIVKLYG  285 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  285 (397)
                      .-...-+.|+-.+.+|.|..++|.++.. ++|+.+|+|++.....     .....++..++|+.+|+++ .||+|+++.+
T Consensus        11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D   90 (411)
T KOG0599|consen   11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD   90 (411)
T ss_pred             hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence            3345566788889999999999998854 5789999999864321     2344567788999999999 5999999999


Q ss_pred             EEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEE
Q 043586          286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV  365 (397)
Q Consensus       286 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  365 (397)
                      +|+.+...++|+|.|+.|.|.+++...   ..+++.+..+|++|+.+|++|||   .+.||||||||+|||+|++.++||
T Consensus        91 ~yes~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~i  164 (411)
T KOG0599|consen   91 VYESDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKI  164 (411)
T ss_pred             eccCcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEE
Confidence            999999999999999999999999653   45889999999999999999999   668999999999999999999999


Q ss_pred             eccccccccCCCCCCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +|||+|+.+..+.. ....+|||+|.|||.+
T Consensus       165 sDFGFa~~l~~Gek-LrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  165 SDFGFACQLEPGEK-LRELCGTPGYLAPETI  194 (411)
T ss_pred             eccceeeccCCchh-HHHhcCCCcccChhhe
Confidence            99999998876544 4457899999999975

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.2e-31  Score=248.55  Aligned_cols=169  Identities=26%  Similarity=0.392  Sum_probs=147.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|++++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36899999999999999999875 58899999998654443344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999986543   4788889999999999999999   66999999999999999999999999999986543 


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                        ......||+.|+|||++
T Consensus       154 --~~~~~~gt~~y~aPE~~  170 (333)
T cd05600         154 --YANSVVGSPDYMAPEVL  170 (333)
T ss_pred             --ccCCcccCccccChhHh
Confidence              22345699999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=6.1e-31  Score=252.72  Aligned_cols=148  Identities=20%  Similarity=0.319  Sum_probs=131.3

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++.+.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999864 688999999976544434445678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999886542   3678888999999999999999   66999999999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=8.5e-31  Score=246.45  Aligned_cols=166  Identities=24%  Similarity=0.352  Sum_probs=141.9

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.||+|+||.||+++.. +++.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            35899999999999864 68999999998654333334567888999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9988876532   4788999999999999999999   679999999999999999999999999999865433333344


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..||+.|+|||++
T Consensus       155 ~~gt~~y~aPE~~  167 (328)
T cd05593         155 FCGTPEYLAPEVL  167 (328)
T ss_pred             ccCCcCccChhhh
Confidence            6799999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=5.6e-31  Score=252.48  Aligned_cols=149  Identities=21%  Similarity=0.323  Sum_probs=131.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36899999999999999999864 68899999997654433333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|..
T Consensus        81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            9999999999987543   3678888899999999999999   66999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=8.4e-31  Score=246.00  Aligned_cols=166  Identities=23%  Similarity=0.344  Sum_probs=141.4

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.||+|+||.||+++.. +++.||+|+++............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            35899999999999864 68999999998654333333467788999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|..++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9988876532   4788999999999999999999   669999999999999999999999999998864333333344


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..||+.|+|||++
T Consensus       155 ~~gt~~y~aPE~~  167 (323)
T cd05595         155 FCGTPEYLAPEVL  167 (323)
T ss_pred             ccCCcCcCCcccc
Confidence            5799999999985

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=245.52  Aligned_cols=169  Identities=29%  Similarity=0.452  Sum_probs=146.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46889999999999999999865 68899999997654433334567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999887543   4788889999999999999999   669999999999999999999999999999866432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .   ....||+.|+|||++
T Consensus       155 ~---~~~~gt~~y~aPE~~  170 (291)
T cd05612         155 T---WTLCGTPEYLAPEVI  170 (291)
T ss_pred             c---ccccCChhhcCHHHH
Confidence            2   235699999999964

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-31  Score=248.75  Aligned_cols=172  Identities=28%  Similarity=0.452  Sum_probs=151.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  294 (397)
                      ..+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+.........+...+|+.+|+++. ||||++++++|++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            4467888999999999999999876 59999999998766543333467889999999998 999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC----CCeEEecccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----FEAFVADFGT  370 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~DFG~  370 (397)
                      +|||++.||.|.+.+...    .+++..+..++.|++.++.|||   +.||+|||+||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998765    2889999999999999999999   6799999999999999633    5799999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |..... .......+|||.|+|||++
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl  210 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVL  210 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhh
Confidence            998876 4455667899999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-32  Score=254.16  Aligned_cols=178  Identities=29%  Similarity=0.506  Sum_probs=151.7

Q ss_pred             cHHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       210 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ..+++....+.+.+...||+|+||+||+|+|-  -.||||+++...-.+. ..+.|.+|+.++++-+|.||+-+.|||..
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            34566666777888899999999999999984  4699999988765544 57899999999999999999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      +.. .||+.+|+|.+|..+++-.+  ..++..+.+.|+.||++||.|||   .++|||||||..|||++++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEeccc
Confidence            887 99999999999999998654  35888999999999999999999   6799999999999999999999999999


Q ss_pred             cccccCC--CCCCeeeccccccccCCCCC
Q 043586          370 TARLLHA--DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~--~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++..-..  .........|...|||||++
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvI  562 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVI  562 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHH
Confidence            9874322  11222334578889999986

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.4e-31  Score=245.22  Aligned_cols=164  Identities=27%  Similarity=0.408  Sum_probs=140.9

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||.||+|+.. +++.||+|+++............+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999865 5789999999765433333456788899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecc
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA  385 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  385 (397)
                      .+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99887543   4788899999999999999999   66999999999999999999999999999986544333344467


Q ss_pred             ccccccCCCCC
Q 043586          386 GTYGYIAPGLP  396 (397)
Q Consensus       386 gt~~y~APE~~  396 (397)
                      ||+.|+|||++
T Consensus       155 gt~~y~aPE~~  165 (312)
T cd05585         155 GTPEYLAPELL  165 (312)
T ss_pred             CCcccCCHHHH
Confidence            99999999974

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9e-31  Score=246.64  Aligned_cols=173  Identities=30%  Similarity=0.423  Sum_probs=147.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...........+.+.+|..++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47899999999999999999865 68899999997644433344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999999865322  4788889999999999999999   669999999999999999999999999999766443


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....||+.|+|||++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~  175 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEIL  175 (331)
T ss_pred             CCccccceeccccccCHHHH
Confidence            322 2334699999999974

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=6.9e-31  Score=250.95  Aligned_cols=178  Identities=25%  Similarity=0.363  Sum_probs=149.9

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      .++....++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344445688999999999999999999865 6789999998754433333345678899999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      +..|+||||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999988643    3677888899999999999999   66999999999999999999999999999


Q ss_pred             ccccCCCCC-CeeeccccccccCCCCC
Q 043586          371 ARLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ++....... ......||+.|+|||++
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVL  215 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHH
Confidence            987643322 22345799999999974

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=1.7e-30  Score=244.24  Aligned_cols=167  Identities=22%  Similarity=0.336  Sum_probs=140.8

Q ss_pred             ceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.||+|+||.||+++. .+++.||+|++.............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3589999999999975 478999999998654333333466778999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|.+++....   .+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT  155 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence            9988876532   478899999999999999999941  58999999999999999999999999999864433333344


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (325)
T cd05594         156 FCGTPEYLAPEVL  168 (325)
T ss_pred             ccCCcccCCHHHH
Confidence            5799999999974

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1e-31  Score=250.08  Aligned_cols=173  Identities=25%  Similarity=0.432  Sum_probs=154.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE-eeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC-MFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv  296 (397)
                      ++|..++++|+|+||.++.++++ +++.||+|++.......+. ++...+|+.++++++|||||.+.+.|..++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57889999999999999999765 6789999999877655443 3467789999999999999999999999887 9999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |+||+||++.+.+.+.+ ...+++.++..++.|++.|+.|||   ++.|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998765 346899999999999999999999   56899999999999999999999999999999887


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ......+.+|||.||.||++
T Consensus       159 ~~~~a~tvvGTp~YmcPEil  178 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEIL  178 (426)
T ss_pred             chhhhheecCCCcccCHHHh
Confidence            76566678899999999974

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=1.8e-30  Score=239.49  Aligned_cols=172  Identities=26%  Similarity=0.359  Sum_probs=145.1

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.............+.+|++++++++|+||+++++++.+++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377789999999999999986 4789999999876544333334567889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|+|.+.+..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            9999999887754322 24788999999999999999999   6699999999999999999999999999998754332


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      . .....||+.|+|||++
T Consensus       157 ~-~~~~~g~~~y~aPE~~  173 (285)
T cd05631         157 T-VRGRVGTVGYMAPEVI  173 (285)
T ss_pred             e-ecCCCCCCCccCHhhh
Confidence            2 2335699999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=1.1e-30  Score=249.07  Aligned_cols=150  Identities=25%  Similarity=0.422  Sum_probs=133.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++............+.+|+.++..++||||+++++.+.+.+..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999865 68899999997654433344567888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            9999999999887543   4788889999999999999999   679999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.97  E-value=9.2e-31  Score=250.12  Aligned_cols=172  Identities=27%  Similarity=0.375  Sum_probs=146.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+++.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            467999999999999999999865 6889999999764433333345677899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999988643    3677788889999999999999   66999999999999999999999999999987643


Q ss_pred             CCC-CeeeccccccccCCCCC
Q 043586          377 DSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ... ......||+.|+|||++
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~  215 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHh
Confidence            322 22345799999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=1.4e-30  Score=245.33  Aligned_cols=173  Identities=27%  Similarity=0.401  Sum_probs=147.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+...........+.+.+|..++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999865 67889999987644333333466888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999875322  4788889999999999999999   679999999999999999999999999999876543


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....||+.|+|||++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~  175 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEIL  175 (331)
T ss_pred             CceeeccccCCcccCCHHHH
Confidence            322 2335699999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=9.2e-32  Score=240.18  Aligned_cols=165  Identities=28%  Similarity=0.438  Sum_probs=135.3

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----Eee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CMF  294 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  294 (397)
                      |...+.+|.|+||.||+|... +++.||||+.-.+....       .+|+++|+.++|||||++.-+|....     ...
T Consensus        26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            566788999999999999864 57899999987765332       35999999999999999998886532     345


Q ss_pred             EEEeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEecccccc
Q 043586          295 LIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTAR  372 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG~a~  372 (397)
                      +|||||+. +|.+.++.. .....++.-.++-+++|+.+||.|||   ..+|+||||||.|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999975 898888742 12234677778889999999999999   5699999999999999975 999999999999


Q ss_pred             ccCCCCCCeeeccccccccCCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      .+..+... .....|..|+|||+++
T Consensus       175 ~L~~~epn-iSYicSRyYRaPELif  198 (364)
T KOG0658|consen  175 VLVKGEPN-ISYICSRYYRAPELIF  198 (364)
T ss_pred             eeccCCCc-eeEEEeccccCHHHHc
Confidence            88766555 3356899999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.97  E-value=2.7e-30  Score=242.74  Aligned_cols=171  Identities=23%  Similarity=0.354  Sum_probs=143.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccC-CccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  297 (397)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.++|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999865 5789999999865433333346778899999999765 5888999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998886543   3778899999999999999999   669999999999999999999999999998754333


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~  173 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEII  173 (324)
T ss_pred             CCceeeecCCccccChhhh
Confidence            3334456799999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.6e-32  Score=245.62  Aligned_cols=170  Identities=35%  Similarity=0.463  Sum_probs=150.7

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ..|...+.||+|+||.||+|.+ ..++.||+|++......+.  .++.++|+.++++++++||.++|+.+..+..+|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de--Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE--IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            3467778899999999999975 4789999999987665543  478899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||.||++.+.++...   .+++....-++++++.|+.|+|   ..+.+|||||+.|||+..+|.+|++|||++.++...
T Consensus        91 ey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999997543   2366677778999999999999   568999999999999999999999999999998877


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .....+++|||.|||||++
T Consensus       165 ~~rr~tfvGTPfwMAPEVI  183 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVI  183 (467)
T ss_pred             hhccccccccccccchhhh
Confidence            7777889999999999987

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.97  E-value=2.4e-30  Score=243.06  Aligned_cols=169  Identities=23%  Similarity=0.402  Sum_probs=141.0

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHH---hhcccCCccceeeEEeeCCEeeEE
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      |++.+.||+|+||.||+|++. +++.||||+++..........+.+.+|.+++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            677889999999999999764 6899999999865433333345566666655   566799999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|...+...    .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            9999999998877542    4788999999999999999999   66999999999999999999999999999876543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........||+.|+|||++
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~  173 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVL  173 (324)
T ss_pred             CCCcccccccCccccCHhHh
Confidence            33334456799999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.97  E-value=2.5e-30  Score=243.62  Aligned_cols=173  Identities=28%  Similarity=0.406  Sum_probs=148.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46899999999999999999864 68899999998765433344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.....  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            99999999999876422  4788889999999999999999   669999999999999999999999999999876543


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....||+.|+|||++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~  175 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVL  175 (330)
T ss_pred             CceeeecccCCccccCHHHh
Confidence            322 2334699999999974

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1e-30  Score=248.27  Aligned_cols=172  Identities=28%  Similarity=0.427  Sum_probs=148.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++............+.+|++++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46899999999999999999865 68999999998654433334567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998764   24788899999999999999999   679999999999999999999999999999876543


Q ss_pred             C-----------------------------CCeeeccccccccCCCCC
Q 043586          378 S-----------------------------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~-----------------------------~~~~~~~gt~~y~APE~~  396 (397)
                      .                             .......||+.|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL  202 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            3                             122335699999999974

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=238.47  Aligned_cols=167  Identities=32%  Similarity=0.467  Sum_probs=149.4

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      -|+++.++|+|+||.||+|.+ .+|+.+|+|.+.....     .+++.+|+.++++++.|++|++||.|.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            366778899999999999965 5799999999876542     3678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||..|+..+.++.+.  ..+++.++..+++..++||+|||   ...-+|||||..|||++.+|.+||+|||.|..+.+..
T Consensus       109 YCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            999999999998654  35889999999999999999999   4577999999999999999999999999999988877


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      ....+..|||.|||||++
T Consensus       184 AKRNTVIGTPFWMAPEVI  201 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVI  201 (502)
T ss_pred             HhhCccccCcccccHHHH
Confidence            777788999999999975

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.97  E-value=2e-30  Score=239.53  Aligned_cols=170  Identities=26%  Similarity=0.383  Sum_probs=142.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++......  ....+.+|++++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC--cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            56999999999999999999865 68899999987543221  1245678999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++ +|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99975 88888764332  3678889999999999999999   669999999999999999999999999999865443


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~  175 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVL  175 (288)
T ss_pred             CccccCceecccccChHHh
Confidence            3333345689999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=3.3e-30  Score=242.55  Aligned_cols=166  Identities=23%  Similarity=0.377  Sum_probs=141.4

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            35899999999999864 6889999999875544444456788899999998 699999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            99988876432   4788999999999999999999   66999999999999999999999999999975433333334


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (329)
T cd05588         155 TFCGTPNYIAPEIL  168 (329)
T ss_pred             cccCCccccCHHHH
Confidence            46799999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=3.7e-30  Score=242.57  Aligned_cols=173  Identities=31%  Similarity=0.407  Sum_probs=146.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.+|+|++...........+.+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999865 57889999987644333333456888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            99999999999975322  4788889999999999999999   669999999999999999999999999999765433


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....||+.|+|||++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~  175 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEIL  175 (332)
T ss_pred             CcceecccccCccccCHHHH
Confidence            322 2335699999999974

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=2.5e-30  Score=244.41  Aligned_cols=174  Identities=25%  Similarity=0.373  Sum_probs=140.4

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||.||+|.+      .+++.||+|+++......  ..+.+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATAS--EHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchH--HHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            46799999999999999999963      235689999987543322  236788999999999 899999999988764


Q ss_pred             -CEeeEEEeeccCCCchhhcccCCC-------------------------------------------------------
Q 043586          291 -KCMFLIYEYMERGSLFCNLHNNED-------------------------------------------------------  314 (397)
Q Consensus       291 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  314 (397)
                       +..++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             468999999999999988864321                                                       


Q ss_pred             ----ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccc
Q 043586          315 ----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTY  388 (397)
Q Consensus       315 ----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~  388 (397)
                          ...+++.++..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++........  .....+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                123677888999999999999999   669999999999999999999999999999865433221  12234678


Q ss_pred             cccCCCCC
Q 043586          389 GYIAPGLP  396 (397)
Q Consensus       389 ~y~APE~~  396 (397)
                      .|+|||++
T Consensus       241 ~y~aPE~~  248 (338)
T cd05102         241 KWMAPESI  248 (338)
T ss_pred             cccCcHHh
Confidence            89999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.97  E-value=4.2e-30  Score=241.32  Aligned_cols=171  Identities=24%  Similarity=0.364  Sum_probs=143.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|..++..+ .|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788999999999999999865 5789999999865433333345667788888887 5899999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+.+....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999998886543   4788899999999999999999   669999999999999999999999999999865433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~  173 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEII  173 (323)
T ss_pred             CCccccCCCChhhcCHHHh
Confidence            3334456799999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.97  E-value=3.2e-30  Score=239.95  Aligned_cols=171  Identities=27%  Similarity=0.383  Sum_probs=142.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........  ...+.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc--chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            367999999999999999999875 688999999875432211  24567899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||++ +++.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 57877776432  24778889999999999999999   66999999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~  175 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVL  175 (303)
T ss_pred             CCccCCCCcccCCCCChHHH
Confidence            33333345689999999964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=5.4e-30  Score=240.52  Aligned_cols=166  Identities=28%  Similarity=0.431  Sum_probs=139.6

Q ss_pred             ceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          225 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      +.||+|+||.||+++.    .+++.||+|.++..... .......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999975    35789999999764322 122235677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++....   .+.+..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999886543   3677788889999999999999   66999999999999999999999999999986544333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......||+.|+|||++
T Consensus       156 ~~~~~~gt~~y~aPE~~  172 (323)
T cd05584         156 VTHTFCGTIEYMAPEIL  172 (323)
T ss_pred             cccccCCCccccChhhc
Confidence            33445799999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.97  E-value=5.1e-30  Score=241.27  Aligned_cols=166  Identities=25%  Similarity=0.395  Sum_probs=140.3

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            35999999999999865 6789999999875433333446677899888877 799999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99988876432   4788899999999999999999   66999999999999999999999999999986443333334


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (329)
T cd05618         155 TFCGTPNYIAPEIL  168 (329)
T ss_pred             cccCCccccCHHHH
Confidence            46799999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.97  E-value=7.2e-30  Score=239.72  Aligned_cols=166  Identities=29%  Similarity=0.426  Sum_probs=137.3

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHH-HHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|++...........+++.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            35999999999999875 68999999997654333222344555554 56788999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99998886533   4788889999999999999999   66999999999999999999999999999986543333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (323)
T cd05575         155 TFCGTPEYLAPEVL  168 (323)
T ss_pred             cccCChhhcChhhh
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.97  E-value=6.8e-30  Score=239.68  Aligned_cols=166  Identities=26%  Similarity=0.390  Sum_probs=136.8

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHH-HHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|++.............+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999875 68899999997654333333345555554 67889999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      ++|...+....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            99988776432   4678888899999999999999   66999999999999999999999999999986433333334


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (321)
T cd05603         155 TFCGTPEYLAPEVL  168 (321)
T ss_pred             cccCCcccCCHHHh
Confidence            46799999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.8e-30  Score=232.58  Aligned_cols=151  Identities=24%  Similarity=0.327  Sum_probs=136.8

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||.|.-|+||.++..+ +..+|+|++.+.....+....+.+.|-+||+.++||.++.+|..++.+...|+||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            346777889999999999999764 5899999999887776666788889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |||+||+|....+++.. ..+++..+.-++..|+-||+|||   ..|||.|||||+||||.++|.+.|+||.++..
T Consensus       157 eyCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             ecCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            99999999988876544 46899999999999999999999   77999999999999999999999999998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.97  E-value=4.2e-30  Score=240.96  Aligned_cols=166  Identities=26%  Similarity=0.434  Sum_probs=139.8

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            35899999999999865 6889999999765433333346677888888877 699999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99998886543   4788899999999999999999   66999999999999999999999999999886543333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (320)
T cd05590         155 TFCGTPDYIAPEIL  168 (320)
T ss_pred             ccccCccccCHHHH
Confidence            46799999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.5e-31  Score=230.93  Aligned_cols=172  Identities=25%  Similarity=0.361  Sum_probs=152.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|+..+.+|+|.||.|-.++-+ +++.||+|++++..............|-++|+..+||.+..+.-.|+..+++|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            56889999999999999999754 78999999998876554444566678999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||..||.|.-++....   .+++....-+...|+.||.|||   +++||.||+|.+|.|+|.||.+||+|||+++.-...
T Consensus       248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999988886532   4788888889999999999999   679999999999999999999999999999977666


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .....+++|||.|.|||++
T Consensus       322 g~t~kTFCGTPEYLAPEVl  340 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVL  340 (516)
T ss_pred             cceeccccCChhhcCchhh
Confidence            6677889999999999986

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=243.08  Aligned_cols=174  Identities=30%  Similarity=0.433  Sum_probs=150.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+...++++||+|.||.|..|....+..||||+++.......  +++|.+|+++|.+++||||++++|+|..++.+++++
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~--r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNA--RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhH--HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            345667889999999999999998889999999998776543  589999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.+++..+.... ......++|+.||+.||+||.   +.++||||+.+.|+|+|.++++||+|||+++.+..+
T Consensus       615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence            9999999999998764332 455667889999999999999   679999999999999999999999999999977655


Q ss_pred             CCCe--eeccccccccCCCCCC
Q 043586          378 SSNR--TLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~~~~--~~~~gt~~y~APE~~l  397 (397)
                      ....  ...+-..+|||||.+|
T Consensus       691 ~yy~vqgr~vlpiRwmawEsil  712 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESIL  712 (807)
T ss_pred             CceeeecceeeeeeehhHHHHH
Confidence            5432  2234567899999764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.97  E-value=5.8e-30  Score=238.27  Aligned_cols=173  Identities=25%  Similarity=0.388  Sum_probs=141.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-----------------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCcc
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV  281 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  281 (397)
                      ++|.+.+.||+|+||.||+|.+.+                 +..||+|.+.......  ...++.+|++++.+++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKN--ARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHH--HHHHHHHHHHHHhhcCCCCee
Confidence            578899999999999999997532                 3469999987654332  246788999999999999999


Q ss_pred             ceeeEEeeCCEeeEEEeeccCCCchhhcccCC----------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043586          282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  345 (397)
Q Consensus       282 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  345 (397)
                      ++++++...+..++||||+++++|.+++....                ....+++..+.+++.|++.||.|||   +.+|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            99999999999999999999999998875421                1124677889999999999999999   6689


Q ss_pred             EEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       346 vH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +||||||+|||++.++.+||+|||+++........  .....++..|+|||++
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  212 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECI  212 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHH
Confidence            99999999999999999999999999865433221  1223457889999974

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.97  E-value=6.4e-30  Score=239.28  Aligned_cols=166  Identities=26%  Similarity=0.422  Sum_probs=137.9

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            35999999999999865 5788999999865433333334556677777654 799999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99998886543   4788889999999999999999   66999999999999999999999999999986544333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (316)
T cd05592         155 TFCGTPDYIAPEIL  168 (316)
T ss_pred             cccCCccccCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=5.6e-30  Score=240.41  Aligned_cols=171  Identities=23%  Similarity=0.365  Sum_probs=143.5

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +|+..+.||+|+||.||+|+.. +++.||+|++...........+.+..|..+++.+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999864 68899999998654333333466778999998886 577888999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998886532   4788999999999999999999   669999999999999999999999999999865433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       155 ~~~~~~~~gt~~y~aPE~~  173 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEII  173 (323)
T ss_pred             CccccCccCCccccCHHHH
Confidence            3333445799999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.97  E-value=5e-30  Score=240.57  Aligned_cols=165  Identities=25%  Similarity=0.409  Sum_probs=139.6

Q ss_pred             eeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      .||+|+||.||+|+.. +++.||+|++...........+.+..|.+++..+ +||||+++++++...+..|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            5899999999999865 5789999999765433333346677899998876 7999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|...+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...........
T Consensus        82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  155 (321)
T cd05591          82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT  155 (321)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence            9988886543   4788889999999999999999   669999999999999999999999999999865443333445


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..||+.|+|||++
T Consensus       156 ~~gt~~y~aPE~~  168 (321)
T cd05591         156 FCGTPDYIAPEIL  168 (321)
T ss_pred             cccCccccCHHHH
Confidence            6799999999964

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.97  E-value=8.2e-30  Score=234.50  Aligned_cols=167  Identities=28%  Similarity=0.382  Sum_probs=141.7

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||+||++... +++.||+|++...........+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            689999999999764 6889999999765544433446778899999999999999999999999999999999999999


Q ss_pred             hhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeec
Q 043586          306 FCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL  384 (397)
Q Consensus       306 ~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  384 (397)
                      .+.+.... ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.............
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            87775322 2235889999999999999999999   6699999999999999999999999999998765544434445


Q ss_pred             cccccccCCCCC
Q 043586          385 AGTYGYIAPGLP  396 (397)
Q Consensus       385 ~gt~~y~APE~~  396 (397)
                      .||+.|+|||++
T Consensus       158 ~g~~~y~aPE~~  169 (280)
T cd05608         158 AGTPGFMAPELL  169 (280)
T ss_pred             CCCcCccCHHHh
Confidence            799999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.97  E-value=8.3e-30  Score=242.26  Aligned_cols=165  Identities=29%  Similarity=0.450  Sum_probs=139.3

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|+..+.||+|+||.||+|++. +++.||+|++......  ...+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED--TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcH--HHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            4566788999999999999864 6899999998654322  234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|....       ..++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999986432       2456677889999999999999   6699999999999999999999999999998765443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......||..|+|||++
T Consensus       223 ~~~~~~~gt~~y~aPE~~  240 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERI  240 (353)
T ss_pred             ccccccccCccccCcccc
Confidence            333445799999999975

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=9e-30  Score=239.27  Aligned_cols=166  Identities=29%  Similarity=0.423  Sum_probs=137.3

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHH-HHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            35899999999999864 68999999997654333333345555655 46778999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|..++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99988876432   4788899999999999999999   66999999999999999999999999999986443333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (325)
T cd05604         155 TFCGTPEYLAPEVI  168 (325)
T ss_pred             cccCChhhCCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.97  E-value=8.5e-30  Score=240.19  Aligned_cols=171  Identities=27%  Similarity=0.423  Sum_probs=143.7

Q ss_pred             CCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  293 (397)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...... .....+.+.+|+.+++.++ ||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999875    35789999998754322 2223456788999999994 99999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++|+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999886543   4788899999999999999999   66999999999999999999999999999986


Q ss_pred             cCCCCC-CeeeccccccccCCCCC
Q 043586          374 LHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ...... ......||+.|+|||++
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~  178 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEII  178 (332)
T ss_pred             ccccCCCccccccCCccccCHHHh
Confidence            543322 22345799999999974

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=1.1e-29  Score=238.71  Aligned_cols=166  Identities=25%  Similarity=0.389  Sum_probs=141.9

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36999999999999864 6789999999876544444456788899999888 699999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|..++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99988876432   4788999999999999999999   66999999999999999999999999999986433333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ..+||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (327)
T cd05617         155 TFCGTPNYIAPEIL  168 (327)
T ss_pred             cccCCcccCCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=1.2e-29  Score=238.35  Aligned_cols=166  Identities=27%  Similarity=0.389  Sum_probs=135.6

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHH-HHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEA-QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|++.............+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            35999999999999865 5788999999765433222223444444 456788999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      ++|.+++....   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99998887533   3677888889999999999999   66999999999999999999999999999986543333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (325)
T cd05602         155 TFCGTPEYLAPEVL  168 (325)
T ss_pred             cccCCccccCHHHH
Confidence            56799999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=1.4e-29  Score=236.97  Aligned_cols=166  Identities=25%  Similarity=0.412  Sum_probs=138.2

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|++. +++.||+|.++..........+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36999999999999875 6889999999765432222235566788888765 899999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            99998886532   4788889999999999999999   66999999999999999999999999999875433333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (316)
T cd05620         155 TFCGTPDYIAPEIL  168 (316)
T ss_pred             ccCCCcCccCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.96  E-value=1.4e-29  Score=237.18  Aligned_cols=165  Identities=27%  Similarity=0.381  Sum_probs=140.3

Q ss_pred             ceeecCCcccEEEEEc----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          225 YCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      +.||+|+||.||+++.    .+++.||+|++....... .....+.+|++++++++||||+++++++..++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5699999999999874    367899999997644322 22345678999999999999999999999999999999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      ++|+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            9999998886532   4788999999999999999999   669999999999999999999999999999876544333


Q ss_pred             eeeccccccccCCCCC
Q 043586          381 RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ~~~~~gt~~y~APE~~  396 (397)
                      .....||+.|+|||++
T Consensus       155 ~~~~~g~~~y~aPE~~  170 (318)
T cd05582         155 AYSFCGTVEYMAPEVV  170 (318)
T ss_pred             eecccCChhhcCHHHH
Confidence            4456799999999974

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=2.2e-29  Score=235.67  Aligned_cols=166  Identities=27%  Similarity=0.437  Sum_probs=137.9

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            35999999999999865 5789999999865432222234566788888764 899999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            99999886532   4778889999999999999999   66999999999999999999999999999986443333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (316)
T cd05619         155 TFCGTPDYIAPEIL  168 (316)
T ss_pred             eecCCccccCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-30  Score=243.68  Aligned_cols=179  Identities=30%  Similarity=0.421  Sum_probs=145.8

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcC--CC--cE-EEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEE
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP--NG--KV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC  287 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  287 (397)
                      .|+-..++..+.+.||+|+||.||+|++.  ++  .. ||||..+.........+++|.+|+++++.++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34444556667789999999999999764  22  23 899998864433344568999999999999999999999999


Q ss_pred             eeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          288 LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       288 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                      ......++|||+|+||+|.++++..+.  .++..+...++.+.|.||+|||   +++++||||..+|+|++.++.+||+|
T Consensus       231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  231 VLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             cCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCc
Confidence            999999999999999999999997654  4888999999999999999999   67999999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+++.-..........--...|+|||.+
T Consensus       306 FGLs~~~~~~~~~~~~~klPirWLAPEtl  334 (474)
T KOG0194|consen  306 FGLSRAGSQYVMKKFLKKLPIRWLAPETL  334 (474)
T ss_pred             cccccCCcceeeccccccCcceecChhhh
Confidence            99988543111111111134579999974

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.96  E-value=1.5e-29  Score=257.64  Aligned_cols=175  Identities=29%  Similarity=0.440  Sum_probs=145.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999865 58999999997654433344578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCC--------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          298 EYMERGSLFCNLHNNE--------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      ||++|++|.+++....        .....++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999998886421        1123566778899999999999999   6699999999999999999999999999


Q ss_pred             cccccCCCC------------------CCeeeccccccccCCCCC
Q 043586          370 TARLLHADS------------------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~------------------~~~~~~~gt~~y~APE~~  396 (397)
                      +++......                  ......+||+.|||||++
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l  203 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERL  203 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHh
Confidence            998662111                  011124699999999974

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3e-29  Score=231.33  Aligned_cols=172  Identities=27%  Similarity=0.354  Sum_probs=145.5

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||++... +++.||+|++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788899999999999999864 688999999976544433334567789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|+|.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            999999988876432 234788999999999999999999   6699999999999999999999999999998754332


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      . .....|++.|+|||++
T Consensus       157 ~-~~~~~~~~~y~aPE~~  173 (285)
T cd05605         157 T-IRGRVGTVGYMAPEVV  173 (285)
T ss_pred             c-cccccCCCCccCcHHh
Confidence            2 2334689999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-29  Score=237.05  Aligned_cols=164  Identities=26%  Similarity=0.396  Sum_probs=136.3

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      ||+|+||.||+|+.. +++.||+|++.............+..|..++...   .||||+++++++...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999865 6899999998764433333334555677777665   699999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++....   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            99998886532   4788999999999999999999   66999999999999999999999999999976544333344


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~gt~~y~aPE~~  168 (330)
T cd05586         155 TFCGTTEYLAPEVL  168 (330)
T ss_pred             CccCCccccCHHHH
Confidence            56799999999974

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=247.22  Aligned_cols=169  Identities=30%  Similarity=0.448  Sum_probs=145.1

Q ss_pred             CccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC------Eee
Q 043586          222 DIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------CMF  294 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  294 (397)
                      ...+.+|+|+||.||+|+. .+|+.||||.++.......  ++...+|++++++++|||||++++.-.+..      ...
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~--~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRP--RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhcccch--HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3456799999999999994 5899999999987654333  477889999999999999999999866543      468


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC--CCC--CeEEecccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKF--EAFVADFGT  370 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~--~~kl~DFG~  370 (397)
                      +|||||.||+|...+.+..+...+++.+.+.+..+++.||.|||   .++|+||||||.||++-  .+|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999998888888999999999999999999999   56999999999999984  334  469999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+.++++. ....++||+.|.+||+.
T Consensus       171 Arel~d~s-~~~S~vGT~~YLhPel~  195 (732)
T KOG4250|consen  171 ARELDDNS-LFTSLVGTEEYLHPELY  195 (732)
T ss_pred             cccCCCCC-eeeeecCchhhcChHHH
Confidence            99887665 45667899999999963

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-31  Score=262.63  Aligned_cols=179  Identities=29%  Similarity=0.398  Sum_probs=157.8

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      .++....++|++++.||+|+||.|..++.+ +++.||+|++.+.....+.....|..|-++|..-+.+-|++++-.|++.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344455678999999999999999999875 6889999999987666555567899999999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      .++|+|||||+||+|..++.+..   .+++..+.-++..|+-||.-+|   +.|+|||||||+|||+|..|.+||+|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999998765   4788888889999999999999   77999999999999999999999999999


Q ss_pred             ccccCCCCC-CeeeccccccccCCCCC
Q 043586          371 ARLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      +-.+..+.. .....+|||.|++||++
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvL  248 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVL  248 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHH
Confidence            988875544 44567899999999975

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=5.6e-29  Score=234.46  Aligned_cols=170  Identities=29%  Similarity=0.362  Sum_probs=145.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+......  ...+++.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999865 6788999998764322  2346788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999887543   378888999999999999999953  3699999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..  .....||+.|+|||++
T Consensus       157 ~~--~~~~~g~~~y~aPE~~  174 (331)
T cd06649         157 SM--ANSFVGTRSYMSPERL  174 (331)
T ss_pred             cc--cccCCCCcCcCCHhHh
Confidence            22  2335699999999975

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.4e-29  Score=239.49  Aligned_cols=171  Identities=26%  Similarity=0.413  Sum_probs=150.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ...|.+...||+|.|+.|..|+.. ++..||+|.+.+....... ++.+.+|+++|..++|||||+++.+......+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            456888999999999999999764 6899999999887655443 34488899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+.+|.+.+++..+..   ..+..+..++.|+..|++|||   ++.|||||||++|||++.+.++||+|||++.++..
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999987654   344778889999999999999   67899999999999999999999999999998874


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .. .....+|++.|+|||+.
T Consensus       208 ~~-~lqt~cgsppyAaPEl~  226 (596)
T KOG0586|consen  208 GL-MLQTFCGSPPYAAPELF  226 (596)
T ss_pred             cc-cccccCCCCCccChHhh
Confidence            33 44557899999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=5.2e-30  Score=251.02  Aligned_cols=175  Identities=25%  Similarity=0.452  Sum_probs=145.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ..+....+.||+|+||+||+|+..      +...||||.++.....+  .+.+|++|+++++.++|||||+++|.|..++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~--~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQ--ARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHH--HHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            345566788999999999999742      35679999998876553  3589999999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCC-----------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      ..++|+|||..|||.++|.....           +.+++..+.+.||.|||.||+||-   ++.+|||||..+|+||.+.
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            99999999999999999875321           234788999999999999999999   5689999999999999999


Q ss_pred             CCeEEeccccccccCCCCCCee--eccccccccCCCCCC
Q 043586          361 FEAFVADFGTARLLHADSSNRT--LLAGTYGYIAPGLPL  397 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~~~--~~~gt~~y~APE~~l  397 (397)
                      ..|||+|||+++..........  ...-..+|||||-|+
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl  678 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL  678 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence            9999999999997654332211  111245899999874

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=3.4e-29  Score=234.63  Aligned_cols=166  Identities=25%  Similarity=0.400  Sum_probs=140.4

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|+.. +++.||+|+++..........+.+.+|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            35999999999999865 5789999999865433333346677899999888 699999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      ++|...+....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99988886542   4788999999999999999999   67999999999999999999999999999976433333334


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...||+.|+|||++
T Consensus       155 ~~~g~~~y~aPE~~  168 (318)
T cd05570         155 TFCGTPDYIAPEIL  168 (318)
T ss_pred             ceecCccccCHHHh
Confidence            45799999999975

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-30  Score=228.38  Aligned_cols=174  Identities=28%  Similarity=0.393  Sum_probs=143.6

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-----
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  289 (397)
                      +....|...+.||+|+||.|+.+... +|+.||||++....... ...++..+|++++++++|+||+.+.+.+..     
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            34456666788999999999999764 78999999997443322 234677789999999999999999999876     


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      -...|+|+|+| +.+|...++...   .++...+..++.|+++||.|+|   +.+|+|||+||+|++++.+...||+|||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence            24699999999 469998887653   3788889999999999999999   6699999999999999999999999999


Q ss_pred             cccccCCC--CCCeeeccccccccCCCCCC
Q 043586          370 TARLLHAD--SSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       370 ~a~~~~~~--~~~~~~~~gt~~y~APE~~l  397 (397)
                      +|+.....  ....+..+.|.+|.|||+.+
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll  200 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLL  200 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHh
Confidence            99987543  22234567899999999864

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-30  Score=232.65  Aligned_cols=173  Identities=27%  Similarity=0.359  Sum_probs=151.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|..-+.||+|+||.||-++.+ +|+.||.|++.+.............+|-.+|+++..+.||.+-..|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            45777889999999999999754 79999999987765554444455678999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ..|.||+|.-+|.+.+. ..+++..++-++.+|+.||++||   ..+||.||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999987665 46899999999999999999999   669999999999999999999999999999987655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ...+||.+|||||++
T Consensus       341 ~~~-~~rvGT~GYMAPEvl  358 (591)
T KOG0986|consen  341 KPI-RGRVGTVGYMAPEVL  358 (591)
T ss_pred             Ccc-ccccCcccccCHHHH
Confidence            443 334899999999985

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=5.2e-29  Score=245.60  Aligned_cols=171  Identities=22%  Similarity=0.250  Sum_probs=142.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-C-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-N-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .|.+.+.||+|++|.||+|... + ++.||+|.+.......   ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~---~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQ---AAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4888999999999999999754 3 5778888775543322   256778999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++|+|.+++... .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999887642 22335788889999999999999999   66999999999999999999999999999987654


Q ss_pred             CCC--CeeeccccccccCCCCC
Q 043586          377 DSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ...  .....+||+.|+|||++
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~  243 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELW  243 (478)
T ss_pred             ccccccccccCCCccccCHhHh
Confidence            322  12345699999999974

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.96  E-value=7.9e-30  Score=245.91  Aligned_cols=185  Identities=33%  Similarity=0.516  Sum_probs=154.9

Q ss_pred             cCCcccHHHHHHHhcC---------CCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHH
Q 043586          205 YDGRIVYEDLIEATEG---------FDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQV  271 (397)
Q Consensus       205 ~~~~~~~~~~~~~~~~---------~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~  271 (397)
                      +.+..+|+|.-++...         ..+.+.||.|.||.||+|+++    ....||||.++....+..  +.+|..|+.|
T Consensus       606 YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gytekq--rrdFL~EAsI  683 (996)
T KOG0196|consen  606 YIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQ--RRDFLSEASI  683 (996)
T ss_pred             ecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHH--Hhhhhhhhhh
Confidence            4455677765544333         345688999999999999875    245799999998765533  4889999999


Q ss_pred             HhhcccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043586          272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  351 (397)
Q Consensus       272 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  351 (397)
                      |.+++||||+++.|+........||+|||++|+|..+|+.+..  .+.+-+.+.+.++||.||.||-   +.++|||||.
T Consensus       684 MGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA  758 (996)
T KOG0196|consen  684 MGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA  758 (996)
T ss_pred             cccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence            9999999999999999999999999999999999999998764  4888999999999999999999   6699999999


Q ss_pred             CCCEEeCCCCCeEEeccccccccCCCCCC-eeeccc--cccccCCCCC
Q 043586          352 SNNILLNSKFEAFVADFGTARLLHADSSN-RTLLAG--TYGYIAPGLP  396 (397)
Q Consensus       352 p~NIll~~~~~~kl~DFG~a~~~~~~~~~-~~~~~g--t~~y~APE~~  396 (397)
                      ..|||++.+..+|++|||+++.++++... .+...|  ..+|.|||.|
T Consensus       759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAI  806 (996)
T KOG0196|consen  759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAI  806 (996)
T ss_pred             hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHh
Confidence            99999999999999999999988766533 333334  3479999976

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=8.9e-29  Score=233.23  Aligned_cols=170  Identities=28%  Similarity=0.364  Sum_probs=144.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||++.+. ++..+|+|.+......  ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH--HHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            367999999999999999999875 6788999988765322  2236788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999987543   367888899999999999999952  3799999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..  .....||+.|+|||++
T Consensus       157 ~~--~~~~~~~~~y~aPE~~  174 (333)
T cd06650         157 SM--ANSFVGTRSYMSPERL  174 (333)
T ss_pred             hc--cccCCCCccccCHHHh
Confidence            22  2234689999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=6.4e-29  Score=238.64  Aligned_cols=162  Identities=27%  Similarity=0.365  Sum_probs=137.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|... +++.||+|....         +.+.+|++++++++||||+++++++......++||
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~  162 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL  162 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence            57999999999999999999864 688999996432         34568999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |++. ++|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+.....
T Consensus       163 e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~  235 (391)
T PHA03212        163 PRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI  235 (391)
T ss_pred             ecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence            9995 68887776432   4788899999999999999999   669999999999999999999999999999754322


Q ss_pred             C-CCeeeccccccccCCCCC
Q 043586          378 S-SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~-~~~~~~~gt~~y~APE~~  396 (397)
                      . .......||+.|+|||++
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~  255 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELL  255 (391)
T ss_pred             cccccccccCccCCCChhhh
Confidence            2 222345799999999975

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.96  E-value=4.7e-29  Score=238.77  Aligned_cols=176  Identities=28%  Similarity=0.356  Sum_probs=143.0

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      ...++|++.+.||+|+||.||+|++      .++..||||+++......  ..+.+.+|+++++.+ +||||+++++++.
T Consensus        32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcH--HHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            3356799999999999999999963      245689999997544322  236788899999999 8999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC------------------------------------------------------
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED------------------------------------------------------  314 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  314 (397)
                      ..+..++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            99999999999999999988864221                                                      


Q ss_pred             ------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          315 ------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       315 ------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                                        ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              123678889999999999999999   66999999999999999999999999999987644


Q ss_pred             CCCCe--eeccccccccCCCCC
Q 043586          377 DSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~--~~~~gt~~y~APE~~  396 (397)
                      .....  ....++..|+|||++
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~  288 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESI  288 (375)
T ss_pred             cccccccCCCCCCcceeChhHh
Confidence            33211  122356679999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=4e-29  Score=239.06  Aligned_cols=178  Identities=28%  Similarity=0.403  Sum_probs=143.8

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeE
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGF  286 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  286 (397)
                      +.-..++|++.+.||+|+||.||+|++      .++..||+|+++.....+.  .+.+.+|+++++.+ +||||++++++
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDE--REALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHH--HHHHHHHHHHHHhhccCCceeeEeeE
Confidence            334456799999999999999999874      2345799999976543322  36788999999999 89999999999


Q ss_pred             EeeCCEeeEEEeeccCCCchhhcccCCC----------------------------------------------------
Q 043586          287 CLHRKCMFLIYEYMERGSLFCNLHNNED----------------------------------------------------  314 (397)
Q Consensus       287 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  314 (397)
                      +...+..++||||+++|+|.+++.....                                                    
T Consensus       111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (374)
T cd05106         111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS  190 (374)
T ss_pred             ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence            9999999999999999999988754210                                                    


Q ss_pred             ---------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          315 ---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       315 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                                     ...+++.++.+++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                           123678889999999999999999   66999999999999999999999999999986644322


Q ss_pred             C--eeeccccccccCCCCC
Q 043586          380 N--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~--~~~~~gt~~y~APE~~  396 (397)
                      .  .....+++.|||||++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~  286 (374)
T cd05106         268 YVVKGNARLPVKWMAPESI  286 (374)
T ss_pred             eeeccCCCCccceeCHHHh
Confidence            1  1122356689999974

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=4.6e-29  Score=230.17  Aligned_cols=171  Identities=28%  Similarity=0.392  Sum_probs=142.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            36899999999999999999875 67899999987653322 22456788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++++.+..+... .  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~-~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEM-P--NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhc-C--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99998766544332 1  24788889999999999999999   669999999999999999999999999999876433


Q ss_pred             CC-CeeeccccccccCCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~~  396 (397)
                      .. ......||+.|+|||++
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~  173 (287)
T cd07848         154 SNANYTEYVATRWYRSPELL  173 (287)
T ss_pred             ccccccccccccccCCcHHH
Confidence            22 22335689999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=240.80  Aligned_cols=155  Identities=30%  Similarity=0.517  Sum_probs=137.1

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      ++-+|.|+.|.||+|++. ++.||||+++.-+.          .+++.|++++||||+.+.|+|.....++||||||..|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elkE----------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE----------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhhh----------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            466999999999999985 67899998865432          3788899999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      -|...++...   .+.....+.+..+||.||.|||   .+.|||||||.-||||..+..+||+|||.++...+. +....
T Consensus       198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            9999998653   4677888999999999999999   668999999999999999999999999999977554 44456


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ++||..|||||+|
T Consensus       271 FaGTVaWMAPEvI  283 (904)
T KOG4721|consen  271 FAGTVAWMAPEVI  283 (904)
T ss_pred             hhhhHhhhCHHHh
Confidence            8999999999986

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.96  E-value=8.1e-29  Score=231.14  Aligned_cols=170  Identities=25%  Similarity=0.366  Sum_probs=141.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.++.......  ...+.+|++++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc--chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            56899999999999999999865 678899999875432211  245678999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++ ++.+++.....  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99975 78777764332  3678889999999999999999   669999999999999999999999999999865443


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+|+.|+|||++
T Consensus       158 ~~~~~~~~~~~~y~aPE~~  176 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVL  176 (309)
T ss_pred             ccccccccccccccCCHHH
Confidence            3333345689999999964

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=9.5e-29  Score=233.49  Aligned_cols=169  Identities=28%  Similarity=0.427  Sum_probs=138.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----CEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  293 (397)
                      +|++.+.||+|+||.||+|+.. +++.||+|++....... ....++.+|++++++++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHV-SDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccc-hhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            4788999999999999999864 68999999987532221 1235678899999999999999999988643     247


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+. ++|.+++....   .+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999995 68888876532   4788999999999999999999   66999999999999999999999999999986


Q ss_pred             cCCCCC---CeeeccccccccCCCCC
Q 043586          374 LHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      ......   ......||+.|+|||++
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~  178 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELC  178 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHH
Confidence            533221   12335699999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.96  E-value=1.8e-28  Score=223.86  Aligned_cols=171  Identities=22%  Similarity=0.351  Sum_probs=141.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|.+.    .+..||+|.++.......  .+.+.+|+.++++++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHH--HHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            46889999999999999999753    356899999886543322  367889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+|++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999887543  24789999999999999999999   669999999999999999999999999987654


Q ss_pred             CCCCCC-eeeccccccccCCCCC
Q 043586          375 HADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ...... .....++..|+|||+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~  180 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAI  180 (266)
T ss_pred             cccchhcccCCCCceeecCHHHH
Confidence            322111 1122356789999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.96  E-value=1.6e-28  Score=224.05  Aligned_cols=175  Identities=22%  Similarity=0.325  Sum_probs=147.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.+......+......+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999999864 68999999886543333333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++..... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999888754221 234788889999999999999999   66999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........|++.|+|||..
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~  178 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERI  178 (267)
T ss_pred             hhHHHhcCCCCccccChhhh
Confidence            33333345688999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-29  Score=246.01  Aligned_cols=172  Identities=25%  Similarity=0.382  Sum_probs=142.3

Q ss_pred             CCCccceeecCCcccEEEEEcCCC-cEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeE-Eee------C
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGF-CLH------R  290 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~  290 (397)
                      ++++.+.|.+|+|+.||.|+...+ ..||+|++-....   ...+...+|+++|+.++ |+|||.++|. ...      .
T Consensus        38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            456778999999999999997765 9999999877643   33578889999999997 9999999993 221      1


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      -+.++.||||.||.|-+++..+... .+++.++++|+.|+++|+++||.. .++|||||||-|||||+.+|..||||||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            3578999999999999999865444 389999999999999999999977 77899999999999999999999999999


Q ss_pred             ccccCCCCCCe---------eeccccccccCCCCC
Q 043586          371 ARLLHADSSNR---------TLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~---------~~~~gt~~y~APE~~  396 (397)
                      |.-........         ....-|+.|+|||++
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI  227 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI  227 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence            87543333111         112479999999985

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4e-29  Score=218.79  Aligned_cols=173  Identities=25%  Similarity=0.439  Sum_probs=144.2

Q ss_pred             cHHHHHHHhcCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEE
Q 043586          210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFC  287 (397)
Q Consensus       210 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  287 (397)
                      .++|+...++     +.+|+|+|+.|-.+. ..+|..||||++.+....   .+.+..+|++++.+++ |+||++++++|
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gH---sR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGH---SRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCch---HHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            3677777776     569999999999986 568999999999876433   2467788999999995 99999999999


Q ss_pred             eeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC---CCeE
Q 043586          288 LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---FEAF  364 (397)
Q Consensus       288 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~k  364 (397)
                      +++...|+|||-|.||.|..+++++.   .+++.++.++.++|+.||.|||   .+||.|||+||+|||-...   .-+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999998764   4788899999999999999999   6799999999999999654   3579


Q ss_pred             EeccccccccCCCCC-------CeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      ||||.++.-+.....       ...+.+|+..|||||++
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence            999998875432211       11245799999999985

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.96  E-value=3.5e-28  Score=224.20  Aligned_cols=171  Identities=25%  Similarity=0.342  Sum_probs=144.2

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |+..+.||+|+||.||+|++. +++.||+|.+...........+.+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999764 6889999998765444333345677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            999999888764322 25889999999999999999999   67999999999999999999999999999976543222


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                       .....|++.|+|||++
T Consensus       158 -~~~~~g~~~~~aPE~~  173 (285)
T cd05632         158 -IRGRVGTVGYMAPEVL  173 (285)
T ss_pred             -ccCCCCCcCccChHHh
Confidence             2334689999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.96  E-value=1.9e-28  Score=235.69  Aligned_cols=175  Identities=25%  Similarity=0.382  Sum_probs=142.8

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  289 (397)
                      ..++|.+.+.||+|+||.||+|.+.      .+..||||+++......  ..+.+.+|+++++++. ||||+++++++..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSS--EKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChH--HHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3568999999999999999999752      23479999997654332  2367889999999996 9999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCC-------------------------------------------------------
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNED-------------------------------------------------------  314 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  314 (397)
                      .+..|+||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999988764210                                                       


Q ss_pred             --------------------------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          315 --------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       315 --------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                                                            ...+++..+..++.|+++||+|||   ..+|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence                                                  123677888999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ++.++.+||+|||+++........  .....+++.|+|||++
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  311 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESI  311 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhh
Confidence            999999999999999866433221  1223467889999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=2.3e-28  Score=225.10  Aligned_cols=163  Identities=20%  Similarity=0.294  Sum_probs=139.2

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEeeEEEeec
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLIYEYM  300 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~  300 (397)
                      ..||+|++|.||+|.+ +|+.||||.++..........+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 688999999987654444445788899999999999999999999877    34689999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      ++|+|.+++....   .+++.....++.|++.|+.|||..  .+++||||||+||+++.++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999987643   478889999999999999999942  378899999999999999999999999998654322  


Q ss_pred             eeeccccccccCCCCC
Q 043586          381 RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ~~~~~gt~~y~APE~~  396 (397)
                       ....||+.|+|||++
T Consensus       178 -~~~~~~~~y~aPE~~  192 (283)
T PHA02988        178 -FKNVNFMVYFSYKML  192 (283)
T ss_pred             -ccccCcccccCHHHh
Confidence             224689999999975

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=2.8e-28  Score=223.94  Aligned_cols=165  Identities=28%  Similarity=0.392  Sum_probs=137.3

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||.||+++.. +|+.||+|.+...........+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            689999999999864 6899999998754333222234556799999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecc
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA  385 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  385 (397)
                      .+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++........ .....
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-~~~~~  155 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA  155 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-eeccC
Confidence            888764332 34788889999999999999999   66999999999999999999999999999987644322 23346


Q ss_pred             ccccccCCCCC
Q 043586          386 GTYGYIAPGLP  396 (397)
Q Consensus       386 gt~~y~APE~~  396 (397)
                      ||+.|+|||++
T Consensus       156 ~~~~y~aPE~~  166 (277)
T cd05607         156 GTNGYMAPEIL  166 (277)
T ss_pred             CCCCccCHHHH
Confidence            89999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-29  Score=230.66  Aligned_cols=166  Identities=27%  Similarity=0.401  Sum_probs=138.1

Q ss_pred             cceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          224 KYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .+.+|+|.||+||-|++ ++|+.||||++.+......+ ...+++|+.||+.+.||.||.+.-.|+..+..++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            36799999999999975 58999999999876544332 26789999999999999999999999999999999999976


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEeccccccccCCCCC
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~~~~~~~~  379 (397)
                       +..+.+-.. ...++++....-++.||+.||.|||   -++|+|+||||+|||+.+   .-.+||||||+|+.+.+.. 
T Consensus       648 -DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-  721 (888)
T KOG4236|consen  648 -DMLEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-  721 (888)
T ss_pred             -hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence             554544332 2335888888889999999999999   568999999999999963   4589999999999886544 


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      .....+|||.|.|||++
T Consensus       722 FRrsVVGTPAYLaPEVL  738 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVL  738 (888)
T ss_pred             hhhhhcCCccccCHHHH
Confidence            34557899999999985

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.96  E-value=3.5e-28  Score=221.85  Aligned_cols=169  Identities=30%  Similarity=0.476  Sum_probs=145.1

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.......   .+.+.+|+.++++++||||+++++++...+..++||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~---~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD---FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch---HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            4699999999999999999986 468899999987553322   245778999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.++++...   .+++..+..++.|++.|+.|||   +.+|+|||+||+||+++.++.+||+|||+++.....
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          86 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            9999999999886532   4788899999999999999999   569999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||.+
T Consensus       160 ~~~~~~~~~~~~y~~PE~~  178 (267)
T cd06646         160 IAKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             ccccCccccCccccCHhHc
Confidence            3333445689999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.96  E-value=2.8e-28  Score=221.14  Aligned_cols=169  Identities=25%  Similarity=0.438  Sum_probs=142.7

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||++++.++..+|+|.+.......    +.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccH----HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            4588889999999999999998888899999887544332    567889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|+|.++++....  .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999998875432  4788999999999999999999   6689999999999999999999999999998654322


Q ss_pred             CC-eeeccccccccCCCCC
Q 043586          379 SN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~-~~~~~gt~~y~APE~~  396 (397)
                      .. .....++..|+|||++
T Consensus       155 ~~~~~~~~~~~~y~aPE~~  173 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVF  173 (256)
T ss_pred             eeccCCCCCchhhCChhhc
Confidence            21 1122356689999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-30  Score=230.70  Aligned_cols=174  Identities=24%  Similarity=0.359  Sum_probs=150.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..+|.++.+||+|+||.|..|..+ +.+.||||++++.........+.-..|-++|+-- +-|.+++++.+|+..+++|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            346999999999999999999766 4678999999887544333345566788888877 57899999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+.||+|..++++.+.   +.++.++-++..||-||-|||   ++||+.||||.+|||+|.+|.+||+|||+++.-.
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999998886543   667888999999999999999   7799999999999999999999999999999776


Q ss_pred             CCCCCeeeccccccccCCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      -+.....+++|||.|+|||+++
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~  523 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIA  523 (683)
T ss_pred             cCCcceeeecCCCcccccceEE
Confidence            6677778899999999999874

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=241.72  Aligned_cols=170  Identities=26%  Similarity=0.375  Sum_probs=145.3

Q ss_pred             CCCccceeecCCcccEEEEEcCCC-cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+++..+|.|+||.||+|..++. -..|.|++......   ..+++.-|++||+.++||+||++++.|...+.+|+..|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseE---ELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEE---ELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchh---HHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            455667799999999999987654 44566777654433   25788999999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||.||-....+-.-+.  .+.+.++.-+++|++.||.|||   ++.|+|||||..|||++-+|.++|+|||.+.......
T Consensus       110 FC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~  184 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR  184 (1187)
T ss_pred             ecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHH
Confidence            9999998877765443  4888999999999999999999   6799999999999999999999999999988766555


Q ss_pred             CCeeeccccccccCCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~l  397 (397)
                      .....++|||+|||||+++
T Consensus       185 qkRDsFIGTPYWMAPEVvm  203 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVM  203 (1187)
T ss_pred             hhhccccCCcccccchhee
Confidence            5667789999999999864

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=2.3e-28  Score=225.90  Aligned_cols=171  Identities=29%  Similarity=0.426  Sum_probs=135.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC--CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEee----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH----  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  289 (397)
                      ++|++.+.||+|+||.||+|+..  +++.||+|.++....... ....+.+|+.+++.+   +||||+++++++..    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            36899999999999999999863  468899999875432211 113445677766665   69999999999853    


Q ss_pred             -CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          290 -RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       290 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                       ....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccc
Confidence             446899999996 588888865432 24788999999999999999999   669999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++...... ......||+.|+|||++
T Consensus       155 g~~~~~~~~~-~~~~~~~~~~y~aPE~~  181 (290)
T cd07862         155 GLARIYSFQM-ALTSVVVTLWYRAPEVL  181 (290)
T ss_pred             cceEeccCCc-ccccccccccccChHHH
Confidence            9998664332 22345689999999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=4.2e-28  Score=223.70  Aligned_cols=171  Identities=26%  Similarity=0.368  Sum_probs=143.6

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |+..+.||+|+||.||++... +++.||+|.+...........+.+.+|+.++++++|++|+.+++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677788999999999999764 6889999998765433333335677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            999999988864322 34788899999999999999999   67999999999999999999999999999976543322


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                       .....||+.|+|||++
T Consensus       158 -~~~~~g~~~y~aPE~~  173 (285)
T cd05630         158 -IKGRVGTVGYMAPEVV  173 (285)
T ss_pred             -ccCCCCCccccChHHH
Confidence             2234699999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.5e-28  Score=242.71  Aligned_cols=177  Identities=26%  Similarity=0.301  Sum_probs=145.2

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC---
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK---  291 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  291 (397)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++....... .....+.+|+.++..++|+||+++++.+...+   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            3457899999999999999999975 478999999987654322 22456788999999999999999988775432   


Q ss_pred             -----EeeEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEE
Q 043586          292 -----CMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV  365 (397)
Q Consensus       292 -----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  365 (397)
                           ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEE
Confidence                 3689999999999999886532 2235788899999999999999999   679999999999999999999999


Q ss_pred             eccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      +|||+++.+.....  ......||+.|+|||++
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~  217 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW  217 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHh
Confidence            99999987643221  22345799999999975

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=5.9e-28  Score=223.24  Aligned_cols=169  Identities=30%  Similarity=0.492  Sum_probs=146.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||++++. +++.+|+|.+...........+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999865 68999999987654443344577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            9999999999887542   4788899999999999999999   669999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         .....|++.|+|||.+
T Consensus       155 ---~~~~~~~~~y~aPE~~  170 (290)
T cd05580         155 ---TYTLCGTPEYLAPEII  170 (290)
T ss_pred             ---CCCCCCCccccChhhh
Confidence               2335689999999974

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.95  E-value=1.4e-29  Score=220.95  Aligned_cols=177  Identities=29%  Similarity=0.384  Sum_probs=143.6

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC---C--CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP---N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  289 (397)
                      +....|+....||+|+||.||+|..+   +  .+.+|+|+++..+..+.- .....+|+..++.++|||++.+..++.. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGi-S~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGI-SMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCc-CHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34567999999999999999999543   2  347999999876432211 1345679999999999999999999887 


Q ss_pred             CCEeeEEEeeccCCCchhhcccCC--CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC----CCe
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----FEA  363 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~  363 (397)
                      +...|+++||.+. +|.+.++-+.  ....++...+..|++||+.|+.|||   ++-|+||||||.|||+..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCee
Confidence            7889999999976 8888776432  2346888899999999999999999   6689999999999999877    999


Q ss_pred             EEeccccccccCCCCCC---eeeccccccccCCCCCC
Q 043586          364 FVADFGTARLLHADSSN---RTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~---~~~~~gt~~y~APE~~l  397 (397)
                      ||+|||+|+.+...-..   ....+-|.+|.|||++|
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL  212 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL  212 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhc
Confidence            99999999988654332   23456799999999875

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.95  E-value=6.1e-28  Score=220.06  Aligned_cols=175  Identities=25%  Similarity=0.353  Sum_probs=148.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|... +++.||+|.++.....+....+++.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999999876 78999999987544333333567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++.... ....+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999998886432 2334788999999999999999999   66999999999999999999999999999986654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........|++.|+|||++
T Consensus       159 ~~~~~~~~~~~~~y~apE~~  178 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCcccceecCCccccCHHHh
Confidence            43333445689999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.95  E-value=2.8e-28  Score=237.81  Aligned_cols=167  Identities=23%  Similarity=0.354  Sum_probs=133.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  290 (397)
                      .++|++.+.||+|+||.||+|... +++.||||++.....       ...+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            357999999999999999999864 688999998865432       234699999999999999999887532      


Q ss_pred             --CEeeEEEeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEe
Q 043586          291 --KCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVA  366 (397)
Q Consensus       291 --~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~  366 (397)
                        ...++||||+++ ++.+++... .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence              247799999975 676665432 12235788899999999999999999   6699999999999999965 479999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||+|+.+..... .....||+.|+|||++
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~  242 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPELM  242 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHHh
Confidence            9999987654332 2335689999999975

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.95  E-value=4.3e-28  Score=221.24  Aligned_cols=175  Identities=23%  Similarity=0.347  Sum_probs=148.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|+. .+++.+|||.+......+.....++.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999985 478999999887654444444568889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++.... ....+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999998886422 2235788999999999999999999   66999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........|++.|+|||+.
T Consensus       159 ~~~~~~~~~~~~~~~ape~~  178 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERI  178 (267)
T ss_pred             CCcccccccCCcCccCHHHh
Confidence            43333345689999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=3.6e-28  Score=223.14  Aligned_cols=175  Identities=23%  Similarity=0.361  Sum_probs=142.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++.......  ...++.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4567999999999999999998753      35679999986543222  235688999999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCC-------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                      ...++||||+++++|.+++.....       ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence            999999999999999998865321       123567888999999999999999   6699999999999999999999


Q ss_pred             EEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ||+|||+++.........  ....+++.|+|||++
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL  193 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence            999999998654332211  122457789999974

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.95  E-value=5.2e-28  Score=219.55  Aligned_cols=169  Identities=34%  Similarity=0.529  Sum_probs=144.0

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |++.+.||+|+||.||+++.. +++.||+|++......... .....+|+.++++++||||+++++++......++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            567889999999999999876 5678999999887655433 23345699999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++...   ..+++..+..++.|+++||.+||   +.+++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             ccccccccccccc---ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999999998732   24788999999999999999999   56999999999999999999999999999986533333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......+|+.|+|||+.
T Consensus       154 ~~~~~~~~~~y~aPE~~  170 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVL  170 (260)
T ss_dssp             EBSSSSSSGGGSCHHHH
T ss_pred             ccccccccccccccccc
Confidence            34456789999999963

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=6e-28  Score=226.00  Aligned_cols=170  Identities=26%  Similarity=0.422  Sum_probs=138.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .+|++.+.||+|+||.||+|++. +++    .||+|.++......  ..+++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46899999999999999999753 333    48999987543322  236788999999999999999999998765 56


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++|+||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccccc
Confidence            799999999999999876432  4778889999999999999999   66999999999999999999999999999987


Q ss_pred             cCCCCCCee--eccccccccCCCCC
Q 043586          374 LHADSSNRT--LLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~--~~~gt~~y~APE~~  396 (397)
                      .........  ...++..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~  183 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESI  183 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHh
Confidence            654333221  12246689999974

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=5.4e-29  Score=235.95  Aligned_cols=166  Identities=25%  Similarity=0.427  Sum_probs=139.7

Q ss_pred             cceeecCCcccEEEEEcC-CCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE--eeEEEee
Q 043586          224 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC--MFLIYEY  299 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~  299 (397)
                      ...||+|+|-+||+|.+. +|..||.-.++..... .....++|..|+.+|+.++||||++++++|.+...  .-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            356999999999999764 5778875544433222 23345889999999999999999999999988654  7799999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEeccccccccCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~  378 (397)
                      +..|+|..++++.+.   ++....+.|++||++||.|||++ .++|+|||||-+||||+ ..|.|||+|+|+|+......
T Consensus       125 ~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  125 FTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             ccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999987653   67788999999999999999998 78999999999999997 56999999999999876554


Q ss_pred             CCeeeccccccccCCCC
Q 043586          379 SNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~  395 (397)
                      ..  ..+|||.|||||+
T Consensus       201 ak--svIGTPEFMAPEm  215 (632)
T KOG0584|consen  201 AK--SVIGTPEFMAPEM  215 (632)
T ss_pred             cc--eeccCccccChHH
Confidence            43  3689999999997

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=4.6e-28  Score=221.08  Aligned_cols=169  Identities=31%  Similarity=0.478  Sum_probs=145.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++......   ...+.+|+.+++.++||||+++++++...+..|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            46788889999999999999764 68899999987654322   245778999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++.++..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999886543   4788999999999999999999   569999999999999999999999999999866544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             ccccccccCcccccChhhh
Confidence            3333445799999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=1.1e-27  Score=218.57  Aligned_cols=171  Identities=29%  Similarity=0.442  Sum_probs=143.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|.+.    +...||+|.++......  ...+|.+|+.++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            56899999999999999999864    24579999987654322  2367888999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++.....  .+++..+..++.|++.|++|||   +++|+|+||||+||+++.++.+||+|||+++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          82 IITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999875432  5789999999999999999999   679999999999999999999999999999977


Q ss_pred             CCCCCCee--eccccccccCCCCC
Q 043586          375 HADSSNRT--LLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~--~~~gt~~y~APE~~  396 (397)
                      ........  ...+++.|+|||..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~  180 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAI  180 (266)
T ss_pred             cccccceeccCCCCCccccChhhh
Confidence            52222111  12346789999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=7.9e-28  Score=245.40  Aligned_cols=171  Identities=26%  Similarity=0.369  Sum_probs=149.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|++. +++.||+|+++..........+.+.+|+.+++.++||||+++++++......|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57899999999999999999875 68899999997654443444577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.+++|.+++....   .+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~  157 (669)
T cd05610          84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR  157 (669)
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence            9999999999886543   3678889999999999999999   569999999999999999999999999999977655


Q ss_pred             CCCeeeccccccccCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~  395 (397)
                      ........+|+.|+|||.
T Consensus       158 ~~~~~~~~~t~~~~~pe~  175 (669)
T cd05610         158 ELNMMDILTTPSMAKPKN  175 (669)
T ss_pred             cccccccccCccccCccc
Confidence            444455679999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.95  E-value=6.3e-28  Score=222.28  Aligned_cols=172  Identities=27%  Similarity=0.376  Sum_probs=143.4

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++...... ...+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4788899999999999999864 68899999987543221 123567789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |++ ++|.+++........+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 588888765444346889999999999999999999   6699999999999999999999999999998654433


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......+++.|+|||++
T Consensus       156 ~~~~~~~~~~~y~aPE~~  173 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVL  173 (285)
T ss_pred             ccccCCcccccccChHHh
Confidence            333334578999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1.2e-27  Score=217.69  Aligned_cols=171  Identities=26%  Similarity=0.457  Sum_probs=144.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.++.....    .+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            3568899999999999999999877889999998765432    256888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.... ...+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999987543 234789999999999999999999   668999999999999999999999999999876532


Q ss_pred             CCCe-eeccccccccCCCCC
Q 043586          378 SSNR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~-~~~~gt~~y~APE~~  396 (397)
                      .... ....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~  176 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAA  176 (261)
T ss_pred             cccccCCCcCceeccCcccc
Confidence            2211 111234579999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=4.8e-28  Score=223.21  Aligned_cols=180  Identities=26%  Similarity=0.390  Sum_probs=147.5

Q ss_pred             cHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEE
Q 043586          210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFC  287 (397)
Q Consensus       210 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  287 (397)
                      .++++....++|++.+.||+|+||.||+|... +++.+|+|++......    ...+.+|+.+++.+ +||||+++++++
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            34566677889999999999999999999764 6789999988654322    14577899999999 699999999987


Q ss_pred             e-----eCCEeeEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          288 L-----HRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       288 ~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      .     .++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence            4     3457899999999999998875321 2234788889999999999999999   66999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++.............|++.|+|||++
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             CEEEccCCceeecccCCCccccccCCCcccChhhh
Confidence            99999999998765433333445699999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=3.7e-28  Score=232.08  Aligned_cols=166  Identities=25%  Similarity=0.413  Sum_probs=142.9

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-c-----CCccceeeEEeeCCE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-H-----RNIVKLYGFCLHRKC  292 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~  292 (397)
                      +|++.+.||+|+||.|.+|.+ .+++.||||+++....-    .++-..|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f----~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF----LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH----HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            789999999999999999975 46999999999876533    355667999999997 4     489999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC--CCCeEEecccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KFEAFVADFGT  370 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DFG~  370 (397)
                      .|||+|.+. .+|.++++.+... .++...+..|+.||++||.+||   ..+|||+||||+||||.+  ...+||+|||.
T Consensus       263 lciVfELL~-~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            999999995 5999999986543 5899999999999999999999   679999999999999964  34899999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      |.+......   ..+-+..|+|||++|
T Consensus       338 Sc~~~q~vy---tYiQSRfYRAPEVIL  361 (586)
T KOG0667|consen  338 SCFESQRVY---TYIQSRFYRAPEVIL  361 (586)
T ss_pred             ccccCCcce---eeeeccccccchhhc
Confidence            987543332   456788999999986

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=6.2e-28  Score=219.46  Aligned_cols=171  Identities=26%  Similarity=0.468  Sum_probs=144.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|...++..||+|.+......    .+.+.+|+.++++++||||+++++++...+..+++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            3578999999999999999999888889999998764432    367888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.... ...+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999887542 234788889999999999999999   568999999999999999999999999999876443


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~  176 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAI  176 (261)
T ss_pred             ceeccCCCccceecCCHHHh
Confidence            221 1223356789999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.95  E-value=6.5e-28  Score=230.88  Aligned_cols=169  Identities=28%  Similarity=0.355  Sum_probs=139.6

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----Ee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  293 (397)
                      +|++.+.||+|+||.||+++. .+++.||+|++...... ....+++.+|+++++.++||||+++++++...+     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478889999999999999986 47899999998654222 122367788999999999999999999998776     78


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+. ++|.+.+...   ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999996 5787777543   24788999999999999999999   66999999999999999999999999999986


Q ss_pred             cCCCCC-CeeeccccccccCCCCC
Q 043586          374 LHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ...... ......+|+.|+|||++
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~  176 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEIL  176 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHH
Confidence            543322 12234689999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.95  E-value=3.3e-28  Score=221.25  Aligned_cols=173  Identities=29%  Similarity=0.494  Sum_probs=147.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..++|++.+.||+|+||.||+|.+.+++.+|+|.+.......   ...+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK---QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh---HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            345688999999999999999998889999999987655422   35678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++..... ..+++.++..++.|++.|+.|||   +++++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          81 TELMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EeecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999999976432 35788999999999999999999   66899999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~  176 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAA  176 (261)
T ss_pred             ccccccCCCCceEecCHHHH
Confidence            33322233467789999963

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=1.1e-27  Score=220.54  Aligned_cols=173  Identities=26%  Similarity=0.453  Sum_probs=142.7

Q ss_pred             cCCCccceeecCCcccEEEEEcCC------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|++.+.||+|+||.||+|....      ...||+|.++.....  ....++.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCH--HHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468889999999999999997532      257999998755433  224678899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCc-------------cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDA-------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      .+++|||+++++|.+++......             ..+++..+..++.|++.||.|||   ..+++||||||+||++++
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcC
Confidence            99999999999999988753211             34778889999999999999999   668999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          360 KFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ++.+||+|||+++.......  ......+++.|+|||++
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAI  198 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHh
Confidence            99999999999986543321  12233568899999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=1.1e-27  Score=217.01  Aligned_cols=172  Identities=28%  Similarity=0.422  Sum_probs=147.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+|... +++.|++|.+....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4778899999999999999864 68999999987543222 234678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.... ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999987642 235788899999999999999999   6699999999999999999999999999998776544


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|++.|+|||+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~  173 (256)
T cd08529         156 NFANTIVGTPYYLSPELC  173 (256)
T ss_pred             chhhccccCccccCHHHh
Confidence            434445689999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=1.7e-27  Score=215.77  Aligned_cols=171  Identities=23%  Similarity=0.395  Sum_probs=145.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||+++.. +++.+|+|.++......  ..+.+.+|+.+++.++||||+++++.+..++..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4788899999999999999865 68899999986543322  23677889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |++++++.+++..... ..+++..+..++.|++.||.|||   +.+++|+||||+||++++++.++++|||.++......
T Consensus        79 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999999988764322 24688889999999999999999   6699999999999999999999999999998765443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|++.|+|||+.
T Consensus       155 ~~~~~~~~~~~~~aPE~~  172 (255)
T cd08219         155 AYACTYVGTPYYVPPEIW  172 (255)
T ss_pred             cccccccCCccccCHHHH
Confidence            333445689999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=1.1e-27  Score=220.61  Aligned_cols=173  Identities=22%  Similarity=0.397  Sum_probs=142.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|.+     .++..+|+|.+......  .....+.+|++++++++||||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP--QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4688889999999999999974     35678999999754332  2236788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCC--------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          294 FLIYEYMERGSLFCNLHNNED--------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      |+||||+++++|.+++.....              ...+++.++..++.|++.||+|||   +++++||||||+||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcC
Confidence            999999999999998853211              124778889999999999999999   668999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          360 KFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ++.+||+|||+++.......  ......++..|+|||+.
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI  198 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHh
Confidence            99999999999986643321  12223467789999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-28  Score=225.87  Aligned_cols=172  Identities=24%  Similarity=0.408  Sum_probs=150.1

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .-|++.+.||+|-|++|-.|++ -+|..||||++.+.+.++.. ...+.+|++.|+-++|||||++|++...+..+|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4577788899999999999975 48999999999987766433 356677999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe-CCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DFG~a~~~~~  376 (397)
                      |.-++|+|++++.++..  .+.+..+.+++.||+.|+.|+|   ...+|||||||+||.+ ..-|-+||+|||++-.+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999987654  4788899999999999999999   5579999999999977 4678999999999988866


Q ss_pred             CCCCeeeccccccccCCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~l  397 (397)
                      +.. .++.+|+..|.|||++|
T Consensus       172 G~k-L~TsCGSLAYSAPEILL  191 (864)
T KOG4717|consen  172 GKK-LTTSCGSLAYSAPEILL  191 (864)
T ss_pred             cch-hhcccchhhccCchhhh
Confidence            554 45678999999999976

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.95  E-value=2.3e-27  Score=219.44  Aligned_cols=171  Identities=29%  Similarity=0.414  Sum_probs=145.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .+.|++.+.||+|+||.||+|+.. +++.+++|.+......   ..+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE---ELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            367899999999999999999875 5889999998765432   246788899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||++++++..++.+...  .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999887754322  4788999999999999999999   66999999999999999999999999999876544


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+++.|+|||++
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~  182 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVV  182 (292)
T ss_pred             cccccceecCCccccCceee
Confidence            33333445689999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=1.2e-27  Score=227.99  Aligned_cols=169  Identities=30%  Similarity=0.350  Sum_probs=137.9

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  291 (397)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++....    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQ-THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccch-hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            4578999999999999999999864 68899999987543221 22356778999999999999999999986543    


Q ss_pred             --EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          292 --CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       292 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                        ..|+||||+++ ++.+.+..     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCC
Confidence              47999999975 56555532     3677888899999999999999   6699999999999999999999999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       169 ~a~~~~~~~~-~~~~~~t~~y~aPE~~  194 (359)
T cd07876         169 LARTACTNFM-MTPYVVTRYYRAPEVI  194 (359)
T ss_pred             CccccccCcc-CCCCcccCCCCCchhc
Confidence            9986533222 2335689999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=1.2e-27  Score=220.74  Aligned_cols=172  Identities=26%  Similarity=0.395  Sum_probs=145.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|.+.......  ....+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH--HHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36888999999999999999875 78999999887543222  2367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++........+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999999988887543233588999999999999999999952  48999999999999999999999999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....|++.|+|||++
T Consensus       157 ~--~~~~~~~~~y~aPE~~  173 (286)
T cd06622         157 L--AKTNIGCQSYMAPERI  173 (286)
T ss_pred             c--cccCCCccCccCcchh
Confidence            2  2234588899999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.95  E-value=8.9e-28  Score=223.27  Aligned_cols=170  Identities=25%  Similarity=0.368  Sum_probs=141.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|.++.......  ...+.+|+.++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc--hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            56899999999999999999865 678999999875432211  245678999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++ ++|.+++.....  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        84 e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          84 EYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             eccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            9997 588887765432  4778889999999999999999   679999999999999999999999999999865443


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+++.|+|||+.
T Consensus       158 ~~~~~~~~~~~~y~~PE~~  176 (301)
T cd07873         158 TKTYSNEVVTLWYRPPDIL  176 (301)
T ss_pred             CCcccccceeecccCcHHH
Confidence            3333334578999999963

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.2e-27  Score=226.60  Aligned_cols=170  Identities=26%  Similarity=0.336  Sum_probs=140.8

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC---
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR---  290 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  290 (397)
                      .+..++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|++++++++||||+++++++...   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSL-IHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhh-HHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            34567899999999999999999975 467899999987643322 2235677899999999999999999987543   


Q ss_pred             ---CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          291 ---KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       291 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                         ...|+++|++ +++|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcC
Confidence               3478999998 77888777532    4788999999999999999999   66999999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+++.....   .....||+.|+|||++
T Consensus       162 fg~~~~~~~~---~~~~~~t~~y~aPE~~  187 (343)
T cd07878         162 FGLARQADDE---MTGYVATRWYRAPEIM  187 (343)
T ss_pred             CccceecCCC---cCCccccccccCchHh
Confidence            9999865432   2335689999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.95  E-value=8.5e-28  Score=218.08  Aligned_cols=169  Identities=25%  Similarity=0.441  Sum_probs=142.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||.|++.++..+|+|.+.......    +.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccH----HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            4588889999999999999998777789999987654322    568889999999999999999999999889999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+.+++|.+++.....  .+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999998875432  4788999999999999999999   6699999999999999999999999999998654432


Q ss_pred             CCe-eeccccccccCCCCC
Q 043586          379 SNR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~-~~~~gt~~y~APE~~  396 (397)
                      ... ....++..|+|||+.
T Consensus       155 ~~~~~~~~~~~~y~~pe~~  173 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVL  173 (256)
T ss_pred             eeecCCCccChhhCCHHHH
Confidence            211 122356679999974

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=8.9e-28  Score=220.79  Aligned_cols=171  Identities=30%  Similarity=0.456  Sum_probs=147.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|++|.||+|++. ++..+|+|.+.......   .+.+.+|++++++++||||+++++++..+...|+|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE---LEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHH---HHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            356899999999999999999864 68899999987654332   36788899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++.....  .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          81 IEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             eeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999988865332  4788999999999999999999   66899999999999999999999999999876654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........|++.|+|||++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~  175 (280)
T cd06611         156 TLQKRDTFIGTPYWMAPEVV  175 (280)
T ss_pred             cccccceeecchhhcCHHHH
Confidence            43333445689999999974

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.95  E-value=1.2e-27  Score=224.02  Aligned_cols=164  Identities=27%  Similarity=0.455  Sum_probs=131.3

Q ss_pred             cceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeEEEe
Q 043586          224 KYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYE  298 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  298 (397)
                      ...||+|+||.||+|+..   +++.||+|.+......     ..+.+|++++++++||||+++++++..  +...|+|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            357999999999999854   4678999998765432     345679999999999999999998864  456899999


Q ss_pred             eccCCCchhhcccCC------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe----CCCCCeEEecc
Q 043586          299 YMERGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVADF  368 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DF  368 (397)
                      |+. ++|.+++....      ....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            996 47777664321      1234788889999999999999999   6699999999999999    45689999999


Q ss_pred             ccccccCCCCC---CeeeccccccccCCCCC
Q 043586          369 GTARLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      |+++.......   ......||+.|+|||++
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHH
Confidence            99987654322   12345789999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=2.3e-27  Score=221.23  Aligned_cols=169  Identities=28%  Similarity=0.337  Sum_probs=143.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||++++. ++..+|+|.+......  ...+++.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP--AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36899999999999999999864 6788999988754322  23467888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...   ..+++..+..++.|+++||.|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus        79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            999999999998754   2478888999999999999999952  48999999999999999999999999998765432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....|++.|+|||+.
T Consensus       154 ~--~~~~~~~~~~~aPE~~  170 (308)
T cd06615         154 M--ANSFVGTRSYMSPERL  170 (308)
T ss_pred             c--cccCCCCcCccChhHh
Confidence            2  2335689999999964

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=1.2e-27  Score=219.78  Aligned_cols=173  Identities=26%  Similarity=0.450  Sum_probs=143.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|.+.+.||+|+||.||+|+..      +++.||+|.++.....+  ..+.+.+|+++++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHH--HHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            46888899999999999999753      34789999987654432  23688899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCC-----------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      .++||||+++++|.+++.....           ...+++.++..++.|++.|+.|||   +.+++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCC
Confidence            9999999999999999875421           234788899999999999999999   66999999999999999999


Q ss_pred             CeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++.......  ......+++.|+|||++
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI  196 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhh
Confidence            999999999986533221  11233467889999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=2.9e-27  Score=217.41  Aligned_cols=164  Identities=27%  Similarity=0.384  Sum_probs=139.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|.+.......  ..+.+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH--HHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3688889999999999999975 468899999987543222  2367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++++++..+.       .+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999886432       3577888899999999999999   669999999999999999999999999999865433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....||+.|+|||++
T Consensus       149 ~--~~~~~~~~~y~aPE~~  165 (279)
T cd06619         149 I--AKTYVGTNAYMAPERI  165 (279)
T ss_pred             c--ccCCCCChhhcCceee
Confidence            2  2335799999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.95  E-value=9.9e-28  Score=217.60  Aligned_cols=168  Identities=26%  Similarity=0.439  Sum_probs=141.0

Q ss_pred             CCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      +|++.+.||+|+||.||+|++.++..+|+|.+.......    +.+.+|++++++++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            478889999999999999998777889999987544322    4577899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++.....  .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          81 MANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            999999999875432  4788999999999999999999   66899999999999999999999999999986543222


Q ss_pred             Ce-eeccccccccCCCCC
Q 043586          380 NR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~-~~~~gt~~y~APE~~  396 (397)
                      .. ....++..|+|||+.
T Consensus       156 ~~~~~~~~~~~y~~Pe~~  173 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVF  173 (256)
T ss_pred             cccCCCCCCccccCHHHh
Confidence            11 111234579999974

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=234.85  Aligned_cols=178  Identities=29%  Similarity=0.478  Sum_probs=156.4

Q ss_pred             HHHHHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      ++.+...++.|++.+.||+|.+|.||+++. .+++.+|+|+.......+    ++...|.++++.. .|||++.++|+|.
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            344445567899999999999999999975 478899999998776554    5667788999888 5999999999986


Q ss_pred             e-----CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          289 H-----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       289 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                      .     ++.+|+|||||.+|+..|+++... ...+.|..+..|++.++.|+.+||   .+.++|||||-.|||++.++.+
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence            4     568999999999999999998766 557899999999999999999999   6689999999999999999999


Q ss_pred             EEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |++|||++..++.......+++|||.|||||++
T Consensus       163 KLvDFGvSaQldsT~grRnT~iGtP~WMAPEVi  195 (953)
T KOG0587|consen  163 KLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVI  195 (953)
T ss_pred             EEeeeeeeeeeecccccccCcCCCcccccceee
Confidence            999999999998887777888999999999986

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=2.6e-27  Score=218.01  Aligned_cols=168  Identities=29%  Similarity=0.409  Sum_probs=142.5

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |++.+.||+|+||.||+|+.. ++..+++|.+......   ..+.+.+|+++++.++|||++++++++..++..++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH---HHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            677788999999999999865 5778899988654432   236788899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|...+....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999988776432  24788999999999999999999   66999999999999999999999999999976544333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......|++.|+|||++
T Consensus       159 ~~~~~~~~~~y~aPE~~  175 (282)
T cd06643         159 RRDSFIGTPYWMAPEVV  175 (282)
T ss_pred             ccccccccccccCHhhc
Confidence            33445689999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.2e-27  Score=233.06  Aligned_cols=164  Identities=25%  Similarity=0.365  Sum_probs=138.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..+|.+.+.||+|+||.||+|.+. .++.||+|....         ..+.+|++++++++||||+++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            347999999999999999999875 578899996432         2355799999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||++. ++|.+++.....  .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99995 688887764322  5889999999999999999999   66999999999999999999999999999987643


Q ss_pred             CCCC--eeeccccccccCCCCC
Q 043586          377 DSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ....  .....||+.|+|||++
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~  334 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVL  334 (461)
T ss_pred             ccccccccccCCCcCCcCHHHH
Confidence            3221  2235699999999975

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.95  E-value=1.5e-27  Score=229.36  Aligned_cols=178  Identities=25%  Similarity=0.392  Sum_probs=144.2

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeE
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGF  286 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~  286 (397)
                      +....++|.+.+.||+|+||.||+|++.      .++.||+|+++.......  .+.+.+|++++.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~--~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSE--KQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhH--HHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            3344456888999999999999999853      346899999986543322  356889999999997 9999999999


Q ss_pred             EeeCCEeeEEEeeccCCCchhhcccCCC----------------------------------------------------
Q 043586          287 CLHRKCMFLIYEYMERGSLFCNLHNNED----------------------------------------------------  314 (397)
Q Consensus       287 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------  314 (397)
                      +...+..++||||+++|+|.++++....                                                    
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            9999999999999999999998865321                                                    


Q ss_pred             -------------------------------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043586          315 -------------------------------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  351 (397)
Q Consensus       315 -------------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  351 (397)
                                                                 ...+++..+..++.|++.||+|||   +++++|||||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlk  266 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLA  266 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCC
Confidence                                                       123567788899999999999999   6799999999


Q ss_pred             CCCEEeCCCCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          352 SNNILLNSKFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       352 p~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      |+||+++.++.+||+|||+++.......  ......+++.|+|||++
T Consensus       267 p~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  313 (401)
T cd05107         267 ARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI  313 (401)
T ss_pred             cceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence            9999999999999999999986543221  11223578899999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.95  E-value=2.1e-27  Score=217.03  Aligned_cols=166  Identities=23%  Similarity=0.313  Sum_probs=135.2

Q ss_pred             eeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .||+|+||.||+|.+.   .+..+|+|.++.......  ...+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQE--QMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHH--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5899999999999754   346799999876543322  25688899999999999999999999999999999999999


Q ss_pred             CCchhhcccCCC--ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          303 GSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       303 g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      |+|.+++.....  ....++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||+++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999875322  223566778889999999999999   669999999999999999999999999999754332211


Q ss_pred             --eeeccccccccCCCCC
Q 043586          381 --RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 --~~~~~gt~~y~APE~~  396 (397)
                        .....|++.|+|||++
T Consensus       157 ~~~~~~~~~~~y~aPE~~  174 (269)
T cd05087         157 VTPDQLWVPLRWIAPELV  174 (269)
T ss_pred             ecCCCcCCcccccCHhHh
Confidence              1234578889999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.95  E-value=2.5e-27  Score=216.29  Aligned_cols=171  Identities=30%  Similarity=0.457  Sum_probs=141.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++.    .+..+|+|.++......  ..+.+.+|+.++++++||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHH--HHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            46888999999999999999753    23479999987644332  2467889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++.....  .+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.++++|||++...
T Consensus        82 lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999875432  4788999999999999999999   669999999999999999999999999999876


Q ss_pred             CCCCCCee---eccccccccCCCCC
Q 043586          375 HADSSNRT---LLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~---~~~gt~~y~APE~~  396 (397)
                      ........   ...++..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~  181 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAI  181 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHh
Confidence            54332211   11235679999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.95  E-value=1.1e-27  Score=219.07  Aligned_cols=172  Identities=28%  Similarity=0.470  Sum_probs=143.7

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR----  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----  290 (397)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+......    ...+.+|+.+++++ +||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4567888999999999999999864 6789999998765432    24677899999998 699999999998753    


Q ss_pred             --CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          291 --KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       291 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                        ...|+||||+++++|.+++..... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccC
Confidence              468999999999999998875322 34788889999999999999999   568999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++.............|++.|+|||++
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHh
Confidence            9998765433334446799999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.95  E-value=2.9e-27  Score=215.93  Aligned_cols=175  Identities=26%  Similarity=0.374  Sum_probs=143.4

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      .+++.+.....||+|+||.||+|++. ++..||+|.+.......   .+.+.+|+.++++++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY---VQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH---HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34555666678999999999999854 67889999887654332   357889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEeccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARL  373 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~  373 (397)
                      +|+||+++++|.+++.........++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999998875422212267788889999999999999   669999999999999986 67999999999986


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ............|++.|+|||+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~  181 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVI  181 (268)
T ss_pred             cccCCCccccCCCCccccChhhh
Confidence            64333333334689999999974

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=3.4e-27  Score=213.89  Aligned_cols=172  Identities=22%  Similarity=0.362  Sum_probs=146.4

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||.++. .+++.+++|.+....... ...+++.+|++++++++|+||+++++++.+.+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            488899999999999999875 468899999987554322 224678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.... ...+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999987643 235788999999999999999999   5689999999999999999999999999998765544


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|++.|+|||+.
T Consensus       156 ~~~~~~~~~~~y~ape~~  173 (256)
T cd08221         156 SMAETVVGTPYYMSPELC  173 (256)
T ss_pred             ccccccCCCccccCHhhc
Confidence            333445689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.4e-27  Score=227.15  Aligned_cols=164  Identities=24%  Similarity=0.338  Sum_probs=137.7

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ...+|++.+.||+|+||.||+|+.. +++.||+|+.....         ...|+.++++++||||+++++++......++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999875 56789999754322         2458999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+. ++|.+++....  ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999995 58888776433  24789999999999999999999   6699999999999999999999999999997543


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ......||+.|+|||++
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~  228 (357)
T PHA03209        209 VAP-AFLGLAGTVETNAPEVL  228 (357)
T ss_pred             cCc-ccccccccccccCCeec
Confidence            222 22335699999999985

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.95  E-value=1.4e-27  Score=220.45  Aligned_cols=175  Identities=22%  Similarity=0.344  Sum_probs=141.4

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+........  ...+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE--RIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999998643      245799998875543222  34678899999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCC-------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                      +..++||||+++|+|.+++.....       ....++..+..++.|++.||.|||   +++|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence            999999999999999999875321       123456778899999999999999   6799999999999999999999


Q ss_pred             EEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ||+|||+++.........  ....++..|+|||..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  193 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL  193 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHh
Confidence            999999998654322211  122356789999974

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=1.3e-27  Score=225.66  Aligned_cols=174  Identities=25%  Similarity=0.379  Sum_probs=140.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee-
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH-  289 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  289 (397)
                      .++|++.+.||+|+||.||+|...      +++.||+|+++......  ..+.+.+|+.++.++ +||||+++++++.. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--EYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHH--HHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            357999999999999999999642      35789999987544332  235677899999999 79999999998865 


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCC-------------------------------------------------------
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNED-------------------------------------------------------  314 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  314 (397)
                      +...+++|||+++++|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence            4568899999999999988754211                                                       


Q ss_pred             ---ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC--eeecccccc
Q 043586          315 ---AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYG  389 (397)
Q Consensus       315 ---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~  389 (397)
                         ...+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+......  .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               125788999999999999999999   669999999999999999999999999999876433221  122346778


Q ss_pred             ccCCCCC
Q 043586          390 YIAPGLP  396 (397)
Q Consensus       390 y~APE~~  396 (397)
                      |+|||++
T Consensus       241 y~aPE~~  247 (337)
T cd05054         241 WMAPESI  247 (337)
T ss_pred             ccCcHHh
Confidence            9999964

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=2.3e-27  Score=219.93  Aligned_cols=168  Identities=27%  Similarity=0.416  Sum_probs=144.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|++.+.||+|++|.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++|||++++++.+..+...|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            4788899999999999999985 468899999987654332   256788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...    .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999999988642    3678889999999999999999   669999999999999999999999999998876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||+.
T Consensus       170 ~~~~~~~~~~~~y~aPE~~  188 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVV  188 (296)
T ss_pred             ccccCcccCCccccCHHHH
Confidence            3333345689999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.95  E-value=2.7e-27  Score=219.41  Aligned_cols=173  Identities=25%  Similarity=0.382  Sum_probs=141.0

Q ss_pred             cCCCccceeecCCcccEEEEEcCC---------------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccce
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN---------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL  283 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  283 (397)
                      ++|++.+.||+|+||.||+++..+               ...||+|.++......  ....+.+|++++++++|||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKT--ARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCcCeE
Confidence            579999999999999999987532               2358999987653322  24678899999999999999999


Q ss_pred             eeEEeeCCEeeEEEeeccCCCchhhcccCCC---------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043586          284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNED---------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNN  354 (397)
Q Consensus       284 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~N  354 (397)
                      ++++...+..++||||+++++|.+++.....         ...+++..+..++.|++.||+|||   +.+++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhh
Confidence            9999999999999999999999998864321         123678889999999999999999   6699999999999


Q ss_pred             EEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          355 ILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       355 Ill~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |+++.++.+||+|||++.........  .....+++.|+|||+.
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  203 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESI  203 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhh
Confidence            99999999999999999865433211  1122356789999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.8e-27  Score=213.19  Aligned_cols=172  Identities=26%  Similarity=0.395  Sum_probs=144.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH--HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ++|++.+.||+|++|.||+|... +++.||+|.+......  .....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999754 6899999998754322  22234678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |+||+++++|.+.+....   .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999887543   3678888999999999999999   6699999999999999999999999999998654


Q ss_pred             CCCCCe---eeccccccccCCCCC
Q 043586          376 ADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      ......   ....|+..|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~  179 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVI  179 (263)
T ss_pred             ccccccccccCCCcCccccCccee
Confidence            322111   234588899999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=4.2e-27  Score=212.85  Aligned_cols=165  Identities=25%  Similarity=0.428  Sum_probs=135.6

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.||+|+||.||+|.+. +++.+|+|.+......  .....+.+|++++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            35899999999999864 6889999988654322  22367889999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe--
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR--  381 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--  381 (397)
                      +|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++..........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999886533  24788999999999999999999   6699999999999999999999999999998654321111  


Q ss_pred             eeccccccccCCCCC
Q 043586          382 TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 ~~~~gt~~y~APE~~  396 (397)
                      ....++..|+|||++
T Consensus       154 ~~~~~~~~y~aPE~~  168 (252)
T cd05084         154 GMKQIPVKWTAPEAL  168 (252)
T ss_pred             CCCCCceeecCchhh
Confidence            111234569999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.95  E-value=2.1e-27  Score=215.87  Aligned_cols=170  Identities=28%  Similarity=0.471  Sum_probs=142.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|...+++.||+|.+.......    +++.+|+.++++++||||+++++++. .+..+++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            46789999999999999999998889999999988655432    56788999999999999999999864 45689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999998865432 35788999999999999999999   679999999999999999999999999999876532


Q ss_pred             CC-CeeeccccccccCCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~~  396 (397)
                      .. ......++..|+|||+.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~  175 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAI  175 (260)
T ss_pred             CcccccCCcccccccCHHHh
Confidence            22 12223456789999964

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.95  E-value=2.2e-27  Score=219.44  Aligned_cols=170  Identities=27%  Similarity=0.393  Sum_probs=141.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|+.. +++.||+|.+........  ...+.+|++++++++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA--PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC--chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            57899999999999999999865 688999999875432211  134667999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.+ +|.+++.....  .+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          83 EYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             ecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            99975 89888765433  4788899999999999999999   669999999999999999999999999998765332


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+++.|+|||+.
T Consensus       157 ~~~~~~~~~~~~~~aPE~~  175 (291)
T cd07844         157 SKTYSNEVVTLWYRPPDVL  175 (291)
T ss_pred             CccccccccccccCCcHHh
Confidence            2222233578899999964

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=2.6e-27  Score=219.68  Aligned_cols=169  Identities=28%  Similarity=0.412  Sum_probs=145.7

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..+|++.+.||+|++|.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            36799999999999999999985 478999999987644332   25678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++.+.    .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999988642    3678889999999999999999   66999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........|++.|+|||++
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~  187 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVV  187 (297)
T ss_pred             CccCcCcccCCccccCHHHH
Confidence            44333445689999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.95  E-value=2.3e-27  Score=216.70  Aligned_cols=165  Identities=23%  Similarity=0.313  Sum_probs=132.6

Q ss_pred             eeecCCcccEEEEEcCC---CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .||+|+||.||+|...+   ...+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATP--DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCCh--HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996533   356888877654322  2236788899999999999999999999999999999999999


Q ss_pred             CCchhhcccCCCc--cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          303 GSLFCNLHNNEDA--VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       303 g~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      |+|.+++......  ...++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++.........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            9999998764321  23457778899999999999999   669999999999999999999999999998754332211


Q ss_pred             --eeeccccccccCCCC
Q 043586          381 --RTLLAGTYGYIAPGL  395 (397)
Q Consensus       381 --~~~~~gt~~y~APE~  395 (397)
                        .....+++.|+|||+
T Consensus       157 ~~~~~~~~~~~y~aPE~  173 (269)
T cd05042         157 ITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             eccCCCCCcccccCHHH
Confidence              122345778999996

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.95  E-value=2.7e-27  Score=215.60  Aligned_cols=169  Identities=27%  Similarity=0.454  Sum_probs=140.5

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++.++..||+|++......    .+++.+|++++++++||||+++++++.. ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            568999999999999999998877778999999764432    2567889999999999999999998754 55799999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.... ...+++..+..++.|++.||+|+|   +.+++||||||+||+++.++.+||+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             cCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999987532 224688899999999999999999   6699999999999999999999999999998664433


Q ss_pred             CCe-eeccccccccCCCCC
Q 043586          379 SNR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~-~~~~gt~~y~APE~~  396 (397)
                      ... ....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~  175 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAA  175 (262)
T ss_pred             cccccCCcccceecCHhHh
Confidence            211 123466789999974

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.95  E-value=1.8e-27  Score=226.39  Aligned_cols=170  Identities=27%  Similarity=0.328  Sum_probs=138.8

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC----
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR----  290 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  290 (397)
                      ...++|++.+.||+|+||.||++... .++.||+|++....... ...+.+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccCh-HHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            35578999999999999999999764 68899999987643222 2235677899999999999999999988653    


Q ss_pred             --CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          291 --KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       291 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                        ...|+||||+++ ++.+.+..     .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeC
Confidence              357999999975 66665542     3678888999999999999999   679999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++....... .....||+.|+|||++
T Consensus       164 g~~~~~~~~~~-~~~~~~t~~y~aPE~~  190 (355)
T cd07874         164 GLARTAGTSFM-MTPYVVTRYYRAPEVI  190 (355)
T ss_pred             cccccCCCccc-cCCccccCCccCHHHH
Confidence            99986543322 2335689999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.1e-28  Score=229.62  Aligned_cols=166  Identities=27%  Similarity=0.415  Sum_probs=141.3

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      -++|+|.||+||-|++. +...+|||.+.......   .+-+.+|+...++++|.|||+++|.+..+++.-+.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~---~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE---VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchh---hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            36999999999999976 45679999997665433   356778999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEeccccccccCCCCCCee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      +|.+++...=....-.+..+-.+.+||++||.|||   .+.|||||||-+|||++ -.|.+||+|||.++.+..-..-..
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            99999975422222366778889999999999999   56899999999999997 579999999999998765554556


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ++.||..|||||++
T Consensus       735 TFTGTLQYMAPEvI  748 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVI  748 (1226)
T ss_pred             ccccchhhhChHhh
Confidence            68899999999986

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=4.3e-27  Score=216.78  Aligned_cols=171  Identities=25%  Similarity=0.438  Sum_probs=141.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--C
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--K  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  291 (397)
                      ..|++.+.||+|+||.||++++     .++..||+|.++.....  ...+.+.+|+.+++.++|||++++++++...  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccH--HHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            3478889999999999999973     35788999998755332  2246788999999999999999999998875  5


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence            68999999999999998865432  4788999999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      +........   .....|+..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~  184 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECL  184 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHh
Confidence            876543321   1234567789999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=3e-27  Score=223.82  Aligned_cols=174  Identities=24%  Similarity=0.369  Sum_probs=139.1

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||.||+|.+      .+++.||||+++......  ..+.+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChH--HHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35799999999999999999963      356889999997644322  235678899999999 689999999988654


Q ss_pred             -CEeeEEEeeccCCCchhhcccCCC-------------------------------------------------------
Q 043586          291 -KCMFLIYEYMERGSLFCNLHNNED-------------------------------------------------------  314 (397)
Q Consensus       291 -~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------  314 (397)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999988764210                                                       


Q ss_pred             ---------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC--eee
Q 043586          315 ---------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTL  383 (397)
Q Consensus       315 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~  383 (397)
                               ...+++.++..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++........  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     123677888999999999999999   679999999999999999999999999999865433221  112


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..+++.|+|||+.
T Consensus       241 ~~~~~~y~aPE~~  253 (343)
T cd05103         241 ARLPLKWMAPETI  253 (343)
T ss_pred             CCCCcceECcHHh
Confidence            3356789999964

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.95  E-value=5.1e-27  Score=212.80  Aligned_cols=172  Identities=30%  Similarity=0.437  Sum_probs=143.6

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  297 (397)
                      +|++.+.||+|++|.||++... +++.||+|++....... ...+.+.+|++++++++|||++++++.+.. ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            5889999999999999999864 57889999986543322 224567889999999999999999998764 44689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999998875322 34789999999999999999999   669999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||+.
T Consensus       156 ~~~~~~~~~~~~y~aPE~~  174 (257)
T cd08223         156 CDMASTLIGTPYYMSPELF  174 (257)
T ss_pred             CCccccccCCcCccChhHh
Confidence            3333445689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=4.5e-27  Score=218.84  Aligned_cols=174  Identities=25%  Similarity=0.386  Sum_probs=142.0

Q ss_pred             hcCCCccceeecCCcccEEEEEc--------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|++.+.||+|+||.||+|+.        .++..||+|.+......  ...+++.+|+.+++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccch--HHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            45688999999999999999963        13457999988754322  2236788999999999 8999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      .....|+||||+++++|.+++.....             ...+++.++..++.|+++||+|||   +++++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence            99999999999999999998875321             134778889999999999999999   66999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +++.++.+||+|||+++........  .....+++.|+|||++
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  211 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL  211 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence            9999999999999999876433221  1223456789999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.95  E-value=3.5e-27  Score=218.11  Aligned_cols=171  Identities=27%  Similarity=0.338  Sum_probs=140.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +++|.+.+.||+|+||.||+|... +++.||+|.+........  ...+.+|+.+++.++|+||+++++++..++..|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV--PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC--cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999754 688999999865432211  23566899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+. +++.+.+....  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             Eeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            99996 67766665432  23677788899999999999999   56899999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+++.|+|||+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~  175 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVL  175 (291)
T ss_pred             CCCCCCCccccccccCCcee
Confidence            33323334578999999974

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.95  E-value=3.9e-27  Score=218.56  Aligned_cols=171  Identities=29%  Similarity=0.393  Sum_probs=144.4

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH--HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +|++.+.||+|++|.||+|... +++.||+|+++.....  .......+..|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999864 6899999999765433  112235667899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+ +++|.+++....  ..+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999987543  24889999999999999999999   66999999999999999999999999999987655


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+++.|+|||++
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~  174 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELL  174 (298)
T ss_pred             CCccccccccceeeeCHHHH
Confidence            43333334578899999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=4.6e-27  Score=217.77  Aligned_cols=174  Identities=24%  Similarity=0.384  Sum_probs=143.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC-----------------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN-----------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI  280 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  280 (397)
                      .++|++.+.||+|+||.||+|+..+                 +..||+|.+......  ...+.+.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            3578999999999999999987532                 246899998765433  224678899999999999999


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhhcccCCC--------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNED--------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      +++++++..++..++||||+++++|.+++.....        ...+++..+..++.|++.||+|||   +.+++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccch
Confidence            9999999999999999999999999998875431        124788999999999999999999   66999999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +||+++.++.++|+|||+++........  .....+++.|+|||+.
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV  204 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence            9999999999999999999865433211  1233467889999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=1.5e-27  Score=244.13  Aligned_cols=181  Identities=24%  Similarity=0.373  Sum_probs=144.6

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--C
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--R  290 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  290 (397)
                      .....++|++.+.||+|+||.||+|+.. ++..+|+|.+....... .....+..|+.+++.++||||++++++|..  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            3345578999999999999999999865 57789999887543322 224678899999999999999999998865  4


Q ss_pred             CEeeEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCC----CCCeEEcCCCCCCEEeCC------
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC----SPSIIHRDISSNNILLNS------  359 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlkp~NIll~~------  359 (397)
                      ...|+||||+++++|.+++.... ....+++..++.|+.||+.||.|||...    ..+|+||||||+|||++.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            57899999999999999887532 1235889999999999999999999532    146999999999999964      


Q ss_pred             -----------CCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          360 -----------KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 -----------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                                 .+.+||+|||+++....... .....||+.|+|||++
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~-~~s~vGTp~YmAPEvL  213 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM-AHSCVGTPYYWSPELL  213 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccccc-ccccCCCccccCHHHH
Confidence                       24589999999987643322 2345699999999975

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=4.9e-27  Score=216.87  Aligned_cols=172  Identities=26%  Similarity=0.471  Sum_probs=142.0

Q ss_pred             cCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.+......   ..+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHH---HHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            5688899999999999999974      23456899988754422   23678899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCC----------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                      .++||||+++++|.+++....          ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999999886432          1224889999999999999999999   669999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +||+|||+++........  .....+++.|+|||++
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  194 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  194 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHh
Confidence            999999999865432211  1223457789999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.95  E-value=8.8e-27  Score=212.36  Aligned_cols=171  Identities=26%  Similarity=0.409  Sum_probs=143.9

Q ss_pred             CCCccceeecCCcccEEEEEcCCCcEEEEEEecccch---HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +|.+.+.||+|+||.||+|...+++.+|+|.+.....   ......+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4788899999999999999888899999999875432   1223346788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++.+..   .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999986543   3678888999999999999999   56899999999999999999999999999886532


Q ss_pred             CC------CCeeeccccccccCCCCC
Q 043586          377 DS------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~------~~~~~~~gt~~y~APE~~  396 (397)
                      ..      .......|+..|+|||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~  180 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVI  180 (265)
T ss_pred             ccccccccccccccCCCccccChhhh
Confidence            11      111234689999999974

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=8e-27  Score=210.70  Aligned_cols=164  Identities=29%  Similarity=0.442  Sum_probs=137.3

Q ss_pred             eeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      .||+|+||.||+|...+++.+|+|.+.......  ....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQE--LKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCCHH--HHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            589999999999998888999999987654332  235688899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe-eec
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLL  384 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~  384 (397)
                      .+++....  ..+++..+..++.|++.||.|+|   +++++||||||+||+++.++.+||+|||++.......... ...
T Consensus        80 ~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKKK--DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            99886543  24788999999999999999999   6699999999999999999999999999997644322211 122


Q ss_pred             cccccccCCCCC
Q 043586          385 AGTYGYIAPGLP  396 (397)
Q Consensus       385 ~gt~~y~APE~~  396 (397)
                      .+++.|+|||+.
T Consensus       155 ~~~~~y~aPE~~  166 (250)
T cd05085         155 QIPIKWTAPEAL  166 (250)
T ss_pred             CCcccccCHHHh
Confidence            346679999974

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.95  E-value=9.5e-27  Score=216.79  Aligned_cols=172  Identities=26%  Similarity=0.360  Sum_probs=143.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||++... +++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36889999999999999999865 57899999987665433344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999986542   4788889999999999999999   669999999999999999999999999998742111


Q ss_pred             CC---------------CeeeccccccccCCCCC
Q 043586          378 SS---------------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~---------------~~~~~~gt~~y~APE~~  396 (397)
                      ..               ......|+..|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  188 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI  188 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhc
Confidence            00               01123578899999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=6.5e-27  Score=215.51  Aligned_cols=170  Identities=30%  Similarity=0.478  Sum_probs=139.1

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  291 (397)
                      ++|++.+.||+|+||.||+|..     .+++.||+|++......   ..+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAE---HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4788899999999999999974     25789999998765432   23678899999999999999999998754  34


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence            6899999999999999986532  24788999999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCCCe---eeccccccccCCCCC
Q 043586          372 RLLHADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      +.........   ....++..|+|||+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  183 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESL  183 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHh
Confidence            8765433211   111234469999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=6.4e-27  Score=219.02  Aligned_cols=153  Identities=27%  Similarity=0.377  Sum_probs=134.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|... +++.||+|.+...........+.+.+|+++++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999875 58999999998765544344577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||+.+++|.+++.... ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999887532 235788899999999999999999   6699999999999999999999999999987653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-27  Score=240.92  Aligned_cols=174  Identities=28%  Similarity=0.457  Sum_probs=142.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC--CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP--NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .+..+..+.||+|.||.||.|...  ++.    .||||.++.....  +...+|.+|..+|+.++|||||+++|++.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~--~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSE--QEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            344566788999999999999754  233    4899998876544  33589999999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCC----ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                      ..++++|||++|+|..++++.+.    ...++..+.+.++.|||+|+.||+   ++++|||||..+|+|++....|||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999987521    235788899999999999999999   66899999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccc--cccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAG--TYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~g--t~~y~APE~~  396 (397)
                      ||+|+.+...........+  ...|||||.+
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl  876 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESL  876 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHH
Confidence            9999954433322221112  3479999975

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.95  E-value=3.6e-27  Score=219.39  Aligned_cols=172  Identities=28%  Similarity=0.460  Sum_probs=138.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc--EEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++. ++.  .+|+|.+......  ...+.+.+|++++.++ +||||+++++++...+..|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCH--HHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            56889999999999999999864 444  4577776643322  2236788899999999 8999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          295 LIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      +||||+++++|.+++.....             ...+++.+++.++.|++.|++|||   +++++||||||+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCC
Confidence            99999999999998875321             124788899999999999999999   67999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++...... ......++..|+|||+.
T Consensus       162 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  195 (303)
T cd05088         162 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESL  195 (303)
T ss_pred             cEEeCccccCcccchhh-hcccCCCcccccCHHHH
Confidence            99999999987432211 11122346679999963

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=4.3e-27  Score=215.76  Aligned_cols=174  Identities=21%  Similarity=0.326  Sum_probs=143.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .++|++.+.||+|+||.||+|...      .+..||+|.+.......  ....+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHH--HHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            357889999999999999999754      24689999987554322  2356788999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCC-------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeE
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF  364 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  364 (397)
                      ..++||||+++++|.+++.....       ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEE
Confidence            99999999999999998865322       123678889999999999999999   67999999999999999999999


Q ss_pred             EeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      |+|||+++.......  ......++..|+|||..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL  193 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHH
Confidence            999999986543321  12234567899999964

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.94  E-value=4.9e-27  Score=216.23  Aligned_cols=171  Identities=26%  Similarity=0.401  Sum_probs=143.3

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+|+.. +++.||+|+++.......  .+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc--hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4888999999999999999875 688999999876543211  2456789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++ +|.+++........+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 88888765443345889999999999999999999   6689999999999999999999999999998654433


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......+++.|+|||++
T Consensus       155 ~~~~~~~~~~~y~~PE~~  172 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVL  172 (284)
T ss_pred             cccccccccccccChHHh
Confidence            322334578999999964

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.9e-27  Score=211.47  Aligned_cols=170  Identities=31%  Similarity=0.478  Sum_probs=146.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|... +++.+++|.+......   ..+.+.+|++++++++||||+++++++......|++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57899999999999999999864 5788999998765433   2467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....  ..+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999998886542  24788899999999999999999   669999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........++..|+|||++
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~  173 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVA  173 (262)
T ss_pred             hhccccccCCccccCchhh
Confidence            3333445789999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=4.8e-27  Score=218.98  Aligned_cols=174  Identities=26%  Similarity=0.392  Sum_probs=141.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|.+.+.||+|+||.||+++..        +...+|+|.+.......  ..+++.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChH--HHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            356899999999999999999752        23579999998653322  235678899999999 7999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      ..+..|+||||+++++|.+++.....             ...+++.++..++.|++.||+|||   +.+++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence            99999999999999999999875421             124788899999999999999999   66999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      +++.++.+||+|||.++.........  ....+++.|+|||++
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  214 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence            99999999999999998654322111  112245689999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=8.5e-27  Score=213.01  Aligned_cols=166  Identities=20%  Similarity=0.315  Sum_probs=132.9

Q ss_pred             eeecCCcccEEEEEcCCC---cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .||+|+||.||+|+..++   ..+++|.+.......  ..+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK--EQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChH--HHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999975433   346677666543322  246789999999999999999999999999999999999999


Q ss_pred             CCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC--C
Q 043586          303 GSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--S  379 (397)
Q Consensus       303 g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~  379 (397)
                      |+|.+++.+... ....++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999876432 223566777889999999999999   5689999999999999999999999999986432211  1


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......|+..|+|||+.
T Consensus       157 ~~~~~~~~~~y~aPE~~  173 (268)
T cd05086         157 TEDDKCVPLRWLAPELV  173 (268)
T ss_pred             cccCCcCcccccCchhc
Confidence            12334688899999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=5.9e-27  Score=213.35  Aligned_cols=170  Identities=28%  Similarity=0.464  Sum_probs=141.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|++.+.||+|++|.||+|.+. .++.||+|.+......    .+++.+|++++++++||||+++++++...+..+++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchH----HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            35788899999999999999865 5789999998754322    356888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999886543 234788899999999999999999   669999999999999999999999999999876443


Q ss_pred             CCCe-eeccccccccCCCCC
Q 043586          378 SSNR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~-~~~~gt~~y~APE~~  396 (397)
                      .... ....+++.|+|||++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~  177 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESL  177 (263)
T ss_pred             eeeccCCCCCccccCCHHHh
Confidence            2211 112346689999964

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-28  Score=195.91  Aligned_cols=170  Identities=27%  Similarity=0.388  Sum_probs=141.4

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+-.++||+|.||+||+|+.. +++.||+|.++....++.. .....+|+-+++.++|.|||++++....+...-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegv-pssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCC-cHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            3555678999999999999854 6889999999876543221 2345679999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||.. +|..+...-..  .++...+..++.|+++|+.|+|   ++.+.|||+||.|.+++.+|+.|++|||+|+.+..+-
T Consensus        82 ~cdq-dlkkyfdslng--~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9964 77766654332  4788889999999999999999   6789999999999999999999999999999876655


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .-.+..+-|.+|.+|.++
T Consensus       156 rcysaevvtlwyrppdvl  173 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVL  173 (292)
T ss_pred             EeeeceeeeeeccCccee
Confidence            444445678999999875

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=5e-27  Score=217.25  Aligned_cols=175  Identities=26%  Similarity=0.404  Sum_probs=143.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  289 (397)
                      ..++|++.+.||+|+||.||++...      ....+|+|.+.......  ...++.+|++++.++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHH--HHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            3456889999999999999999753      23679999987653332  235688899999999 79999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccC-------------CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNN-------------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                      ++..+++|||+++|+|.+++...             .....+++..++.++.|++.|+.|||   +.+|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            99999999999999999988643             12235788999999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ++.++.+||+|||+++.+.......  ....++..|+|||+.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  206 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEAL  206 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHh
Confidence            9999999999999998765432211  112346789999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=3.9e-27  Score=224.85  Aligned_cols=169  Identities=27%  Similarity=0.322  Sum_probs=138.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  290 (397)
                      ..++|++.+.||+|+||.||+|... .++.||||++....... ...+.+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            4578999999999999999999764 68899999987543221 2235677899999999999999999987643     


Q ss_pred             -CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          291 -KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       291 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                       ...|+||||+++ ++.+.+..     .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999975 67666642     3677888999999999999999   6799999999999999999999999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++...... ......||+.|+|||++
T Consensus       172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         172 LARTAGTSF-MMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             CccccCCCC-cccCCcccCCcCCHHHH
Confidence            998654322 22335689999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.94  E-value=7.6e-28  Score=242.25  Aligned_cols=175  Identities=27%  Similarity=0.456  Sum_probs=140.8

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe-----
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-----  288 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----  288 (397)
                      .+-..+|+..+.||+|+||.||+++.+ ||+.||||++.... .+. ......+|+..+++++|||||+++..|.     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~-~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~  552 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDK-LYSKILREVKLLARLNHPNVVRYYSAWVESTAE  552 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHH-HHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence            455677888999999999999999976 89999999998876 322 2356778999999999999999984321     


Q ss_pred             --------------------------------------------------------------------------------
Q 043586          289 --------------------------------------------------------------------------------  288 (397)
Q Consensus       289 --------------------------------------------------------------------------------  288 (397)
                                                                                                      
T Consensus       553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~  632 (1351)
T KOG1035|consen  553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN  632 (1351)
T ss_pred             cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence                                                                                            


Q ss_pred             ---------------------------eC-------CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHH
Q 043586          289 ---------------------------HR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL  334 (397)
Q Consensus       289 ---------------------------~~-------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l  334 (397)
                                                 +.       ..+||-||||+..++.++++++....  .....++++++|++||
T Consensus       633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGL  710 (1351)
T KOG1035|consen  633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGL  710 (1351)
T ss_pred             ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHH
Confidence                                       00       23689999999888888887654321  3567889999999999


Q ss_pred             HHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC----C--------------CCCCeeeccccccccCCCCC
Q 043586          335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH----A--------------DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       335 ~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~----~--------------~~~~~~~~~gt~~y~APE~~  396 (397)
                      .|+|   +.|||||||||.||++|++..|||+|||+|+...    .              +....+..+||.-|+|||++
T Consensus       711 aYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll  787 (1351)
T KOG1035|consen  711 AYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL  787 (1351)
T ss_pred             HHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence            9999   6689999999999999999999999999998721    0              01123567899999999975

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.94  E-value=5.1e-27  Score=216.25  Aligned_cols=171  Identities=29%  Similarity=0.403  Sum_probs=143.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++...||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.++++++|||++++++++..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888999999999999999875 68999999886543211 12356778999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++++++..++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            9999988877665322   4788999999999999999999   569999999999999999999999999999876554


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........++..|+|||++
T Consensus       154 ~~~~~~~~~~~~~~aPE~~  172 (286)
T cd07847         154 GDDYTDYVATRWYRAPELL  172 (286)
T ss_pred             cccccCcccccccCCHHHH
Confidence            4333345688899999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=3.7e-27  Score=227.08  Aligned_cols=164  Identities=25%  Similarity=0.374  Sum_probs=138.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ..+|++.+.||+|+||.||+|...   .++.||+|.+....        ...+|++++++++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            357999999999999999999643   45789999886532        3457999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|||++. ++|.+++...   ..+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999996 6888877432   34789999999999999999999   669999999999999999999999999999876


Q ss_pred             CCCCCC--eeeccccccccCCCCC
Q 043586          375 HADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ......  .....||+.|+|||++
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~  259 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELL  259 (392)
T ss_pred             CcccccccccccccccCccCHhHh
Confidence            543322  2245799999999975

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=3e-27  Score=217.60  Aligned_cols=172  Identities=24%  Similarity=0.348  Sum_probs=140.4

Q ss_pred             CCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      +|++.+.||+|+||.||+|++.      +++.||+|++......  ...+.+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4777888999999999999753      3578999999755432  2246788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCC-------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          294 FLIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      ++++||+.+++|.+++....             ....+++..+..++.|++.||+|+|   +.+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCC
Confidence            99999999999998875321             1224778889999999999999999   6699999999999999999


Q ss_pred             CCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +.+||+|||+++........  .....+++.|+|||.+
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAI  198 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHH
Confidence            99999999999866433221  1223467889999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=7.7e-27  Score=214.51  Aligned_cols=170  Identities=25%  Similarity=0.398  Sum_probs=138.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++. +++    .||+|.++......  ..+.+.+|+.+++.+.||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK--ANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHH--HHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            56888999999999999999753 444    48999987654332  236788899999999999999999998754 47


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++++||+++|+|.+++....  ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+++.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            79999999999999987543  24788999999999999999999   66999999999999999999999999999987


Q ss_pred             cCCCCCCee--eccccccccCCCCC
Q 043586          374 LHADSSNRT--LLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~--~~~gt~~y~APE~~  396 (397)
                      .........  ...+++.|+|||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESI  183 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHh
Confidence            654332211  12346789999974

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.94  E-value=2.7e-27  Score=218.17  Aligned_cols=171  Identities=30%  Similarity=0.400  Sum_probs=144.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888999999999999999875 58899999886543332 22356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++++++..+....   ..+++.++..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999998887766532   23788999999999999999999   568999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........++..|+|||+.
T Consensus       154 ~~~~~~~~~~~~y~aPE~~  172 (286)
T cd07846         154 GEVYTDYVATRWYRAPELL  172 (286)
T ss_pred             ccccCcccceeeccCcHHh
Confidence            4333345688999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=7.5e-27  Score=216.54  Aligned_cols=168  Identities=27%  Similarity=0.430  Sum_probs=144.9

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+.......   .+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK---KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch---HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4688999999999999999975 478999999987543322   356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999888643    3788999999999999999999   669999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||.+
T Consensus       169 ~~~~~~~~~~~~y~aPE~~  187 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVV  187 (296)
T ss_pred             cccCCCcCCCccccCcchh
Confidence            4333345689999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=6e-27  Score=212.91  Aligned_cols=170  Identities=28%  Similarity=0.471  Sum_probs=141.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|...++..+|+|.+.......    +.+.+|+.++++++|||++++++++. ....+++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            35789999999999999999998888889999987654332    46888999999999999999999875 45688999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999998875322 34788999999999999999999   568999999999999999999999999999866443


Q ss_pred             CCCe-eeccccccccCCCCC
Q 043586          378 SSNR-TLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~-~~~~gt~~y~APE~~  396 (397)
                      .... ....++..|+|||+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~  175 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             ccccccCCCCCccccChHHH
Confidence            2211 122356679999964

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=8.6e-27  Score=214.25  Aligned_cols=170  Identities=24%  Similarity=0.365  Sum_probs=137.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|.+......  ...+++..|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccch--HHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            46888899999999999999864 344    4778877543222  223677888889999999999999998764 457


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++++||+++|+|.+++.....  .+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            889999999999999875432  4788999999999999999999   66899999999999999999999999999986


Q ss_pred             cCCCCC--CeeeccccccccCCCCC
Q 043586          374 LHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ......  ......++..|+|||+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~  183 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESI  183 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHh
Confidence            643322  12234577789999974

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.94  E-value=1.2e-26  Score=211.49  Aligned_cols=172  Identities=26%  Similarity=0.411  Sum_probs=141.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccch--HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  293 (397)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.....  ......+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46889999999999999999864 588999998864321  1222346788999999999999999999998763  468


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....   .+++.....++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999886542   3677888999999999999999   56899999999999999999999999999986


Q ss_pred             cCCCC---CCeeeccccccccCCCCC
Q 043586          374 LHADS---SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~---~~~~~~~gt~~y~APE~~  396 (397)
                      .....   .......|+..|+|||..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVI  181 (265)
T ss_pred             cccccccccccccCCCCccccChhhh
Confidence            54311   112334689999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.94  E-value=6.2e-27  Score=216.44  Aligned_cols=181  Identities=30%  Similarity=0.398  Sum_probs=148.2

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeE
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGF  286 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  286 (397)
                      ++.+++..+.++|++.+.||+|+||.||++... +++.+|+|.+......    ...+.+|+.+++++ +|||+++++++
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            344566667889999999999999999999864 6889999998754322    24567899999999 79999999999


Q ss_pred             EeeC-----CEeeEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          287 CLHR-----KCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       287 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      +...     +..++||||+++++|.++++... ....+++..+..++.|++.||+|||   +.+++||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCC
Confidence            8753     35899999999999998876421 2235788999999999999999999   6699999999999999999


Q ss_pred             CCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.+||+|||++..............|++.|+|||++
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI  200 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhhh
Confidence            999999999998765433333345689999999974

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=1e-26  Score=215.12  Aligned_cols=172  Identities=26%  Similarity=0.448  Sum_probs=142.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      .+|.+.+.||+|+||.||+|+..      ++..+++|.+.......   .+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            45788899999999999999742      35568899887654332   3568889999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      .++||||+++++|.+++.....             ...+++..++.++.|++.|++|||   +++++||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence            9999999999999999865321             234788999999999999999999   669999999999999999


Q ss_pred             CCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          360 KFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ++.+||+|||+++.......  ......+++.|+|||++
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  197 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  197 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHh
Confidence            99999999999986543321  11234567889999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.94  E-value=1.1e-26  Score=215.61  Aligned_cols=172  Identities=27%  Similarity=0.425  Sum_probs=137.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-C--cEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-G--KVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|...+ +  ..+++|.++.....  ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            578999999999999999998653 3  34788887743222  1236788899999999 7999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          295 LIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      +||||+++++|.+++.....             ...+++..+..++.|++.|++|||   +.+++||||||+||+++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCC
Confidence            99999999999999865321             124788899999999999999999   66999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||++........ ......+..|+|||+.
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~  190 (297)
T cd05089         157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESL  190 (297)
T ss_pred             eEEECCcCCCccccceec-cCCCCcCccccCchhh
Confidence            999999999874322111 1112235579999974

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.6e-27  Score=213.24  Aligned_cols=169  Identities=36%  Similarity=0.498  Sum_probs=146.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||.|++|.||+|+.. +++.||+|.+......  .....+.+|+++++.++||||+++++++.++...|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE--DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccc--hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36888899999999999999865 6889999998765322  22356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...    .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999988753    5788999999999999999999   668999999999999999999999999999887654


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||++
T Consensus       152 ~~~~~~~~~~~~y~~PE~~  170 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVI  170 (274)
T ss_pred             ccccccccCCccccChhhh
Confidence            4334445789999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=217.37  Aligned_cols=163  Identities=18%  Similarity=0.141  Sum_probs=127.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC--CCcEEEEEEecccch--HHHHHHHHHHHHHHHHhhcccCCccc-eeeEEeeCC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVK-LYGFCLHRK  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~  291 (397)
                      ..++|++.+.||+|+||+||+|++.  +++.+|||++.....  ......+.+.+|++++++++|+|++. ++++    +
T Consensus        16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~   91 (365)
T PRK09188         16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----G   91 (365)
T ss_pred             ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----C
Confidence            4567999999999999999999764  577789998753311  11223467899999999999999985 4432    4


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEeCCCCCeEEecccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DFG~  370 (397)
                      ..|+||||++|++|.. ...      ..   ...++.|+++||.|||   +.||+|||| ||+|||++.++.+||+|||+
T Consensus        92 ~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         92 KDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             CcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence            5799999999999863 211      01   1457889999999999   669999999 99999999999999999999


Q ss_pred             ccccCCCCCC--------eeeccccccccCCCCC
Q 043586          371 ARLLHADSSN--------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~--------~~~~~gt~~y~APE~~  396 (397)
                      |+.+......        .+...+++.|+|||++
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~  192 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDAL  192 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccC
Confidence            9977554321        1345688999999985

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=1e-26  Score=217.61  Aligned_cols=163  Identities=27%  Similarity=0.463  Sum_probs=130.4

Q ss_pred             ceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeEEEee
Q 043586          225 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLIYEY  299 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~  299 (397)
                      ..||+|+||.||+|+..   ++..||+|.+......     ..+.+|++++++++||||+++++++..  +...++||||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            57999999999999864   4578999998765432     356789999999999999999998854  5678999999


Q ss_pred             ccCCCchhhcccC------CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe----CCCCCeEEeccc
Q 043586          300 MERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVADFG  369 (397)
Q Consensus       300 ~~~g~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DFG  369 (397)
                      +.+ ++.+++...      .....+++..+..++.|++.||.|||   +.+|+||||||+||++    +.++.+||+|||
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            964 776666422      11234788889999999999999999   6699999999999999    566899999999


Q ss_pred             cccccCCCCC---CeeeccccccccCCCCC
Q 043586          370 TARLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      +++.......   ......||+.|+|||++
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  187 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELL  187 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHh
Confidence            9987654322   12335689999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=1.1e-26  Score=210.76  Aligned_cols=167  Identities=29%  Similarity=0.495  Sum_probs=142.4

Q ss_pred             ceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          225 YCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      +.||+|+||.||+|....    +..|++|.+.......  ..+.+.+|++.++.++|+||+++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            358999999999998753    7889999998765443  3477889999999999999999999999999999999999


Q ss_pred             cCCCchhhcccCCC------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          301 ERGSLFCNLHNNED------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       301 ~~g~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ++++|.+++.....      ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999876421      245899999999999999999999   679999999999999999999999999999877


Q ss_pred             CCCC--CCeeeccccccccCCCCC
Q 043586          375 HADS--SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~--~~~~~~~gt~~y~APE~~  396 (397)
                      ....  .......+++.|+|||..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~  179 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESL  179 (262)
T ss_pred             ccccccccccCCCcCccccCHHHh
Confidence            5433  122334578899999964

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=9.8e-27  Score=211.55  Aligned_cols=169  Identities=26%  Similarity=0.461  Sum_probs=139.8

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|++|.||+|.+.++..+|+|.+......    .+.+.+|++++++++|||++++++++. .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            468889999999999999999877778999988754432    256788999999999999999999875 456889999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.... ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999987543 234788899999999999999999   6689999999999999999999999999998664332


Q ss_pred             CC-eeeccccccccCCCCC
Q 043586          379 SN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~-~~~~~gt~~y~APE~~  396 (397)
                      .. .....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~  175 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             ccccCCCccchhhCCHHHh
Confidence            21 1123466789999964

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=6.1e-27  Score=216.10  Aligned_cols=170  Identities=30%  Similarity=0.452  Sum_probs=134.2

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEee-----C
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH-----R  290 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~  290 (397)
                      +|++.+.||+|+||.||+|+.. +++.||+|.++.....+. ....+.+|+++++++   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4888999999999999999865 688999999875432211 112344566666655   69999999998864     3


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCc
Confidence            458999999974 88887765432 34788999999999999999999   66999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++....... .....||+.|+|||++
T Consensus       155 ~~~~~~~~~-~~~~~~~~~y~aPE~~  179 (288)
T cd07863         155 ARIYSCQMA-LTPVVVTLWYRAPEVL  179 (288)
T ss_pred             cccccCccc-CCCccccccccCchHh
Confidence            986643322 2334689999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.94  E-value=6.2e-27  Score=216.66  Aligned_cols=171  Identities=28%  Similarity=0.394  Sum_probs=143.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  295 (397)
                      ++|++.+.||+|+||.||+|.+. +++.+|+|.++.....+ .....+.+|+.++++++||||+++++++...  +..|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            56888999999999999999875 58899999997654332 2234567899999999999999999999877  88999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||++ ++|.+++.....  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          84 VMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             EehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999997 488887765432  4789999999999999999999   6689999999999999999999999999998765


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........+++.|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~  178 (293)
T cd07843         158 SPLKPYTQLVVTLWYRAPELL  178 (293)
T ss_pred             CCccccccccccccccCchhh
Confidence            543333334578999999974

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=9.9e-27  Score=215.02  Aligned_cols=172  Identities=25%  Similarity=0.388  Sum_probs=139.8

Q ss_pred             CCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      +|++.+.||+|+||.||+|...      ....+++|.+.......  ..+++.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS--ELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHH--HHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4778899999999999999753      23578888887554332  236788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCC---------------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          294 FLIYEYMERGSLFCNLHNNE---------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      ++||||+.+++|.+++....                     ....+++..+..++.|++.||+|||   +.+++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhh
Confidence            99999999999998875421                     1124788899999999999999999   66999999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +||++++++.+||+|||+++........  .....++..|+|||++
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~  201 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL  201 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence            9999999999999999999865433221  1223456789999964

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=7.1e-27  Score=212.44  Aligned_cols=171  Identities=29%  Similarity=0.522  Sum_probs=144.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|.+.+.||+|+||.||+|...+++.+|+|.+......    .+++.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4678999999999999999999888889999998865433    256888999999999999999999999888999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++..+..++.|++.|+.|||   +++++|+||||+||+++.++.+||+|||.++.....
T Consensus        81 e~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             eccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            99999999999876432 34788999999999999999999   668999999999999999999999999999876432


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....++..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~  176 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAA  176 (261)
T ss_pred             hhhhhhccCCCccccCHHHh
Confidence            211 1122345689999964

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=1.1e-26  Score=216.02  Aligned_cols=173  Identities=25%  Similarity=0.365  Sum_probs=142.8

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||.||++..      ..+..||+|.++......  ..+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSS--EREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChH--HHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            35689999999999999999963      235579999987654322  236788999999999 799999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      +..++||||+++|+|.+++..... ..+++.++..++.|++.|++|||   +++++|+||||+||+++.++.+|++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999875332 23789999999999999999999   66999999999999999999999999999


Q ss_pred             ccccCCCCCC--eeeccccccccCCCCC
Q 043586          371 ARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ++........  .....+++.|+|||++
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  215 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESI  215 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhh
Confidence            9866433221  1123467789999964

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=4e-27  Score=213.80  Aligned_cols=170  Identities=30%  Similarity=0.465  Sum_probs=146.7

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|++++++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999875 689999999976544333345788999999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+.+++|.+++...   ..+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999988754   24788899999999999999999   6689999999999999999999999999998764432


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                       ......|+..|+|||+.
T Consensus       155 -~~~~~~~~~~y~~PE~~  171 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVL  171 (258)
T ss_pred             -cccccCCChhhcCHHHH
Confidence             22335688999999964

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.94  E-value=1.3e-26  Score=211.09  Aligned_cols=173  Identities=30%  Similarity=0.456  Sum_probs=147.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||.|+||.||+|... ++..+|+|++.......  ..+.+.+|+++++.++|+|++++++.+..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47899999999999999999854 67899999987544332  2467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++........+++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            99999999999876433335788999999999999999999   669999999999999999999999999999876554


Q ss_pred             CCC----eeeccccccccCCCCC
Q 043586          378 SSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~----~~~~~gt~~y~APE~~  396 (397)
                      ...    .....|++.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~  178 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVM  178 (267)
T ss_pred             ccccccccccccCChhhcChHHH
Confidence            332    2334689999999974

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=1.4e-26  Score=210.34  Aligned_cols=163  Identities=25%  Similarity=0.402  Sum_probs=132.5

Q ss_pred             eeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .||+|+||.||+|.+.   .+..||+|++......  ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~--~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEK--SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccCh--HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            3899999999999753   3557999998765432  234678899999999999999999998864 468999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe-
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-  381 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-  381 (397)
                      ++|.+++....  ..+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++......... 
T Consensus        79 ~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          79 GPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99999886433  24788999999999999999999   6699999999999999999999999999998654433221 


Q ss_pred             --eeccccccccCCCCC
Q 043586          382 --TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 --~~~~gt~~y~APE~~  396 (397)
                        ....+++.|+|||+.
T Consensus       154 ~~~~~~~~~~y~aPE~~  170 (257)
T cd05115         154 ARSAGKWPLKWYAPECI  170 (257)
T ss_pred             ccCCCCCCcccCCHHHH
Confidence              111235789999963

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.8e-26  Score=209.17  Aligned_cols=167  Identities=26%  Similarity=0.450  Sum_probs=143.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|... ++.||+|.+.....    ..+++.+|+.+++.++|+||+++++++...+..++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            357889999999999999999875 78899999976644    2367888999999999999999999999888999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999875432 24789999999999999999999   669999999999999999999999999999876322


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ..   ...++..|+|||++
T Consensus       156 ~~---~~~~~~~~~ape~~  171 (256)
T cd05039         156 QD---SGKLPVKWTAPEAL  171 (256)
T ss_pred             cc---cCCCcccccCchhh
Confidence            22   22346679999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=1.1e-26  Score=215.28  Aligned_cols=172  Identities=23%  Similarity=0.401  Sum_probs=140.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-----------------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCcc
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-----------------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV  281 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv  281 (397)
                      ++|++.+.||+|+||.||+++..                 ++..+|+|.+......  ...+++.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK--NARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcc
Confidence            56899999999999999998532                 2346899998764322  2246788999999999999999


Q ss_pred             ceeeEEeeCCEeeEEEeeccCCCchhhcccCCC--------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043586          282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNED--------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  353 (397)
Q Consensus       282 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  353 (397)
                      ++++++...+..++||||+++++|.+++.....        ...+++.++..++.|++.|++|||   +.+++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence            999999999999999999999999998875321        123677889999999999999999   669999999999


Q ss_pred             CEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          354 NILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       354 NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      ||+++.++.++|+|||+++.+......  .....+++.|+|||+
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  203 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWES  203 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHH
Confidence            999999999999999999865433211  112234678999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.94  E-value=3.2e-27  Score=217.49  Aligned_cols=170  Identities=28%  Similarity=0.408  Sum_probs=141.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||+|+.. +|+.||+|.++...... .....+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4788899999999999999865 68899999987543221 122456789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |++ ++|.+++....  ..+++..+..++.||++||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            997 57877775432  24789999999999999999999   6699999999999999999999999999998665443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......+++.|+|||++
T Consensus       154 ~~~~~~~~~~~y~aPE~~  171 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVL  171 (284)
T ss_pred             CCcCCCccccCCcChHHH
Confidence            333334678999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=1.8e-26  Score=210.12  Aligned_cols=160  Identities=26%  Similarity=0.363  Sum_probs=131.0

Q ss_pred             ceeecCCcccEEEEEcCC-------------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          225 YCIGTGGYGSVYKAQLPN-------------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      +.||+|+||.||+|.+.+             ...+++|.+......   ....+.+|+.+++.++||||+++++++..+.
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRD---ISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhh---HHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999997532             235888887654322   2357888999999999999999999999998


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC-------eE
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE-------AF  364 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------~k  364 (397)
                      ..++||||+++++|..++....  ..+++..+..++.|+++||+|||   +++|+||||||+|||++.++.       +|
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999988776432  24788889999999999999999   679999999999999987664       89


Q ss_pred             EeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++|||++......    ....|+..|+|||++
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~  180 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECV  180 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhh
Confidence            9999998755322    224578899999974

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=1.2e-26  Score=213.57  Aligned_cols=180  Identities=29%  Similarity=0.460  Sum_probs=147.9

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeE
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGF  286 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  286 (397)
                      .++.++....+.|++.+.||+|+||.||+|+.. +++.+|+|.+......    ..++..|+.+++++ +||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH----HHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            345566667788999999999999999999864 6789999998654322    24677899999998 69999999999


Q ss_pred             Eee------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          287 CLH------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       287 ~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      +..      ....|++|||+++|+|.+++..... ..+++..+..++.|++.|+.|||   +.+++|+||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence            853      4578999999999999988865332 24677888899999999999999   6699999999999999999


Q ss_pred             CCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.++|+|||++..............|++.|+|||.+
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l  193 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  193 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhhc
Confidence            999999999988654333333445689999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=1.2e-26  Score=210.10  Aligned_cols=168  Identities=35%  Similarity=0.481  Sum_probs=146.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|...+ ++.+++|.+.....     .+++.+|++++++++||||+++++++......|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            578999999999999999998764 78999999875432     367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....  ..+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999886533  24788999999999999999999   568999999999999999999999999999876554


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|+..|+|||++
T Consensus       153 ~~~~~~~~~~~~y~~PE~~  171 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVI  171 (256)
T ss_pred             ccccccccCCccccCHHHH
Confidence            4333445689999999963

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=4.7e-27  Score=215.70  Aligned_cols=168  Identities=33%  Similarity=0.462  Sum_probs=142.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.......  ..+.+.+|++++++++||||+++++++..+...++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchH--HHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4666778999999999999754 57889999987544332  24678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++...    .+++..+..++.|++.|+.|||   .++++|+||+|+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKPG----PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999999888642    4788889999999999999999   6799999999999999999999999999998765443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|+..|+|||+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~  173 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             hhhhcccCcccccCHHHh
Confidence            333345688999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=9.8e-27  Score=217.61  Aligned_cols=174  Identities=25%  Similarity=0.398  Sum_probs=140.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.++......  ....+.+|+++++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--DLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChH--HHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            367889999999999999999642        24578999987543322  246688899999999 6999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      ..+..++||||+++|+|.+++.....             ...+++.++..++.|++.||.|||   +++++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence            99999999999999999998865321             134788899999999999999999   66999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      +++.++.+||+|||+++.........  ....+++.|+|||++
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEAL  208 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHH
Confidence            99999999999999998664322211  112245679999964

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.94  E-value=2.6e-26  Score=210.78  Aligned_cols=168  Identities=34%  Similarity=0.472  Sum_probs=143.5

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      -|++.+.||+|+||.||+|.. .+++.||+|.+.......  ..+.+.+|+.++++++||||+++++++..+...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH--HHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            477788999999999999975 468899999886544322  24678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++...    .+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999888642    4788899999999999999999   6699999999999999999999999999998665433


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|+..|+|||+.
T Consensus       156 ~~~~~~~~~~~y~~PE~~  173 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             hhhccccCCccccChhhh
Confidence            333345689999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1.6e-26  Score=212.00  Aligned_cols=159  Identities=23%  Similarity=0.341  Sum_probs=129.2

Q ss_pred             eeecCCcccEEEEEcC-------------------------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc
Q 043586          226 CIGTGGYGSVYKAQLP-------------------------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI  280 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni  280 (397)
                      .||+|+||.||+|.+.                         ....||+|.+.....   .....+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence            5899999999998641                         123588898865432   223578889999999999999


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      +++++++......++||||+++|+|..++....  ..+++..+..++.|+++||+|||   +++|+||||||+||+++.+
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence            999999999999999999999999988886432  24788889999999999999999   6699999999999999764


Q ss_pred             C-------CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          361 F-------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~-------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +       .+|++|||++.......    ...++..|+|||++
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~aPe~~  192 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSRE----ERVERIPWIAPECV  192 (274)
T ss_pred             CcccCccceeeecCCcccccccccc----ccccCCcccCchhh
Confidence            4       37999999986543221    23578889999965

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=1.9e-26  Score=210.91  Aligned_cols=172  Identities=26%  Similarity=0.402  Sum_probs=135.5

Q ss_pred             CCccceeecCCcccEEEEEcCCC-c--EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------C
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPNG-K--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K  291 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~~-~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  291 (397)
                      |.+.+.||+|+||.||+|++.+. .  .+|+|.++...... ...+.+.+|+++++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTR-SEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            35678899999999999987543 2  58999887643222 2246788899999999999999999987532      2


Q ss_pred             EeeEEEeeccCCCchhhcccCC---CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                      ..+++|||+++|+|.+++....   ....+++..+..++.|++.||+|||   .++|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCC
Confidence            4689999999999988764321   2234788999999999999999999   569999999999999999999999999


Q ss_pred             ccccccCCCCCC--eeeccccccccCCCCC
Q 043586          369 GTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |+++........  .....+++.|+|||+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  186 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESL  186 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHc
Confidence            999876443221  1223467789999974

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.94  E-value=6.8e-27  Score=216.38  Aligned_cols=166  Identities=28%  Similarity=0.437  Sum_probs=140.0

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |.....||+|+||.||++... ++..||+|++.......   .+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHH---HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            333466999999999999764 68899999986544322   35688899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++...    .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999887532    3678899999999999999999   66999999999999999999999999999986544333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......|++.|+|||+.
T Consensus       174 ~~~~~~~~~~y~aPE~~  190 (292)
T cd06658         174 KRKSLVGTPYWMAPEVI  190 (292)
T ss_pred             cCceeecCccccCHHHH
Confidence            33445689999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=6.6e-27  Score=231.57  Aligned_cols=177  Identities=21%  Similarity=0.273  Sum_probs=133.4

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC--CCcEEEEEE--------------ecccchHHHHHHHHHHHHHHHHhhcccCC
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP--NGKVFALKK--------------LHTSETEELAFIKSFRNEAQVLSQVLHRN  279 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~n  279 (397)
                      ...++|++.+.||+|+||.||+|..+  .+...+.|.              +.............+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34678999999999999999998643  222222221              11111111123456889999999999999


Q ss_pred             ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCC--ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe
Q 043586          280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL  357 (397)
Q Consensus       280 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll  357 (397)
                      |+++++++...+..|+|+|++. +++.+++.....  .......++..++.|++.||.|||   +++|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEE
Confidence            9999999999999999999995 567666543211  112335667789999999999999   6699999999999999


Q ss_pred             CCCCCeEEeccccccccCCCCC-CeeeccccccccCCCCC
Q 043586          358 NSKFEAFVADFGTARLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       358 ~~~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      +.++.+||+|||+++.+..... ......||+.|+|||++
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~  340 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEIL  340 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhh
Confidence            9999999999999987654332 22345799999999985

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=2.2e-26  Score=209.86  Aligned_cols=171  Identities=30%  Similarity=0.486  Sum_probs=142.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH------HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE------ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      .|.+...||+|++|.||+|... +++.+|+|.+......      .....+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677889999999999999764 5789999988654321      22334678899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .++||||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999886542   4778889999999999999999   6699999999999999999999999999998


Q ss_pred             ccCCCCC------CeeeccccccccCCCCC
Q 043586          373 LLHADSS------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~------~~~~~~gt~~y~APE~~  396 (397)
                      .......      ......|++.|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~  184 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVV  184 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHh
Confidence            7653221      11234588999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.4e-26  Score=211.22  Aligned_cols=170  Identities=26%  Similarity=0.429  Sum_probs=139.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CC----cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|.+. ++    ..+|+|.+......  .....+.+|+.++++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSP--KANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            46888899999999999999754 23    25899988765432  234678899999999999999999999987 788


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++|+|.+++.....  .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999876433  3788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCCeee--ccccccccCCCCC
Q 043586          374 LHADSSNRTL--LAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~--~~gt~~y~APE~~  396 (397)
                      ..........  ..++..|+|||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESI  183 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHh
Confidence            6543322111  1235679999964

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=2e-26  Score=212.30  Aligned_cols=170  Identities=30%  Similarity=0.403  Sum_probs=144.7

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+|++. +++.||+|++....... ...+.+.+|+.++++++||||+++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4788999999999999999864 68999999987654322 223678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+ +++|.+++....  ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999886543  34788999999999999999999   6699999999999999999999999999998765433


Q ss_pred             C-CeeeccccccccCCCCC
Q 043586          379 S-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~-~~~~~~gt~~y~APE~~  396 (397)
                      . ......|+..|+|||++
T Consensus       154 ~~~~~~~~~~~~y~aPE~~  172 (286)
T cd07832         154 PRLYSHQVATRWYRAPELL  172 (286)
T ss_pred             CCccccccCcccccCceee
Confidence            1 12334689999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=6e-27  Score=212.95  Aligned_cols=168  Identities=38%  Similarity=0.578  Sum_probs=134.9

Q ss_pred             ccceeecCCcccEEEEEcC-----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          223 IKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.+.||.|+||.||+|.+.     .+..|+||.++.....+  ..+.+.+|++.+++++||||++++|++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEE--EEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHH--HHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccc--cceeeeecccccccccccccccccccccccccccccc
Confidence            4578999999999999875     35689999996643332  2478899999999999999999999999888899999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.... ...+++..+..|+.|+++||.|||   +.+++|+||+++||+++.++.+||+|||++......
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            9999999999998752 235889999999999999999999   558999999999999999999999999999876322


Q ss_pred             CCC--eeeccccccccCCCCC
Q 043586          378 SSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~--~~~~~gt~~y~APE~~  396 (397)
                      ...  .....+...|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~  177 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVL  177 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHH
T ss_pred             ccccccccccccccccccccc
Confidence            221  1223467789999963

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=1.5e-26  Score=209.87  Aligned_cols=158  Identities=26%  Similarity=0.425  Sum_probs=131.9

Q ss_pred             ceeecCCcccEEEEEcCCCc-----------EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          225 YCIGTGGYGSVYKAQLPNGK-----------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      +.||+|+||.||+|.+.+..           .+++|.+......    ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            35899999999999875432           5777876654322    3678889999999999999999999988 778


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-------CeEEe
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-------EAFVA  366 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-------~~kl~  366 (397)
                      ++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++       .+||+
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999998876432  4788889999999999999999   66999999999999999887       79999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||++.....    .....++..|+|||++
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~  176 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECI  176 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhh
Confidence            9999986543    2224577889999974

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.94  E-value=2e-26  Score=209.47  Aligned_cols=170  Identities=25%  Similarity=0.453  Sum_probs=142.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||++...++..+|+|.+......    .+.+.+|++++++++|+||+++++++.. ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhH----HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            4678999999999999999999877888999988764332    3578889999999999999999999887 7789999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.... ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999987543 234788889999999999999999   568999999999999999999999999999865432


Q ss_pred             CCC-eeeccccccccCCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~~  396 (397)
                      ... .....++..|+|||++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~  175 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAI  175 (260)
T ss_pred             CcccccCCcccccccCHhHh
Confidence            221 1223356779999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=1.8e-26  Score=209.20  Aligned_cols=165  Identities=25%  Similarity=0.422  Sum_probs=138.0

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe-eCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-HRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||++... +..+|+|.++....     .+.+.+|+.++++++|+|++++++++. .++..++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            46889999999999999999875 77899999865432     256888999999999999999999765 456789999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999875432 24788899999999999999999   669999999999999999999999999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .   ....++..|+|||+.
T Consensus       156 ~---~~~~~~~~y~aPE~~  171 (256)
T cd05082         156 Q---DTGKLPVKWTAPEAL  171 (256)
T ss_pred             C---CCCccceeecCHHHH
Confidence            2   123356689999964

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=2.5e-26  Score=208.22  Aligned_cols=170  Identities=26%  Similarity=0.384  Sum_probs=144.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH--HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +|+..+.||+|++|.||+|... +++.|++|.+......  .....+.+.+|+++++.++||||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777889999999999999876 7899999998654321  122346788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999887542   3778889999999999999999   66999999999999999999999999999886543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .. ......|++.|+|||.+
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~  173 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVI  173 (258)
T ss_pred             cc-cccccCCCcceeCHHHh
Confidence            33 22345689999999964

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=2.3e-26  Score=211.81  Aligned_cols=167  Identities=28%  Similarity=0.405  Sum_probs=137.1

Q ss_pred             CCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEe
Q 043586          221 FDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCM  293 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  293 (397)
                      |++.+.||+|+||+||++..     .+++.||+|.++.....  ...+.+.+|+++++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            48889999999999988642     35788999998765332  1236788899999999999999999988753  468


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++...    .+++.++..++.|++.|+.|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            9999999999999988653    3789999999999999999999   66999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccccccccCCCCC
Q 043586          374 LHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      .......   .....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~  182 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECL  182 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHh
Confidence            6543221   1122356679999964

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.94  E-value=1.6e-26  Score=218.06  Aligned_cols=173  Identities=25%  Similarity=0.388  Sum_probs=140.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  289 (397)
                      .+|++.+.||+|+||.||+|+..        .+..||+|.++.....  ...+++.+|+++++++ +||||+++++++..
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD--KDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH--HHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            46899999999999999999642        1236899988754322  2246788999999999 79999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCC-------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                      .+..+++|||+++|+|.+++....             ....+++.+++.++.|++.||+|||   .++++||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEE
Confidence            999999999999999999887532             1224778889999999999999999   669999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ++.++.+||+|||+++.........  ....++..|+|||++
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL  208 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence            9999999999999998664322211  112345679999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.94  E-value=1.9e-26  Score=211.27  Aligned_cols=173  Identities=21%  Similarity=0.372  Sum_probs=142.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|++...||+|+||.||+|+..      +.+.+++|.+......  ...+.+.+|++++++++||||+++++++.+.+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccch--HHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            56888999999999999999853      3467999988654332  234678899999999999999999999999899


Q ss_pred             eeEEEeeccCCCchhhcccCCCc------cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDA------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      .++||||+++++|.+++......      ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999998754421      14789999999999999999999   6689999999999999999999999


Q ss_pred             ccccccccCCCCC-CeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      |||+++....... ......++..|+|||.+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhh
Confidence            9999875432221 12233567789999964

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=201.04  Aligned_cols=175  Identities=26%  Similarity=0.352  Sum_probs=145.7

Q ss_pred             hcCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|.+.+.+|+|+|+.||.++ ..+++.||+|++......+   .+..++|++..++++|||+++++++...+     .
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~---~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQED---IEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHH---HHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            4679999999999999999997 4678999999998776443   36778899999999999999999887543     3


Q ss_pred             EeeEEEeeccCCCchhhcccCCCc-cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDA-VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ..|++++|...|+|.+.+...... ..+++.+.+.|+.++++||++||+. .++.+||||||.||++.+++.+++.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence            599999999999999988765433 3689999999999999999999966 44699999999999999999999999999


Q ss_pred             ccccCCCCCC---------eeeccccccccCCCCC
Q 043586          371 ARLLHADSSN---------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~---------~~~~~gt~~y~APE~~  396 (397)
                      ++.....-..         ......|..|.|||++
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf  210 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELF  210 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchhe
Confidence            9865322111         1123478999999974

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=2.7e-26  Score=210.67  Aligned_cols=169  Identities=33%  Similarity=0.463  Sum_probs=144.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|+..+.||+|+||.||+|.+. ++..||+|.+.......  ..+.+.+|+.++++++||||+++++++.++...++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            45777888999999999999865 58899999987544322  2367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...    .+++.++..++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999988643    3678888999999999999999   669999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........++..|+|||+.
T Consensus       155 ~~~~~~~~~~~~y~apE~~  173 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             ccccccccCcccccCHhHh
Confidence            3333445688999999974

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.94  E-value=4.1e-26  Score=207.65  Aligned_cols=170  Identities=33%  Similarity=0.490  Sum_probs=145.2

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+.++++++|+||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            4788899999999999999864 6889999998766543 2345788999999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++....   .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999887542   3678888999999999999999   6689999999999999999999999999998765433


Q ss_pred             CCe----eeccccccccCCCCC
Q 043586          379 SNR----TLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~----~~~~gt~~y~APE~~  396 (397)
                      ...    ....+++.|+|||++
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~  175 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVI  175 (264)
T ss_pred             CcccccccCCcCCcCccChhhc
Confidence            221    124578899999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=2.2e-26  Score=208.72  Aligned_cols=165  Identities=26%  Similarity=0.444  Sum_probs=138.7

Q ss_pred             ceeecCCcccEEEEEcCC--C--cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          225 YCIGTGGYGSVYKAQLPN--G--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......  ...+++.+|++++++++||||+++++.+.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            358999999999998643  3  36899999876653  345788999999999999999999999988 8899999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      ++++|.+++..... ..+++..+..++.|++.||+|||   .++++|+||||+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999876542 35789999999999999999999   679999999999999999999999999999876543221


Q ss_pred             ---eeeccccccccCCCCC
Q 043586          381 ---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ---~~~~~gt~~y~APE~~  396 (397)
                         .....++..|+|||+.
T Consensus       154 ~~~~~~~~~~~~y~~pE~~  172 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESL  172 (257)
T ss_pred             eecccCCCCCceecCHHHh
Confidence               1123477889999964

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.2e-26  Score=211.10  Aligned_cols=168  Identities=33%  Similarity=0.525  Sum_probs=143.8

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc---cCCccceeeEEeeCCEeeE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  295 (397)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.......  ..+++.+|+.++++++   |||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCch--hHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            477788999999999999986 478999999987543222  2356788999999997   9999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++...    .+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999887643    4788999999999999999999   6699999999999999999999999999998776


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........|+..|+|||+.
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~  173 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVI  173 (277)
T ss_pred             CCccccccccCCcceeCHHHh
Confidence            544434445799999999964

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=2.5e-26  Score=211.30  Aligned_cols=172  Identities=24%  Similarity=0.461  Sum_probs=141.2

Q ss_pred             cCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      .+|+..+.||+|+||.||++..      .++..+|+|.+......   ..+.+.+|+++++.++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHH---HHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            4678889999999999999963      24568899988754432   23678899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCC------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      .+++|||+++++|.+++.....            ...+++..+..++.|++.|++|||   +.+++||||||+||+++++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCC
Confidence            9999999999999998875421            124788999999999999999999   6699999999999999999


Q ss_pred             CCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +.+||+|||+++........  .....+++.|+|||+.
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI  196 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHh
Confidence            99999999999765432211  1123357789999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=3e-26  Score=209.58  Aligned_cols=172  Identities=24%  Similarity=0.385  Sum_probs=138.2

Q ss_pred             CCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE----
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC----  292 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  292 (397)
                      |++.+.||+|+||.||+|...    .+..||+|+++...... ...+.+.+|++.++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            567889999999999999764    24679999987643322 224678899999999999999999998866543    


Q ss_pred             --eeEEEeeccCCCchhhcccCC---CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          293 --MFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       293 --~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                        .+++|||+++++|.+++....   ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECC
Confidence              799999999999988875431   2235788999999999999999999   56999999999999999999999999


Q ss_pred             cccccccCCCCCC--eeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ||+++........  .....++..|+|||++
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  187 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESL  187 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhc
Confidence            9999876443321  1122356789999974

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2.1e-26  Score=210.60  Aligned_cols=173  Identities=31%  Similarity=0.475  Sum_probs=145.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCC---
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK---  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---  291 (397)
                      .+++|++.+.||+|++|.||+|+.. +++.+++|++......    .+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE----EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh----HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4578999999999999999999875 5789999998765432    25688999999999 6999999999997644   


Q ss_pred             ---EeeEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          292 ---CMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       292 ---~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                         ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999998876532 1235788999999999999999999   67999999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||++..............|++.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVI  185 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHh
Confidence            99998765443333445689999999964

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=2.3e-26  Score=211.65  Aligned_cols=172  Identities=24%  Similarity=0.387  Sum_probs=137.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHH-HhhcccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+++.. +|+.||+|+++........  .++..|... ++..+||||+++++++..++..|+|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH--HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            46889999999999999999865 6899999998765432221  344456665 5566899999999999999999999


Q ss_pred             EeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          297 YEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |||++ ++|.+++... .....+++..+..++.|++.|++|||+.  .+++||||||+||+++.++.+||+|||++....
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99996 5777766542 2224588999999999999999999942  289999999999999999999999999998664


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... .....|+..|+|||++
T Consensus       156 ~~~~-~~~~~~~~~y~aPE~~  175 (283)
T cd06617         156 DSVA-KTIDAGCKPYMAPERI  175 (283)
T ss_pred             cccc-cccccCCccccChhhc
Confidence            3222 2334689999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.94  E-value=3.3e-26  Score=211.49  Aligned_cols=171  Identities=30%  Similarity=0.454  Sum_probs=142.5

Q ss_pred             CCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchHH-HHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  293 (397)
                      +|++.+.||+|+||.||+++.    .+|+.||+|.+....... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999975    368899999987643321 12235678899999999 599999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999887543   4678888889999999999999   66999999999999999999999999999986


Q ss_pred             cCCCCC-CeeeccccccccCCCCC
Q 043586          374 LHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ...... ......|+..|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             cccccccccccccCCcccCChhhc
Confidence            643322 12235689999999975

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=2.5e-26  Score=209.55  Aligned_cols=171  Identities=27%  Similarity=0.451  Sum_probs=143.0

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccch---HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSET---EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      +|+..+.||+|++|.||+|+. .+++.||+|.+.....   ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999975 5789999999875431   222345788999999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEecccccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLL  374 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~~  374 (397)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999887533   4788899999999999999999   66999999999999998775 5999999999876


Q ss_pred             CCCCC----CeeeccccccccCCCCC
Q 043586          375 HADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      .....    ......||..|+|||+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~  180 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVL  180 (268)
T ss_pred             ccccccCCccccccccccceeCHhHh
Confidence            54321    11234688999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-28  Score=225.20  Aligned_cols=172  Identities=26%  Similarity=0.387  Sum_probs=150.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCc-EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+++.+..+|-|+||.|=.++..+.+ .+|+|++++...-+....+....|-++|..++.|.||++|..|.+..+.|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34566678999999999998865443 48999998766555455577888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |-|-||.+...+..++   .++...+.-++..+++|++|||   +++||.|||||+|.++|.+|-+||.|||+|+++..+
T Consensus       500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            9999999999997654   4777888889999999999999   779999999999999999999999999999998776


Q ss_pred             CCCeeeccccccccCCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~l  397 (397)
                      ....+ ++|||.|.|||++|
T Consensus       574 ~KTwT-FcGTpEYVAPEIIL  592 (732)
T KOG0614|consen  574 RKTWT-FCGTPEYVAPEIIL  592 (732)
T ss_pred             Cceee-ecCCcccccchhhh
Confidence            65544 89999999999986

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=2.6e-26  Score=209.82  Aligned_cols=171  Identities=32%  Similarity=0.521  Sum_probs=139.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-C---cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-G---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|.... +   ..||+|.+......  ...++|..|+.+++.++||||+++++++..++..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            357888999999999999998642 3   36999998764322  22467899999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++....  ..+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999887543  24788999999999999999999   569999999999999999999999999999865


Q ss_pred             CCCCCCe---eeccc--cccccCCCCC
Q 043586          375 HADSSNR---TLLAG--TYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~---~~~~g--t~~y~APE~~  396 (397)
                      .......   ....|  +..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAI  183 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHh
Confidence            4332211   11112  4579999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=2.3e-26  Score=211.37  Aligned_cols=174  Identities=19%  Similarity=0.318  Sum_probs=142.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC-----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  291 (397)
                      .++|++.+.||+|+||.||+|.+.+     +..|++|.+.......  ..+.+.+|+.++++++||||+++++++.. +.
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEI--QVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4678899999999999999998754     6889999887543322  24678889999999999999999998776 56


Q ss_pred             EeeEEEeeccCCCchhhcccCCCc-----cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDA-----VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      ..++++||+++++|.+++......     ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999988654322     35889999999999999999999   6699999999999999999999999


Q ss_pred             ccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |||+++.+......  .....++..|+|||+.
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~  191 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESL  191 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence            99999866433221  1122356789999964

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.3e-26  Score=207.77  Aligned_cols=172  Identities=26%  Similarity=0.402  Sum_probs=141.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccc--hHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE--TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  293 (397)
                      .+|++.+.||+|+||.||+|+.. +++.||+|.+....  .......+.+.+|++++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999864 68999999875432  11223356788999999999999999999998764  468


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+.+....   .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999998886532   3678889999999999999999   66999999999999999999999999999986


Q ss_pred             cCCCC---CCeeeccccccccCCCCC
Q 043586          374 LHADS---SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~---~~~~~~~gt~~y~APE~~  396 (397)
                      .....   .......|+..|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVI  181 (264)
T ss_pred             cccccccCccccccCCcccccCHhhh
Confidence            54311   112335689999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=2.7e-26  Score=215.85  Aligned_cols=169  Identities=15%  Similarity=0.262  Sum_probs=137.1

Q ss_pred             ccceeecC--CcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          223 IKYCIGTG--GYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       223 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      +.+.||+|  +|++||+++. .+++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45679999  6789999976 478999999997654322 2245677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++|+|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||.+........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999998865322 24788999999999999999999   66899999999999999999999999987654322111


Q ss_pred             -------CeeeccccccccCCCCC
Q 043586          380 -------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 -------~~~~~~gt~~y~APE~~  396 (397)
                             ......++..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~  180 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVL  180 (327)
T ss_pred             cccccccccccccceecccChHHh
Confidence                   11223467889999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.94  E-value=3.7e-26  Score=207.81  Aligned_cols=170  Identities=32%  Similarity=0.497  Sum_probs=148.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|+.. +++.|++|++......  ...+.+.+|+..+++++|||++++++++...+..++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36888999999999999999876 5899999998876542  22467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCC-CCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++...   ..+++..+..++.|+++|++|||   + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998754   34788999999999999999999   6 7999999999999999999999999999987755


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........++..|+|||+.
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~  172 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERI  172 (264)
T ss_pred             CCCcccceeecccccCHhhh
Confidence            44443345688999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=2.2e-26  Score=208.53  Aligned_cols=172  Identities=26%  Similarity=0.389  Sum_probs=144.7

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.+|+++.. +++.||+|.+....... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4888999999999999999754 68899999987543222 223578899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+.+..... ..+++.++..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988865322 24688889999999999999999   6699999999999999999999999999998765443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|++.|+|||+.
T Consensus       156 ~~~~~~~~~~~~~~pe~~  173 (256)
T cd08218         156 ELARTCIGTPYYLSPEIC  173 (256)
T ss_pred             hhhhhccCCccccCHHHh
Confidence            333345688999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=216.82  Aligned_cols=173  Identities=29%  Similarity=0.487  Sum_probs=139.6

Q ss_pred             CCCccceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF  294 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  294 (397)
                      +|++.+.||+|++|.||+|...   +++.||+|.+...........+.+.+|+.++++++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999864   4789999999874322122235667899999999999999999999988  7899


Q ss_pred             EEEeeccCCCchhhcccCCC--ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC----CCCeEEecc
Q 043586          295 LIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS----KFEAFVADF  368 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~DF  368 (397)
                      +||||+++ ++.+.+.....  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 66666543221  225788899999999999999999   668999999999999999    999999999


Q ss_pred             ccccccCCCCC---CeeeccccccccCCCCC
Q 043586          369 GTARLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      |+++.......   ......+|+.|+|||+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  187 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELL  187 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHH
Confidence            99987644322   12234688999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.1e-27  Score=222.42  Aligned_cols=149  Identities=20%  Similarity=0.342  Sum_probs=132.7

Q ss_pred             cCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .-|..++.||-|+||+|.+++ ..+...||+|.+++...-.+........|-+||+..+.+-||+++-.|++.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            456777889999999999986 4456789999998877666666677888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ||++||++..+|.+.+   .+++..+.-++..+..|+++.|   ..|+|||||||+|||||.+|.+||+|||++.-
T Consensus       709 dYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTG  778 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  778 (1034)
T ss_pred             eccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecccccc
Confidence            9999999999887643   4778888889999999999999   77999999999999999999999999999874

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=3.3e-26  Score=208.04  Aligned_cols=176  Identities=25%  Similarity=0.432  Sum_probs=145.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  296 (397)
                      +|++.+.+|.|+||.||++... +++.+|+|.+....... ...+++.+|++++++++||||+++++++..  ....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            4788899999999999999754 67899999987543322 224678889999999999999999998764  4568999


Q ss_pred             EeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |||+++++|.+++.... ....+++..++.++.|++.|+.|||..+  +.+++|+||||+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            99999999999886532 2235788999999999999999999443  56899999999999999999999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ............|++.|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~  182 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQL  182 (265)
T ss_pred             ccCCcccccccccCCCccChhhh
Confidence            76544323445689999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-27  Score=219.70  Aligned_cols=173  Identities=25%  Similarity=0.354  Sum_probs=144.3

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHH-----HHHHHHHHHhhcc---cCCccceeeE
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIK-----SFRNEAQVLSQVL---HRNIVKLYGF  286 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~E~~~l~~l~---h~niv~l~~~  286 (397)
                      ....+|...+.+|+|+||.|+.|.++ +...|+||.+.+...-.....+     ..--|+.||++++   |+||++++++
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            34456889999999999999999765 5678999988775433222221     2346999999998   9999999999


Q ss_pred             EeeCCEeeEEEeec-cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEE
Q 043586          287 CLHRKCMFLIYEYM-ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV  365 (397)
Q Consensus       287 ~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  365 (397)
                      |++++++|++||-. ++.+|.+++....   .+++.++..|++||+.|+++||   +.||||||||-+|+.+|.+|-+||
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence            99999999999975 5678888887543   4889999999999999999999   679999999999999999999999


Q ss_pred             eccccccccCCCCCCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +|||.|.....+  .-..++||.+|+|||++
T Consensus       712 idfgsaa~~ksg--pfd~f~gtv~~aapevl  740 (772)
T KOG1152|consen  712 IDFGSAAYTKSG--PFDVFVGTVDYAAPEVL  740 (772)
T ss_pred             eeccchhhhcCC--Ccceeeeeccccchhhh
Confidence            999999765433  33567899999999985

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.94  E-value=5.6e-26  Score=207.29  Aligned_cols=172  Identities=26%  Similarity=0.399  Sum_probs=141.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccch--HHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSET--EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  293 (397)
                      .+|+..+.||+|+||.||+|... +++.||+|++.....  ......+.+.+|+.++++++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36889999999999999999764 688999998865422  122334678899999999999999999998875  4678


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++++||+++++|.+++....   .+++.....++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999886543   3678888999999999999999   66899999999999999999999999999986


Q ss_pred             cCCCC---CCeeeccccccccCCCCC
Q 043586          374 LHADS---SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~---~~~~~~~gt~~y~APE~~  396 (397)
                      .....   .......++..|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVI  181 (266)
T ss_pred             cccccccCCccccCCccccccCHHHh
Confidence            54321   112234588999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=2.3e-26  Score=211.09  Aligned_cols=165  Identities=28%  Similarity=0.376  Sum_probs=138.6

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999754 6889999998765433333345667899999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecc
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA  385 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  385 (397)
                      .+++..... ..+++..+..++.|++.|+.|||   ..+++||||+|+||+++.++.+||+|||.+....... ......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-KIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC-cccccc
Confidence            998875432 35788999999999999999999   6699999999999999999999999999998654322 223345


Q ss_pred             ccccccCCCCC
Q 043586          386 GTYGYIAPGLP  396 (397)
Q Consensus       386 gt~~y~APE~~  396 (397)
                      ++..|+|||+.
T Consensus       156 ~~~~y~~PE~~  166 (277)
T cd05577         156 GTPGYMAPEVL  166 (277)
T ss_pred             CCCCcCCHHHh
Confidence            88899999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.94  E-value=9.7e-27  Score=215.88  Aligned_cols=166  Identities=27%  Similarity=0.435  Sum_probs=140.2

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |+....||+|+||.||++... +++.||+|.+.......   .+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            333456999999999999764 68899999986543322   35678899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++...    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999998877542    3788899999999999999999   66899999999999999999999999999976654433


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......|++.|+|||++
T Consensus       173 ~~~~~~~~~~y~aPE~~  189 (297)
T cd06659         173 KRKSLVGTPYWMAPEVI  189 (297)
T ss_pred             cccceecCccccCHHHH
Confidence            33445789999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=1.9e-26  Score=212.83  Aligned_cols=174  Identities=28%  Similarity=0.458  Sum_probs=142.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .++|++.+.||+|+||.||+|+..      ++..||+|.+......  ...+.+.+|+.++++++||||+++++++..++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            357899999999999999999753      4678999998765432  22367889999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCC-------------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          292 CMFLIYEYMERGSLFCNLHNNE-------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      ..++||||+++++|.+++....                   ....+++..++.++.|++.||+|||   ..+++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccH
Confidence            9999999999999999886421                   1124678889999999999999999   66999999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +||+++.++.++|+|||++.........  .....++..|+|||..
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESI  204 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHH
Confidence            9999999999999999998865432211  1122356679999963

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=2.1e-26  Score=211.35  Aligned_cols=174  Identities=29%  Similarity=0.384  Sum_probs=140.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .++|++.+.||+|++|.||+|.+.      .+..||+|.+........  ...+.+|+.++++++|+||+++++++.+.+
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD--ESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHH--HHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            467899999999999999999764      356789998865443322  356888999999999999999999999988


Q ss_pred             EeeEEEeeccCCCchhhcccCCC----ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC---CeE
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF---EAF  364 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~k  364 (397)
                      ..++||||+++++|.+++.....    ...+++..+..++.||+.|++|||   +.+++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence            99999999999999998875432    124788999999999999999999   66899999999999998654   589


Q ss_pred             EeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      |+|||+++.........  ....++..|+|||++
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF  193 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence            99999998763322111  112235679999964

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.2e-27  Score=214.24  Aligned_cols=174  Identities=28%  Similarity=0.406  Sum_probs=145.8

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHH----HHHHHHHHHHHHHHhhcccCCccceeeEEee-CCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  292 (397)
                      ++|-+...+|+|+|+.||+|.+ ...+.||||+-...+.+.    ..+.+...+|.++.+.++||.||++++++.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            3566677899999999999965 457788999865544332    3455677889999999999999999999975 567


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC---CCCCeEEeccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKFEAFVADFG  369 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DFG  369 (397)
                      +|-|+|||+|.+|..+++.++   .+++.++..|+.||+.||.||.+. +++|+|-||||.|||+-   ..|.+||+|||
T Consensus       543 FCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG  618 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG  618 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence            899999999999998898654   478999999999999999999987 78999999999999994   46899999999


Q ss_pred             cccccCCCCCC-------eeeccccccccCCCCC
Q 043586          370 TARLLHADSSN-------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~-------~~~~~gt~~y~APE~~  396 (397)
                      +++.++.+...       ....+||.+|.+||.+
T Consensus       619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcF  652 (775)
T KOG1151|consen  619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECF  652 (775)
T ss_pred             hhhhccCCccCcccceeeecccCceeeecCccee
Confidence            99998765433       2456799999999975

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.94  E-value=3.8e-26  Score=212.90  Aligned_cols=168  Identities=32%  Similarity=0.411  Sum_probs=140.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|... +++.||+|++...........+++.+|+++++.++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            55888899999999999999864 68899999986543333333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+. |++.+.+.....  .+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 577666653322  4788999999999999999999   668999999999999999999999999999765432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                          ....|++.|+|||++
T Consensus       169 ----~~~~~~~~y~aPE~~  183 (307)
T cd06607         169 ----NSFVGTPYWMAPEVI  183 (307)
T ss_pred             ----CCccCCccccCceee
Confidence                234688999999974

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=2e-26  Score=212.33  Aligned_cols=169  Identities=28%  Similarity=0.380  Sum_probs=143.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+++.. +++.||+|++......  ...+.+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKS--SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcc--hHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            46888899999999999999864 6889999988654322  23467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.+++.|+.|||+.  .+++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999998886532   478889999999999999999952  48999999999999999999999999998754322


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....|+..|+|||++
T Consensus       158 ~--~~~~~~~~~~~aPE~~  174 (284)
T cd06620         158 I--ADTFVGTSTYMSPERI  174 (284)
T ss_pred             c--cCccccCcccCCHHHH
Confidence            2  2235689999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=1.8e-26  Score=227.29  Aligned_cols=170  Identities=19%  Similarity=0.280  Sum_probs=133.4

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc------CCccceeeE
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH------RNIVKLYGF  286 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~  286 (397)
                      +....++|++.+.||+|+||.||+|.+. +++.||||+++.....    .+.+..|+.+++.++|      +++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY----TRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh----HHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3344678999999999999999999864 5788999999653221    2345567777777665      458888888


Q ss_pred             EeeC-CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----
Q 043586          287 CLHR-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----  361 (397)
Q Consensus       287 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----  361 (397)
                      +... ...++|||++ +++|.+++....   .+++..+..|+.||+.||+|||+.  .+|+||||||+|||++.++    
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccc
Confidence            8764 5789999998 678888876542   478889999999999999999942  4899999999999998765    


Q ss_pred             ------------CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 ------------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                                  .+||+|||.+.....   .....+||+.|+|||++
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~  317 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVV  317 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHh
Confidence                        499999998864322   22346799999999985

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.94  E-value=2.5e-26  Score=211.88  Aligned_cols=171  Identities=33%  Similarity=0.421  Sum_probs=143.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|... +++.||+|+++..... ....+.+.+|++++++++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36889999999999999999865 5789999998754322 222467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++++.+..+....   ..+++.++..++.|++.|+.|||   ..+++|+||+|+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999987666554432   23788899999999999999999   568999999999999999999999999999876554


Q ss_pred             CC-CeeeccccccccCCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~~  396 (397)
                      .. ......++..|+|||++
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~  173 (288)
T cd07833         154 PASPLTDYVATRWYRAPELL  173 (288)
T ss_pred             ccccccCcccccCCcCCchh
Confidence            32 22345688999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.1e-27  Score=207.52  Aligned_cols=173  Identities=24%  Similarity=0.388  Sum_probs=152.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  295 (397)
                      .++|++...||+|+|+.|..+++. +.+.||+|++++....+....+..+.|-.+..+. +||.+|.++.+|+....+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            357999999999999999999865 6788999999887665555556677788888776 69999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |.||++||+|.-++++..   .+++..+.-+...|.-||.|||   ++||+.||+|.+|+|+|.+|.+||+|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999988886543   4888999999999999999999   6799999999999999999999999999999876


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+....++++|||.|+|||++
T Consensus       403 ~~gd~tstfcgtpnyiapeil  423 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEIL  423 (593)
T ss_pred             CCCcccccccCCCcccchhhh
Confidence            666677789999999999985

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.94  E-value=1.8e-26  Score=212.55  Aligned_cols=171  Identities=29%  Similarity=0.404  Sum_probs=142.2

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|+..+.||+|++|.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999864 68899999887543221 122567889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+. ++|.+++.... ...+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 58888776533 235788999999999999999999   6689999999999999999999999999998665433


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......+++.|+|||+.
T Consensus       155 ~~~~~~~~~~~y~aPE~~  172 (284)
T cd07860         155 RTYTHEVVTLWYRAPEIL  172 (284)
T ss_pred             cccccccccccccCCeEE
Confidence            333334578899999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=3.8e-26  Score=211.52  Aligned_cols=168  Identities=29%  Similarity=0.421  Sum_probs=144.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||++... +++.||+|.+.......   .+.+.+|+.+++.++|||++++++++...+..|+|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK---KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH---HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            57899999999999999999754 67899999986543222   356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.+.    .+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999988643    3678889999999999999999   669999999999999999999999999998766544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||++
T Consensus       169 ~~~~~~~~~~~~y~~PE~~  187 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVV  187 (293)
T ss_pred             ccccccccCChhhcCchhh
Confidence            4333445689999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=1.5e-26  Score=210.76  Aligned_cols=169  Identities=30%  Similarity=0.399  Sum_probs=144.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||++... +++.+|+|.+......  ...+++.+|++++++++||||+++++++...+..++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            36788899999999999999875 6889999998765433  22467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCC-CCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS-PSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++....  ..+++..+..++.|++.|++|||   + .+++|+||||+||+++.++.++|+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999887543  35788889999999999999999   5 6999999999999999999999999999876543


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .....  ..|+..|+|||++
T Consensus       154 ~~~~~--~~~~~~y~~PE~~  171 (265)
T cd06605         154 SLAKT--FVGTSSYMAPERI  171 (265)
T ss_pred             HHhhc--ccCChhccCHHHH
Confidence            22211  5689999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.94  E-value=6e-26  Score=205.65  Aligned_cols=170  Identities=30%  Similarity=0.499  Sum_probs=142.1

Q ss_pred             CCccceeecCCcccEEEEEcCC-----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      +++.+.||+|+||.||++++.+     +..||+|.+.......  ..+.+.+|++.+..++||||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            4567889999999999998753     4889999997665432  24678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      +|||+++++|.+++...... .+++.++..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999998754321 2789999999999999999999   6699999999999999999999999999998765


Q ss_pred             CCCCCee-eccccccccCCCCC
Q 043586          376 ADSSNRT-LLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~-~~~gt~~y~APE~~  396 (397)
                      ....... ...+++.|+|||..
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~  176 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESL  176 (258)
T ss_pred             cccccccccCCCcccccChHHh
Confidence            4422211 22367899999964

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=4.6e-26  Score=207.98  Aligned_cols=171  Identities=31%  Similarity=0.475  Sum_probs=140.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CC---cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|+..+.||+|+||.||+|+.. ++   ..+|+|.+.......  ..+.+.+|++++++++|||++++.+++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEK--QRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHH--HHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            46788899999999999999864 23   379999987653322  2367889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++....  ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999886533  24788899999999999999999   668999999999999999999999999999866


Q ss_pred             CCCCCCee---eccccccccCCCCC
Q 043586          375 HADSSNRT---LLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~---~~~gt~~y~APE~~  396 (397)
                      ........   ....++.|+|||+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~  182 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAI  182 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHh
Confidence            43322111   11234579999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=5.2e-26  Score=206.40  Aligned_cols=163  Identities=27%  Similarity=0.420  Sum_probs=133.6

Q ss_pred             eeecCCcccEEEEEc---CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .||+|+||.||+|.+   .+++.+|+|+++..... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND-PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCc-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            489999999999964   35788999998754322 2335778899999999999999999998864 467899999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe-
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-  381 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-  381 (397)
                      ++|.+++....   .+++..+..++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++......... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999886532   4788999999999999999999   6699999999999999999999999999998765433211 


Q ss_pred             --eeccccccccCCCCC
Q 043586          382 --TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 --~~~~gt~~y~APE~~  396 (397)
                        ....+++.|+|||.+
T Consensus       154 ~~~~~~~~~~y~aPE~~  170 (257)
T cd05116         154 AKTHGKWPVKWYAPECM  170 (257)
T ss_pred             ecCCCCCCccccCHhHh
Confidence              122345789999964

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.94  E-value=3.7e-26  Score=207.08  Aligned_cols=169  Identities=27%  Similarity=0.462  Sum_probs=141.7

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .+|++.+.||+|+||.||+|.+.++..+|+|.+.......    ..+.+|++++++++|||++++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            4678889999999999999988778899999987654332    467789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.....  .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999988865432  4678889999999999999999   5689999999999999999999999999998654322


Q ss_pred             CC-eeeccccccccCCCCC
Q 043586          379 SN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~-~~~~~gt~~y~APE~~  396 (397)
                      .. .....++.+|+|||+.
T Consensus       155 ~~~~~~~~~~~~~~aPe~~  173 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVF  173 (256)
T ss_pred             ccccCCCccchhhcCHhHh
Confidence            11 1122356789999974

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=5.1e-26  Score=206.99  Aligned_cols=163  Identities=29%  Similarity=0.449  Sum_probs=140.4

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||.|++|.||+|+.. +++.+|+|++...........+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999875 4889999999765544334457789999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecc
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA  385 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  385 (397)
                      .+++.+..   .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||.++...... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99987543   3788889999999999999999   6799999999999999999999999999998765433 223346


Q ss_pred             ccccccCCCCC
Q 043586          386 GTYGYIAPGLP  396 (397)
Q Consensus       386 gt~~y~APE~~  396 (397)
                      |++.|+|||++
T Consensus       154 ~~~~~~~PE~~  164 (262)
T cd05572         154 GTPEYVAPEII  164 (262)
T ss_pred             CCcCccChhHh
Confidence            89999999974

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.94  E-value=2.9e-26  Score=212.30  Aligned_cols=173  Identities=26%  Similarity=0.344  Sum_probs=139.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCE----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKC----  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----  292 (397)
                      ++|++.+.||+|+||.||+|.+. +++.||+|+++...... .....+.+|+.+++.++ ||||+++++++...+.    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46889999999999999999865 68999999886543221 12256778999999995 6999999999887665    


Q ss_pred             -eeEEEeeccCCCchhhcccCCC--ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEecc
Q 043586          293 -MFLIYEYMERGSLFCNLHNNED--AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADF  368 (397)
Q Consensus       293 -~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DF  368 (397)
                       .|+||||+++ ++.+++.....  ...+++..+..++.||+.||.|||   +.+++||||||+||+++. ++.+||+||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999985 78877764322  235789999999999999999999   669999999999999998 899999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++.+...........+++.|+|||++
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~  183 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVL  183 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHh
Confidence            9998664433333334578899999964

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.94  E-value=4.8e-26  Score=206.24  Aligned_cols=164  Identities=26%  Similarity=0.455  Sum_probs=137.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||++.. +++.||+|.++....     .+.+.+|+.++++++|||++++++++... ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            4588999999999999999975 577899999876432     25678899999999999999999998765 4799999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++..... ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        79 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          79 LMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999875432 34788899999999999999999   6699999999999999999999999999997643321


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                         .....+..|+|||++
T Consensus       155 ---~~~~~~~~y~~pe~~  169 (254)
T cd05083         155 ---DNSKLPVKWTAPEAL  169 (254)
T ss_pred             ---CCCCCCceecCHHHh
Confidence               112345679999974

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=4.3e-26  Score=209.60  Aligned_cols=163  Identities=25%  Similarity=0.301  Sum_probs=130.2

Q ss_pred             eeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHh---hcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLS---QVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      .||+|+||.||+++.. +++.+|+|.+.............+.+|..+++   ..+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999864 68899999987643321111123334444333   3469999999999999999999999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR  381 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  381 (397)
                      +++|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.......  .
T Consensus        81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~  152 (279)
T cd05633          81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (279)
T ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence            999998886543   4789999999999999999999   6689999999999999999999999999987553322  2


Q ss_pred             eeccccccccCCCCC
Q 043586          382 TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 ~~~~gt~~y~APE~~  396 (397)
                      ....||+.|+|||..
T Consensus       153 ~~~~~~~~y~aPE~~  167 (279)
T cd05633         153 HASVGTHGYMAPEVL  167 (279)
T ss_pred             cCcCCCcCccCHHHh
Confidence            234689999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=7.2e-26  Score=207.17  Aligned_cols=171  Identities=26%  Similarity=0.412  Sum_probs=141.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH-------HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      +|.+.+.||+|+||.||+|... +++.+|+|.++.....       .....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3677789999999999999754 6889999988643211       1123457888999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccc
Confidence            9999999999999999887642   4788889999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCC--CeeeccccccccCCCCC
Q 043586          372 RLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      +.......  ......|+..|+|||+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~  182 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVI  182 (272)
T ss_pred             ccccccccccccccccCCccccCHHHh
Confidence            86543221  12234588999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=8.8e-26  Score=207.69  Aligned_cols=171  Identities=28%  Similarity=0.430  Sum_probs=142.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  291 (397)
                      ++|++.+.||+|+||.||+|++.     ++..+|+|.+......  ...+.+.+|+++++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            46788899999999999999753     3688999999866543  234688999999999999999999999887  55


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            78999999999999999876432  4788999999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCCCe---eeccccccccCCCCC
Q 043586          372 RLLHADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      ..........   ....++..|+|||+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  184 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECL  184 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHH
Confidence            8765332211   112345679999964

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.93  E-value=5.2e-26  Score=210.59  Aligned_cols=172  Identities=27%  Similarity=0.407  Sum_probs=139.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|++|.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++......|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            46889999999999999999865 68899999986543221 22356778999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~~~~  376 (397)
                      ||++ +++.+.+..... ...++..+..++.||+.||+|||   +++++||||||+||+++. ++.+||+|||++.....
T Consensus        81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9996 578777654332 23577888899999999999999   669999999999999985 56799999999986544


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+++.|+|||++
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~  175 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEIL  175 (294)
T ss_pred             CccccccCceeecccCHHHH
Confidence            33333334678999999964

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.93  E-value=3.2e-27  Score=205.24  Aligned_cols=167  Identities=29%  Similarity=0.430  Sum_probs=136.7

Q ss_pred             HhcCCCcc-ceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee----
Q 043586          217 ATEGFDIK-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----  289 (397)
Q Consensus       217 ~~~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----  289 (397)
                      .+++|.+. ++||-|-.|.|..+.. .+++.+|+|++....        ..++|++..-.. .|||||+++++|..    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            44566654 4689999999999965 478999999987653        345688876665 59999999999865    


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEe
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVA  366 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~  366 (397)
                      ...+.+|||.|+||.|...++.++.. .+++.++..|++||+.|+.|||   +.+|.||||||+|+|...   +..+||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence            45688999999999999999876543 5899999999999999999999   679999999999999964   5678999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||+|+.-.... ...+.+.||.|.|||++
T Consensus       207 DfGFAK~t~~~~-~L~TPc~TPyYvaPevl  235 (400)
T KOG0604|consen  207 DFGFAKETQEPG-DLMTPCFTPYYVAPEVL  235 (400)
T ss_pred             ccccccccCCCc-cccCCcccccccCHHHh
Confidence            999999754432 33446789999999975

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=8.6e-26  Score=206.54  Aligned_cols=165  Identities=29%  Similarity=0.472  Sum_probs=131.9

Q ss_pred             eeecCCcccEEEEEcCC-Cc--EEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeecc
Q 043586          226 CIGTGGYGSVYKAQLPN-GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      .||+|+||.||+|++.+ +.  .+++|.++.....  ...+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCH--HHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            58999999999998753 33  4688887743322  1235788899999999 79999999999999999999999999


Q ss_pred             CCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          302 RGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       302 ~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                      +++|.+++.....             ...+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCC
Confidence            9999998875321             124788899999999999999999   669999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |++....... .......+..|+|||+.
T Consensus       157 gl~~~~~~~~-~~~~~~~~~~y~apE~~  183 (270)
T cd05047         157 GLSRGQEVYV-KKTMGRLPVRWMAIESL  183 (270)
T ss_pred             CCccccchhh-hccCCCCccccCChHHH
Confidence            9986432111 11122345679999974

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=7.7e-26  Score=206.77  Aligned_cols=170  Identities=29%  Similarity=0.413  Sum_probs=138.3

Q ss_pred             cCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|.+.+.||+|+||.||+|.+.+    ...||+|........  ...+.+.+|+.++++++||||+++++++.+ +..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSP--SVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            458888999999999999997543    346899988765422  223678899999999999999999998875 4578


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++.....  .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||+++..
T Consensus        83 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999999875432  4788999999999999999999   669999999999999999999999999999866


Q ss_pred             CCCCCC-eeeccccccccCCCCC
Q 043586          375 HADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ...... .....+++.|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~  180 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESI  180 (270)
T ss_pred             ccccceecCCCCccccccChhhh
Confidence            443221 1122345689999964

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2.9e-26  Score=208.27  Aligned_cols=160  Identities=23%  Similarity=0.412  Sum_probs=131.8

Q ss_pred             ceeecCCcccEEEEEcCC--------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          225 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +.||+|+||.||+|....        ...+|+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR---NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhH---HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            358999999999997532        23478887754332   2246788899999999999999999999998999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC--------eEEecc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--------AFVADF  368 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~DF  368 (397)
                      |||+++|+|.+++.....  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999999876433  4788889999999999999999   669999999999999987765        589999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |++.....    .....+++.|+|||++
T Consensus       153 g~~~~~~~----~~~~~~~~~y~aPE~~  176 (258)
T cd05078         153 GISITVLP----KEILLERIPWVPPECI  176 (258)
T ss_pred             ccccccCC----chhccccCCccCchhc
Confidence            99875432    2234688999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=4.6e-26  Score=207.13  Aligned_cols=164  Identities=31%  Similarity=0.477  Sum_probs=140.4

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||.||+++.. +++.+++|.+...........+.+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            589999999999876 4899999999776554444567888999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC------
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS------  379 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------  379 (397)
                      .+++....   .+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99887543   4788999999999999999999   66999999999999999999999999999886543321      


Q ss_pred             --CeeeccccccccCCCCC
Q 043586          380 --NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 --~~~~~~gt~~y~APE~~  396 (397)
                        ......+++.|+|||+.
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~  173 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVI  173 (265)
T ss_pred             cccccCcccCccccCHHHh
Confidence              22334688899999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-26  Score=199.60  Aligned_cols=168  Identities=24%  Similarity=0.360  Sum_probs=135.9

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEe
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .+.+..+|.|+.|.|+++++. +|...|||.+........  .+++...++++.... .|+||+.+|||..+...++.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee--~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH--HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            344556999999999999865 689999999987654433  367777888777664 8999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      .|.. -...+++....  ++++.-.-++...+++||.||.+.|  +|+|||+||+|||+|+.|++|+||||++.++.+..
T Consensus       172 lMs~-C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9842 44444443322  4777778889999999999999854  99999999999999999999999999999876654


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .. +..+|-+.|||||.+
T Consensus       247 Ah-trsAGC~~YMaPERi  263 (391)
T KOG0983|consen  247 AH-TRSAGCAAYMAPERI  263 (391)
T ss_pred             cc-ccccCCccccCcccc
Confidence            43 335699999999975

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=8.5e-26  Score=208.31  Aligned_cols=171  Identities=33%  Similarity=0.464  Sum_probs=147.7

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      .++.|++...+|+|++|.||+|.+. ++..+++|++.....    ..+.+.+|++.++.++|+|++++++++...+..|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            4567888899999999999999876 688999999976544    23677889999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |+||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999998653  25888999999999999999999   6799999999999999999999999999987665


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........+++.|+|||++
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~  188 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVI  188 (286)
T ss_pred             cchhhhccccCCcccCCHhHh
Confidence            443333344588999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.1e-25  Score=203.39  Aligned_cols=165  Identities=28%  Similarity=0.442  Sum_probs=137.7

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCC
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGS  304 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~  304 (397)
                      +.||+|+||.||++...+++.||+|.+......  ...+.+.+|++++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            358999999999998877999999998765443  234678899999999999999999999999999999999999999


Q ss_pred             chhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe--e
Q 043586          305 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR--T  382 (397)
Q Consensus       305 L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~  382 (397)
                      |.+++.....  .+++..+..++.+++.|++|||   +++++||||||+||+++.++.+||+|||+++.........  .
T Consensus        79 l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9998865432  4678889999999999999999   6689999999999999999999999999998654322111  1


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...++..|+|||++
T Consensus       154 ~~~~~~~y~~PE~~  167 (251)
T cd05041         154 LKQIPIKWTAPEAL  167 (251)
T ss_pred             cCcceeccCChHhh
Confidence            12345679999964

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.5e-25  Score=202.45  Aligned_cols=170  Identities=31%  Similarity=0.441  Sum_probs=147.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+++.. +++.|++|.+....... ...+.+.+|++++++++|||++++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE-EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH-HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4788899999999999999765 67899999998765422 234678999999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++...   ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999988754   24788999999999999999999   6799999999999999999999999999998776544


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......++..|+|||+.
T Consensus       154 ~~~~~~~~~~~y~~pe~~  171 (254)
T cd06627         154 KDDASVVGTPYWMAPEVI  171 (254)
T ss_pred             ccccccccchhhcCHhhh
Confidence            433445689999999964

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=2e-27  Score=240.34  Aligned_cols=173  Identities=31%  Similarity=0.460  Sum_probs=144.4

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +-+++-...||.|.||.||.|.. .+|...|+|.++..... ......+.+|+.++..++|||+|+++|+=..++..+|.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34566677899999999999974 57899999988765544 33456778899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||||++|+|.+.+....   ..++.....+..|++.|++|||   ..|||||||||+||+++..|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecC
Confidence            99999999999886432   2455666678899999999999   66999999999999999999999999999998755


Q ss_pred             CCC----CeeeccccccccCCCCCC
Q 043586          377 DSS----NRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       377 ~~~----~~~~~~gt~~y~APE~~l  397 (397)
                      ...    ......|||.|||||++.
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit 1411 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVIT 1411 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhc
Confidence            431    123457999999999873

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=6.6e-26  Score=210.93  Aligned_cols=170  Identities=26%  Similarity=0.440  Sum_probs=137.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|+..+.||+|+||.||+|.+. ++.    .+|+|.+.......  ...++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPK--ANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHH--HHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            46788899999999999999763 343    57888887544322  234688899999999999999999998764 46


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++++||+++|+|.+++.....  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence            789999999999998875432  4788889999999999999999   66999999999999999999999999999987


Q ss_pred             cCCCCCC--eeeccccccccCCCCC
Q 043586          374 LHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      .......  .....++..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~  183 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECI  183 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHh
Confidence            6433221  1123356789999964

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.93  E-value=1.3e-25  Score=203.34  Aligned_cols=171  Identities=26%  Similarity=0.422  Sum_probs=143.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|+..+.||+|++|.||++... +++.+|+|.+....... ...+.+.+|++++++++|||++++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4788899999999999999764 68899999987653322 224678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+++.... ...+++..+..++.|++.|+.|||   +++++|+||||+||+++.+ +.+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999987543 224788899999999999999999   6699999999999999855 56899999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ....|++.|+|||..
T Consensus       156 ~~~-~~~~~~~~y~aPE~~  173 (256)
T cd08220         156 SKA-YTVVGTPCYISPELC  173 (256)
T ss_pred             ccc-cccccCCcccCchhc
Confidence            322 234689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=6.2e-26  Score=211.66  Aligned_cols=172  Identities=32%  Similarity=0.424  Sum_probs=140.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMF  294 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  294 (397)
                      .++|++.+.||+|+||.||+|... +++.||+|+++...... .....+.+|+.++++++|+||+++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            467999999999999999999864 68999999987543221 1113456799999999999999999998765  5689


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+.+ +|.+++....  ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999964 7877776432  34788999999999999999999   668999999999999999999999999999876


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...........+++.|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~  180 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELL  180 (309)
T ss_pred             CCccCCCCcccccccccChhhh
Confidence            5443333334468889999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.93  E-value=1.2e-25  Score=206.67  Aligned_cols=163  Identities=25%  Similarity=0.297  Sum_probs=130.5

Q ss_pred             eeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHH---HHHhhcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      .||+|+||.||+|+.. +++.||+|.+.............+..|.   ..++...||+|+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999764 5889999998764322111112233343   34444579999999999999999999999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR  381 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  381 (397)
                      +++|.+++...   ..+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++.......  .
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            99999888643   24889999999999999999999   6689999999999999999999999999997654322  2


Q ss_pred             eeccccccccCCCCC
Q 043586          382 TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 ~~~~gt~~y~APE~~  396 (397)
                      ....|+..|+|||++
T Consensus       153 ~~~~~~~~y~aPE~~  167 (278)
T cd05606         153 HASVGTHGYMAPEVL  167 (278)
T ss_pred             cCcCCCcCCcCcHHh
Confidence            234699999999974

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.93  E-value=8.9e-26  Score=207.78  Aligned_cols=170  Identities=28%  Similarity=0.408  Sum_probs=141.4

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |++.+.||+|++|.||+|... +|..||+|++....... ...+.+.+|++++++++|||++++++++.+++..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            677889999999999999764 78999999987543221 1225677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      ++ ++|.+++..... ..+++..+..++.|+++||+|||   +++++||||+|+||+++.++.++|+|||+++.......
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 689888865432 34789999999999999999999   56999999999999999999999999999986544333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......+++.|+|||++
T Consensus       155 ~~~~~~~~~~~~aPE~~  171 (283)
T cd07835         155 TYTHEVVTLWYRAPEIL  171 (283)
T ss_pred             ccCccccccCCCCCcee
Confidence            22334578899999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.6e-25  Score=203.16  Aligned_cols=163  Identities=30%  Similarity=0.417  Sum_probs=133.5

Q ss_pred             ceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          225 YCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      +.||+|+||.||+|.+..    +..+|+|.+......  ...+++.+|+.+++.++||||+++++++. .+..++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            359999999999997532    368999998876543  22367889999999999999999999876 44679999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      ++++|.+++....   .+++..+..++.|++.|++|||   ..+++|+||||+||+++.++.+||+|||+++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997643   4788999999999999999999   568999999999999999999999999999876443322


Q ss_pred             ee---eccccccccCCCCC
Q 043586          381 RT---LLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ~~---~~~gt~~y~APE~~  396 (397)
                      ..   ...++..|+|||..
T Consensus       152 ~~~~~~~~~~~~y~aPE~~  170 (257)
T cd05060         152 YRATTAGRWPLKWYAPECI  170 (257)
T ss_pred             cccccCccccccccCHHHh
Confidence            11   11234679999964

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=1.3e-25  Score=204.31  Aligned_cols=164  Identities=26%  Similarity=0.403  Sum_probs=130.9

Q ss_pred             eeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CCEeeEEEeec
Q 043586          226 CIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIYEYM  300 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  300 (397)
                      .||+|+||.||+|.+.    +...+|+|.+......  ...+.+.+|+.+++.++||||+++++++.. ++..++||||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCH--HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            5899999999999753    2457999988543222  224678889999999999999999997764 55688999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC-
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS-  379 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  379 (397)
                      .+++|.+++.....  ..++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||+++....... 
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          80 KHGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999875432  3567778889999999999999   66999999999999999999999999999986543221 


Q ss_pred             ---CeeeccccccccCCCCC
Q 043586          380 ---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ---~~~~~~gt~~y~APE~~  396 (397)
                         ......+++.|+|||+.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~  174 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESL  174 (262)
T ss_pred             eecccccCcCCccccChhHh
Confidence               11223467789999964

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.93  E-value=5.6e-26  Score=208.49  Aligned_cols=172  Identities=31%  Similarity=0.479  Sum_probs=145.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|.+.+.||+|++|.||+|... +++.||+|++...........+.+.+|.+++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999865 78999999987643333333467888999999998 99999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999887543   4889999999999999999999   66999999999999999999999999999986543


Q ss_pred             CCC--------------------CeeeccccccccCCCCC
Q 043586          377 DSS--------------------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~--------------------~~~~~~gt~~y~APE~~  396 (397)
                      ...                    ......|+..|+|||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  194 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELL  194 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHh
Confidence            221                    12234578999999964

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.93  E-value=2.2e-25  Score=208.78  Aligned_cols=167  Identities=30%  Similarity=0.395  Sum_probs=139.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+..+.||+|+||.||+++.. ++..+|+|++...........+.+.+|++++++++|||++++++++..+...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677788999999999999864 688999999875433333334678889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+.+ ++.+.+....  ..+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.+||+|||++...... 
T Consensus       106 ~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            9974 7777765432  24788999999999999999999   669999999999999999999999999998754332 


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                         ....|++.|+|||++
T Consensus       179 ---~~~~~~~~y~aPE~~  193 (317)
T cd06635         179 ---NSFVGTPYWMAPEVI  193 (317)
T ss_pred             ---ccccCCccccChhhh
Confidence               234689999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.93  E-value=8.4e-26  Score=204.73  Aligned_cols=172  Identities=24%  Similarity=0.402  Sum_probs=143.2

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|+||.||+|... ++..+|+|.+....... ...+.+.+|+++++.++|+||+++++.+...+..++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4788899999999999999865 57889999987643221 123567889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+++..... ..+++..+..++.|++.|+.|||   +.+++|+||||+||++++++ .+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998875432 24788999999999999999999   56899999999999999875 4699999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||+.
T Consensus       156 ~~~~~~~~~~~~~~ape~~  174 (257)
T cd08225         156 MELAYTCVGTPYYLSPEIC  174 (257)
T ss_pred             cccccccCCCccccCHHHH
Confidence            3333344689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.93  E-value=2.3e-25  Score=205.38  Aligned_cols=166  Identities=28%  Similarity=0.432  Sum_probs=140.8

Q ss_pred             CCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |...+.||+|++|.||++.. .+++.+++|++.......   .+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            45557899999999999985 468899999886543322   35678899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++++|.+++...    .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||.+........
T Consensus        98 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648          98 LEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999999988652    3788889999999999999999   66999999999999999999999999999876544333


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......|++.|+|||..
T Consensus       171 ~~~~~~~~~~y~aPE~~  187 (285)
T cd06648         171 RRKSLVGTPYWMAPEVI  187 (285)
T ss_pred             ccccccCCccccCHHHh
Confidence            33345689999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.93  E-value=1.8e-25  Score=204.13  Aligned_cols=174  Identities=28%  Similarity=0.472  Sum_probs=141.8

Q ss_pred             CCCccceeecCCcccEEEEEcCC--CcEEEEEEecccch-------HHHHHHHHHHHHHHHHhh-cccCCccceeeEEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPN--GKVFALKKLHTSET-------EELAFIKSFRNEAQVLSQ-VLHRNIVKLYGFCLH  289 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  289 (397)
                      +|++.+.||+|+||.||+|.+..  ++.+|+|.+.....       .......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999998754  68899998864321       122234567788888875 799999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                      ++..+++|||+++++|.+++... .....+++..++.++.|++.|+.|||+.  .+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999998887532 1223578889999999999999999942  47999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |.+....... ......|+..|+|||+.
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~  185 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIV  185 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhh
Confidence            9998765433 23345689999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=9.6e-26  Score=212.92  Aligned_cols=169  Identities=27%  Similarity=0.447  Sum_probs=137.8

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|++.+.||+|+||.||+|.. .+++.||+|.+......  ....++.+|+.++++++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            46899999999999999999975 46899999998643222  2235677899999999999999999987654     3


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++|+||+.+ ++.+.+...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence            57999999964 777666532    4788899999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      +........   .....||+.|+|||.+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIM  181 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHh
Confidence            865432221   1234689999999964

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.93  E-value=2e-25  Score=206.51  Aligned_cols=162  Identities=28%  Similarity=0.441  Sum_probs=138.3

Q ss_pred             ceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      ..||+|+||.||++.. .+++.||+|++......   ..+.+.+|+.+++.++|+|++++++++..++..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchh---HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            5699999999999976 47899999998654332   2366888999999999999999999999999999999999999


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeee
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL  383 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~  383 (397)
                      +|.+++...    .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||++............
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            998877532    3678889999999999999999   669999999999999999999999999998766543333344


Q ss_pred             ccccccccCCCCC
Q 043586          384 LAGTYGYIAPGLP  396 (397)
Q Consensus       384 ~~gt~~y~APE~~  396 (397)
                      ..|++.|+|||+.
T Consensus       176 ~~~~~~y~~pE~~  188 (292)
T cd06657         176 LVGTPYWMAPELI  188 (292)
T ss_pred             cccCccccCHHHh
Confidence            5689999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=4.2e-27  Score=223.71  Aligned_cols=170  Identities=30%  Similarity=0.489  Sum_probs=151.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|+....+|.|++|.|||+++. .++..|+|+++.....+.   .-.++|+-+++.++||||+.+++.+...+..|+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~---~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDF---SGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccc---cccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            467999999999999999999875 688999999987665543   4567899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||||.+|+|++.-+-..   .+++.++..+++..++|+.|||   +.+-+|||||-.||++++.|.+|++|||.+..+..
T Consensus        91 MEycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999998776543   4788888899999999999999   66889999999999999999999999999998877


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .-.....+.|||.|||||+.
T Consensus       165 ti~KrksfiGtpywmapEva  184 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVA  184 (829)
T ss_pred             hhhhhhcccCCccccchhHH
Confidence            77777788999999999973

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=4e-25  Score=199.98  Aligned_cols=173  Identities=28%  Similarity=0.455  Sum_probs=147.0

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||++... +++.+|+|++...... ....+.+.+|+++++.++|||++++.+.+...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4788899999999999999865 6889999998765432 1224678889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+.+.... ....+++..+..++.+++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999887642 1245889999999999999999999   569999999999999999999999999999876554


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........|++.|+|||..
T Consensus       157 ~~~~~~~~~~~~y~~pe~~  175 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELC  175 (258)
T ss_pred             cceecceeeeecccChhHh
Confidence            4333445689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=4.5e-25  Score=198.81  Aligned_cols=168  Identities=36%  Similarity=0.531  Sum_probs=145.7

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|+..+.||+|++|.||++... +++.+++|++......   ..+.+.+|++.++.++|||++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKE---KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchh---HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778899999999999999875 6889999999876541   23678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++....  ..+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999887643  35788999999999999999999   6699999999999999999999999999998765443


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      . .....|+..|+|||++
T Consensus       153 ~-~~~~~~~~~~~~PE~~  169 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVI  169 (253)
T ss_pred             c-ccceecCCcccCHHHH
Confidence            2 2345689999999964

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=2.8e-25  Score=205.03  Aligned_cols=171  Identities=32%  Similarity=0.389  Sum_probs=140.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  295 (397)
                      ++|+..+.||.|++|.||+|... +++.+|+|.+......  ...+++.+|++++++++||||+++++++..  .+..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            36788899999999999999874 6789999998765432  224678899999999999999999999865  347899


Q ss_pred             EEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          296 IYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999988765421 2234788889999999999999999   669999999999999999999999999998765


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .....  ....++..|+|||.+
T Consensus       156 ~~~~~--~~~~~~~~y~~pE~~  175 (287)
T cd06621         156 VNSLA--GTFTGTSFYMAPERI  175 (287)
T ss_pred             ccccc--ccccCCccccCHHHh
Confidence            43222  234578899999964

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.93  E-value=2.4e-25  Score=211.60  Aligned_cols=169  Identities=27%  Similarity=0.338  Sum_probs=138.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  290 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+....... ...+.+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4578999999999999999999864 78999999986532221 2235677899999999999999999988643     


Q ss_pred             -CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          291 -KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       291 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                       ...|+||||+. ++|.+.+...     +++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence             35799999996 4787776532     678888999999999999999   6699999999999999999999999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~  189 (353)
T cd07850         164 LARTAGTSFM-MTPYVVTRYYRAPEVI  189 (353)
T ss_pred             cceeCCCCCC-CCCCcccccccCHHHH
Confidence            9987644322 2334689999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.93  E-value=2e-25  Score=207.38  Aligned_cols=174  Identities=36%  Similarity=0.529  Sum_probs=140.7

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC---
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK---  291 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  291 (397)
                      ...++|++.+.||+|+||.||+|... +++.||+|+++...... .....+.+|++++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            34578999999999999999999875 58899999987543221 11245678999999999999999999987654   


Q ss_pred             -------EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeE
Q 043586          292 -------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF  364 (397)
Q Consensus       292 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  364 (397)
                             ..++|+||+++ ++...+...  ...+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEE
Confidence                   78999999976 666666543  225788999999999999999999   66999999999999999999999


Q ss_pred             EeccccccccCCCCC-CeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      |+|||.+........ ......+++.|+|||.+
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~  189 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELL  189 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHh
Confidence            999999987654332 12223468889999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=2e-25  Score=208.03  Aligned_cols=173  Identities=28%  Similarity=0.458  Sum_probs=138.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  291 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+....... .....+.+|++++++++||||+++++++...+    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            3457999999999999999999865 68999999886543221 11234567999999999999999999987643    


Q ss_pred             ----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          292 ----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       292 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                          ..++||||+.+ ++.+.+....  ..+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence                45999999964 7777765432  24788999999999999999999   56999999999999999999999999


Q ss_pred             cccccccCCCCCC----eeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      ||++.........    .....++..|+|||++
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  195 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELL  195 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHh
Confidence            9999866432221    1234578899999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.7e-25  Score=200.36  Aligned_cols=162  Identities=26%  Similarity=0.367  Sum_probs=132.5

Q ss_pred             ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHH-hhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.||+|+||.||+|... +++.||+|.+.............+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999864 6889999998765433222233445555544 445899999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      ++|.+++....   .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999886543   4788889999999999999999   66999999999999999999999999999875433    22


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                      ...|++.|+|||..
T Consensus       152 ~~~~~~~y~~pe~~  165 (260)
T cd05611         152 KFVGTPDYLAPETI  165 (260)
T ss_pred             cCCCCcCccChhhh
Confidence            34688999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.93  E-value=6.4e-26  Score=214.12  Aligned_cols=172  Identities=31%  Similarity=0.461  Sum_probs=142.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcCC---Cc--EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLPN---GK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ..+.....++||.|-||.||+|.+.+   |+  .||||.-+.+...+.  .+.|..|..+|+.++||||++++|+|.+. 
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~--tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD--TEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh--HHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            34445567789999999999997532   32  488898877655543  48899999999999999999999999764 


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+|||.++.|.|..+++.++.  .++......++.||+.||+|||   +..+|||||...|||+....-+||+|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence            58999999999999999997655  4788888999999999999999   779999999999999999999999999999


Q ss_pred             cccCCCCCCeeec-cccccccCCCCC
Q 043586          372 RLLHADSSNRTLL-AGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~-~gt~~y~APE~~  396 (397)
                      +-+.++....... .-...|||||-+
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESI  564 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESI  564 (974)
T ss_pred             hhccccchhhccccccceeecCcccc
Confidence            9876655433221 123469999964

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.93  E-value=2e-25  Score=210.80  Aligned_cols=171  Identities=34%  Similarity=0.444  Sum_probs=139.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC--CE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR--KC  292 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~  292 (397)
                      ..++|++.+.||+|+||.||+|.+. +++.+|+|++....... .....+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            4567899999999999999999865 67899999886432221 1134567899999999 999999999998653  46


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .|+||||++ ++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999997 5888877643    4678888999999999999999   6699999999999999999999999999998


Q ss_pred             ccCCCCC-----CeeeccccccccCCCCC
Q 043586          373 LLHADSS-----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~-----~~~~~~gt~~y~APE~~  396 (397)
                      .......     ......||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  184 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEIL  184 (337)
T ss_pred             ccccccccccCcchhcccccccccCceee
Confidence            6644321     12234689999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.93  E-value=2.7e-25  Score=210.41  Aligned_cols=170  Identities=27%  Similarity=0.361  Sum_probs=140.0

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC--
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--  291 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  291 (397)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++....  
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            34567899999999999999999975 47899999998653322 223356788999999999999999999987643  


Q ss_pred             ----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          292 ----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       292 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                          ..++||||+ +++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence                458999999 67888777532    4788999999999999999999   66999999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||++.......   ....+++.|+|||++
T Consensus       162 fg~~~~~~~~~---~~~~~~~~y~aPE~~  187 (343)
T cd07880         162 FGLARQTDSEM---TGYVVTRWYRAPEVI  187 (343)
T ss_pred             cccccccccCc---cccccCCcccCHHHH
Confidence            99998654322   234578999999964

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.93  E-value=3.6e-25  Score=203.83  Aligned_cols=169  Identities=34%  Similarity=0.489  Sum_probs=140.5

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEeeEEE
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIY  297 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  297 (397)
                      |++.+.||+|++|.||+|+.. +++.+|+|++.... ......+.+.+|++++++++|||++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            677889999999999999875 58899999998764 1112235678899999999999999999999988  8899999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++ +|.+++....  ..+++..+..++.|++.|++|||   ..+++|+||||+||++++++.+||+|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99974 8888776542  35788999999999999999999   568999999999999999999999999999876544


Q ss_pred             CC-CeeeccccccccCCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~~  396 (397)
                      .. ......++..|+|||.+
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~  173 (287)
T cd07840         154 NSADYTNRVITLWYRPPELL  173 (287)
T ss_pred             CcccccccccccccCCceee
Confidence            32 12234578899999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.93  E-value=4.6e-25  Score=209.02  Aligned_cols=174  Identities=26%  Similarity=0.342  Sum_probs=142.6

Q ss_pred             HHHHHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ..++....++|++.+.||+|+||.||+|.. .+++.||+|++....... ...+.+.+|+.++++++||||+++++++..
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhh-HHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            456677889999999999999999999975 478899999987643222 223567789999999999999999998864


Q ss_pred             C------CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          290 R------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       290 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                      .      ...+++++++ +++|.+++...    .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            3      3468888887 77888777532    3788899999999999999999   5699999999999999999999


Q ss_pred             EEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+|||+++.....   .....|++.|+|||+.
T Consensus       160 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~  189 (345)
T cd07877         160 KILDFGLARHTDDE---MTGYVATRWYRAPEIM  189 (345)
T ss_pred             EEeccccccccccc---ccccccCCCccCHHHH
Confidence            99999999865332   2234688999999963

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.93  E-value=1.1e-24  Score=203.75  Aligned_cols=166  Identities=31%  Similarity=0.404  Sum_probs=138.3

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |...+.||+|+||.||+|+.. +++.|++|++...........+.+.+|+++++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999999864 6889999998754433333346788899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +. +++.+.+....  ..+++.++..++.|++.|+.|||   +.+++|+||||+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 57777765432  24788999999999999999999   56999999999999999999999999999864322   


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                       .....|+..|+|||++
T Consensus       174 -~~~~~~~~~y~aPE~~  189 (313)
T cd06633         174 -ANSFVGTPYWMAPEVI  189 (313)
T ss_pred             -CCCccccccccChhhc
Confidence             2235689999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.93  E-value=7e-25  Score=198.41  Aligned_cols=170  Identities=31%  Similarity=0.429  Sum_probs=146.4

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  296 (397)
                      +|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|+.++++++||||+++++.+...  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4777889999999999999876 6889999998766532 22347888999999999999999999999988  889999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +||+++++|.+++....   .+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999987643   5789999999999999999999   56999999999999999999999999999987765


Q ss_pred             CCC--CeeeccccccccCCCCC
Q 043586          377 DSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ...  ......++..|+|||+.
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             ccccccccCCCCCccccCHhhh
Confidence            443  12335689999999974

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=8.2e-25  Score=199.79  Aligned_cols=168  Identities=26%  Similarity=0.403  Sum_probs=136.9

Q ss_pred             HHHHHHHhcCCCcccee--ecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeE
Q 043586          211 YEDLIEATEGFDIKYCI--GTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGF  286 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  286 (397)
                      ..+.....++|++.+.+  |+|+||.||+++.. +++.+|+|.+........        |+.....+ +||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~   77 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYS   77 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEE
Confidence            35556667788888877  99999999999864 678899999865432211        22222222 69999999999


Q ss_pred             EeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEE
Q 043586          287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFV  365 (397)
Q Consensus       287 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl  365 (397)
                      +..++..++||||+++++|.+++....   .+++.++..++.|+++|+.|||   +.+++||||||+||+++.++ .++|
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         78 VTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             EecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence            999999999999999999999987543   5789999999999999999999   66899999999999999988 9999


Q ss_pred             eccccccccCCCCCCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +|||+++......    ...|+..|+|||++
T Consensus       152 ~dfg~~~~~~~~~----~~~~~~~y~aPE~~  178 (267)
T PHA03390        152 CDYGLCKIIGTPS----CYDGTLDYFSPEKI  178 (267)
T ss_pred             ecCccceecCCCc----cCCCCCcccChhhh
Confidence            9999988654322    24589999999975

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.92  E-value=5.4e-25  Score=202.31  Aligned_cols=166  Identities=27%  Similarity=0.346  Sum_probs=135.4

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeC--CEeeEE
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR--KCMFLI  296 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  296 (397)
                      |++.+.||+|+||.||+|+.. +++.||+|+++........  ....+|+.+++++. |||++++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh--hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            667889999999999999864 6889999998764322211  23346888999885 99999999999987  889999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||++ +++.+.+....  ..+++.++..++.|++.||+|||   ..+++||||||+||+++. +.+||+|||+++....
T Consensus        79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99997 57877776432  24789999999999999999999   569999999999999999 9999999999987644


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... ....+++.|+|||+.
T Consensus       152 ~~~~-~~~~~~~~y~aPE~~  170 (282)
T cd07831         152 KPPY-TEYISTRWYRAPECL  170 (282)
T ss_pred             CCCc-CCCCCCcccCChhHh
Confidence            3322 234588999999964

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.92  E-value=5.8e-25  Score=202.95  Aligned_cols=171  Identities=30%  Similarity=0.435  Sum_probs=141.6

Q ss_pred             CCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  293 (397)
                      +|++.+.||+|++|.||+++.    .+++.||+|.++..... .....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999874    35788999998754322 222346788899999999 599999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....   .+++..+..++.|+++||.|||   ..+++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            99999999999998886432   4778889999999999999999   66999999999999999999999999999886


Q ss_pred             cCCCCCC-eeeccccccccCCCCC
Q 043586          374 LHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ....... .....|++.|+|||..
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~  178 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             cccccccccccccCCccccCHHHh
Confidence            5443221 2234689999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.92  E-value=2e-25  Score=210.51  Aligned_cols=171  Identities=28%  Similarity=0.402  Sum_probs=140.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKC  292 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~  292 (397)
                      .++|++.+.||+|++|.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            367999999999999999999864 6899999998754322 1223567789999999999999999998763    346


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .++||||+. ++|.+++....   .+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999995 68888886432   3788999999999999999999   5699999999999999999999999999998


Q ss_pred             ccCCCCCC----eeeccccccccCCCCC
Q 043586          373 LLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      ........    .....|+..|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELL  183 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHh
Confidence            65432221    1234689999999974

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.92  E-value=3.2e-25  Score=204.60  Aligned_cols=170  Identities=27%  Similarity=0.311  Sum_probs=136.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +|+..+.||+|+||.||++... +++.+|+|.+.......  ....+.+|+.++.++. ||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK--EQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChH--HHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4566678999999999999764 68999999987654332  2367888999999996 999999999999999999999


Q ss_pred             eeccCCCchhhc---ccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          298 EYMERGSLFCNL---HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       298 e~~~~g~L~~~l---~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ||+.. ++.++.   ... ....+++..+..++.|++.||+|||+.  .+++||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             ecccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            99864 554432   221 123578899999999999999999952  48999999999999999999999999999865


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... ....|++.|+|||++
T Consensus       159 ~~~~~~-~~~~~~~~y~aPE~~  179 (288)
T cd06616         159 VDSIAK-TRDAGCRPYMAPERI  179 (288)
T ss_pred             ccCCcc-ccccCccCccCHHHh
Confidence            433222 223589999999974

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=2.5e-25  Score=210.22  Aligned_cols=171  Identities=25%  Similarity=0.356  Sum_probs=139.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|.+.+.||+|+||.||+|+.. +++.||+|.+....... .....+.+|+.+++.++||||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNR-IDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            357899999999999999999864 68999999987542221 1134567899999999999999999988654     3


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+|+||+. ++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            4799999996 68888776432   4788999999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.............++..|+|||.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~  180 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELL  180 (337)
T ss_pred             cccCCCcccccccccccCccChHHH
Confidence            8765433333345688999999964

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.7e-25  Score=197.98  Aligned_cols=164  Identities=30%  Similarity=0.458  Sum_probs=141.3

Q ss_pred             eecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|+||.||++... +++.+|+|.+...........+.+..|+++++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999865 5889999998876544433456788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecc
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA  385 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  385 (397)
                      .+++....   .+++.....++.|++.|+.|+|   +.+++|+||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99887543   4788999999999999999999   56999999999999999999999999999987654433334456


Q ss_pred             ccccccCCCCC
Q 043586          386 GTYGYIAPGLP  396 (397)
Q Consensus       386 gt~~y~APE~~  396 (397)
                      ++..|+|||..
T Consensus       155 ~~~~~~~Pe~~  165 (250)
T cd05123         155 GTPEYLAPEVL  165 (250)
T ss_pred             CCccccChHHh
Confidence            89999999974

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=9.2e-25  Score=199.87  Aligned_cols=172  Identities=27%  Similarity=0.399  Sum_probs=135.5

Q ss_pred             CCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----  291 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  291 (397)
                      |.+.+.||+|+||.||+|.+.    +++.||+|.+........ ..+++.+|++++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSS-DIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            567788999999999999753    368899999876543222 2467888999999999999999999886532     


Q ss_pred             -EeeEEEeeccCCCchhhcccC---CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          292 -CMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       292 -~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                       ..++++||+.+|+|.+++...   .....+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECc
Confidence             247899999999998776432   12234788889999999999999999   66999999999999999999999999


Q ss_pred             cccccccCCCCCC--eeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ||.++........  .....+++.|++||..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  187 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESL  187 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHH
Confidence            9999866433221  1223456789999963

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.92  E-value=2.8e-25  Score=202.86  Aligned_cols=166  Identities=30%  Similarity=0.432  Sum_probs=134.2

Q ss_pred             eeecCCcccEEEEEcCC-------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          226 CIGTGGYGSVYKAQLPN-------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .||+|+||.||+|+..+       ++.+|+|.+......  .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATD--QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccch--hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            58999999999997642       357899988654322  123678889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCC----CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-----CeEEeccc
Q 043586          299 YMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-----EAFVADFG  369 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-----~~kl~DFG  369 (397)
                      |+++++|.+++....    ....+++.++..++.|++.|++|||   +.+++|+||||+||+++.++     .++++|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999886432    1234788999999999999999999   66899999999999999877     89999999


Q ss_pred             cccccCCCCCC--eeeccccccccCCCCC
Q 043586          370 TARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +++........  .....++..|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  185 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESL  185 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHH
Confidence            99865432211  1123457889999964

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.92  E-value=5e-25  Score=207.96  Aligned_cols=171  Identities=28%  Similarity=0.320  Sum_probs=137.5

Q ss_pred             cCCC-ccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHH-----------HHHHHHHHHHHHhhcccCCccceee
Q 043586          219 EGFD-IKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELA-----------FIKSFRNEAQVLSQVLHRNIVKLYG  285 (397)
Q Consensus       219 ~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  285 (397)
                      ++|. +.+.||+|+||.||+|+.. +++.||+|++.........           ....+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4555 3467999999999999864 6899999998654322100           0124678999999999999999999


Q ss_pred             EEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEE
Q 043586          286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV  365 (397)
Q Consensus       286 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  365 (397)
                      ++...+..++||||+. ++|.+++....   .+++.....++.|++.||.|||   +.+++|+||||+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 58888876432   4788899999999999999999   669999999999999999999999


Q ss_pred             eccccccccCCC--------------CCCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHAD--------------SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~--------------~~~~~~~~gt~~y~APE~~  396 (397)
                      +|||+++....+              ........+++.|+|||++
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  205 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELL  205 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhc
Confidence            999999865411              1111223478899999975

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=7e-26  Score=187.23  Aligned_cols=171  Identities=25%  Similarity=0.343  Sum_probs=137.0

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +......||+|++|.|-+-++ .+|...|+|.++.......  .++...|+++..+. ..|.+|.++|.+......|+.|
T Consensus        47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~--q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE--QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH--HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            344456699999999988765 4799999999987654433  36778899887766 6999999999999999999999


Q ss_pred             eeccCCCchhhccc-CCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |.|+. +|..+-.+ ......+++.-.-+|+..+++||.|||++  ..++|||+||+|||++.+|.+|+||||++..+.+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99963 66544332 12223578888889999999999999984  5899999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      +-. .+...|-..|||||.+
T Consensus       202 SiA-kt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  202 SIA-KTMDAGCKPYMAPERI  220 (282)
T ss_pred             hhH-HHHhcCCCccCChhhc
Confidence            433 3435688899999975

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=6.5e-25  Score=201.94  Aligned_cols=168  Identities=26%  Similarity=0.392  Sum_probs=139.5

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEe
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      |++.+.||+|++|.||+|+.. +++.||+|++........  .....+|+..+++++ |||++++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            667889999999999999875 578899999876433211  123456899999999 9999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+ ++++.+.+.... ...+++..+..++.|++.+|.|||   +++++|+||+|+||+++.++.++|+|||.++......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 789988887543 235789999999999999999999   5699999999999999999999999999998765432


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      . .....++..|+|||++
T Consensus       154 ~-~~~~~~~~~~~aPE~~  170 (283)
T cd07830         154 P-YTDYVSTRWYRAPEIL  170 (283)
T ss_pred             C-cCCCCCcccccCceee
Confidence            2 2234688999999964

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=3.7e-25  Score=200.29  Aligned_cols=171  Identities=26%  Similarity=0.381  Sum_probs=143.9

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|++.+.||+|++|.||+++.. +++.+|+|.+........ ...++.+|+++++.++||||+++++++......++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK-EREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH-HHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            4788899999999999999754 688999999876443322 23567789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+++..... ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999988865221 234788899999999999999999   679999999999999999999999999999876554


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....|++.|+|||+.
T Consensus       157 ~--~~~~~~~~~~~~Pe~~  173 (256)
T cd08530         157 M--AKTQIGTPHYMAPEVW  173 (256)
T ss_pred             C--cccccCCccccCHHHH
Confidence            2  2234588999999964

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.92  E-value=1e-24  Score=202.18  Aligned_cols=170  Identities=28%  Similarity=0.387  Sum_probs=136.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|++|.||+|.+.+ ++.||||.++.......  ..++.+|+.++.+.. ||||+++++++......|+|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEE--NKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHH--HHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            568899999999999999998764 88999999976433222  245566777676664 99999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+. +++.+++.....  .+++..+..++.|++.|++|||+.  ++|+||||+|+||+++.++.+||+|||++..+..
T Consensus        93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            99985 466666544222  578888999999999999999952  4899999999999999999999999999986643


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... ....+++.|+|||++
T Consensus       168 ~~~~-~~~~~~~~y~aPE~~  186 (296)
T cd06618         168 SKAK-TRSAGCAAYMAPERI  186 (296)
T ss_pred             CCcc-cCCCCCccccCHhhc
Confidence            3322 223578899999975

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=9.5e-25  Score=212.81  Aligned_cols=176  Identities=17%  Similarity=0.255  Sum_probs=131.4

Q ss_pred             hcCCCccceeecCCcccEEEEEc-----------------CCCcEEEEEEecccchHHHH-----------HHHHHHHHH
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-----------------PNGKVFALKKLHTSETEELA-----------FIKSFRNEA  269 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~  269 (397)
                      .++|++.++||+|+||.||+|..                 ..++.||||++.........           ..+....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999953                 23567999998754322110           012334577


Q ss_pred             HHHhhcccCCc-----cceeeEEee--------CCEeeEEEeeccCCCchhhcccCCC---------------------c
Q 043586          270 QVLSQVLHRNI-----VKLYGFCLH--------RKCMFLIYEYMERGSLFCNLHNNED---------------------A  315 (397)
Q Consensus       270 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~  315 (397)
                      .++.+++|.++     ++++++|..        .+..|+||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77888876554     667777653        3568999999999999998864211                     1


Q ss_pred             cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe-eeccccccccCCC
Q 043586          316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGTYGYIAPG  394 (397)
Q Consensus       316 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~gt~~y~APE  394 (397)
                      ..+++..+..++.|++.||.|+|   +.+|+||||||+||+++.++.+||+|||+++......... ....+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12456778899999999999999   5689999999999999999999999999997654332211 1223589999999


Q ss_pred             CC
Q 043586          395 LP  396 (397)
Q Consensus       395 ~~  396 (397)
                      .+
T Consensus       381 ~l  382 (507)
T PLN03224        381 EL  382 (507)
T ss_pred             hh
Confidence            75

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.92  E-value=7.8e-25  Score=204.19  Aligned_cols=167  Identities=29%  Similarity=0.413  Sum_probs=138.4

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|+..+.||+|+||.||+|+.. +++.+|+|.+...........+++.+|+++++.++|+|++++++++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4667788999999999999864 678899999875332222234567889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+. |++.+.+....  ..+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 57777665432  24788889999999999999999   569999999999999999999999999998765432 


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                         ....|++.|+|||++
T Consensus       169 ---~~~~~~~~y~aPE~~  183 (308)
T cd06634         169 ---NXFVGTPYWMAPEVI  183 (308)
T ss_pred             ---ccccCCccccCHHHH
Confidence               234688999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-26  Score=198.93  Aligned_cols=167  Identities=29%  Similarity=0.381  Sum_probs=133.2

Q ss_pred             cceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeecc
Q 043586          224 KYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      ...||.|+||+|++-.+ +.|+..|||+++.......  .+++..|.+...+- +.||||+++|.+...+..|+-||.|+
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~ke--q~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKE--QKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHH--HHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            35599999999999865 5799999999988765433  37788888875555 68999999999999999999999995


Q ss_pred             CCCchhhccc--CCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          302 RGSLFCNLHN--NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       302 ~g~L~~~l~~--~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                       .++..+.+.  ......+++.-.-+|....+.||.||-+.  ..|+|||+||+|||+|..|.+||||||++..+..+-.
T Consensus       147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA  223 (361)
T ss_pred             -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence             355433321  11223577777788888899999999874  4899999999999999999999999999987754433


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                       .+.-+|-..|||||.+
T Consensus       224 -kT~daGCrpYmAPERi  239 (361)
T KOG1006|consen  224 -KTVDAGCRPYMAPERI  239 (361)
T ss_pred             -hhhccCCccccChhcc
Confidence             2334688899999975

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=5.7e-25  Score=207.06  Aligned_cols=169  Identities=30%  Similarity=0.405  Sum_probs=141.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----Ee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  293 (397)
                      +|++.+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccccc-chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788899999999999999875 5889999998764321 222467888999999999999999999988765     78


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+. ++|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999997 48888876543   5888999999999999999999   66999999999999999999999999999997


Q ss_pred             cCCCCC---CeeeccccccccCCCCC
Q 043586          374 LHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      ......   ......+|+.|+|||++
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~  178 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELL  178 (330)
T ss_pred             ecccccccccccccccccCcCCceee
Confidence            655431   22334689999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=9.1e-25  Score=205.50  Aligned_cols=172  Identities=25%  Similarity=0.378  Sum_probs=140.3

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-C
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-R  290 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~  290 (397)
                      ++...+++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++.+++.. .
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            34456788999999999999999999754 78999999886532221 123567789999999999999999999876 5


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...+++|||+ +++|.+++...    .+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||.
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence            5789999999 56888777532    3677778889999999999999   66999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.......   ....+++.|+|||++
T Consensus       155 ~~~~~~~~---~~~~~~~~y~aPE~~  177 (328)
T cd07856         155 ARIQDPQM---TGYVSTRYYRAPEIM  177 (328)
T ss_pred             ccccCCCc---CCCcccccccCceee
Confidence            98653322   224578899999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=1.3e-24  Score=204.60  Aligned_cols=167  Identities=22%  Similarity=0.288  Sum_probs=134.6

Q ss_pred             ceeecC--CcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          225 YCIGTG--GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       225 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      ..||+|  +||+||++++. +++.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  88999999864 78999999987654332 234788899999999999999999999999999999999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC-
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN-  380 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  380 (397)
                      ++++.+++..... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++++|||.+......... 
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999998876432 24788889999999999999999   669999999999999999999999999865433221111 


Q ss_pred             ------eeeccccccccCCCCC
Q 043586          381 ------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ------~~~~~gt~~y~APE~~  396 (397)
                            .....++..|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~  180 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELL  180 (328)
T ss_pred             cccccccccccCccCccChhhh
Confidence                  1112356679999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.92  E-value=6.3e-25  Score=201.77  Aligned_cols=169  Identities=31%  Similarity=0.410  Sum_probs=141.8

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |+..+.||+|++|.||+|+.. +++.+|+|.+...... ....+.+.+|+.++++++|+|++++++++...+..++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc-ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            566788999999999999875 5899999999865422 12235677899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||.++.......
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            97 58999887643  24889999999999999999999   56899999999999999999999999999987654433


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......++..|+|||++
T Consensus       154 ~~~~~~~~~~~~aPE~~  170 (282)
T cd07829         154 TYTHEVVTLWYRAPEIL  170 (282)
T ss_pred             ccCccccCcCcCChHHh
Confidence            33334567889999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=211.35  Aligned_cols=178  Identities=29%  Similarity=0.466  Sum_probs=151.6

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEE
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC  287 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  287 (397)
                      +.+++|+....+.....+||-|.||.||.|.|+. .-.||||.++.+...    .++|.+|+.+|+.++|||+|+++|+|
T Consensus       257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe----veEFLkEAAvMKeikHpNLVqLLGVC  332 (1157)
T KOG4278|consen  257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVC  332 (1157)
T ss_pred             CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh----HHHHHHHHHHHHhhcCccHHHHhhhh
Confidence            3456777777778889999999999999998864 568999999876654    58899999999999999999999999


Q ss_pred             eeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          288 LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       288 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                      .....+|||+|||..|+|.+++++-.. ..++.-..+.++.||..||+||.   .+.+|||||...|+|+.++..+|++|
T Consensus       333 T~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  333 THEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             ccCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeec
Confidence            999999999999999999999987543 35666677889999999999999   66899999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccc---cccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAG---TYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~g---t~~y~APE~~  396 (397)
                      ||+++++..+..  +...|   ...|.|||-+
T Consensus       409 FGLsRlMtgDTY--TAHAGAKFPIKWTAPEsL  438 (1157)
T KOG4278|consen  409 FGLSRLMTGDTY--TAHAGAKFPIKWTAPESL  438 (1157)
T ss_pred             cchhhhhcCCce--ecccCccCcccccCcccc
Confidence            999998865443  22234   3359999954

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=4.8e-25  Score=205.88  Aligned_cols=170  Identities=25%  Similarity=0.386  Sum_probs=143.7

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ..|++.++||.|+.+.||++...+.+.||+|++..... +.+....|.+|+..|.+++ |.+|+++++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            46889999999999999999998889999998865443 3455788999999999995 999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||-+ .+|..++.+....  .+...++.+..||+.|+.++|   ..||||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus       440 E~Gd-~DL~kiL~k~~~~--~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSI--DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             eccc-ccHHHHHHhccCC--CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            9874 6999999865432  332367889999999999999   56999999999999875 468999999999988765


Q ss_pred             CCC--eeeccccccccCCCCC
Q 043586          378 SSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~--~~~~~gt~~y~APE~~  396 (397)
                      ...  ....+||+.||+||.+
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl  533 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEAL  533 (677)
T ss_pred             ccceeeccccCcccccCHHHH
Confidence            543  3446899999999975

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-24  Score=199.46  Aligned_cols=169  Identities=30%  Similarity=0.444  Sum_probs=141.8

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |++.+.||+|++|.||+|... +++.+++|.+....... .....+.+|++++++++||||+++++++..++..++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567788999999999999865 68899999987654331 2236778899999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +++ ++.+.+....  ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            975 8877776532  35788999999999999999999   66899999999999999999999999999987755442


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      ......++..|+|||.+
T Consensus       154 ~~~~~~~~~~~~~PE~~  170 (283)
T cd05118         154 PYTHYVVTRWYRAPELL  170 (283)
T ss_pred             cccCccCcccccCcHHH
Confidence            22334588899999974

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.92  E-value=1.5e-24  Score=202.82  Aligned_cols=168  Identities=18%  Similarity=0.207  Sum_probs=134.1

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.+.+|.|+++.||++.. +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..+++|||+++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccch-hHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            344455555655666554 68999999997653222 2346789999999999999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC---
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS---  379 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---  379 (397)
                      +++.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+........   
T Consensus        84 ~~l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999998875422 24778889999999999999999   66899999999999999999999999999876543221   


Q ss_pred             ----CeeeccccccccCCCCC
Q 043586          380 ----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ----~~~~~~gt~~y~APE~~  396 (397)
                          ......++..|+|||++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             ccccccccccccccccCHHHh
Confidence                11234578889999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.92  E-value=2.9e-24  Score=197.86  Aligned_cols=169  Identities=31%  Similarity=0.463  Sum_probs=137.0

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEeeCCE----
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLHRKC----  292 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----  292 (397)
                      |++.+.||+|+||.||+|++. +++.||+|+++...... .....+.+|+.+++++   +|||++++++++...+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            677889999999999999876 48999999997543322 1124566788777666   59999999999988776    


Q ss_pred             -eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          293 -MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       293 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                       .+++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence             9999999974 78887765432 24789999999999999999999   668999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ......... ....+++.|+|||+.
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~PE~~  178 (287)
T cd07838         155 RIYSFEMAL-TSVVVTLWYRAPEVL  178 (287)
T ss_pred             eeccCCccc-ccccccccccChHHh
Confidence            876443322 233578899999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=2.1e-24  Score=204.31  Aligned_cols=166  Identities=31%  Similarity=0.409  Sum_probs=135.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  290 (397)
                      .++|.+.+.||+|+||.||+|... +++.||+|++......+ ...+.+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            368999999999999999999864 68999999987543221 2235677899999999999999999998754      


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...++|+||+.. ++.....     ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            246899999964 6655442     13788889999999999999999   66899999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++......   ....+++.|+|||++
T Consensus       164 ~~~~~~~~---~~~~~~~~y~aPE~~  186 (342)
T cd07879         164 ARHADAEM---TGYVVTRWYRAPEVI  186 (342)
T ss_pred             CcCCCCCC---CCceeeecccChhhh
Confidence            98653322   234578999999974

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.91  E-value=2.7e-24  Score=202.75  Aligned_cols=169  Identities=27%  Similarity=0.391  Sum_probs=134.9

Q ss_pred             CCCccceeecCCcccEEEEEcC-C--CcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC----C
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR----K  291 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~  291 (397)
                      +|++.+.||+|+||.||+++.. +  +..||+|++...... ....+.+.+|+++++++ .||||+++++.+...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4788899999999999999865 3  778999998753222 11235677899999999 599999999875432    4


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++++||+. ++|.+++....   .+++..+..++.|++.||+|||   ..+++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5789999986 68888876432   4788999999999999999999   669999999999999999999999999999


Q ss_pred             cccCCCCC----CeeeccccccccCCCCC
Q 043586          372 RLLHADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      +.......    ......||+.|+|||+.
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  181 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIM  181 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHH
Confidence            86543221    12234689999999964

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.91  E-value=1.3e-24  Score=202.67  Aligned_cols=172  Identities=31%  Similarity=0.456  Sum_probs=136.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  290 (397)
                      .++|++.+.||+|+||.||+|... +++.+|+|++......+. ....+.+|++++++++||||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            468999999999999999999865 688999999865432211 123566899999999999999999987543      


Q ss_pred             --CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          291 --KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       291 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                        ...++||||+.+ ++...+....  ..+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcC
Confidence              346999999965 6666665432  25889999999999999999999   669999999999999999999999999


Q ss_pred             ccccccCCCCCC-----------eeeccccccccCCCCC
Q 043586          369 GTARLLHADSSN-----------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~-----------~~~~~gt~~y~APE~~  396 (397)
                      |+++........           .+...|++.|+|||++
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELL  198 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHh
Confidence            999865432211           1223578899999964

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=6.4e-27  Score=198.82  Aligned_cols=171  Identities=30%  Similarity=0.480  Sum_probs=134.1

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--------C
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--------R  290 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  290 (397)
                      .|+-...||+|.||.||+|+.. +++.||+|++-...... .+-....+|+++|..++|+|++.+++.|..        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKe-GfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcccc-CCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4555678999999999999865 57788988764422111 112345679999999999999999988854        3


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...|+|+++|+. +|.-++...  ...++..++.+++.++..||.|+|   ...|+|||+||+|+|++.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence            458999999975 777777643  245888999999999999999999   66899999999999999999999999999


Q ss_pred             ccccCCCCC----CeeeccccccccCCCCCC
Q 043586          371 ARLLHADSS----NRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       371 a~~~~~~~~----~~~~~~gt~~y~APE~~l  397 (397)
                      |+.+.....    ..+..+-|.+|.+||.+|
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllL  201 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLL  201 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhh
Confidence            976543222    123345689999999875

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.91  E-value=3.9e-24  Score=198.15  Aligned_cols=171  Identities=22%  Similarity=0.301  Sum_probs=123.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHH--HH------HHHHHHHHHHHHhhcccCCccceeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEE--LA------FIKSFRNEAQVLSQVLHRNIVKLYGF  286 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~--~~------~~~~~~~E~~~l~~l~h~niv~l~~~  286 (397)
                      ++|++.+.||+|+||.||+|+..+    +..+|+|+........  ..      .......+...+..+.|+++++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            579999999999999999998654    3456666543222110  00      00122334455666789999999997


Q ss_pred             EeeCC----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          287 CLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       287 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                      +....    ..++++|++. .++.+.+....   ..++..+..++.|++.||+|||   +.+|+||||||+|||++.++.
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            76543    4578888774 35555554321   2467778899999999999999   669999999999999999999


Q ss_pred             eEEeccccccccCCCC-------CCeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADS-------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~-------~~~~~~~gt~~y~APE~~  396 (397)
                      ++|+|||+|+.+....       .......||+.|+|||+.
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~  205 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAH  205 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHh
Confidence            9999999998764322       112334699999999964

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.91  E-value=1.9e-24  Score=196.38  Aligned_cols=173  Identities=27%  Similarity=0.375  Sum_probs=137.0

Q ss_pred             CCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchH--HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +|.+.+.||+|+||.||++++.. +..+++|.++.....  ......++.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47888999999999999997643 444555655432211  111124566789999999999999999999998899999


Q ss_pred             EeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          297 YEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |||+++++|.+++.... ....+++..++.++.|++.|+.|||   +.+++|+||||+||+++. +.+||+|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999988876421 2235889999999999999999999   669999999999999975 569999999998765


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........|++.|+|||..
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~  177 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEAL  177 (260)
T ss_pred             CCcccccCCCCCcCccCHHHH
Confidence            544433445689999999963

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=4.6e-25  Score=214.05  Aligned_cols=166  Identities=25%  Similarity=0.457  Sum_probs=135.9

Q ss_pred             CccceeecCCcccEEEEEc-CCC----cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          222 DIKYCIGTGGYGSVYKAQL-PNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ...++||+|+||+||+|.| +.|    -+||+|++........  .+++.+|+-+|.+++|||+++++++|.... ..+|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~--s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKA--SIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchh--hHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            3457899999999999965 334    3689998876554432  378899999999999999999999998776 8899


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ++||+.|+|.++++.++.  .+.....+.|..|||+||.|||   .+++|||||..+||||..-..+||.|||+|+....
T Consensus       776 tq~mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999987654  4677888999999999999999   56899999999999999999999999999998876


Q ss_pred             CCCCeeeccc--cccccCCCC
Q 043586          377 DSSNRTLLAG--TYGYIAPGL  395 (397)
Q Consensus       377 ~~~~~~~~~g--t~~y~APE~  395 (397)
                      +........|  .+.|||=|.
T Consensus       851 d~~ey~~~~gK~pikwmale~  871 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALES  871 (1177)
T ss_pred             ccccccccccccCcHHHHHHH
Confidence            6554433322  234665543

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=6.6e-24  Score=182.80  Aligned_cols=145  Identities=19%  Similarity=0.208  Sum_probs=109.4

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHH-----------------------HHHHHHHHHHHHhhcccCCc
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-----------------------FIKSFRNEAQVLSQVLHRNI  280 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~ni  280 (397)
                      ...||+|++|.||+|...+|+.||+|+++........                       ......+|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999999888999999999765321100                       01223459999999998887


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      .....+...  ..++||||++++++.......   ..+++.++..++.|++.+|.|+|+  ..+|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-C
Confidence            544433222  238999999987765443221   247788899999999999999942  45899999999999998 4


Q ss_pred             CCeEEeccccccccCC
Q 043586          361 FEAFVADFGTARLLHA  376 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~  376 (397)
                      +.++|+|||+|.....
T Consensus       154 ~~v~LiDFG~a~~~~~  169 (190)
T cd05147         154 GKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CcEEEEEccccccCCC
Confidence            7899999999986533

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1e-25  Score=193.66  Aligned_cols=169  Identities=30%  Similarity=0.390  Sum_probs=137.2

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----Eee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----CMF  294 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  294 (397)
                      .+-.+.||-|+||+||.+.++ +|+.||.|++..-. ......+++.+|++++..++|.|++..++..+...     +.|
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344577999999999999864 79999999986533 23334577888999999999999999999877543     478


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +++|.|. .+|...+-..   ..++...++-+..||++||.|||   +.+|.||||||.|.|++.+...||||||+|+..
T Consensus       134 V~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccccc
Confidence            8999995 4887777543   34777788889999999999999   669999999999999999999999999999976


Q ss_pred             CCCCC-CeeeccccccccCCCCCC
Q 043586          375 HADSS-NRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       375 ~~~~~-~~~~~~gt~~y~APE~~l  397 (397)
                      +.+.. ..+..+-|.+|.|||+++
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLM  230 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLM  230 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhh
Confidence            55443 234456788999999864

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=8.6e-25  Score=208.90  Aligned_cols=169  Identities=24%  Similarity=0.429  Sum_probs=141.8

Q ss_pred             CCccceeecCCcccEEEEEcC--CC--cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP--NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ....+.||+|+||+|++|.|.  +|  ..||||.++......  ...+|.+|+.+|.+++|||++++||...+ ....+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            345577999999999999875  34  368999998876553  35899999999999999999999999887 668899


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||.++.|+|.+.++. .....+.......++.|||.||.||.   +++.|||||...|+++...-.+||+|||+.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 34456778888999999999999999   67999999999999999999999999999998876


Q ss_pred             CCCCeeec---cccccccCCCCC
Q 043586          377 DSSNRTLL---AGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~---~gt~~y~APE~~  396 (397)
                      ......+.   --...|.|||.+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsL  287 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESL  287 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHh
Confidence            55543221   123469999965

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.91  E-value=3.9e-24  Score=202.48  Aligned_cols=168  Identities=27%  Similarity=0.363  Sum_probs=139.6

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE---
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC---  292 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  292 (397)
                      ..++|++...||+|++|.||+|+.. +++.||+|++....... ...+.+.+|+.+++.++|||++++++++...+.   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4578999999999999999999875 57899999987543222 223567789999999999999999998876554   


Q ss_pred             ---eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          293 ---MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       293 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                         .++|+||+ +++|.+++...    .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999999 66898887642    4788999999999999999999   6699999999999999999999999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++......   .....+++.|+|||.+
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~  187 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPEIM  187 (343)
T ss_pred             cccccccc---ccCCcccccccCHHHH
Confidence            99865433   2234688899999963

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=6.9e-24  Score=211.59  Aligned_cols=169  Identities=23%  Similarity=0.292  Sum_probs=119.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-C----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeE-----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-N----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF-----  286 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-----  286 (397)
                      ..++|++.+.||+|+||.||+|++. +    +..||+|++.......     .+..|  .+....+.++..+...     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4578999999999999999999875 4    6899999876533211     11111  1111122222222211     


Q ss_pred             -EeeCCEeeEEEeeccCCCchhhcccCCCc-----------------cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043586          287 -CLHRKCMFLIYEYMERGSLFCNLHNNEDA-----------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  348 (397)
Q Consensus       287 -~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  348 (397)
                       .......++||||+.+++|.+++......                 .......+..++.|++.||+|||   +++|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence             23456799999999999999888643211                 01122345679999999999999   6699999


Q ss_pred             CCCCCCEEeCC-CCCeEEeccccccccCCCCC-CeeeccccccccCCCC
Q 043586          349 DISSNNILLNS-KFEAFVADFGTARLLHADSS-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       349 dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~-~~~~~~gt~~y~APE~  395 (397)
                      ||||+|||++. ++.+||+|||+|+.+..... ......||+.|||||.
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~  328 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ  328 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHH
Confidence            99999999985 68999999999986643322 2344679999999995

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.90  E-value=5.6e-24  Score=201.35  Aligned_cols=167  Identities=26%  Similarity=0.370  Sum_probs=134.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-------  290 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  290 (397)
                      .+|++.+.||+|+||.||+|... +++.||+|++......   ..+.+.+|+++++.++||||+++++++...       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~---~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCc---hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            57899999999999999999764 6889999998765432   235677899999999999999999876543       


Q ss_pred             -------CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCC
Q 043586          291 -------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFE  362 (397)
Q Consensus       291 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~  362 (397)
                             ...|+||||++ ++|.+++...    .+++..+..++.|++.||.|||   +.+++||||||+||+++. ++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~  153 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLV  153 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCce
Confidence                   35789999997 5887777532    3788899999999999999999   569999999999999984 567


Q ss_pred             eEEeccccccccCCCCC---CeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      +|++|||.++.......   ......|+..|+|||++
T Consensus       154 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  190 (342)
T cd07854         154 LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL  190 (342)
T ss_pred             EEECCcccceecCCccccccccccccccccccCHHHH
Confidence            89999999986533211   11223578899999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.90  E-value=1.6e-23  Score=187.75  Aligned_cols=150  Identities=23%  Similarity=0.253  Sum_probs=124.8

Q ss_pred             CCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCchhh
Q 043586          230 GGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCN  308 (397)
Q Consensus       230 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~  308 (397)
                      |.+|.||++++. +++.||+|.++....        +.+|...+....||||+++++++...+..++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999864 688999999976432        22344555556799999999999999999999999999999998


Q ss_pred             cccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeeccccc
Q 043586          309 LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY  388 (397)
Q Consensus       309 l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~  388 (397)
                      +....   .+++..+..++.|++.||+|||   +++++||||||+||+++.++.++++|||.+.......   ....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---DGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc---ccCCcCc
Confidence            86542   3788999999999999999999   6699999999999999999999999999887654322   2234677


Q ss_pred             cccCCCCC
Q 043586          389 GYIAPGLP  396 (397)
Q Consensus       389 ~y~APE~~  396 (397)
                      .|+|||+.
T Consensus       147 ~y~aPE~~  154 (237)
T cd05576         147 MYCAPEVG  154 (237)
T ss_pred             cccCCccc
Confidence            89999974

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.90  E-value=4.1e-24  Score=191.82  Aligned_cols=179  Identities=23%  Similarity=0.314  Sum_probs=144.3

Q ss_pred             CcccHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--C----C
Q 043586          207 GRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--R----N  279 (397)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~----n  279 (397)
                      |...++.-...+++|.+...+|+|.||.|-.+.+. .+..||+|+++.-...    .+...-|+++++++.+  |    -
T Consensus        77 GH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY----reAa~iEi~vLqki~~~DP~g~~r  152 (415)
T KOG0671|consen   77 GHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY----REAALIEIEVLQKINESDPNGKFR  152 (415)
T ss_pred             ceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH----hhHHHHHHHHHHHHHhcCCCCceE
Confidence            33333333344788999999999999999999754 4789999999865443    3556679999999942  2    3


Q ss_pred             ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       280 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      ++++.+||...++.++|+|.+ |-++.+++..+.. .+++..++..|++|++++++|||   +.+++|-||||+|||+-+
T Consensus       153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVS  227 (415)
T ss_pred             EEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEec
Confidence            788899999999999999998 6699999987543 46889999999999999999999   779999999999999832


Q ss_pred             --------------------CCCeEEeccccccccCCCCCCeeeccccccccCCCCCC
Q 043586          360 --------------------KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       360 --------------------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                                          ...+|++|||.|+.-....   +..+.|..|.|||++|
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViL  282 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVIL  282 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchhee
Confidence                                1347899999998754433   4467899999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.90  E-value=8.6e-23  Score=176.46  Aligned_cols=145  Identities=21%  Similarity=0.289  Sum_probs=112.3

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchH-----------------------HHHHHHHHHHHHHHHhhcccCCc
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----------------------ELAFIKSFRNEAQVLSQVLHRNI  280 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~~~E~~~l~~l~h~ni  280 (397)
                      ...||+|++|.||+|+..+|+.||||+++.....                       .......+.+|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999878999999999865211                       00012334679999999999988


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhh-cccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      .....+....  .++||||++|+++... +..    ..++..+...++.|++.++.++|+  ..||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence            6555443332  4899999998765433 322    235677889999999999999994  15999999999999999 


Q ss_pred             CCCeEEeccccccccCCC
Q 043586          360 KFEAFVADFGTARLLHAD  377 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~  377 (397)
                      ++.++|+|||+|+.....
T Consensus       153 ~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         153 DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             CCCEEEEEcccceecCCC
Confidence            899999999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.88  E-value=2.2e-23  Score=203.32  Aligned_cols=162  Identities=27%  Similarity=0.387  Sum_probs=130.3

Q ss_pred             cceeecCCcc-cEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEeecc
Q 043586          224 KYCIGTGGYG-SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       224 ~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      .+.+|.|+.| .||+|.+. ++.||||++-....      ....+|+..|+.. +||||+++++.-.++.+.|+..|.|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~------~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF------DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH------HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            4568899886 68999884 78999998876543      3456899999999 59999999999999999999999996


Q ss_pred             CCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---C--CCeEEeccccccccC
Q 043586          302 RGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---K--FEAFVADFGTARLLH  375 (397)
Q Consensus       302 ~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~DFG~a~~~~  375 (397)
                       .+|.+++... ........-..+.+..|+++||++||   +.+||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence             5999999874 11111111345778999999999999   679999999999999975   3  478999999999987


Q ss_pred             CCCCC---eeeccccccccCCCCC
Q 043586          376 ADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      .+.+.   .....||-+|+|||++
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L  686 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQL  686 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHH
Confidence            66543   2345699999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.88  E-value=1.2e-23  Score=176.64  Aligned_cols=164  Identities=22%  Similarity=0.363  Sum_probs=137.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCC--E
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK--C  292 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  292 (397)
                      ..++|++.+++|+|.++.||.|.. .+.+.++||++++...      +.+.+|+.+|..++ ||||+++++...++.  .
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            356899999999999999999974 5678899999987653      56778999999997 999999999988754  5


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEeccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTA  371 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG~a  371 (397)
                      ..+++||+++.+...+..      .++...+..++.++++||.|+|   +.||+|||+||.|+++|.. -..+|+|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchH
Confidence            779999999877755443      2566778889999999999999   7799999999999999964 57899999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .++.++.... ..+.+..|--||++
T Consensus       181 EFYHp~~eYn-VRVASRyfKGPELL  204 (338)
T KOG0668|consen  181 EFYHPGKEYN-VRVASRYFKGPELL  204 (338)
T ss_pred             hhcCCCceee-eeeehhhcCCchhe
Confidence            9987765543 34577888999986

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=5.2e-22  Score=175.77  Aligned_cols=169  Identities=35%  Similarity=0.543  Sum_probs=143.1

Q ss_pred             CCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |.+.+.||+|++|.||++...+ ++.+|+|.+......  ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5667889999999999998764 889999999876543  1246788999999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC-
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS-  378 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  378 (397)
                      +++++|.+++......  +++.....++.+++.++.|||   ..+++|+|++|+||+++.++.++|+|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            9999999988754321  678889999999999999999   5699999999999999999999999999998775442 


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......++..|++||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~  171 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVL  171 (225)
T ss_pred             ccccceeccCCcCCHhHh
Confidence            122334678899999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.3e-22  Score=202.58  Aligned_cols=178  Identities=29%  Similarity=0.404  Sum_probs=144.6

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCcccee
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLY  284 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  284 (397)
                      ++...++..+.+.+|+|.||.|++|...        ....||||.++......  ..+.+..|+++|+.+ +||||+.++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~--~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSS--EKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcH--HHHHHHHHHHHHHHhcCCcchhhhe
Confidence            4444555667779999999999999632        14579999998766552  247899999999999 599999999


Q ss_pred             eEEeeCCEeeEEEeeccCCCchhhcccCC-----C------c--cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043586          285 GFCLHRKCMFLIYEYMERGSLFCNLHNNE-----D------A--VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  351 (397)
Q Consensus       285 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~------~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  351 (397)
                      |+|..++..++|+||+..|+|.++++..+     .      .  ..++..+.+.++.|||.|++||+   +.++|||||.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhh
Confidence            99999999999999999999999998655     0      0  13778899999999999999999   6689999999


Q ss_pred             CCCEEeCCCCCeEEeccccccccCCCCCCe-eecccc--ccccCCCCC
Q 043586          352 SNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGT--YGYIAPGLP  396 (397)
Q Consensus       352 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~-~~~~gt--~~y~APE~~  396 (397)
                      .+|||+..+..+||+|||+|+......... +...|+  ..|||||.+
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl  493 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESL  493 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHh
Confidence            999999999999999999999665544433 222232  249999964

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.87  E-value=1.4e-21  Score=170.53  Aligned_cols=163  Identities=37%  Similarity=0.608  Sum_probs=138.4

Q ss_pred             eecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCc
Q 043586          227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      ||+|++|.||++...+ ++.+++|++.......  ..+.+.+|++.++.++|++++++++++......++++||+.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998754 8999999998765432  236788999999999999999999999999999999999999999


Q ss_pred             hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEeccccccccCCCCCCeeec
Q 043586          306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLLHADSSNRTLL  384 (397)
Q Consensus       306 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~~~~~~~~~~~~  384 (397)
                      .+++....  ..+++..+..++.++++++.+||   ..+++|+||+|.||+++. ++.++|+|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99887542  24788899999999999999999   569999999999999999 8999999999998765443222334


Q ss_pred             cccccccCCCCC
Q 043586          385 AGTYGYIAPGLP  396 (397)
Q Consensus       385 ~gt~~y~APE~~  396 (397)
                      .++..|++||..
T Consensus       154 ~~~~~~~~pe~~  165 (215)
T cd00180         154 VGTPAYMAPEVL  165 (215)
T ss_pred             cCCCCccChhHh
Confidence            578899999963

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-22  Score=193.74  Aligned_cols=163  Identities=25%  Similarity=0.361  Sum_probs=136.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      +++.|.+...+|.|+|+.|-.+.. .+++..++|++.....       +-.+|+.++... +||||+++.+.+.++...|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence            477899999999999999999975 4678899999987632       233577776666 6999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe-CCCCCeEEeccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL-NSKFEAFVADFGTARL  373 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~DFG~a~~  373 (397)
                      +|||++.|+-+.+.+...+.   .. .++..|+.+|+.|+.|||   .+|+||||+||+|||+ +..+.++|+|||.++.
T Consensus       393 ~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            99999999999887765432   22 677789999999999999   5699999999999999 5899999999999997


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ....   ....+-|..|.|||++
T Consensus       466 ~~~~---~~tp~~t~~y~APEvl  485 (612)
T KOG0603|consen  466 LERS---CDTPALTLQYVAPEVL  485 (612)
T ss_pred             Cchh---hcccchhhcccChhhh
Confidence            7654   2223568899999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.9e-22  Score=173.45  Aligned_cols=167  Identities=22%  Similarity=0.377  Sum_probs=132.0

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceee-EEeeCCE
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYG-FCLHRKC  292 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~  292 (397)
                      ...+.|.+.+.+|+|.||.+-.++++ +...+|+|.+......    .++|.+|...--.+ .|.||+.-++ .|+..+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~   96 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA   96 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence            34457889999999999999999876 5678899988776544    36788888765555 4899998766 5777888


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC--CCCCeEEecccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKFEAFVADFGT  370 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DFG~  370 (397)
                      ..+++||++.|+|.+-+...    .+.+....+++.|+++|++|||   +..+||||||.+|||+-  +..++||||||.
T Consensus        97 YvF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~  169 (378)
T KOG1345|consen   97 YVFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGL  169 (378)
T ss_pred             EEEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeeccc
Confidence            88999999999998777542    4677888999999999999999   77999999999999993  456899999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++.....-..   .--+..|.|||+.
T Consensus       170 t~k~g~tV~~---~~~~~~y~~pe~~  192 (378)
T KOG1345|consen  170 TRKVGTTVKY---LEYVNNYHAPELC  192 (378)
T ss_pred             ccccCceehh---hhhhcccCCcHHH
Confidence            9865432221   2245568888863

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.86  E-value=2.7e-21  Score=172.91  Aligned_cols=157  Identities=33%  Similarity=0.509  Sum_probs=134.5

Q ss_pred             CcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCchhhc
Q 043586          231 GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL  309 (397)
Q Consensus       231 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l  309 (397)
                      +||.||+|... +++.+|+|++........  .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999876 489999999987654322  368889999999999999999999999999999999999999999988


Q ss_pred             ccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeecccccc
Q 043586          310 HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYG  389 (397)
Q Consensus       310 ~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~  389 (397)
                      .....   +++..+..++.+++.++.|||   ..+++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus        79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRGR---LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             HhccC---CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            75432   788899999999999999999   5699999999999999999999999999998765442 2234568899


Q ss_pred             ccCCCCC
Q 043586          390 YIAPGLP  396 (397)
Q Consensus       390 y~APE~~  396 (397)
                      |+|||..
T Consensus       152 ~~~pE~~  158 (244)
T smart00220      152 YMAPEVL  158 (244)
T ss_pred             CCCHHHH
Confidence            9999963

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.86  E-value=2.1e-22  Score=177.02  Aligned_cols=167  Identities=31%  Similarity=0.341  Sum_probs=133.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  291 (397)
                      .+|.-...+|.|.- .|..+.+. .++.||+|+....... ....++..+|..++..+.|+||++++.++.-..      
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            35666677888877 55555432 5789999988665322 222356678999999999999999999987543      


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+|||+|. .+|.+.+..     +++......|..|++.|+.|||   +.||+||||||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence            5899999996 588887762     4677889999999999999999   679999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      +.-..+ -..+..+.|..|.|||+++
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil  190 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVIL  190 (369)
T ss_pred             cccCcc-cccCchhheeeccCchhee
Confidence            865444 2334567899999999975

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=7e-22  Score=183.49  Aligned_cols=181  Identities=22%  Similarity=0.269  Sum_probs=149.1

Q ss_pred             CcccHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc------cCC
Q 043586          207 GRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL------HRN  279 (397)
Q Consensus       207 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~n  279 (397)
                      |.+.+.-.+....+|.+....|+|-|+.|.+|++. .|..||||+|+......    +.=.+|+++|+++.      --|
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~H  495 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFH  495 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhH
Confidence            33333334445678999999999999999999864 57899999999877654    34456999999996      248


Q ss_pred             ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       280 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      +++++..|...+++|+|+|-+. .+|.+.++..+....+....+..++.|+.-||..|-   ..+|+|.||||+|||+++
T Consensus       496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE  571 (752)
T KOG0670|consen  496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNE  571 (752)
T ss_pred             HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEecc
Confidence            9999999999999999999984 699999998887778889999999999999999999   669999999999999986


Q ss_pred             C-CCeEEeccccccccCCCCCCeeeccccccccCCCCCC
Q 043586          360 K-FEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       360 ~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~l  397 (397)
                      . ..+||||||.|........  +...-+..|.|||++|
T Consensus       572 ~k~iLKLCDfGSA~~~~enei--tPYLVSRFYRaPEIiL  608 (752)
T KOG0670|consen  572 SKNILKLCDFGSASFASENEI--TPYLVSRFYRAPEIIL  608 (752)
T ss_pred             CcceeeeccCccccccccccc--cHHHHHHhccCcceee
Confidence            4 6789999999987654332  3334566799999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=2.3e-20  Score=162.80  Aligned_cols=157  Identities=15%  Similarity=0.173  Sum_probs=124.5

Q ss_pred             ccCCcccHHHHHH--HhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHH------HHHHHHHHhhc
Q 043586          204 NYDGRIVYEDLIE--ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS------FRNEAQVLSQV  275 (397)
Q Consensus       204 ~~~~~~~~~~~~~--~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l  275 (397)
                      -.+....|.++..  ..++|.+.+.+|+|+||.||.+.. ++..+|+|.++......+.....      +.+|++.+.++
T Consensus        14 ~~~~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL   92 (232)
T PRK10359         14 YKDNDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV   92 (232)
T ss_pred             ecCCcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH
Confidence            3344555555543  367899999999999999999866 56789999998765554444344      67999999999


Q ss_pred             ccCCccceeeEEeeC--------CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 043586          276 LHRNIVKLYGFCLHR--------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIH  347 (397)
Q Consensus       276 ~h~niv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  347 (397)
                      .||+|..+.+++...        +..++||||++|.+|.++..       ++.    ....+++.++..+|   ..|++|
T Consensus        93 ~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H  158 (232)
T PRK10359         93 RSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVS  158 (232)
T ss_pred             HHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCcc
Confidence            999999999987643        35789999999999977631       222    24669999999999   669999


Q ss_pred             cCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          348 RDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       348 ~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+||+||+++.+| ++++|||..+....
T Consensus       159 ~Dikp~Nili~~~g-i~liDfg~~~~~~e  186 (232)
T PRK10359        159 GDPHKGNFIVSKNG-LRIIDLSGKRCTAQ  186 (232)
T ss_pred             CCCChHHEEEeCCC-EEEEECCCcccccc
Confidence            99999999999998 99999998876543

>PRK10345 hypothetical protein; Provisional

Probab=99.84  E-value=2.1e-20  Score=162.54  Aligned_cols=137  Identities=18%  Similarity=0.221  Sum_probs=104.3

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-----ccCCccceeeEEeeCC---E-e
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-----LHRNIVKLYGFCLHRK---C-M  293 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~  293 (397)
                      -...||+|+||.||. .-.++.. +||++.......   .+.+.+|+++++.+     .||||++++|+++++.   . .
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~---~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGG---DKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcCe-EEEEEeccccch---HHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            346799999999996 3334444 799887643322   35788999999999     5799999999999863   4 3


Q ss_pred             eEEEee--ccCCCchhhcccCCCccccChHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCEEeCC----CCCeEEe
Q 043586          294 FLIYEY--MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL-AYLHHDCSPSIIHRDISSNNILLNS----KFEAFVA  366 (397)
Q Consensus       294 ~lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlkp~NIll~~----~~~~kl~  366 (397)
                      .+||||  +.+++|.+++.+.    .+++.  ..++.+++.++ +|||   +++|+||||||+|||++.    ++.++|+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            378999  5579999999653    24444  35678888777 9999   669999999999999974    3479999


Q ss_pred             c-cccccc
Q 043586          367 D-FGTARL  373 (397)
Q Consensus       367 D-FG~a~~  373 (397)
                      | ||....
T Consensus       152 Dg~G~~~~  159 (210)
T PRK10345        152 DNIGESTF  159 (210)
T ss_pred             ECCCCcce
Confidence            9 555443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=9.4e-21  Score=160.49  Aligned_cols=165  Identities=19%  Similarity=0.310  Sum_probs=133.6

Q ss_pred             hcCCCccceeecCCcccEEEEE-cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc-CCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l  295 (397)
                      ...|.++++||.|+||.+|.|. ..+|..||||.-......     -++..|.++...+++ ..|..+..+..+..+-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            4579999999999999999996 458999999987654432     356679999999975 678888888888889999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~  372 (397)
                      |||.+ |.+|.++..--  ...++..+++.++.|++.-++|+|   .++++||||||+|+|..-   ...+.++|||+|+
T Consensus        89 VMdLL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eeecc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchh
Confidence            99998 77888776532  224788899999999999999999   568999999999999863   3567899999999


Q ss_pred             ccCCCCCC-------eeeccccccccCC
Q 043586          373 LLHADSSN-------RTLLAGTYGYIAP  393 (397)
Q Consensus       373 ~~~~~~~~-------~~~~~gt~~y~AP  393 (397)
                      .+.+..+.       .+...||..|++-
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhh
Confidence            87653322       2345799999763

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.84  E-value=2.6e-21  Score=176.06  Aligned_cols=148  Identities=28%  Similarity=0.402  Sum_probs=127.6

Q ss_pred             HHHHHHHhcCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceee
Q 043586          211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYG  285 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~  285 (397)
                      +++.....+.|...++||+|+|+.||++...    ..+.||+|.+......     .+..+|+++|..+. +.||+.+.+
T Consensus        28 ~q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~  102 (418)
T KOG1167|consen   28 RQDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNG  102 (418)
T ss_pred             HhhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchh
Confidence            3445566778999999999999999999643    4678999999876654     45778999999995 999999999


Q ss_pred             EEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeE
Q 043586          286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAF  364 (397)
Q Consensus       286 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~k  364 (397)
                      ++..++...+|+||++.....++...      ++..++..+++.+..||.++|   .+|||||||||+|++.+. .+.-.
T Consensus       103 ~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~  173 (418)
T KOG1167|consen  103 CFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGV  173 (418)
T ss_pred             hhccCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCce
Confidence            99999999999999998877776653      567888999999999999999   779999999999999984 57778


Q ss_pred             Eecccccc
Q 043586          365 VADFGTAR  372 (397)
Q Consensus       365 l~DFG~a~  372 (397)
                      |+|||+|.
T Consensus       174 LvDFgLA~  181 (418)
T KOG1167|consen  174 LVDFGLAQ  181 (418)
T ss_pred             EEechhHH
Confidence            99999997

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=6e-20  Score=163.53  Aligned_cols=148  Identities=20%  Similarity=0.215  Sum_probs=113.2

Q ss_pred             cCCCccceeecCCcccEEEEE--cCCCcEEEEEEecccchH---------------------HHHHHHHHHHHHHHHhhc
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETE---------------------ELAFIKSFRNEAQVLSQV  275 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l  275 (397)
                      ..|++.+.||+|++|.||+|.  ..+|+.||+|+++.....                     .......+.+|++.+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358889999999999999998  568999999998754311                     001123467899999999


Q ss_pred             ccCC--ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCC
Q 043586          276 LHRN--IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS-IIHRDISS  352 (397)
Q Consensus       276 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlkp  352 (397)
                      .+..  +.+++++    ...++||||++++++........   .....++..++.|++.++.+||   ..+ ++||||||
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            7633  3444443    23589999999988876543221   2445567789999999999999   568 99999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      +||+++ ++.++|+|||.|.....+
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccCCc
Confidence            999999 889999999999865543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=4.1e-20  Score=157.90  Aligned_cols=137  Identities=17%  Similarity=0.156  Sum_probs=107.5

Q ss_pred             CccceeecCCcccEEEEEcCCCcEEEEEEecccchHHH-HHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEee
Q 043586          222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL-AFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      .+...+++|+||+||.+.. .+..++.+.+........ .....+.+|+++|+++. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3557799999999998876 577788777766554321 11235789999999995 5889999886    346899999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEeCCCCCeEEeccccccccCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI-SSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +.|.+|.+....          ....++.|++.++.++|   ..||+|||| ||+|||++.++.++|+|||+|.....
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~  144 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP  144 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence            999888643311          11347789999999999   669999999 79999999999999999999986543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=2.4e-20  Score=164.92  Aligned_cols=163  Identities=21%  Similarity=0.309  Sum_probs=134.1

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .|.++++||+|+||+++.|+. -+++.||||.-......     -++..|.+.++.+. .++|..++-+...+.+-.+||
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            699999999999999999974 47899999975543322     34667888888885 689999999999988889999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-----CCeEEecccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-----FEAFVADFGTAR  372 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~DFG~a~  372 (397)
                      |.+ |.+|.|+..--++  .++..++..+|.|++.-++|+|   ++..|.|||||+|+||..-     ..+.++|||+|+
T Consensus       104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            998 7788887764433  4889999999999999999999   6689999999999999743     457899999999


Q ss_pred             ccCCCCCC-------eeeccccccccCC
Q 043586          373 LLHADSSN-------RTLLAGTYGYIAP  393 (397)
Q Consensus       373 ~~~~~~~~-------~~~~~gt~~y~AP  393 (397)
                      .+.+..+.       .....||.+||+-
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSI  205 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSI  205 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEe
Confidence            98765442       2456799999973

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.8e-19  Score=158.64  Aligned_cols=138  Identities=20%  Similarity=0.324  Sum_probs=114.5

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccch-----HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      +.||+|++|.||+|++ ++..+++|+......     .......++.+|++++..++|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4689999999999987 567889998654321     1112235678899999999999998888887777888999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ++|++|.+.+...      .+ .+..++.+++.+|.++|   ..+++|+|++|+||+++ ++.++++|||.++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            9999999887542      12 67889999999999999   66999999999999999 789999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.7e-19  Score=156.99  Aligned_cols=147  Identities=19%  Similarity=0.214  Sum_probs=112.1

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHH-------------------HHHHHHHHHHHHHHhh
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-------------------LAFIKSFRNEAQVLSQ  274 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~~~~~~~E~~~l~~  274 (397)
                      +......|.+.+.||+|+||.||++...+|+.||||+++......                   ........+|..++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            333333478889999999999999998889999999876532110                   0011236778999999


Q ss_pred             cccCC--ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          275 VLHRN--IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       275 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      +.|++  +.+.++.    ...++||||++|++|......         .....++.+++.++.++|   ..+++||||||
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAY---KHGIIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCc
Confidence            98874  4444442    345899999999988654321         234568899999999999   56999999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +||+++.++.++|+|||++.....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999976544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.2e-19  Score=170.03  Aligned_cols=168  Identities=26%  Similarity=0.342  Sum_probs=132.6

Q ss_pred             CCCccceeecCCcccEEEEEcCCC--cEEEEEEecccchHHHHHHHHHHHHHHHHhhccc----CCccceeeEE-eeCCE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH----RNIVKLYGFC-LHRKC  292 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~  292 (397)
                      +|.+.+.||+|+||.||.+.....  ..+|+|..........   ..+..|..++..+..    +++..+++.+ ....+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999986543  4788887765432211   145668888888863    6899999999 57888


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-----CCeEEec
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-----FEAFVAD  367 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-----~~~kl~D  367 (397)
                      .|+||+.+ |.+|.++..... ...++..++..|+.|++.+|+++|   +.|++||||||+|+.+...     ..+.+.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99999988 789999776554 446899999999999999999999   6799999999999999865     4689999


Q ss_pred             ccccc--ccCCCC--------CCeeeccccccccCCCC
Q 043586          368 FGTAR--LLHADS--------SNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       368 FG~a~--~~~~~~--------~~~~~~~gt~~y~APE~  395 (397)
                      ||+|+  .+....        .....+.||..|++++.
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~  208 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINV  208 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHH
Confidence            99999  432211        11234569999998763

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=3.4e-19  Score=177.95  Aligned_cols=144  Identities=19%  Similarity=0.267  Sum_probs=114.0

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEe-ccc----chHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKL-HTS----ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~----~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      .....|...+.||+|+||.||+|.+.+.. +++|+. ...    ........+++.+|+++++.++|++++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            33445567889999999999999876544 333432 211    111222346788999999999999999888888777


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...++||||+++++|.+++.           ....++.++++++.|||   +.+++|||+||+||++ .++.++|+|||+
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            78899999999999987764           34668999999999999   6699999999999999 678999999999


Q ss_pred             ccccC
Q 043586          371 ARLLH  375 (397)
Q Consensus       371 a~~~~  375 (397)
                      ++...
T Consensus       474 a~~~~  478 (535)
T PRK09605        474 GKYSD  478 (535)
T ss_pred             cccCC
Confidence            98754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=8.2e-19  Score=152.91  Aligned_cols=134  Identities=19%  Similarity=0.330  Sum_probs=108.2

Q ss_pred             eecCCcccEEEEEcCCCcEEEEEEecccch-----HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          227 IGTGGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      ||+|++|.||+|.+ ++..+++|.......     +.....+++.+|++++..++|+++.....++......++||||++
T Consensus         2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            79999999999986 567889998654321     112223677889999999999887666666666777899999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      |++|.+.+....       .   .++.+++.+|.++|   ..+++|+|++|+||+++ ++.++++|||+++...
T Consensus        81 g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~  140 (199)
T TIGR03724        81 GKPLKDVIEEGN-------D---ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD  140 (199)
T ss_pred             CccHHHHHhhcH-------H---HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence            999988765321       0   68999999999999   66999999999999999 8899999999988643

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.79  E-value=1e-18  Score=162.99  Aligned_cols=171  Identities=36%  Similarity=0.511  Sum_probs=142.0

Q ss_pred             CCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccC-CccceeeEEeeCCEeeEEEee
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  299 (397)
                      |.+...+|.|+||.||++...  ..+++|.+.............+.+|+.+++.+.|+ +++++.+.+......+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999876  78899998876554433457889999999999988 799999999877788999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccccCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLHADS  378 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~~~~~~  378 (397)
                      +.++++.+.+........++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966654321124778889999999999999999   56899999999999999988 79999999998654433


Q ss_pred             C------CeeeccccccccCCCCC
Q 043586          379 S------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~------~~~~~~gt~~y~APE~~  396 (397)
                      .      ......||..|+|||.+
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~  180 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVL  180 (384)
T ss_pred             ccccccccccccccccccCCHHHh
Confidence            2      23456799999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=9.8e-19  Score=161.73  Aligned_cols=134  Identities=24%  Similarity=0.428  Sum_probs=113.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-----c---CCccceeeEEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----H---RNIVKLYGFCLH  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~  289 (397)
                      .+|.+.++||-|-|++||.|.+. +.+.||+|+.+....    +.+....|+++|++++     |   .+||++++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh----YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH----YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH----HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            67899999999999999999865 567899999876543    3466778999999995     2   379999999975


Q ss_pred             ----CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          290 ----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       290 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                          +.+++||+|++ |.+|..+|.+... ..++...++.|++||+.||.|||.+|  ||+|.||||+|||+..+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence                45799999999 7899998886543 35889999999999999999999976  99999999999999644

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.77  E-value=3.3e-18  Score=147.52  Aligned_cols=141  Identities=20%  Similarity=0.229  Sum_probs=101.1

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHH---------------------HHHHHHHHHhhcccCC--c
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------------------SFRNEAQVLSQVLHRN--I  280 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~h~n--i  280 (397)
                      .+.||+|+||.||+|...+++.||||+++...........                     ....|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998764322111111                     1135666677765443  4


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhh-cccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCN-LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      .+.+++    ...++||||++++++... +....    .. .++..++.+++.++.++|.  ..+|+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence            444443    235899999998654321 11110    11 5577899999999999994  16999999999999999 


Q ss_pred             CCCeEEeccccccccCC
Q 043586          360 KFEAFVADFGTARLLHA  376 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~  376 (397)
                      ++.++++|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            89999999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.76  E-value=6.7e-18  Score=139.87  Aligned_cols=136  Identities=19%  Similarity=0.151  Sum_probs=113.7

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--CCccceeeEEeeCCEeeEEEeec
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      +.+.+|+|.++.||++...+ ..+++|.......     ...+.+|+..+..++|  +++++++++....+..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            35679999999999999754 7899999876543     2467889999999987  58999999988888899999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +++.+...          +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||.++..
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            98777543          34556678999999999999654468999999999999999999999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.75  E-value=1.9e-18  Score=155.86  Aligned_cols=180  Identities=16%  Similarity=0.262  Sum_probs=140.9

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG  285 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  285 (397)
                      .++....++++....+-+|.||.||+|.|.      +.+.|-+|.++....+-  ....+..|...+..+.|||+.++.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~i--Qv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQI--QVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHH--HHHHHHHHHHHHhcCcCCCccceeE
Confidence            455555667888888899999999999654      34556778777655442  2467888999999999999999999


Q ss_pred             EEee-CCEeeEEEeeccCCCchhhcc-----cCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          286 FCLH-RKCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       286 ~~~~-~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      ++.+ ....++.+.++.-|+|..++.     .......++..+.+.++.|++.|++|||   +.++||.||...|.++|+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            8876 456788899999999999987     3333445777888999999999999999   779999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          360 KFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ...+||+|-.+++.+.+.....  ...-....||+||.+
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal  470 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEAL  470 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHH
Confidence            9999999999999765543211  011124469999854

>PLN03150 hypothetical protein; Provisional

Probab=99.71  E-value=2e-17  Score=167.09  Aligned_cols=119  Identities=35%  Similarity=0.561  Sum_probs=107.4

Q ss_pred             CCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccC
Q 043586           32 LSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS  111 (397)
Q Consensus        32 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~  111 (397)
                      ++.|+|++|.++|.+|..+..+++|+.|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            78899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCCCCCCCcccc-cccceeccCCCCCcCCCCcCCCCCCC
Q 043586          112 NKLSGPVPFSNEQL-SSMYIVRLSPNKGLCGNFSALPSCDA  151 (397)
Q Consensus       112 n~l~~~~~~~~~~l-~~l~~l~l~~n~~~c~~~~~~~~~~~  151 (397)
                      |+++|.+|..+..+ .++..+++.+|..+|+.+ .++.|..
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~~  539 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACGP  539 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCCC-CCCCCcc
Confidence            99999999887653 456778999999999854 4566754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.1e-16  Score=141.02  Aligned_cols=139  Identities=20%  Similarity=0.272  Sum_probs=105.3

Q ss_pred             ceee-cCCcccEEEEEcCCCcEEEEEEecccch----------HHHHHHHHHHHHHHHHhhcccCCc--cceeeEEeeCC
Q 043586          225 YCIG-TGGYGSVYKAQLPNGKVFALKKLHTSET----------EELAFIKSFRNEAQVLSQVLHRNI--VKLYGFCLHRK  291 (397)
Q Consensus       225 ~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  291 (397)
                      ..|| .|+.|+||.++.. +..+++|.+.....          .......++.+|++++.+++|+++  ++.+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4587 8899999999875 67889998854221          001123567889999999998885  66777654322


Q ss_pred             ----EeeEEEeeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          292 ----CMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       292 ----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                          ..++||||++| .+|.+++...    .++..    .+.+++.++.+||   ..||+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 6888777542    23332    3678999999999   6699999999999999999999999


Q ss_pred             ccccccccC
Q 043586          367 DFGTARLLH  375 (397)
Q Consensus       367 DFG~a~~~~  375 (397)
                      |||.++...
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999998754

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.69  E-value=4.6e-17  Score=174.55  Aligned_cols=132  Identities=41%  Similarity=0.630  Sum_probs=55.9

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++|++|+|++|.+.+.+|..++.+++|++|+|++|.+.+.+|..+..+++|++|+|++|.+++.+|..++++++|+.|+
T Consensus       163 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~  242 (968)
T PLN00113        163 FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLD  242 (968)
T ss_pred             CCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEE
Confidence            34444444444444334444444444444444444444434444444444444444444444444444444444444444


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      +++|.+.+.+|..++.+++|+.|++++|.+++..|..+..+++|+.+++++|
T Consensus       243 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  294 (968)
T PLN00113        243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN  294 (968)
T ss_pred             CcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCC
Confidence            4444444444444444444444444444444444444444444444444443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.67  E-value=3.1e-17  Score=171.57  Aligned_cols=116  Identities=16%  Similarity=0.168  Sum_probs=85.0

Q ss_pred             ccc-CCccceeeEEe-------eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 043586          275 VLH-RNIVKLYGFCL-------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII  346 (397)
Q Consensus       275 l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  346 (397)
                      ++| +||.++++++.       .....+.++||+ +++|.+++....  ..+++.+++.++.||++||.|||   +++|+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            345 57788888772       234577888988 569999997532  34889999999999999999999   67999


Q ss_pred             EcCCCCCCEEeCC-------------------CCCeEEeccccccccCCCC----------------CCeeecccccccc
Q 043586          347 HRDISSNNILLNS-------------------KFEAFVADFGTARLLHADS----------------SNRTLLAGTYGYI  391 (397)
Q Consensus       347 H~dlkp~NIll~~-------------------~~~~kl~DFG~a~~~~~~~----------------~~~~~~~gt~~y~  391 (397)
                      ||||||+|||++.                   ++.+|++|||+++......                .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   4556677777765422100                0011235899999


Q ss_pred             CCCCC
Q 043586          392 APGLP  396 (397)
Q Consensus       392 APE~~  396 (397)
                      |||++
T Consensus       183 APE~~  187 (793)
T PLN00181        183 SPEED  187 (793)
T ss_pred             Chhhh
Confidence            99986

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.64  E-value=1.2e-16  Score=159.49  Aligned_cols=167  Identities=24%  Similarity=0.335  Sum_probs=127.1

Q ss_pred             ccceeecCCcccEEEEEc-CCCcEEEEEEecc---cchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          223 IKYCIGTGGYGSVYKAQL-PNGKVFALKKLHT---SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ....+|.|++|.|+.... ...+.++.|..+.   ...........+..|+.+-..+.|||++..+..+.+....+-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456789999997777753 3344455554431   122222233346778888889999999888887777666666699


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||++ +|..++....   .+...++-.+++|++.|+.|+|   ..||.|||+||+|++++.+|.+||+|||.+..+.-+.
T Consensus       402 ~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 9998887542   3666778889999999999999   6699999999999999999999999999998664433


Q ss_pred             C----CeeeccccccccCCCCC
Q 043586          379 S----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~----~~~~~~gt~~y~APE~~  396 (397)
                      .    .....+|+..|+|||.+
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~  496 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVL  496 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccc
Confidence            3    23456799999999975

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=4.3e-16  Score=159.00  Aligned_cols=166  Identities=27%  Similarity=0.329  Sum_probs=123.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc---cCCccceeeEEeeCCEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~  294 (397)
                      .+.|.+...+|+|+||.||+|...+|+.||+|+-++...++--...      +++.+++   -+-|..+..++...+.-+
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccCCcce
Confidence            4568888899999999999999888999999998876654211111      2223333   244556666667777889


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-------CCCeEEec
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KFEAFVAD  367 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~kl~D  367 (397)
                      +|+||.+.|+|.+++...   ..++|..++.++.|++.-++.||   ..+|||+||||+|.||..       ..-++|+|
T Consensus       771 lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            999999999999999733   35889999999999999999999   569999999999999942       34579999


Q ss_pred             cccccccCC--CCCCeeeccccccccCCCC
Q 043586          368 FGTARLLHA--DSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       368 FG~a~~~~~--~~~~~~~~~gt~~y~APE~  395 (397)
                      ||.+-.+.-  +...-+..++|-.+-.+|+
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM  874 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEM  874 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHH
Confidence            999875532  2222333445555555554

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=3.8e-15  Score=144.24  Aligned_cols=143  Identities=21%  Similarity=0.230  Sum_probs=100.8

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHH-------------------------------HH------HHHHH
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-------------------------------FI------KSFRN  267 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------~~------~~~~~  267 (397)
                      +.||.|++|.||+|+..+|+.||||+.++.......                               ..      -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            679999999999999999999999998765321100                               00      13556


Q ss_pred             HHHHHhhcc-----cCCccceeeEE-eeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHH-HHHHHHhC
Q 043586          268 EAQVLSQVL-----HRNIVKLYGFC-LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH-ALAYLHHD  340 (397)
Q Consensus       268 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~~LH~~  340 (397)
                      |++.+.+++     ++++ .+-..+ ......++||||++|+++.+.......  ..   ....++.+++. .+..+|  
T Consensus       203 Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       203 EAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH--
Confidence            777666664     2332 222222 223457899999999999876643211  11   23456666665 467778  


Q ss_pred             CCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       341 ~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                       ..|++|+|+||.||+++.++.++++|||++..+..
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             56999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.62  E-value=5.8e-17  Score=153.11  Aligned_cols=144  Identities=23%  Similarity=0.215  Sum_probs=120.5

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +-+|+.|+.|||++|.|...-++.+...++|++|+|++|+++...++.|..|.+|++|+|+.|.++..--..|..+++|+
T Consensus       289 lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~  368 (873)
T KOG4194|consen  289 LFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLH  368 (873)
T ss_pred             ccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhh
Confidence            45788899999999999888888888889999999999999888888888888999999999988866667788888899


Q ss_pred             EEEccCcccccCCc---hhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCCcC
Q 043586           82 WLDISNNKIEGSIP---GEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSA  145 (397)
Q Consensus        82 ~L~l~~N~~~~~~p---~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~~~  145 (397)
                      .|||++|.|++.+-   ..|..|++|+.|++.+|++..+.-.+|.++..|+.|+|.+|......+.+
T Consensus       369 ~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nA  435 (873)
T KOG4194|consen  369 KLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNA  435 (873)
T ss_pred             hhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccc
Confidence            99999998887664   34777888889999999988777788888999999999888766555444

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.59  E-value=2.6e-17  Score=132.88  Aligned_cols=131  Identities=29%  Similarity=0.473  Sum_probs=102.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ++.+++.|.|++|+++ .+|..+..+.+|+.|++++|+++ .+|..+++++.|+.|+++-|++. .+|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            4566788888888888 56777888888888888888887 67888888888888888888888 788888888888888


Q ss_pred             EccCccccc-CCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           84 DISNNKIEG-SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        84 ~l~~N~~~~-~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      |+..|.++. .+|..|..|..|+.|++++|.+. .+|...+++++|+++.+..|..
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl  162 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL  162 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence            888877743 46777777777777788888777 4455567777777777777653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.59  E-value=6.9e-17  Score=130.43  Aligned_cols=136  Identities=26%  Similarity=0.417  Sum_probs=119.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCC-CcCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS-GKIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L   80 (397)
                      ++.|.+|++|++++|++. .+|..++.+++|+.|+++-|++. .+|..|++++.|+.|||+.|++. ..+|+.|..++.|
T Consensus        52 ia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tl  129 (264)
T KOG0617|consen   52 IAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTL  129 (264)
T ss_pred             HHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHH
Confidence            467889999999999988 68888999999999999999997 88999999999999999998887 3589999999999


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +.|++++|.+. .+|..++.+.+|+.|.+.+|.+- .+|..++.+++|..+++.+|+....
T Consensus       130 ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vl  188 (264)
T KOG0617|consen  130 RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVL  188 (264)
T ss_pred             HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeec
Confidence            99999999998 68888999999999999999987 5678888899999999999875443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.59  E-value=8.9e-17  Score=153.86  Aligned_cols=159  Identities=26%  Similarity=0.367  Sum_probs=129.3

Q ss_pred             eecCCcccEEEEE----cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEeecc
Q 043586          227 IGTGGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       227 ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      +|+|+||.|+.++    ...+..+|+|+.++......... ....|..++..++ ||.++++...++.+...+++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            6899999999864    23577889998876543222111 4456888899997 9999999999999999999999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR  381 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  381 (397)
                      ||++...+.....   +.......+...++-+++++|   +.+++|||+|++||+++.+|.+++.|||+++..-..... 
T Consensus        81 gg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM---FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            9999887765443   455566667888999999999   779999999999999999999999999999876443322 


Q ss_pred             eeccccccccCCCCC
Q 043586          382 TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 ~~~~gt~~y~APE~~  396 (397)
                         +||..|||||++
T Consensus       154 ---cgt~eymApEI~  165 (612)
T KOG0603|consen  154 ---CGTYEYRAPEII  165 (612)
T ss_pred             ---ccchhhhhhHhh
Confidence               899999999985

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.55  E-value=9e-15  Score=143.33  Aligned_cols=148  Identities=19%  Similarity=0.174  Sum_probs=95.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC-CcEEEEEEecccchHH-------------------------------HHHHH--
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEE-------------------------------LAFIK--  263 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------------~~~~~--  263 (397)
                      -..|+. +.+|+|++|.||+|+..+ |+.||||+.++.....                               .+..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999877 9999999998653110                               01111  


Q ss_pred             ----HHHHHHHHHhhcc----cCCccceeeEEee-CCEeeEEEeeccCCCchhh--cccCC-CccccChHHHHHHHHHHH
Q 043586          264 ----SFRNEAQVLSQVL----HRNIVKLYGFCLH-RKCMFLIYEYMERGSLFCN--LHNNE-DAVELDWAKRVNIVKAMA  331 (397)
Q Consensus       264 ----~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~-~~~~~~~~~~~~i~~~i~  331 (397)
                          ++.+|+..+.+++    +...+.+-.++.+ ....++||||++|+.+.+.  +...+ ....+....+..++.|+.
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif  277 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF  277 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence                2344555555553    3333333333322 3456799999999999764  22211 111122222333333332


Q ss_pred             HHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEeccccccccCC
Q 043586          332 HALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHA  376 (397)
Q Consensus       332 ~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG~a~~~~~  376 (397)
                                ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       278 ----------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ----------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                      34999999999999999888    999999999987654

>PLN03150 hypothetical protein; Provisional

Probab=99.54  E-value=2.7e-14  Score=144.50  Aligned_cols=110  Identities=26%  Similarity=0.414  Sum_probs=102.8

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      .++.|+|++|.+.|.+|..++.+++|+.|+|++|.++|.+|..+..+++|+.|+|++|+++|.+|+.++++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcccccCCchhhccC-CCCceeeccCCcCCC
Q 043586           87 NNKIEGSIPGEITEL-SRLDYLNLSSNKLSG  116 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~-~~L~~l~l~~n~l~~  116 (397)
                      +|.+++.+|..++.+ .++..+++.+|....
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCcccc
Confidence            999999999998764 567889999997543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.51  E-value=3.5e-15  Score=129.00  Aligned_cols=165  Identities=21%  Similarity=0.350  Sum_probs=129.2

Q ss_pred             CCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      ..+..+|.+...|..|+|+|. |..+++|++....... ...++|..|.-.++.+.||||+.+++.|..+....++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            344556888999999999996 4556678877654432 23478999999999999999999999999999999999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe--ccccccccCCCC
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA--DFGTARLLHADS  378 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~--DFG~a~~~~~~~  378 (397)
                      +.|+|...+++... ...+..++++++.++++|++|||+- .+-|.---+.+..+++|++.+++|.  |--++.  .   
T Consensus       270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--q---  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q---  342 (448)
T ss_pred             cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--e---
Confidence            99999999997543 3578889999999999999999975 3445555788999999999998874  322211  1   


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                        .......|.||+||.+
T Consensus       343 --e~gr~y~pawmspeal  358 (448)
T KOG0195|consen  343 --EVGRAYSPAWMSPEAL  358 (448)
T ss_pred             --ccccccCcccCCHHHH
Confidence              1112457889999964

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.49  E-value=2.7e-15  Score=142.03  Aligned_cols=132  Identities=29%  Similarity=0.300  Sum_probs=58.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      .++++|+|..|+++..-.+.+.+|+.|+.||||+|.|+..-++.+.-+.+|.+|+|++|+|+...+++|..+..|++|+|
T Consensus       269 ~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnL  348 (873)
T KOG4194|consen  269 EKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNL  348 (873)
T ss_pred             cccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcc
Confidence            34444444444444333334444444444444444444444444444444444444444444434444444444444444


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCC---CcccccccceeccCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF---SNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~---~~~~l~~l~~l~l~~n~  137 (397)
                      ++|+++..-...|..+++|+.|||++|.++..+.+   .|..+++|..|+|.+|+
T Consensus       349 s~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq  403 (873)
T KOG4194|consen  349 SHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ  403 (873)
T ss_pred             cccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence            44444444344444444444444444444433322   23344444444444443

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.49  E-value=2e-13  Score=115.56  Aligned_cols=131  Identities=21%  Similarity=0.237  Sum_probs=96.0

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc-cceeeEEeeCCEeeEEEeeccCC
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI-VKLYGFCLHRKCMFLIYEYMERG  303 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  303 (397)
                      +.++.|.++.||+++.. ++.|++|........    ...+.+|+.+++.+.+.++ .+++.+..  ...++||||++|.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            56889999999999875 778999997654321    1245679999999876554 44555433  3457999999998


Q ss_pred             CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       304 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ++.+.-        .   ....++.+++++++.||...  ..+++|+|++|.||+++ ++.++++|||.+...
T Consensus        77 ~l~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          77 ELLTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            775430        1   11235678999999999542  12369999999999999 678999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=4.3e-14  Score=128.40  Aligned_cols=113  Identities=27%  Similarity=0.392  Sum_probs=83.8

Q ss_pred             ccCCccceeeEEee---------------------------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHH
Q 043586          276 LHRNIVKLYGFCLH---------------------------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK  328 (397)
Q Consensus       276 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~  328 (397)
                      +|||||++.++|.+                           +...|+||.-.+ .+|.+++..+.    .+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence            49999999987742                           235899999885 48888887653    34556677899


Q ss_pred             HHHHHHHHHHhCCCCCeEEcCCCCCCEEe--CCCC--CeEEeccccccccCCC------CCCeeeccccccccCCCCC
Q 043586          329 AMAHALAYLHHDCSPSIIHRDISSNNILL--NSKF--EAFVADFGTARLLHAD------SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       329 ~i~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~--~~kl~DFG~a~~~~~~------~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++|+.|||   .+||.|||+|++|||+  |+|+  ...|+|||.+---+..      .+..-...|...-||||+.
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            9999999999   6799999999999999  4444  4578999987532210      0111224578889999974

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.43  E-value=2.8e-14  Score=136.20  Aligned_cols=131  Identities=37%  Similarity=0.485  Sum_probs=82.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCch-hhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPN-ELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .|..|+.||||+|+|. ..|..+..-.++-.|+||+|+|. .+|. -|-+++-|-+||||+|++. .+|+.+.++..|++
T Consensus       101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt  177 (1255)
T KOG0444|consen  101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT  177 (1255)
T ss_pred             ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence            4555666666666666 56666666666666666666665 3443 3446666777777777776 56666666666666


Q ss_pred             EEccCccccc-------------------------CCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           83 LDISNNKIEG-------------------------SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        83 L~l~~N~~~~-------------------------~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |.|++|++..                         .+|.++..+.+|..+|+|.|.+. .+|.++-.+.+|..|+||+|.
T Consensus       178 L~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~  256 (1255)
T KOG0444|consen  178 LKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNK  256 (1255)
T ss_pred             hhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCc
Confidence            6666666532                         23455555566666666666666 456666666666666666665


Q ss_pred             C
Q 043586          138 G  138 (397)
Q Consensus       138 ~  138 (397)
                      .
T Consensus       257 i  257 (1255)
T KOG0444|consen  257 I  257 (1255)
T ss_pred             e
Confidence            3

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.42  E-value=2.7e-14  Score=144.04  Aligned_cols=168  Identities=21%  Similarity=0.238  Sum_probs=126.2

Q ss_pred             CCCccceeecCCcccEEEEEcCCCcEEEEEEecccc-hHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|...+.+|.+.|=+|.+|+++.|. |+||++-+.. .......++..+|++ ....+|||.+.+..+-..+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998887 8889886543 222222233344555 666789999999888777888899999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |... +|.|.+..+.   -+...+.+-|+.|++.|+.-+|   ..||+|+|||.+|||++.-.-+.|+||..-+...-+.
T Consensus       102 yvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9964 9999887543   3566677789999999999999   6699999999999999999999999998666432211


Q ss_pred             C---Ceeec----cccccccCCCCC
Q 043586          379 S---NRTLL----AGTYGYIAPGLP  396 (397)
Q Consensus       379 ~---~~~~~----~gt~~y~APE~~  396 (397)
                      .   ..+.+    ..--.|+|||.+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERF  199 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERF  199 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhh
Confidence            1   11111    122359999964

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=5.8e-12  Score=107.78  Aligned_cols=141  Identities=16%  Similarity=0.160  Sum_probs=99.8

Q ss_pred             ceeecCCcccEEEEEcCC-------CcEEEEEEecccch-----------------------HHHHHHHHHHHHHHHHhh
Q 043586          225 YCIGTGGYGSVYKAQLPN-------GKVFALKKLHTSET-----------------------EELAFIKSFRNEAQVLSQ  274 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~  274 (397)
                      ..||.|.-+.||.|...+       +..+|||+.+....                       ..........+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            568999999999997543       47899998864210                       000111123489999999


Q ss_pred             ccc--CCccceeeEEeeCCEeeEEEeeccCCCchh-hcccCCCccccChHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCC
Q 043586          275 VLH--RNIVKLYGFCLHRKCMFLIYEYMERGSLFC-NLHNNEDAVELDWAKRVNIVKAMAHALAYL-HHDCSPSIIHRDI  350 (397)
Q Consensus       275 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl  350 (397)
                      +..  -++.+++++    ...++||||+.+..+.. .++.    ..++..+...+..+++.+|..+ |   ..+++|+|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            964  456667765    45689999997654422 1221    1234455667889999999999 6   559999999


Q ss_pred             CCCCEEeCCCCCeEEeccccccccCCC
Q 043586          351 SSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       351 kp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ++.||+++ ++.+.++|||.+-....+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            99999997 468999999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.41  E-value=5.9e-13  Score=119.98  Aligned_cols=168  Identities=20%  Similarity=0.283  Sum_probs=103.9

Q ss_pred             CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc----------cCCccceeeEEe-
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL----------HRNIVKLYGFCL-  288 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------h~niv~l~~~~~-  288 (397)
                      +.....||.|+++.||.+++. +++.+|+|++...........+++.+|.-....+.          |-.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345678999999999999875 58999999987655444444577777765555532          223333333322 


Q ss_pred             --------eC---C-----EeeEEEeeccCCCchhhccc---CCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043586          289 --------HR---K-----CMFLIYEYMERGSLFCNLHN---NED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  348 (397)
Q Consensus       289 --------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  348 (397)
                              ..   .     ..+++|+-+ .++|.+.+..   ... ...+....+..+..|+++.+++||   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                    11   1     135677777 4588766542   111 122334455677799999999999   5699999


Q ss_pred             CCCCCCEEeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCC
Q 043586          349 DISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       349 dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ||||+|++++.+|.++|+||+.........   .....+..|.+||.
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~~~~~~~~~PPe~  213 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RCSEFPVAFTPPEL  213 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEE---EGGGS-TTTS-HHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCcee---eccCCCcccCChhh
Confidence            999999999999999999998876543211   11234567888884

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.40  E-value=2.2e-14  Score=136.91  Aligned_cols=133  Identities=32%  Similarity=0.456  Sum_probs=87.7

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCC-CcCChhhcCCCCCcEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS-GKIPSQIASMKNLTWL   83 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L   83 (397)
                      +++|+.|+||+|+|+ .+....+...+|+.|+||.|+++ .+|.++..++.|+.|++.+|+++ .-+|+.++++.+|+.+
T Consensus       244 l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf  321 (1255)
T KOG0444|consen  244 LRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF  321 (1255)
T ss_pred             hhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence            444444444444444 23333334444555555555554 56666666666777777766655 2266777777777777


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      ..++|.+. ..|+.++.|..|+.|.|+.|++- .+|.++.-++.+..||+..|+.+--
T Consensus       322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM  377 (1255)
T KOG0444|consen  322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM  377 (1255)
T ss_pred             Hhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence            77777776 67888888888888888888887 5678888888889999988875543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=4.4e-12  Score=104.92  Aligned_cols=134  Identities=20%  Similarity=0.310  Sum_probs=102.3

Q ss_pred             eeecCCcccEEEEEcCCCcEEEEEEecc-----cchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeec
Q 043586          226 CIGTGGYGSVYKAQLPNGKVFALKKLHT-----SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      .+++|+-+.+|.+.+.+. .+++|.=.+     ...+..-..++..+|++++.+++--.|....=+..+++...++|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            478999999999987543 355554322     12222223467789999999998777777777777888889999999


Q ss_pred             cCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          301 ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       301 ~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|..|.+.+...          ...++..+-.-+.-||   ..||+|+||.++||++..+. +.++|||++..-
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            998888777643          1346677777788899   66999999999999998775 899999999854

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.39  E-value=1.8e-14  Score=130.93  Aligned_cols=124  Identities=34%  Similarity=0.513  Sum_probs=58.6

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhc-CCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIA-SMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~   84 (397)
                      +.|+.||...|-+. .+|+.++++.+|+-|||..|.+. .+| +|.++..|.+|+++.|+++ .+|.+.+ .+.+|..||
T Consensus       183 ~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLD  258 (565)
T KOG0472|consen  183 KRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLD  258 (565)
T ss_pred             HHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeee
Confidence            33444444444433 34444555555555555555554 344 4444555555555555554 3443333 444555555


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      +.+|++. ..|+.+.-+.+|+.||+|+|.+++. |..++++ .|..+.+.+|
T Consensus       259 LRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnl-hL~~L~leGN  307 (565)
T KOG0472|consen  259 LRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLGNL-HLKFLALEGN  307 (565)
T ss_pred             ccccccc-cCchHHHHhhhhhhhcccCCccccC-Ccccccc-eeeehhhcCC
Confidence            5555554 3444455555555555555555432 3344444 4444444444

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.38  E-value=9.5e-12  Score=102.46  Aligned_cols=147  Identities=17%  Similarity=0.214  Sum_probs=109.0

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEec-----ccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLH-----TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ....+-||+-+.|+++.+. |+.++||.-.     ....+..-..++..+|++.+.+++--.|....=++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567899999999999985 6666666432     222233333567889999999998777777766777777788999


Q ss_pred             eeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC---CeEEeccccccc
Q 043586          298 EYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF---EAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DFG~a~~  373 (397)
                      ||++| .++.+++........ .......++.+|-+.+.-||   ..+++|+||..+||++.+++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 466777665433222 22223678899999999999   77999999999999997655   347999999864


Q ss_pred             c
Q 043586          374 L  374 (397)
Q Consensus       374 ~  374 (397)
                      -
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            3

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.36  E-value=1.1e-13  Score=125.83  Aligned_cols=124  Identities=30%  Similarity=0.429  Sum_probs=82.3

Q ss_pred             EEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCccc
Q 043586           11 LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI   90 (397)
Q Consensus        11 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~   90 (397)
                      +.+++|.++ .+|..++.+++|+.|+|++|.+. .+|.+++.+..||.|+++.|+|. .+|..+-.+..|+.+-.++|++
T Consensus       417 l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi  493 (565)
T KOG0472|consen  417 LVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQI  493 (565)
T ss_pred             HHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccc
Confidence            455555544 66666777777777777777765 56666777767777777777776 5666666666666666666777


Q ss_pred             ccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           91 EGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        91 ~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ....|+.+.+|.+|..||+.+|.+. .+|..+++++++..+++++|+.
T Consensus       494 ~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  494 GSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             cccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCcc
Confidence            6555555777777777777777766 3455566677777777777653

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.35  E-value=1.3e-13  Score=125.16  Aligned_cols=73  Identities=27%  Similarity=0.205  Sum_probs=58.6

Q ss_pred             hcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCCcCC
Q 043586           74 IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSAL  146 (397)
Q Consensus        74 ~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~~~~  146 (397)
                      |.++++|+.|+|++|.|+.+-+.+|.....++.|.|..|+|...-...|.++..|..|+|++|+.+|..+.+.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF  342 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAF  342 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccc
Confidence            5567788888888888888888888888888888888888877767778888888888888888887665443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.34  E-value=7.3e-13  Score=111.07  Aligned_cols=127  Identities=32%  Similarity=0.402  Sum_probs=52.4

Q ss_pred             CCCCCCCEEEcCCCcccccCCcccc-CCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhh-cCCCCC
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLG-LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL   80 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L   80 (397)
                      .+...+++|+|++|+|+. + +.++ .+.+|+.|||++|.++. ++ .+..++.|+.|++++|+|+ .+++.+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT-
T ss_pred             cccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcC
Confidence            345678999999999984 4 3466 68999999999999984 54 5888999999999999999 465555 468999


Q ss_pred             cEEEccCcccccCC-chhhccCCCCceeeccCCcCCCCCC---CCcccccccceeccC
Q 043586           81 TWLDISNNKIEGSI-PGEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLS  134 (397)
Q Consensus        81 ~~L~l~~N~~~~~~-p~~~~~~~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~l~l~  134 (397)
                      +.|++++|+|.... -..++.+++|+.|++.+|+++....   ..+..+++|..||..
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~  148 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ  148 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence            99999999997532 2567889999999999999985421   223456777777654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=1.7e-11  Score=108.42  Aligned_cols=143  Identities=22%  Similarity=0.265  Sum_probs=109.0

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--CCccceeeEEeeC---CEeeEEEee
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHR---KCMFLIYEY  299 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lv~e~  299 (397)
                      +.++.|..+.+|+++..+|+.+++|........  .....+.+|+++++.+++  ..+.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998877789999998654321  012467889999999976  3467778777654   256899999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC--------------------------------------  341 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------  341 (397)
                      ++|.++.+.+..    ..++..+...++.++++++..||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999888765531    12566677778888888888888420                                      


Q ss_pred             ---------------CCCeEEcCCCCCCEEeCC--CCCeEEeccccccc
Q 043586          342 ---------------SPSIIHRDISSNNILLNS--KFEAFVADFGTARL  373 (397)
Q Consensus       342 ---------------~~~ivH~dlkp~NIll~~--~~~~kl~DFG~a~~  373 (397)
                                     ...++|+|++|.||+++.  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           245799999999999998  66789999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.31  E-value=1.4e-13  Score=136.78  Aligned_cols=131  Identities=32%  Similarity=0.359  Sum_probs=98.8

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      ++.|+.|+|.+|.|+...-+.|.++.+|+.|+|++|++.......+.++..|++|+||+|+|+ .+|..+..++.|++|.
T Consensus       358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~  436 (1081)
T KOG0618|consen  358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR  436 (1081)
T ss_pred             hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence            456777888888887776667888888888888888887444456777888888888888888 6888888888888888


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ..+|++. ..| .+..+++|+.+|++.|+|+...-......++|+.+|+++|..
T Consensus       437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            8888887 466 778888888888888888754222222336788888888863

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=2.1e-12  Score=130.44  Aligned_cols=133  Identities=31%  Similarity=0.435  Sum_probs=91.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|+.++.|..|++|.||.++++ ..+.+|+| +++....       +++   ++.....|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-------lRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-------LRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-------hhc---cccccCCccee----------------
Confidence            57899999999999999999876 46778884 3332211       111   33333344433                


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                           |+-...++..+   .++.        +++.+++|+|   +.+|+|||+||+|.+|+.-|.+|++|||+.+..-..
T Consensus       136 -----gDc~tllk~~g---~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKNIG---PLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhcccCC---CCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 34434444322   1222        2278899999   789999999999999999999999999998854211


Q ss_pred             C---------------CCeeeccccccccCCCCCC
Q 043586          378 S---------------SNRTLLAGTYGYIAPGLPL  397 (397)
Q Consensus       378 ~---------------~~~~~~~gt~~y~APE~~l  397 (397)
                      .               -.....+|||.|+|||+++
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            1               0124468999999999975

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.25  E-value=5.7e-13  Score=120.99  Aligned_cols=136  Identities=24%  Similarity=0.338  Sum_probs=124.0

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccC-ccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS-NKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +..+.++|..|+|+...|.+|+.+++|+.||||+|.|+-.-|+.|.++++|..|-+-+ |+|+......|.++.+|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3567899999999988888999999999999999999988999999999998887766 999976667899999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +.-|++.-+..+.|..+++|..|.+-+|.+......++..+..++.+++..|++.|.
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd  203 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD  203 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc
Confidence            999999988899999999999999999999877667899999999999999988774

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.22  E-value=2.3e-12  Score=128.92  Aligned_cols=173  Identities=22%  Similarity=0.312  Sum_probs=133.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC--CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  295 (397)
                      ..|.+.+.||+|+|+.|-.....  ....+|+|.+..... .....+....|..+-..+. |+|++.+++.....+..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~-~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPK-SEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCC-ccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            35777788999999999888653  345567776655431 1122345556777777776 9999999999999999999


Q ss_pred             EEeeccCCCchhhc-ccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccc
Q 043586          296 IYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARL  373 (397)
Q Consensus       296 v~e~~~~g~L~~~l-~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~  373 (397)
                      .++|..++++.+.+ +..  ....+...+..+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..
T Consensus        99 ~~~~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccccCC--ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            99999999999888 432  2134556677799999999999994  23899999999999999999 999999999998


Q ss_pred             cCC-CCCC--eeeccc-cccccCCCCC
Q 043586          374 LHA-DSSN--RTLLAG-TYGYIAPGLP  396 (397)
Q Consensus       374 ~~~-~~~~--~~~~~g-t~~y~APE~~  396 (397)
                      +.. ....  ....+| ++.|+|||..
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~  201 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHL  201 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccc
Confidence            765 2222  233468 9999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.22  E-value=1.5e-11  Score=104.62  Aligned_cols=76  Identities=21%  Similarity=0.094  Sum_probs=63.2

Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCee
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT  382 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  382 (397)
                      |+|.+++..++  ..+++.++..++.|++.||.|||+.   +      ||+||+++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            67888887543  2489999999999999999999943   4      999999999999999  99998764432    


Q ss_pred             eccccccccCCCCC
Q 043586          383 LLAGTYGYIAPGLP  396 (397)
Q Consensus       383 ~~~gt~~y~APE~~  396 (397)
                       ..||+.|||||++
T Consensus        64 -~~g~~~y~aPE~~   76 (176)
T smart00750       64 -SRVDPYFMAPEVI   76 (176)
T ss_pred             -CCCcccccChHHh
Confidence             2589999999975

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.20  E-value=3.8e-12  Score=126.81  Aligned_cols=132  Identities=29%  Similarity=0.319  Sum_probs=108.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      |.++..|++|+|++|+|.......+.++..|+.|+||+|+++ .+|..+..+..|++|...+|++. ..| .+..++.|+
T Consensus       379 l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  379 LVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             hccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            457889999999999999666668999999999999999998 89999999999999999999999 788 899999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      .+|++.|.++...-..--..++|++||+++|.-...-...+..+..+...+++-|
T Consensus       456 ~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  456 VLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             EEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            9999999997654333334489999999999843333445566666666555544

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.19  E-value=1.5e-12  Score=123.39  Aligned_cols=131  Identities=32%  Similarity=0.468  Sum_probs=104.6

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +++|..|++|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|..++.+..|..|+.+.|.+. .+|+.++++.+|+
T Consensus       117 i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr  192 (722)
T KOG0532|consen  117 ICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR  192 (722)
T ss_pred             hhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH
Confidence            456778888888888888 6777666554 788888888886 67777887788888888888888 6888888888888


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      .|.+..|.+. .+|.+++ .-.|..||++.|+++ .+|-.|..++.|+.+.|.+|+-+
T Consensus       193 ~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq  247 (722)
T KOG0532|consen  193 DLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ  247 (722)
T ss_pred             HHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence            8888888887 4677777 445888899999988 67888888999999999888743

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=4.4e-10  Score=95.86  Aligned_cols=131  Identities=22%  Similarity=0.343  Sum_probs=85.1

Q ss_pred             cEEEEEcCCCcEEEEEEecccc-----------------------hHHHHHHHHHHHHHHHHhhcccC--CccceeeEEe
Q 043586          234 SVYKAQLPNGKVFALKKLHTSE-----------------------TEELAFIKSFRNEAQVLSQVLHR--NIVKLYGFCL  288 (397)
Q Consensus       234 ~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  288 (397)
                      .||.|...+|..+|+|+.+...                       ...........+|.+.|.++..-  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            3899998889999999886421                       01112235678899999999765  566676553 


Q ss_pred             eCCEeeEEEeecc--CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          289 HRKCMFLIYEYME--RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       289 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                         .-.+||||++  |..+.. +....    ++......++.+++..+..+++  ..|++|+|+.+.||+++++ .+.++
T Consensus        80 ---~~~ivME~I~~~G~~~~~-l~~~~----~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPR-LKDVD----LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGC-HHHCG----GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE-
T ss_pred             ---CCEEEEEecCCCccchhh-HHhcc----ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEEE
Confidence               3469999998  544433 32211    1234456678888886666432  5699999999999999988 99999


Q ss_pred             ccccccccCC
Q 043586          367 DFGTARLLHA  376 (397)
Q Consensus       367 DFG~a~~~~~  376 (397)
                      |||.+.....
T Consensus       149 Df~qav~~~~  158 (188)
T PF01163_consen  149 DFGQAVDSSH  158 (188)
T ss_dssp             -GTTEEETTS
T ss_pred             ecCcceecCC
Confidence            9999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.16  E-value=3.4e-11  Score=115.54  Aligned_cols=121  Identities=31%  Similarity=0.498  Sum_probs=98.8

Q ss_pred             HhhcccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043586          272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDIS  351 (397)
Q Consensus       272 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  351 (397)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+...  ...+++.-...+++++++||+|+|.  ++-..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeec
Confidence            35678999999999999999999999999999999999863  3458888899999999999999996  3344999999


Q ss_pred             CCCEEeCCCCCeEEeccccccccCCC--CCCeeeccccccccCCCCC
Q 043586          352 SNNILLNSKFEAFVADFGTARLLHAD--SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       352 p~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~APE~~  396 (397)
                      +.|.++|....+||+|||+.......  ........-..-|.|||++
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPell  123 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELL  123 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHh
Confidence            99999999999999999999876431  1111111234458999975

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.7e-09  Score=97.68  Aligned_cols=144  Identities=18%  Similarity=0.147  Sum_probs=100.4

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHH--------HHHHHHHHHHHHHhhcccCCc--cceeeEEee-----
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL--------AFIKSFRNEAQVLSQVLHRNI--VKLYGFCLH-----  289 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  289 (397)
                      +.+-+.....|++..+ +|+.|.||..........        .....+.+|.+.+.++...+|  ++++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3445444455777766 577899997754432210        001146789999999865444  344556543     


Q ss_pred             CCEeeEEEeeccCC-CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-------CC
Q 043586          290 RKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------KF  361 (397)
Q Consensus       290 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------~~  361 (397)
                      ....++|||++++. +|.+++..... ...+......++.+++..+.-||   ..||+|+|+++.|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999875 78877753211 12345567789999999999999   669999999999999975       46


Q ss_pred             CeEEeccccccc
Q 043586          362 EAFVADFGTARL  373 (397)
Q Consensus       362 ~~kl~DFG~a~~  373 (397)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            889999998864

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.11  E-value=4.8e-11  Score=82.53  Aligned_cols=61  Identities=38%  Similarity=0.489  Sum_probs=33.8

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccC
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL   66 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l   66 (397)
                      ++|++|+|++|+++...+..|..+++|+.|++++|.++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            3455555555555544445555555555555555555544445555555555555555543

...

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.10  E-value=1.6e-10  Score=117.71  Aligned_cols=77  Identities=32%  Similarity=0.307  Sum_probs=45.0

Q ss_pred             cCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccC
Q 043586           55 GLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLS  134 (397)
Q Consensus        55 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~  134 (397)
                      +|+.|+|++|+|+ .+|..   .++|+.|++++|++++ +|..   +.+|+.|++++|+++ .+|..+..++++..++++
T Consensus       383 ~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs  453 (788)
T PRK15387        383 GLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE  453 (788)
T ss_pred             ccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence            3444444444444 23322   2345556666666553 3432   235666777777776 456667778888888888


Q ss_pred             CCCCcC
Q 043586          135 PNKGLC  140 (397)
Q Consensus       135 ~n~~~c  140 (397)
                      +|+..+
T Consensus       454 ~N~Ls~  459 (788)
T PRK15387        454 GNPLSE  459 (788)
T ss_pred             CCCCCc
Confidence            887554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=7.1e-11  Score=99.12  Aligned_cols=118  Identities=29%  Similarity=0.357  Sum_probs=40.9

Q ss_pred             cCCCcccccCCccccCCCCCCEEeccCCcccccCchhhh-hcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccc
Q 043586           13 VGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT-WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIE   91 (397)
Q Consensus        13 L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~   91 (397)
                      |..+.|. ..|. +.+..+++.|+|.+|.|+ .+. .++ .+.+|+.|+|++|.|+ .++ .+..+++|+.|++++|+|+
T Consensus         4 lt~~~i~-~~~~-~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    4 LTANMIE-QIAQ-YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             ccccccc-cccc-cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence            3444444 3443 455668999999999998 443 566 5889999999999999 454 5888999999999999999


Q ss_pred             cCCchhh-ccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCC
Q 043586           92 GSIPGEI-TELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        92 ~~~p~~~-~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~  137 (397)
                      .. +..+ ..+++|+.|++++|+|...-. ..+..+++|..+++.+|+
T Consensus        78 ~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   78 SI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             cc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence            64 4444 579999999999999986432 345678899999999995

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.08  E-value=1.9e-11  Score=107.59  Aligned_cols=128  Identities=29%  Similarity=0.333  Sum_probs=105.9

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ..|++|||++|.|+ .+.++..-++.++.|++|+|.+. .+ +++..+++|+.||||+|.++ .+-++-.++.+.++|.|
T Consensus       284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v-~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TV-QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhhccccccchh-hhhhhhhhccceeEEecccccee-ee-hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            35899999999998 78899999999999999999997 34 34888999999999999999 67788788899999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCc
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~  139 (397)
                      ++|.|.. + ..+..+.+|..||+++|+|...-. ..++.++-|+.+.+-+|+..
T Consensus       360 a~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  360 AQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             hhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            9999863 2 347788899999999999874311 34566777788888888643

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.08  E-value=7.5e-11  Score=81.56  Aligned_cols=59  Identities=37%  Similarity=0.587  Sum_probs=29.8

Q ss_pred             CCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcc
Q 043586           31 DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNK   89 (397)
Q Consensus        31 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~   89 (397)
                      +|+.|++++|+++...+..|.++++|++|++++|+++...|..|.++++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            44555555555554333445555555555555555554444445555555555555554

...

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.08  E-value=1.3e-11  Score=116.62  Aligned_cols=99  Identities=24%  Similarity=0.382  Sum_probs=85.8

Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      +.|+.|++|...+|.+|+..+......++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            588999999999999999877666678889999999999999999      37999999999999999999999999999


Q ss_pred             cccCCCC------CCeeeccccccccCCCCC
Q 043586          372 RLLHADS------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~------~~~~~~~gt~~y~APE~~  396 (397)
                      .......      ...+..+||..||+||-+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi  434 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQI  434 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHH
Confidence            8775544      123456799999999965

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.06  E-value=2.8e-11  Score=113.25  Aligned_cols=134  Identities=22%  Similarity=0.232  Sum_probs=80.1

Q ss_pred             CCCCCCEEEcCCCcccc------cCCccccCCCCCCEEeccCCcccccCchhhhhccc---CCeEeccCccCCC----cC
Q 043586            4 NLKNLIELDVGSNSLIG------PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTG---LLGLNLSSNKLSG----KI   70 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~------~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~   70 (397)
                      ..++|+.|+++++.+.+      .++..+..+++|+.|++++|.+.+..+..+..+.+   |++|++++|.+++    .+
T Consensus        49 ~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l  128 (319)
T cd00116          49 PQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL  128 (319)
T ss_pred             hCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH
Confidence            44567777777766652      23345566677777777777776555556655555   7777777777662    22


Q ss_pred             ChhhcCC-CCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCCC----CCCCcccccccceeccCCCC
Q 043586           71 PSQIASM-KNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSGP----VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        71 p~~~~~l-~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ...+..+ ++|+.|++++|.+++.    ++..+..+.+|+.|++++|.+++.    ++..+..+++|+.+++++|.
T Consensus       129 ~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~  204 (319)
T cd00116         129 AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNG  204 (319)
T ss_pred             HHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCc
Confidence            2344455 6677777777776632    233455556677777777776632    11223334466667776664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=1.1e-10  Score=112.22  Aligned_cols=171  Identities=25%  Similarity=0.237  Sum_probs=129.6

Q ss_pred             cCCCccceeec--CCcccEEEEEc---CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGT--GGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  292 (397)
                      ..|.+...+|.  |.+|.||.++.   .++..+|+|+-+........ ..+=.+|+...+.++ |++.++.+..+...+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCc
Confidence            34667788999  99999999875   46788999984433221111 112234777777774 9999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEec
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH----ALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVAD  367 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D  367 (397)
                      .++-+|++. .++.++.+....  .++....+....+...    |+.++|   +..++|-|+||+||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence            999999995 688887775433  3566777778888888    999999   7799999999999999998 8899999


Q ss_pred             cccccccCCCCCCe-----eeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNR-----TLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~-----~~~~gt~~y~APE~~  396 (397)
                      ||+...+....-..     ....|...|++||..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~  300 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL  300 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh
Confidence            99999876544211     122577789999974

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.99  E-value=1.1e-09  Score=112.22  Aligned_cols=100  Identities=27%  Similarity=0.484  Sum_probs=64.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|+|+ .+|..+.  ++|+.|++++|+|+ .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|++
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L  269 (754)
T PRK15370        199 EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL  269 (754)
T ss_pred             cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence            35777888888777 4555443  47777777777776 4565553  35777777777776 5666554  36777777


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      ++|+|+. +|..+.  ++|+.|++++|++++.
T Consensus       270 s~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L  298 (754)
T PRK15370        270 FHNKISC-LPENLP--EELRYLSVYDNSIRTL  298 (754)
T ss_pred             cCCccCc-cccccC--CCCcEEECCCCccccC
Confidence            7777763 455442  4677777777776643

>PLN03210 Resistant to P

Probab=98.98  E-value=1.7e-09  Score=117.51  Aligned_cols=61  Identities=26%  Similarity=0.406  Sum_probs=34.3

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCc
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN   64 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   64 (397)
                      ..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+.++++|+.|++++|
T Consensus       631 ~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c  691 (1153)
T PLN03210        631 HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC  691 (1153)
T ss_pred             ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence            3456666666665543334443 555666666666665544455555655666666666554

syringae 6; Provisional

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.97  E-value=1e-09  Score=112.31  Aligned_cols=99  Identities=32%  Similarity=0.551  Sum_probs=69.2

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|.+. .+|..+.  .+|+.|+|++|+|+ .+|..+.  ++|+.|++
T Consensus       220 ~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~L  290 (754)
T PRK15370        220 GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSV  290 (754)
T ss_pred             cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEEC
Confidence            57899999999988 4666553  47888888888887 6676664  57888888888888 5676654  47888888


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSG  116 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~  116 (397)
                      ++|++++ +|..+.  ++|+.|++++|.++.
T Consensus       291 s~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~  318 (754)
T PRK15370        291 YDNSIRT-LPAHLP--SGITHLNVQSNSLTA  318 (754)
T ss_pred             CCCcccc-Ccccch--hhHHHHHhcCCcccc
Confidence            8888874 443332  245555555555553

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.97  E-value=2.9e-09  Score=103.71  Aligned_cols=123  Identities=15%  Similarity=0.218  Sum_probs=98.4

Q ss_pred             cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccC
Q 043586          240 LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELD  319 (397)
Q Consensus       240 ~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  319 (397)
                      ..++..|.|...+.....   ......+-++.++.++||||+++++.++..+..|+|+|-+.  .|...+++.      .
T Consensus        34 k~~~~~vsVF~~~~~~~~---~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~  102 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGE---VTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------G  102 (690)
T ss_pred             eccCCceEEEEEeCCCch---hhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------H
Confidence            446788888888765541   12445567888999999999999999999999999999985  455455432      2


Q ss_pred             hHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          320 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       320 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ...+...+.||+.||.|||+.+  +++|++|.-+.|+|+..|..||++|-.+....
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            3455667899999999999754  89999999999999999999999999886543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.97  E-value=1e-08  Score=90.10  Aligned_cols=141  Identities=23%  Similarity=0.244  Sum_probs=99.9

Q ss_pred             CCccceeecCCcccEEEEEcCCCcEEEEEEecccchH-------------------HHHHHHHHHHHHHHHhhcccC--C
Q 043586          221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-------------------ELAFIKSFRNEAQVLSQVLHR--N  279 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~~~~~E~~~l~~l~h~--n  279 (397)
                      +.++..||-|.-+.||.|..+.|.++|||.=+....+                   -...+...++|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4566889999999999999999999999965432111                   011234567899999999654  6


Q ss_pred             ccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       280 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                      +.+.+++    +...+||||++|-.|...-        ++....-.++..|++-+.-.-   ..|+||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEec
Confidence            7777766    4567999999986664321        112233344555555444444   348999999999999999


Q ss_pred             CCCeEEeccccccccCC
Q 043586          360 KFEAFVADFGTARLLHA  376 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~  376 (397)
                      +|.+.++||--+.....
T Consensus       238 dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         238 DGDIVVIDWPQAVPISH  254 (304)
T ss_pred             CCCEEEEeCcccccCCC
Confidence            99999999987765443

>PLN03210 Resistant to P

Probab=98.97  E-value=2.6e-09  Score=116.02  Aligned_cols=80  Identities=30%  Similarity=0.365  Sum_probs=36.2

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      .+|+.|+|++|++. .+|..+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|++
T Consensus       611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            34445555554444 3444444445555555544432223332 444445555555444333344444444444444444


Q ss_pred             cC
Q 043586           86 SN   87 (397)
Q Consensus        86 ~~   87 (397)
                      ++
T Consensus       689 ~~  690 (1153)
T PLN03210        689 SR  690 (1153)
T ss_pred             CC
Confidence            44

syringae 6; Provisional

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.96  E-value=4.9e-10  Score=114.21  Aligned_cols=109  Identities=28%  Similarity=0.349  Sum_probs=79.7

Q ss_pred             CCCEEEcCCCcccccCCccccC-----------------CCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGL-----------------LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK   69 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~-----------------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~   69 (397)
                      +|++|+|++|+|++ +|.....                 .++|+.|+|++|+|++ +|..   .++|+.|++++|+|+ .
T Consensus       343 ~Lq~LdLS~N~Ls~-LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-s  416 (788)
T PRK15387        343 GLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-S  416 (788)
T ss_pred             ccceEecCCCccCC-CCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-C
Confidence            56667777766663 3321111                 1256667777777763 4432   367999999999999 5


Q ss_pred             CChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccc
Q 043586           70 IPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQL  125 (397)
Q Consensus        70 ~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l  125 (397)
                      +|...   .+|+.|++++|+|+ .+|..+..+++|+.|++++|++++..+..+..+
T Consensus       417 IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        417 LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            77643   46888999999998 689999999999999999999998877666443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.96  E-value=1.5e-10  Score=108.33  Aligned_cols=134  Identities=27%  Similarity=0.246  Sum_probs=94.3

Q ss_pred             CCCCCEEEcCCCcccc----cCCccccCCCCCCEEeccCCcccc------cCchhhhhcccCCeEeccCccCCCcCChhh
Q 043586            5 LKNLIELDVGSNSLIG----PIPSTLGLLTDLSYLDLSRNQFNS------SIPNELTWLTGLLGLNLSSNKLSGKIPSQI   74 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~N~l~~------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~   74 (397)
                      +.+|++|+++++.++.    .++..+...++|+.|++++|.+.+      .++..+..+++|+.|++++|.+.+..+..+
T Consensus        22 l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~  101 (319)
T cd00116          22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVL  101 (319)
T ss_pred             HhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHH
Confidence            4568888888888743    256667777888888888887762      234456667788888888888876666666


Q ss_pred             cCCCC---CcEEEccCccccc----CCchhhccC-CCCceeeccCCcCCCCC----CCCcccccccceeccCCCCC
Q 043586           75 ASMKN---LTWLDISNNKIEG----SIPGEITEL-SRLDYLNLSSNKLSGPV----PFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        75 ~~l~~---L~~L~l~~N~~~~----~~p~~~~~~-~~L~~l~l~~n~l~~~~----~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ..+.+   |+.|++++|.+.+    .+...+..+ ++|+.|++++|.+++..    +..+..+++++.+++++|..
T Consensus       102 ~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l  177 (319)
T cd00116         102 ESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGI  177 (319)
T ss_pred             HHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCC
Confidence            66665   8888888888763    233445666 78888888888887432    23344556788888887753

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.91  E-value=9.9e-09  Score=100.42  Aligned_cols=144  Identities=19%  Similarity=0.200  Sum_probs=93.9

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHH-------------------------------H------HHHHHH
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-------------------------------F------IKSFRN  267 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------~------~~~~~~  267 (397)
                      ..|+.++-|.||+|++.+|+.||||+.++.-...-.                               .      .-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            578999999999999999999999998764321100                               0      012445


Q ss_pred             HHHHHhhcc-----cCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHH-HHHHhCC
Q 043586          268 EAQVLSQVL-----HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL-AYLHHDC  341 (397)
Q Consensus       268 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~  341 (397)
                      |...+.+++     .|++.-..=|++......++|||++|-.+.+...-...  ..+.   ..++..++++. .-+-   
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~---k~ia~~~~~~f~~q~~---  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDR---KELAELLVRAFLRQLL---  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCH---HHHHHHHHHHHHHHHH---
Confidence            666666664     23332222233334567899999999888776422111  2332   22333333321 1111   


Q ss_pred             CCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       342 ~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ..|++|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            23899999999999999999999999999987654

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.91  E-value=3.4e-10  Score=107.69  Aligned_cols=106  Identities=38%  Similarity=0.628  Sum_probs=98.7

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      -|+.|-+++|+++ .+|+.++.+..|..||.+.|.+. .+|..++++.+|+.|++..|.+. .+|+.++.|+ |..||++
T Consensus       144 pLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfS  219 (722)
T KOG0532|consen  144 PLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFS  219 (722)
T ss_pred             cceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecc
Confidence            3899999999998 79999999999999999999998 78889999999999999999999 7899999776 9999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      .|+++ .+|..|..|..|++|.|.+|.|..+
T Consensus       220 cNkis-~iPv~fr~m~~Lq~l~LenNPLqSP  249 (722)
T KOG0532|consen  220 CNKIS-YLPVDFRKMRHLQVLQLENNPLQSP  249 (722)
T ss_pred             cCcee-ecchhhhhhhhheeeeeccCCCCCC
Confidence            99998 6999999999999999999999854

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.90  E-value=8.6e-10  Score=106.17  Aligned_cols=152  Identities=22%  Similarity=0.238  Sum_probs=119.4

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEc--CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCC
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRK  291 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  291 (397)
                      .....+|..+..||.|.|+.|+....  .++..|++|............+.. ..|+.+...+ .|.+++++...|....
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCccccc
Confidence            33456788899999999999999853  468899999887654443322222 3466666666 4999999888888777


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEecccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGT  370 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG~  370 (397)
                      ..|+--|||++++......   -...+++...+++..|++.++.++|   ++.++|+|+||+||++..+ +..++.|||.
T Consensus       340 ~~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccc
Confidence            7889999999988876552   1224667778899999999999999   7799999999999999876 8889999999


Q ss_pred             ccc
Q 043586          371 ARL  373 (397)
Q Consensus       371 a~~  373 (397)
                      +..
T Consensus       414 ~t~  416 (524)
T KOG0601|consen  414 WTR  416 (524)
T ss_pred             ccc
Confidence            874

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.87  E-value=1.3e-09  Score=105.15  Aligned_cols=127  Identities=39%  Similarity=0.522  Sum_probs=89.9

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|.....+.+|+.|.++
T Consensus       141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~  217 (394)
T COG4886         141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS  217 (394)
T ss_pred             hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence            7888888888877 56667788888888888888887 56666657788888888888888 677766666667778888


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +|++. ..+..+..+.++..+.+.+|++... +.....+.+++.+++++|..
T Consensus       218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~n~i  267 (394)
T COG4886         218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQI  267 (394)
T ss_pred             CCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceeccccccc
Confidence            77533 3455566666677777777766532 44555566666666666653

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.84  E-value=6.4e-10  Score=98.07  Aligned_cols=111  Identities=30%  Similarity=0.327  Sum_probs=94.5

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      -++.++.|++++|.+.. +. .+..|++|+.||||+|.++ .+.++-..+-+.+.|.|++|.+. . -+.+.++-+|..|
T Consensus       305 L~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE-~-LSGL~KLYSLvnL  379 (490)
T KOG1259|consen  305 LAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIE-T-LSGLRKLYSLVNL  379 (490)
T ss_pred             hccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHh-h-hhhhHhhhhheec
Confidence            36889999999999983 33 3889999999999999997 56677778999999999999997 2 3567888899999


Q ss_pred             EccCcccccC-CchhhccCCCCceeeccCCcCCCCCC
Q 043586           84 DISNNKIEGS-IPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        84 ~l~~N~~~~~-~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      |+++|+|... -...++++|.|+.+.|.+|++.+.+.
T Consensus       380 Dl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd  416 (490)
T KOG1259|consen  380 DLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD  416 (490)
T ss_pred             cccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence            9999999753 24578999999999999999997654

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.79  E-value=2.7e-09  Score=103.06  Aligned_cols=132  Identities=40%  Similarity=0.542  Sum_probs=97.7

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCC-CCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLT-DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++.++.|++.+|.++ .+|.....+. +|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.
T Consensus       114 ~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~  190 (394)
T COG4886         114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN  190 (394)
T ss_pred             cccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhh
Confidence            4566888888888887 5666666664 8888888888887 66667888888888888888888 67777667788888


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      |++++|++. .+|.....+..|+.|++++|.+. ..+..+..+..+..+.+++|...+
T Consensus       191 L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~  246 (394)
T COG4886         191 LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED  246 (394)
T ss_pred             eeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence            888888887 46665566667888888888543 334556667777777777776544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=7.3e-08  Score=84.21  Aligned_cols=107  Identities=24%  Similarity=0.324  Sum_probs=83.0

Q ss_pred             HHHHHHHHHHhhcccCC--ccceeeEEeeCC----EeeEEEeeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHH
Q 043586          263 KSFRNEAQVLSQVLHRN--IVKLYGFCLHRK----CMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA  335 (397)
Q Consensus       263 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~  335 (397)
                      .+..+|...+.++....  .++.+++.....    ..++|+|++++ .+|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            35677888888886443  455667666532    45899999987 478887765322   445567789999999999


Q ss_pred             HHHhCCCCCeEEcCCCCCCEEeCCCC---CeEEeccccccccC
Q 043586          336 YLHHDCSPSIIHRDISSNNILLNSKF---EAFVADFGTARLLH  375 (397)
Q Consensus       336 ~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DFG~a~~~~  375 (397)
                      -||   ..||+|+|+++.|||++.++   .+.++||+-++...
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            999   66999999999999999887   88999999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.74  E-value=2.9e-07  Score=81.52  Aligned_cols=139  Identities=17%  Similarity=0.232  Sum_probs=85.8

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC--ccceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      ..||+|..+.||+.   .+..+++|........     ....+|.++++.+..-.  +.+.+++....+...+|||+++|
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~-----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDK-----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCCH-----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            46899999999984   2556788988764322     34577999999986443  46788888777788899999998


Q ss_pred             CC-chhhc---------------------ccCCCccccChHHHH-HHHHH----------HHH-HHHHHHh-CCCCCeEE
Q 043586          303 GS-LFCNL---------------------HNNEDAVELDWAKRV-NIVKA----------MAH-ALAYLHH-DCSPSIIH  347 (397)
Q Consensus       303 g~-L~~~l---------------------~~~~~~~~~~~~~~~-~i~~~----------i~~-~l~~LH~-~~~~~ivH  347 (397)
                      .+ +...+                     |.... ......... .+..+          +.. ...+|.. .....++|
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~-~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKC-DTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCC-CCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            64 21111                     11000 000100000 00000          000 1112211 11345789


Q ss_pred             cCCCCCCEEeCCCCCeEEeccccccc
Q 043586          348 RDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       348 ~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      +|+.|.||++++++ +.++||+.+..
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcCc
Confidence            99999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=3.8e-07  Score=79.58  Aligned_cols=160  Identities=22%  Similarity=0.265  Sum_probs=105.1

Q ss_pred             cccHHHHHHHhcCCCccce---eecCCcccEEEEEcCCCcEEEEEEecccchHHHH---------------------HHH
Q 043586          208 RIVYEDLIEATEGFDIKYC---IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA---------------------FIK  263 (397)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~---ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------------------~~~  263 (397)
                      ..+++.+....++..+...   |+.|.-+.||+|...++..+|+|+++.....-..                     ...
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            3455666666666666554   5567777899999888999999998754322111                     012


Q ss_pred             HHHHHHHHHhhcc--cCCccceeeEEeeCCEeeEEEeeccCCCc-hhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC
Q 043586          264 SFRNEAQVLSQVL--HRNIVKLYGFCLHRKCMFLIYEYMERGSL-FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD  340 (397)
Q Consensus       264 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  340 (397)
                      ...+|...|.++.  +-.+.+.+++..    -.+||||+..... .-.|+.    ..+...++..+..++++.+.-|-..
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~  185 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKE  185 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHh
Confidence            2346777777774  334445555432    3599999954311 111111    1122225667788888888887742


Q ss_pred             CCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       341 ~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                        .++||+||..-|||+. ++.+.++|||-|.....+.
T Consensus       186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             --cCcccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence              4899999999999999 8899999999987665443

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.66  E-value=7.3e-10  Score=108.15  Aligned_cols=129  Identities=32%  Similarity=0.376  Sum_probs=104.1

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCCh-hhcCCCCCcEEEc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPS-QIASMKNLTWLDI   85 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l   85 (397)
                      .|...+.++|.|. .+..++.-++.|+.|||++|+++..  +.+..|+.|++|||+.|.|. .+|. ...++. |..|.+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l  239 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL  239 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence            3677888999998 7888999999999999999999854  38899999999999999999 4553 344555 999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCcCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGLCGN  142 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~c~~  142 (397)
                      ++|.++..  ..+.++.+|+.||+++|-|.+--. ..+.-+.+|..|+|.+|+.-|..
T Consensus       240 rnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  240 RNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             cccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            99999753  357889999999999999875422 12345667888999999977753

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.65  E-value=2.3e-09  Score=83.98  Aligned_cols=104  Identities=31%  Similarity=0.440  Sum_probs=85.2

Q ss_pred             CCEEEcCCCcccccCCc---cccCCCCCCEEeccCCcccccCchhhhh-cccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            8 LIELDVGSNSLIGPIPS---TLGLLTDLSYLDLSRNQFNSSIPNELTW-LTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         8 L~~L~L~~n~l~~~~p~---~l~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      +..++|++++|. .+++   .+.....|+..+|++|.|. .+|..|.. .+-++.|+|++|+|+ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            456888888875 4444   4556677888899999998 56666654 458999999999999 799999999999999


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      +++.|++. ..|..+..+.+|..|+..+|.+.
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            99999998 47777888999999999999887

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.60  E-value=9.9e-07  Score=76.20  Aligned_cols=149  Identities=19%  Similarity=0.208  Sum_probs=94.0

Q ss_pred             ccHHHHHH--HhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHH------HHHHHHHhhcccCCc
Q 043586          209 IVYEDLIE--ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSF------RNEAQVLSQVLHRNI  280 (397)
Q Consensus       209 ~~~~~~~~--~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~E~~~l~~l~h~ni  280 (397)
                      ..+.++.+  ...+|...+.+-......|.+-.. +|+.+++|..+.......+....|      .+++..+.+++...+
T Consensus        19 ~~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~   97 (229)
T PF06176_consen   19 EKYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGF   97 (229)
T ss_pred             hHHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCc
Confidence            34444433  345677777777766666666665 578899998876543322222222      344444555543322


Q ss_pred             cc---eeeEEe-----eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          281 VK---LYGFCL-----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       281 v~---l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      ..   ++-+..     .....+++|||++|..|.+...       ++.    .++..+++++.-+|   ..|++|+|..|
T Consensus        98 ~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hp  163 (229)
T PF06176_consen   98 TEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHP  163 (229)
T ss_pred             cccccceeeeeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHH---HcCCccCCCCc
Confidence            22   222222     1234668999999988765432       222    24566778889999   66999999999


Q ss_pred             CCEEeCCCCCeEEeccccccc
Q 043586          353 NNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~  373 (397)
                      .|++++.++ ++++||+..+.
T Consensus       164 gNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  164 GNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             CcEEEECCc-EEEEECccccc
Confidence            999999654 89999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.57  E-value=9e-09  Score=80.67  Aligned_cols=112  Identities=23%  Similarity=0.310  Sum_probs=87.2

Q ss_pred             CCCCCCEEEcCCCcccccCCccc-cCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ....|+..+|++|.+.. .|+.| ..++.++.|+|++|.++ .+|.++..++.|+.|+++.|.+. ..|..+..+.+|..
T Consensus        51 ~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~  127 (177)
T KOG4579|consen   51 KGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDM  127 (177)
T ss_pred             CCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHH
Confidence            34567888999999984 55555 45679999999999998 78999999999999999999999 78998888999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      |+..+|.+. .+|..+-.-...-..++.++.+.+.-+
T Consensus       128 Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  128 LDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             hcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            999999987 455443322333344556666665444

>PRK09902 hypothetical protein; Provisional

Probab=98.56  E-value=7.8e-07  Score=76.53  Aligned_cols=142  Identities=18%  Similarity=0.102  Sum_probs=99.8

Q ss_pred             eecCCcccEEEEEcCCCcEEEEEEecccchHH---HHHHHHHHHHHHHHhhcccCC--ccceeeEEe-e----CCEeeEE
Q 043586          227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVLHRN--IVKLYGFCL-H----RKCMFLI  296 (397)
Q Consensus       227 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lv  296 (397)
                      -|+|+.+-|++.... |+.+-+|.-.......   +.....|.+|...+.++...+  +.++. ++. .    .-..++|
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            467888889998765 4468888764211100   112357889999999996433  44444 332 1    1246799


Q ss_pred             EeeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC--eEEeccccccc
Q 043586          297 YEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--AFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DFG~a~~  373 (397)
                      +|-+.+ .+|.+++.... ..+.+......+..++++.+.-||   ..|+.|+|+.+.||+++.++.  ++++||--++.
T Consensus       104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998864 57777765432 223466667889999999999999   669999999999999986667  99999987764


Q ss_pred             c
Q 043586          374 L  374 (397)
Q Consensus       374 ~  374 (397)
                      .
T Consensus       180 ~  180 (216)
T PRK09902        180 R  180 (216)
T ss_pred             h
Confidence            3

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.56  E-value=5.6e-07  Score=87.98  Aligned_cols=141  Identities=18%  Similarity=0.171  Sum_probs=91.0

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHH----------------------------HHHH------HHHHHHHH
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE----------------------------LAFI------KSFRNEAQ  270 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------~~~~------~~~~~E~~  270 (397)
                      +.||.-+.|.||+|+.++|+.||||+-++.-...                            .+..      -+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            5689999999999999999999999977643211                            0001      13445555


Q ss_pred             HHhhcc----cCC------ccceeeEEeeCCEeeEEEeeccCCCchhh--cccCCCccccChHHHHHHHHHHHHHHHHHH
Q 043586          271 VLSQVL----HRN------IVKLYGFCLHRKCMFLIYEYMERGSLFCN--LHNNEDAVELDWAKRVNIVKAMAHALAYLH  338 (397)
Q Consensus       271 ~l~~l~----h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH  338 (397)
                      -..+++    |-+      |.+++..+  .....++||||+|..+.+.  +.+.    .++...+..-+.+...-+-+-|
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~----gi~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR----GISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc----CCCHHHHHHHHHHHHHHHHHhc
Confidence            544443    444      33333322  3457899999999887654  3322    2444443333333322233333


Q ss_pred             hCCCCCeEEcCCCCCCEEeCC----CCCeEEeccccccccCC
Q 043586          339 HDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHA  376 (397)
Q Consensus       339 ~~~~~~ivH~dlkp~NIll~~----~~~~kl~DFG~a~~~~~  376 (397)
                           |++|.|=.|.||+++.    ++.+.+-|||+...+..
T Consensus       321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence                 8999999999999984    67899999999886543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.55  E-value=6.2e-08  Score=86.85  Aligned_cols=124  Identities=23%  Similarity=0.349  Sum_probs=91.1

Q ss_pred             HHHhhcccCCccceeeEEeeC-----CEeeEEEeeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCC
Q 043586          270 QVLSQVLHRNIVKLYGFCLHR-----KCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSP  343 (397)
Q Consensus       270 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  343 (397)
                      .-+-++.|.||++++.|+.+.     .+..+++|||+.|++.+++++.+. ...+......+++.||..||.|||.. .+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            445566799999999998754     357899999999999999986432 33466666788999999999999976 88


Q ss_pred             CeEEcCCCCCCEEeCCCCCeEEeccccccccCCC-----CCCeeeccccccccCCCC
Q 043586          344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-----SSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       344 ~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~-----~~~~~~~~gt~~y~APE~  395 (397)
                      +|+|+++..+-|++..+|-+|++---- ......     ........+-++|.|||+
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~s  253 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPES  253 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCc
Confidence            999999999999999999888742111 111100     001122346788999986

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.50  E-value=3.8e-08  Score=95.51  Aligned_cols=124  Identities=30%  Similarity=0.322  Sum_probs=54.2

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      .++.+++..|.+.. +-..+..+++|+.|++..|.|.. +...+..+++|++|+|++|.|+...+  +..++.|+.|+++
T Consensus        73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~  148 (414)
T KOG0531|consen   73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLS  148 (414)
T ss_pred             hHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhheec
Confidence            34444444444442 22234445555555555555542 22224445555555555555542211  2333445555555


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~  137 (397)
                      +|.|...  ..+..+..|+.+++++|.++...+ . ...+.+++.+++++|.
T Consensus       149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~  197 (414)
T KOG0531|consen  149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNS  197 (414)
T ss_pred             cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCc
Confidence            5555421  123334455555555555543322 1 2334444444444443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.48  E-value=8.9e-07  Score=84.26  Aligned_cols=141  Identities=19%  Similarity=0.322  Sum_probs=105.6

Q ss_pred             cccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEeeEEEeeccC-CCc
Q 043586          232 YGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLIYEYMER-GSL  305 (397)
Q Consensus       232 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-g~L  305 (397)
                      -.+.|++.. .+|..|++|++........   ..-..-++.++++.|+|+|++.+++..    +...++|++|.++ ++|
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            357889864 4899999999954332211   111235678899999999999998873    4568999999986 566


Q ss_pred             hhhcccCC------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          306 FCNLHNNE------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       306 ~~~l~~~~------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      .+.--...            .....++...+.++.|+..||.++|   +.|..-+-|.|.+|+++.+.+++|...|....
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceee
Confidence            55432211            1123667889999999999999999   55899999999999999999999988887776


Q ss_pred             cCCCC
Q 043586          374 LHADS  378 (397)
Q Consensus       374 ~~~~~  378 (397)
                      +..+.
T Consensus       443 l~~d~  447 (655)
T KOG3741|consen  443 LQEDP  447 (655)
T ss_pred             ecCCC
Confidence            65444

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.46  E-value=3.3e-06  Score=74.98  Aligned_cols=143  Identities=22%  Similarity=0.262  Sum_probs=83.8

Q ss_pred             ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC--ccceeeEEee---CCEeeEEEee
Q 043586          225 YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLYGFCLH---RKCMFLIYEY  299 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~---~~~~~lv~e~  299 (397)
                      +.++.|..+.||+....+ ..+++|..... .    ....+.+|..+++.+....  +.+++.+...   ....+++|++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~----~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-D----AAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH-H----HHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-C----CHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            568999999999999876 68999997665 1    1256678889988886433  5667765433   3457899999


Q ss_pred             ccCCCchh----------------hc---ccC-CCccccChHH---------HHHH------------HHHHHH-HHHHH
Q 043586          300 MERGSLFC----------------NL---HNN-EDAVELDWAK---------RVNI------------VKAMAH-ALAYL  337 (397)
Q Consensus       300 ~~~g~L~~----------------~l---~~~-~~~~~~~~~~---------~~~i------------~~~i~~-~l~~L  337 (397)
                      ++|..+..                .+   +.. ..........         ....            ...+.. .++.+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99987766                00   011 0000001000         0000            011122 23333


Q ss_pred             Hh----CCCCCeEEcCCCCCCEEeC-CCCCeEEeccccccc
Q 043586          338 HH----DCSPSIIHRDISSNNILLN-SKFEAFVADFGTARL  373 (397)
Q Consensus       338 H~----~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a~~  373 (397)
                      +.    .....++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            32    1256799999999999999 666668999998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.39  E-value=4.8e-08  Score=90.51  Aligned_cols=134  Identities=28%  Similarity=0.260  Sum_probs=67.6

Q ss_pred             CCCCCCEEEcCCCcccccCC--ccccCCCCCCEEeccCCcccccCch--hhhhcccCCeEeccCccCCCcCChhh-cCCC
Q 043586            4 NLKNLIELDVGSNSLIGPIP--STLGLLTDLSYLDLSRNQFNSSIPN--ELTWLTGLLGLNLSSNKLSGKIPSQI-ASMK   78 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~   78 (397)
                      ++..|+.+.|.+.... ..+  +....+++++.||||.|.|..+.|-  -...+++|+.|+|+.|++.-...+.. ..++
T Consensus       119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~  197 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS  197 (505)
T ss_pred             hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence            4455666666655544 222  2445566666666666666543332  23346666666666666652111111 1345


Q ss_pred             CCcEEEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           79 NLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +|+.|.|+.+.++.... ..+..+|+|+.|+|..|..-..-.....-+..|+.|+|++|+.
T Consensus       198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~l  258 (505)
T KOG3207|consen  198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNL  258 (505)
T ss_pred             hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcc
Confidence            56666666666553221 2234456666666666642222223334455556666666543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.39  E-value=5.5e-06  Score=87.27  Aligned_cols=80  Identities=25%  Similarity=0.405  Sum_probs=57.5

Q ss_pred             cceeecCCcccEEEEEcCCC---cEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCc--cceeeEEeeC---CEee
Q 043586          224 KYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNI--VKLYGFCLHR---KCMF  294 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~  294 (397)
                      ...++.|.+..+|+....++   ..+++|+.........  ...+.+|+++++.+. |+++  .+++.++.+.   +..|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~--~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQS--AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCcc--HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence            45688999999999876553   4678887654332111  145778999999995 6665  7788887664   4678


Q ss_pred             EEEeeccCCCc
Q 043586          295 LIYEYMERGSL  305 (397)
Q Consensus       295 lv~e~~~~g~L  305 (397)
                      +||||++|..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999998654

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.38  E-value=7.5e-08  Score=93.45  Aligned_cols=132  Identities=34%  Similarity=0.354  Sum_probs=98.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|+.|+|.+|+|.+ +...+..+++|+.|++++|.|+...+  +..++.|+.|++++|.|+ .+ ..+..+++|+
T Consensus        91 l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~-~~-~~~~~l~~L~  165 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLIS-DI-SGLESLKSLK  165 (414)
T ss_pred             cccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhheeccCcch-hc-cCCccchhhh
Confidence            5678899999999999884 44447889999999999999985543  677778999999999998 23 4455688899


Q ss_pred             EEEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           82 WLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        82 ~L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      .+++++|++....+ . ...+.+|+.+++++|.+...  ..+..+..+..+++..|...+.
T Consensus       166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~  223 (414)
T KOG0531|consen  166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKL  223 (414)
T ss_pred             cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceec
Confidence            99999999986544 2 57788899999999988733  3344444555556677755443

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.37  E-value=7.2e-06  Score=73.67  Aligned_cols=141  Identities=13%  Similarity=0.116  Sum_probs=85.7

Q ss_pred             eecCCc-ccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEeeccCCC
Q 043586          227 IGTGGY-GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGS  304 (397)
Q Consensus       227 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~  304 (397)
                      |..|.. ..||+.... +..+++|+.....      .....+|+++++.+. +--+.+++++....+..++|||+++|.+
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            455555 789999765 4678888876543      134557888888884 4446678888777677899999999977


Q ss_pred             chhhcc-------------------cCCC-ccccCh--HHHHHHHH--------------------HHHHHHHHHHh---
Q 043586          305 LFCNLH-------------------NNED-AVELDW--AKRVNIVK--------------------AMAHALAYLHH---  339 (397)
Q Consensus       305 L~~~l~-------------------~~~~-~~~~~~--~~~~~i~~--------------------~i~~~l~~LH~---  339 (397)
                      +.+...                   .... ......  ........                    .+......|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            754321                   1000 000000  00000000                    01111222211   


Q ss_pred             -CCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          340 -DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       340 -~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                       .....++|+|+.|.||+++.++.+.|+||+.|...
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g  194 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA  194 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence             11346899999999999999877889999988643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.35  E-value=2.5e-07  Score=96.52  Aligned_cols=108  Identities=31%  Similarity=0.358  Sum_probs=86.3

Q ss_pred             CCCCCEEEcCCCc--ccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            5 LKNLIELDVGSNS--LIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         5 l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .+.|+.|-+..|.  +....++.|..++.|..|||++|.=-+.+|..+++|.+|++|+|++..++ .+|..+.+++.|.+
T Consensus       544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~  622 (889)
T KOG4658|consen  544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY  622 (889)
T ss_pred             CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence            3467888888886  55445556788888889999888777788888888888888888888888 78888888888888


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCc
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNK  113 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~  113 (397)
                      |++..+.-...+|.....|.+|++|.+-...
T Consensus       623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  623 LNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             eccccccccccccchhhhcccccEEEeeccc
Confidence            8888887665667777778888888876554

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.34  E-value=3e-06  Score=72.65  Aligned_cols=104  Identities=23%  Similarity=0.292  Sum_probs=81.2

Q ss_pred             HHHHHHhhccc-CCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043586          267 NEAQVLSQVLH-RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI  345 (397)
Q Consensus       267 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  345 (397)
                      .|.-+++.+.+ +++++++|+|-    .++|+||...+++...-.........+|..+.+|+.++++.+.++++.....+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888876 69999999993    36789999877664221110111236899999999999999999997644557


Q ss_pred             EEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          346 IHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       346 vH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      .-.|++|+|+-++++|++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	397
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-33
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-33
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		9e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-21
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-20
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-20
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-20
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-20
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-19
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-19
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-19
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-18
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		7e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		9e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-14
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-14
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-14
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-14
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-14
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-14
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-14
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-14
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		6e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-13
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		9e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-12
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-12
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-12
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-12
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-12
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-12
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		5e-12
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		5e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-12
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-12
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-12
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-12
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-12
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-12
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-12
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-12
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-12
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-12
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-12
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		6e-12
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		6e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-12
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-12
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-12
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-12
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		8e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-11
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-11
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-11
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-11
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-11
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-11
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-11
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-11
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		9e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-10
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-10
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-10
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-10
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-10
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-10
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-10
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-10
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-10
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-10
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-10
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-10
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-10
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		5e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		7e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-10
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-10
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		9e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-10
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-09
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-09
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-09
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-09
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		8e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		9e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		9e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-08
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		4e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-08
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-08
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		6e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		8e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-08
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		9e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		9e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-08
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		9e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-08
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-08
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-07
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-07
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-07
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-07
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-07
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-07
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-07
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-07
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-07
3soa_A	444	Full-Length Human Camkii Length = 444		7e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		9e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-06
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-06
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		4e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		6e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		6e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-06
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		6e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-06
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		8e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		8e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		8e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-06
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		9e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-05
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-05
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-05
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-05
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-05
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-05
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-05
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-05
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		7e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		7e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		6e-04
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		6e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-04
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		7e-04
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 76/190 (40%), Positives = 107/190 (56%), Gaps = 8/190 (4%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE--ELAFIKSF 265
           R    +L  A++ F  K  +G GG+G VYK +L +G + A+K+L    T+  EL     F
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGEL----QF 74
Query: 266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF-CNLHNNEDAVELDWAKRV 324
           + E +++S  +HRN+++L GFC+      L+Y YM  GS+  C     E    LDW KR 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL-HADSSNRTL 383
            I    A  LAYLH  C P IIHRD+ + NILL+ +FEA V DFG A+L+ + D      
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 384 LAGTYGYIAP 393
           + G  G+IAP
Sbjct: 195 VRGXIGHIAP 204

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 76/190 (40%), Positives = 107/190 (56%), Gaps = 8/190 (4%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE--ELAFIKSF 265
           R    +L  A++ F  K  +G GG+G VYK +L +G + A+K+L     +  EL     F
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGEL----QF 82
Query: 266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF-CNLHNNEDAVELDWAKRV 324
           + E +++S  +HRN+++L GFC+      L+Y YM  GS+  C     E    LDW KR 
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 142
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL-HADSSNRTL 383
            I    A  LAYLH  C P IIHRD+ + NILL+ +FEA V DFG A+L+ + D      
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 384 LAGTYGYIAP 393
           + GT G+IAP
Sbjct: 203 VRGTIGHIAP 212

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 72/189 (38%), Positives = 103/189 (54%), Gaps = 9/189 (4%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 267
           R+   DL EAT  FD K+ IG G +G VYK  L +G   ALK+  T E+ +         
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFE--T 84
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNI 326
           E + LS   H ++V L GFC  R  M LIY+YME G+L  +L+ ++   + + W +R+ I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSN-RTLL 384
               A  L YLH   + +IIHRD+ S NILL+  F   + DFG ++     D ++   ++
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 385 AGTYGYIAP 393
            GT GYI P
Sbjct: 202 KGTLGYIDP 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 64/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY  RG ++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 71/189 (37%), Positives = 101/189 (53%), Gaps = 9/189 (4%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 267
           R+   DL EAT  FD K+ IG G +G VYK  L +G   ALK+  T E+ +         
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEFE--T 84
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNI 326
           E + LS   H ++V L GFC  R  M LIY+YME G+L  +L+ ++   + + W +R+ I
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR--LLHADSSNRTLL 384
               A  L YLH   + +IIHRD+ S NILL+  F   + DFG ++       +    ++
Sbjct: 145 CIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 385 AGTYGYIAP 393
            GT GYI P
Sbjct: 202 KGTLGYIDP 210

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY  RG ++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALS 127
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLPPEM 182

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 203

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 139
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 140 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 194

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+  N K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 123 YCH---SKKVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 177

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEM 177

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 121
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 122 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 176

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/178 (35%), Positives = 95/178 (53%), Gaps = 9/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E FDI   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI++LYG+      ++LI EY   G+++  L   +     D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 126
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 127 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 180

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L+GT  Y+ P +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--CHAPSSRRTTLSGTLDYLPPEM 178

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 63/178 (35%), Positives = 96/178 (53%), Gaps = 9/178 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPP 180

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 119
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 120 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 127
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 128 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 63/180 (35%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 148
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 149 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 203

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 180

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 179

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 124
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ P +
Sbjct: 125 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 179

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 97/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +A+FG +  +HA SS RT L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEM 180

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/178 (34%), Positives = 94/178 (52%), Gaps = 9/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E FDI   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S + H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI++LYG+      ++LI EY   G+++  L   +     D  +    +  +A+AL+Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYC 128
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 129 H---SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 181

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 177

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 123
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 178

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 122
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 123 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRAALCGTLDYLPPEM 177

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEM 180

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 62/180 (34%), Positives = 96/180 (53%), Gaps = 9/180 (5%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           A E F+I   +G G +G+VY A+    K + ALK L  ++ E+       R E ++ S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI++LYG+      ++LI EY   G+++  L   +   + D  +    +  +A+AL+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           Y H   S  +IHRDI   N+LL S  E  +ADFG +  +HA SS R  L GT  Y+ P +
Sbjct: 126 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEM 180

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FDI   +G G +G+VY A+    K + ALK L  S+ E+       R E ++ S + H
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI+++Y +   RK ++L+ E+  RG L+  L  +      D  +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 131
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ P +
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEM 184

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 9/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FDI   +G G +G+VY A+    K + ALK L  S+ E+       R E ++ S + H
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI+++Y +   RK ++L+ E+  RG L+  L  +      D  +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYC 130
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ P +
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEM 183

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 64/172 (37%), Positives = 90/172 (52%), Gaps = 11/172 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H N+V+L
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            GF      + L+Y YM  GSL   L   +    L W  R  I +  A+ + +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
             IHRDI S NILL+  F A ++DFG AR     A +   + + GT  Y+AP
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/172 (37%), Positives = 89/172 (51%), Gaps = 11/172 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H N+V+L
Sbjct: 39  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 95
Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            GF      + L+Y YM  GSL   L   +    L W  R  I +  A+ + +LH +   
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 154
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
             IHRDI S NILL+  F A ++DFG AR     A +     + GT  Y+AP
Sbjct: 155 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/172 (37%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V+++  H N+V+L
Sbjct: 33  MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVMAKCQHENLVEL 89
Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            GF      + L+Y YM  GSL   L   +    L W  R  I +  A+ + +LH +   
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH- 148
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
             IHRDI S NILL+  F A ++DFG AR     A       + GT  Y+AP
Sbjct: 149 --IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 93/173 (53%), Gaps = 3/173 (1%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
            +IK  IG G +G+V++A+  +G   A+K L   +      +  F  E  ++ ++ H NI
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V   G       + ++ EY+ RGSL+  LH +    +LD  +R+++   +A  + YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +P I+HRD+ S N+L++ K+   V DFG +RL  +        AGT  ++AP
Sbjct: 157 -NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAP 208

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 93/178 (52%), Gaps = 9/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+I   +G G +G+VY A+      + ALK L  S+ E+       R E ++ + + H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI++LY +   R+ ++LI EY  RG L+  L   + +   D  +   I++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYC 139
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           H      +IHRDI   N+LL  K E  +ADFG +  +HA S  R  + GT  Y+ P +
Sbjct: 140 H---GKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEM 192

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 53/173 (30%), Positives = 94/173 (54%), Gaps = 3/173 (1%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
            +IK  IG G +G+V++A+  +G   A+K L   +      +  F  E  ++ ++ H NI
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNI 96
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V   G       + ++ EY+ RGSL+  LH +    +LD  +R+++   +A  + YLH+ 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +P I+HR++ S N+L++ K+   V DFG +RL  +   +    AGT  ++AP
Sbjct: 157 -NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/171 (36%), Positives = 85/171 (49%), Gaps = 11/171 (6%)
Query: 228 GTGGYGSVYKAQLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           G GG+G VYK  + N  V A+KKL       TEEL   + F  E +V ++  H N+V+L 
Sbjct: 31  GEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELK--QQFDQEIKVXAKCQHENLVELL 87
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           GF      + L+Y Y   GSL   L   +    L W  R  I +  A+ + +LH +    
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-- 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
            IHRDI S NILL+  F A ++DFG AR     A     + + GT  Y AP
Sbjct: 146 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/174 (35%), Positives = 90/174 (51%), Gaps = 12/174 (6%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
            +++  +G G +G V KA+    K  A+K++  SE+E  AFI   R     LS+V H NI
Sbjct: 11  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHPNI 64
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           VKLYG CL+  C  L+ EY E GSL+  LH  E       A  ++     +  +AYLH  
Sbjct: 65  VKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 341 CSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
              ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++AP
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 173

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 90/173 (52%), Gaps = 12/173 (6%)
Query: 222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +++  +G G +G V KA+    K  A+K++  SE+E  AFI   R     LS+V H NIV
Sbjct: 11  EVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQ----LSRVNHPNIV 64
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           KLYG CL+  C  L+ EY E GSL+  LH  E       A  ++     +  +AYLH   
Sbjct: 65  KLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 342 SPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
             ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++AP
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 172

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 84/179 (46%), Gaps = 14/179 (7%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           ++  IG GG+G VY+A     +V      H  + +    I++ R EA++ + + H NI+ 
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L G CL    + L+ E+   G L   L       ++     VN    +A  + YLH +  
Sbjct: 71  LRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAI 126
Query: 343 PSIIHRDISSNNILLNSKFE--------AFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             IIHRD+ S+NIL+  K E          + DFG AR  H   + +   AG Y ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAP 183

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 226 CIGTGGYGSVYKAQLP--NGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
            IG G +G VYK  L   +GK     A+K L    TE+      F  EA ++ Q  H NI
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQFSHHNI 108
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           ++L G     K M +I EYME G+L   L   +   E    + V +++ +A  + YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYL--- 163
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            + + +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 20/195 (10%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSET 256
            +ED  EA   F          I+  IG G +G V     +LP  +    A+K L +  T
Sbjct: 15  TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 74
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV 316
           E+    + F +EA ++ Q  H N++ L G       + +I E+ME GSL   L  N+   
Sbjct: 75  EKQR--RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 132
Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
            +   + V +++ +A  + YL      + +HRD+++ NIL+NS     V+DFG +R L  
Sbjct: 133 TV--IQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 187
Query: 377 DSSNRTLLAGTYGYI 391
           D+S+ T  +   G I
Sbjct: 188 DTSDPTYTSALGGKI 202

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 96/170 (56%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 20  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 75
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SI
Sbjct: 76  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 129
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 179

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 96/170 (56%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SI
Sbjct: 88  YST-KPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 141
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 15/175 (8%)
Query: 223 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V + +L  P  K    A+K L    TE     + F +EA ++ Q  H 
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 75
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G   +   + ++ E+ME G+L  F  L++ +  V     + V +++ +A  + Y
Sbjct: 76  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRY 131
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
           L      S +HRD+++ NIL+NS     V+DFG +R L  +SS+ T  +   G I
Sbjct: 132 L---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
              +K + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVL 122
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+L+N + E  +ADFG AR         T    T  Y AP
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 130
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
              +K + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVL 122
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+L+N + E  +ADFG AR         T    T  Y AP
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG AR+L  D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD 200

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/178 (33%), Positives = 96/178 (53%), Gaps = 20/178 (11%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG GG+G V+K +L   K V A+K L       ETE +   + F+ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           KLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 342 SPSIIHRDISSNNILLNSKFE-----AFVADFGTARL-LHADSSNRTLLAGTYGYIAP 393
           +P I+HRD+ S NI L S  E     A VADFGT++  +H+ S     L G + ++AP
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSG----LLGNFQWMAP 195

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 21  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 76
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 77  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 130
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 180

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 102/191 (53%), Gaps = 14/191 (7%)
Query: 207 GRIVYEDLIEATEG-FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKS 264
           GR    D  E  +G   +   IG+G +G+VYK +  +G V A+K L+ T+ T +   +++
Sbjct: 22  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQA 77
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           F+NE  VL +  H NI+   G+   +  + ++ ++ E  SL+ +LH  E   E+   K +
Sbjct: 78  FKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLI 134
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRT 382
           +I +  A  + YLH   + SIIHRD+ SNNI L+      + DFG  T +   + S    
Sbjct: 135 DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 383 LLAGTYGYIAP 393
            L+G+  ++AP
Sbjct: 192 QLSGSILWMAP 202

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 86/167 (51%), Gaps = 7/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
              +K + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCH---DRRVL 122
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+L+N + E  +ADFG AR         T    T  Y AP
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 18  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 73
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 74  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 127
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 177

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 15/175 (8%)
Query: 223 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V + +L  P  K    A+K L    TE     + F +EA ++ Q  H 
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR--REFLSEASIMGQFEHP 77
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G   +   + ++ E+ME G+L  F  L++ +  V     + V +++ +A  + Y
Sbjct: 78  NIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV----IQLVGMLRGIASGMRY 133
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
           L      S +HRD+++ NIL+NS     V+DFG +R L  +SS+ T  +   G I
Sbjct: 134 L---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 102/191 (53%), Gaps = 14/191 (7%)
Query: 207 GRIVYEDLIEATEG-FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKS 264
           GR    D  E  +G   +   IG+G +G+VYK +  +G V A+K L+ T+ T +   +++
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQA 78
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           F+NE  VL +  H NI+   G+   +  + ++ ++ E  SL+ +LH  E   E+   K +
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLI 135
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRT 382
           +I +  A  + YLH   + SIIHRD+ SNNI L+      + DFG  T +   + S    
Sbjct: 136 DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 383 LLAGTYGYIAP 393
            L+G+  ++AP
Sbjct: 193 QLSGSILWMAP 203

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +   +  + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 102/191 (53%), Gaps = 14/191 (7%)
Query: 207 GRIVYEDLIEATEG-FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKS 264
           GR    D  E  +G   +   IG+G +G+VYK +  +G V A+K L+ T+ T +   +++
Sbjct: 15  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQA 70
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           F+NE  VL +  H NI+   G+   +  + ++ ++ E  SL+ +LH  E   E+   K +
Sbjct: 71  FKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLI 127
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRT 382
           +I +  A  + YLH   + SIIHRD+ SNNI L+      + DFG  T +   + S    
Sbjct: 128 DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 383 LLAGTYGYIAP 393
            L+G+  ++AP
Sbjct: 185 QLSGSILWMAP 195

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 96/170 (56%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 87
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +    + + ++ ++ E  SL+ +LH +E   E+   K ++I +  A  + YLH   + SI
Sbjct: 88  YSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLH---AKSI 141
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 102/191 (53%), Gaps = 14/191 (7%)
Query: 207 GRIVYEDLIEATEG-FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKS 264
           GR    D  E  +G   +   IG+G +G+VYK +  +G V A+K L+ T+ T +   +++
Sbjct: 23  GRRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQA 78
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           F+NE  VL +  H NI+   G+   +  + ++ ++ E  SL+ +LH  E   E+   K +
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLI 135
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRT 382
           +I +  A  + YLH   + SIIHRD+ SNNI L+      + DFG  T +   + S    
Sbjct: 136 DIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 383 LLAGTYGYIAP 393
            L+G+  ++AP
Sbjct: 193 QLSGSILWMAP 203

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 163 L---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 37  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 94
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 150
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 151 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 77
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 133
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 13/170 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLH-TSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G+VYK +  +G V A+K L+ T+ T +   +++F+NE  VL +  H NI+   G
Sbjct: 16  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQ--LQAFKNEVGVLRKTRHVNILLFMG 71
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           +    + + ++ ++ E  SL+ +LH  E   E+   K ++I +  A  + YLH   + SI
Sbjct: 72  YSTAPQ-LAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLH---AKSI 125
Query: 346 IHRDISSNNILLNSKFEAFVADFG--TARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+ SNNI L+      + DFG  T +   + S     L+G+  ++AP
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSET 256
            YED  +    F          I   +G G +G V   + +LP+ K    A+K L    T
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNED 314
           E+    + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ + 
Sbjct: 85  EKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 142
Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            V     + V +++ +A  + YL        +HRD+++ NIL+NS     V+DFG +R+L
Sbjct: 143 TV----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 195
Query: 375 HAD 377
             D
Sbjct: 196 EDD 198

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSET 256
            YED  +    F          I   +G G +G V   + +LP+ K    A+K L    T
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNED 314
           E+    + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ + 
Sbjct: 87  EKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            V     + V +++ +A  + YL        +HRD+++ NIL+NS     V+DFG +R+L
Sbjct: 145 TV----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 375 HAD 377
             D
Sbjct: 198 EDD 200

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 88/183 (48%), Gaps = 24/183 (13%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSET 256
            YED  +    F          I   +G G +G V   + +LP+ K    A+K L    T
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNED 314
           E+    + F  EA ++ Q  H NI++L G     K + ++ EYME GSL  F   H+ + 
Sbjct: 87  EKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF 144
Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            V     + V +++ +A  + YL        +HRD+++ NIL+NS     V+DFG +R+L
Sbjct: 145 TV----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 375 HAD 377
             D
Sbjct: 198 EDD 200

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ EYME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG  R+L  D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 98/181 (54%), Gaps = 12/181 (6%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           IEA+E   +   IG+G +G+VYK +  +G V A+K L   +     F ++FRNE  VL +
Sbjct: 33  IEASEVM-LSTRIGSGSFGTVYKGKW-HGDV-AVKILKVVDPTPEQF-QAFRNEVAVLRK 88
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
             H NI+   G+ + +  + ++ ++ E  SL+ +LH  E   ++   + ++I +  A  +
Sbjct: 89  TRHVNILLFMGY-MTKDNLAIVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGM 145
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL--AGTYGYIA 392
            YLH   + +IIHRD+ SNNI L+      + DFG A +    S ++ +    G+  ++A
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 393 P 393
           P
Sbjct: 203 P 203

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 90/184 (48%), Gaps = 21/184 (11%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           +  E FD+   +G G YGSVYKA     G++ A+K++   E++    IK    E  ++ Q
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV-ESDLQEIIK----EISIMQQ 80
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNN---EDAVELDWAKRVNIVKA 329
               ++VK YG       ++++ EY   GS+     L N    ED +         I+++
Sbjct: 81  CDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-------ATILQS 133
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYG 389
               L YLH       IHRDI + NILLN++  A +ADFG A  L    + R  + GT  
Sbjct: 134 TLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF 190
Query: 390 YIAP 393
           ++AP
Sbjct: 191 WMAP 194

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 95/178 (53%), Gaps = 20/178 (11%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG GG+G V+K +L   K V A+K L       ETE +   + F+ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           KLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 342 SPSIIHRDISSNNILLNSKFE-----AFVADFG-TARLLHADSSNRTLLAGTYGYIAP 393
           +P I+HRD+ S NI L S  E     A VADFG + + +H+ S     L G + ++AP
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG----LLGNFQWMAP 195

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 11/173 (6%)
Query: 223 IKYCIGTGGYGSVYKA--QLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V     +LP  +    A+K L +  TE+    + F +EA ++ Q  H 
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHP 68
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           N++ L G       + +I E+ME GSL   L  N+    +   + V +++ +A  + YL 
Sbjct: 69  NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTV--IQLVGMLRGIAAGMKYL- 125
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
                + +HR +++ NIL+NS     V+DFG +R L  D+S+ T  +   G I
Sbjct: 126 --ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 7/181 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++ Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 278 RNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 334
            NIV+ Y   + R    ++++ EY E G L   +    ++   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 335 AYLHH--DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 393 P 393
           P
Sbjct: 185 P 185

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 223 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V   +L  P  +    A+K L    T++    + F +EA ++ Q  H 
Sbjct: 33  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHP 90
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NI+ L G     K + +I EYME GSL   L  N+    +   + V +++ +   + YL 
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS 148
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                S +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 149 ---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 184

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSET 256
            YED  +A   F          I+  IG G +G V   + +LP  +    A+K L    T
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV 316
           E+    + F  EA ++ Q  H NI+ L G     K + ++ EYME GSL   L  N+   
Sbjct: 64  EKQR--RDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF 121
Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
            +   + V +++ ++  + YL        +HRD+++ NIL+NS     V+DFG +R+L  
Sbjct: 122 TV--IQLVGMLRGISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED 176
Query: 377 D 377
           D
Sbjct: 177 D 177

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 7/181 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++ Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 278 RNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 334
            NIV+ Y   + R    ++++ EY E G L   +    ++   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 335 AYLHH--DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 393 P 393
           P
Sbjct: 185 P 185

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 223 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V   +L  P  +    A+K L    T++    + F +EA ++ Q  H 
Sbjct: 12  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHP 69
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NI+ L G     K + +I EYME GSL   L  N+    +   + V +++ +   + YL 
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS 127
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                S +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 128 ---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 163

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 223 IKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V   +L  P  +    A+K L    T++    + F +EA ++ Q  H 
Sbjct: 18  IEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR--RDFLSEASIMGQFDHP 75
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NI+ L G     K + +I EYME GSL   L  N+    +   + V +++ +   + YL 
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLS 133
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                S +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 134 ---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDD 169

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 23/184 (12%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G   K      G+V  +K+L   + E     ++F  E +V+  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                K +  I EY++ G+L   + + +   +  W++RV+  K +A  +AYLH   S +I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLL--------------HADSSNRTLLAGTYGYI 391
           IHRD++S+N L+       VADFG ARL+                D   R  + G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 392 APGL 395
           AP +
Sbjct: 190 APEM 193

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 20  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 77
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ E ME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 133
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 134 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 171

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I   +G G +G V   + +LP+ K    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           NI++L G     K + ++ E ME GSL  F   H+ +  V     + V +++ +A  + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTV----IQLVGMLRGIASGMKY 162
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R+L  D
Sbjct: 163 L---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 24/183 (13%)
Query: 210 VYEDLIEATEGF---------DIKYCIGTGGYGSVY--KAQLPNGKVF--ALKKLHTSET 256
            YED  +    F          I   +G G +G V   + +LP+ K    A+K L    T
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNED 314
           E+    + F  EA ++ Q  H NI++L G     K + ++ E ME GSL  F   H+ + 
Sbjct: 87  EKQR--RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF 144
Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            V     + V +++ +A  + YL        +HRD+++ NIL+NS     V+DFG +R+L
Sbjct: 145 TV----IQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVL 197
Query: 375 HAD 377
             D
Sbjct: 198 EDD 200

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 94/178 (52%), Gaps = 20/178 (11%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKL----HTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG GG+G V+K +L   K V A+K L       ETE +   + F+ E  ++S + H NIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           KLYG   +   M  + E++  G L+  L +   A  + W+ ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPRM--VMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ- 141
Query: 342 SPSIIHRDISSNNILLNSKFE-----AFVADFG-TARLLHADSSNRTLLAGTYGYIAP 393
           +P I+HRD+ S NI L S  E     A VADF  + + +H+ S     L G + ++AP
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSG----LLGNFQWMAP 195

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 7/181 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++ Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 278 RNIVKLYGFCLHRK--CMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 334
            NIV+ Y   + R    ++++ EY E G L   +    ++   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 335 AYLHH--DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D        GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 393 P 393
           P
Sbjct: 185 P 185

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G YG VYKA+   G++ ALK++     +E     + R E  +L ++ H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               +C+ L++E+ME+  L   L  N+  ++ D   ++ + + +   +A+ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLL-RGVAHCHQH---RIL 141
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           HRD+   N+L+NS     +ADFG AR       + T    T  Y AP +
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 85/169 (50%), Gaps = 7/169 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G YG VYKA+   G++ ALK++     +E     + R E  +L ++ H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               +C+ L++E+ME+  L   L  N+  ++ D   ++ + + +   +A+ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQ-DSQIKIYLYQLL-RGVAHCHQH---RIL 141
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
           HRD+   N+L+NS     +ADFG AR       + T    T  Y AP +
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/181 (32%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAF------IKSFR----NEAQVLSQV 275
           +G+G YG V   +  NG    A+K +  S+ ++  +      I+ F     NE  +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI+KL+     +K  +L+ E+ E G LF  + N     E D A   NI+K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---NIMKQILSGIC 160
Query: 336 YLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           YLH     +I+HRDI   NILL   NS     + DFG +     D   R  L   Y YIA
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIA 216
Query: 393 P 393
           P
Sbjct: 217 P 217

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 88/179 (49%), Gaps = 16/179 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHAL 334
             I++++G     + +F+I +Y+E G LF  L  ++   + V   +A  V +      AL
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL------AL 119
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S  II+RD+   NILL+      + DFG A+ +         L GT  YIAP
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYXLCGTPDYIAP 172

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 77
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 133
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 74
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 130
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 78
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 79  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 134
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 135 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 173

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 105
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 161
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 79
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 80  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 135
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 136 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 174

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 92
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 148
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 81
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 82  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 137
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 138 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 176

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 72
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 128
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 129 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 167

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 80
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 81  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 136
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 137 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 175

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 74
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 130
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 73
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 129
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 130 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 168

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 92
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 148
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 149 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 187

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 74
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 130
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 223 IKYCIGTGGYGSVY--KAQLPNGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           I+  IG G +G V   + +LP  +    A+K L    TE+    + F  EA ++ Q  H 
Sbjct: 47  IERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQR--RDFLCEASIMGQFDHP 104
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           N+V L G     K + ++ E+ME G+L  F   H+ +  V     + V +++ +A  + Y
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV----IQLVGMLRGIAAGMRY 160
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           L        +HRD+++ NIL+NS     V+DFG +R++  D
Sbjct: 161 L---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 86/179 (48%), Gaps = 26/179 (14%)
Query: 230 GGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV--LSQVLHRNIVKLYGFC 287
           G +G V+KAQL N  V A+K     + +      S++NE +V  L  + H NI++  G  
Sbjct: 35  GRFGCVWKAQLLNEYV-AVKIFPIQDKQ------SWQNEYEVYSLPGMKHENILQFIGAE 87
Query: 288 LHRKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-- 341
                    ++LI  + E+GSL   L  N     + W +  +I + MA  LAYLH D   
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPG 143
Query: 342 -----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAP 393
                 P+I HRDI S N+LL +   A +ADFG A    A  S  +     GT  Y+AP
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAP 202

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               + +++I EYM +GSL   L ++E    L   K ++    +A  +AY+      + I
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYI 132
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH 375
           HRD+ + N+L++      +ADFG AR++ 
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVIE 161

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
           HRD+++ N L+N +    V+DFG +R +  D    ++
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSV 179

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 84/176 (47%), Gaps = 19/176 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +K  +G G +G V+ A+  N    K   L  +   +   LA  K F+ EA++L+ + H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAV-----------ELDWAKRVNI 326
           IVK YG C     + +++EYM+ G L  F   H  +  +           EL  ++ ++I
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
              +A  + YL    S   +HRD+++ N L+ +     + DFG +R +++    R 
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 77
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +  A  +D  K +     +   + YL  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAH--AERIDHIKLLQYTSQICKGMEYL-- 133
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 6/179 (3%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E F +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q
Sbjct: 8   EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           + H +I++LY +      ++L+ E    G +   L N       + A+  + +  +   +
Sbjct: 68  LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR--HFMHQIITGM 125
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S  I+HRD++ +N+LL       +ADFG A  L         L GT  YI+P
Sbjct: 126 LYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQ 270
           IEA+    I+  IG+G  G V   +L  P  +    A+K L    TE     + F +EA 
Sbjct: 46  IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEAS 102
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVK 328
           ++ Q  H NI++L G     +   ++ EYME GSL  F   H+ +  +     + V +++
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI----MQLVGMLR 158
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            +   + YL        +HRD+++ N+L++S     V+DFG +R+L  D
Sbjct: 159 GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 9/151 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 142
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N L+N +    V+DFG +R +  D
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 16/169 (9%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQL--PNGK--VFALKKLHTSETEELAFIKSFRNEAQ 270
           IEA+    I+  IG+G  G V   +L  P  +    A+K L    TE     + F +EA 
Sbjct: 46  IEASR-IHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEAS 102
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVK 328
           ++ Q  H NI++L G     +   ++ EYME GSL  F   H+ +  +     + V +++
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTI----MQLVGMLR 158
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            +   + YL        +HRD+++ N+L++S     V+DFG +R+L  D
Sbjct: 159 GVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 86/177 (48%), Gaps = 24/177 (13%)
Query: 223 IKYCIGTGGYGSVYKAQLPN-----GKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +K  +G G +G V+ A+  N      K+  A+K L  +        K F  EA++L+ + 
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR---KDFHREAELLTNLQ 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAV---------ELDWAKRVN 325
           H +IVK YG C+    + +++EYM+ G L  F   H   DAV         EL  ++ ++
Sbjct: 74  HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH-GPDAVLMAEGNPPTELTQSQMLH 132
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           I + +A  + YL    S   +HRD+++ N L+       + DFG +R +++    R 
Sbjct: 133 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 22  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 18  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 128
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 129 EKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 22  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 15  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 125
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 15  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 125
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 77
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI E++  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 78  KYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 133
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 134 -GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 172

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 78
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 133
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+N +    V+DFG +R +  D 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 18  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 74
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 128
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 129 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 166

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 126
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+N +    V+DFG +R +  D 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+N +    V+DFG +R +  D 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 22  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 72
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 127
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+N +    V+DFG +R +  D 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 19  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 129
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 21  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 77
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 131
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 73
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 128
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 22  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 125
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 157

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 19  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 129
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 67
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L       +    + + + K +  A+ YL    S   +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLE---SKQFL 122
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+N +    V+DFG +R +  D 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 22  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 78
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 133 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 170

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 19/184 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTS----ETEELAFIKSFRNEAQ 270
           E F++   +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 271 VLSQVLHRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
           +L +V H  IV L Y F    K ++LI EY+  G LF  L      +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYG 389
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 390 YIAP 393
           Y+AP
Sbjct: 187 YMAP 190

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/184 (32%), Positives = 89/184 (48%), Gaps = 19/184 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTS----ETEELAFIKSFRNEAQ 270
           E F++   +G GGYG V++ +       GK+FA+K L  +      ++ A  K+ RN   
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--- 73
Query: 271 VLSQVLHRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
           +L +V H  IV L Y F    K ++LI EY+  G LF  L      +E D A     +  
Sbjct: 74  ILEEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME-DTA--CFYLAE 129
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYG 389
           ++ AL +LH      II+RD+   NI+LN +    + DFG  +    D +      GT  
Sbjct: 130 ISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 390 YIAP 393
           Y+AP
Sbjct: 187 YMAP 190

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 68
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 123
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 66
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 67  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 124
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 125 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 158

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 15/160 (9%)
Query: 227 IGTGGYGSVYKA-----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV        Q   G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 75
Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C    R+ + LI EY+  GSL   L  +++ +  D  K +     +   + YL  
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIKLLQYTSQICKGMEYL-- 131
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             +   IHR++++ NIL+ ++    + DFG  ++L  D  
Sbjct: 132 -GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKE 170

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+     N    A+K L          +++F  EA ++  + H  +V+LY  
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               + +++I E+M +GSL   L ++E    L   K ++    +A  +AY+      + I
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERK---NYI 131
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH 375
           HRD+ + N+L++      +ADFG AR++ 
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVIE 160

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIE----EAEVMMKLSHPKLVQLYGV 90
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L++E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 145
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 177

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 30  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 86
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 140
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 141 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 178

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 17  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 127
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 128 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 19  MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 129
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 167

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 322
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 323 KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 381 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKIRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 14/187 (7%)
Query: 216 EATEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLH-TSET---EELAFIK-SFRNEA 269
           E  + +D K  IG G    V +      G  FA+K +  T+E    E+L  ++ + R E 
Sbjct: 91  EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 270 QVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
            +L QV  H +I+ L         MFL+++ M +G LF  L    + V L   +  +I++
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKETRSIMR 207
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
           ++  A+++LH +   +I+HRD+   NILL+   +  ++DFG +  L      R  L GT 
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE-LCGTP 263
Query: 389 GYIAPGL 395
           GY+AP +
Sbjct: 264 GYLAPEI 270

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 269
           +++ TE   +K  +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA
Sbjct: 34  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 91
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVN 325
            +++ + H ++V+L G CL    + L+ + M  G L   +H ++D +     L+W   V 
Sbjct: 92  LIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 148
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           I K M     YL       ++HRD+++ N+L+ S     + DFG ARLL  D   
Sbjct: 149 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 196

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+++ NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLAAANILVGENLVCKVADFGLARLIE 165

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 13  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 68
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 69  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 126
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 127 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 169

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 62
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 63  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 121 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 154

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 12  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 67
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 68  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 125
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 126 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 168

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLL-DFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 88/186 (47%), Gaps = 17/186 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLS 273
           E F++   +GTG YG V+  +       GK++A+K L  +   ++    +  R E QVL 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 274 QVLHRN-IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI-VKAM 330
            +     +V L Y F    K + LI +Y+  G LF +L   E   E      V I V  +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYG 389
             AL +LH      II+RDI   NILL+S     + DFG ++   AD + R     GT  
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 390 YIAPGL 395
           Y+AP +
Sbjct: 226 YMAPDI 231

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 64
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 65  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 122
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 123 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 156

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G +G VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 15  MKHKLGGGQFGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 71
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 125
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 163

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 23/164 (14%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY       K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 36  MKHKLGGGQYGEVYVGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 92
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L G C      +++ EYM  G+L            LD+ +  N  +  A  L Y+    S
Sbjct: 93  LLGVCTLEPPFYIVTEYMPYGNL------------LDYLRECNREEVTAVVLLYMATQIS 140
Query: 343 PSI--------IHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
            ++        IHRD+++ N L+       VADFG +RL+  D+
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDT 184

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 70
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 71  KLVQLYA-VVSEEPIYIVTEYMNKGSLL-DFLKGETGKYLRLPQLVDMSAQIASGMAYVE 128
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 129 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 162

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 65
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 66  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 123
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 6   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 61
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 62  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 119
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 120 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 162

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 59
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 60  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 117
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 59
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 60  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 117
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 10  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 65
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 66  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 123
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 166

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 239
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 240 KLVQLYA-VVSEEPIYIVGEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 298 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 331

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVIEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 5   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 60
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 61  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 118
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 119 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 161

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 4   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 59
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 60  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 117
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 224 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI------SSAMEYL 334
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHR++++ N L+       VADFG +RL+  D+
Sbjct: 335 EKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 9   WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 64
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 65  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 122
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 123 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 165

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 10/166 (6%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G +G V+          A+K L        AF+     EA
Sbjct: 14  WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 69
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 70  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 127
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+ 
Sbjct: 128 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 170

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L        AF+     EA ++ Q+ H+ +V+LY  
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 70
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            + ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + I
Sbjct: 71  VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH 375
           HRD+ + NIL++      +ADFG ARL+ 
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIE 155

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVCEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 70
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L++E+ME G L   L         +    + +   +   +AYL      S+I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEE---ASVI 125
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 157

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 63
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + + ++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 64  KLVQLYA-VVSEEPIXIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 122 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 155

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 20/175 (11%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEA 269
           +++ TE   +K  +G+G +G+VYK   +P G+   +    K+    T   A ++ F +EA
Sbjct: 11  ILKETELKRVK-VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEA 68
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVN 325
            +++ + H ++V+L G CL    + L+ + M  G L   +H ++D +     L+W   V 
Sbjct: 69  LIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWC--VQ 125
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           I K M     YL       ++HRD+++ N+L+ S     + DFG ARLL  D   
Sbjct: 126 IAKGMM----YLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE 173

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G V+     N    A+K +      E  FI+    EA+V+ ++ H  +V+LYG 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYGV 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           CL +  + L+ E+ME G L   L         +    + +   +   +AYL   C   +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYLEEAC---VI 126
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L+       V+DFG  R +  D 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 17/161 (10%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +K+ +G G YG VY+      K ++L     +  E+   ++ F  EA V+ ++ H N+V+
Sbjct: 263 MKHKLGGGQYGEVYEGVW---KKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQ 319
Query: 283 LYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           L G C      ++I E+M  G+L      CN       V L  A ++      + A+ YL
Sbjct: 320 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQI------SSAMEYL 373
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                 + IHR++++ N L+       VADFG +RL+  D+
Sbjct: 374 E---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 411

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L           +SF  EAQ++ ++ H  +V+LY  
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQLYA- 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            +  + ++++ EYM +GSL   L + E    L     V++   +A  +AY+      + I
Sbjct: 72  VVSEEPIYIVTEYMNKGSLLDFLKDGEGRA-LKLPNLVDMAAQVAAGMAYIERM---NYI 127
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH 375
           HRD+ S NIL+ +     +ADFG ARL+ 
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIE 156

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 85/170 (50%), Gaps = 15/170 (8%)
Query: 227 IGTGGYGSVYKAQLPN-GKVFALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A+  + G+  A+K   L   +  EL F     NE  ++    H N+V++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-----NEVVIMRDYQHFNVVEM 107
Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           Y   L  + ++++ E+++ G+L     +    V L+  +   + +A+  ALAYLH   + 
Sbjct: 108 YKSYLVGEELWVLMEFLQGGAL----TDIVSQVRLNEEQIATVCEAVLQALAYLH---AQ 160
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++AP
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAP 210

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 86/181 (47%), Gaps = 15/181 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+I   IG G +  V   ++   G+V+A+K ++  +  +   +  FR E  VL     
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK--RVNIVKAM--AHA 333
           R I +L+        ++L+ EY   G L   L    + +  + A+     IV A+   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 392
           L Y         +HRDI  +NILL+      +ADFG+   L AD + R+L+A GT  Y++
Sbjct: 181 LGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 393 P 393
           P
Sbjct: 232 P 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 11/185 (5%)
Query: 211 YEDLIEA-TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED  E   E   +   +G G  G V+          A+K L        AF+     EA
Sbjct: 4   WEDAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EA 59
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++ Q+ H+ +V+LY   + ++ +++I EYME GSL  +       ++L   K +++   
Sbjct: 60  NLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQ 117
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH-ADSSNRTLLAGTY 388
           +A  +A++      + IHRD+ + NIL++      +ADFG ARL+  A+ + R       
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI 174
Query: 389 GYIAP 393
            + AP
Sbjct: 175 KWTAP 179

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 82
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 133
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 187

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 91
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 142
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 143 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 196

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 93
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 144
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 145 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 198

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 18/182 (9%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHR 278
           F++   +G G YG VYK + +  G++ A+K +  +  EE    +  + E  +L +   HR
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHR 81
Query: 279 NIVKLYGFCLHR------KCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMA 331
           NI   YG  + +        ++L+ E+   GS+   + N + + ++ +W     I + + 
Sbjct: 82  NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREIL 139
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
             L++LH      +IHRDI   N+LL    E  + DFG +  L      R    GT  ++
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 392 AP 393
           AP
Sbjct: 197 AP 198

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 18/175 (10%)
Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V K +  + G++ A+KK   S+ +++    + R E ++L Q+ H N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVEL-----DWAKRVNIVKAMAHALAYLHHD 340
            C  +K  +L++E+++        H   D +EL     D+      +  + + + + H  
Sbjct: 92  VCKKKKRWYLVFEFVD--------HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            S +IIHRDI   NIL++      + DFG AR L A          T  Y AP L
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +G L  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVMEYMSKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQ----EAQVMKKLRHE 240
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 241 KLVQLYA-VVSEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 298
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG  RL+ 
Sbjct: 299 R---MNYVHRDLRAANILVGENLVCKVADFGLGRLIE 332

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 213
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 264
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 265 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 318

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L        AF++    EAQV+ ++ H 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHE 73
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY   +  + ++++ EYM +G L  +    E    L   + V++   +A  +AY+ 
Sbjct: 74  KLVQLYAV-VSEEPIYIVTEYMSKGCLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 131
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + +HRD+ + NIL+       VADFG ARL+ 
Sbjct: 132 RM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 165

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 32/177 (18%)
Query: 227 IGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           IG G +G V++A+ P         + A+K L    + ++     F+ EA ++++  + NI
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMAEFDNPNI 112
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSL-----------FCNLHNNEDAVE----------LD 319
           VKL G C   K M L++EYM  G L            C+L +++ +            L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 320 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
            A+++ I + +A  +AYL        +HRD+++ N L+       +ADFG +R +++
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E + I   +G GG  +VY A+  + N KV A+K +     E+   +K F  E    SQ+ 
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H+NIV +        C +L+ EY+E G        +   + +D A  +N    +   + +
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIE-GPTLSEYIESHGPLSVDTA--INFTNQILDGIKH 126
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIAP 393
            H      I+HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +P
Sbjct: 127 AH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +EDL+   +       IG G +G V+  +L  +  + A+K    +   +L     F  EA
Sbjct: 113 HEDLVLGEQ-------IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEA 163
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
           ++L Q  H NIV+L G C  ++ ++++ E ++ G     L    +   L     + +V  
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGD 221
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            A  + YL   C    IHRD+++ N L+  K    ++DFG +R
Sbjct: 222 AAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 86
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 137
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 138 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 191

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 83/181 (45%), Gaps = 15/181 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+I   IG G +G V   +L N  KVFA+K L+  E  + A    FR E  VL     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK----RVNIVKAMAHA 333
           + I  L+        ++L+ +Y   G L   L   ED +  + A+     + I     H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIA 392
           L Y         +HRDI  +NIL++      +ADFG+   L  D + ++ +A GT  YI+
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 393 P 393
           P
Sbjct: 245 P 245

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           ++  E ++I   +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILA 63
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV- 327
              H  IVKL G   H   ++++ E+   G++        DA+ L+  +     ++ +V 
Sbjct: 64  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVVC 115
Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGT 387
           + M  AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT
Sbjct: 116 RQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 388 YGYIAP 393
             ++AP
Sbjct: 173 PYWMAP 178

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 15/163 (9%)
Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +EDL+   +       IG G +G V+  +L  +  + A+K    +   +L     F  EA
Sbjct: 113 HEDLVLGEQ-------IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK--AKFLQEA 163
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
           ++L Q  H NIV+L G C  ++ ++++ E ++ G     L    +   L     + +V  
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGD 221
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            A  + YL   C    IHRD+++ N L+  K    ++DFG +R
Sbjct: 222 AAAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSR 261

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H NIVKL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHALAYLHHD 340
             +   ++++ E+   G++        DAV L+  +     ++ +V K    AL YLH +
Sbjct: 103 FYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAP 204

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKL 283
           C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  H NI+  
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLRHENILGF 96
Query: 284 YGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +  +     ++LI  Y E GSL+  L        LD    + IV ++A  LA+LH 
Sbjct: 97  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 152
Query: 340 DC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-----GTYG 389
           +       P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +      GT  
Sbjct: 153 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 211
Query: 390 YIAP 393
           Y+AP
Sbjct: 212 YMAP 215

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 21/175 (12%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +  +GK+ A+KK  L   +  EL F     NE  ++    H N+V++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLF-----NEVVIMRDYQHENVVEM 136
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  A+  AL+ LH  
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------AAVCLAVLQALSVLH-- 187
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            +  +IHRDI S++ILL       ++DFG    +  +   R  L GT  ++AP L
Sbjct: 188 -AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPEL 241

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 9/149 (6%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G V+          A+K L        AF+     EA ++ Q+ H+ +V+LY  
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA- 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
            + ++ +++I EYME GSL  +       ++L   K +++   +A  +A++      + I
Sbjct: 72  VVTQEPIYIITEYMENGSL-VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH 375
           HR++ + NIL++      +ADFG ARL+ 
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIE 156

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 162
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   + +L GT  YIAP
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 21/186 (11%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           ++  E ++I   +G G +G VYKA+    G + A K + T   EEL   + +  E ++L+
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILA 71
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV- 327
              H  IVKL G   H   ++++ E+   G++        DA+ L+  +     ++ +V 
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV--------DAIMLELDRGLTEPQIQVVC 123
Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGT 387
           + M  AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT
Sbjct: 124 RQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 388 YGYIAP 393
             ++AP
Sbjct: 181 PYWMAP 186

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H NI+KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y+H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 146
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK +     + DFG +    A    +  + GT  YIAP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAP 197

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKL 283
           C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  H NI+  
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLRHENILGF 67
Query: 284 YGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +  +     ++LI  Y E GSL+  L        LD    + IV ++A  LA+LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 340 DC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-----GTYG 389
           +       P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +      GT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 182
Query: 390 YIAP 393
           Y+AP
Sbjct: 183 YMAP 186

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H NI+KLY
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 115
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y+H +    
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 169
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAP
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAP 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 84/172 (48%), Gaps = 11/172 (6%)
Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H NI+KLY
Sbjct: 39  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y+H +    
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 152
Query: 345 IIHRDISSNNILLNSKFEA---FVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK +     + DFG +    A    +  + GT  YIAP
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI-GTAYYIAP 203

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 89/182 (48%), Gaps = 16/182 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+I   IG G +G V   Q  +  K++A+K ++  +  E   +++   E Q++  + H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHA 333
             +V L+      + MF++ + +  G L  +L  N    E+ V+L        +  +  A
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-------FICELVMA 127
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L YL +     IIHRD+  +NILL+      + DF  A +L  ++   T +AGT  Y+AP
Sbjct: 128 LDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTMAGTKPYMAP 183
Query: 394 GL 395
            +
Sbjct: 184 EM 185

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 83/172 (48%), Gaps = 11/172 (6%)
Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H NI+KLY
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 116
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y+H +    
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---K 170
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK +     + DFG +    A    +  +   Y YIAP
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAP 221

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 107 FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 160
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   + +L GT  YIAP
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 88/184 (47%), Gaps = 28/184 (15%)
Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKL 283
           C+G G YG V++       V    K+ +S  E     KS+  E ++ + V+  H NI+  
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAV--KIFSSRDE-----KSWFRETELYNTVMLRHENILGF 67
Query: 284 YGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +  +     ++LI  Y E GSL+  L        LD    + IV ++A  LA+LH 
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 340 DC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-----GTYG 389
           +       P+I HRD+ S NIL+    +  +AD G A ++H+ S+N+  +      GT  
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKR 182
Query: 390 YIAP 393
           Y+AP
Sbjct: 183 YMAP 186

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +D+K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 86
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF ++   E   E D +   + ++ +  ++AY
Sbjct: 87  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 143
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 199

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H NIVKL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHALAYLHHD 340
             +   ++++ E+   G++        DAV L+  +     ++ +V K    AL YLH +
Sbjct: 103 FYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAP 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 19/173 (10%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G +G VYKAQ     V A  K+  +++EE   ++ +  E  +L+   H NIVKL   
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE--LEDYMVEIDILASCDHPNIVKLLDA 102
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK-----RVNIV-KAMAHALAYLHHD 340
             +   ++++ E+   G++        DAV L+  +     ++ +V K    AL YLH +
Sbjct: 103 FYYENNLWILIEFCAGGAV--------DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               IIHRD+ + NIL     +  +ADFG +         R    GT  ++AP
Sbjct: 155 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 204

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 10/168 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 92
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L        LD  +   I++ +   L YLH   S   
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEKK 145
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 193

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 37/195 (18%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+ +V+ Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQYVVRYY 68
Query: 285 GFCLHRK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
              L R+              +F+  EY E G+L+  +H+     + D   R  + + + 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR--LFRQIL 126
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH--------------AD 377
            AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H                
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 378 SSNRTLLAGTYGYIA 392
           S N T   GT  Y+A
Sbjct: 184 SDNLTSAIGTAMYVA 198

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG G  G V  A +   GK  A+KK  L   +  EL F     NE  ++    H N+V +
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-----NEVVIMRDYHHDNVVDM 107
Query: 284 YGFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           Y   L    ++++ E++E G+L     +   NE+ +         +  ++  AL+YLH+ 
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-------ATVCLSVLRALSYLHNQ 160
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               +IHRDI S++ILL S     ++DFG    +  +   R  L GT  ++AP
Sbjct: 161 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAP 210

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 136
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   + +L GT  YIAP
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 273
           AT  ++    IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 274 QVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 325
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 8/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GT G   V K +L   KV A+K L+  +   L  +   R E Q L    H +I+KLY  
Sbjct: 26  VGTFGKVKVGKHELTGHKV-AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
                 +F++ EY+  G LF  +  N     LD  +   + + +   + Y H      ++
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VV 138
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+LL++   A +ADFG + ++ +D        G+  Y AP
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRXSCGSPNYAAP 184

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 273
           AT  ++    IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 274 QVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 325
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 19/168 (11%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEA--QVLS 273
           AT  ++    IG G YG+VYKA+ P+ G   ALK +     EE   I + R  A  + L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 274 QVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVN 325
              H N+V+L   C   +      + L++E++++     +L    D      L      +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAETIKD 116
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 138
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   +  L GT  YIAP
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 85  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 138
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   +  L GT  YIAP
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 10/168 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L        LD  +   I++ +   L YLH   S   
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEKK 140
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 188

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKE 65
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----M 330
           + H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQL 119
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
              LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y
Sbjct: 120 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 391 IAP 393
            AP
Sbjct: 177 RAP 179

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +D+K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 62
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF ++   E   E D +   + ++ +  ++AY
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 119
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 120 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 175

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 10/168 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L        LD  +   I++ +   L YLH   S   
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEKK 125
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 173

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +D+K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF ++   E   E D +   + ++ +  ++AY
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 120
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 75/168 (44%), Gaps = 7/168 (4%)
Query: 227 IGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++    + K VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH +    +
Sbjct: 89  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEAR--YYLRQIVLGCQYLHRN---RV 142
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   +  L GT  YIAP
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 91/180 (50%), Gaps = 12/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +D+K  +G G +  V +      G  FA K ++T +     F K    EA++  ++ 
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF ++   E   E D +   + ++ +  ++AY
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAY 120
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            H   S  I+HR++   N+LL SK +     +ADFG A  ++ DS      AGT GY++P
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 76/168 (45%), Gaps = 10/168 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       KV A+K +   E      I+  + E  VLSQ     + K YG
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 72
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L        LD  +   I++ +   L YLH   S   
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLH---SEKK 125
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 173

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 86/183 (46%), Gaps = 15/183 (8%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L +
Sbjct: 7   EFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKE 65
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----M 330
           + H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +
Sbjct: 66  LNHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQL 119
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
              LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y
Sbjct: 120 LQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 391 IAP 393
            AP
Sbjct: 177 RAP 179

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 223 IKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           +K+ +G G +G V+ A+    LP      +      E  E A  + F+ EA++L+ + H+
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTMLQHQ 103
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKRVNI 326
           +IV+ +G C   + + +++EYM  G L  F   H          ED     L   + + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS----SNRT 382
              +A  + YL        +HRD+++ N L+       + DFG +R +++        RT
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 383 LL 384
           +L
Sbjct: 221 ML 222

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 11/172 (6%)
Query: 226 CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V   +    G+  A+K +   + ++    +S   E Q+L Q+ H NI KLY
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLY 92
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y H +    
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---K 146
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK +     + DFG +    A    +  + GT  YIAP
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI-GTAYYIAP 197

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 70
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +VKL+   + ++ +++I E+M +GSL   L ++E + +    K ++    +A  +A++ 
Sbjct: 71  KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIE 128
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + IHRD+ + NIL+++     +ADFG AR++ 
Sbjct: 129 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 162

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-----NI 280
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+     ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V  +GF      ++++ E   R SL   LH    AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               +IHRD+   N+ LN   +  + DFG A  +  D   +  L GT  YIAP
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-----NI 280
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+     ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V  +GF      ++++ E   R SL   LH    AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               +IHRD+   N+ LN   +  + DFG A  +  D   +  L GT  YIAP
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 223 IKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           +K+ +G G +G V+ A+    LP      +      E  E A  + F+ EA++L+ + H+
Sbjct: 16  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTMLQHQ 74
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKRVNI 326
           +IV+ +G C   + + +++EYM  G L  F   H          ED     L   + + +
Sbjct: 75  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 134
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
              +A  + YL        +HRD+++ N L+       + DFG +R +++    R 
Sbjct: 135 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 187

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 80/176 (45%), Gaps = 20/176 (11%)
Query: 223 IKYCIGTGGYGSVYKAQ----LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           +K+ +G G +G V+ A+    LP      +      E  E A  + F+ EA++L+ + H+
Sbjct: 22  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR-QDFQREAELLTMLQHQ 80
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL--FCNLH--------NNEDAV--ELDWAKRVNI 326
           +IV+ +G C   + + +++EYM  G L  F   H          ED     L   + + +
Sbjct: 81  HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 140
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
              +A  + YL        +HRD+++ N L+       + DFG +R +++    R 
Sbjct: 141 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 193

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 15/182 (8%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 114
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y 
Sbjct: 115 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 171
Query: 392 AP 393
           AP
Sbjct: 172 AP 173

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 18/174 (10%)
Query: 227 IGTGGYG-SVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G ++      +G+ + +K+++ S        +S R E  VL+ + H NIV+   
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRE 90
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMAHALAYLHH 339
                  ++++ +Y E G LF  ++        ED + LDW   V I  A+ H      H
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWF--VQICLALKHV-----H 142
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           D    I+HRDI S NI L       + DFG AR+L++         GT  Y++P
Sbjct: 143 D--RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 265
            E +D+   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
           + E  +   + H N+VK YG        +L  EY   G LF  +  +    E D A+R  
Sbjct: 52  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-- 383
               +   + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 384 LAGTYGYIAPGL 395
           + GT  Y+AP L
Sbjct: 166 MXGTLPYVAPEL 177

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 81/157 (51%), Gaps = 9/157 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 243
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +VKL+   + ++ +++I E+M +GSL   L ++E + +    K ++    +A  +A++ 
Sbjct: 244 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIE 301
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                + IHRD+ + NIL+++     +ADFG AR++ 
Sbjct: 302 QR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 115
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEIXINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 115
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 115
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 65
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 119
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 120 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 176

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-----NI 280
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+     ++
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 88
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V  +GF      ++++ E   R SL   LH    AV    A+    ++     + YLH++
Sbjct: 89  VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 145
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               +IHRD+   N+ LN   +  + DFG A  +  D   +  L GT  YIAP
Sbjct: 146 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 84/178 (47%), Gaps = 24/178 (13%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V+K +    G++ A+KK   SE + +    + R E ++L Q+ H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR---VNIVKAMA----HALAYLH 338
               ++ + L++EY +   L           ELD  +R    ++VK++      A+ + H
Sbjct: 70  VFRRKRRLHLVFEYCDHTVLH----------ELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 339 -HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            H+C    IHRD+   NIL+       + DFG ARLL   S        T  Y +P L
Sbjct: 120 KHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 7/177 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+I   IG G +G V   ++ N  +++A+K L+  E  + A    FR E  VL     
Sbjct: 74  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 133
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           + I  L+        ++L+ +Y   G L   L   ED +  D A+    +  M  A+  +
Sbjct: 134 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 191
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
           H       +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+P
Sbjct: 192 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 245

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-----NI 280
           +G GG+   Y+   +   +VFA K +  S       +K  + E       +H+     ++
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKS-----MLLKPHQKEKMSTEIAIHKSLDNPHV 104
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V  +GF      ++++ E   R SL   LH    AV    A+    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLL-ELHKRRKAVTEPEAR--YFMRQTIQGVQYLHNN 161
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               +IHRD+   N+ LN   +  + DFG A  +  D   +  L GT  YIAP
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 86  SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLH---S 135
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 136 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 186

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLH---S 134
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAP 185

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 7/177 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+I   IG G +G V   ++ N  +++A+K L+  E  + A    FR E  VL     
Sbjct: 90  EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDC 149
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           + I  L+        ++L+ +Y   G L   L   ED +  D A+    +  M  A+  +
Sbjct: 150 QWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY--IGEMVLAIDSI 207
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
           H       +HRDI  +N+LL+      +ADFG+   ++ D + ++ +A GT  YI+P
Sbjct: 208 HQ---LHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISP 261

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLH---S 134
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  + +
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINA 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 13/172 (7%)
Query: 227 IGTGGYGSVY--KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G YG V   K +L  G   A+K +  S     +   +  +E  VL Q+ H NI+KLY
Sbjct: 29  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   ++  +L+ E    G LF  +   +   E+D A    I+K +     YLH     +
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLH---KHN 141
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK       + DFG +         +  L GT  YIAP
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL-GTAYYIAP 192

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+ A        A+K +          +++F  EA V+  + H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHD 237
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +VKL+   + ++ +++I E+M +GSL   L ++E + +    K ++    +A  +A++ 
Sbjct: 238 KLVKLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIE 295
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
                + IHRD+ + NIL+++     +ADFG AR+
Sbjct: 296 QR---NYIHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/176 (30%), Positives = 79/176 (44%), Gaps = 7/176 (3%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NIVKL         ++L++E++ +     +L    DA  L       I   +   L  L
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALTGIPLPLIKSYLFQLLQGL 116
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G YG V+K+     G+V A+KK+  +        ++FR E  +L+++  H NIV L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 285 GFCL--HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                 + + ++L+++YME      +LH    A  L+   +  +V  +   + YLH   S
Sbjct: 76  NVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLH---S 127
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             ++HRD+  +NILLN++    VADFG +R
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSR 157

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 6   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 60
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 61  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 117
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 392 APGL 395
           AP L
Sbjct: 175 APEL 178

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 222 DIKY--CIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           DIK+   IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 26  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 83
Query: 277 HR-NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAK 322
           H  NI+ L G C HR  ++L  EY   G+L   L               N  A  L   +
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            ++    +A  + YL        IHRD+++ NIL+   + A +ADFG +R
Sbjct: 144 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQ-----DLKTFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 222 DIKY--CIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           DIK+   IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 16  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 73
Query: 277 HR-NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAK 322
           H  NI+ L G C HR  ++L  EY   G+L   L               N  A  L   +
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            ++    +A  + YL        IHRD+++ NIL+   + A +ADFG +R
Sbjct: 134 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 265
            E +D+   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
           + E  +   + H N+VK YG        +L  EY   G LF  +  +    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-- 383
               +   + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 384 LAGTYGYIAPGL 395
           + GT  Y+AP L
Sbjct: 166 MXGTLPYVAPEL 177

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 4   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 58
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 59  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 115
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 392 APGL 395
           AP L
Sbjct: 173 APEL 176

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 80/192 (41%), Gaps = 33/192 (17%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK------------SF 265
            E +D+   +G G YG V   QL   +V          TEE   +K            + 
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRV----------TEEAVAVKIVDMKRAVDCPENI 51
Query: 266 RNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
           + E  +   + H N+VK YG        +L  EY   G LF  +  +    E D A+R  
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR-- 108
Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-- 383
               +   + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  
Sbjct: 109 FFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 384 LAGTYGYIAPGL 395
           + GT  Y+AP L
Sbjct: 166 MCGTLPYVAPEL 177

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+K       +V A+K +   E E+    +  + E  VLSQ     + K YG
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEI--EDIQQEITVLSQCDSSYVTKYYG 88
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
             L    +++I EY+  GS    L     A   D  +   ++K +   L YLH   S   
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLH---SEKK 141
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRDI + N+LL+ + +  +ADFG A  L      R    GT  ++AP
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 189

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 43/188 (22%)
Query: 230 GGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKL 283
           G +G V+KAQL N     K+F L+             +S+++E ++ S   + H N+++ 
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDK-----------QSWQSEREIFSTPGMKHENLLQF 74
Query: 284 -----YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                 G  L  + ++LI  + ++GSL   L  N     + W +  ++ + M+  L+YLH
Sbjct: 75  IAAEKRGSNLEVE-LWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLH 129
Query: 339 HDC--------SPSIIHRDISSNNILLNSKFEAFVADFGTARLLH-----ADSSNRTLLA 385
            D          PSI HRD  S N+LL S   A +ADFG A          D+  +    
Sbjct: 130 EDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV--- 186
Query: 386 GTYGYIAP 393
           GT  Y+AP
Sbjct: 187 GTRRYMAP 194

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 84
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 85  SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLH---S 134
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAP 185

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G YG V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 87/183 (47%), Gaps = 19/183 (10%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E +D+   IG G +G V   +   + KV+A+K L   E  + +    F  E  +++   
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
              +V+L+      K ++++ EYM  G L  NL +N D  E  WAK       +  AL  
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDL-VNLMSNYDVPE-KWAKFY--TAEVVLALDA 189
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR------LLHADSSNRTLLAGTYGY 390
           +H   S  +IHRD+  +N+LL+      +ADFGT        ++H D++      GT  Y
Sbjct: 190 IH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-----VGTPDY 241
Query: 391 IAP 393
           I+P
Sbjct: 242 ISP 244

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           T+ + +   +G G +  V +  ++P G+ +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF      ED V  ++    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++       +L +  DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLS-----MDLKDFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GT G   + + QL   KV A+K L+  +   L  +   + E Q L    H +I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
                  F++ EY+  G LF  +  +    E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+LL++   A +ADFG + ++      RT   G+  Y AP
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+ +V+ Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVMLLASLNHQYVVRYY 68
Query: 285 GFCLHRK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
              L R+              +F+  EY E  +L+  +H+     + D   R  + + + 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWR--LFRQIL 126
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH--------------AD 377
            AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H                
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 378 SSNRTLLAGTYGYIA 392
           S N T   GT  Y+A
Sbjct: 184 SDNLTSAIGTAMYVA 198

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 13/172 (7%)
Query: 227 IGTGGYGSVY--KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G YG V   K +L  G   A+K +  S     +   +  +E  VL Q+ H NI+KLY
Sbjct: 12  LGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   ++  +L+ E    G LF  +   +   E+D A    I+K +     YLH     +
Sbjct: 71  EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAA---VIMKQVLSGTTYLH---KHN 124
Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+LL SK       + DFG +         +  L   Y YIAP
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAP 175

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L +  DA  L     + ++K+    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKDFMDASALT-GIPLPLIKSYLFQLL 113
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 114 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKTFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 63
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 117
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 118 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           T+ + +   +G G +  V +  ++P G+ +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF      ED V  ++    +    +   L  
Sbjct: 62  HPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILES 115
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++H     I+HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 115
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 116 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++       +L +  DA  L     + ++K+    + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLS-----MDLKDFMDASALT-GIPLPLIKSYLFQLL 115
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 116 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 115
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 116 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++++     +L    DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHVDQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 114
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 115 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 113
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 113
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 113
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 61
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 115
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 116 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 59
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 113
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++ +     +L    DA  L     + ++K+    + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLL 114
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 115 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 62
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V AL K+   +TE      +   E  +L ++ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNH 61
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 115
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 116 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 172

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 15/180 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V AL K+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MAHA 333
            NIVKL         ++L++E++ +     +L    DA  L     + ++K+    +   
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQ-----DLKKFMDASALT-GIPLPLIKSYLFQLLQG 114
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LA+ H   S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 115 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 8/167 (4%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GT G   + + QL   KV A+K L+  +   L  +   + E Q L    H +I+KLY  
Sbjct: 21  VGTFGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
                  F++ EY+  G LF  +  +    E++ A+R  + + +  A+ Y H      ++
Sbjct: 80  ISTPTDFFMVMEYVSGGELFDYICKHGRVEEME-ARR--LFQQILSAVDYCHRHM---VV 133
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           HRD+   N+LL++   A +ADFG + ++ +D        G+  Y AP
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRDSCGSPNYAAP 179

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEAQV 271
           L  A + ++    IG G YG V+KA+ L NG  F ALK++     EE   + + R  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 272 --LSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
             L    H N+V+L+  C   +      + L++E++++          E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 199 VFSIW-NYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSET 256
           VF IW  Y  + V        + +DI   +GTG +G V++  +   G  FA K + T   
Sbjct: 136 VFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV 316
            +    ++ R E Q +S + H  +V L+        M +IYE+M  G LF  + +  + +
Sbjct: 196 SDK---ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252
Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF--EAFVADFGTARLL 374
             D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + DFG    L
Sbjct: 253 SEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
Query: 375 HADSSNRTLLAGTYGYIAP 393
               S + +  GT  + AP
Sbjct: 308 DPKQSVK-VTTGTAEFAAP 325

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 62
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++       +L    DA  L     + ++K+    + 
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFLS-----MDLKKFMDASALT-GIPLPLIKSYLFQLL 116
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 117 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 15/161 (9%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
           + E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKEL 60
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA----MA 331
            H NIVKL         ++L++E++       +L    DA  L     + ++K+    + 
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLS-----MDLKKFMDASALT-GIPLPLIKSYLFQLL 114
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             LA+ H   S  ++HRD+   N+L+N++    +ADFG AR
Sbjct: 115 QGLAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEAQV 271
           L  A + ++    IG G YG V+KA+ L NG  F ALK++     EE   + + R  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 272 --LSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
             L    H N+V+L+  C   +      + L++E++++          E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H N ++  G
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 286 FCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             L     +L+ EY +   S    +H       L   +   +       LAYLH   S +
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH---SHN 174
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +IHRD+ + NILL+      + DFG+A ++    +      GT  ++AP
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAP 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 90/195 (46%), Gaps = 37/195 (18%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V KA+   + + +A+KK+  +E E+L+ I S   E  +L+ + H+ +V+ Y
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILS---EVXLLASLNHQYVVRYY 68
Query: 285 GFCLHRK-------------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
              L R+              +F+  EY E  +L+  +H+     + D   R  + + + 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWR--LFRQIL 126
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH--------------AD 377
            AL+Y+H   S  IIHR++   NI ++      + DFG A+ +H                
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 378 SSNRTLLAGTYGYIA 392
           S N T   GT  Y+A
Sbjct: 184 SDNLTSAIGTAXYVA 198

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLHHDCSP 343
                K + L++E+ ++     +L    D+   +LD     + +  +   L + H   S 
Sbjct: 69  VLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +++HRD+   N+L+N   E  +ADFG AR
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVF-ALKKLHTSETEELAFIKSFRNEAQV 271
           L  A + ++    IG G YG V+KA+ L NG  F ALK++     EE   + + R  A +
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 272 --LSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
             L    H N+V+L+  C   +      + L++E++++          E  V  +  K  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-- 123
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           +++  +   L +LH   S  ++HRD+   NIL+ S  +  +ADFG AR+
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 81/171 (47%), Gaps = 17/171 (9%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  + NIV    
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVNYLD 85
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE---LDWAKRVNIVKAMAHALAYLHHDCS 342
             L    ++++ EY+  GSL        D V    +D  +   + +    AL +LH   S
Sbjct: 86  SYLVGDELWVVMEYLAGGSLT-------DVVTETCMDEGQIAAVCRECLQALEFLH---S 135
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +IHR+I S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 136 NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 186

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 23/182 (12%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQ 274
           F+ K  +GTG +  V  A+    GK+FA+K      L   E+       S  NE  VL +
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKES-------SIENEIAVLRK 76
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           + H NIV L         ++L+ + +  G LF  +       E D +    +++ +  A+
Sbjct: 77  IKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---TLIRQVLDAV 133
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEA---FVADFGTARLLHADSSNRTLLAGTYGYI 391
            YLH      I+HRD+   N+L  S+ E     ++DFG ++ +       +   GT GY+
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYV 189
Query: 392 AP 393
           AP
Sbjct: 190 AP 191

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 199 VFSIW-NYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKL---HT 253
           VF IW  Y  + V        + +DI   +GTG +G V++  +   G  FA K +   H 
Sbjct: 30  VFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 89
Query: 254 SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE 313
           S+ E      + R E Q +S + H  +V L+        M +IYE+M  G LF  + +  
Sbjct: 90  SDKE------TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 143
Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF--EAFVADFGTA 371
           + +  D A  V  ++ +   L ++H +   + +H D+   NI+  +K   E  + DFG  
Sbjct: 144 NKMSEDEA--VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 198
Query: 372 RLLHADSSNRTLLAGTYGYIAP 393
             L    S + +  GT  + AP
Sbjct: 199 AHLDPKQSVK-VTTGTAEFAAP 219

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 9/183 (4%)
Query: 213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 271
           DL    E +++   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 122
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
           ++      +V+L+      + ++++ EYM  G L  NL +N D  E  WA+       + 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPE-KWARFY--TAEVV 178
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGY 390
            AL  +H   S   IHRD+  +N+LL+      +ADFGT   ++ +   R   A GT  Y
Sbjct: 179 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 235
Query: 391 IAP 393
           I+P
Sbjct: 236 ISP 238

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 91/184 (49%), Gaps = 28/184 (15%)
Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKL 283
           C+G G YG V++  L +G+  A+K + +S  E+     S+  E ++ + VL  H NI+  
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVK-IFSSRDEQ-----SWFRETEIYNTVLLRHDNILGF 67
Query: 284 YGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +  +     ++LI  Y E GSL+  L      +E   A R+ +  + A  LA+LH 
Sbjct: 68  IASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ--TLEPHLALRLAV--SAACGLAHLHV 123
Query: 340 DC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-----GTYG 389
           +       P+I HRD  S N+L+ S  +  +AD G A ++H+  S+   +      GT  
Sbjct: 124 EIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKR 182
Query: 390 YIAP 393
           Y+AP
Sbjct: 183 YMAP 186

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 9/183 (4%)
Query: 213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 271
           DL    E +++   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
           ++      +V+L+      + ++++ EYM  G L  NL +N D  E  WA+       + 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPE-KWARF--YTAEVV 183
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGY 390
            AL  +H   S   IHRD+  +N+LL+      +ADFGT   ++ +   R   A GT  Y
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 391 IAP 393
           I+P
Sbjct: 241 ISP 243

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 9/183 (4%)
Query: 213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQV 271
           DL    E +++   IG G +G V   +  +  KV+A+K L   E  + +    F  E  +
Sbjct: 68  DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 127
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
           ++      +V+L+      + ++++ EYM  G L  NL +N D  E  WA+       + 
Sbjct: 128 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPE-KWARF--YTAEVV 183
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGY 390
            AL  +H   S   IHRD+  +N+LL+      +ADFGT   ++ +   R   A GT  Y
Sbjct: 184 LALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 391 IAP 393
           I+P
Sbjct: 241 ISP 243

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 13/169 (7%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ H N ++  G
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 286 FCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             L     +L+ EY +   S    +H       L   +   +       LAYLH   S +
Sbjct: 83  CYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +IHRD+ + NILL+      + DFG+A ++    +      GT  ++AP
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPYWMAP 180

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 222 DIKY--CIGTGGYGSVYKAQLPNGKV---FALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           DIK+   IG G +G V KA++    +    A+K++    +++    + F  E +VL ++ 
Sbjct: 23  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLG 80
Query: 277 HR-NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAK 322
           H  NI+ L G C HR  ++L  EY   G+L   L               N  A  L   +
Sbjct: 81  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            ++    +A  + YL        IHR++++ NIL+   + A +ADFG +R
Sbjct: 141 LLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 278 RNIVKLYGFCLHR-KCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAH 332
              VKLY FC    + ++    Y + G L   +      +E       A+ V+       
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS------- 148
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGY 390
           AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y
Sbjct: 149 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 391 IAPGL 395
           ++P L
Sbjct: 206 VSPEL 210

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 129 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 177

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 85/172 (49%), Gaps = 14/172 (8%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGK----VFALKKLHTSETEELAFIKSFRNE 268
           +++ TE   +K  +G+G +G+VYK   +P+G+      A+K L  + + +    K   +E
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           A V++ V    + +L G CL    + L+ + M  G L    H  E+   L     +N   
Sbjct: 70  AYVMAGVGSPYVSRLLGICLT-STVQLVTQLMPYGCLLD--HVRENRGRLGSQDLLNWCM 126
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            +A  ++YL       ++HRD+++ N+L+ S     + DFG ARLL  D + 
Sbjct: 127 QIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE 175

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 125
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 126 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 15  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 71
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 72  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 128
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 129 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 177

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 12  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 68
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 69  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 125
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 126 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 174

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 175

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 180

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKE 173

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 13  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 70  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 126
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 127 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 175

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 14  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 70
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 71  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 127
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 128 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 176

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 36  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 92
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL      LI + M  G L   +  ++D +     L+W   V
Sbjct: 93  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 149
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 150 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 198

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/178 (32%), Positives = 80/178 (44%), Gaps = 30/178 (16%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V K Q  P+G + A K +H      L    + RN+     QVLH      IV
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------NIVKAMAHALA 335
             YG       + +  E+M+ GSL        D V L  AKR+       +  A+   LA
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSL--------DQV-LKEAKRIPEEILGKVSIAVLRGLA 128
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y+AP
Sbjct: 129 YLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMAP 182

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 17  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 73
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 74  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 130
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 131 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 179

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 88/172 (51%), Gaps = 14/172 (8%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 8   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 64
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +   +   +N   
Sbjct: 65  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCV 121
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            +A  + YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 122 QIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 170

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 21  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 77
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 78  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 134
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 135 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 183

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 80/184 (43%), Gaps = 17/184 (9%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLS 273
            E +D+   +G G  G V   QL   +V     A+K +      +    ++ + E  +  
Sbjct: 5   VEDWDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINK 59
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
            + H N+VK YG        +L  EY   G LF  +  +    E D A+R      +   
Sbjct: 60  MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQR--FFHQLMAG 116
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           + YLH      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 392 APGL 395
           AP L
Sbjct: 174 APEL 177

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S++ H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 94
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 10  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 66
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 67  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 121
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 122 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 176
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 177 QYVSPEL 183

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S++ H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKLNHQ 108
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 5   ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 61
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 62  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 118
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 119 QIAKGMN----YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 9   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 121
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 122 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 392 APGL 395
           +P L
Sbjct: 179 SPEL 182

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 145
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 392 APGL 395
           +P L
Sbjct: 203 SPEL 206

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 275
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 99
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVK 328
            H NIV L G C H   + +I EY   G L   L        + ED   L+    ++   
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 160 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 207

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 77
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++LI EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 78  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCHQ---KR 131
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFG 156

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 392 APGL 395
           +P L
Sbjct: 202 SPEL 205

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 7   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 119
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 120 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 392 APGL 395
           +P L
Sbjct: 177 SPEL 180

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 120
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 392 APGL 395
           +P L
Sbjct: 178 SPEL 181

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 197 QYVSPEL 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 392 APGL 395
           +P L
Sbjct: 202 SPEL 205

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 147
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 148 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 392 APGL 395
           +P L
Sbjct: 205 SPEL 208

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 199 QYVSPEL 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 142
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 392 APGL 395
           +P L
Sbjct: 200 SPEL 203

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 74/176 (42%), Gaps = 26/176 (14%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 277
           IG G +G VYK  + N         HT E   +  I            + E  VLSQ   
Sbjct: 27  IGKGSFGEVYKG-IDN---------HTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 76
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             I + +G  L    +++I EY+  GS    L        L+      I++ +   L YL
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP----LEETYIATILREILKGLDYL 132
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S   IHRDI + N+LL+ + +  +ADFG A  L      R    GT  ++AP
Sbjct: 133 H---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAP 185

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 88
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 89  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 143
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 144 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 198
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 199 QYVSPEL 205

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLF 80
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++LI EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCHQ---KR 134
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFG 159

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 27/171 (15%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 275
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVK 328
            H NIV L G C H   + +I EY   G L   L        + ED   L+    ++   
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 168 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 215

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI---VKAMAHALAYLHHDC 341
                 K ++L+ EY   G +F  L      V   W K        + +  A+ Y H   
Sbjct: 73  EVIETEKTLYLVMEYASGGEVFDYL------VAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFG 369
              I+HRD+ + N+LL++     +ADFG
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFG 151

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 12/149 (8%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLHHDCSP 343
                K + L++E+ ++     +L    D+   +LD     + +  +   L + H   S 
Sbjct: 69  VLHSDKKLTLVFEFCDQ-----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +++HRD+   N+L+N   E  +A+FG AR
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 144
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 392 APGL 395
           +P L
Sbjct: 202 SPEL 205

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 74/180 (41%), Gaps = 9/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
              VKLY      + ++    Y + G   C L         D          +  AL YL
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNG---CLLKYIRKIGSFDETCTRFYTAEIVSALEYL 148
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAPGL 395
           H      IIHRD+   NILLN      + DFGTA++L  +S         GT  Y++P L
Sbjct: 149 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 205

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 85
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 146 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 192

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTA 196
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 197 QYVSPEL 203

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 27/156 (17%)
Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H NIV L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67
Query: 286 FCLHRKCMFLIYEYMER---------GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
                K + L++EY+++         G++  N+HN    V+L        +  +   LAY
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNII-NMHN----VKL-------FLFQLLRGLAY 115
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            H      ++HRD+   N+L+N + E  +ADFG AR
Sbjct: 116 CHRQ---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 81/180 (45%), Gaps = 11/180 (6%)
Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           T+ + +   IG G +  V +  +L  G  +A K ++T +       K    EA++   + 
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQK-LEREARICRLLK 61
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIV+L+         +L+++ +  G LF      ED V  ++    +    +   L  
Sbjct: 62  HSNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIQQILEA 115
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           + H     ++HRD+   N+LL SK +     +ADFG A  +  D       AGT GY++P
Sbjct: 116 VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 108
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + +V  A +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 89
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 90  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 144
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S         GT 
Sbjct: 145 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 199
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 200 QYVSPEL 206

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 93
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 154 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 16/177 (9%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+++  +G G    VY+  Q    K +ALK L  +  +++      R E  VL ++ H N
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIV-----RTEIGVLLRLSHPN 109
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I+KL         + L+ E +  G LF  +       E D A   + VK +  A+AYLH 
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAYLHE 166
Query: 340 DCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +    I+HRD+   N+L  +        +ADFG ++++      +T + GT GY AP
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAP 219

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 201

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 126
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 127 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 392 APGL 395
           +P L
Sbjct: 184 SPEL 187

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 110
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 171 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 217

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLM----EALIISKFNHQ 108
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 169 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 215

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 100
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 161 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 207

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 35/195 (17%)
Query: 220 GFDIKYC--IGTGGYGSVYKAQLP-NGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQV 275
           G D K    IG+GG+G V+KA+   +GK + +K++ + +E  E         E + L+++
Sbjct: 10  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE--------REVKALAKL 61
Query: 276 LHRNIVKLYGFCL-----------------HRKCMFLIYEYMERGSLFCNLHNNEDAVEL 318
            H NIV  Y  C                    KC+F+  E+ ++G+L   +       +L
Sbjct: 62  DHVNIVH-YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKL 119
Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           D    + + + +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  D 
Sbjct: 120 DKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND- 175
Query: 379 SNRTLLAGTYGYIAP 393
             R    GT  Y++P
Sbjct: 176 GKRXRSKGTLRYMSP 190

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 392 APGL 395
           +P L
Sbjct: 199 SPEL 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 82/176 (46%), Gaps = 9/176 (5%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + ++  IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H N
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPN 75
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IVKL+      K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H 
Sbjct: 76  IVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQ 132
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
                I+HRD+ + N+LL+      +ADFG +      +   T   G+  Y AP L
Sbjct: 133 KY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT-FCGSPPYAAPEL 184

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A+K +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 46  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 98
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 99  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 151
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 209
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 210 HRVGTKRYMAP 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 204 NYDGRIV------YEDL--------IEATEG-----FDIKYCIGTGGYGSVYK-AQLPNG 243
            YDG  +      YED+        +E  +G     +DI   +G+G +G V++  +   G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           +VF  K ++T    +   +K   NE  +++Q+ H  ++ L+     +  M LI E++  G
Sbjct: 77  RVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +   +   ++  A+ +N ++     L ++H     SI+H DI   NI+  +K  +
Sbjct: 134 ELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKAS 188
Query: 364 FVA--DFGTARLLHADSSNRTLLAGTYGYIAPGL 395
            V   DFG A  L+ D   +   A T  + AP +
Sbjct: 189 SVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEI 221

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAF---IKSFRNEA--Q 270
           AT  ++    IG G YG+VYKA+ P+ G   ALK +             I + R  A  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 271 VLSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVE---LDWAK 322
            L    H N+V+L   C   +      + L++E++++     +L    D      L    
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----DLRTYLDKAPPPGLPAET 121
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
             ++++     L +LH +C   I+HRD+   NIL+ S     +ADFG AR+
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLHT--SETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 120
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG AR ++  S  R
Sbjct: 181 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 18/174 (10%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKK--LHTSETEELAFIKSFRNEAQ 270
           +++ TE   IK  +G+G +G+VYK   +P G+   +    +   E       K   +EA 
Sbjct: 45  ILKETEFKKIK-VLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNI 326
           V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V I
Sbjct: 104 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQI 160
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 161 AKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 78/184 (42%), Gaps = 17/184 (9%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A +L   + +A+K L      +   +     E  V+S++ H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHA 333
              VKLY      + ++    Y + G L   +      +E       A+ V+       A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS-------A 141
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S         GT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 392 APGL 395
           +P L
Sbjct: 199 SPEL 202

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 48/208 (23%)
Query: 220 GFDIKYC--IGTGGYGSVYKAQLP-NGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQV 275
           G D K    IG+GG+G V+KA+   +GK + ++++ + +E  E         E + L+++
Sbjct: 11  GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE--------REVKALAKL 62
Query: 276 LHRNIVKLYGFCL------------------------------HRKCMFLIYEYMERGSL 305
            H NIV  Y  C                                 KC+F+  E+ ++G+L
Sbjct: 63  DHVNIVH-YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL 121
Query: 306 FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV 365
              +       +LD    + + + +   + Y+H   S  +IHRD+  +NI L    +  +
Sbjct: 122 EQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 366 ADFGTARLLHADSSNRTLLAGTYGYIAP 393
            DFG    L  D   RT   GT  Y++P
Sbjct: 178 GDFGLVTSLKND-GKRTRSKGTLRYMSP 204

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 5/173 (2%)
Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  R IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
               +  + L+   M  G +  +++N +ED       + +     +   L +LH     +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---N 309
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP L L
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 5/173 (2%)
Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  R IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
               +  + L+   M  G +  +++N +ED       + +     +   L +LH     +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---N 309
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP L L
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 5/173 (2%)
Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  R IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
               +  + L+   M  G +  +++N +ED       + +     +   L +LH     +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---N 309
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP L L
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 139
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 5/173 (2%)
Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  R IV L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY 252
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
               +  + L+   M  G +  +++N +ED       + +     +   L +LH     +
Sbjct: 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---N 309
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP L L
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR----TLLAGTY 388
           AL + H +    IIHRD+   NIL+++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAI-ADSGNSVXQTAAVIGTA 183
Query: 389 GYIAP 393
            Y++P
Sbjct: 184 QYLSP 188

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 23/187 (12%)
Query: 219 EGFDIKYCIGTGGYGS-VYKAQLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQ 274
           E F     +G G + + V   +L   + +A+K   K H  +  ++ ++   R+   V+S+
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERD---VMSR 86
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAM 330
           + H   VKLY      + ++    Y + G L   +      +E       A+ V+     
Sbjct: 87  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS----- 141
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTY 388
             AL YLH      IIHRD+   NILLN      + DFGTA++L  +S  +      GT 
Sbjct: 142 --ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTA 196
Query: 389 GYIAPGL 395
            Y++P L
Sbjct: 197 QYVSPEL 203

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 33  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 85
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 86  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 138
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 139 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 196
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 197 HRVGTKRYMAP 207

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 56  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 167
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 111
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLH 375
            YL  +     IHRDI++ N LL       VA   DFG AR ++
Sbjct: 172 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 212

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 134
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLH 375
            YL  +     IHRDI++ N LL       VA   DFG AR ++
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 227 IGTGGYGSVY-KAQLPNGKVFALKKLHTSETEELAFIKS-FRNEAQVLSQVLHRNIVKLY 284
           +G+G +  V+   Q   GK+FALK +  S     AF  S   NE  VL ++ H NIV L 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                    +L+ + +  G LF  +       E D +    +++ +  A+ YLH +    
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHEN---G 126
Query: 345 IIHRDISSNNILL-----NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRD+   N+L      NSK    + DFG +++    +   +   GT GY+AP
Sbjct: 127 IVHRDLKPENLLYLTPEENSKI--MITDFGLSKM--EQNGIMSTACGTPGYVAP 176

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 14/178 (7%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVF----ALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F     IG G +G V  A+    +VF     L+K    + +E   I S RN   +L  V 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNVK 97
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 335
           H  +V L+        ++ + +Y+  G LF +L      +E     R     A +A AL 
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASALG 153
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YLH   S +I++RD+   NILL+S+    + DFG  +     +S  +   GT  Y+AP
Sbjct: 154 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAP 208

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A++ +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 80  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 133
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 13  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 65
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 66  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 118
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 119 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 176
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 177 HRVGTKRYMAP 187

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A++ +  ++    +  K FR E +++  + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFG 158

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 10  LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 62
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 63  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 115
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 116 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 173
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 174 HRVGTKRYMAP 184

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H N+V+L G 
Sbjct: 20  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 73
Query: 287 CLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           +HRD+++ N+L++    A V+DFG  +   A S+  T
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT 164

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 10/152 (6%)
Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LYG  L    M ++ E    GSL   L  ++    L    R  +   +A  + YL    S
Sbjct: 76  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLE---S 129
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
              IHRD+++ N+LL ++    + DFG  R L
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 57  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 168
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 8   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 60
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 61  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 113
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 114 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 171
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 172 HRVGTKRYMAP 182

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 36/191 (18%)
Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNI 280
           ++  IG G +G V++ +   G+  A+K   + E       +S+  EA++   V+  H NI
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENI 59
Query: 281 VKLYGFCLHR-------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +   GF             ++L+ +Y E GSLF  L+     VE      + +  + A  
Sbjct: 60  L---GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASG 112
Query: 334 LAYLHHDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----- 383
           LA+LH +       P+I HRD+ S NIL+       +AD G A  +  DS+  T+     
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPN 170
Query: 384 -LAGTYGYIAP 393
              GT  Y+AP
Sbjct: 171 HRVGTKRYMAP 181

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 18/192 (9%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFR 266
           RIVY      +  F +K  +G G YG V  A   P G++ A+KK+   +    A +++ R
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR 58
Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE--YMERGSLFCNLHNNEDAVELDWAKRV 324
            E ++L    H NI+ +  F + R   F  +   Y+ +  +  +LH       L      
Sbjct: 59  -EIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH---ADSSNR 381
             +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++    AD+S  
Sbjct: 116 YFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 382 T-LLAGTYGYIA 392
           T   +G   Y+A
Sbjct: 173 TGQQSGMTEYVA 184

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 30  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 141
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 227 IGTGGYGSVY----KAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G+G YG V     K       +  ++K   S +     ++    E  VL  + H NI+K
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE----EVAVLKLLDHPNIMK 100
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           LY F   ++  +L+ E  + G LF  + +     E+D A    I+K +   + YLH    
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA---VIIKQVLSGVTYLH---K 154
Query: 343 PSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +I+HRD+   N+LL SK +     + DFG + +       +  L GT  YIAP
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL-GTAYYIAP 207

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 149
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 9/152 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G+G +G V   +       A+K +      E  F +    EAQ + ++ H  +VK YG 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGV 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C     ++++ EY+  G L   L ++   +E   ++ + +   +   +A+L    S   I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           HRD+++ N L++      V+DFG  R +  D 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 11/186 (5%)
Query: 213 DLIEATEGFD---IKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNE 268
           DL+E    +D    +  +G G YG VY  + L N    A+K++   ++    + +    E
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEE 69
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
             +   + H+NIV+  G       + +  E +  GSL   L +    ++ +        K
Sbjct: 70  IALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK 129
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGT 387
            +   L YLH +    I+HRDI  +N+L+N+      ++DFGT++ L   +       GT
Sbjct: 130 QILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGT 186
Query: 388 YGYIAP 393
             Y+AP
Sbjct: 187 LQYMAP 192

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 18  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 74
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 75  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 131
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 132 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 180

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKL- 283
           IG G YG+VYK  L    V A+K          A  ++F NE  +    L  H NI +  
Sbjct: 21  IGRGRYGAVYKGSLDERPV-AVKVF------SFANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 284 ----YGFCLHRKCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                     R    L+ EY   GSL  + +LH +      DW     +  ++   LAYL
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS------DWVSSCRLAHSVTRGLAYL 127
Query: 338 HHDC------SPSIIHRDISSNNILLNSKFEAFVADFGTA------RLLHADSSNRTLLA 385
           H +        P+I HRD++S N+L+ +     ++DFG +      RL+     +   ++
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS 187
Query: 386 --GTYGYIAP 393
             GT  Y+AP
Sbjct: 188 EVGTIRYMAP 197

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 22/176 (12%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE   IK  + +G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 11  ILKETEFKKIK-VLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDE 67
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRV 324
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D +     L+W   V
Sbjct: 68  AYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--V 124
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
            I K M     YL       ++HRD+++ N+L+ +     + DFG A+LL A+   
Sbjct: 125 QIAKGMN----YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 35  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 146
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 147
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H N+V+L G 
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 82
Query: 287 CLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           +HRD+++ N+L++    A V+DFG  +   A S+  T
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT 173

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 227 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H NIV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 86
Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C       + LI E++  GSL   L  N++ + L   +++     +   + YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG- 143
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 147
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G Y +VYK       V+   K    ++EE     + R E  ++ ++ H NIV+LY  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR-EISLMKELKHENIVRLYDV 71
Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR---VNIVK----AMAHALAYLHH 339
                 + L++E+M+      +L    D+  +    R   +N+VK     +   LA+ H 
Sbjct: 72  IHTENKLTLVFEFMDN-----DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    I+HRD+   N+L+N + +  + DFG AR
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + YL    S 
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL---ASK 151
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 286 FCLHR-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            C  +     +C   ++L++++ E     L  N+      V+   ++   +++ + + L 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLY 139
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           Y+H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H N+V+L G 
Sbjct: 14  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 67
Query: 287 CLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           +HRD+++ N+L++    A V+DFG  +   A S+  T
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDT 158

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 286 FCLHR-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            C  +     +C   ++L++++ E     L  N+      V+   ++   +++ + + L 
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLY 139
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           Y+H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H N+V L  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 286 FCLHR-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            C  +     +C   ++L++++ E     L  N+      V+   ++   +++ + + L 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLY 139
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           Y+H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + YL   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYL--- 149
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 22/170 (12%)
Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G VY+ Q+      P+    A+K L    SE +EL F+     EA ++S+  H+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----EALIISKFNHQ 94
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE----DAVELDWAKRVNIVKAMAHAL 334
           NIV+  G  L     F++ E M  G L   L            L     +++ + +A   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA---DFGTARLLHADSSNR 381
            YL  +     IHRDI++ N LL       VA   DFG A+ ++  S  R
Sbjct: 155 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYR 201

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTY 388
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 389 GYIAP 393
            Y++P
Sbjct: 184 QYLSP 188

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H N+V+L G 
Sbjct: 201 IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 254
Query: 287 CLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  +   + 
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 346 IHRDISSNNILLNSKFEAFVADFGTAR 372
           +HRD+++ N+L++    A V+DFG  +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V+KA+    G+  ALKK+   E E+  F  +   E ++L  + H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 286 FCLHR-----KC---MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            C  +     +C   ++L++++ E     L  N+      V+   ++   +++ + + L 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLY 138
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           Y+H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 139 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 86/185 (46%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTY 388
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 389 GYIAP 393
            Y++P
Sbjct: 184 QYLSP 188

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 14/164 (8%)
Query: 227 IGTGGYGSV----YKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V    Y  +  N G+  A+K L          I   + E ++L  + H NIV
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIV 74
Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C       + LI E++  GSL   L  N++ + L   +++     +   + YL  
Sbjct: 75  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYLG- 131
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             S   +HRD+++ N+L+ S+ +  + DFG  + +  D    T+
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFR 266
           RIVY      +  F +K  +G G YG V  A   P G++ A+KK+   +    A +++ R
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR 58
Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE--YMERGSLFCNLHNNEDAVELDWAKRV 324
            E ++L    H NI+ +  F + R   F  +   Y+ +  +  +LH       L      
Sbjct: 59  -EIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL 384
             +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++   +++ +  
Sbjct: 116 YFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 385 AG 386
            G
Sbjct: 173 TG 174

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 14/182 (7%)
Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFR 266
           RIVY      +  F +K  +G G YG V  A   P G++ A+KK+   +    A +++ R
Sbjct: 4   RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR 58
Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE--YMERGSLFCNLHNNEDAVELDWAKRV 324
            E ++L    H NI+ +  F + R   F  +   Y+ +  +  +LH       L      
Sbjct: 59  -EIKILKHFKHENIITI--FNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ 115
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL 384
             +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++   +++ +  
Sbjct: 116 YFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172
Query: 385 AG 386
            G
Sbjct: 173 TG 174

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G +  V  A+ +  GK  A+K +  ++    +  K FR E ++   + H NIVKL+
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKLF 79
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 K ++L+ EY   G +F  L  +    E +   +    + +  A+ Y H      
Sbjct: 80  EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKF---RQIVSAVQYCHQKF--- 133
Query: 345 IIHRDISSNNILLNSKFEAFVADFG 369
           I+HRD+ + N+LL++     +ADFG
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFG 158

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 33/198 (16%)
Query: 205 YDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIK 263
           ++ R VY DL            +G+G YG+V  A     G   A+KKL+     EL   +
Sbjct: 21  WEVRAVYRDL----------QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 70
Query: 264 SFRNEAQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYM--ERGSLFCNLHNNEDA 315
           ++R E ++L  + H N++ L       + +      +L+  +M  + G L  +    ED 
Sbjct: 71  AYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 129
Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           ++        +V  M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR   
Sbjct: 130 IQF-------LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--Q 177
Query: 376 ADSSNRTLLAGTYGYIAP 393
           ADS     +  T  Y AP
Sbjct: 178 ADSEMXGXVV-TRWYRAP 194

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 226 CIGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
            +G+G +G+V+K   +P G   K+    K+   ++   +F ++  +    +  + H +IV
Sbjct: 38  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHIV 96
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 337
           +L G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     YL
Sbjct: 97  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YL 149
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
                  ++HR++++ N+LL S  +  VADFG A LL  D   
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 189

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 8/172 (4%)
Query: 224 KYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +  +G G YG VY  + L N    A+K++   ++    + +    E  +   + H+NIV+
Sbjct: 13  RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---YSQPLHEEIALHKHLKHKNIVQ 69
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
             G       + +  E +  GSL   L +    ++ +        K +   L YLH +  
Sbjct: 70  YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN-- 127
Query: 343 PSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
             I+HRDI  +N+L+N+      ++DFGT++ L   +       GT  Y+AP
Sbjct: 128 -QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 178

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 12/179 (6%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 338 HHDCSPSIIHRDISSNNILLNSK---FEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 81/185 (43%), Gaps = 21/185 (11%)
Query: 218 TEGFDIKYCIGTGGYGSVYK------AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 271
           T+ + +   +G G +  V +       Q    K+   KKL   + ++L        EA++
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL------EREARI 83
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
              + H NIV+L+         +L+++ +  G LF      ED V  ++    +    + 
Sbjct: 84  CRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELF------EDIVAREYYSEADASHCIH 137
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTY 388
             L  ++H     I+HRD+   N+LL SK +     +ADFG A  +  +       AGT 
Sbjct: 138 QILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTP 197
Query: 389 GYIAP 393
           GY++P
Sbjct: 198 GYLSP 202

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 211
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 31/175 (17%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 275
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV----------- 324
            H NIV L G C H   + +I EY   G L   L      +E D A  +           
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           +    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 81/182 (44%), Gaps = 15/182 (8%)
Query: 212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALK---KLHTSETEELAFIKSFRNE 268
           ED++   + F +   +G G +GSV +AQL       +K   K+  ++    + I+ F  E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNL---HNNEDAVELD 319
           A  + +  H ++ KL G  L  +         +I  +M+ G L   L      E+   L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 320 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
               V  +  +A  + YL    S + IHRD+++ N +L       VADFG +R +++   
Sbjct: 136 LQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 380 NR 381
            R
Sbjct: 193 YR 194

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 31/175 (17%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 275
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV----------- 324
            H NIV L G C H   + +I EY   G L   L      +E D A  +           
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           +    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 168 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKL---HTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G + +VYKA+  N  ++ A+KK+   H SE ++    ++   E ++L ++ H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKD-GINRTALREIKLLQELSHPNIIG 76
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L     H+  + L++++ME   L   + +N   +     K   ++      L YLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYLHQHW- 132
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
             I+HRD+  NN+LL+      +ADFG A+   + +        T  Y AP L
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 195 NSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT 253
           +S    SI N +  +  +DL    E       +G G YG V K + +P+G++ A+K++  
Sbjct: 34  DSKACISIGNQNFEVKADDLEPIME-------LGRGAYGVVEKMRHVPSGQIMAVKRIRA 86
Query: 254 S--ETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG--SLFCNL 309
           +    E+   +       + +        V  YG       +++  E M+      +  +
Sbjct: 87  TVNSQEQKRLLMDLDISMRTVDCPF---TVTFYGALFREGDVWICMELMDTSLDKFYKQV 143
Query: 310 HNNEDAVELDWAKR--VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD 367
            +    +  D   +  V+IVKA+ H  + L      S+IHRD+  +N+L+N+  +  + D
Sbjct: 144 IDKGQTIPEDILGKIAVSIVKALEHLHSKL------SVIHRDVKPSNVLINALGQVKMCD 197
Query: 368 FGTARLLHADSSNRTLLAGTYGYIAP 393
           FG +  L  DS  +T+ AG   Y+AP
Sbjct: 198 FGISGYL-VDSVAKTIDAGCKPYMAP 222

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 226 CIGTGGYGSVYKA-QLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
            +G+G +G+V+K   +P G   K+    K+   ++   +F ++  +    +  + H +IV
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHIV 78
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYL 337
           +L G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     YL
Sbjct: 79  RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY----YL 131
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
                  ++HR++++ N+LL S  +  VADFG A LL  D   
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ 171

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L  +    IV
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 75
Query: 282 KLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G  +   R+ + L+ EY+  G L   L  +     LD ++ +     +   + YL  
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG- 132
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             S   +HRD+++ NIL+ S+    +ADFG A+LL  D
Sbjct: 133 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 168

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L  +    IV
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 87
Query: 282 KLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G  +   R+ + L+ EY+  G L   L  +     LD ++ +     +   + YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG- 144
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             S   +HRD+++ NIL+ S+    +ADFG A+LL  D
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L  +    IV
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 74
Query: 282 KLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G  +   R+ + L+ EY+  G L   L  +     LD ++ +     +   + YL  
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG- 131
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             S   +HRD+++ NIL+ S+    +ADFG A+LL  D
Sbjct: 132 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 167

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 125
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L  + +N     GT  Y++P
Sbjct: 126 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANE--FVGTRSYMSP 175

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 47  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 105
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +  N+    L  A        M  A+ YLH +    IIHRD+   N+LL+S+ E 
Sbjct: 106 ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 159
Query: 364 F---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + DFG +++L   S  RT L GT  Y+AP
Sbjct: 160 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 191

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 12/179 (6%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 338 HHDCSPSIIHRDISSNNILLNSK---FEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 221 FDIKYCIGTGGYGSVY---KAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F++   +G G +G V+   K   P+ G ++A+K L  +  +    +++ + E  +L+ V 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  +VKL Y F    K ++LI +++  G LF  L       E D    V    A +A  L
Sbjct: 89  HPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALGL 143
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+AP
Sbjct: 144 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAP 199

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 438 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 490
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 525

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 12/179 (6%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E ++I   +G G +G V K +     + +A+K ++ +  +        R E ++L ++ H
Sbjct: 22  ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDH 80
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y+
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYM 137
Query: 338 HHDCSPSIIHRDISSNNILLNSK---FEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H     +I+HRD+   NILL SK    +  + DFG +     ++  +  + GT  YIAP
Sbjct: 138 H---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI-GTAYYIAP 192

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 9/177 (5%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           F  K  +G+G +G V+  +  +  +  + K    +  ++  ++    E +VL  + H NI
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLDHPNI 82
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHH 339
           +K++        M+++ E  E G L   + + +     L       ++K M +ALAY H 
Sbjct: 83  IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH- 141
Query: 340 DCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  ++H+D+   NIL           + DFG A L  +D  + T  AGT  Y+AP
Sbjct: 142 --SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAP 195

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + ++++  IG+G    V  A   P  +  A+K+++  + +    +     E Q +SQ  H
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 72
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAKRVNIVKAMAH 332
            NIV  Y   + +  ++L+ + +  GS+   + +        +  LD +    I++ +  
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH-----ADSSNRTLLAGT 387
            L YLH +     IHRD+ + NILL       +ADFG +  L        +  R    GT
Sbjct: 133 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 388 YGYIAP 393
             ++AP
Sbjct: 190 PCWMAP 195

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 38  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + +L   
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL--- 149
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 153
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 157
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 16/186 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + ++++  IG+G    V  A   P  +  A+K+++  + +    +     E Q +SQ  H
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHH 67
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAKRVNIVKAMAH 332
            NIV  Y   + +  ++L+ + +  GS+   + +        +  LD +    I++ +  
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-----SSNRTLLAGT 387
            L YLH +     IHRD+ + NILL       +ADFG +  L        +  R    GT
Sbjct: 128 GLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 388 YGYIAP 393
             ++AP
Sbjct: 185 PCWMAP 190

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 39  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + +L   
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL--- 150
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 437 GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 489
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 8/149 (5%)
Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G VY   L   +GK         +   ++  +  F  E  ++    H N++ L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           G CL  +    ++  YM+ G L   + N      +     +     +A  + +L    S 
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL---ASK 152
Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +HRD+++ N +L+ KF   VADFG AR
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 40  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 98
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +  N+    L  A        M  A+ YLH +    IIHRD+   N+LL+S+ E 
Sbjct: 99  ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 152
Query: 364 F---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + DFG +++L   S  RT L GT  Y+AP
Sbjct: 153 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 184

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +  N+    L  A        M  A+ YLH +    IIHRD+   N+LL+S+ E 
Sbjct: 100 ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153
Query: 364 F---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + DFG +++L   S  RT L GT  Y+AP
Sbjct: 154 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 185

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +  N+    L  A        M  A+ YLH +    IIHRD+   N+LL+S+ E 
Sbjct: 100 ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153
Query: 364 F---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + DFG +++L   S  RT L GT  Y+AP
Sbjct: 154 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 185

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 67/152 (44%), Gaps = 14/152 (9%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTS-----ETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VY   L +      KK+H +        ++  +  F  E  ++    H N++
Sbjct: 36  IGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 282 KLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
            L G CL  +    ++  YM+ G L   + N      +     +     +A  + +L   
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFL--- 147
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            S   +HRD+++ N +L+ KF   VADFG AR
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    +      + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    +      + +V  ++  + YL      +
Sbjct: 95  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 182

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 62
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R +      
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 381 R 381
           R
Sbjct: 180 R 180

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL---------------FCNLHNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L               F   HN E+  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEE--QLSSKD 151
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 11/171 (6%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +  V +  ++  G+ +A K ++T +       K    EA++   + H NIV+L+ 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQK-LEREARICRLLKHPNIVRLHD 88
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                   +LI++ +  G LF      ED V  ++    +    +   L  + H     +
Sbjct: 89  SISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 346 IHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +HRD+   N+LL SK +     +ADFG A  +  +       AGT GY++P
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 193

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F++   +G G +G V+  +  +G    +++A+K L  +  +    +++ + E  +L +V 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  IVKL Y F    K ++LI +++  G LF  L       E D    V    A +A AL
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALAL 139
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+AP
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 32/181 (17%)
Query: 226 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLH---------------------NNEDAVEL 318
           ++KLYG C     + LI EY + GSL   L                      ++ D   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                ++    ++  + YL      S++HRD+++ NIL+    +  ++DFG +R ++ + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 379 S 379
           S
Sbjct: 205 S 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLREKH 186
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 187 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 234

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F++   +G G +G V+  +  +G    +++A+K L  +  +    +++ + E  +L +V 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  IVKL Y F    K ++LI +++  G LF  L       E D    V    A +A AL
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALAL 139
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+AP
Sbjct: 140 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 195

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 93  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 180

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 244 KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG 303
           K+ + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G
Sbjct: 41  KIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG 99
Query: 304 SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
            LF  +  N+    L  A        M  A+ YLH +    IIHRD+   N+LL+S+ E 
Sbjct: 100 ELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEED 153
Query: 364 F---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + DFG +++L   S  RT L GT  Y+AP
Sbjct: 154 CLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 185

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 77
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 381 R 381
           R
Sbjct: 195 R 195

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 15/179 (8%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F++   +G G +G V+  +  +G    +++A+K L  +  +    +++ + E  +L +V 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 85
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  IVKL Y F    K ++LI +++  G LF  L       E D    V    A +A AL
Sbjct: 86  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAELALAL 140
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH   S  II+RD+   NILL+ +    + DFG ++             GT  Y+AP
Sbjct: 141 DHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 196

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 71
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R +      
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 381 R 381
           R
Sbjct: 189 R 189

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 79  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 131
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 166

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 70
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 381 R 381
           R
Sbjct: 188 R 188

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V    +   G+ +A+K L          +     E++VL    H  
Sbjct: 12  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 71
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL YL
Sbjct: 72  LTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYL 126
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 127 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 179

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    + +    + +V  ++  + YL      +
Sbjct: 85  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKN---IIELVHQVSMGMKYLEES---N 137
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    +      + +V  ++  + YL      +
Sbjct: 73  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 125
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 160

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 193 ATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA------QLPNGKVF 246
           + N + VF     D + VY   +   + + +   +G+G  G V  A      +    ++ 
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 168
Query: 247 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF 306
           + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G LF
Sbjct: 169 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF 227
Query: 307 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-- 364
             +  N+   E   A        M  A+ YLH +    IIHRD+   N+LL+S+ E    
Sbjct: 228 DKVVGNKRLKE---ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281
Query: 365 -VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            + DFG +++L   S  RT L GT  Y+AP
Sbjct: 282 KITDFGHSKILGETSLMRT-LCGTPTYLAP 310

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 122
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 193 ATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA------QLPNGKVF 246
           + N + VF     D + VY   +   + + +   +G+G  G V  A      +    ++ 
Sbjct: 125 SRNKVFVFFDLTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRII 182
Query: 247 ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF 306
           + +K       E     +   E ++L ++ H  I+K+  F    +  +++ E ME G LF
Sbjct: 183 SKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELF 241
Query: 307 CNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-- 364
             +  N+   E   A        M  A+ YLH +    IIHRD+   N+LL+S+ E    
Sbjct: 242 DKVVGNKRLKE---ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 295
Query: 365 -VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            + DFG +++L   S  RT L GT  Y+AP
Sbjct: 296 KITDFGHSKILGETSLMRT-LCGTPTYLAP 324

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 64
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 381 R 381
           R
Sbjct: 182 R 182

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 9/155 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G+G +G+V K   Q+         K+  +E  + A       EA V+ Q+ +  IV++ 
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C     M L+ E  E G L   L  N    +      + +V  ++  + YL      +
Sbjct: 75  GICEAESWM-LVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEES---N 127
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
            +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 71
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 132 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 381 R 381
           R
Sbjct: 189 R 189

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 122
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 122
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 28/182 (15%)
Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
            IG G +G V++A+L      A+KK+           K F+N E Q++  V H N+V L 
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKVLQD--------KRFKNRELQIMRIVKHPNVVDLK 98
Query: 285 GFCL----HRKCMF--LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK----AMAHAL 334
            F       +  +F  L+ EY+       + H      +L     + ++K     +  +L
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPETVYRASRH----YAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           AY+H   S  I HRDI   N+LL+       + DFG+A++L A   N + +   Y Y AP
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY-YRAP 210
Query: 394 GL 395
            L
Sbjct: 211 EL 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V    +   G+ +A+K L          +     E++VL    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL YL
Sbjct: 67  LTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYL 121
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 149
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 199

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 68
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 129 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 381 R 381
           R
Sbjct: 186 R 186

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 70
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 131 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 381 R 381
           R
Sbjct: 188 R 188

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVL 276
           FD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTR 63
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL
Sbjct: 64  HPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSAL 118
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 122
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 122
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 172

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTY 388
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 389 GYIAP 393
            Y++P
Sbjct: 184 QYLSP 188

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L  +    IV
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 71
Query: 282 KLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G  +   R  + L+ EY+  G L   L  +     LD ++ +     +   + YL  
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG- 128
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             S   +HRD+++ NIL+ S+    +ADFG A+LL  D
Sbjct: 129 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 164

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFI---KSFRNEAQVLSQV-LHRNIV 281
           +G G +G V +A     GK  A+ K+     +  A     ++  +E +++S +  H NIV
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLH--------------------NNEDAVELDWA 321
            L G C H   + +I EY   G L   L                     + ED   L+  
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             ++    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 8/165 (4%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAY 126
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
           L    S   +HRDI++ N+L++S     + DFG +R +   +  +
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXK 168

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V    +   G+ +A+K L          +     E++VL    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL YL
Sbjct: 67  LTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYL 121
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 17/179 (9%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS---ETEELAFIKSFRNEAQVLSQVL 276
           FD    +G G +G V    +   G+ +A+K L        +E+A   +   E++VL    
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTR 66
Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL
Sbjct: 67  HPFLTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSAL 121
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 122 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 177

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V    +   G+ +A+K L          +     E++VL    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL YL
Sbjct: 67  LTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYL 121
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V    +   G+ +A+K L          +     E++VL    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           +  L Y F  H +  F++ EY   G LF +L       E    +R     A +  AL YL
Sbjct: 67  LTALKYAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSALEYL 121
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 79/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 99
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 160 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 381 R 381
           R
Sbjct: 217 R 217

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EYM  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    VADFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 98  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 154
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 155 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 190

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 126
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FC--NLHNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L             +C    HN E+  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE--QLSSKD 151
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 73  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 130 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 165

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 75  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 131
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 127
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTY 388
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 128 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 183
Query: 389 GYIAP 393
            Y++P
Sbjct: 184 QYLSP 188

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EYM  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYMPGGDMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    VADFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 134
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 192
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 193 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 126
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 127 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 162

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 8/181 (4%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           E F++   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 18  EDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H  +  ++     ++ +F + EY+  G L   +++ +   + D ++       +   L +
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 134
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP 396
           LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAP + 
Sbjct: 135 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEIL 191
Query: 397 L 397
           L
Sbjct: 192 L 192

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 72  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 128
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 129 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 164

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +D +  +GTG +  V  A+    +     K    E  E     S  NE  VL ++ H NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE-GKEGSMENEIAVLHKIKHPNI 78
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH-- 133
Query: 341 CSPSIIHRDISSNNIL---LNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+AP
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 77
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG L   L        NN        
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 138 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 381 R 381
           R
Sbjct: 195 R 195

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 78
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FC--NLHNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L             +C    HN E+  +L    
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEE--QLSSKD 136
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 137 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 67  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAY 123
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 18/172 (10%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR----NIV 281
           +G G  G V+K +  P+G V A K +H      L    + RN+     QVLH      IV
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIH------LEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
             YG       + +  E+M+ GSL   L       E    K V+I  A+   L YL    
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSI--AVIKGLTYLRE-- 141
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 142 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--FVGTRSYMSP 191

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 27/145 (18%)
Query: 8   LIELDVGSNSLIGPIPXXXXXXXXXXXXXXXRNQFNSSIPNEXXXXXXXXXXXXXXXXXX 67
           ++ LD+  N L G IP                N  + SIP+E                  
Sbjct: 631 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE------------------ 672
Query: 68  XXIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
                 +  ++ L  LD+S+NK++G IP  ++ L+ L  ++LS+N LSGP+P    Q  +
Sbjct: 673 ------VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQFET 725
Query: 128 MYIVRLSPNKGLCGNFSALPSCDAT 152
               +   N GLCG    LP CD +
Sbjct: 726 FPPAKFLNNPGLCG--YPLPRCDPS 748

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 86
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 87  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 144
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 145 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 85
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 86  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 143
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 144 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 93
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 94  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 151
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 32/181 (17%)
Query: 226 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLH---------------------NNEDAVEL 318
           ++KLYG C     + LI EY + GSL   L                      ++ D   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 379 S 379
           S
Sbjct: 205 S 205

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 16/185 (8%)
Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 87
Query: 277 HRNIVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 88  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 144
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTY 388
           AL + H +    IIHRD+   NI++++     V DFG AR + ADS N       + GT 
Sbjct: 145 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI-ADSGNSVTQTAAVIGTA 200
Query: 389 GYIAP 393
            Y++P
Sbjct: 201 QYLSP 205

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 9/151 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E  +I   IG G +G VY  +        L  +     ++L   K+F+ E     Q  H 
Sbjct: 33  EQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQL---KAFKREVMAYRQTRHE 89
Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           N+V   G C+    + +I    +  +L+  + + +  + LD  K   I + +   + YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH 147
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
              +  I+H+D+ S N+  ++  +  + DFG
Sbjct: 148 ---AKGILHKDLKSKNVFYDNG-KVVITDFG 174

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        PN     A+K L +  TE+   +    +E +++  +  H
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKH 82
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDWAK 322
           +NI+ L G C     +++I EY  +G+L   L               HN E+  +L    
Sbjct: 83  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE--QLSSKD 140
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H
Sbjct: 141 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 23/182 (12%)
Query: 221 FDIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           +D +  +GTG +  V  A+      L   K  A K L   E        S  NE  VL +
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG-------SMENEIAVLHK 72
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           + H NIV L         ++LI + +  G LF  +       E D ++   ++  +  A+
Sbjct: 73  IKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAV 129
Query: 335 AYLHHDCSPSIIHRDISSNNIL---LNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
            YLH      I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+
Sbjct: 130 KYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYV 185
Query: 392 AP 393
           AP
Sbjct: 186 AP 187

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 32/181 (17%)
Query: 226 CIGTGGYGSVYKAQLPNGK------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
            +G G +G V KA   + K        A+K L   E    + ++   +E  VL QV H +
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--KENASPSELRDLLSEFNVLKQVNHPH 87
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLH---------------------NNEDAVEL 318
           ++KLYG C     + LI EY + GSL   L                      ++ D   L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ + 
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 379 S 379
           S
Sbjct: 205 S 205

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 27/145 (18%)
Query: 8   LIELDVGSNSLIGPIPXXXXXXXXXXXXXXXRNQFNSSIPNEXXXXXXXXXXXXXXXXXX 67
           ++ LD+  N L G IP                N  + SIP+E                  
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDE------------------ 675
Query: 68  XXIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
                 +  ++ L  LD+S+NK++G IP  ++ L+ L  ++LS+N LSGP+P    Q  +
Sbjct: 676 ------VGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQFET 728
Query: 128 MYIVRLSPNKGLCGNFSALPSCDAT 152
               +   N GLCG    LP CD +
Sbjct: 729 FPPAKFLNNPGLCG--YPLPRCDPS 751

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 64
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-------SLFCNLHNNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG       SL   + NN        
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N  +   F   + DFG  R ++     
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 381 R 381
           R
Sbjct: 182 R 182

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 24/181 (13%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKA-------QLPNGKVFALKKLH--TSETEELAFIKSFRN 267
           A E   +   +G G +G VY+          P  +V A+K ++   S  E + F+    N
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFL----N 67
Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDW 320
           EA V+ +    ++V+L G     +   +I E M RG L   L        NN        
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +K + +   +A  +AYL+ +     +HRD+++ N ++   F   + DFG  R ++     
Sbjct: 128 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 381 R 381
           R
Sbjct: 185 R 185

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 3/174 (1%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           ++K Y   +    + ++ E  + G L   + + +    L       + K      + L H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPERTVWKYFVQLCSALEH 151
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  ++HRDI   N+ + +     + D G  R   + ++    L GT  Y++P
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAY 506
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L++S     + DFG +R + 
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 19/185 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--------ETEELAFIKSFRNEA 269
           E ++ K  +G G    V +    P  K +A+K +  +        E +EL   ++   E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 74
Query: 270 QVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
            +L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
           A+   +  LH     +I+HRD+   NILL+      + DFG +  L      R+ + GT 
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS-VCGTP 187
Query: 389 GYIAP 393
            Y+AP
Sbjct: 188 SYLAP 192

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 227 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G   +G VYK  L    P  +  A+      +  E    + FR+EA + +++ H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKR--------VNIVKA 329
           L G     + + +I+ Y   G L   L     H++  + + D   +        V++V  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 330 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           +A  + YL  HH     ++H+D+++ N+L+  K    ++D G  R ++A
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 197

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 78/169 (46%), Gaps = 24/169 (14%)
Query: 227 IGTGGYGSVYKAQL----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G   +G VYK  L    P  +  A+      +  E    + FR+EA + +++ H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKR--------VNIVKA 329
           L G     + + +I+ Y   G L   L     H++  + + D   +        V++V  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 330 MAHALAYL--HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           +A  + YL  HH     ++H+D+++ N+L+  K    ++D G  R ++A
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           + FD+   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 335
           H  +V L+        +F + EY+  G L  ++       E    +      A ++ AL 
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 124
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAP
Sbjct: 125 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 179

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           + FD+   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 335
           H  +V L+        +F + EY+  G L  ++       E    +      A ++ AL 
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 120
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAP
Sbjct: 121 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 175

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +D +  +GTG +  V  A+    +     K    E  E     S  NE  VL ++ H NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE-GKEGSMENEIAVLHKIKHPNI 78
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH-- 133
Query: 341 CSPSIIHRDISSNNIL---LNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+AP
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 80/179 (44%), Gaps = 37/179 (20%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKL---------HTSETEELAFIKSFRNEAQVLSQV- 275
           +G G +G V +A     GK  A+ K+         H  E E L       +E +++S + 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALM------SELKIMSHLG 107
Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL---------------HNNEDAVELDW 320
            H NIV L G C H   + +I EY   G L   L               HN E+  +L  
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEE--QLSS 165
Query: 321 AKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
              ++    +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS+
Sbjct: 166 RDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--------ETEELAFIKSFRNEA 269
           E ++ K  +G G    V +    P  K +A+K +  +        E +EL   ++   E 
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 61
Query: 270 QVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
            +L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 118
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
           A+   +  LH     +I+HRD+   NILL+      + DFG +  L      R  + GT 
Sbjct: 119 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTP 174
Query: 389 GYIAP 393
            Y+AP
Sbjct: 175 SYLAP 179

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 11/176 (6%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +D +  +GTG +  V  A+    +     K    E  E     S  NE  VL ++ H NI
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALE-GKEGSMENEIAVLHKIKHPNI 78
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V L         ++LI + +  G LF  +       E D ++   ++  +  A+ YLH  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR---LIFQVLDAVKYLH-- 133
Query: 341 CSPSIIHRDISSNNIL---LNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               I+HRD+   N+L   L+   +  ++DFG +++    S   T   GT GY+AP
Sbjct: 134 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAP 187

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 70  HPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAY 126
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L+++     + DFG +R + 
Sbjct: 127 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME 162

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 75/178 (42%), Gaps = 10/178 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           + FD+   IG G Y  V   +L    +++A+K +      +   I   + E  V  Q   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALA 335
           H  +V L+        +F + EY+  G L  ++       E    +      A ++ AL 
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLALN 135
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIAP
Sbjct: 136 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAP 190

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 49/226 (21%)
Query: 214 LIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEEL--AFIKSFRNEAQ 270
           L+E  + + +K  IG G YG V  A +     + A+K ++ ++  ++    ++  + E +
Sbjct: 21  LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------------- 310
           ++ ++ H NI +LY      + + L+ E    G L   L+                    
Sbjct: 81  LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 311 ----NNEDAV---------ELDWAKR----VNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
                NE+A+          LD+ +R     NI++ +  AL YLH+     I HRDI   
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPE 197
Query: 354 NILL--NSKFEAFVADFGTA----RLLHADSSNRTLLAGTYGYIAP 393
           N L   N  FE  + DFG +    +L + +    T  AGT  ++AP
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 8/181 (4%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           E F +   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H  +  ++     ++ +F + EY+  G L   +++ +   + D ++       +   L +
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILGLQF 133
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP 396
           LH   S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAP + 
Sbjct: 134 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEIL 190
Query: 397 L 397
           L
Sbjct: 191 L 191

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TEE   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEE--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 19/185 (10%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--------ETEELAFIKSFRNEA 269
           E ++ K  +G G    V +    P  K +A+K +  +        E +EL   ++   E 
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR--EATLKEV 74
Query: 270 QVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
            +L +V  H NI++L          FL+++ M++G LF  L    + V L   +   I++
Sbjct: 75  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMR 131
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
           A+   +  LH     +I+HRD+   NILL+      + DFG +  L      R  + GT 
Sbjct: 132 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTP 187
Query: 389 GYIAP 393
            Y+AP
Sbjct: 188 SYLAP 192

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 223 IKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE-------ELAFIKSFRNEAQVLSQ 274
           ++  +  GG+  VY+AQ + +G+ +ALK+L ++E E       E+ F+K           
Sbjct: 32  VRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG------- 84
Query: 275 VLHRNIVKLYGFCLHR----------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
             H NIV+   FC             +  FL+   + +G L   L   E    L     +
Sbjct: 85  --HPNIVQ---FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL 139
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA 371
            I      A+ ++H    P IIHRD+   N+LL+++    + DFG+A
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 218 TEGFDIKYCIGTGGYGSVYK-AQLPNGKVFA-----LKKLHTSETEELAFIKSFRNEAQV 271
           TE + +   +G G +  V +  ++  G+ +A      KKL   + ++L        EA++
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------EREARI 63
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
              + H NIV+L+         +LI++ +  G LF      ED V  ++    +    + 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF------EDIVAREYYSEADASHCIQ 117
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTY 388
             L  + H     ++HR++   N+LL SK +     +ADFG A  +  +       AGT 
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 389 GYIAP 393
           GY++P
Sbjct: 178 GYLSP 182

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G G +GSV +   ++   ++    K+    TE+ A  +    EAQ++ Q+ +  IV+L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C   + + L+ E    G L   L    + + +  +    ++  ++  + YL      +
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 130
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
            +HRD+++ N+LL ++  A ++DFG ++ L AD S  T
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL----HRKCMF--LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F       +  ++  L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 193

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 71/159 (44%), Gaps = 8/159 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           E  ++  CIG G +G V++     P     A+           +  + F  EA  + Q  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H +IVKL G  +    +++I E    G L   L   +    LD A  +     ++ ALAY
Sbjct: 450 HPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAY 506
Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           L    S   +HRDI++ N+L+++     + DFG +R + 
Sbjct: 507 LE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYME 542

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 26/182 (14%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKLY 284
           IG G YG V+  +    KV A+K   T  TEE ++ +    E ++   VL  H NI+   
Sbjct: 45  IGKGRYGEVWMGKWRGEKV-AVKVFFT--TEEASWFR----ETEIYQTVLMRHENILGFI 97
Query: 285 GFCLH----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
              +        ++LI +Y E GSL+  L     +  LD    + +  +    L +LH +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 341 C-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL----LAGTYGYI 391
                  P+I HRD+ S NIL+       +AD G A    +D++   +      GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 392 AP 393
            P
Sbjct: 214 PP 215

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 193

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 81/181 (44%), Gaps = 16/181 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFAL---KKLHTSETEELAFIKSFRNEAQVLSQ 274
           + FD+   IG G Y  V   +L    +++A+   KK   ++ E++ ++++   E  V  Q
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQ 108
Query: 275 VL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAH 332
              H  +V L+        +F + EY+  G L  ++       E    +      A ++ 
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISL 164
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           AL YLH      II+RD+  +N+LL+S+    + D+G  +         +   GT  YIA
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 393 P 393
           P
Sbjct: 222 P 222

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 193

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IGTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    VADFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG VYKA      +  A+K++     EE     + R E  +L ++ HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-SPS 344
              H   + LI+EY E   L   +  N D         + ++K+  + L    + C S  
Sbjct: 101 VIHHNHRLHLIFEYAE-NDLKKYMDKNPDV-------SMRVIKSFLYQLINGVNFCHSRR 152
Query: 345 IIHRDISSNNILLNSKFEA-----FVADFGTAR 372
            +HRD+   N+LL+    +      + DFG AR
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 8/168 (4%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A    +G+  A+KKL      E+   +++R E  +L  + H N++ L  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                  +   Y++                +E    K   +V  M   L Y+H   S  +
Sbjct: 109 VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIH---SAGV 165
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y AP
Sbjct: 166 VHRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAP 210

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 193

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 193

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  LAGT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLAGTPEY 204
Query: 391 IAPGLPL 397
           +AP + L
Sbjct: 205 LAPEIIL 211

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 193

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 80
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 81  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 140
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 141 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 194

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 80/179 (44%), Gaps = 12/179 (6%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+    +G G +G V  A++   G ++A+K L      +   ++    E ++LS  L 
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS--LA 80
Query: 278 RN---IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
           RN   + +L+        +F + E++  G L  ++  +      D A+       +  AL
Sbjct: 81  RNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISAL 137
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +LH      II+RD+  +N+LL+ +    +ADFG  +    +        GT  YIAP
Sbjct: 138 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAP 193

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K+F+N E Q++ ++ H NIV+L 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMRKLDHCNIVRLR 79
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 140 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 193

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 28/180 (15%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRN---- 279
           IG G YGSV K    P+G++ A+K++ ++  E        + + Q+L    V+ R+    
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--------KEQKQLLMDLDVVMRSSDCP 81
Query: 280 -IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHA 333
            IV+ YG        ++  E M   + F   +       +D +  +   ++ +  A   A
Sbjct: 82  YIVQFYGALFREGDCWICMELM--STSFDKFYKYVYSVLDDVIPEEILGKITL--ATVKA 137
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L +L  +    IIHRDI  +NILL+      + DFG +  L  DS  +T  AG   Y+AP
Sbjct: 138 LNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAP 194

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 83
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 84  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 143
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 144 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 197

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 98
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 99  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 159 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 212

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 205

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 92
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 93  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 152
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 153 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 206

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 87
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 88  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 147
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 148 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 201

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 91
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 92  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 151
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 152 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 205

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 84
Query: 285 GFCL------HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F            + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 85  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 144
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 145 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 198

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 107
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 108 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 167
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 168 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 221

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 70/129 (54%), Gaps = 14/129 (10%)
Query: 229 TGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 288
            G YG +++ ++    +  L K H + +E      SF   A ++S++ H+++V  YG C+
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCV 82
Query: 289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 348
                 L+ E+++ GSL   L  N++ + + W  ++ + K +A A+ +L  +   ++IH 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEEN---TLIHG 137
Query: 349 DISSNNILL 357
           ++ + NILL
Sbjct: 138 NVCAKNILL 146

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/188 (25%), Positives = 84/188 (44%), Gaps = 28/188 (14%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+   C+G GG+G V++A+    KV    +A+K++      ELA  K  R E + L+++ 
Sbjct: 7   FEPIQCLGRGGFGVVFEAK---NKVDDCNYAIKRIRLP-NRELAREKVMR-EVKALAKLE 61
Query: 277 HRNIVKLYGFCLHRKCMFL-------IYEYMERGSLFCNLHNNEDAV-------ELDWAK 322
           H  IV+ +   L +            +Y Y++     C   N +D +       E + + 
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ--LCRKENLKDWMNGRCTIEERERSV 119
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
            ++I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D   +T
Sbjct: 120 CLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 383 LLAGTYGY 390
           +L     Y
Sbjct: 177 VLTPMPAY 184

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPEL 227

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 22/175 (12%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A    +G+  A+KKL      E+   +++R E  +L  + H N++ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 286 FCLHRKCM------FLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                  +      +L+  +M+        L  +E+ ++        +V  M   L Y+H
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-------LVYQMLKGLKYIH 143
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
              S  ++HRD+   N+ +N   E  + DFG AR  HAD +  T    T  Y AP
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR--HAD-AEMTGYVVTRWYRAP 192

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 113
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 173
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 174 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 227

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 31/187 (16%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKV------FALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           FDI+  IG G + +VYK       V         +KL  SE +       F+ EA+ L  
Sbjct: 30  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ------RFKEEAEXLKG 81
Query: 275 VLHRNIVKLY----GFCLHRKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIV 327
           + H NIV+ Y         +KC+ L+ E    G+L   L      +  V   W +++   
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI--- 138
Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAG 386
                 L +LH   +P IIHRD+  +NI +     +  + D G A L  A  +   +  G
Sbjct: 139 ---LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI--G 192
Query: 387 TYGYIAP 393
           T  + AP
Sbjct: 193 TPEFXAP 199

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 45  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 104
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 160
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 202

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 115
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 116 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 175
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 176 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 117
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 118 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 177
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 178 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 231

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 69/129 (53%), Gaps = 14/129 (10%)
Query: 229 TGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL 288
            G YG +++ ++    +  L K H + +E      SF   A ++S++ H+++V  YG C 
Sbjct: 32  VGDYGQLHETEV---LLKVLDKAHRNYSE------SFFEAASMMSKLSHKHLVLNYGVCF 82
Query: 289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR 348
                 L+ E+++ GSL   L  N++ + + W  ++ + K +A A+ +L  +   ++IH 
Sbjct: 83  CGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEEN---TLIHG 137
Query: 349 DISSNNILL 357
           ++ + NILL
Sbjct: 138 NVCAKNILL 146

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 21/178 (11%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQVLHRNIVKLY 284
           IG G +G VY+A+L  +G++ A+KK+           K F+N E Q++ ++ H NIV+L 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMRKLDHCNIVRLR 158
Query: 285 GFCL---HRK---CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            F      +K    + L+ +Y+         H +     L        +  +  +LAY+H
Sbjct: 159 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 218
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
              S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y AP L
Sbjct: 219 ---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPEL 272

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 37  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 96
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 152
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 194

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 36  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 95
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 151
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 193

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 29  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 88
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 186

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 30  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 89
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 145
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 187

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 79/158 (50%), Gaps = 9/158 (5%)
Query: 227 IGTGGYGSVYKA--QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           +G G +GSV +   ++   ++    K+    TE+ A  +    EAQ++ Q+ +  IV+L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C   + + L+ E    G L   L    + + +  +    ++  ++  + YL      +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 456
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
            +HR++++ N+LL ++  A ++DFG ++ L AD S  T
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTS--ETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G G YG V K + +P+G++ A+K++  +    E+   +       + +        V  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF---TVTF 71
Query: 284 YGFCLHRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKR--VNIVKAMAHALAYLHH 339
           YG       +++  E M+      +  + +    +  D   +  V+IVKA+ H  + L  
Sbjct: 72  YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               S+IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y+AP
Sbjct: 130 ----SVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAP 178

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 35  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 94
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 150
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 192

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 75  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 190
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 232

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 81  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 140
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 196
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 238

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 146
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 188

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 146
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 188

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APAIIL 211

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 146
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 29  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 88
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 144
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAP 393
           N+L  SK    +    DFG A+     +S+ +L    Y   Y+AP
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAP 186

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWXLXGTPEY 204
Query: 391 IAPGLPL 397
           +AP + L
Sbjct: 205 LAPEIIL 211

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 29/174 (16%)
Query: 242 NGKVFALKKLHTSETEE-LAFIKS-------------FRNEAQVLSQVLHRNIVKLYGFC 287
           + K +ALKK   S  E+   F KS             F+NE Q+++ + +   +   G  
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112
Query: 288 LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--------NIVKAMAHALAYLHH 339
            +   +++IYEYME  S+   L  +E    LD              I+K++ ++ +Y+H+
Sbjct: 113 TNYDEVYIIYEYMENDSI---LKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +   +I HRD+  +NIL++      ++DFG +  +       +   GTY ++ P
Sbjct: 170 E--KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--RGTYEFMPP 219

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 34  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 93
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 94  FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 144
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 145 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYLAPEIIL 197

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 87
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 148 SCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 15/181 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +++   +G+G +  V K  Q   GK +A   +KK   S +      +    E  +L ++ 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NI+ L+    ++  + LI E +  G LF  L   E   E D A     +K +   + Y
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEA--TQFLKQILDGVHY 123
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L  K        + DFG A  + A +  + +  GT  ++A
Sbjct: 124 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVA 179
Query: 393 P 393
           P
Sbjct: 180 P 180

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE---PHARFYAAQIVLTFEYL 157
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 89
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 150 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 24/187 (12%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEY 204
Query: 391 IAPGLPL 397
           +AP + L
Sbjct: 205 LAPEIIL 211

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 92
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I EY  +G+L   L              N     ++ +   V
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 153 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEA 269
           +ED+ + T        +G G Y  V  A  L NGK +A+K +        + +  FR E 
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRV--FR-EV 61
Query: 270 QVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           + L Q   ++NI++L  F       +L++E ++ GS+  ++   +   E + ++   +V+
Sbjct: 62  ETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASR---VVR 118
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNS 359
            +A AL +LH   +  I HRD+   NIL  S
Sbjct: 119 DVAAALDFLH---TKGIAHRDLKPENILCES 146

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 138
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 139 LTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 192
Query: 392 APGLPL 397
           AP + L
Sbjct: 193 APEIIL 198

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 152
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 153 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 206

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 152
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 153 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 206
Query: 392 APGLPL 397
           AP + L
Sbjct: 207 APEIIL 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 15/181 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +++   +G+G +  V K  Q   GK +A   +KK   S +      +    E  +L ++ 
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NI+ L+    ++  + LI E +  G LF  L   E   E D A     +K +   + Y
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE-DEA--TQFLKQILDGVHY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L  K        + DFG A  + A +  + +  GT  ++A
Sbjct: 131 LH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVA 186
Query: 393 P 393
           P
Sbjct: 187 P 187

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT---LCGTPEYLAPEIIL 212

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 80/180 (44%), Gaps = 10/180 (5%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L       E            +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           H   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 79/178 (44%), Gaps = 10/178 (5%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           +VKL         ++++ EY+  G +F +L       E            +     YLH 
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH- 179
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 232

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 75  NGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I K++  A+ YLH   S +I HRD+   
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTE-REASEIXKSIGEAIQYLH---SINIAHRDVKPE 190
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           N+L  SK    +    DFG A+   + +S  T     Y Y+AP
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAP 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 141
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 396 PL 397
            L
Sbjct: 199 ML 200

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    +R  + LI E +  G LF  L   E   E    +  + +K +   + Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 82/184 (44%), Gaps = 22/184 (11%)
Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------ 333
           +VKL         ++++ EY+  G +F +L             R +   A  +A      
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIVLT 174
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT---LCGTPEYLAP 228
Query: 394 GLPL 397
            + L
Sbjct: 229 EIIL 232

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 22/128 (17%)
Query: 266 RNEAQVLSQVLHRNIVKLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
           + E Q+L ++ H+N+++L    +   ++ M+++ EY       C +    D+V     KR
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY-----CVCGMQEMLDSVP---EKR 105
Query: 324 VNIVKAMAH------ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH-- 375
             + +A  +       L YLH   S  I+H+DI   N+LL +     ++  G A  LH  
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162
Query: 376 -ADSSNRT 382
            AD + RT
Sbjct: 163 AADDTCRT 170

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 191

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EY+  G +F +L       E            +     YLH   S  
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 162
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 24/180 (13%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EY+  G +F +L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 77/173 (44%), Gaps = 10/173 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EY+  G +F +L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + I   +G G +G V  A     G+  ALK ++     +         E   L  + H +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I+KLY     +  + ++ EY   G+   +     D +    A+R    + +  A+ Y H 
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCHR 121
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                I+HRD+   N+LL+      +ADFG + ++  D +      G+  Y AP
Sbjct: 122 H---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 171

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 141
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 396 PL 397
            L
Sbjct: 199 ML 200

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 24/180 (13%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    +R  + LI E +  G LF  L   E   E    +  + +K +   + Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + I   +G G +G V  A     G+  ALK ++     +         E   L  + H +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I+KLY     +  + ++ EY   G+   +     D +    A+R    + +  A+ Y H 
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCHR 131
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                I+HRD+   N+LL+      +ADFG + ++  D +      G+  Y AP
Sbjct: 132 H---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 181

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 150
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 200

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + I   +G G +G V  A     G+  ALK ++     +         E   L  + H +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I+KLY     +  + ++ EY   G+   +     D +    A+R    + +  A+ Y H 
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCHR 125
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                I+HRD+   N+LL+      +ADFG + ++  D +      G+  Y AP
Sbjct: 126 H---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 175

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 96
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 97  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 149
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 396 PL 397
            L
Sbjct: 207 ML 208

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 141
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 396 PL 397
            L
Sbjct: 199 ML 200

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 43/77 (55%), Gaps = 3/77 (3%)
Query: 73  QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVR 132
           ++   KNL  LD+ NN+I G++P  +T+L  L  LN+S N L G +P     L    +  
Sbjct: 239 KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSA 297
Query: 133 LSPNKGLCGNFSALPSC 149
            + NK LCG  S LP+C
Sbjct: 298 YANNKCLCG--SPLPAC 312

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 141
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 396 PL 397
            L
Sbjct: 199 ML 200

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    +R  + LI E +  G LF  L   E   E    +  + +K +   + Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIML 191

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIML 195

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 88
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 89  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 141
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 396 PL 397
            L
Sbjct: 199 ML 200

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 73/174 (41%), Gaps = 9/174 (5%)
Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + I   +G G +G V  A     G+  ALK ++     +         E   L  + H +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I+KLY     +  + ++ EY   G+   +     D +    A+R    + +  A+ Y H 
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA--GNELFDYIVQRDKMSEQEARR--FFQQIISAVEYCHR 130
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                I+HRD+   N+LL+      +ADFG + ++  D +      G+  Y AP
Sbjct: 131 H---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAP 180

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 90
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 143
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 396 PL 397
            L
Sbjct: 201 ML 202

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMAGFVA-TRWYRAPEIML 195

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 73/161 (45%), Gaps = 15/161 (9%)
Query: 242 NGKVFALKKLHTSETEELAFIK---SFRNEAQV---LSQVLH-RNIVKLY-GFCLHRKCM 293
           NGKV  +    T E   L  ++     R E ++    SQ  H   IV +Y      RKC+
Sbjct: 31  NGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90
Query: 294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN 353
            ++ E ++ G LF  + +  D    +  +   I+K++  A+ YLH   S +I HRD+   
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTE-REASEIMKSIGEAIQYLH---SINIAHRDVKPE 146
Query: 354 NILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYGYI 391
           N+L  SK    +    DFG A+    +  +++    + G I
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVI 187

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 165
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGXVA-TRWYRAPEIML 215

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +   + Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 269
           A E   +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 76
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++  + H +IVKL G  +  +  ++I E    G L   L  N++++++     V     
Sbjct: 77  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 133
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +  + 
Sbjct: 134 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 179

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 165
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 215

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 24/180 (13%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWXLCGTPEYLAPEIIL 211

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 109 IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 161
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 396 PL 397
            L
Sbjct: 219 ML 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 24/171 (14%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALK------KLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +GSV +  L      +LK      KL  S   E   I+ F +EA  +    H N+
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE---IEEFLSEAACMKDFSHPNV 98
Query: 281 VKLYGFCLHRKCM-----FLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAM 330
           ++L G C+           +I  +M+ G L     +  L      + L       ++K M
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ-----TLLKFM 153
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
                 + +  + + +HRD+++ N +L       VADFG ++ +++    R
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    +R  + LI E +  G LF  L   E    L   +  + +K +   + Y
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + ++  IG G +G V  A     ++  A KK+     E+   +  F+ E +++  + H N
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPN 67
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I++LY        ++L+ E    G LF  + +     E D A+   I+K +  A+AY H 
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 123
Query: 340 DCSPSIIHRDISSNNILL-----NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               ++ HRD+   N L      +S  +  + DFG A         RT + GT  Y++P
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTPYYVSP 177

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 164
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 214

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  FA+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 108 YSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 79  DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 131
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 132 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 181

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 269
           A E   +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 60
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++  + H +IVKL G  +  +  ++I E    G L   L  N++++++     V     
Sbjct: 61  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 117
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +  + 
Sbjct: 118 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 163

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 396 PL 397
            L
Sbjct: 197 ML 198

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEA 269
           A E   +   +G G +G VY+    N K       V   KK  T + +E      F +EA
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-----KFMSEA 64
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA 329
            ++  + H +IVKL G  +  +  ++I E    G L   L  N++++++     V     
Sbjct: 65  VIMKNLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQ 121
Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           +  A+AYL    S + +HRDI+  NIL+ S     + DFG +R +  + 
Sbjct: 122 ICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 146
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 396 PL 397
            L
Sbjct: 204 ML 205

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 155
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 205

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 94
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 95  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 147
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 148 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 396 PL 397
            L
Sbjct: 205 ML 206

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 85
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 86  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 138
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 139 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 396 PL 397
            L
Sbjct: 196 ML 197

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 86
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 87  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 139
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 396 PL 397
            L
Sbjct: 197 ML 198

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 191

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 28/201 (13%)
Query: 206 DGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE--------T 256
           D  +++ED+ E  E       IG G +  V +      G+ FA+K +  ++        T
Sbjct: 17  DDDVLFEDVYELCE------VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDA- 315
           E+L      + EA +   + H +IV+L         +++++E+M+   L   +    DA 
Sbjct: 71  EDL------KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTAR 372
                A   + ++ +  AL Y H +   +IIHRD+   N+LL SK  +    + DFG A 
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAI 181
Query: 373 LLHADSSNRTLLAGTYGYIAP 393
            L           GT  ++AP
Sbjct: 182 QLGESGLVAGGRVGTPHFMAP 202

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 18/179 (10%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + ++  IG G +G V  A     ++  A KK+     E+   +  F+ E +++  + H N
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPN 84
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I++LY        ++L+ E    G LF  + +     E D A+   I+K +  A+AY H 
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH- 140
Query: 340 DCSPSIIHRDISSNNILL-----NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               ++ HRD+   N L      +S  +  + DFG A         RT + GT  Y++P
Sbjct: 141 --KLNVAHRDLKPENFLFLTDSPDSPLK--LIDFGLAARFKPGKMMRTKV-GTPYYVSP 194

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 148 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 150
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 200

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL---AGTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 93
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 94  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 146
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLL---AGTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 396 PL 397
            L
Sbjct: 204 ML 205

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 227 IGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V+K  +   G   A K + T   ++   +K   NE  V++Q+ H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYD 153
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
               +  + L+ EY++ G LF  + +   +  ELD    +  +K +   + ++H      
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD---TILFMKQICEGIRHMHQ---MY 207
Query: 345 IIHRDISSNNILLNSK--FEAFVADFGTAR 372
           I+H D+   NIL  ++   +  + DFG AR
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 156
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 206

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 197

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 75  DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 127
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 128 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 177

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 24/183 (13%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGY 390
               YLH   S  +I+RD+   N++++ +    V DFG A+ +      RT  L GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG----RTWXLCGTPEY 204
Query: 391 IAP 393
           +AP
Sbjct: 205 LAP 207

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 197

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 38/196 (19%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE------------ 268
           +++K  +GTGG+G            + L+ +H    E++A IK  R E            
Sbjct: 16  WEMKERLGTGGFG------------YVLRWIHQDTGEQVA-IKQCRQELSPKNRERWCLE 62
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAK 322
            Q++ ++ H N+V         + +       L  EY E G L   L+  E+   L    
Sbjct: 63  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSS 379
              ++  ++ AL YLH +    IIHRD+   NI+L    +     + D G A+ L     
Sbjct: 123 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 179
Query: 380 NRTLLAGTYGYIAPGL 395
             T   GT  Y+AP L
Sbjct: 180 C-TEFVGTLQYLAPEL 194

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGXVATRWYRAPEIML 195

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 164
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 214

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 142
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 192

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 81/196 (41%), Gaps = 38/196 (19%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE------------ 268
           +++K  +GTGG+G            + L+ +H    E++A IK  R E            
Sbjct: 17  WEMKERLGTGGFG------------YVLRWIHQDTGEQVA-IKQCRQELSPKNRERWCLE 63
Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAK 322
            Q++ ++ H N+V         + +       L  EY E G L   L+  E+   L    
Sbjct: 64  IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 123
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSS 379
              ++  ++ AL YLH +    IIHRD+   NI+L    +     + D G A+ L     
Sbjct: 124 IRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL 180
Query: 380 NRTLLAGTYGYIAPGL 395
             T   GT  Y+AP L
Sbjct: 181 C-TEFVGTLQYLAPEL 195

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +DI   +G+G +  V K  +   G  +A   +KK  +  +      +    E  +L QVL
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NI+ L+    +R  + LI E +  G LF  L   E   E    +  + +K +   + Y
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQILDGVNY 130
Query: 337 LHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   +  I H D+   NI+L  K        + DFG A  +      + +  GT  ++A
Sbjct: 131 LH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVA 186
Query: 393 PGL 395
           P +
Sbjct: 187 PEI 189

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS---------ETEELAFIKSFRNEAQ 270
           ++I   IG G YG V  A+    G+  A+KK+  +            EL  +K F+++  
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 116
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           +  + + R  V    F    K ++++ + ME   L   +H+++  + L+  +    +  +
Sbjct: 117 IAIKDILRPTVPYGEF----KSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVR--YFLYQL 168
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR----TLLAG 386
              L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T    
Sbjct: 169 LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 225
Query: 387 TYGYIAPGLPL 397
           T  Y AP L L
Sbjct: 226 TRWYRAPELML 236

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 29/182 (15%)
Query: 223 IKYCIGTGGYGSV-----YKAQLPNGKVFALKKL------HTSETEELAFIKSFRNEAQV 271
           I+  +G G +G V     YK Q      F  ++L      H     E++++K  R     
Sbjct: 13  IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR----- 67
Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
                H +I+KLY        + ++ EY   G LF  +   +   E D  +R    + + 
Sbjct: 68  -----HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEKKRMTE-DEGRR--FFQQII 118
Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
            A+ Y H      I+HRD+   N+LL+      +ADFG + ++  D +      G+  Y 
Sbjct: 119 CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYA 174
Query: 392 AP 393
           AP
Sbjct: 175 AP 176

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 150
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 200

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 144
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 194

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 176 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 157
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 207

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 165
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 215

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 168
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 218

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL +   + +   K    E ++L  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 201

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 143
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 193

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 168
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D      +A T  Y AP + L
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMXGYVA-TRWYRAPEIML 218

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 197

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 142
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 192

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 152
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 202

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 156
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 206

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 141
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 191

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 157
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 207

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 150
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 200

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 197

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 157
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLAR--HTD-DEMTGYVATRWYRAPEIML 201

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 85/181 (46%), Gaps = 13/181 (7%)
Query: 216 EATEGFDIKYCIGTGGYGSVYK-AQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E + I   +G G +G V++  +  + K +  K +    T+++      + E  +L+ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV----KKEISILNI 57
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
             HRNI+ L+      + + +I+E++    +F  +  N  A EL+  + V+ V  +  AL
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEAL 115
Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVA--DFGTARLLHADSSNRTLLAGTYGYIA 392
            +LH   S +I H DI   NI+  ++  + +   +FG AR L    + R L      Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP-EYYA 171
Query: 393 P 393
           P
Sbjct: 172 P 172

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 201

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 24/181 (13%)
Query: 221 FDIKYCIGTGGYGSVYKA--QLPNGKVFALKKL-HTSETEELAFIKSFRNEAQVLSQVLH 277
           +++K CI  GG G +Y A  +  NG+   LK L H+ + E  A   + R   Q L++V+H
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER---QFLAEVVH 138
Query: 278 RNIVKLYGFCLHRK-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
            +IV+++ F  H         +++ EY+   SL           +L  A+ +  +  +  
Sbjct: 139 PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-----KRSKGQKLPVAEAIAYLLEILP 193
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           AL+YLH   S  +++ D+   NI+L  +    + D G    +++       L GT G+ A
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEEQLKLI-DLGAVSRINSFG----YLYGTPGFQA 245
Query: 393 P 393
           P
Sbjct: 246 P 246

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 143
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 396 PL 397
            L
Sbjct: 201 ML 202

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 81/191 (42%), Gaps = 38/191 (19%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEA 269
           E  +    +G+G +G V      N   + + K   S    +  +K         +  +E 
Sbjct: 45  ENLEFGKVLGSGAFGKVM-----NATAYGISKTGVSIQVAVKMLKEKADSSEREALMSEL 99
Query: 270 QVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-----NEDAVELDWAKR 323
           ++++Q+  H NIV L G C     ++LI+EY   G L   L +     +ED +E +  KR
Sbjct: 100 KMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 324 VN---------------IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF 368
           +                    +A  + +L      S +HRD+++ N+L+       + DF
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 369 GTARLLHADSS 379
           G AR + +DS+
Sbjct: 217 GLARDIMSDSN 227

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 72/168 (42%), Gaps = 27/168 (16%)
Query: 227 IGTGGYGSVYKAQL-------PNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQV-LH 277
           +G G +G V  A+        P   V  A+K L    TE+   +    +E +++  +  H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKH 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------------NNEDAVELDWAKRV 324
           +NI+ L G C     +++I  Y  +G+L   L              N     ++ +   V
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +    +A  + YL    S   IHRD+++ N+L+       +ADFG AR
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 159 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 151
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 152 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 204

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A++K+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 25/191 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTS---------ETEELAFIKSFRNEAQ 270
           ++I   IG G YG V  A+    G+  A+KK+  +            EL  +K F+++  
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI 115
Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           +  + + R  V    F    K ++++ + ME   L   +H+++  + L+  +    +  +
Sbjct: 116 IAIKDILRPTVPYGEF----KSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVR--YFLYQL 167
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR----TLLAG 386
              L Y+H   S  +IHRD+  +N+L+N   E  + DFG AR L    +      T    
Sbjct: 168 LRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224
Query: 387 TYGYIAPGLPL 397
           T  Y AP L L
Sbjct: 225 TRWYRAPELML 235

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L    H NI+ +  
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLAFRHENIIGIND 90
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 91  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 143
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 396 PL 397
            L
Sbjct: 201 ML 202

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 10/173 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 48  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EY   G +F +L       E            +     YLH   S  
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 161
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 211

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 10/173 (5%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 41  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 100
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EY+  G +F +L       E            +     YLH   S  
Sbjct: 101 FSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYLH---SLD 154
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 204

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 76  DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 129 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 79/182 (43%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 92
Query: 286 FCL-----HRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++++ + ME     L    H + D +          +  +   L Y+H
Sbjct: 93  IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI-------CYFLYQILRGLKYIH 145
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 396 PL 397
            L
Sbjct: 203 ML 204

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 19/179 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR---NEAQVLSQVLHRNIVK 282
           +G G   +V++ +    G +FA+K  +      ++F++       E +VL ++ H+NIVK
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 283 LYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           L+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 341 CSPSIIHRDISSNNILL----NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
               I+HR+I   NI+     + +    + DFG AR L  D      L GT  Y+ P +
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDM 186

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 8/175 (4%)
Query: 221 FDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V    +   G+ +A+K L          +     E +VL    H  
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 71
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +  L Y F  H +  F++ EY   G LF +L + E     D A+       +  AL YLH
Sbjct: 72  LTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYLH 127
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 128 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 180

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 227 IGTGGYGSVYKA----QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY      Q  N    A+K L  S   E+  +++F  E  ++  + H N++ 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 283 LYGFCLHRKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           L G  L  + +  ++  YM  G L   + + +    +     ++    +A  + YL    
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV--KDLISFGLQVARGMEYL---A 141
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
               +HRD+++ N +L+  F   VADFG AR
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 8/175 (4%)
Query: 221 FDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V    +   G+ +A+K L          +     E +VL    H  
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 70
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +  L Y F  H +  F++ EY   G LF +L + E     D A+       +  AL YLH
Sbjct: 71  LTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYLH 126
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 127 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 179

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 8/175 (4%)
Query: 221 FDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V    +   G+ +A+K L          +     E +VL    H  
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 69
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +  L Y F  H +  F++ EY   G LF +L + E     D A+       +  AL YLH
Sbjct: 70  LTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYLH 125
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 126 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAP 178

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL +   + +   K    E ++L  + H N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 94
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 151
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP + L
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDE-MTGYVATRWYRAPEIML 201

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 83/171 (48%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 176 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPP 225

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 8/175 (4%)
Query: 221 FDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V    +   G+ +A+K L          +     E +VL    H  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +  L Y F  H +  F++ EY   G LF +L + E     D A+       +  AL YLH
Sbjct: 210 LTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYLH 265
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 266 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 8/175 (4%)
Query: 221 FDIKYCIGTGGYGSV-YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V    +   G+ +A+K L          +     E +VL    H  
Sbjct: 153 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 212
Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           +  L Y F  H +  F++ EY   G LF +L + E     D A+       +  AL YLH
Sbjct: 213 LTALKYSFQTHDRLCFVM-EYANGGELFFHL-SRERVFSEDRARFYGA--EIVSALDYLH 268
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +   ++++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 269 SE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 321

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 69  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 128
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY+  G +F +L             R +   A  +A        YLH
Sbjct: 129 FSFKDNSNLYMVMEYVPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 179
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 180 ---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 18/165 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR-NEAQVLSQVLHRNIVKLY 284
           +G G +G V++ +    G   A+KK+          ++ FR  E    + +    IV LY
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 151
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +E GSL   L   +  +  D A  +  +      L YLH   S  
Sbjct: 152 GAVREGPWVNIFMELLEGGSLG-QLVKEQGCLPEDRA--LYYLGQALEGLEYLH---SRR 205
Query: 345 IIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTY 388
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 57/110 (51%), Gaps = 9/110 (8%)
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 322
           ++ E  +L  + H +I+K  G C  +  K + L+ EY+  GSL   L  +   +    A+
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL----AQ 118
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            +   + +   +AYLH   S   IHR++++ N+LL++     + DFG A+
Sbjct: 119 LLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/122 (28%), Positives = 56/122 (45%), Gaps = 9/122 (7%)
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NIVKL+     +   FL+ E +  G LF  +   +   E + +    I++ +  A+++
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS---YIMRKLVSAVSH 121
Query: 337 LHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +H      ++HRD+   N+L    N   E  + DFG ARL   D+        T  Y AP
Sbjct: 122 MH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 394 GL 395
            L
Sbjct: 179 EL 180

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N   + +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG  R  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + D+G AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 14/185 (7%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRN-----EA 269
           E ++ +     +G+G +G V+ A      K   +K +   +  E  +I+  +      E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 270 QVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVK 328
            +LS+V H NI+K+     ++    L+ E    G  LF  +  +     LD      I +
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFR 137
Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
            +  A+ YL       IIHRDI   NI++   F   + DFG+A  L       T   GT 
Sbjct: 138 QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTI 193
Query: 389 GYIAP 393
            Y AP
Sbjct: 194 EYCAP 198

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 70/166 (42%), Gaps = 14/166 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
           YL+   +   +HRD+++ N ++   F   + DFG  R ++  +  R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYR 187

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSF---RNEAQVLSQVLHRNIVK 282
           +G G   +V++ +    G +FA+K  +      ++F++       E +VL ++ H+NIVK
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNN-----ISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 283 LYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           L+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L  +
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 341 CSPSIIHRDISSNNILL----NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
               I+HR+I   NI+     + +    + DFG AR L  D    +L  GT  Y+ P +
Sbjct: 132 ---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHPDM 186

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 83/191 (43%), Gaps = 24/191 (12%)
Query: 217 ATEGFDIK-------YCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS--ETEELAFIKSFR 266
           A E F++K         +G G YG V K + +P+G++ A+K++  +    E+   +    
Sbjct: 25  AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLD 84
Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKR- 323
              + +        V  YG       +++  E  +      +  + +    +  D   + 
Sbjct: 85  ISXRTVDCPF---TVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKI 141
Query: 324 -VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
            V+IVKA+ H  + L      S+IHRD+  +N+L+N+  +    DFG +  L  D   + 
Sbjct: 142 AVSIVKALEHLHSKL------SVIHRDVKPSNVLINALGQVKXCDFGISGYL-VDDVAKD 194
Query: 383 LLAGTYGYIAP 393
           + AG   Y AP
Sbjct: 195 IDAGCKPYXAP 205

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 9/184 (4%)
Query: 216 EATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E +     +G+G YGSV  +  + +G   A+KKL       +   +++R E ++L  
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKH 106
Query: 275 VLHRNIVKLYGFCLHRKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           + H N++ L         +    + Y+    +  +L+N     +L       ++  +   
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D    T    T  Y AP
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTD-DEMTGYVATRWYRAP 220
Query: 394 GLPL 397
            + L
Sbjct: 221 EIML 224

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 13/175 (7%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 284 YGFCLHRKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                    +    E Y+    +  +L+N   +  L       +V  +   L Y+H   S
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             IIHRD+  +N+ +N   E  + DFG AR   AD    T    T  Y AP + L
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QAD-EEMTGYVATRWYRAPEIML 201

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 18/173 (10%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           ++  + ++IK+ IG G YG VY A   N  K  A+KK++    E+L   K    E  +L+
Sbjct: 24  VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRM-FEDLIDCKRILREITILN 82
Query: 274 QVLHRNIVKLYGFCLHRKC-----MFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNI 326
           ++    I++L+   +         ++++ E  +     LF      +  + L       I
Sbjct: 83  RLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLF------KTPIFLTEQHVKTI 136
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           +  +     ++H      IIHRD+   N LLN      + DFG AR +++D  
Sbjct: 137 LYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 175

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     KV  A+KK+  S  E   + +    E ++L +  H NI+ +  
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGIND 108
Query: 286 FCL-----HRKCMFLIYEYM--ERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                     K ++L+   M  +   L    H + D +          +  +   L Y+H
Sbjct: 109 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHI-------CYFLYQILRGLKYIH 161
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGYIAPGL 395
              S +++HRD+  +N+LLN+  +  + DFG AR+   D  +   L     T  Y AP +
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 396 PL 397
            L
Sbjct: 219 ML 220

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HRD+++ N ++   F   + DFG  R
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 177

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 16/176 (9%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   + +  G  +A+K L   +  +L  I+   NE ++L  V    + KL 
Sbjct: 49  TLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELD---WAKRVNIVKAMAHALAYLHHDC 341
                   ++++ EY   G +F +L       E     +A ++ +         YLH   
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLT------FEYLH--- 159
Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 152
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H  +   T    T  Y AP + L
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIML 202

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 95  DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D     +    GT  Y+ P
Sbjct: 148 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDXXXVVKDSQVGTVNYMPP 197

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLS 244
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY--- 336
           +V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y   
Sbjct: 245 LVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAE 300
Query: 337 ----LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGY 390
               L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 356
Query: 391 IAP 393
           +AP
Sbjct: 357 MAP 359

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 82/186 (44%), Gaps = 22/186 (11%)
Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA---- 333
             +VKL         ++++ EY+  G +F +L             R +   A  +A    
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---------IGRFSEPHARFYAAQIV 151
Query: 334 --LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
               YLH   S  +I+RD+   N+L++ +    V DFG A+ +   +     L GT   +
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WXLCGTPEAL 205
Query: 392 APGLPL 397
           AP + L
Sbjct: 206 APEIIL 211

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLS 244
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY--- 336
           +V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y   
Sbjct: 245 LVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAE 300
Query: 337 ----LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGY 390
               L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 356
Query: 391 IAP 393
           +AP
Sbjct: 357 MAP 359

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR-NEAQVLSQVLHRNIVKLY 284
           +G G +G V++ +    G   A+KK+          ++ FR  E    + +    IV LY
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVR---------LEVFRAEELMACAGLTSPRIVPLY 132
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +E GSL   L   +  +  D A  +  +      L YLH   S  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLG-QLVKEQGCLPEDRA--LYYLGQALEGLEYLH---SRR 186
Query: 345 IIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTY 388
           I+H D+ ++N+LL+S    A + DFG A  L  D   + LL G Y
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLS 244
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY--- 336
           +V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y   
Sbjct: 245 LVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAE 300
Query: 337 ----LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGY 390
               L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 356
Query: 391 IAP 393
           +AP
Sbjct: 357 MAP 359

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 33/187 (17%)
Query: 224 KYCIGTGGYGS-VYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQV-LHRNI 280
           K  +G G  G+ VY+    N  V A+K++       L    SF + E Q+L +   H N+
Sbjct: 29  KDVLGHGAEGTIVYRGMFDNRDV-AVKRI-------LPECFSFADREVQLLRESDEHPNV 80
Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWA----KRVNIVKAMAHALAY 336
           ++ +     R+  ++  E        C     E   + D+A    + + +++     LA+
Sbjct: 81  IRYFCTEKDRQFQYIAIE-------LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 337 LHHDCSPSIIHRDISSNNILL-----NSKFEAFVADFGTARLLHADS---SNRTLLAGTY 388
           LH   S +I+HRD+  +NIL+     + K +A ++DFG  + L       S R+ + GT 
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 389 GYIAPGL 395
           G+IAP +
Sbjct: 191 GWIAPEM 197

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 24/183 (13%)
Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F +   IG GG+G VY  +  + GK++A+K L          IK  + E   L++ +  +
Sbjct: 190 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR------IKMKQGETLALNERIMLS 243
Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY--- 336
           +V   G C    CM   +   ++ S   +L N  D   L +    + V + A    Y   
Sbjct: 244 LVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGD---LHYHLSQHGVFSEADMRFYAAE 299
Query: 337 ----LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--GTYGY 390
               L H  +  +++RD+   NILL+      ++D G A     D S +   A  GT+GY
Sbjct: 300 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGY 355
Query: 391 IAP 393
           +AP
Sbjct: 356 MAP 358

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 152
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H  +   T    T  Y AP + L
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIML 202

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 152
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DFG AR  H  +   T    T  Y AP + L
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLAR--HT-ADEMTGYVATRWYRAPEIML 202

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 13/175 (7%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 284 YGFCLHRKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                    +    E Y+    +  +L+N      L       +V  +   L Y+H   S
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---S 141
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             IIHRD+  +N+ +N   E  + DFG AR   AD    T    T  Y AP + L
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QAD-EEMTGYVATRWYRAPEIML 193

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/110 (27%), Positives = 57/110 (51%), Gaps = 9/110 (8%)
Query: 265 FRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 322
           ++ E  +L  + H +I+K  G C  +  K + L+ EY+  GSL   L  +   +    A+
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGL----AQ 118
Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            +   + +   +AYLH   +   IHR++++ N+LL++     + DFG A+
Sbjct: 119 LLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAK 165

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++L  V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVMEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N++++ +    V DFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 13/175 (7%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G YGSV   Y A+L   +  A+KKL       +   +++R E ++L  + H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 284 YGFCLHRKCMFLIYE-YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                    +    E Y+    +  +L+N      L       +V  +   L Y+H   S
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH---S 149
Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
             IIHRD+  +N+ +N   E  + DFG AR   AD      +A T  Y AP + L
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVA-TRWYRAPEIML 201

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 349
           ++C+ +I E ME G LF  +    D    +  +   I++ +  A+ +LH   S +I HRD
Sbjct: 98  KRCLLIIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRD 153
Query: 350 ISSNNILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAP 393
           +   N+L  SK +  V    DFG A+    +++   L    Y   Y+AP
Sbjct: 154 VKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAP 198

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 226 CIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +GTG +G V   +    G  +A+K L   +  +L  I+   NE ++   V    +VKL 
Sbjct: 49  TLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLE 108
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA------LAYLH 338
                   ++++ EY   G +F +L             R +   A  +A        YLH
Sbjct: 109 FSFKDNSNLYMVLEYAPGGEMFSHLRR---------IGRFSEPHARFYAAQIVLTFEYLH 159
Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
              S  +I+RD+   N+L++ +    VADFG A+ +   +     L GT  Y+AP + L
Sbjct: 160 ---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT---WXLCGTPEYLAPEIIL 212

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 9/175 (5%)
Query: 227 IGTGGYGSVYKAQLPNGKV-FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V  A     K   A+KK+  S  E   + +    E Q+L +  H N++ +  
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKI--SPFEHQTYCQRTLREIQILLRFRHENVIGIRD 108
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                    +   Y+ +  +  +L+    + +L        +  +   L Y+H   S ++
Sbjct: 109 ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIH---SANV 165
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLL---HADSSNRTLLAGTYGYIAPGLPL 397
           +HRD+  +N+L+N+  +  + DFG AR+    H  +   T    T  Y AP + L
Sbjct: 166 LHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 53/109 (48%), Gaps = 13/109 (11%)
Query: 290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRD 349
           ++C+ +I E ME G LF  +    D    +  +   I++ +  A+ +LH   S +I HRD
Sbjct: 79  KRCLLIIMECMEGGELFSRIQERGDQAFTE-REAAEIMRDIGTAIQFLH---SHNIAHRD 134
Query: 350 ISSNNILLNSKFEAFV---ADFGTARLLHADSSNRTLLAGTYG--YIAP 393
           +   N+L  SK +  V    DFG A+    +++   L    Y   Y+AP
Sbjct: 135 VKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYVAP 179

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 63/133 (47%), Gaps = 11/133 (8%)
Query: 242 NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC--LHRKCMFLIYEY 299
            G++ A+K L      +      ++ E  +L  + H +I+K  G C       + L+ EY
Sbjct: 59  TGEMVAVKALKADAGPQ--HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEY 116
Query: 300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 359
           +  GSL   L  +     +  A+ +   + +   +AYLH   +   IHRD+++ N+LL++
Sbjct: 117 VPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDN 169
Query: 360 KFEAFVADFGTAR 372
                + DFG A+
Sbjct: 170 DRLVKIGDFGLAK 182

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+      NL      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 227 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G  S+Y     N   G++ A+K L      +L     ++ E ++L  + H +IV
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEHIV 74
Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C  +  K + L+ EY+  GSL   L  +   V L  A+ +   + +   +AYLH 
Sbjct: 75  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGL--AQLLLFAQQICEGMAYLH- 129
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +   IHR +++ N+LL++     + DFG A+
Sbjct: 130 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 160

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 16/153 (10%)
Query: 227 IGTGGYG--SVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G  S+Y     N   G++ A+K L      +L     ++ E ++L  + H +IV
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLR--SGWQREIEILRTLYHEHIV 73
Query: 282 KLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           K  G C  +  K + L+ EY+  GSL   L  +   V L  A+ +   + +   +AYLH 
Sbjct: 74  KYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH--CVGL--AQLLLFAQQICEGMAYLH- 128
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +   IHR +++ N+LL++     + DFG A+
Sbjct: 129 --AQHYIHRALAARNVLLDNDRLVKIGDFGLAK 159

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 195 NSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYG----SVYKAQLPNGKVFALKK 250
            ++GV SI       ++ + I+ T+G+++K  IG G Y      ++KA      V  + K
Sbjct: 2   QTVGVHSIVQQ----LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK 57
Query: 251 LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH 310
                TEE+  +  +           H NI+ L       K ++++ E M+ G L   + 
Sbjct: 58  SKRDPTEEIEILLRYGQ---------HPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108
Query: 311 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVA 366
             +   E + +    ++  +   + YLH   +  ++HRD+  +NIL      +     + 
Sbjct: 109 RQKFFSEREASA---VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 367 DFGTARLLHADSSNRTLLAGTYGYIAP 393
           DFG A+ L A++        T  ++AP
Sbjct: 163 DFGFAKQLRAENGLLMTPCYTANFVAP 189

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 6/168 (3%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+   M  G L  ++++   A     A+ V     +   L  LH +    I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHRE---RI 307
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++RD+   NILL+      ++D G A  +    + +  + GT GY+AP
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAP 354

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 6/168 (3%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R +V L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+   M  G L  ++++   A     A+ V     +   L  LH +    I
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAG-FPEARAVFYAAEICCGLEDLHRE---RI 307
Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++RD+   NILL+      ++D G A  +    + +  + GT GY+AP
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-GTVGYMAP 354

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 82/171 (47%), Gaps = 13/171 (7%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLY 284
           IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++LY
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            + +  + ++++   ME G++  N    +    +D  +R +  K M  A+  +H      
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---G 175
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
           I+H D+   N L+       + DFG A  +  D+++  +    G   Y+ P
Sbjct: 176 IVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + DF  AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFYLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 14/171 (8%)
Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G  G V+K +    G V A+K++  S  +E    +   +   VL       IV+ +G
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV--NIVKAMAHALAYLHHDCSP 343
             +    +F+  E M  G+    L      ++    +R+   +  A+  AL YL      
Sbjct: 92  TFITNTDVFIAMELM--GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKE--KH 144
Query: 344 SIIHRDISSNNILLNSKFEAFVADFG-TARLLHADSSNRTLLAGTYGYIAP 393
            +IHRD+  +NILL+ + +  + DFG + RL+   + +R+  AG   Y+AP
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAP 193

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 180
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  +  FG AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLY 284
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 116
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +E GSL   L      +  D A  +  +      L YLH   +  
Sbjct: 117 GAVREGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRA--LYYLGQALEGLEYLH---TRR 170
Query: 345 IIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTY 388
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLY 284
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 132
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +E GSL   L      +  D A  +  +      L YLH   +  
Sbjct: 133 GAVREGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRA--LYYLGQALEGLEYLH---TRR 186
Query: 345 IIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTY 388
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y
Sbjct: 187 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 14/162 (8%)
Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + ++I++ IGTG YG V +A      +V A+KK+     E+L   K    E  +L+++ H
Sbjct: 53  DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNH 111
Query: 278 RNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
            ++VK+    + +       ++++ E  +  S F  L      V L       ++  +  
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLFRT--PVYLTELHIKTLLYNLLV 167
Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            + Y+H   S  I+HRD+   N L+N      V DFG AR +
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 180
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 136
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+      NL      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 135
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 88  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 141
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 142 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 173

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 136
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+      NL      +ELD  +   ++  M   + +L
Sbjct: 82  LNVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLXGIKHL 135
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 167

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 143
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 143
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 15/181 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 P 393
           P
Sbjct: 186 P 186

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 9/173 (5%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G+G YGSV  A     G   A+KKL       +   +++R E ++L  + H N++ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 286 -FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F   R        Y+    +  +L+N     +L       ++  +   L Y+H   S  
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SAD 145
Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLPL 397
           IIHRD+  +N+ +N   E  + D G AR  H D    T    T  Y AP + L
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLAR--HTDDE-MTGYVATRWYRAPEIML 195

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 128
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 184
Query: 393 PGL 395
           P +
Sbjct: 185 PEI 187

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L   +  A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +L+ E M+      NL      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKTLEEFQDVYLVMELMD-----ANL-XQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR 174

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 73/165 (44%), Gaps = 18/165 (10%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR-NIVKLY 284
           +G G +G V++ +    G   A+KK+          ++ FR E  V    L    IV LY
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR---------LEVFRVEELVACAGLSSPRIVPLY 130
Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +E GSL   L      +  D A  +  +      L YLH   +  
Sbjct: 131 GAVREGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRA--LYYLGQALEGLEYLH---TRR 184
Query: 345 IIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTY 388
           I+H D+ ++N+LL+S    A + DFG A  L  D   ++LL G Y
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 128
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 184
Query: 393 PGL 395
           P +
Sbjct: 185 PEI 187

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HR++++ N ++   F   + DFG  R
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 179

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/165 (23%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+  V   + L +G  +ALK++   E ++    +  + EA +     H NI++L  
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDR---EEAQREADMHRLFNHPNILRLVA 93
Query: 286 FCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHALAYLHHD 340
           +CL  +      +L+  + +RG+L+  +   +D    L   + + ++  +   L  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR--LLHADSSNRTL 383
            +    HRD+   NILL  + +  + D G+     +H + S + L
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 227 IGTGGYGSVYKA---QLPNGKVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G VY+     +  G+      + T +E+  L     F NEA V+      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVNIVKAMAHALA 335
           L G     +   ++ E M  G L   L        NN         + + +   +A  +A
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           YL+   +   +HR++++ N ++   F   + DFG  R
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTR 178

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 42/199 (21%)
Query: 220 GFDI--KYC----IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVL 272
           GFD+  +Y     +G GG G V+ A   +  K  A+KK+  ++ +    +K    E +++
Sbjct: 6   GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQS---VKHALREIKII 62
Query: 273 SQVLHRNIVKLY--------------GFCLHRKCMFLIYEYMERGSLFCNLHNN-EDAVE 317
            ++ H NIVK++              G       ++++ EYME      +L N  E    
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVLEQGPL 117
Query: 318 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHA 376
           L+   R+ + + +   L Y+H   S +++HRD+   N+ +N++     + DFG AR++  
Sbjct: 118 LEEHARLFMYQLL-RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 377 DSSNRTLLAGTYGYIAPGL 395
             S++       G+++ GL
Sbjct: 174 HYSHK-------GHLSEGL 185

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 75/173 (43%), Gaps = 18/173 (10%)
Query: 215 IEATEGFDIKYCIGTGGYGSVYKAQLPNG-KVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           +   + + IK+ IG G YG VY A   N  K  A+KK++    E+L   K    E  +L+
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILN 80
Query: 274 QVLHRNIVKLYGFC-----LHRKCMFLIYEYMERG--SLFCNLHNNEDAVELDWAKRVNI 326
           ++    I++LY        L    ++++ E  +     LF      +  + L       I
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF------KTPIFLTEEHIKTI 134
Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           +  +     ++H      IIHRD+   N LLN      V DFG AR ++++  
Sbjct: 135 LYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H+NI+ L  
Sbjct: 32  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 90
Query: 286 FCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH 
Sbjct: 91  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 143
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 144 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 221 FDIKYCIGTGGYGSVYK-AQLPNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K  +   G  +A   +KK  T  +      +    E  +L ++ 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E    +    +K + + + Y
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQILNGVYY 129
Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           LH   S  I H D+   NI+L      K    + DFG A  +   +  + +  GT  ++A
Sbjct: 130 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVA 185
Query: 393 PGL 395
           P +
Sbjct: 186 PEI 188

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/207 (22%), Positives = 88/207 (42%), Gaps = 27/207 (13%)
Query: 195 NSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYG----SVYKAQLPNGKVFALKK 250
            ++GV SI       ++ + I+ T+G+++K  IG G Y      ++KA      V  + K
Sbjct: 2   QTVGVHSIVQQ----LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK 57
Query: 251 LHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH 310
                TEE+  +  +           H NI+ L       K ++++ E  + G L   + 
Sbjct: 58  SKRDPTEEIEILLRYGQ---------HPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL 108
Query: 311 NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVA 366
             +   E + +    ++  +   + YLH   +  ++HRD+  +NIL      +     + 
Sbjct: 109 RQKFFSEREASA---VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 367 DFGTARLLHADSSNRTLLAGTYGYIAP 393
           DFG A+ L A++        T  ++AP
Sbjct: 163 DFGFAKQLRAENGLLXTPCYTANFVAP 189

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G  G V  A     G   A+KKL      +    +++R E  +L  V H+NI+ L  
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 88
Query: 286 FCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
               +K +      +L+ E M+  +L   +H     +ELD  +   ++  M   + +LH 
Sbjct: 89  VFTPQKTLEEFQDVYLVMELMD-ANLCQVIH-----MELDHERMSYLLYQMLCGIKHLH- 141
Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 142 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 24/206 (11%)
Query: 207 GRIVYEDLIEATEG----FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE----- 257
           G     DLI         + ++  I +G YG+V       G   A+K++  + ++     
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 258 ---ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----RKCMFLIYEYMERGSLFCNL 309
              +    K    E ++L+   H NI+ L    +H        ++L+ E M R  L   +
Sbjct: 66  ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI 124
Query: 310 HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
           H+    +        +I   M H L  LH      ++HRD+   NILL    +  + DF 
Sbjct: 125 HDQRIVISPQ-----HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 370 TARLLHADSSNRTLLAGTYGYIAPGL 395
            AR   AD +N+T       Y AP L
Sbjct: 180 LAREDTAD-ANKTHYVTHRWYRAPEL 204

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 24/206 (11%)
Query: 207 GRIVYEDLIEATEG----FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE----- 257
           G     DLI         + ++  I +G YG+V       G   A+K++  + ++     
Sbjct: 6   GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65
Query: 258 ---ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----RKCMFLIYEYMERGSLFCNL 309
              +    K    E ++L+   H NI+ L    +H        ++L+ E M R  L   +
Sbjct: 66  ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVI 124
Query: 310 HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG 369
           H+    +        +I   M H L  LH      ++HRD+   NILL    +  + DF 
Sbjct: 125 HDQRIVISPQ-----HIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 370 TARLLHADSSNRTLLAGTYGYIAPGL 395
            AR   AD +N+T       Y AP L
Sbjct: 180 LAREDTAD-ANKTHYVTHRWYRAPEL 204

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 34  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 91  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 144
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 145 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 33  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 90  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 143
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 144 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 37  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 94  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 147
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 148 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+      NL +    +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+      NL +    +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 83  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 136
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 137 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 80/183 (43%), Gaps = 9/183 (4%)
Query: 213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGK-VFALKKLHTSETEELAFIKSFRNEAQV 271
           D ++ T+ F+    +G G +G V  A     + ++A+K L      +   ++    E +V
Sbjct: 14  DRVKLTD-FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRV 72
Query: 272 LSQVLHRNIVKLYGFCLHR-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           L+ +     +     C      ++ + EY+  G L   +++ +   +    + V     +
Sbjct: 73  LALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEI 129
Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
           +  L +LH      II+RD+  +N++L+S+    +ADFG  +    D        GT  Y
Sbjct: 130 SIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDY 186
Query: 391 IAP 393
           IAP
Sbjct: 187 IAP 189

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 277
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 278 R-NIVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
             N+V L G C      + +I E+ + G+L   L +  +   + +         + H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIC 148
Query: 336 Y-------LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+     C +      +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ----MELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+      NL +    +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLVGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 24/169 (14%)
Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIK---------SFRNEAQVLSQVLH 277
           +G G +G V +A       F + K  T  T  +  +K         +  +E ++L  + H
Sbjct: 35  LGRGAFGQVIEAD-----AFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 278 R-NIVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
             N+V L G C      + +I E+ + G+L   L +  +   + +         + H + 
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF-VPYKDLYKDFLTLEHLIX 148
Query: 336 Y-------LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           Y       +    S   IHRD+++ NILL+ K    + DFG AR ++ D
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 206 DGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE--------T 256
           D  +++ED+ E  E       IG G +  V +      G+ FA+K +  ++        T
Sbjct: 19  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 72
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDA- 315
           E+L      + EA +   + H +IV+L         +++++E+M+   L   +    DA 
Sbjct: 73  EDL------KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 126
Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTAR 372
                A   + ++ +  AL Y H +   +IIHRD+  + +LL SK  +    +  FG A 
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 183
Query: 373 LLHADSSNRTLLAGTYGYIAP 393
            L           GT  ++AP
Sbjct: 184 QLGESGLVAGGRVGTPHFMAP 204

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 21/155 (13%)
Query: 227 IGTGGYGSV---YKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           IG+G  G V   Y A L      A+KKL      +    +++R E  ++  V H+NI+ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 284 YGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 +K +      +++ E M+      NL +    +ELD  +   ++  M   + +L
Sbjct: 89  LNVFTPQKSLEEFQDVYIVMELMD-----ANL-SQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           H   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 218 TEGFDIKYCIGTGGYGS----VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           ++G+ +K  IG G Y      V+KA      V  + K     +EE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
              H NI+ L       K ++L+ E M  G L   +   +   E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 334 LAYLHHDCSPSIIHRDISSNNILL---NSKFEAF-VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A+ L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 390 YIAP 393
           ++AP
Sbjct: 191 FVAP 194

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 218 TEGFDIKYCIGTGGYGS----VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLS 273
           ++G+ +K  IG G Y      V+KA      V  + K     +EE+  +  +        
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQ------ 79
Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
              H NI+ L       K ++L+ E M  G L   +   +   E + +    ++  +   
Sbjct: 80  ---HPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS---FVLHTIGKT 133
Query: 334 LAYLHHDCSPSIIHRDISSNNILL---NSKFEAF-VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   S  ++HRD+  +NIL    +   E   + DFG A+ L A++        T  
Sbjct: 134 VEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 390 YIAP 393
           ++AP
Sbjct: 191 FVAP 194

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 206 DGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSE--------T 256
           D  +++ED+ E  E       IG G +  V +      G+ FA+K +  ++        T
Sbjct: 17  DDDVLFEDVYELCE------VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLST 70
Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDA- 315
           E+L      + EA +   + H +IV+L         +++++E+M+   L   +    DA 
Sbjct: 71  EDL------KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK 360
                A   + ++ +  AL Y H +   +IIHRD+  + +LL SK
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASK 166

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	397
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-70
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-61
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-57
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-52
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-51
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	8e-48
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-44
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-43
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-40
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	8e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-21
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-43
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-41
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-37
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-36
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-35
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-34
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-33
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-41
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-41
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-41
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-41
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-40
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-40
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-30
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-29
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-06
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-28
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-28
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-28
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-25
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-24
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-23
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-27
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-27
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-27
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-26
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-20
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-15
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-08
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-27
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-27
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-26
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-18
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-15
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-08
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-26
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-26
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-26
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-26
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-26
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-26
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-26
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-25
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-25
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-25
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-25
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-25
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	7e-25
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-22
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-21
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-17
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-25
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-25
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-25
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-24
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-24
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-24
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-24
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	4e-24
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	4e-24
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-24
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	6e-24
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-23
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-23
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-23
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-23
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	6e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-21
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-15
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-09
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-23
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-23
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-22
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-22
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-21
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-20
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-19
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	8e-18
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-13
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-22
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-19
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-13
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-22
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-21
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-06
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-22
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-22
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-22
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-21
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-21
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-21
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	9e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-20
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-17
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-08
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-07
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-04
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-20
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-20
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-18
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-20
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-19
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-18
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-17
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-20
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-20
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-20
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	6e-20
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-20
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-18
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-09
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-10
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-06
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	9e-06
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-18
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-15
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-11
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-07
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-05
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-18
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-12
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	6e-10
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-07
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-17
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-17
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-15
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	7e-13
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-17
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-13
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-16
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-11
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-16
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-16
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-11
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-16
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-13
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-04
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-15
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-10
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-11
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-15
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-14
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-08
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-15
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-11
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-15
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-14
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-13
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	3e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-13
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-11
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-15
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-10
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-08
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-15
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-14
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-12
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-10
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-13
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-12
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-13
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-11
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-12
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-10
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-09
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-08
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	4e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	7e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-10
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	7e-13
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-12
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-12
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-11
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	8e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	6e-10
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	8e-08
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-08
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-07
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-05
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-10
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-05
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-04
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-07
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	7e-06
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	8e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	6e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  223 bits (571), Expect = 2e-70
 Identities = 73/185 (39%), Positives = 106/185 (57%), Gaps = 4/185 (2%)

Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 270
             +L  A++ F  K  +G GG+G VYK +L +G + A+K+L   E         F+ E +
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTEVE 79

Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKA 329
           ++S  +HRN+++L GFC+      L+Y YM  GS+   L    ++   LDW KR  I   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN-RTLLAGTY 388
            A  LAYLH  C P IIHRD+ + NILL+ +FEA V DFG A+L+    ++  T + GT 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 389 GYIAP 393
           G+IAP
Sbjct: 200 GHIAP 204

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  199 bits (509), Expect = 3e-61
 Identities = 79/218 (36%), Positives = 111/218 (50%), Gaps = 12/218 (5%)

Query: 180 VKRKYKKPKLKAN-ATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA 238
           +  KY K     N A +S  +    +Y  R+   DL EAT  FD K+ IG G +G VYK 
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFESY--RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58

Query: 239 QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE 298
            L +G   ALK+     ++    I+ F  E + LS   H ++V L GFC  R  M LIY+
Sbjct: 59  VLRDGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115

Query: 299 YMERGSLFCNLH-NNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL 357
           YME G+L  +L+ ++   + + W +R+ I    A  L YLH      IIHRD+ S NILL
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILL 172

Query: 358 NSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAP 393
           +  F   + DFG ++           T++ GT GYI P
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  188 bits (479), Expect = 6e-57
 Identities = 63/194 (32%), Positives = 93/194 (47%), Gaps = 17/194 (8%)

Query: 211 YEDLIEATEGFDIKYC------IGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-LAFIK 263
           + +L   T  FD +        +G GG+G VYK  + N    A+KKL            +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 264 SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
            F  E +V+++  H N+V+L GF      + L+Y YM  GSL   L   +    L W  R
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS----S 379
             I +  A+ + +LH +     IHRDI S NILL+  F A ++DFG AR     +    +
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 380 NRTLLAGTYGYIAP 393
           +R  + GT  Y+AP
Sbjct: 193 SR--IVGTTAYMAP 204

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  175 bits (445), Expect = 4e-52
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 14/211 (6%)

Query: 183 KYKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPN 242
            Y  P  +             +    I + DL       +IK  IG G +G+V++A+  +
Sbjct: 12  DYDIPTTENLYFQGAMDGDDMD----IPWCDL-------NIKEKIGAGSFGTVHRAEW-H 59

Query: 243 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER 302
           G   A+K L   +      +  F  E  ++ ++ H NIV   G       + ++ EY+ R
Sbjct: 60  GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118

Query: 303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE 362
           GSL+  LH +    +LD  +R+++   +A  + YLH+  +P I+HR++ S N+L++ K+ 
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYT 177

Query: 363 AFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             V DFG +RL  +   +    AGT  ++AP
Sbjct: 178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  174 bits (442), Expect = 2e-51
 Identities = 63/198 (31%), Positives = 91/198 (45%), Gaps = 26/198 (13%)

Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 270
            E+L   +    +      G +G V+KAQL N  V A+K     +       +S++NE +
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYV-AVKIFPIQDK------QSWQNEYE 68

Query: 271 V--LSQVLHRNIVKLYGFCLH----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           V  L  + H NI++  G           ++LI  + E+GSL   L  N     + W +  
Sbjct: 69  VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELC 124

Query: 325 NIVKAMAHALAYLHHD-------CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           +I + MA  LAYLH D         P+I HRDI S N+LL +   A +ADFG A    A 
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 378 SS--NRTLLAGTYGYIAP 393
            S  +     GT  Y+AP
Sbjct: 185 KSAGDTHGQVGTRRYMAP 202

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  164 bits (416), Expect = 8e-48
 Identities = 56/174 (32%), Positives = 88/174 (50%), Gaps = 12/174 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
            +++  +G G +G V KA+    K  A+K++ +         K+F  E + LS+V H NI
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER-----KAFIVELRQLSRVNHPNI 63

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           VKLYG CL+  C+  + EY E GSL+  LH  E       A  ++     +  +AYLH  
Sbjct: 64  VKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 341 CSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
              ++IHRD+   N+LL +      + DFGTA  +    +N     G+  ++AP
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK---GSAAWMAP 172

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  162 bits (412), Expect = 2e-47
 Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 25/196 (12%)

Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH----TSETEELAFI 262
            +   ++       + +  IG GG+G V+K + + +  V A+K L       ETE +   
Sbjct: 15  TLADNEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67

Query: 263 KSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAK 322
           + F+ E  ++S + H NIVKLYG   +   M  + E++  G L+  L +      + W+ 
Sbjct: 68  QEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAH--PIKWSV 123

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-----VADFGTARLLHAD 377
           ++ ++  +A  + Y+ +  +P I+HRD+ S NI L S  E       VADFG ++     
Sbjct: 124 KLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS 182

Query: 378 SSNRTLLAGTYGYIAP 393
            S      G + ++AP
Sbjct: 183 VSGLL---GNFQWMAP 195

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  159 bits (405), Expect = 1e-46
 Identities = 56/181 (30%), Positives = 86/181 (47%), Gaps = 16/181 (8%)

Query: 222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA-FIKSFRNEAQVLSQVLHRNI 280
            ++  IG GG+G VY+A    G   A+K       E+++  I++ R EA++ + + H NI
Sbjct: 10  TLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           + L G CL    + L+ E+   G L   L        +     VN    +A  + YLH +
Sbjct: 69  IALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDE 124

Query: 341 CSPSIIHRDISSNNILLNSKFEAF--------VADFGTARLLHADSSNRTLLAGTYGYIA 392
               IIHRD+ S+NIL+  K E          + DFG AR  H   + +   AG Y ++A
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMA 182

Query: 393 P 393
           P
Sbjct: 183 P 183

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  154 bits (392), Expect = 4e-44
 Identities = 49/204 (24%), Positives = 80/204 (39%), Gaps = 32/204 (15%)

Query: 211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQ 270
             +     +   +   IG G YG+VYK  L + +  A+K    +        ++F NE  
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKN 57

Query: 271 V--LSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
           +  +  + H NI +                 L+ EY   GSL   L  +      DW   
Sbjct: 58  IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSS 113

Query: 324 VNIVKAMAHALAYLHHD------CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             +  ++   LAYLH +        P+I HRD++S N+L+ +     ++DFG +  L  +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 378 SSNR--------TLLAGTYGYIAP 393
              R            GT  Y+AP
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAP 197

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  152 bits (387), Expect = 2e-43
 Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 6/150 (4%)

Query: 1   EIGNLKNLIE-LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
             G+   L   + +  N L G IP T   L +L+++DLSRN                  +
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           +L+ N L+  +   +   KNL  LD+ NN+I G++P  +T+L  L  LN+S N L G +P
Sbjct: 227 HLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

Query: 120 FSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
                L    +   + NK LCG  S LP+C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  143 bits (364), Expect = 4e-40
 Identities = 48/139 (34%), Positives = 77/139 (55%), Gaps = 3/139 (2%)

Query: 1   EIGNLKNLIELDV-GSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
            + NL  L  L + G N+L+GPIP  +  LT L YL ++    + +IP+ L+ +  L+ L
Sbjct: 71  SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLD-YLNLSSNKLSGPV 118
           + S N LSG +P  I+S+ NL  +    N+I G+IP      S+L   + +S N+L+G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190

Query: 119 PFSNEQLSSMYIVRLSPNK 137
           P +   L ++  V LS N 
Sbjct: 191 PPTFANL-NLAFVDLSRNM 208

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  113 bits (285), Expect = 8e-29
 Identities = 37/130 (28%), Positives = 61/130 (46%), Gaps = 3/130 (2%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFN--SSIPNELTWLTGLLGLNLSS-NKLS 67
            D  + + +G +  T      ++ LDLS         IP+ L  L  L  L +   N L 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 68  GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
           G IP  IA +  L +L I++  + G+IP  ++++  L  L+ S N LSG +P S   L +
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 128 MYIVRLSPNK 137
           +  +    N+
Sbjct: 151 LVGITFDGNR 160

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 91.4 bits (228), Expect = 7e-21
 Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 7/123 (5%)

Query: 22  IPSTLGLLTDLS----YLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG--KIPSQIA 75
           I   LG  T LS      D     +   + +  T    +  L+LS   L     IPS +A
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 76  SMKNLTWLDISN-NKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLS 134
           ++  L +L I   N + G IP  I +L++L YL ++   +SG +P    Q+ ++  +  S
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 135 PNK 137
            N 
Sbjct: 134 YNA 136

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (380), Expect = 6e-43
 Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 11/169 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +     G ++K +   G    +K L   +       + F  E   L    H N++ + G 
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 287 CLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           C         LI  +M  GSL+  LH   + V +D ++ V     MA  +A+LH    P 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHT-LEPL 133

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I    ++S +++++    A ++         +             ++AP
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAP 177

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  151 bits (383), Expect = 8e-43
 Identities = 44/190 (23%), Positives = 83/190 (43%), Gaps = 21/190 (11%)

Query: 209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNE 268
           I +E L       +I   IG G +G VY  +  +G+V A++ +      E   +K+F+ E
Sbjct: 30  IPFEQL-------EIGELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNE-DQLKAFKRE 79

Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
                Q  H N+V   G C+    + +I    +  +L+  + + +    LD  K   I +
Sbjct: 80  VMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQ 137

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-----TL 383
            +   + YLH   +  I+H+D+ S N+  ++  +  + DFG   +     + R      +
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRI 193

Query: 384 LAGTYGYIAP 393
             G   ++AP
Sbjct: 194 QNGWLCHLAP 203

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  157 bits (399), Expect = 2e-42
 Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 3/149 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++  L      ++ S    G    T      + +LD+S N  +  IP E+  +  L  LN
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L  N +SG IP ++  ++ L  LD+S+NK++G IP  ++ L+ L  ++LS+N LSGP+P 
Sbjct: 663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPE 722

Query: 121 SNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
              Q  +    +   N GLCG    LP C
Sbjct: 723 MG-QFETFPPAKFLNNPGLCG--YPLPRC 748

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  154 bits (391), Expect = 3e-41
 Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 6/150 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + N   L+ L +  N L G IPS+LG L+ L  L L  N     IP EL ++  L  L 
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L  N L+G+IPS +++  NL W+ +SNN++ G IP  I  L  L  L LS+N  SG +P 
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 121 SNEQLSSMYIVRLSPNKGLCGNFS-ALPSC 149
                 S+  + L+ N      F+  +P+ 
Sbjct: 533 ELGDCRSLIWLDLNTN-----LFNGTIPAA 557

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (359), Expect = 4e-37
 Identities = 45/139 (32%), Positives = 76/139 (54%), Gaps = 2/139 (1%)

Query: 1   EIGN--LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
            +       L EL + +N   G IP TL   ++L  L LS N  + +IP+ L  L+ L  
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L L  N L G+IP ++  +K L  L +  N + G IP  ++  + L++++LS+N+L+G +
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506

Query: 119 PFSNEQLSSMYIVRLSPNK 137
           P    +L ++ I++LS N 
Sbjct: 507 PKWIGRLENLAILKLSNNS 525

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  141 bits (358), Expect = 6e-37
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 4/139 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +G+   L  LD+  N L G     +   T+L  L++S NQF   IP     L  L  L+
Sbjct: 218 FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLS 275

Query: 61  LSSNKLSGKIPSQIA-SMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           L+ NK +G+IP  ++ +   LT LD+S N   G++P      S L+ L LSSN  SG +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 120 FSN-EQLSSMYIVRLSPNK 137
                ++  + ++ LS N+
Sbjct: 336 MDTLLKMRGLKVLDLSFNE 354

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  140 bits (355), Expect = 2e-36
 Identities = 43/139 (30%), Positives = 65/139 (46%), Gaps = 3/139 (2%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLG-LLTDLSYLDLSRNQFNSSIPNEL--TWLTGLLG 58
           +  ++ L  LD+  N   G +P +L  L   L  LDLS N F+  I   L       L  
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L L +N  +GKIP  +++   L  L +S N + G+IP  +  LS+L  L L  N L G +
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 119 PFSNEQLSSMYIVRLSPNK 137
           P     + ++  + L  N 
Sbjct: 459 PQELMYVKTLETLILDFND 477

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  137 bits (348), Expect = 1e-35
 Identities = 44/128 (34%), Positives = 71/128 (55%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +G+L  L +L +  N L G IP  L  +  L  L L  N     IP+ L+  T L  ++
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS+N+L+G+IP  I  ++NL  L +SNN   G+IP E+ +   L +L+L++N  +G +P 
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556

Query: 121 SNEQLSSM 128
           +  + S  
Sbjct: 557 AMFKQSGK 564

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  133 bits (336), Expect = 4e-34
 Identities = 49/139 (35%), Positives = 69/139 (49%), Gaps = 5/139 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            LK+L  L +  N   G IP  L G    L+ LDLS N F  ++P      + L  L LS
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326

Query: 63  SNKLSGKIP-SQIASMKNLTWLDISNNKIEGSIPGEITELS-RLDYLNLSSNKLSGPVP- 119
           SN  SG++P   +  M+ L  LD+S N+  G +P  +T LS  L  L+LSSN  SGP+  
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386

Query: 120 -FSNEQLSSMYIVRLSPNK 137
                  +++  + L  N 
Sbjct: 387 NLCQNPKNTLQELYLQNNG 405

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  132 bits (334), Expect = 1e-33
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 15/156 (9%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTL---GLLTDLSYLDLSRNQFNSSIPNELTWLTGLL 57
               L +L  LD+ +NS+ G             +L +L +S N+ +  +   ++    L 
Sbjct: 146 GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLE 203

Query: 58  GLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
            L++SSN  S  IP  +     L  LDIS NK+ G     I+  + L  LN+SSN+  GP
Sbjct: 204 FLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP 262

Query: 118 VPFSNEQLSSMYIVRLSPNK-------GLCGNFSAL 146
           +P     L S+  + L+ NK        L G    L
Sbjct: 263 IPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTL 296

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  131 bits (333), Expect = 1e-33
 Identities = 40/136 (29%), Positives = 67/136 (49%), Gaps = 4/136 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E+  +K L  L +  N L G IPS L   T+L+++ LS N+    IP  +  L  L  L 
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILK 520

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS+N  SG IP+++   ++L WLD++ N   G+IP  + + S      +++N ++G    
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYV 576

Query: 121 SNEQLSSMYIVRLSPN 136
             +          + N
Sbjct: 577 YIKNDGMKKECHGAGN 592

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  131 bits (331), Expect = 2e-33
 Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 10/155 (6%)

Query: 1   EIGNLKNLIELDVGSN--SLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
            I N     E     N     G     L  L+  +  +++   +             ++ 
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 636

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L++S N LSG IP +I SM  L  L++ +N I GSIP E+ +L  L+ L+LSSNKL G +
Sbjct: 637 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 696

Query: 119 PFSNEQLSSMYIVRLS--------PNKGLCGNFSA 145
           P +   L+ +  + LS        P  G    F  
Sbjct: 697 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPP 731

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  129 bits (327), Expect = 6e-33
 Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 7/141 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGL-LTDLSYLDLSRNQFNSSIPNELTW---LTGL 56
            +G+   L  L+V SN+L  P   + GL L  L  LDLS N  + +             L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180

Query: 57  LGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG 116
             L +S NK+SG +   ++   NL +LD+S+N     IP  + + S L +L++S NKLSG
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSG 237

Query: 117 PVPFSNEQLSSMYIVRLSPNK 137
               +    + + ++ +S N+
Sbjct: 238 DFSRAISTCTELKLLNISSNQ 258

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  121 bits (306), Expect = 4e-30
 Identities = 36/139 (25%), Positives = 60/139 (43%), Gaps = 6/139 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + N  NL  + + +N L G IP  +G L +L+ L LS N F+ +IP EL     L+ L+
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLD 544

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN--KLSGPV 118
           L++N  +G IP+ +          I+ N I G     I         + + N  +  G  
Sbjct: 545 LNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIR 600

Query: 119 PFSNEQLSSMYIVRLSPNK 137
                +LS+     ++   
Sbjct: 601 SEQLNRLSTRNPCNITSRV 619

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  119 bits (300), Expect = 2e-29
 Identities = 41/155 (26%), Positives = 64/155 (41%), Gaps = 10/155 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP--NELTWLTGLLG 58
            + +L  L  L + ++ + G +         L+ LDLSRN  +  +     L   +GL  
Sbjct: 72  SLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKF 130

Query: 59  LNLSSNKLSGKIP-SQIASMKNLTWLDISNNKIEGSIPGEITE---LSRLDYLNLSSNKL 114
           LN+SSN L      S    + +L  LD+S N I G+             L +L +S NK+
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 115 SGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
           SG V  S     ++  + +S N         L  C
Sbjct: 191 SGDVDVSR--CVNLEFLDVSSNN-FSTGIPFLGDC 222

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  118 bits (298), Expect = 5e-29
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 11/144 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPS--TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLL 57
                 +L  LD+  NSL GP+ +  +LG  + L +L++S N  +          L  L 
Sbjct: 95  GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE 154

Query: 58  GLNLSSNKLSGKIPSQIA---SMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
            L+LS+N +SG              L  L IS NKI G +   ++    L++L++SSN  
Sbjct: 155 VLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212

Query: 115 SGPVP-FSNEQLSSMYIVRLSPNK 137
           S  +P   +   S++  + +S NK
Sbjct: 213 STGIPFLGD--CSALQHLDISGNK 234

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  107 bits (270), Expect = 2e-25
 Identities = 34/131 (25%), Positives = 57/131 (43%), Gaps = 7/131 (5%)

Query: 4   NLKNLIELDVGSNSL---IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               +  +D+ S  L      + S+L  LT L  L LS +  N S+         L  L+
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 61  LSSNKLSGKIPS--QIASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGP 117
           LS N LSG + +   + S   L +L++S+N ++         +L+ L+ L+LS+N +SG 
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 118 VPFSNEQLSSM 128
                      
Sbjct: 167 NVVGWVLSDGC 177

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  147 bits (374), Expect = 1e-41
 Identities = 53/182 (29%), Positives = 88/182 (48%), Gaps = 23/182 (12%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G   K      G+V  +K+L   + E     ++F  E +V+  + H N++K  G
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ---RTFLKEVKVMRCLEHPNVLKFIG 74

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                K +  I EY++ G+L   + + +   +  W++RV+  K +A  +AYLH   S +I
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLH---SMNI 129

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLL--------------HADSSNRTLLAGTYGYI 391
           IHRD++S+N L+       VADFG ARL+                D   R  + G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 392 AP 393
           AP
Sbjct: 190 AP 191

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  147 bits (372), Expect = 2e-41
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 33/201 (16%)

Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 267
           R V  D+        +  C+G G YG V++     G+  A+K   + +       KS+  
Sbjct: 4   RTVARDI-------TLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFR 49

Query: 268 EAQV--LSQVLHRNIVKLYGFCLHRKC----MFLIYEYMERGSLFCNLHNNEDAVELDWA 321
           E ++     + H NI+      +  +     ++LI  Y E GSL+  L        LD  
Sbjct: 50  ETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTV 105

Query: 322 KRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
             + IV ++A  LA+LH +       P+I HRD+ S NIL+    +  +AD G A +   
Sbjct: 106 SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQ 165

Query: 377 DSS----NRTLLAGTYGYIAP 393
            ++          GT  Y+AP
Sbjct: 166 STNQLDVGNNPRVGTKRYMAP 186

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  145 bits (369), Expect = 4e-41
 Identities = 53/169 (31%), Positives = 91/169 (53%), Gaps = 11/169 (6%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG+G +G+VYK +  +G V A+K L+ +       +++F+NE  VL +  H NI+   G+
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
                 + ++ ++ E  SL+ +LH +E   + +  K ++I +  A  + YLH   + SII
Sbjct: 89  ST-APQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH---AKSII 142

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLH--ADSSNRTLLAGTYGYIAP 393
           HRD+ SNNI L+      + DFG A      + S     L+G+  ++AP
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  147 bits (372), Expect = 5e-41
 Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 33/201 (16%)

Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN 267
           R + + +        +   IG G YG V+  +   G+  A+K   T+E        S+  
Sbjct: 33  RTIAKQI-------QMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA------SWFR 78

Query: 268 EAQV--LSQVLHRNIVKLYGFCLHRKC----MFLIYEYMERGSLFCNLHNNEDAVELDWA 321
           E ++     + H NI+      +        ++LI +Y E GSL+  L +      LD  
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAK 134

Query: 322 KRVNIVKAMAHALAYLH-----HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
             + +  +    L +LH         P+I HRD+ S NIL+       +AD G A    +
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194

Query: 377 DSSNRTLL----AGTYGYIAP 393
           D++   +      GT  Y+ P
Sbjct: 195 DTNEVDIPPNTRVGTKRYMPP 215

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  143 bits (363), Expect = 8e-40
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 28/197 (14%)

Query: 214 LIEATEGFDIKY--CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQV 271
           L++ T    I     IG G +G V++ +   G+  A+K   + E       +S+  EA++
Sbjct: 35  LVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEI 87

Query: 272 --LSQVLHRNIVKLYGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
                + H NI+               ++L+ +Y E GSLF  L+       +     + 
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIK 143

Query: 326 IVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +  + A  LA+LH +       P+I HRD+ S NIL+       +AD G A    + +  
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203

Query: 381 RTLL----AGTYGYIAP 393
             +      GT  Y+AP
Sbjct: 204 IDIAPNHRVGTKRYMAP 220

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (304), Expect = 2e-31
 Identities = 48/182 (26%), Positives = 81/182 (44%), Gaps = 18/182 (9%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +     IG G +G     +   +G+ + +K+++ S        +  R E  VL+ + H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKH 82

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN------EDAVELDWAKRVNIVKAMA 331
            NIV+          ++++ +Y E G LF  ++        ED + LDW  +      + 
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQ------IC 135

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYI 391
            AL ++H      I+HRDI S NI L       + DFG AR+L++         GT  Y+
Sbjct: 136 LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYL 192

Query: 392 AP 393
           +P
Sbjct: 193 SP 194

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (294), Expect = 3e-30
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 10/171 (5%)

Query: 226 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G YG VY    L N    A+K++   ++      +    E  +   + H+NIV+  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYL 85

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G       + +  E +  GSL   L +    ++ +        K +   L YLH      
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 142

Query: 345 IIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           I+HRDI  +N+L+N+     +  +DFGT++ L   +       GT  Y+AP
Sbjct: 143 IVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  117 bits (294), Expect = 3e-30
 Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 19/184 (10%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
             F I+  IG G +  VY+A  L +G   ALKK+   +  +         E  +L Q+ H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN--------EDAVELDWAKRVNIVKA 329
            N++K Y   +    + ++ E  + G L   + +         E  V             
Sbjct: 92  PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-------WKYFVQ 144

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYG 389
           +  AL ++H   S  ++HRDI   N+ + +     + D G  R   + ++    L GT  
Sbjct: 145 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY 201

Query: 390 YIAP 393
           Y++P
Sbjct: 202 YMSP 205

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  116 bits (293), Expect = 3e-30
 Identities = 60/174 (34%), Positives = 91/174 (52%), Gaps = 9/174 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+I   +G G +G+VY A+   +  + ALK L  ++ E+       R E ++ S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I++LYG+      ++LI EY   G+++  L       E         +  +A+AL+Y H 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE-QRTAT--YITELANALSYCH- 126

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  +IHRDI   N+LL S  E  +ADFG +  +HA SS RT L GT  Y+ P
Sbjct: 127 --SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPP 176

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  115 bits (291), Expect = 7e-30
 Identities = 40/200 (20%), Positives = 81/200 (40%), Gaps = 30/200 (15%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
             F+   C+G GG+G V++A+   +   +A+K++     E     +    E + L+++ H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62

Query: 278 RNIVKLYGFCLHRKCM------------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
             IV+ +   L +               ++  +   + +L   ++      E + +  ++
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS------- 378
           I   +A A+ +LH   S  ++HRD+  +NI         V DFG    +  D        
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 379 -----SNRTLLAGTYGYIAP 393
                +  T   GT  Y++P
Sbjct: 180 PMPAYARHTGQVGTKLYMSP 199

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  113 bits (285), Expect = 6e-29
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 47/206 (22%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+    +G G +G V KA+   + + +A+KK+  +E +    + +  +E  +L+ + H+ 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK----LSTILSEVMLLASLNHQY 63

Query: 280 IVKLYGFCLHR-------------KCMFLIYEYMERGSLF-----CNLHNNEDAVELDWA 321
           +V+ Y   L R               +F+  EY E G+L+      NL+   D       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----- 118

Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD---- 377
               + + +  AL+Y+H   S  IIHRD+   NI ++      + DFG A+ +H      
Sbjct: 119 --WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 378 ----------SSNRTLLAGTYGYIAP 393
                     S N T   GT  Y+A 
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVAT 199

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  113 bits (284), Expect = 6e-29
 Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 29/190 (15%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F     IG+GG+G V+KA+   +GK + +K++  +        +    E + L+++ H N
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65

Query: 280 IVKLYGF----------------CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
           IV   G                     KC+F+  E+ ++G+L           +LD    
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE-QWIEKRRGEKLDKVLA 124

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
           + + + +   + Y+H   S  +I+RD+  +NI L    +  + DFG    L  D      
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR- 180

Query: 384 LAGTYGYIAP 393
             GT  Y++P
Sbjct: 181 SKGTLRYMSP 190

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  112 bits (282), Expect = 1e-28
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 7/181 (3%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++ Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64

Query: 278 RNIVKLYG-FCLHRKCMFLIY-EYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHAL 334
            NIV+ Y            I  EY E G L   +    ++   LD    + ++  +  AL
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 335 AYLH--HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 393 P 393
           P
Sbjct: 185 P 185

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  112 bits (282), Expect = 2e-28
 Identities = 39/175 (22%), Positives = 80/175 (45%), Gaps = 19/175 (10%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKL 283
            IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++   +  I++L
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           Y + +  + ++++ E      L   L   + +++    K     K M  A+  +H     
Sbjct: 94  YDYEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIH---QH 146

Query: 344 SIIHRDISSNNILLNS---KFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
            I+H D+   N L+     K    + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 147 GIVHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  112 bits (281), Expect = 2e-28
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 13/174 (7%)

Query: 226 CIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            IG G + +VYK          A  +L   +  + +  + F+ EA++L  + H NIV+ Y
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 285 GFCL----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
                    +KC+ L+ E M  G+L   L   +    +      +  + +   L +LH  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH-T 147

Query: 341 CSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +P IIHRD+  +NI +        + D G A L    +S    + GT  ++AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAP 199

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  110 bits (278), Expect = 4e-28
 Identities = 58/178 (32%), Positives = 90/178 (50%), Gaps = 17/178 (9%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FDI   +G G +G+VY A+   N  + ALK L  S+ E+       R E ++ S + H N
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHALA 335
           I+++Y +   RK ++L+ E+  RG L+  L  +    E       +     ++ +A AL 
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQR-----SAT--FMEELADALH 128

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           Y H      +IHRDI   N+L+  K E  +ADFG +  +HA S  R  + GT  Y+ P
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRTMCGTLDYLPP 181

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  112 bits (281), Expect = 5e-28
 Identities = 52/176 (29%), Positives = 75/176 (42%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F+    +G G  G V+K    P+G V A K +H               E QVL +   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNS 90

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             IV  YG       + +  E+M+ GSL   L       E    K   +  A+   L YL
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK---VSIAVIKGLTYL 147

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                  I+HRD+  +NIL+NS+ E  + DFG +  L  DS   +   GT  Y++P
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANS-FVGTRSYMSP 199

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  110 bits (278), Expect = 5e-28
 Identities = 57/180 (31%), Positives = 80/180 (44%), Gaps = 16/180 (8%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E F     IG G +G V+K       KV A+K +   E E+   I+  + E  VLSQ  
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE--IEDIQQEITVLSQCD 78

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN---NEDAVELDWAKRVNIVKAMAHA 333
              + K YG  L    +++I EY+  GS    L     +E  +         I++ +   
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKG 131

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L YLH   S   IHRDI + N+LL+   E  +ADFG A  L      R    GT  ++AP
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  115 bits (289), Expect = 5e-28
 Identities = 38/139 (27%), Positives = 57/139 (41%), Gaps = 2/139 (1%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
                  L  LDVG N++    P     L  L  L+L  N+ +        + T L  L+
Sbjct: 44  NFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH 103

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG--PV 118
           L SN +     +     KNL  LD+S+N +  +  G   +L  L  L LS+NK+      
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE 163

Query: 119 PFSNEQLSSMYIVRLSPNK 137
                  SS+  + LS N+
Sbjct: 164 ELDIFANSSLKKLELSSNQ 182

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  106 bits (266), Expect = 4e-25
 Identities = 37/133 (27%), Positives = 55/133 (41%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
             N+  L++  N L     +     + L+ LD+  N  +   P     L  L  LNL  N
Sbjct: 24  PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
           +LS       A   NLT L + +N I+        +   L  L+LS N LS     +  Q
Sbjct: 84  ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143

Query: 125 LSSMYIVRLSPNK 137
           L ++  + LS NK
Sbjct: 144 LENLQELLLSNNK 156

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  106 bits (266), Expect = 4e-25
 Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 7/143 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL--TGLLGL 59
               KNLI LD+  N L      T   L +L  L LS N+  +    EL     + L  L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE---LSRLDYLNLSSNKLSG 116
            LSSN++    P    ++  L  L ++N ++  S+  ++      + +  L+LS+++LS 
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 117 --PVPFSNEQLSSMYIVRLSPNK 137
                F   + +++ ++ LS N 
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNN 259

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  104 bits (262), Expect = 1e-24
 Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 11/147 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
              L +L  LD+G N +   +       L ++  + LS N++     N    +  L  L 
Sbjct: 401 FSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460

Query: 61  LSSNKLSG--KIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS--- 115
           L    L      PS    ++NLT LD+SNN I       +  L +L+ L+L  N L+   
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLW 520

Query: 116 -----GPVPFSNEQLSSMYIVRLSPNK 137
                G   +  + LS ++I+ L  N 
Sbjct: 521 KHANPGGPIYFLKGLSHLHILNLESNG 547

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  102 bits (257), Expect = 8e-24
 Identities = 34/141 (24%), Positives = 60/141 (42%), Gaps = 5/141 (3%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW---LTGLL 57
           +I    +L +L++ SN +    P     +  L  L L+  Q   S+  +L      T + 
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225

Query: 58  GLNLSSNKLSGKIPSQIASMK--NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            L+LS+++LS    +    +K  NLT LD+S N +          L +L+Y  L  N + 
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285

Query: 116 GPVPFSNEQLSSMYIVRLSPN 136
                S   L ++  + L  +
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRS 306

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (253), Expect = 2e-23
 Identities = 31/149 (20%), Positives = 47/149 (31%), Gaps = 9/149 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS--------SIPNELTW 52
               L+NL  LD+ +N++       L  L  L  LDL  N                 L  
Sbjct: 475 PFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           L+ L  LNL SN            +  L  +D+  N +             L  LNL  N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594

Query: 113 KLSGPVPFS-NEQLSSMYIVRLSPNKGLC 140
            ++            ++  + +  N   C
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (253), Expect = 2e-23
 Identities = 35/147 (23%), Positives = 59/147 (40%), Gaps = 10/147 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS--SIPNELTWLTGLLG 58
           E   L+N+ E+ +  N  +    ++  L+  L  L L R    +  S P+    L  L  
Sbjct: 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIE--------GSIPGEITELSRLDYLNLS 110
           L+LS+N ++      +  ++ L  LD+ +N +         G     +  LS L  LNL 
Sbjct: 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544

Query: 111 SNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           SN          + L  + I+ L  N 
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNN 571

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (251), Expect = 4e-23
 Identities = 35/141 (24%), Positives = 57/141 (40%), Gaps = 5/141 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW----LTGLL 57
              LK L  L++  N + G   +    L +L YL LS +  +       T+     + L 
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

Query: 58  GLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG-EITELSRLDYLNLSSNKLSG 116
            LNL+ NK+S       + + +L  LD+  N+I   + G E   L  +  + LS NK   
Sbjct: 385 ILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ 444

Query: 117 PVPFSNEQLSSMYIVRLSPNK 137
               S   + S+  + L    
Sbjct: 445 LTRNSFALVPSLQRLMLRRVA 465

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 28/145 (19%), Positives = 54/145 (37%), Gaps = 11/145 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLL--TDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              ++  L + ++ L     +T   L  T+L+ LDLS N  N    +   WL  L    L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNN---------KIEGSIPGEITELSRLDYLNLSSN 112
             N +       +  + N+ +L++  +          +          L  L++LN+  N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
            + G        L ++  + LS + 
Sbjct: 340 DIPGIKSNMFTGLINLKYLSLSNSF 364

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 26/131 (19%), Positives = 50/131 (38%), Gaps = 3/131 (2%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           +    D     L   +P    L T+++ L+L+ NQ         T  + L  L++  N +
Sbjct: 5   SHEVADCSHLKLTQ-VPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 67  SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLS 126
           S   P     +  L  L++ +N++           + L  L+L SN +         +  
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 127 SMYIVRLSPNK 137
           ++  + LS N 
Sbjct: 122 NLITLDLSHNG 132

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.5 bits (233), Expect = 8e-21
 Identities = 33/150 (22%), Positives = 55/150 (36%), Gaps = 13/150 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRN---------QFNSSIPNELT 51
               L  L    +  N++      +L  L ++ YL+L R+                    
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326

Query: 52  WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEIT----ELSRLDYL 107
           WL  L  LN+  N + G   +    + NL +L +SN+          T      S L  L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386

Query: 108 NLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           NL+ NK+S     +   L  + ++ L  N+
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 27/108 (25%), Positives = 44/108 (40%), Gaps = 3/108 (2%)

Query: 30  TDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNK 89
                 D S  +  + +P++L   T +  LNL+ N+L     +       LT LD+  N 
Sbjct: 4   VSHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60

Query: 90  IEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           I    P    +L  L  LNL  N+LS     +    +++  + L  N 
Sbjct: 61  ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  112 bits (282), Expect = 6e-28
 Identities = 42/154 (27%), Positives = 71/154 (46%), Gaps = 10/154 (6%)

Query: 227 IGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
           IG G +G V+  +L   N  V A+K    +   +L     F  EA++L Q  H NIV+L 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLV-AVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLI 178

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
           G C  ++ ++++ E ++ G     L      + +     + +V   A  + YL    S  
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLE---SKC 233

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
            IHRD+++ N L+  K    ++DFG +R      
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  110 bits (276), Expect = 2e-27
 Identities = 39/188 (20%), Positives = 75/188 (39%), Gaps = 21/188 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +     +G GG+  V   + L +G  +ALK++   E ++       + EA +     H N
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA---QREADMHRLFNHPN 87

Query: 280 IVKLYGFCLHRK----CMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHAL 334
           I++L  +CL  +      +L+  + +RG+L+  +   +D    L   + + ++  +   L
Sbjct: 88  ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA--------- 385
             +H   +    HRD+   NILL  + +  + D G+                        
Sbjct: 148 EAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 386 GTYGYIAP 393
            T  Y AP
Sbjct: 205 CTISYRAP 212

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  110 bits (276), Expect = 2e-27
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 25/167 (14%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G+G +G+VYK        KV    A+K+L   TS       +     EA V++ V + +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPH 78

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           + +L G CL    + LI + M  G L   +  ++D +     L+W   V I K M     
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN---- 131

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           YL       ++HRD+++ N+L+ +     + DFG A+LL A+     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  108 bits (273), Expect = 2e-27
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 6/174 (3%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F +   +G G +  VY+A+ +  G   A+K +      +   ++  +NE ++  Q+ H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           I++LY +      ++L+ E    G +   L N       + A+    +  +   + YLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH--FMHQIITGMLYLH- 129

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  I+HRD++ +N+LL       +ADFG A  L         L GT  YI+P
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  113 bits (285), Expect = 2e-27
 Identities = 26/153 (16%), Positives = 55/153 (35%), Gaps = 17/153 (11%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW--LTGLLG 58
             G+   L  L++  N +     +  G    +  L  + N+    IPN      ++ +  
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSA 406

Query: 59  LNLSSNKLSG-------KIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
           ++ S N++          +        N++ +++SNN+I        +  S L  +NL  
Sbjct: 407 IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466

Query: 112 NKLSG-------PVPFSNEQLSSMYIVRLSPNK 137
           N L+            + +    +  + L  NK
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  110 bits (278), Expect = 1e-26
 Identities = 31/161 (19%), Positives = 59/161 (36%), Gaps = 14/161 (8%)

Query: 1   EIGNLKNLIELDVGSNSLI--------GPIPSTLGLLTDLSYLDLSRNQFNS-SIPNELT 51
            +  L  +  ++V  N  I            +   +   +  + +  N   +  +   L 
Sbjct: 268 FLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327

Query: 52  WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
            +  L  L    N+L GK+P+   S   L  L+++ N+I            +++ L+ + 
Sbjct: 328 KMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386

Query: 112 NKLSG-PVPFSNEQLSSMYIVRLSPNK---GLCGNFSALPS 148
           NKL   P  F  + +S M  +  S N+       NF  L  
Sbjct: 387 NKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDP 427

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  108 bits (273), Expect = 6e-26
 Identities = 29/162 (17%), Positives = 58/162 (35%), Gaps = 20/162 (12%)

Query: 2   IGNLKNLIELDVGSNSL-------IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW-- 52
                 L  +++  N L       +            L+ +DL  N+  + + ++     
Sbjct: 453 FSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATT 511

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISN------NKIEGSIPGEITELSRLDY 106
           L  L+G++LS N  S   P+Q  +   L    I N      N+     P  IT    L  
Sbjct: 512 LPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQ 570

Query: 107 LNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPS 148
           L + SN +      + +   ++ ++ +  N  +  + S +  
Sbjct: 571 LQIGSNDIRK---VNEKITPNISVLDIKDNPNISIDLSYVCP 609

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  104 bits (261), Expect = 2e-24
 Identities = 29/145 (20%), Positives = 46/145 (31%), Gaps = 13/145 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGL--LTDLSYLDLSRNQFNSSIPNE------LTW 52
              N   L  +D+  N L   +        L  L  +DLS N F S  P +      L  
Sbjct: 483 NFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKG 540

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
                  +   N+   + P  I    +LT L I +N I   +  +I     +  L++  N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDN 597

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
                            +  L  +K
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDK 622

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 16/123 (13%), Positives = 42/123 (34%), Gaps = 6/123 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
                    ++   SN++   +   +  LT L    +  + F +    E          N
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----EN 231

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
               +       +  ++K+LT +++ N      +P  +  L  +  +N++ N+       
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291

Query: 121 SNE 123
            ++
Sbjct: 292 KDD 294

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 18/143 (12%), Positives = 43/143 (30%), Gaps = 7/143 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQF----NSSIPNELTWLTGL 56
            + +   +  L +      G +P  +G LT+L  L L  +          P  ++     
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 57  LGLNLSSNKLSGKIPSQIA--SMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
                                   +L    I+++  + SI        +   +   SN +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 115 SGPVPFSNEQLSSMYIVRLSPNK 137
           +  V  +  +L+ +    +  + 
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSP 217

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 15/141 (10%), Positives = 33/141 (23%), Gaps = 8/141 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLL--TDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
            I    +  +                     +DL    ++ +    SI            
Sbjct: 128 GISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQ 187

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +   SN ++  +   +  +  L    + N+        E  E       N    +     
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYKTE 241

Query: 119 PFSNEQLSSMYIVRLSPNKGL 139
               + L  +  V +     L
Sbjct: 242 DLKWDNLKDLTDVEVYNCPNL 262

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 13/109 (11%), Positives = 32/109 (29%), Gaps = 9/109 (8%)

Query: 1   EIGNLKNLIELDVG------SNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLT 54
           +  N   L    +        N  +   P  + L   L+ L +  N     +  ++    
Sbjct: 531 QPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI--TP 587

Query: 55  GLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSR 103
            +  L++  N       S +          +  +K +     +  ++ R
Sbjct: 588 NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQDIRGCDALDIKR 636

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 17/128 (13%), Positives = 38/128 (29%), Gaps = 6/128 (4%)

Query: 16  NSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG----KIP 71
           +        +L     ++ L L     +  +P+ +  LT L  L L S+          P
Sbjct: 67  DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126

Query: 72  SQIASMKNLTWLDISNNKIEGSIPGEIT--ELSRLDYLNLSSNKLSGPVPFSNEQLSSMY 129
             I++  +           + +        + S L    ++S+     +  S+       
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186

Query: 130 IVRLSPNK 137
            +    N 
Sbjct: 187 QIGQLSNN 194

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 12/63 (19%), Positives = 22/63 (34%)

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           N   +    +    + S   +T L +      G +P  I +L+ L+ L L S+       
Sbjct: 63  NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122

Query: 120 FSN 122
              
Sbjct: 123 LFG 125

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  110 bits (276), Expect = 2e-27
 Identities = 39/175 (22%), Positives = 79/175 (45%), Gaps = 19/175 (10%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKL 283
            IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++      I++L
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           Y + +  + ++++ E      L   L   + +++    K     K M  A+  +H     
Sbjct: 75  YDYEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIH---QH 127

Query: 344 SIIHRDISSNNILLNS---KFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAP 393
            I+H D+   N L+     K    + DFG A  +  D+++  +    GT  Y+ P
Sbjct: 128 GIVHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  109 bits (274), Expect = 2e-27
 Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 19/176 (10%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E ++I   +G G +G VYKA+    G + A K + T   EEL        E ++L+   
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI---VEIEILATCD 74

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMA 331
           H  IVKL G   H   ++++ E+   G++       +    E  +++       + + M 
Sbjct: 75  HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQML 127

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGT 387
            AL +LH   S  IIHRD+ + N+L+  + +  +ADFG +         R    GT
Sbjct: 128 EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (277), Expect = 2e-27
 Identities = 35/197 (17%), Positives = 64/197 (32%), Gaps = 27/197 (13%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQV 271
           ++   + + +G G +  VY+A         N + F LK    +   E           + 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMER 120

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF--CNLHNNEDAVELDWAKRVNIVKA 329
           L   +    +K Y   L +    L+ E    G+L    NL+ N     +     ++    
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-----------VADFGTARLLHADS 378
           M + +  +H      IIH DI  +N +L + F              + D G +  +    
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 379 SNRTL--LAGTYGYIAP 393
                     T G+   
Sbjct: 238 KGTIFTAKCETSGFQCV 254

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  113 bits (284), Expect = 2e-27
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 4/142 (2%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGLN 60
             +L+NLI LD+               L+ L  L ++ N F  +  P+  T L  L  L+
Sbjct: 417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 476

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP- 119
           LS  +L    P+   S+ +L  L++S+N            L+ L  L+ S N +      
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536

Query: 120 -FSNEQLSSMYIVRLSPNKGLC 140
              +   SS+  + L+ N   C
Sbjct: 537 ELQH-FPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  110 bits (277), Expect = 1e-26
 Identities = 35/144 (24%), Positives = 59/144 (40%), Gaps = 3/144 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
              +   L  LD+    +          L+ LS L L+ N   S      + L+ L  L 
Sbjct: 47  SFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEG-SIPGEITELSRLDYLNLSSNKLSGPVP 119
                L+      I  +K L  L++++N I+   +P   + L+ L++L+LSSNK+     
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166

Query: 120 FSNEQLSSMYIVRLSPNKGLCGNF 143
                L  M ++ LS +  L  N 
Sbjct: 167 TDLRVLHQMPLLNLSLD--LSLNP 188

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  108 bits (273), Expect = 5e-26
 Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 1/132 (0%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           +   LD+  N L      +     +L  LDLSR +  +        L+ L  L L+ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 67  SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL-SGPVPFSNEQL 125
                   + + +L  L      +       I  L  L  LN++ N + S  +P     L
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 126 SSMYIVRLSPNK 137
           +++  + LS NK
Sbjct: 149 TNLEHLDLSSNK 160

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  105 bits (264), Expect = 7e-25
 Identities = 32/121 (26%), Positives = 50/121 (41%), Gaps = 4/121 (3%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
             +L +L  LD+  N L   G    +    T L YLDLS N    ++ +    L  L  L
Sbjct: 343 EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHL 401

Query: 60  NLSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +   + L       +  S++NL +LDIS+     +  G    LS L+ L ++ N      
Sbjct: 402 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461

Query: 119 P 119
            
Sbjct: 462 L 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  104 bits (262), Expect = 2e-24
 Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 2/118 (1%)

Query: 1   EIGNLKNLIELDVGSNSLIGPI-PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
               L +L  L +  NS      P     L +L++LDLS+ Q     P     L+ L  L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITEL-SRLDYLNLSSNKLSG 116
           N+S N            + +L  LD S N I  S   E+    S L +LNL+ N  + 
Sbjct: 500 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 557

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 6/131 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           IP    L      LDLS N               L  L+LS  ++         S+ +L+
Sbjct: 22  IPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK---- 137
            L ++ N I+    G  + LS L  L      L+    F    L ++  + ++ N     
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 138 GLCGNFSALPS 148
            L   FS L +
Sbjct: 140 KLPEYFSNLTN 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 39/162 (24%), Positives = 63/162 (38%), Gaps = 15/162 (9%)

Query: 2   IGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL---- 56
           IG+LK L EL+V  N +    +P     LT+L +LDLS N+  S    +L  L  +    
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 57  LGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGE-ITELSRLDYLNLSSNKLS 115
           L L+LS N ++   P     +  L  L + NN    ++    I  L+ L+   L   +  
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

Query: 116 G--------PVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
                              ++   RL+       +   L +C
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 85.1 bits (211), Expect = 5e-18
 Identities = 29/159 (18%), Positives = 54/159 (33%), Gaps = 23/159 (14%)

Query: 1   EIGNLKNLIELDVGSNSL-------------------IGPIPSTLGLLTDLSYLDLSRNQ 41
           +         L++ +                       G    +   L  L +LDLSRN 
Sbjct: 299 DFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358

Query: 42  FN--SSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI- 98
            +            T L  L+LS N +   + S    ++ L  LD  ++ ++      + 
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417

Query: 99  TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
             L  L YL++S              LSS+ +++++ N 
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 25/133 (18%), Positives = 49/133 (36%), Gaps = 5/133 (3%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               L+NL  LD+    L    P+    L+ L  L++S N F S        L  L  L+
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 524

Query: 61  LSSNKLSGKIPSQIASM-KNLTWLDISNNKIEGSIPGE--ITELSRLDYLNLSSNKLSG- 116
            S N +      ++     +L +L+++ N    +   +  +  +     L +   ++   
Sbjct: 525 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECA 584

Query: 117 -PVPFSNEQLSSM 128
            P       + S+
Sbjct: 585 TPSDKQGMPVLSL 597

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 33/175 (18%), Positives = 52/175 (29%), Gaps = 41/175 (23%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSY----LDLSRNQFNSSIPNELTWLTGL 56
              NL NL  LD+ SN +     + L +L  +      LDLS N  N   P     +  L
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202

Query: 57  LGLNLSSNKLSGKIPSQI----------------------------ASMKNLTWLDISNN 88
             L L +N  S  +                                ++++ L  L I   
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262

Query: 89  KIE------GSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           ++         I      L+ +   +L S  +     FS         + L   K
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCK 315

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 68.9 bits (169), Expect = 9e-13
 Identities = 34/179 (18%), Positives = 56/179 (31%), Gaps = 34/179 (18%)

Query: 2   IGNLKNLIELDV------GSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSS---IPNELTW 52
           I  L  L    +         +L     S L  L +L+  +      +     I +    
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIE-------------------GS 93
           LT +   +L S  +        +       L++ N K                     G 
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338

Query: 94  IPGEITELSRLDYLNLSSNKLS--GPVPFSNEQLSSMYIVRLSPNK--GLCGNFSALPS 148
                 +L  L++L+LS N LS  G    S+   +S+  + LS N    +  NF  L  
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 19/88 (21%), Positives = 38/88 (43%), Gaps = 4/88 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLG-LLTDLSYLDLSRNQFNSSIPNE--LTWLTGLLG 58
              L +L  LD   N ++      L    + L++L+L++N F  +  ++  L W+     
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDIS 86
           L +   ++    PS    M  +  L+I+
Sbjct: 574 LLVEVERMECATPSDKQGMP-VLSLNIT 600

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  109 bits (275), Expect = 2e-27
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
               D    IG G  G V  A+   +G+  A+K +   + +    +    NE  ++    
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQ 100

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N+V++Y   L  + ++++ E+++ G+L  ++ +     E   A    + +A+  ALAY
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIAT---VCEAVLQALAY 156

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   +  +IHRDI S++ILL       ++DFG    +  D   R  L GT  ++AP
Sbjct: 157 LH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  109 bits (275), Expect = 2e-27
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 7/168 (4%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++       +VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH      +
Sbjct: 109 FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARY--YLRQIVLGCQYLH---RNRV 162

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   + +L GT  YIAP
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (271), Expect = 3e-27
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 19/156 (12%)

Query: 227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G V+        KV A+K +      E  FI+    EA+V+ ++ H  +V+LYG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMMKLSHPKLVQLYG 70

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHHDC 341
            CL +  + L+ E+ME G L   L            L     V         +AYL    
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV------CEGMAYL---E 121

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
              +IHRD+++ N L+       V+DFG  R +  D
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  108 bits (273), Expect = 3e-27
 Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 7/168 (4%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG+   ++       +VFA K +  S   +    +    E  +   + H+++V  +G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +F++ E   R SL   LH    A+    A+    ++ +     YLH      +
Sbjct: 83  FFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPEARY--YLRQIVLGCQYLH---RNRV 136

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           IHRD+   N+ LN   E  + DFG A  +  D   + +L GT  YIAP
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (272), Expect = 3e-27
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + +     IG G  G+VY A  +  G+  A+++++  +  +   I    NE  V+ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI---INEILVMRENK 75

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           + NIV      L    ++++ EY+  GSL   +        +D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEF 131

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   S  +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (274), Expect = 6e-27
 Identities = 38/175 (21%), Positives = 77/175 (44%), Gaps = 19/175 (10%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKL 283
            IG+GG   V++      +++A+K ++  E +    + S+RNE   L+++      I++L
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
           Y + +  + ++++ E      L   L   + +++    K     K M  A+  +H     
Sbjct: 122 YDYEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKS--YWKNMLEAVHTIH---QH 174

Query: 344 SIIHRDISSNNILLNS---KFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
            I+H D+   N L+     K    + DFG A  +  D+++       G   Y+ P
Sbjct: 175 GIVHSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (277), Expect = 8e-27
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 11/180 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +  +  +G G +G V        G+  A+K +   + ++    +S   E Q+L Q+ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NI+KLY F   +   +L+ E    G LF  + + +   E+D A+   I++ +   + Y
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGITY 141

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +H      I+HRD+   N+LL SK +     + DFG +    A    +    GT  YIAP
Sbjct: 142 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD-KIGTAYYIAP 197

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  108 bits (271), Expect = 8e-27
 Identities = 47/190 (24%), Positives = 81/190 (42%), Gaps = 28/190 (14%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
              F++   +G G YG VYK + +  G++ A+K +  +  E     +  + E  +L +  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYS 78

Query: 277 -HRNIVKLYGFCLHRKC------MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN---- 325
            HRNI   YG  + +        ++L+ E+   GS+        D ++      +     
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-------TDLIKNTKGNTLKEEWI 131

Query: 326 --IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             I + +   L++LH      +IHRDI   N+LL    E  + DFG +  L      R  
Sbjct: 132 AYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 384 LAGTYGYIAP 393
             GT  ++AP
Sbjct: 189 FIGTPYWMAP 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  108 bits (272), Expect = 1e-26
 Identities = 30/170 (17%), Positives = 70/170 (41%), Gaps = 12/170 (7%)

Query: 218 TEGFDIKYCIGTG--GYGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVL 272
              +++   IG G     +V  A+  P G+   +++  L     E + F+   + E  V 
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL---QGELHVS 80

Query: 273 SQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
               H NIV      +    ++++  +M  GS   +L        ++      I++ +  
Sbjct: 81  KLFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDGMNELAIAYILQGVLK 139

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           AL Y+HH      +HR + +++IL++   + +++   +   + +    + 
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  106 bits (267), Expect = 2e-26
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 20/188 (10%)

Query: 219 EGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK--KLHTSETEELAFIKSFRNEAQVLSQV 275
           + ++++  IG+G    V  A   P  +  A+K   L   +T     +     E Q +SQ 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQC 70

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAM 330
            H NIV  Y   + +  ++L+ + +  GS+              +  LD +    I++ +
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG-----TARLLHADSSNRTLLA 385
              L YLH       IHRD+ + NILL       +ADFG             +  R    
Sbjct: 131 LEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187

Query: 386 GTYGYIAP 393
           GT  ++AP
Sbjct: 188 GTPCWMAP 195

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  106 bits (266), Expect = 2e-26
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +GTG +G V   +       A+K +      E  FI+    EA+V+  + H  +V+LYG 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIE----EAKVMMNLSHEKLVQLYGV 87

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C  ++ +F+I EYM  G L   L            + + + K +  A+ YL    S   +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFL 142

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N L+N +    V+DFG +R +  D
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  107 bits (268), Expect = 2e-26
 Identities = 47/183 (25%), Positives = 75/183 (40%), Gaps = 33/183 (18%)

Query: 224 KYCIGTGGYGSVYKAQ-LPNGKVFALKK--LHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +  +G G +G V++ +    G   A+KK  L     EEL             + +    I
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELV----------ACAGLSSPRI 112

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAY 336
           V LYG       + +  E +E GSL   +       ED         +  +      L Y
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA-------LYYLGQALEGLEY 165

Query: 337 LHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTL-----LAGTYGY 390
           LH   +  I+H D+ ++N+LL+S    A + DFG A  L  D   ++L     + GT  +
Sbjct: 166 LH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222

Query: 391 IAP 393
           +AP
Sbjct: 223 MAP 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  106 bits (267), Expect = 3e-26
 Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 10/175 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHR 278
            +    +G+G  G V+K +    G V A+K++  S  +E    K    +  V+       
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHDCP 84

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            IV+ +G  +    +F+  E M   +            E    K   +  A+  AL YL 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK---MTVAIVKALYYLK 141

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                 +IHRD+  +NILL+ + +  + DFG +  L  D   +   AG   Y+AP
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSAGCAAYMAP 193

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  105 bits (265), Expect = 3e-26
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 9/152 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVF-ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG VY+       +  A+K L     E   F+K    EA V+ ++ H N+V+L G
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMKEIKHPNLVQLLG 76

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            C      ++I E+M  G+L   L       E+     + +   ++ A+ YL      + 
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE---KKNF 132

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           IHRD+++ N L+       VADFG +RL+  D
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  106 bits (267), Expect = 3e-26
 Identities = 50/182 (27%), Positives = 83/182 (45%), Gaps = 20/182 (10%)

Query: 210 VYEDLIEATEGFD---------IKYCIGTGGYGSVYKAQL---PNGKVF-ALKKLHTSET 256
            YE+   A   F          I+  IG+G  G V   +L       V  A+K L    T
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT 90

Query: 257 EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV 316
           E     + F +EA ++ Q  H NI++L G     +   ++ EYME GSL   L  ++   
Sbjct: 91  ERQR--RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-- 146

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           +    + V +++ +   + YL        +HRD+++ N+L++S     V+DFG +R+L  
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203

Query: 377 DS 378
           D 
Sbjct: 204 DP 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  107 bits (268), Expect = 3e-26
 Identities = 41/189 (21%), Positives = 79/189 (41%), Gaps = 22/189 (11%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTS--ETEELAFIKSFRNEAQVLSQ 274
            + +++   IG G +  V +      G+ FA+K +  +   +      +  + EA +   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV-------NIV 327
           + H +IV+L         +++++E+M+   L        + V+   A  V       + +
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVASHYM 136

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLL 384
           + +  AL Y H     +IIHRD+  + +LL SK  +    +  FG A  L          
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

Query: 385 AGTYGYIAP 393
            GT  ++AP
Sbjct: 194 VGTPHFMAP 202

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  105 bits (264), Expect = 4e-26
 Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 18/161 (11%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V + +   P+GK    A+K L      +   +  F  E   +  + HRN+++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLH 338
           LYG  L    M ++ E    GSL   L  ++          +A  V + + M     YL 
Sbjct: 86  LYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA--VQVAEGMG----YLE 138

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
              S   IHRD+++ N+LL ++    + DFG  R L  +  
Sbjct: 139 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  105 bits (265), Expect = 4e-26
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E FD+   +G G YGSVYKA     G++ A+K++          ++    E  ++ Q  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCD 82

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
             ++VK YG       ++++ EY   GS+   +      +  D      I+++    L Y
Sbjct: 83  SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEY 140

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH       IHRDI + NILLN++  A +ADFG A  L    + R  + GT  ++AP
Sbjct: 141 LH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (270), Expect = 4e-26
 Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 25/186 (13%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQ 274
           + +   +G+G  G V  A +    K  A++     K       E     +   E ++L +
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLF----CNLHNNEDAVELDWAKRVNIVKAM 330
           + H  I+K+  F    +  +++ E ME G LF     N    E        K       M
Sbjct: 197 LNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-----CKL--YFYQM 248

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGT 387
             A+ YLH      IIHRD+   N+LL+S+ E     + DFG +++L   S  RT L GT
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGT 304

Query: 388 YGYIAP 393
             Y+AP
Sbjct: 305 PTYLAP 310

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  107 bits (269), Expect = 5e-26
 Identities = 39/188 (20%), Positives = 76/188 (40%), Gaps = 33/188 (17%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRN 279
           F  K  +G G  G++    + + +  A+K++                E Q+L +   H N
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL------PECFSFADREVQLLRESDEHPN 79

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +++ +     R+  ++  E     +L          H   +         + +++     
Sbjct: 80  VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEP--------ITLLQQTTSG 130

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFE-----AFVADFGTARLLHADSSNRTLL---A 385
           LA+LH   S +I+HRD+  +NIL++         A ++DFG  + L     + +      
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 386 GTYGYIAP 393
           GT G+IAP
Sbjct: 188 GTEGWIAP 195

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  105 bits (263), Expect = 6e-26
 Identities = 40/162 (24%), Positives = 78/162 (48%), Gaps = 15/162 (9%)

Query: 223 IKYCIGTGGYGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLH 277
               +G G +GSV +        ++  A+K L   T + +    ++    EAQ++ Q+ +
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDN 69

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             IV+L G C   + + L+ E    G L   L    +  E+  +    ++  ++  + YL
Sbjct: 70  PYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL 126

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
                 + +HRD+++ N+LL ++  A ++DFG ++ L AD S
Sbjct: 127 ---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  104 bits (261), Expect = 8e-26
 Identities = 38/151 (25%), Positives = 71/151 (47%), Gaps = 9/151 (5%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G+G +G V   +       A+K +      E  F +    EAQ + ++ H  +VK YG 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ----EAQTMMKLSHPKLVKFYGV 71

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
           C     ++++ EY+  G L   L ++     L+ ++ + +   +   +A+L    S   I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLE---SHQFI 126

Query: 347 HRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           HRD+++ N L++      V+DFG  R +  D
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  105 bits (264), Expect = 9e-26
 Identities = 47/167 (28%), Positives = 78/167 (46%), Gaps = 25/167 (14%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF---ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G+G +G+VYK        KV    A+K+L   TS       +     EA V++ V + +
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----EAYVMASVDNPH 78

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           + +L G CL    + LI + M  G L   +  ++D +     L+W   V I K M     
Sbjct: 79  VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQIAKGMN---- 131

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           YL       ++HRD+++ N+L+ +     + DFG A+LL A+     
Sbjct: 132 YLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH 175

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  107 bits (269), Expect = 1e-25
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)

Query: 223 IKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +K+ +G G YG VY+      +  V A+K L     E   F+K    EA V+ ++ H N+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTV-AVKTLKEDTMEVEEFLK----EAAVMKEIKHPNL 278

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V+L G C      ++I E+M  G+L   L       E+     + +   ++ A+ YL   
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 335

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
              + IHR++++ N L+       VADFG +RL+  D
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  105 bits (263), Expect = 1e-25
 Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 18/175 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLY 284
           IG G YGSV K    P+G++ A+K++ ++  E+    K    +  V +       IV+ Y
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFY 87

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN------IVKAMAHALAYLH 338
           G        ++  E M   S           V       +       I  A   AL +L 
Sbjct: 88  GALFREGDCWICMELMS-TSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +    IIHRDI  +NILL+      + DFG +  L  DS  +T  AG   Y+AP
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDAGCRPYMAP 194

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  107 bits (269), Expect = 1e-25
 Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 12/214 (5%)

Query: 184 YKKPKLKANATNSIGVFSIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKA-QLPN 242
           +      +   N      +    G  +       +E +     +G+G YG V        
Sbjct: 2   HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61

Query: 243 GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER 302
               A+K +  +     +       E  VL  + H NI+KLY F   ++  +L+ E  + 
Sbjct: 62  HVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE 362
           G LF  + +     E+D A    I+K +   + YLH     +I+HRD+   N+LL SK +
Sbjct: 121 GELFDEIIHRMKFNEVDAAV---IIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174

Query: 363 AF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
                + DFG + +   +        GT  YIAP
Sbjct: 175 DALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAP 207

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  105 bits (263), Expect = 1e-25
 Identities = 54/158 (34%), Positives = 81/158 (51%), Gaps = 12/158 (7%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           IG G +G VYK  L   +GK     A+K L    TE+      F  EA ++ Q  H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSHHNII 109

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           +L G     K M +I EYME G+L   L   +   E    + V +++ +A  + YL    
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           + + +HRD+++ NIL+NS     V+DFG +R+L  D  
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  104 bits (262), Expect = 1e-25
 Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 13/180 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + +   +G G   +V++ +    G +FA+K  +         +     E +VL ++ H+N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68

Query: 280 IVKLYGF--CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           IVKL+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYGYIAP 393
                  I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHP 184

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  105 bits (263), Expect = 1e-25
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + F     IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N ++  G  L     +L+ EY   GS    L  ++  ++        +       LAY
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAA--VTHGALQGLAY 169

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   S ++IHRD+ + NILL+      + DFG+A    +  +      GT  ++AP
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSFVGTPYWMAP 219

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  104 bits (261), Expect = 1e-25
 Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 22/164 (13%)

Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +G V   +        G+  A+K L          I   + E ++L  + H NIV
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHENIV 86

Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           K  G C       + LI E++  GSL   L  N++ +     L +A ++         + 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI------CKGMD 140

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           YL    S   +HRD+++ N+L+ S+ +  + DFG  + +  D  
Sbjct: 141 YLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (262), Expect = 2e-25
 Identities = 53/180 (29%), Positives = 78/180 (43%), Gaps = 25/180 (13%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G+G  G V  A +    K  A+K     K       E     +   E ++L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLF----CNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           +K+  F    +  +++ E ME G LF     N    E        K       M  A+ Y
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEAT-----CKL--YFYQMLLAVQY 129

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH      IIHRD+   N+LL+S+ E     + DFG +++L   S  RT L GT  Y+AP
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT-LCGTPTYLAP 185

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  105 bits (264), Expect = 2e-25
 Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 11/156 (7%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           +G G +G V   +L  P+ K    A+K L    TE+    + F  EA ++ Q  H NI++
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHPNIIR 110

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L G     K + ++ EYME GSL   L  ++   +    + V +++ +A  + YL     
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLS---D 165

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
              +HRD+++ NIL+NS     V+DFG  R+L  D 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  104 bits (261), Expect = 2e-25
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 23/164 (14%)

Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G + A+K+L  S  ++    + F+ E Q+L  +    IV
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQ---RDFQREIQILKALHSDFIV 87

Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           K  G      R+ + L+ EY+  G L   L  +   ++    L ++    I K M     
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGME---- 141

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           YL    S   +HRD+++ NIL+ S+    +ADFG A+LL  D  
Sbjct: 142 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  103 bits (258), Expect = 2e-25
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 12/180 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E ++I   +G G +G V K       + +A+K ++ +  +      +   E ++L ++ 
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLD 79

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H NI+KL+         +++ E    G LF  +   +   E D A+   I+K +   + Y
Sbjct: 80  HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITY 136

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +H     +I+HRD+   NILL SK +     + DFG +     ++  +    GT  YIAP
Sbjct: 137 MH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIAP 192

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (267), Expect = 3e-25
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 34/184 (18%)

Query: 223 IKYCIGTGGYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +K CI  GG G +Y A    + NG+   LK L  S   E         E Q L++V+H +
Sbjct: 84  VKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAE--AQAMAMAERQFLAEVVHPS 140

Query: 280 IVKLYGFCLH-----RKCMFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAH 332
           IV+++ F  H         +++ EY+   SL       + +    L  A+ +  +  +  
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-------KRSKGQKLPVAEAIAYLLEILP 193

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTARLLHADSSNRTLLAGTYG 389
           AL+YLH   S  +++ D+   NI+L     K    + D G    +++       L GT G
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEEQLK----LIDLGAVSRINSFGY----LYGTPG 242

Query: 390 YIAP 393
           + AP
Sbjct: 243 FQAP 246

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  103 bits (259), Expect = 4e-25
 Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 25/164 (15%)

Query: 227 IGTGGYGSVYKAQL----PNGKVF-ALK--KLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G+G +G+V+K        + K+   +K  +  +      A           +  + H +
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD----HMLAIGSLDHAH 76

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           IV+L G C     + L+ +Y+  GSL  ++  +  A+     L+W   V I K M     
Sbjct: 77  IVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG--VQIAKGMY---- 129

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           YL       ++HR++++ N+LL S  +  VADFG A LL  D  
Sbjct: 130 YLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (257), Expect = 5e-25
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 23/163 (14%)

Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 74

Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           K  G C    R+ + LI EY+  GSL   L  +++ ++    L +     I K M     
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME---- 128

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           YL    +   IHRD+++ NIL+ ++    + DFG  ++L  D 
Sbjct: 129 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (263), Expect = 5e-25
 Identities = 44/171 (25%), Positives = 79/171 (46%), Gaps = 12/171 (7%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V K       + +A+K ++ +  +      +   E ++L ++ H NI+KL+ 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFE 88

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                   +++ E    G LF  +   +   E D A+   I+K +   + Y+H     +I
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---IIKQVFSGITYMH---KHNI 142

Query: 346 IHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +HRD+   NILL SK +     + DFG +     ++  +    GT  YIAP
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD-RIGTAYYIAP 192

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  104 bits (262), Expect = 6e-25
 Identities = 44/192 (22%), Positives = 84/192 (43%), Gaps = 35/192 (18%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 271
           TE + +   +G G +  V +  ++  G+ +A       KL   + ++L        EA++
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL------EREARI 63

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRV 324
              + H NIV+L+         +LI++ +  G LF       + +       E D +   
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELF-------EDIVAREYYSEADASH-- 114

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNR 381
             ++ +  A+ + H      ++HR++   N+LL SK +     +ADFG A  +  +    
Sbjct: 115 -CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 382 TLLAGTYGYIAP 393
              AGT GY++P
Sbjct: 171 FGFAGTPGYLSP 182

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  105 bits (264), Expect = 7e-25
 Identities = 30/140 (21%), Positives = 53/140 (37%), Gaps = 1/140 (0%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP-NELTWLTGLLGLN 60
             +L+ L+ LD+   +           LT L+ L ++ N F  +   N     T L  L+
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS  +L         ++  L  L++S+N +         +L  L  L+ S N++      
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGI 539

Query: 121 SNEQLSSMYIVRLSPNKGLC 140
                 S+    L+ N   C
Sbjct: 540 LQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 97.0 bits (242), Expect = 5e-22
 Identities = 40/139 (28%), Positives = 56/139 (40%), Gaps = 2/139 (1%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
               L+ L  LD   ++L      S    L  L YLD+S              LT L  L
Sbjct: 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTL 453

Query: 60  NLSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
            ++ N       S + A+  NLT+LD+S  ++E    G    L RL  LN+S N L    
Sbjct: 454 KMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLD 513

Query: 119 PFSNEQLSSMYIVRLSPNK 137
                QL S+  +  S N+
Sbjct: 514 SSHYNQLYSLSTLDCSFNR 532

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 33/134 (24%), Positives = 55/134 (41%), Gaps = 5/134 (3%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           +   +D+  N L      +    ++L +LDLSR +  +        L  L  L L+ N +
Sbjct: 33  STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92

Query: 67  SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG---PVPFSNE 123
               P   + + +L  L     K+       I +L  L  LN++ N +     P  FSN 
Sbjct: 93  QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN- 151

Query: 124 QLSSMYIVRLSPNK 137
            L+++  V LS N 
Sbjct: 152 -LTNLVHVDLSYNY 164

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 37/159 (23%), Positives = 57/159 (35%), Gaps = 18/159 (11%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
              L +L  LD+  N+L   G    +      L +LDLS N     +      L  L  L
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA-IIMSANFMGLEELQHL 404

Query: 60  NLSSNKLSGKIP-SQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +   + L      S   S++ L +LDIS    +    G    L+ L+ L ++ N      
Sbjct: 405 DFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNT 464

Query: 119 P---FSNEQ------LSSMYIVRLSPNKGLCGNFSALPS 148
               F+N        LS   + ++S      G F  L  
Sbjct: 465 LSNVFANTTNLTFLDLSKCQLEQISW-----GVFDTLHR 498

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 7/121 (5%)

Query: 2   IGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL---- 56
           IG L  L +L+V  N +    +P+    LT+L ++DLS N   +   N+L +L       
Sbjct: 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVN 183

Query: 57  LGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGE-ITELSRLDYLNLSSNKLS 115
           L L++S N +   I  Q      L  L +  N    +I    +  L+ L    L   +  
Sbjct: 184 LSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFK 242

Query: 116 G 116
            
Sbjct: 243 D 243

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 28/131 (21%), Positives = 53/131 (40%), Gaps = 6/131 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           +P    + +    +DLS N          +  + L  L+LS  ++          + +L+
Sbjct: 26  VPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK---- 137
            L ++ N I+   PG  + L+ L+ L     KL+    F   QL ++  + ++ N     
Sbjct: 84  NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSC 143

Query: 138 GLCGNFSALPS 148
            L   FS L +
Sbjct: 144 KLPAYFSNLTN 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 75.1 bits (185), Expect = 8e-15
 Identities = 26/138 (18%), Positives = 50/138 (36%), Gaps = 10/138 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L N+  + +   S+       +        L + R Q       +L +L  L    L
Sbjct: 281 FHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL---TL 335

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG--EITELSRLDYLNLSSNKLSGPVP 119
           + NK S  I  +  ++ +L++LD+S N +  S          + L +L+LS N       
Sbjct: 336 TMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-S 392

Query: 120 FSNEQLSSMYIVRLSPNK 137
            +   L  +  +    + 
Sbjct: 393 ANFMGLEELQHLDFQHST 410

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 29/159 (18%), Positives = 53/159 (33%), Gaps = 17/159 (10%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGL-LTDLSYLDLSRNQFNS---------SIPNEL 50
           +      L EL +  N     I  T    L  L    L   +F           SI   L
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258

Query: 51  TWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLS 110
             +T +    L+          +   + N++ + ++   I      ++ +  +   L++ 
Sbjct: 259 CDVT-IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSII 315

Query: 111 SNKLSGPVPFSNEQLSSMYIVRLSPNKG-LCGNFSALPS 148
             +L     F    L  +  + L+ NKG +     ALPS
Sbjct: 316 RCQLKQ---FPTLDLPFLKSLTLTMNKGSISFKKVALPS 351

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 10/52 (19%), Positives = 17/52 (32%), Gaps = 2/52 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL 53
              L +L  LD   N +             L++ +L+ N   + I  E    
Sbjct: 517 YNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV-ACIC-EHQKF 566

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  101 bits (255), Expect = 7e-25
 Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 9/152 (5%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
            +G G +G V+          A+K L        AF+     EA ++ Q+ H+ +V+LY 
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA----EANLMKQLQHQRLVRLYA 75

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                  +++I EYME GSL   L       +L   K +++   +A  +A++      + 
Sbjct: 76  VVTQEP-IYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIE---ERNY 130

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           IHRD+ + NIL++      +ADFG ARL+  +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  104 bits (261), Expect = 8e-25
 Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 9/159 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+ A        A+K +        AF+     EA V+  + H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHD 243

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +VKL+     ++ +++I E+M +GSL   L ++E + +    K ++    +A  +A++ 
Sbjct: 244 KLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIE 301

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                + IHRD+ + NIL+++     +ADFG AR++  +
Sbjct: 302 ---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  103 bits (259), Expect = 9e-25
 Identities = 44/180 (24%), Positives = 80/180 (44%), Gaps = 13/180 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + +   +G G   +V++ +    G +FA+K  +         +     E +VL ++ H+N
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKN 68

Query: 280 IVKLYGF--CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
           IVKL+        +   LI E+   GSL+  L    +A  L  ++ + +++ +   + +L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYGYIAP 393
                  I+HR+I   NI+     +      + DFG AR L  D    +L  GT  Y+ P
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY-GTEEYLHP 184

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (254), Expect = 9e-25
 Identities = 49/185 (26%), Positives = 89/185 (48%), Gaps = 22/185 (11%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 271
           ++ +D+K  +G G +  V +      G  FA K     KL   + ++L        EA++
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------EREARI 58

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
             ++ H NIV+L+         +L+++ +  G LF ++   E   E D +     ++ + 
Sbjct: 59  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH---CIQQIL 115

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTY 388
            ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++   +     AGT 
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG-FAGTP 171

Query: 389 GYIAP 393
           GY++P
Sbjct: 172 GYLSP 176

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  105 bits (263), Expect = 9e-25
 Identities = 39/158 (24%), Positives = 78/158 (49%), Gaps = 15/158 (9%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF-ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV +        ++  A+K L   T + +    ++    EAQ++ Q+ +  IV
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPYIV 399

Query: 282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           +L G C   + + L+ E    G L   L    +  E+  +    ++  ++  + YL    
Sbjct: 400 RLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYL---E 453

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
             + +HR++++ N+LL ++  A ++DFG ++ L AD S
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  101 bits (254), Expect = 1e-24
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 11/156 (7%)

Query: 227 IGTGGYGSVYKAQLPNGKVF---ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G +G+V K      KV    A+K L  +E  + A       EA V+ Q+ +  IV++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            G C   +   L+ E  E G L   L  N     +     + +V  ++  + YL      
Sbjct: 84  IGICE-AESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ES 136

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           + +HRD+++ N+LL ++  A ++DFG ++ L AD +
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  102 bits (257), Expect = 1e-24
 Identities = 48/192 (25%), Positives = 89/192 (46%), Gaps = 36/192 (18%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 271
           ++ +D+K  +G G +  V +      G  FA K     KL   + ++L        EA++
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL------EREARI 81

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRV 324
             ++ H NIV+L+         +L+++ +  G LF       + +       E D +   
Sbjct: 82  CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF-------EDIVAREFYSEADAS--- 131

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNR 381
           + ++ +  ++AY H   S  I+HR++   N+LL SK +     +ADFG A  ++   +  
Sbjct: 132 HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188

Query: 382 TLLAGTYGYIAP 393
              AGT GY++P
Sbjct: 189 G-FAGTPGYLSP 199

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  101 bits (253), Expect = 1e-24
 Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 11/155 (7%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G +G V        KV A+K +    T +     +F  EA V++Q+ H N+V+L G 
Sbjct: 29  IGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-----AFLAEASVMTQLRHSNLVQLLGV 82

Query: 287 CLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            +  K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL      + 
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNNF 138

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
           +HRD+++ N+L++    A V+DFG  +   +    
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (255), Expect = 1e-24
 Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 23/164 (14%)

Query: 227 IGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV 281
           +G G +GSV   +        G+V A+KKL  S  E L   + F  E ++L  + H NIV
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIEILKSLQHDNIV 105

Query: 282 KLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALA 335
           K  G C    R+ + LI EY+  GSL   L  +++ ++    L +     I K M     
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT--SQICKGME---- 159

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
           YL    +   IHRD+++ NIL+ ++    + DFG  ++L  D  
Sbjct: 160 YLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (259), Expect = 2e-24
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 11/148 (7%)

Query: 226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
            IG G +G V        KV A+K +    T + AF+     EA V++Q+ H N+V+L G
Sbjct: 200 TIGKGEFGDVMLGDYRGNKV-AVKCIKNDATAQ-AFLA----EASVMTQLRHSNLVQLLG 253

Query: 286 FCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
             +  K  ++++ EYM +GSL   L +   +  L     +     +  A+ YL      +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNN 309

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTAR 372
            +HRD+++ N+L++    A V+DFG  +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK 337

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (255), Expect = 2e-24
 Identities = 16/198 (8%), Positives = 41/198 (20%), Gaps = 38/198 (19%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +  G    V+    +   + FALK          + ++         +++L  +  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 286 FC--------------------------LHRKCMFLIYEYMERGSLFCNLHNNEDAVE-- 317
                                              L+        L       +      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 318 --LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
                     +   +    A L    S  ++H   + +N+ +       + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242

Query: 376 ADSSNRTLLAGTYGYIAP 393
              +     +    Y   
Sbjct: 243 KVGTRGPASSVPVTYAPR 260

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  101 bits (253), Expect = 2e-24
 Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG G VY+A+     ++ ALK +  + + +  F    + EA+   ++   ++V ++ 
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
           F      +++    +    L   L        L   + V IV+ +  AL   H       
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIAP 393
            HRD+   NIL+++   A++ DFG A     +   +     GT  Y+AP
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAP 204

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (257), Expect = 3e-24
 Identities = 39/195 (20%), Positives = 81/195 (41%), Gaps = 32/195 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRN 279
              +  +G G  G+V       G+  A+K++       + F      E ++L++   H N
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPN 70

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLF----CNLHNNEDAVELDWAKRVNIVKAMAHALA 335
           +++ Y      + +++  E     +L         ++E+         +++++ +A  +A
Sbjct: 71  VIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF-------------VADFGTARLLHADSSNRT 382
           +LH   S  IIHRD+   NIL+++                  ++DFG  + L +  S+  
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 383 L----LAGTYGYIAP 393
                 +GT G+ AP
Sbjct: 187 TNLNNPSGTSGWRAP 201

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  102 bits (257), Expect = 3e-24
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 11/153 (7%)

Query: 226 CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V+        +V A+K L        AF++    EAQV+ ++ H  +V+LY
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLY 245

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                 + ++++ EYM +GSL   L        L   + V++   +A  +AY+      +
Sbjct: 246 AVVS-EEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMN 300

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            +HRD+ + NIL+       VADFG ARL+  +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  100 bits (250), Expect = 3e-24
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 16/157 (10%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNI 280
           IG G +G V++     P       A+K     TS++    F++    EA  + Q  H +I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ----EALTMRQFDHPHI 78

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           VKL G       +++I E    G L   L   +    LD A  +     ++ ALAYL   
Sbjct: 79  VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLE-- 133

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            S   +HRDI++ N+L++S     + DFG +R +   
Sbjct: 134 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  101 bits (254), Expect = 3e-24
 Identities = 45/179 (25%), Positives = 86/179 (48%), Gaps = 12/179 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + +DI   +G+G +G V++  +   G+VF  K ++T    +     + +NE  +++Q+ 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 106

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H  ++ L+     +  M LI E++  G LF  +    +  ++  A+ +N ++     L +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKH 164

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +H     SI+H DI   NI+  +K  + V   DFG A  L+ D   +     T  + AP
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAP 219

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  101 bits (254), Expect = 3e-24
 Identities = 41/170 (24%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V+K  +   G   A K + T   ++    +  +NE  V++Q+ H N+++LY 
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYD 153

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               +  + L+ EY++ G LF  +   +++  L     +  +K +   + ++H      I
Sbjct: 154 AFESKNDIVLVMEYVDGGELFDRI--IDESYNLTELDTILFMKQICEGIRHMH---QMYI 208

Query: 346 IHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +H D+   NIL  ++    +   DFG AR        +    GT  ++AP
Sbjct: 209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTPEFLAP 257

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  100 bits (250), Expect = 4e-24
 Identities = 43/172 (25%), Positives = 81/172 (47%), Gaps = 13/172 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLY 284
           +G G YG V K + +P+G++ A+K++  +   +    K    +  + +  V     V  Y
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ--EQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 285 GFCLHRKCMFLIYEYMERGSL---FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           G       +++  E M+  SL   +  + +    +  D   +  I  ++  AL +LH   
Sbjct: 73  GALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLHSKL 129

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           S  +IHRD+  +N+L+N+  +  + DFG +  L  D   + + AG   Y+AP
Sbjct: 130 S--VIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDAGCKPYMAP 178

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  103 bits (258), Expect = 4e-24
 Identities = 46/183 (25%), Positives = 77/183 (42%), Gaps = 16/183 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +++K  +GTGG+G V +      G+  A+K+     + +    + +  E Q++ ++ H N
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPN 73

Query: 280 IVKLY------GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +V                   L  EY E G L   L+  E+   L       ++  ++ A
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGY 390
           L YLH      IIHRD+   NI+L    +     + D G A+ L         + GT  Y
Sbjct: 134 LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV-GTLQY 189

Query: 391 IAP 393
           +AP
Sbjct: 190 LAP 192

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  101 bits (253), Expect = 4e-24
 Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 15/184 (8%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLS 273
            + +DI   +G+G +  V K  +   G  +A K   K  +  +      +    E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           QVLH NI+ L+    +R  + LI E +  G LF  L   E   E +     + +K +   
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDG 127

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + GT  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPE 183

Query: 390 YIAP 393
           ++AP
Sbjct: 184 FVAP 187

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (257), Expect = 4e-24
 Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 11/153 (7%)

Query: 226 CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY 284
            +G G +G V+        +V A+K L        AF++    EAQV+ ++ H  +V+LY
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMKKLRHEKLVQLY 328

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                   ++++ EYM +GSL   L        L   + V++   +A  +AY+      +
Sbjct: 329 AVVSEEP-IYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMN 383

Query: 345 IIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            +HRD+ + NIL+       VADFG ARL+  +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDN 416

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  100 bits (252), Expect = 4e-24
 Identities = 53/187 (28%), Positives = 84/187 (44%), Gaps = 30/187 (16%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ F+++  +G G    VY+  Q    K +ALK L  +  ++       R E  VL ++ 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-----IVRTEIGVLLRLS 106

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRVNIVKA 329
           H NI+KL         + L+ E +  G LF       D +       E D A     VK 
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELF-------DRIVEKGYYSERDAAD---AVKQ 156

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAG 386
           +  A+AYLH      I+HRD+   N+L  +        +ADFG ++++      +T + G
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCG 212

Query: 387 TYGYIAP 393
           T GY AP
Sbjct: 213 TPGYCAP 219

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  102 bits (257), Expect = 5e-24
 Identities = 46/184 (25%), Positives = 78/184 (42%), Gaps = 22/184 (11%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + +DI   +GTG +G V++  +   G  FA K + T    +    ++ R E Q +S + 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLR 212

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNL-----HNNEDAVELDWAKRVNIVKAMA 331
           H  +V L+        M +IYE+M  G LF  +       +ED         V  ++ + 
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-------VEYMRQVC 265

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYG 389
             L ++H     + +H D+   NI+  +K    +   DFG    L    S +    GT  
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-GTAE 321

Query: 390 YIAP 393
           + AP
Sbjct: 322 FAAP 325

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 38/177 (21%), Positives = 66/177 (37%), Gaps = 10/177 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           + F     +G G YG V+K +   +G+++A+K+  +              E     +V  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQ 115

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H   V+L         ++L  E     SL  +      ++          ++    ALA+
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW--GYLRDTLLALAH 172

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   S  ++H D+   NI L  +    + DFG    L    +      G   Y+AP
Sbjct: 173 LH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAP 225

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 99.6 bits (249), Expect = 9e-24
 Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 15/184 (8%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLS 273
            + +DI   +G+G +  V K  +   G  +A K   K  +  +      +    E  +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           QVLH N++ L+    +R  + LI E +  G LF  L   E   E +     + +K +   
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---SFIKQILDG 127

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   +  I H D+   NI+L  K        + DFG A  +      +  + GT  
Sbjct: 128 VNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN-IFGTPE 183

Query: 390 YIAP 393
           ++AP
Sbjct: 184 FVAP 187

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (254), Expect = 9e-24
 Identities = 54/181 (29%), Positives = 77/181 (42%), Gaps = 21/181 (11%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTS----------ETEELAFIKSFRNEAQVLSQV 275
           +G+G YG V    +       A+K +  S                F +   NE  +L  +
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI+KL+     +K  +L+ E+ E G LF  + N     E D A    I+K +   + 
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN---IMKQILSGIC 160

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIA 392
           YLH     +I+HRDI   NILL +K       + DFG +     D   R    GT  YIA
Sbjct: 161 YLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD-RLGTAYYIA 216

Query: 393 P 393
           P
Sbjct: 217 P 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 47/171 (27%), Positives = 74/171 (43%), Gaps = 14/171 (8%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +G V  A Q       A KK+     E+   +  F+ E +++  + H NI++LY 
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                  ++L+ E    G LF  + +     E D A+   I+K +  A+AY H     ++
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---IMKDVLSAVAYCH---KLNV 127

Query: 346 IHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
            HRD+   N L  +        + DFG A         RT   GT  Y++P
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT-KVGTPYYVSP 177

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  100 bits (250), Expect = 1e-23
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 28/190 (14%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 271
            + +D K  IG G    V +      G  FA+K         S  +     ++ R E  +
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 272 LSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKR 323
           L QV  H +I+ L         MFL+++ M +G LF       D +       E +    
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELF-------DYLTEKVALSEKETRS- 204

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             I++++  A+++LH   + +I+HRD+   NILL+   +  ++DFG +  L      R  
Sbjct: 205 --IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE- 258

Query: 384 LAGTYGYIAP 393
           L GT GY+AP
Sbjct: 259 LCGTPGYLAP 268

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 15/184 (8%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLS 273
            + +++   +G+G +  V K  Q   GK +A K   K   S +      +    E  +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           ++ H NI+ L+    ++  + LI E +  G LF  L   E   E +       +K +   
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---QFLKQILDG 120

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   S  I H D+   NI+L  K        + DFG A  + A +  +  + GT  
Sbjct: 121 VHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN-IFGTPE 176

Query: 390 YIAP 393
           ++AP
Sbjct: 177 FVAP 180

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 8/169 (4%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G GG  +VY A+        A+K +     E+   +K F  E    SQ+ H+NIV +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                 C +L+ EY+E  +L   + ++     L     +N    +   + + H      I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RI 132

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIAP 393
           +HRDI   NIL++S     + DFG A+ L   S  +T  + GT  Y +P
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 17/181 (9%)

Query: 221 FDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F  K  +G+G +G V+   +  +G    +K ++   ++    ++    E +VL  + H N
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPN 81

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV----ELDWAKRVNIVKAMAHALA 335
           I+K++        M+++ E  E G L   + + +       E   A+   ++K M +ALA
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE---LMKQMMNALA 138

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIA 392
           Y H   S  ++H+D+   NIL           + DFG A L  +D  +    AGT  Y+A
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN-AAGTALYMA 194

Query: 393 P 393
           P
Sbjct: 195 P 195

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 24/162 (14%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNI 280
           +G G +G VY+       G+    A+K      +   +  F+     EA ++  + H +I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS----EAVIMKNLDHPHI 75

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAY 336
           VKL G     +  ++I E    G L   L  N+++++    + ++ ++        A+AY
Sbjct: 76  VKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQI------CKAMAY 128

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           L    S + +HRDI+  NIL+ S     + DFG +R +  + 
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 44/184 (23%), Positives = 78/184 (42%), Gaps = 23/184 (12%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            E + I   +G G +G V++  +  + K +  K +    T+        + E  +L+   
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIAR 59

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLF-----CNLHNNEDAVELDWAKRVNIVKAMA 331
           HRNI+ L+      + + +I+E++    +F          NE  +       V+ V  + 
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI-------VSYVHQVC 112

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYG 389
            AL +LH   S +I H DI   NI+  ++  + +   +FG AR L    + R  L     
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPE 168

Query: 390 YIAP 393
           Y AP
Sbjct: 169 YYAP 172

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 98.0 bits (245), Expect = 2e-23
 Identities = 49/187 (26%), Positives = 80/187 (42%), Gaps = 29/187 (15%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + F     +G+G +  V+   Q   GK+FALK +  S         S  NE  VL ++ 
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIK 64

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV-------ELDWAKRVNIVKA 329
           H NIV L          +L+ + +  G LF       D +       E D +    +++ 
Sbjct: 65  HENIVTLEDIYESTTHYYLVMQLVSGGELF-------DRILERGVYTEKDASL---VIQQ 114

Query: 330 MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAG 386
           +  A+ YLH      I+HRD+   N+L  +  E     + DFG +++    +   +   G
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTACG 169

Query: 387 TYGYIAP 393
           T GY+AP
Sbjct: 170 TPGYVAP 176

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 24/163 (14%)

Query: 227 IGTGGYGSVYKAQLPN-----GKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +G V            G++ A+K L           + +    E  +L  + H +
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ----EIDILRTLYHEH 94

Query: 280 IVKLYGFCLHRKC--MFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHALA 335
           I+K  G C       + L+ EY+  GSL   L  +   +   L +A    I + MA    
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFA--QQICEGMA---- 148

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           YLH   +   IHRD+++ N+LL++     + DFG A+ +    
Sbjct: 149 YLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 38/193 (19%), Positives = 79/193 (40%), Gaps = 26/193 (13%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKS--------------FR 266
           + I   +  G +  +   +  + K +ALKK   S  E+                    F+
Sbjct: 33  YRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK 91

Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 326
           NE Q+++ + +   +   G   +   +++IYEYME  S+           + ++   + I
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPI 150

Query: 327 VKA------MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN 380
                    + ++ +Y+H+    +I HRD+  +NIL++      ++DFG +   +     
Sbjct: 151 QVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE--YMVDKK 206

Query: 381 RTLLAGTYGYIAP 393
                GTY ++ P
Sbjct: 207 IKGSRGTYEFMPP 219

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 40/172 (23%), Positives = 70/172 (40%), Gaps = 17/172 (9%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLY 284
           +G G +    K     + + FA+K +              + E   L     H NIVKL+
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITALKLCEGHPNIVKLH 72

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
                +   FL+ E +  G LF  +   +   E + +    I++ +  A++++H      
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---IMRKLVSAVSHMH---DVG 126

Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           ++HRD+   N+L   + +     + DFG ARL   D+        T  Y AP
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 35/171 (20%), Positives = 75/171 (43%), Gaps = 30/171 (17%)

Query: 227 IGTGGYGSVYKAQLPNGKVFA-----------LKKLHTSETEELAFIKSFRNEAQVLSQV 275
           +G G +  ++K        +            L K H + +E       F   A ++S++
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES------FFEAASMMSKL 69

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H+++V  YG C+      L+ E+++ GSL   L  N++ + + W  ++ + K +A A+ 
Sbjct: 70  SHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMH 127

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF--------VADFGTARLLHADS 378
           +L      ++IH ++ + NILL  + +          ++D G +  +    
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 97.7 bits (244), Expect = 5e-23
 Identities = 43/184 (23%), Positives = 77/184 (41%), Gaps = 15/184 (8%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLS 273
            + +D    +G+G +  V K  +   G  +A K   K  T  +      +    E  +L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           ++ H N++ L+    ++  + LI E +  G LF  L   E   E +       +K + + 
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---EFLKQILNG 126

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYG 389
           + YLH   S  I H D+   NI+L  +        + DFG A  +   +  +  + GT  
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-IFGTPE 182

Query: 390 YIAP 393
           ++AP
Sbjct: 183 FVAP 186

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.3 bits (243), Expect = 6e-23
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 21/179 (11%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G +  V     L   + +A+K +                E ++L Q   HRN+++L 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELI 77

Query: 285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
            F       +L++E M  GS+  ++H      EL+ +    +V+ +A AL +LH   +  
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLH---NKG 131

Query: 345 IIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTL-------LAGTYGYIAP 393
           I HRD+   NIL     +     + DF     +  +     +         G+  Y+AP
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.4 bits (243), Expect = 6e-23
 Identities = 41/182 (22%), Positives = 79/182 (43%), Gaps = 19/182 (10%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           T+G+++K  IG G Y    +         FA+K +  S+       +    E ++L +  
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYG 73

Query: 277 -HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
            H NI+ L       K ++++ E M+ G L   +   +   E + +    ++  +   + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA---VLFTITKTVE 130

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARLLHADSSNRTLLAGTYGYI 391
           YLH   +  ++HRD+  +NIL   +        + DFG A+ L A++        T  ++
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187

Query: 392 AP 393
           AP
Sbjct: 188 AP 189

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =   99 bits (249), Expect = 7e-23
 Identities = 32/151 (21%), Positives = 59/151 (39%), Gaps = 15/151 (9%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGL--LTDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
              N   L  +D+  N L   +        L  LS +D+S N F SS P +    + L  
Sbjct: 723 NYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKA 780

Query: 59  LNL------SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
             +        N++  + P+ I +  +L  L I +N I   +  ++    +L  L+++ N
Sbjct: 781 FGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADN 837

Query: 113 KL-SGPVP-FSNEQLSSMYIVRLSPNKGLCG 141
              S  V        + MY++     + + G
Sbjct: 838 PNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =   99 bits (249), Expect = 8e-23
 Identities = 27/151 (17%), Positives = 53/151 (35%), Gaps = 15/151 (9%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPN--ELTWLTGLLG 58
             G    L +L +  N +             +  L  S N+    IPN      +  +  
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGS 648

Query: 59  LNLSSNKLSGKIPSQIASM-----KNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNK 113
           ++ S NK+  +  +   SM      N + + +S N+I+          S +  + LS+N 
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708

Query: 114 LS-------GPVPFSNEQLSSMYIVRLSPNK 137
           ++        P   + +    +  + L  NK
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =   99 bits (249), Expect = 8e-23
 Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 17/150 (11%)

Query: 1   EIGNLKNLIELDVGSNSLIGP---------IPSTLGLLTDLSYLDLSRNQFNSSIPNE-- 49
            + +L  L  L++  N  I           +         +    +  N      P    
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASAS 568

Query: 50  LTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLN 108
           L  +  L  L+   NK+   + +   +   LT L +  N+IE  IP +      +++ L 
Sbjct: 569 LQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLG 625

Query: 109 LSSNKLSG-PVPFSNEQLSSMYIVRLSPNK 137
            S NKL   P  F+ + +  M  V  S NK
Sbjct: 626 FSHNKLKYIPNIFNAKSVYVMGSVDFSYNK 655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 93.8 bits (233), Expect = 8e-21
 Identities = 20/132 (15%), Positives = 43/132 (32%), Gaps = 11/132 (8%)

Query: 1   EIGNLKNLIELDVGSNSL------IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLT 54
           E+  +K    + +    +      I  I   +  LT L  +  + + F            
Sbjct: 413 EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AV 467

Query: 55  GLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
                N    K         +++K+LT +++ N      +P  + +L  L  LN++ N+ 
Sbjct: 468 DWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527

Query: 115 SGPVPFSNEQLS 126
                   +   
Sbjct: 528 ISAAQLKADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 18/165 (10%), Positives = 45/165 (27%), Gaps = 29/165 (17%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++ N   +  L +      G +P  +G LT+L  L    +    S               
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 61  LSSNKLSGKIPS-QIASMKNLTWLDISNNKIEG--------------------------- 92
              +++        +   + L   D+  + I                             
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437

Query: 93  -SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN 136
             I   I  L++L  +  +++  +      + + ++    +   N
Sbjct: 438 TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYEN 482

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 16/127 (12%), Positives = 41/127 (32%), Gaps = 1/127 (0%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
            + +        I     L      LD    ++ S   N  T  +     N   +    +
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINN-TIHSLNWNFNKELDMWGDQ 314

Query: 70  IPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMY 129
               + +   +T L ++    +G +P  I +L+ L  L+  ++  +       ++  +  
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374

Query: 130 IVRLSPN 136
           +     +
Sbjct: 375 MSEERKH 381

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 14/109 (12%), Positives = 32/109 (29%), Gaps = 9/109 (8%)

Query: 1   EIGNLKNLIEL------DVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLT 54
           +  N   L         D   N ++   P+ +     L  L +  N     +  +L    
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TP 827

Query: 55  GLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSR 103
            L  L+++ N       + +          +  +K +     +   + R
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIER 876

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 15/129 (11%), Positives = 37/129 (28%), Gaps = 4/129 (3%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
             +   +         L     ++ L L+       +P+ +  LT L  L+  ++  +  
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362

Query: 70  IPSQIASMKNLTWLDISNNKIEGSIP----GEITELSRLDYLNLSSNKLSGPVPFSNEQL 125
                         +   ++I              L+  D L  + N+     P   +  
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422

Query: 126 SSMYIVRLS 134
            S+   ++ 
Sbjct: 423 ISLKDTQIG 431

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 15/128 (11%), Positives = 37/128 (28%), Gaps = 2/128 (1%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI 70
           LD  +        +      + +  +   + +      +L     + GL+L+     G++
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339

Query: 71  PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV-PFSNEQLSSMY 129
           P  I  +  L  L    +    S      E    D      +++         +    + 
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLN 399

Query: 130 IVRLSPNK 137
           +  L  + 
Sbjct: 400 LSDLLQDA 407

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 96.2 bits (240), Expect = 8e-23
 Identities = 37/195 (18%), Positives = 71/195 (36%), Gaps = 30/195 (15%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR 278
           F     IG+G +GSV+K     +G ++A+K+            ++   E    + +  H 
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHS 71

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNL-HNNEDAVELDWAKRVNIVKAMAHALAYL 337
           ++V+ +        M +  EY   GSL   +  N         A+  +++  +   L Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFV-------------------ADFGTARLLHADS 378
           H   S S++H DI  +NI ++                           D G    +    
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---- 184

Query: 379 SNRTLLAGTYGYIAP 393
           S+  +  G   ++A 
Sbjct: 185 SSPQVEEGDSRFLAN 199

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 45/188 (23%), Positives = 77/188 (40%), Gaps = 25/188 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +  GG+  VY+AQ + +G+ +ALK+L ++E E+    ++   E   + ++  H NIV+  
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVCFMKKLSGHPNIVQFC 92

Query: 285 GFCLHRK-------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
                 K         FL+   + +G L   L   E    L     + I      A+ ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA------------ 385
           H    P IIHRD+   N+LL+++    + DFG+A  +                       
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 386 GTYGYIAP 393
            T  Y  P
Sbjct: 212 TTPMYRTP 219

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 26/139 (18%), Positives = 45/139 (32%), Gaps = 2/139 (1%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               L NL  LD+    +      T      L  L L+ N         L+    L  L 
Sbjct: 52  TFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLF 111

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG--PV 118
                +S      + + K L  L + +N I      +     +L  L+  +N +      
Sbjct: 112 FIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171

Query: 119 PFSNEQLSSMYIVRLSPNK 137
             S+ Q ++   + L+ N 
Sbjct: 172 DMSSLQQATNLSLNLNGND 190

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 27/133 (20%), Positives = 46/133 (34%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
             +   L+   N L     +T   L +L++LDL+R Q      +       L  L L++N
Sbjct: 32  PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
            L     + ++  K L  L      I       +     L+ L L SN +S         
Sbjct: 92  PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151

Query: 125 LSSMYIVRLSPNK 137
              + ++    N 
Sbjct: 152 TEKLKVLDFQNNA 164

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 3/130 (2%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           + NL+NL ELD+  + +         L  L+ L  L+LS N+  S           L  L
Sbjct: 346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELL 405

Query: 60  NLSSNKLSGKIP-SQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +L+  +L  K   S   ++  L  L++S++ ++ S       L  L +LNL  N      
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465

Query: 119 PFSNEQLSSM 128
                 L ++
Sbjct: 466 IQKTNSLQTL 475

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 93.9 bits (234), Expect = 6e-21
 Identities = 39/139 (28%), Positives = 58/139 (41%), Gaps = 4/139 (2%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI---PNELTWLTGLLG 58
             NL  L  L++  + L          L  L +L+L  N F        N L  L  L  
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L LS   LS        S+K +  +D+S+N++  S    ++ L  + YLNL+SN +S  +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539

Query: 119 PFSNEQLSSMYIVRLSPNK 137
           P     LS    + L  N 
Sbjct: 540 PSLLPILSQQRTINLRQNP 558

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 30/140 (21%), Positives = 51/140 (36%), Gaps = 5/140 (3%)

Query: 2   IGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
                 L  LD+    L      S    L  L  L+LS +  + S       L  L  LN
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455

Query: 61  LSSNKLSGKI---PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
           L  N          + + ++  L  L +S   +        T L  +++++LS N+L+  
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 118 VPFSNEQLSSMYIVRLSPNK 137
              +   L  +Y+  L+ N 
Sbjct: 516 SIEALSHLKGIYL-NLASNH 534

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 30/143 (20%), Positives = 58/143 (40%), Gaps = 8/143 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGL 59
            +  L  L +L + +N        +      L++L +  N     +    L  L  L  L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355

Query: 60  NLSSNKL--SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG- 116
           +LS + +  S     Q+ ++ +L  L++S N+          E  +L+ L+L+  +L   
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415

Query: 117 --PVPFSNEQLSSMYIVRLSPNK 137
               PF N  L  + ++ LS + 
Sbjct: 416 DAQSPFQN--LHLLKVLNLSHSL 436

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 90.8 bits (226), Expect = 5e-20
 Identities = 35/138 (25%), Positives = 65/138 (47%), Gaps = 4/138 (2%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
                L ELD+ +  L   +PS L  L+ L  L LS N+F +      +    L  L++ 
Sbjct: 275 HCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333

Query: 63  SNKLSGKIPSQ-IASMKNLTWLDISNNKIEGS--IPGEITELSRLDYLNLSSNKLSGPVP 119
            N    ++ +  + +++NL  LD+S++ IE S     ++  LS L  LNLS N+      
Sbjct: 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKT 393

Query: 120 FSNEQLSSMYIVRLSPNK 137
            + ++   + ++ L+  +
Sbjct: 394 EAFKECPQLELLDLAFTR 411

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 20/128 (15%), Positives = 39/128 (30%), Gaps = 3/128 (2%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
             +  +  L   IP    L      L+ S N   +      + L  L  L+L+  ++   
Sbjct: 16  TYNCENLGLNE-IPG--TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72

Query: 70  IPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMY 129
                 S   L  L ++ N +       ++    L +L      +S           ++ 
Sbjct: 73  HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132

Query: 130 IVRLSPNK 137
            + L  N 
Sbjct: 133 SLYLGSNH 140

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 25/117 (21%), Positives = 48/117 (41%), Gaps = 5/117 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  L  L  L +    L          L  ++++DLS N+  SS    L+ L   + LNL
Sbjct: 472 LQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK-GIYLNL 530

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +SN +S  +PS +  +     +++  N ++ +          L++   +  KL    
Sbjct: 531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYF--LEWYKENMQKLEDTE 583

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 24/143 (16%), Positives = 48/143 (33%), Gaps = 8/143 (5%)

Query: 1   EIGNLKNL--IELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW--LTGL 56
           ++ +L+    + L++  N  I  I            L+    Q    I   L    +  L
Sbjct: 172 DMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSL 230

Query: 57  LGLNLSSNKLSGKIPSQIASMK--NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
                         P+    +   ++  +++  +             S L  L+L++  L
Sbjct: 231 WLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL 290

Query: 115 SGPVPFSNEQLSSMYIVRLSPNK 137
           S  +P     LS++  + LS NK
Sbjct: 291 SE-LPSGLVGLSTLKKLVLSANK 312

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 12/161 (7%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY   L   +GK    A+K L+         +  F  E  ++    H N++ 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 90

Query: 283 LYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           L G CL  +    ++  YM+ G L   + N            +     +A  + YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLA--- 145

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           S   +HRD+++ N +L+ KF   VADFG AR ++       
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 45/158 (28%), Positives = 72/158 (45%), Gaps = 16/158 (10%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRNI 280
           IG G +G V++     P       A+K     TS++    F++    EA  + Q  H +I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ----EALTMRQFDHPHI 453

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           VKL G       +++I E    G L   L   +    LD A  +     ++ ALAYL   
Sbjct: 454 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLE-- 508

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
            S   +HRDI++ N+L++S     + DFG +R +   +
Sbjct: 509 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 37/136 (27%), Positives = 65/136 (47%), Gaps = 8/136 (5%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + N+  L  L +G+N +    P  L  L+ L++L++  NQ +    N +  LT L  LN+
Sbjct: 217 VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNV 272

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            SN++S    S + ++  L  L ++NN++       I  L+ L  L LS N ++   P +
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330

Query: 122 NEQLSSMYIVRLSPNK 137
           +  LS M     +   
Sbjct: 331 S--LSKMDSADFANQV 344

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 92.6 bits (231), Expect = 4e-21
 Identities = 38/137 (27%), Positives = 70/137 (51%), Gaps = 9/137 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + NL NL EL +  +++    P  L  LT +  L+L  N  N S  + L+ +TGL  L 
Sbjct: 105 ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLT 161

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           ++ +K+    P  IA++ +L  L ++ N+IE   P  +  L+ L Y     N+++   P 
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPV 217

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N  ++ +  +++  NK
Sbjct: 218 AN--MTRLNSLKIGNNK 232

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 88.8 bits (221), Expect = 8e-20
 Identities = 33/115 (28%), Positives = 56/115 (48%), Gaps = 6/115 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + NL  L  L++G+N +     + +  LT L  L++  NQ  S I   L  L+ L  L 
Sbjct: 238 PLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI-SDISV-LNNLSQLNSLF 293

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           L++N+L  +    I  + NLT L +S N I    P  +  LS++D  + ++  + 
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 30/137 (21%), Positives = 61/137 (44%), Gaps = 8/137 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + +L +L       N +    P  +  +T L+ L +  N+     P  L  L+ L  L 
Sbjct: 194 PLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           + +N++S    + +  +  L  L++ +N+I       +  LS+L+ L L++N+L      
Sbjct: 250 IGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDME 305

Query: 121 SNEQLSSMYIVRLSPNK 137
               L+++  + LS N 
Sbjct: 306 VIGGLTNLTTLFLSQNH 322

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 86.1 bits (214), Expect = 7e-19
 Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 9/137 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            I  L NL  L++  N +    P  L  L  L+ L +  N+   +  + L  LT L  L 
Sbjct: 61  GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELY 116

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L+ + +S   P  +A++  +  L++  N     +   ++ ++ L+YL ++ +K+    P 
Sbjct: 117 LNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTPI 173

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N  L+ +Y + L+ N+
Sbjct: 174 AN--LTDLYSLSLNYNQ 188

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 10/136 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             +L   I   +   S+   +      L  ++ L ++  +  +SI   + +LT L  LNL
Sbjct: 18  DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASIQ-GIEYLTNLEYLNL 73

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           + N+++   P  ++++  LT L I  NKI  +    +  L+ L  L L+ + +S   P +
Sbjct: 74  NGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISPLA 129

Query: 122 NEQLSSMYIVRLSPNK 137
           N  L+ MY + L  N 
Sbjct: 130 N--LTKMYSLNLGANH 143

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.7 bits (169), Expect = 5e-13
 Identities = 24/130 (18%), Positives = 51/130 (39%), Gaps = 10/130 (7%)

Query: 8   LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS 67
              L       I  I      L +     L +      +      L  +  L ++  K++
Sbjct: 2   AATLATLPAP-INQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 68  GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
             I   I  + NL +L+++ N+I    P  ++ L +L  L + +NK++      N  L++
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQN--LTN 111

Query: 128 MYIVRLSPNK 137
           +  + L+ + 
Sbjct: 112 LRELYLNEDN 121

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 12/161 (7%)

Query: 227 IGTGGYGSVYKAQL--PNGKVF--ALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY   L   +GK    A+K L+         +  F  E  ++    H N++ 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLS 154

Query: 283 LYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           L G CL  +    ++  YM+ G L   + N            +     +A  + +L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA--- 209

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
           S   +HRD+++ N +L+ KF   VADFG AR ++    +  
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 31/148 (20%), Positives = 55/148 (37%), Gaps = 6/148 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           + G    +  LD+  N +              L +L+L  N     +  ++     L  L
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV-FAKLKTL 196

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS-GPV 118
           +LSSNKL+  +  +  S   +TW+ + NNK+   I   +     L++ +L  N    G +
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 119 PFSNEQLSSMYIVRLSPNKGLCGNFSAL 146
                +   +  V     K L G     
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQNEEE 282

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 7/114 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             N        V  +SL   + S      ++  LDLS N  +     +L   T L  LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           SSN L       + S+  L  LD++NN ++     E+     ++ L+ ++N +S
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 83.1 bits (206), Expect = 5e-18
 Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 11/138 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++     L  L++ SN L   +   L  L+ L  LDL+ N     +         +  L+
Sbjct: 53  DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLV----GPSIETLH 105

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVP 119
            ++N +S ++       +    + ++NNKI      +    SR+ YL+L  N++      
Sbjct: 106 AANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 120 FSNEQLSSMYIVRLSPNK 137
                  ++  + L  N 
Sbjct: 163 ELAASSDTLEHLNLQYNF 180

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 75.8 bits (187), Expect = 1e-15
 Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 2/94 (2%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           I              ++ +    ++ +       +  L+LS N LS    + +A    L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            L++S+N +      ++  LS L  L+L++N + 
Sbjct: 62  LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 20/85 (23%), Positives = 38/85 (44%), Gaps = 2/85 (2%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
                   ++ + L   + S   S  N+  LD+S N +      ++   ++L+ LNLSSN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
            L   +   +  LS++  + L+ N 
Sbjct: 69  VLYETLDLES--LSTLRTLDLNNNY 91

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 95.0 bits (237), Expect = 4e-22
 Identities = 33/157 (21%), Positives = 58/157 (36%), Gaps = 16/157 (10%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL---------T 51
            +     L  L +  N L   +P+++  L  L  L +      + +P  L          
Sbjct: 122 TMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180

Query: 52  WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
            L  L  L L    +   +P+ IA+++NL  L I N+ +  ++   I  L +L+ L+L  
Sbjct: 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238

Query: 112 NKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPS 148
                  P      + +  + L      C N   LP 
Sbjct: 239 CTALRNYPPIFGGRAPLKRLILKD----CSNLLTLPL 271

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 28/137 (20%), Positives = 57/137 (41%), Gaps = 4/137 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E   L NL  L +    +   +P+++  L +L  L +  +   S++   +  L  L  L+
Sbjct: 178 EHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELD 235

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISN-NKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           L         P        L  L + + + +  ++P +I  L++L+ L+L        +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 120 FSNEQLSSMYIVRLSPN 136
               QL +  I+ + P+
Sbjct: 295 SLIAQLPANCIILVPPH 311

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.3 bits (230), Expect = 4e-21
 Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 1/115 (0%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            I NL+NL  L + ++ L   +   +  L  L  LDL       + P        L  L 
Sbjct: 201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           L        +P  I  +  L  LD+        +P  I +L     + +  +  +
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 31/149 (20%), Positives = 53/149 (35%), Gaps = 13/149 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLG---------LLTDLSYLDLSRNQFNSSIPNELT 51
            I +L  L EL + +   +  +P  L           L +L  L L       S+P  + 
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI-RSLPASIA 203

Query: 52  WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
            L  L  L + ++ LS  +   I  +  L  LD+       + P      + L  L L  
Sbjct: 204 NLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262

Query: 112 -NKLSGPVPFSNEQLSSMYIVRLSPNKGL 139
            + L   +P    +L+ +  + L     L
Sbjct: 263 CSNLLT-LPLDIHRLTQLEKLDLRGCVNL 290

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 26/160 (16%), Positives = 47/160 (29%), Gaps = 24/160 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP------------N 48
              +      L    ++ + P    L         D +R                     
Sbjct: 7   HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGR 66

Query: 49  ELTWLTGLLG---------LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEIT 99
            L     LL          L L S  L  + P Q   + +L  + I    +   +P  + 
Sbjct: 67  ALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQ 124

Query: 100 ELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL 139
           + + L+ L L+ N L   +P S   L+ +  + +     L
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPEL 163

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 47.2 bits (113), Expect = 4e-06
 Identities = 8/56 (14%), Positives = 18/56 (32%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL 56
           +I  L  L +LD+     +  +PS +  L     + +  +       +        
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 18/159 (11%)

Query: 227 IGTGGYGSVYKAQLPNG-----KVFALKKLH--TSETEELAFIKSFRNEAQVLSQVLHRN 279
           IG G +G VY  +  +      +  A+K L   T   +  AF++    E  ++  + H N
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLR----EGLLMRGLNHPN 83

Query: 280 IVKLYGFCLHRKCM-FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           ++ L G  L  + +  ++  YM  G L   + + +          ++    +A  + YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLA 141

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                  +HRD+++ N +L+  F   VADFG AR +   
Sbjct: 142 ---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 94.2 bits (235), Expect = 5e-22
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 19/190 (10%)

Query: 216 EATEGFDIKY----CIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIK-S 264
            +T GF   Y     +G G    V +    P  K +A+K        +   EE+  ++ +
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 265 FRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
              E  +L +V  H NI++L          FL+++ M++G LF  L       E +  K 
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK- 128

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             I++A+   +  LH     +I+HRD+   NILL+      + DFG +  L      R  
Sbjct: 129 --IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE- 182

Query: 384 LAGTYGYIAP 393
           + GT  Y+AP
Sbjct: 183 VCGTPSYLAP 192

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 24/165 (14%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 277
           +G G +G VY+ Q+          +V A+K L    SE +EL F+     EA ++S+  H
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLM----EALIISKFNH 92

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +NIV+  G  L     F++ E M  G L  F             L     +++ + +A  
Sbjct: 93  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFV---ADFGTARLLH 375
             YL        IHRDI++ N LL       V    DFG AR ++
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 194

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 94.7 bits (236), Expect = 6e-22
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 26/165 (15%)

Query: 227 IGTGGYGSVYKAQLPNGKVF---ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-HRNI 280
           IG G +G V KA++    +    A+K++  + S+ +   F      E +VL ++  H NI
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG----ELEVLCKLGHHPNI 88

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVNIV 327
           + L G C HR  ++L  EY   G+L                   N  A  L   + ++  
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +A  + YL        IHRD+++ NIL+   + A +ADFG +R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 48/165 (29%), Positives = 72/165 (43%), Gaps = 24/165 (14%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 277
           +G G +G VY+ Q+          +V A+K L    SE +EL F+     EA ++S+  H
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFL----MEALIISKFNH 133

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL--F--CNLHNNEDAVELDWAKRVNIVKAMAHA 333
           +NIV+  G  L     F++ E M  G L  F             L     +++ + +A  
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFV---ADFGTARLLH 375
             YL        IHRDI++ N LL       V    DFG AR ++
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 24/167 (14%)

Query: 227 IGTGGYGSVYKAQL-------PNGKVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 277
           +G G +G VY+          P  +V A+K +    S  E + F+     EA V+ +   
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMRERIEFLN----EASVMKEFNC 87

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL--F-----CNLHNNEDAVELDWAKRVNIVKAM 330
            ++V+L G     +   +I E M RG L  +       + NN        +K + +   +
Sbjct: 88  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           A  +AYL+   +   +HRD+++ N ++   F   + DFG  R ++  
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 56/177 (31%), Positives = 83/177 (46%), Gaps = 11/177 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+I   IG G +G V   +L    KVFA+K L+  E  + A    FR E  VL     + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           I  L Y F      ++L+ +Y   G L   L   ED +  + A+      A M  A+  +
Sbjct: 136 ITTLHYAFQDDNN-LYLVMDYYVGGDLLTLLSKFEDRLPEEMAR---FYLAEMVIAIDSV 191

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
           H       +HRDI  +NIL++      +ADFG+   L  D + ++ +A GT  YI+P
Sbjct: 192 H---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 245

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 41/183 (22%), Positives = 73/183 (39%), Gaps = 33/183 (18%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQVLHR-N 279
           +G G +  V +      G+ +A K     +       E+       +E  VL        
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI------LHEIAVLELAKSCPR 90

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLF------CNLHNNEDAVELDWAKRVNIVKAMAHA 333
           ++ L+    +   + LI EY   G +F           +E+ V       + ++K +   
Sbjct: 91  VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV-------IRLIKQILEG 143

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGY 390
           + YLH     +I+H D+   NILL+S +      + DFG +R +      R ++ GT  Y
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM-GTPEY 199

Query: 391 IAP 393
           +AP
Sbjct: 200 LAP 202

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+I   IG G +  V   ++   G+V+A+K ++  +  +   +  FR E  VL     R 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 280 IVKLYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           I +L+ F       ++L+ EY   G L   L    + +  + A+      A +  A+  +
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR---FYLAEIVMAIDSV 178

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA-GTYGYIAP 393
           H       +HRDI  +NILL+      +ADFG+   L AD + R+L+A GT  Y++P
Sbjct: 179 H---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 14/175 (8%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLY- 284
           +G GG   V+ A+ L + +  A+K L      + +F   FR EAQ  + + H  IV +Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 285 -GF--CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
            G          +++ EY++  +L   +H       +   + + ++     AL + H + 
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN- 135

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT---LLAGTYGYIAP 393
              IIHRD+   NI++++     V DFG AR +    ++ T    + GT  Y++P
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 30/174 (17%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 277
           +G   +G VYK  L           V A+K L           F      EA + +++ H
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGPLREEFRH----EAMLRARLQH 71

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRV 324
            N+V L G     + + +I+ Y   G L                  +      L+    V
Sbjct: 72  PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           ++V  +A  + YL    S  ++H+D+++ N+L+  K    ++D G  R ++A  
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 23/165 (13%)

Query: 227 IGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +GSV +AQL           V  LK    + ++   F++    EA  + +  H +
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLR----EAACMKEFDHPH 86

Query: 280 IVKLYGFCL------HRKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAM 330
           + KL G  L            +I  +M+ G L   L  +   E+   L     V  +  +
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           A  + YL    S + IHRD+++ N +L       VADFG +R ++
Sbjct: 147 ACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 92.9 bits (231), Expect = 5e-21
 Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 26/178 (14%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G  G V +       + FALK L              R E ++  +     +IV++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 121

Query: 285 GFC----LHRKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALAYLH 338
                    RKC+ ++ E ++ G LF  + +  D    E + +    I+K++  A+ YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---EIMKSIGEAIQYLH 178

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIAP 393
              S +I HRD+   N+L  SK       + DFG A+   + +S  T    T  Y+AP
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP 232

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 29/173 (16%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL- 276
           +G G +G V +A            KV A+K L       E+ A +     E +++S +  
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMS----ELKIMSHLGQ 108

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR-----------VN 325
           H NIV L G C H   + +I EY   G L   L      +E D A             ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
               +A  +A+L    S + IHRD+++ N+LL +   A + DFG AR +  DS
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.8 bits (226), Expect = 7e-21
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 29/172 (16%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKLHT-SETEELAFIKSFRNEAQVLSQVLHR 278
           +G G +G V+ A+  N         V A+K L   +      F +    EA++L+ + H 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAARKDFQR----EAELLTNLQHE 77

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAKRVN 325
           +IVK YG C     + +++EYM+ G L               +    +   EL  ++ ++
Sbjct: 78  HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
           I   +A  + YL    S   +HRD+++ N L+ +     + DFG +R +++ 
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 36/164 (21%), Positives = 69/164 (42%), Gaps = 22/164 (13%)

Query: 227 IGTGGYGSVYKAQLPNGK-------VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +GSV +  L           V  +K  ++S+ E   F+     EA  +    H N
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLS----EAACMKDFSHPN 97

Query: 280 IVKLYGFCL-----HRKCMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMA 331
           +++L G C+           +I  +M+ G L   L  +        +     +  +  +A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
             + YL    + + +HRD+++ N +L       VADFG ++ ++
Sbjct: 158 LGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.1 bits (227), Expect = 9e-21
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 8/149 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK      G   ALK++   ++EE     + R E  ++ ++ H NIV+LY 
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKL-DSEEGTPSTAIR-EISLMKELKHENIVRLYD 70

Query: 286 FCLHRKCMFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
                  + L++E+M+        +         L+          +   LA+ H +   
Sbjct: 71  VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--- 127

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTAR 372
            I+HRD+   N+L+N + +  + DFG AR
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 41/149 (27%), Positives = 78/149 (52%), Gaps = 8/149 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V K +    G++ A+KK   S+ +++    + R E ++L Q+ H N+V L  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLE 91

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
            C  +K  +L++E+++  ++  +L    + ++    +    +  + + + + H   S +I
Sbjct: 92  VCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ--KYLFQIINGIGFCH---SHNI 145

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLL 374
           IHRDI   NIL++      + DFG AR L
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTL 174

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 48/225 (21%), Positives = 84/225 (37%), Gaps = 55/225 (24%)

Query: 218 TEGFDIKYCIGTGGYGSVYKA-QLPNGKVFALK-----KLHTSETEELAFIKSFRNEAQV 271
            + + +K  IG G YG V  A +     + A+K     K+     ++   ++  + E ++
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKD---VERIKTEVRL 81

Query: 272 LSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV------- 324
           + ++ H NI +LY      + + L+ E    G L   L+   D      A  V       
Sbjct: 82  MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141

Query: 325 ------------------------------NIVKAMAHALAYLHHDCSPSIIHRDISSNN 354
                                         NI++ +  AL YLH   +  I HRDI   N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPEN 198

Query: 355 ILLNSKFEAFV--ADFGTARLLHADSSNR----TLLAGTYGYIAP 393
            L ++     +   DFG ++  +  ++      T  AGT  ++AP
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 18/179 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F+I   IG G +G V   Q     K++A+K ++  +  E   +++   E Q++  + H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 280 IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNN----EDAVELDWAKRVNIVKAMAHAL 334
           +V L Y F      MF++ + +  G L  +L  N    E+ V+L   +       +  AL
Sbjct: 77  LVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE-------LVMAL 128

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YL    +  IIHRD+  +NILL+      + DF  A +L  ++   T +AGT  Y+AP
Sbjct: 129 DYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYMAP 183

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 31/144 (21%), Positives = 55/144 (38%), Gaps = 6/144 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           + G    +  LD+  N +              L +L+L  N     +  ++     L  L
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQVV-FAKLKTL 196

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS-GPV 118
           +LSSNKL+  +  +  S   +TW+ + NNK+   I   +     L++ +L  N    G +
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTL 254

Query: 119 PFSNEQLSSMYIVRLSPNKGLCGN 142
                +   +  V     K L G 
Sbjct: 255 RDFFSKNQRVQTVAKQTVKKLTGQ 278

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 86.8 bits (215), Expect = 1e-18
 Identities = 30/114 (26%), Positives = 49/114 (42%), Gaps = 7/114 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             N        V  +SL   + S      ++  LDLS N  +     +L   T L  LNL
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           SSN L       + S+  L  LD++NN ++     E+     ++ L+ ++N +S
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 81.0 bits (200), Expect = 7e-17
 Identities = 27/138 (19%), Positives = 54/138 (39%), Gaps = 11/138 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++     L  L++ SN L   +   L  L+ L  LDL+ N     +         +  L+
Sbjct: 53  DLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELLV----GPSIETLH 105

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVP 119
            ++N +S ++       +    + ++NNKI      +    SR+ YL+L  N++      
Sbjct: 106 AANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 120 FSNEQLSSMYIVRLSPNK 137
                  ++  + L  N 
Sbjct: 163 ELAASSDTLEHLNLQYNF 180

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 18/94 (19%), Positives = 38/94 (40%), Gaps = 2/94 (2%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           I              ++ +    ++ +       +  L+LS N LS    + +A    L 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            L++S+N +      ++  LS L  L+L++N + 
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 20/85 (23%), Positives = 38/85 (44%), Gaps = 2/85 (2%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
                   ++ + L   + S   S  N+  LD+S N +      ++   ++L+ LNLSSN
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
            L   +   +  LS++  + L+ N 
Sbjct: 69  VLYETLDLES--LSTLRTLDLNNNY 91

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 14/165 (8%), Positives = 37/165 (22%), Gaps = 30/165 (18%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E  +   +  + + +N L+  I   L    +L + DL  N F+     +  +        
Sbjct: 209 EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQT 266

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIE----------------------------G 92
           ++   +              T         E                             
Sbjct: 267 VAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETE 326

Query: 93  SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
            +  E    +R   ++    +    +     +  +   +      
Sbjct: 327 RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKA 371

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 13/155 (8%), Positives = 32/155 (20%), Gaps = 27/155 (17%)

Query: 1   EIGNLKNLIELDVGSNSL-IGPIPSTLGLLTDLSYLDLSRNQ------------------ 41
            +   +NL   D+  N    G +         +  +     +                  
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 42  -FNSSIPNELTWLTGLLGLNLSSNKL-------SGKIPSQIASMKNLTWLDISNNKIEGS 93
                      +   L+ L    + L       + ++  +  +      +D    +    
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTV 351

Query: 94  IPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSM 128
           I            L      L   V       + +
Sbjct: 352 IDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 10/68 (14%), Positives = 25/68 (36%)

Query: 70  IPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMY 129
           I     +        ++++ ++ ++         +  L+LS N LS          + + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 130 IVRLSPNK 137
           ++ LS N 
Sbjct: 62  LLNLSSNV 69

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.4 bits (97), Expect = 4e-04
 Identities = 14/122 (11%), Positives = 29/122 (23%), Gaps = 8/122 (6%)

Query: 1   EIGNLKNLIELDVGSNSL-------IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL 53
                  LI L    ++L          +            +D  + Q+ + I       
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359

Query: 54  TGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNK 113
              + L      L  ++ +   +   L          +  +     E S L  L     +
Sbjct: 360 QAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKR 418

Query: 114 LS 115
             
Sbjct: 419 YE 420

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 8/149 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG V+K +    G++ A+KK   SE + +    + R E ++L Q+ H N+V L  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLE 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
               ++ + L++EY +  ++   L   +  V     K  +I      A+ + H     + 
Sbjct: 70  VFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH---KHNC 123

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLL 374
           IHRD+   NIL+       + DFG ARLL
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLL 152

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 37/170 (21%), Positives = 74/170 (43%), Gaps = 26/170 (15%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +G G +G V+ A+  N         V A+K L  +        + F+ EA++L+ + H++
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAELLTMLQHQH 104

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSL------------FCNLHNNEDAVELDWAKRVNIV 327
           IV+ +G C   + + +++EYM  G L                  +     L   + + + 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
             +A  + YL        +HRD+++ N L+       + DFG +R +++ 
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 227 IGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL 276
           +G G +G V  A+               A+K L    +E +    +     E +++  + 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIG 98

Query: 277 -HRNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAK 322
            H+NI+ L G C     +++I EY  +G+L             +    N     ++ +  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++  
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 38/182 (20%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVLH 277
           +G G +G V KA   +         V A+K L  + S +E    +     E  VL QV H
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPSELRDLLS----EFNVLKQVNH 85

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSL---------------------FCNLHNNEDAV 316
            +++KLYG C     + LI EY + GSL                       +  ++ D  
Sbjct: 86  PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
            L     ++    ++  + YL       ++HRD+++ NIL+    +  ++DFG +R ++ 
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 377 DS 378
           + 
Sbjct: 203 ED 204

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 7/146 (4%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           IG G YG VYKAQ   G+ FALKK+   + +E     + R E  +L ++ H NIVKLY  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYDV 68

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
              +K + L++E++++  L   L   E  +E   AK  + +  + + +AY H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDRR---VL 122

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+   N+L+N + E  +ADFG AR
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 31/176 (17%)

Query: 227 IGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL 276
           +G G +G V  A+               A+K L    +E +    +     E +++  + 
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS----EMEMMKMIG 144

Query: 277 -HRNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAK 322
            H+NI+ L G C     +++I EY  +G+L             +    N     ++ +  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR ++   
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.3 bits (217), Expect = 2e-20
 Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 3/115 (2%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I  L NL  L +    +       L  LT L+ LD+S +  + SI  ++  L  +  ++L
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG 116
           S N     I   + ++  L  L+I  + +       I +  +L+ L   S  + G
Sbjct: 144 SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 82.3 bits (204), Expect = 1e-18
 Identities = 23/136 (16%), Positives = 50/136 (36%), Gaps = 5/136 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I    N+ +L + +        + +  L++L  L +      S     L+ LT L  L++
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S +     I ++I ++  +  +D+S N     I   +  L  L  LN+  + +       
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE 178

Query: 122 NEQLSSMYIVRLSPNK 137
           +     +  +      
Sbjct: 179 D--FPKLNQLYAFSQT 192

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.7 bits (192), Expect = 6e-17
 Identities = 21/138 (15%), Positives = 62/138 (44%), Gaps = 7/138 (5%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               + +L  + + + + +  + + +    ++  L ++     +  P  ++ L+ L  L 
Sbjct: 39  TEAQMNSLTYITLANIN-VTDL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN-KLSGPVP 119
           +    ++      ++ + +LT LDIS++  + SI  +I  L +++ ++LS N  ++  +P
Sbjct: 95  IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154

Query: 120 FSNEQLSSMYIVRLSPNK 137
                L  +  + +  + 
Sbjct: 155 LKT--LPELKSLNIQFDG 170

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 73.1 bits (180), Expect = 3e-15
 Identities = 22/136 (16%), Positives = 52/136 (38%), Gaps = 7/136 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
             K  +   +G +S    I  T   +  L+Y+ L+     + +   + +   +  L +++
Sbjct: 21  TFKAYLNGLLGQSS-TANI--TEAQMNSLTYITLANINV-TDLTG-IEYAHNIKDLTINN 75

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE 123
              +    + I+ + NL  L I    +       ++ L+ L  L++S +     +     
Sbjct: 76  IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 124 QLSSMYIVRLSPNKGL 139
            L  +  + LS N  +
Sbjct: 134 TLPKVNSIDLSYNGAI 149

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 43/137 (31%), Positives = 71/137 (51%), Gaps = 10/137 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + +L NL +LD+ +N +    P  L  LT L+ L L  NQ ++  P  L  LT L  L 
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLE 293

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L+ N+L    P  I+++KNLT+L +  N I    P  ++ L++L  L   +NK+S     
Sbjct: 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSL 349

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N  L+++  +    N+
Sbjct: 350 AN--LTNINWLSAGHNQ 364

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 45/137 (32%), Positives = 73/137 (53%), Gaps = 10/137 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + NL  L  LD+ SN +     S L  LT+L  L  + NQ +   P  L  LT L  L+
Sbjct: 172 PLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 227

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L+ N+L       +AS+ NLT LD++NN+I    P  ++ L++L  L L +N++S   P 
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 283

Query: 121 SNEQLSSMYIVRLSPNK 137
           +   L+++  + L+ N+
Sbjct: 284 AG--LTALTNLELNENQ 298

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 29/136 (21%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L   ++  +G  ++   +      L  ++ L   R    S   + + +L  L  +N 
Sbjct: 20  DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S+N+L+   P  + ++  L  + ++NN+I    P  +  L+ L  L L +N+++   P  
Sbjct: 76  SNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLK 131

Query: 122 NEQLSSMYIVRLSPNK 137
           N  L+++  + LS N 
Sbjct: 132 N--LTNLNRLELSSNT 145

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 38/137 (27%), Positives = 66/137 (48%), Gaps = 11/137 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            + NL  L+++ + +N +    P  L  LT+L+ L L  NQ     P  L  LT L  L 
Sbjct: 85  PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LSSN +S    S ++ + +L  L   N   +      +  L+ L+ L++SSNK+S     
Sbjct: 141 LSSNTISD--ISALSGLTSLQQLSFGNQVTDLK---PLANLTTLERLDISSNKVSDISVL 195

Query: 121 SNEQLSSMYIVRLSPNK 137
           +   L+++  +  + N+
Sbjct: 196 AK--LTNLESLIATNNQ 210

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 8/126 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +  L  L  L++  N L    P  +  L +L+YL L  N  +   P  ++ LT L  L 
Sbjct: 282 PLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF 337

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
             +NK+S    S +A++ N+ WL   +N+I    P  +  L+R+  L L+    +     
Sbjct: 338 FYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVN 393

Query: 121 SNEQLS 126
               +S
Sbjct: 394 YKANVS 399

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 32/121 (26%), Positives = 57/121 (47%), Gaps = 8/121 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             +L  +  L      +       +  L +L+ ++ S NQ     P  L  LT L+ + +
Sbjct: 42  QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILM 97

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           ++N+++   P  +A++ NLT L + NN+I    P  +  L+ L+ L LSSN +S     S
Sbjct: 98  NNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS 153

Query: 122 N 122
            
Sbjct: 154 G 154

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 81.5 bits (202), Expect = 5e-17
 Identities = 28/122 (22%), Positives = 52/122 (42%), Gaps = 6/122 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            I NLKNL  L +  N++    P  +  LT L  L    N+ +    + L  LT +  L+
Sbjct: 304 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLS 359

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
              N++S   P  +A++  +T L +++     +       +S  + +   +  L  P   
Sbjct: 360 AGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATI 417

Query: 121 SN 122
           S+
Sbjct: 418 SD 419

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 80.8 bits (200), Expect = 8e-17
 Identities = 38/137 (27%), Positives = 69/137 (50%), Gaps = 11/137 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +  L NL +++  +N L    P  L  LT L  + ++ NQ     P  L  LT L GL 
Sbjct: 63  GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L +N+++   P  + ++ NL  L++S+N I       ++ L+ L  L+   N+++   P 
Sbjct: 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKPL 173

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N  L+++  + +S NK
Sbjct: 174 AN--LTTLERLDISSNK 188

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 24/130 (18%), Positives = 55/130 (42%), Gaps = 9/130 (6%)

Query: 8   LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS 67
           L    +  ++ I  I  T   L +     L +     ++    T L  +  L      + 
Sbjct: 3   LGSATITQDTPINQI-FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK 59

Query: 68  GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
                 +  + NLT ++ SNN++    P  +  L++L  + +++N+++   P +N  L++
Sbjct: 60  --SIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN--LTN 113

Query: 128 MYIVRLSPNK 137
           +  + L  N+
Sbjct: 114 LTGLTLFNNQ 123

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 7/146 (4%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGF 286
           +G G YG VYKA+   G++ ALK++     +E     + R E  +L ++ H NIV L   
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR-EISLLKELHHPNIVSLIDV 87

Query: 287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII 346
               +C+ L++E+ME+  L   L  N+  ++    K    +  +   +A+ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK--IYLYQLLRGVAHCHQHR---IL 141

Query: 347 HRDISSNNILLNSKFEAFVADFGTAR 372
           HRD+   N+L+NS     +ADFG AR
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR 167

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 31/175 (17%)

Query: 227 IGTGGYGSVYKAQLPNGKVF--------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL 276
           +G G +G V  A+               A+K L    +E +    I     E +++  + 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----EMEMMKMIG 132

Query: 277 -HRNIVKLYGFCLHRKCMFLIYEYMERGSL-------------FCNLHNNEDAVELDWAK 322
            H+NI+ L G C     +++I EY  +G+L             +    ++    +L    
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 323 RVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
            V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H  
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 90.1 bits (223), Expect = 4e-20
 Identities = 26/198 (13%), Positives = 63/198 (31%), Gaps = 38/198 (19%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQ--------------- 270
           +G     +  +A     G+ F +   + +E      IK  + E                 
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 271 ----------VLSQVLHRNIVKLYGFCLHRKCM--FLIYEYME--RGSLFCNLHNNEDAV 316
                     ++     + ++++         +  F +Y  M+    +    L ++    
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 317 E-LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
           + L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 376 ADSSNRTLLAGTYGYIAP 393
                R + + + G+  P
Sbjct: 257 ---GARVVSSVSRGFEPP 271

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 88.7 bits (221), Expect = 4e-20
 Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 21/154 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG VYKA+    G+V ALKK+      E     + R E  +L ++ H NIVKL  
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLD 69

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLH---NNEDAVELDWAKRVNIVKAMAH----ALAYLH 338
                  ++L++E++       +L    +      +     + ++K+        LA+ H
Sbjct: 70  VIHTENKLYLVFEFLH-----QDLKKFMDASALTGIP----LPLIKSYLFQLLQGLAFCH 120

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
                 ++HRD+   N+L+N++    +ADFG AR
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 32/176 (18%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL- 276
           +G G +G V +A             V A+K L    + +E  A +     E ++L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMS----ELKILIHIGH 89

Query: 277 HRNIVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM----- 330
           H N+V L G C      + +I E+ + G+L   L +  +          ++ K       
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 331 --------AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
                   A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D 
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 88.8 bits (221), Expect = 6e-20
 Identities = 45/147 (30%), Positives = 74/147 (50%), Gaps = 9/147 (6%)

Query: 227 IGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G Y +VYK +      + ALK++   E EE A   + R E  +L  + H NIV L+ 
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRL-EHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 67

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                K + L++EY+++  L   L +  + + +   K    +  +   LAY H      +
Sbjct: 68  IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK--LFLFQLLRGLAYCH---RQKV 121

Query: 346 IHRDISSNNILLNSKFEAFVADFGTAR 372
           +HRD+   N+L+N + E  +ADFG AR
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 36/180 (20%)

Query: 227 IGTGGYGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQVLSQVL-H 277
           +G+G +G V  A              A+K L      +E  A +     E ++++Q+  H
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS----ELKMMTQLGSH 108

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM------- 330
            NIV L G C     ++LI+EY   G L   L +  +    D  +  N  +         
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 331 -------------AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                        A  + +L      S +HRD+++ N+L+       + DFG AR + +D
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.0 bits (219), Expect = 8e-20
 Identities = 39/147 (26%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G YG+V+KA+     ++ ALK++   + +E     + R E  +L ++ H+NIV+L+ 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                K + L++E+ ++  L     +    ++ +  K  + +  +   L + H      +
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK--SFLFQLLKGLGFCHSRN---V 122

Query: 346 IHRDISSNNILLNSKFEAFVADFGTAR 372
           +HRD+   N+L+N   E  +A+FG AR
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR 149

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 89.7 bits (222), Expect = 8e-20
 Identities = 28/201 (13%), Positives = 60/201 (29%), Gaps = 39/201 (19%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ----------- 274
           +G     +  +A     G+ F +   + +E      IK  + E   L             
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 275 -----------VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV------- 316
                      V      K+    L  + M+++  +     +  NL    + +       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 317 -ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH 375
             L    R+ +   +   LA LH      ++H  +   +I+L+ +   F+  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260

Query: 376 ADSSNRTLLAGTYG---YIAP 393
             +S  + +   +      A 
Sbjct: 261 DGASAVSPIGRGFAPPETTAE 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 48/181 (26%), Positives = 75/181 (41%), Gaps = 27/181 (14%)

Query: 224 KYCIGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIV 281
           K  +G G  G V +      G+  ALK L+ S           R E     Q     +IV
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--------PKARQEVDHHWQASGGPHIV 85

Query: 282 KLYGFC----LHRKCMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKAMAHALA 335
            +          ++C+ +I E ME G LF  +    D    E + A+   I++ +  A+ 
Sbjct: 86  CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE---IMRDIGTAIQ 142

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGTYGYIA 392
           +LH   S +I HRD+   N+L  SK +     + DFG A+    ++        T  Y+A
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVA 197

Query: 393 P 393
           P
Sbjct: 198 P 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 88.5 bits (220), Expect = 9e-20
 Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 16/153 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG VYKA      +  A+K++     EE     + R E  +L ++ HRNI++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKS 100

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPS 344
              H   + LI+EY E      +L    +   ++      + +  + + + + H   S  
Sbjct: 101 VIHHNHRLHLIFEYAE-----NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRR 152

Query: 345 IIHRDISSNNILLNSKFEAF-----VADFGTAR 372
            +HRD+   N+LL+    +      + DFG AR
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 50/177 (28%), Positives = 71/177 (40%), Gaps = 33/177 (18%)

Query: 227 IGTGGYGSVYKAQLPNG-------KVFALKKL--HTSETEELAFIKSFRNEAQVLSQVL- 276
           +G G +G V +A             V A+K L      TE  A +     E +VLS +  
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLTEREALMS----ELKVLSYLGN 85

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSL---------------FCNLHNNEDAVELDWA 321
           H NIV L G C       +I EY   G L                      +D + LD  
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
             ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 47/176 (26%), Positives = 81/176 (46%), Gaps = 11/176 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +++   IG G +G V   +     KV+A+K L   E  + +    F  E  +++      
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYLH 338
           +V+L+      + ++++ EYM  G L   + N +  V   WA+      A +  AL  +H
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--VPEKWAR---FYTAEVVLALDAIH 185

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYIAP 393
              S   IHRD+  +N+LL+      +ADFGT   ++ +   R     GT  YI+P
Sbjct: 186 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 21/182 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F     +G G + +V  A+     + +A+K L      +   +     E  V+S++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHA 333
            VKLY      + ++    Y + G L   +               +          +  A
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK---------IGSFDETCTRFYTAEIVSA 142

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN-RTL-LAGTYGYI 391
           L YLH      IIHRD+   NILLN      + DFGTA++L  +S   R     GT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 392 AP 393
           +P
Sbjct: 200 SP 201

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 36/180 (20%)

Query: 227 IGTGGYGSVYKAQLPNGKVF------ALKKL--HTSETEELAFIKSFRNEAQVLSQVLHR 278
           IG G +G V++A+ P    +      A+K L    S   +  F +    EA ++++  + 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----EAALMAEFDNP 110

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM-------- 330
           NIVKL G C   K M L++EYM  G L   L +         +      +A         
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 331 -------------AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
                        A  +AYL        +HRD+++ N L+       +ADFG +R +++ 
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 41/150 (27%), Positives = 71/150 (47%), Gaps = 11/150 (7%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEAQVLSQVLHRNIVK 282
           +G G + +VYKA+     ++ A+KK+      E        + R E ++L ++ H NI+ 
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIG 76

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
           L     H+  + L++++ME   L   + +N   +     K    +      L YLH    
Sbjct: 77  LLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIK--AYMLMTLQGLEYLHQH-- 131

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             I+HRD+  NN+LL+      +ADFG A+
Sbjct: 132 -WILHRDLKPNNLLLDENGVLKLADFGLAK 160

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 41/165 (24%), Positives = 79/165 (47%), Gaps = 20/165 (12%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
             ++    IG G +G V+KA+    G+  ALKK+     +E   I + R E ++L  + H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKH 75

Query: 278 RNIVKLYG--------FCLHRKCMFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIV 327
            N+V L          +   +  ++L++++ E     L  N+      V+   ++   ++
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVM 130

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           + + + L Y+H +    I+HRD+ + N+L+       +ADFG AR
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 29/115 (25%), Positives = 47/115 (40%), Gaps = 6/115 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
            L+ L   + G  +  G   +       L  LDLS N    +       W + L  LNLS
Sbjct: 202 TLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLS 261

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
              L  ++P  + +   L+ LD+S N+++   P    EL ++  L+L  N     
Sbjct: 262 FTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 27/119 (22%), Positives = 40/119 (33%), Gaps = 8/119 (6%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT----WLTGLLGLN 60
              L  L +     +      + +   LS LDLS N                   L  L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 61  LSSNK---LSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
           L +      SG   +  A+   L  LD+S+N +  +         S+L+ LNLS   L 
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 28/157 (17%), Positives = 47/157 (29%), Gaps = 17/157 (10%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGL----LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
             +L  L++ + S          L       L  L +++    +    ++     L  L+
Sbjct: 120 GPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179

Query: 61  LSSNKLSGKIPSQIA----SMKNLTWLDISNNK---IEGSIPGEITELSRLDYLNLSSNK 113
           LS N   G+     A        L  L + N       G          +L  L+LS N 
Sbjct: 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNS 239

Query: 114 LSG-PVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
           L       S +  S +  + LS           +P  
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTG-----LKQVPKG 271

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 27/144 (18%), Positives = 46/144 (31%), Gaps = 10/144 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTG--LLGLNL 61
           +LK L        S I      +  ++ L  L L   +   + P  L   TG  L  LNL
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 62  SSNKLSGKIPS----QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
            +   + +       Q      L  L I+          ++     L  L+LS N   G 
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 118 VPFSNE----QLSSMYIVRLSPNK 137
               +     +  ++ ++ L    
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAG 212

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 32/136 (23%), Positives = 58/136 (42%), Gaps = 7/136 (5%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             +L +L  L +  N +          L+ L  L        S     +  L  L  LN+
Sbjct: 72  YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

Query: 62  SSNKL-SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDY----LNLSSNKLSG 116
           + N + S K+P   +++ NL  LD+S+NKI+     ++  L ++      L+LS N ++ 
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 117 --PVPFSNEQLSSMYI 130
             P  F   +L  + +
Sbjct: 192 IQPGAFKEIRLHKLTL 207

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 37/139 (26%), Positives = 60/139 (43%), Gaps = 2/139 (1%)

Query: 1   EIGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
               L+ L  LD   ++L      S    L +L YLD+S      +       L+ L  L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450

Query: 60  NLSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
            ++ N         I   ++NLT+LD+S  ++E   P     LS L  LN++SN+L    
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510

Query: 119 PFSNEQLSSMYIVRLSPNK 137
               ++L+S+  + L  N 
Sbjct: 511 DGIFDRLTSLQKIWLHTNP 529

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.8 bits (210), Expect = 5e-18
 Identities = 32/120 (26%), Positives = 51/120 (42%), Gaps = 6/120 (5%)

Query: 4   NLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +L +L  LD+  N L   G    +    T L YLDLS N    ++ +    L  L  L+ 
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDF 403

Query: 62  SSNKLSGKIPSQIA--SMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
             + L  ++       S++NL +LDIS+     +  G    LS L+ L ++ N       
Sbjct: 404 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.4 bits (209), Expect = 6e-18
 Identities = 30/132 (22%), Positives = 51/132 (38%), Gaps = 1/132 (0%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           +   LD+  N L      +     +L  LDLSR +  +        L+ L  L L+ N +
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 67  SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL-SGPVPFSNEQL 125
                   + + +L  L      +       I  L  L  LN++ N + S  +P     L
Sbjct: 89  QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148

Query: 126 SSMYIVRLSPNK 137
           +++  + LS NK
Sbjct: 149 TNLEHLDLSSNK 160

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 33/133 (24%), Positives = 55/133 (41%), Gaps = 1/133 (0%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            +   L  LD+    +          L+ LS L L+ N   S      + L+ L  L   
Sbjct: 49  FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKI-EGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
              L+      I  +K L  L++++N I    +P   + L+ L++L+LSSNK+       
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168

Query: 122 NEQLSSMYIVRLS 134
              L  M ++ LS
Sbjct: 169 LRVLHQMPLLNLS 181

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 30/131 (22%), Positives = 47/131 (35%), Gaps = 6/131 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           IP    L      LDLS N               L  L+LS  ++         S+ +L+
Sbjct: 22  IPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK---- 137
            L ++ N I+    G  + LS L  L      L+    F    L ++  + ++ N     
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 138 GLCGNFSALPS 148
            L   FS L +
Sbjct: 140 KLPEYFSNLTN 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 4/116 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            L +L  L +  NS            L +L++LDLS+ Q     P     L+ L  LN++
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           SN+L          + +L  + +  N  + S P  I  LSR  +LN +S K  G  
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-IDYLSR--WLNKNSQKEQGSA 555

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 36/158 (22%), Positives = 62/158 (39%), Gaps = 17/158 (10%)

Query: 1   EIGNLKNLIELDVGSNSL------IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLT 54
           +   L+ L  L +    L      +  I      LT++S   L        + +  ++  
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKD-FSYNF 304

Query: 55  GLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           G   L L + K     P+    +K+L  L  ++NK   +      +L  L++L+LS N L
Sbjct: 305 GWQHLELVNCKFGQ-FPTL--KLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGL 359

Query: 115 S--GPVPFSNEQLSSMYIVRLSPNK--GLCGNFSALPS 148
           S  G    S+   +S+  + LS N    +  NF  L  
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 397

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 32/180 (17%), Positives = 56/180 (31%), Gaps = 18/180 (10%)

Query: 2   IGNLKNL----IELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-------L 50
           +  L  +    + LD+  N +   I         L  L L  N  + ++          L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227

Query: 51  TWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGS---IPGEITELSRLDYL 107
                +LG   +   L     S +  + NLT  +     ++     I      L+ +   
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287

Query: 108 NLSSNKLSGPVPFS-NEQLSSMYIVRLSPNKGLCGNFSALPSCDAT--KPATLFVEIFLP 164
           +L S  +     FS N     + +V     +       +L     T  K    F E+ LP
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 347

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 46.6 bits (111), Expect = 9e-06
 Identities = 24/93 (25%), Positives = 39/93 (41%), Gaps = 3/93 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L+NL  LD+    L    P+    L+ L  L+++ NQ  S        LT L  + L
Sbjct: 466 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSI 94
            +N        +I  +    WL+ ++ K +GS 
Sbjct: 526 HTNPWDC-SCPRIDYLSR--WLNKNSQKEQGSA 555

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.5 bits (209), Expect = 4e-18
 Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 24/166 (14%)

Query: 223 IKYCIGTGGYGSVYKAQ---LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
               +G G YG VYKA+     + K +ALK++     E      S   E  +L ++ H N
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-----EGTGISMSACREIALLRELKHPN 79

Query: 280 IVKLYGFCLHR--KCMFLIYEYMERGSL--FCNLHNNEDAVELDWAKRVNIVKAMAH--- 332
           ++ L    L    + ++L+++Y E   L      H    A +        +VK++ +   
Sbjct: 80  VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138

Query: 333 -ALAYLHHDCSPSIIHRDISSNNILLNSKFEAF----VADFGTARL 373
             + YLH +    ++HRD+   NIL+  +        +AD G ARL
Sbjct: 139 DGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 32/146 (21%), Positives = 57/146 (39%), Gaps = 7/146 (4%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
                L  L +  N+L     + L     L  +DLS N+    + +    +  L  L +S
Sbjct: 223 PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 280

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           +N+L   +      +  L  LD+S+N +   +     +  RL+ L L  N +   +  S 
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST 337

Query: 123 EQLSSMYIVRLSPNKGLCGNFSALPS 148
               ++  + LS N   C +  AL  
Sbjct: 338 --HHTLKNLTLSHNDWDCNSLRALFR 361

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 31/138 (22%), Positives = 62/138 (44%), Gaps = 13/138 (9%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++  + +L   +V  N L     STL +   +  LD S N   + +   +     L  L 
Sbjct: 181 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVRGPV--NVELTILK 232

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP 119
           L  N L+    + + +   L  +D+S N++E  I      ++ RL+ L +S+N+L   + 
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LN 288

Query: 120 FSNEQLSSMYIVRLSPNK 137
              + + ++ ++ LS N 
Sbjct: 289 LYGQPIPTLKVLDLSHNH 306

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 28/147 (19%), Positives = 61/147 (41%), Gaps = 4/147 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L N   +   ++++     + L     +  L+L+  Q          +   +  L +  
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFS 121
           N +   +P  +  ++  LT L +  N +  S+P  I     +L  L++S+N L      +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPS 148
            +  +S+  ++LS N+    + S +PS
Sbjct: 161 FQATTSLQNLQLSSNRLTHVDLSLIPS 187

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 7/137 (5%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            + + +  L++    +             +  L +  N      P+    +  L  L L 
Sbjct: 66  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPF 120
            N LS  +P  I  +   LT L +SNN +E  I  +     + L  L LSSN+L+  V  
Sbjct: 126 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDL 182

Query: 121 SNEQLSSMYIVRLSPNK 137
           S   + S++   +S N 
Sbjct: 183 SL--IPSLFHANVSYNL 197

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 5/114 (4%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
                + +L +G N++    P     +  L+ L L RN  +S           L  L++S
Sbjct: 90  AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 149

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           +N L  +I      +  +L  L +S+N++   +   ++ +  L + N+S N LS
Sbjct: 150 NNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 199

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 19/132 (14%), Positives = 40/132 (30%), Gaps = 4/132 (3%)

Query: 8   LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS 67
             ++ +   +           L +   +    +         L     +  LNL+  ++ 
Sbjct: 23  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82

Query: 68  GKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFSNEQL 125
            +I +   A    +  L +  N I   +P  +   +  L  L L  N LS          
Sbjct: 83  -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNT 140

Query: 126 SSMYIVRLSPNK 137
             +  + +S N 
Sbjct: 141 PKLTTLSMSNNN 152

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 15/117 (12%), Positives = 39/117 (33%), Gaps = 2/117 (1%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           I S L        + +     +     E   L     +   ++ +     + + S + + 
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72

Query: 82  WLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
            L++++ +IE  I          +  L +  N +    P   + +  + ++ L  N 
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 10/100 (10%), Positives = 35/100 (35%), Gaps = 2/100 (2%)

Query: 39  RNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI 98
           R      I + L +      +++           +  ++ N   +   N+ +   +P  +
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64

Query: 99  -TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
                +++ LNL+  ++     ++     ++  + +  N 
Sbjct: 65  LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 104

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 17/90 (18%), Positives = 27/90 (30%), Gaps = 6/90 (6%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               +  L  LD+  N L+  +         L  L L  N    ++         L  L 
Sbjct: 290 YGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSI-VTLKLST--HHTLKNLT 345

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKI 90
           LS N       S  A  +N+    + +   
Sbjct: 346 LSHNDWDC--NSLRALFRNVARPAVDDADQ 373

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.1 bits (203), Expect = 7e-18
 Identities = 17/152 (11%), Positives = 48/152 (31%), Gaps = 17/152 (11%)

Query: 226 CIGTGGYGSVYKA---QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
             G       ++A    L   +  AL  +          ++   +    LS++    + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE--LDWAKRVNIVKAMAHALAYLHHD 340
           +      R    ++ E++  GSL       ++  +        +  ++++A A    H  
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSL-------QEVADTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
               +       + + ++   +  +A   T  
Sbjct: 149 ---GVALSIDHPSRVRVSIDGDVVLAYPATMP 177

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 84.2 bits (208), Expect = 7e-18
 Identities = 33/147 (22%), Positives = 56/147 (38%), Gaps = 9/147 (6%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
                L  L +  N+L     + L     L  +DLS N+    I       +  L  L +
Sbjct: 229 PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYI 285

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S+N+L   +      +  L  LD+S+N +   +     +  RL+ L L  N +   +  S
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS 342

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPS 148
                ++  + LS N   C +  AL  
Sbjct: 343 T--HHTLKNLTLSHNDWDCNSLRALFR 367

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 30/137 (21%), Positives = 62/137 (45%), Gaps = 11/137 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++  + +L   +V  N L     STL +   +  LD S N   + +   +     L  L 
Sbjct: 187 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVRGPV--NVELTILK 238

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L  N L+    + + +   L  +D+S N++E  +     ++ RL+ L +S+N+L   +  
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNL 295

Query: 121 SNEQLSSMYIVRLSPNK 137
             + + ++ ++ LS N 
Sbjct: 296 YGQPIPTLKVLDLSHNH 312

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 28/147 (19%), Positives = 61/147 (41%), Gaps = 4/147 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L N   +   ++++     + L     +  L+L+  Q          +   +  L +  
Sbjct: 49  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFS 121
           N +   +P  +  ++  LT L +  N +  S+P  I     +L  L++S+N L      +
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 166

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPS 148
            +  +S+  ++LS N+    + S +PS
Sbjct: 167 FQATTSLQNLQLSSNRLTHVDLSLIPS 193

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 73.0 bits (179), Expect = 4e-14
 Identities = 32/138 (23%), Positives = 54/138 (39%), Gaps = 9/138 (6%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
            + + +  L++    +             +  L +  N     +P      +  L  L L
Sbjct: 72  DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLPPHVFQNVPLLTVLVL 130

Query: 62  SSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP 119
             N LS  +P  I  +   LT L +SNN +E  I  +     + L  L LSSN+L+  V 
Sbjct: 131 ERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VD 187

Query: 120 FSNEQLSSMYIVRLSPNK 137
            S   + S++   +S N 
Sbjct: 188 LSL--IPSLFHANVSYNL 203

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 26/114 (22%), Positives = 50/114 (43%), Gaps = 5/114 (4%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
                + +L +G N++    P     +  L+ L L RN  +S           L  L++S
Sbjct: 96  AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMS 155

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           +N L  +I      +  +L  L +S+N++   +   ++ +  L + N+S N LS
Sbjct: 156 NNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS 205

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 17/110 (15%), Positives = 35/110 (31%), Gaps = 4/110 (3%)

Query: 8   LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS 67
             ++ +   +           L +   +    +         L     +  LNL+  ++ 
Sbjct: 29  FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 88

Query: 68  GKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
            +I +   A    +  L +  N I   +P  +   +  L  L L  N LS
Sbjct: 89  -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 136

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 19/120 (15%), Positives = 43/120 (35%), Gaps = 8/120 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           I S L        + +     +     E   L     +   ++ +  K+P+ +  S + +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSG--PVPFSNEQLSSMYIVRLSPNK 137
             L++++ +IE  I          +  L +  N +    P  F N  +  + ++ L  N 
Sbjct: 78  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN--VPLLTVLVLERND 134

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 11/107 (10%), Positives = 36/107 (33%), Gaps = 2/107 (1%)

Query: 32  LSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIE 91
             Y    R      I + L +      +++           +  ++ N   +   N+ + 
Sbjct: 5   QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR 64

Query: 92  GSIPGEI-TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
             +P  +     +++ LNL+  ++     ++     ++  + +  N 
Sbjct: 65  -KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA 110

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 43/160 (26%), Positives = 71/160 (44%), Gaps = 22/160 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAF---IKSFRNEA---QVLSQVLHRN 279
           IG G YG+VYKA+   +G   ALK +             I + R E    + L    H N
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75

Query: 280 IVKLYGFCLHRKC-----MFLIYEYMER--GSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           +V+L   C   +      + L++E++++   +      +      L      ++++    
Sbjct: 76  VVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----DKAPPPGLPAETIKDLMRQFLR 131

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            L +LH +C   I+HRD+   NIL+ S     +ADFG AR
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 81.7 bits (202), Expect = 4e-17
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 42/181 (23%)

Query: 222 DIKYC----IGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ Y     IG G +G VY+A+L  +G++ A+KK+   +  +       R E Q++ ++ 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------R-ELQIMRKLD 105

Query: 277 HRNIVKLYGFCLHR------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           H NIV+L  F            + L+ +Y+        ++            R      +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYR-----VARHYSRAKQTLPV 155

Query: 331 AH----------ALAYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSS 379
            +          +LAY+H   S  I HRDI   N+LL+       + DFG+A+ L     
Sbjct: 156 IYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 380 N 380
           N
Sbjct: 213 N 213

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 16/129 (12%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               L  L   +    SL    P+   L + L  L +S N+  +S+P   + L  L    
Sbjct: 199 LPSELYKLWAYNNRLTSL----PA---LPSGLKELIVSGNRL-TSLPVLPSELKEL---M 247

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           +S N+L+  +P   +    L  L +  N++   +P  +  LS    +NL  N LS     
Sbjct: 248 VSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302

Query: 121 SNEQLSSMY 129
           +  +++S  
Sbjct: 303 ALREITSAP 311

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 30/130 (23%), Positives = 52/130 (40%), Gaps = 20/130 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
               L  L         L         L + L  L +  NQ  +S+P     L     L+
Sbjct: 99  LPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQL-TSLPVLPPGLQ---ELS 147

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           +S N+L+  +P+  +    L  L   NN++  S+P      S L  L++S N+L+  +P 
Sbjct: 148 VSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLP---MLPSGLQELSVSDNQLAS-LPT 198

Query: 121 SNEQLSSMYI 130
              +L  ++ 
Sbjct: 199 LPSELYKLWA 208

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 24/126 (19%), Positives = 44/126 (34%), Gaps = 16/126 (12%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
                 L+VG + L   +P  L     ++ L +  N    S+P     L     L +S N
Sbjct: 39  NNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPALPPELR---TLEVSGN 91

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
           +L+  +P     +  L+        +           S L  L +  N+L+  +P     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPVLPPG 142

Query: 125 LSSMYI 130
           L  + +
Sbjct: 143 LQELSV 148

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 17/88 (19%), Positives = 36/88 (40%), Gaps = 8/88 (9%)

Query: 28  LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISN 87
           L    + L++  +   +++P+ L     +  L +  N L+  +P+       L  L++S 
Sbjct: 38  LNNGNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPP---ELRTLEVSG 90

Query: 88  NKIEGSIPGEITELSRLDYLNLSSNKLS 115
           N++  S+P     L  L   +     L 
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP 117

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 21/125 (16%), Positives = 50/125 (40%), Gaps = 9/125 (7%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
              L EL V  N L   +P     L     L +S N+  +S+P   + L  L   ++  N
Sbjct: 220 PSGLKELIVSGNRLTS-LPVLPSELK---ELMVSGNRL-TSLPMLPSGLLSL---SVYRN 271

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQ 124
           +L+ ++P  +  + + T +++  N +       + E++     +    +       +  +
Sbjct: 272 QLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRE 330

Query: 125 LSSMY 129
             +++
Sbjct: 331 TRALH 335

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 6/108 (5%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN 64
              L+ L V  N L   +P +L  L+  + ++L  N  +      L  +T   G +    
Sbjct: 260 PSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPII 318

Query: 65  KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           +      S     + L  L  ++      +P    E +  D  ++   
Sbjct: 319 RFDMAGASAPRETRAL-HLAAADWL----VPAREGEPAPADRWHMFGQ 361

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 6/137 (4%)

Query: 3   GNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGL 59
           G+L  L  L +  N L  +  I      +  L  LD+S+N  +        +W   LL L
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           N+SSN L+  I   +     +  LD+ +NKI+ SIP ++ +L  L  LN++SN+L     
Sbjct: 405 NMSSNILTDTIFRCLPP--RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPD 461

Query: 120 FSNEQLSSMYIVRLSPN 136
              ++L+S+  + L  N
Sbjct: 462 GIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 34/157 (21%), Positives = 49/157 (31%), Gaps = 6/157 (3%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           I +L  L  L +  N +     S      +L YLDLS N+    I         L  L+L
Sbjct: 41  ILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDL 97

Query: 62  SSNKL-SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           S N   +  I  +  +M  L +L +S   +E S    I  L+    L +           
Sbjct: 98  SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP 157

Query: 121 SNEQLSSMYIVRLSPNKGLCGNFSALPSCDATKPATL 157
               L       L         F  +        A L
Sbjct: 158 EG--LQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 26/149 (17%), Positives = 58/149 (38%), Gaps = 5/149 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           +LK L    V S+    P      + ++++  + + +          + ++  L L+ S+
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIP---GEITELSRLDYLNLSSNKLSGPVPF 120
           N L+  +      +  L  L +  N+++  +       T++  L  L++S N +S     
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392

Query: 121 SN-EQLSSMYIVRLSPNKGLCGNFSALPS 148
            +     S+  + +S N      F  LP 
Sbjct: 393 GDCSWTKSLLSLNMSSNILTDTIFRCLPP 421

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 35/151 (23%), Positives = 59/151 (39%), Gaps = 7/151 (4%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK 65
           +    L++  N +     S +  L+ L  L +S N+      +   +   L  L+LS NK
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80

Query: 66  LSGKIPSQIASMKNLTWLDISNNKIEGSIP--GEITELSRLDYLNLSSNKLSGPVPFSNE 123
           L  KI        NL  LD+S N  + ++P   E   +S+L +L LS+  L         
Sbjct: 81  LV-KISCH--PTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136

Query: 124 QLSSMYIV-RLSPNKGLCGNFSALPSCDATK 153
            L+   ++  L    G   +   L   +   
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTES 167

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 32/139 (23%), Positives = 58/139 (41%), Gaps = 11/139 (7%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI 70
           +D   N LI  +P    L    + L++S+N  +    +++  L+ L  L +S N++    
Sbjct: 5   VDRSKNGLIH-VPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 71  PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS---GPVPFSNEQLSS 127
            S     + L +LD+S+NK+   I         L +L+LS N          F N  +S 
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGN--MSQ 116

Query: 128 MYIVRLSPNKGLCGNFSAL 146
           +  + LS       +   +
Sbjct: 117 LKFLGLSTTHLEKSSVLPI 135

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 29/135 (21%), Positives = 46/135 (34%), Gaps = 8/135 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS-SIPNELTWLTGLLGLNLS 62
             + L  LD+  N L   I        +L +LDLS N F++  I  E   ++ L  L LS
Sbjct: 67  FNQELEYLDLSHNKL-VKISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLS 123

Query: 63  SNKLSGKIPSQIASMKNLT-WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           +  L       IA +      L +     E   P     L   +  +L     +      
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPE---GLQDFNTESLHIVFPTNKEFHF 180

Query: 122 NEQLSSMYIVRLSPN 136
              +S   +  L  +
Sbjct: 181 ILDVSVKTVANLELS 195

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 44.5 bits (105), Expect = 4e-05
 Identities = 22/140 (15%), Positives = 46/140 (32%), Gaps = 7/140 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-----TWLTGLLG 58
            L NL   ++ +          L   T + Y  +S  +    +         T L  L  
Sbjct: 221 KLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSI 280

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
             + S+              N+   + + +          +++S   +L+ S+N L+   
Sbjct: 281 HQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD-T 339

Query: 119 PFSN-EQLSSMYIVRLSPNK 137
            F N   L+ +  + L  N+
Sbjct: 340 VFENCGHLTELETLILQMNQ 359

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 79.9 bits (198), Expect = 8e-17
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 34/165 (20%)

Query: 227 IGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL---SQVLHRNIV 281
           IG G YG V+KA+     G+  ALK++     EE   + + R E  VL       H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 77

Query: 282 KLY-----GFCLHRKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNI----VKAMA 331
           +L+             + L++E++++           D    LD      +    +K M 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-----------DLTTYLDKVPEPGVPTETIKDMM 126

Query: 332 H----ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
                 L +LH      ++HRD+   NIL+ S  +  +ADFG AR
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 80.9 bits (200), Expect = 8e-17
 Identities = 34/140 (24%), Positives = 54/140 (38%), Gaps = 9/140 (6%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI---PNELTWLTGLLGL 59
             L+ +  + V ++ +     S    L  L +LDLS N                  L  L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 60  NLSSNKLS--GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
            LS N L    K    + ++KNLT LDIS N     +P       ++ +LNLSS  +   
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV- 424

Query: 118 VPFSNEQLSSMYIVRLSPNK 137
                    ++ ++ +S N 
Sbjct: 425 --VKTCIPQTLEVLDVSNNN 442

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 26/157 (16%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
            G   +L  L +  N L  +      L  L +L+ LD+SRN F   +P+   W   +  L
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFL 415

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLD-------------- 105
           NLSS  +   + + I   + L  LD+SNN ++ S    +  L  L               
Sbjct: 416 NLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASL 471

Query: 106 -----YLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
                 + +S N+L        ++L+S+  + L  N 
Sbjct: 472 FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNP 508

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 33/147 (22%), Positives = 61/147 (41%), Gaps = 2/147 (1%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS-SIPNELTWLTGLLGLNLS 62
           +L +L  LD+  N L     S  G L+ L YL+L  N + +  + +    LT L  L + 
Sbjct: 72  SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 63  SNKLSGKIPSQ-IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           + +   +I     A + +L  L+I    +       +  +  + +L L  ++ +  +   
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPS 148
            + LSS+  + L         FS LP 
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPV 218

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 31/138 (22%), Positives = 55/138 (39%), Gaps = 2/138 (1%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +    NL  L + S+ +          L  L +LDLS N  +S   +    L+ L  LNL
Sbjct: 46  LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105

Query: 62  SSNKLSG-KIPSQIASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP 119
             N      + S   ++ NL  L I N +    I   +   L+ L+ L + +  L     
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165

Query: 120 FSNEQLSSMYIVRLSPNK 137
            S + +  ++ + L  ++
Sbjct: 166 QSLKSIRDIHHLTLHLSE 183

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 26/140 (18%), Positives = 49/140 (35%), Gaps = 2/140 (1%)

Query: 2   IGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGL 59
            G L +L  L++  N      + S    LT+L  L +   +  S I       LT L  L
Sbjct: 94  FGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            + +  L       + S++++  L +  ++    +      LS + YL L    L+    
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213

Query: 120 FSNEQLSSMYIVRLSPNKGL 139
                      ++    +G 
Sbjct: 214 SPLPVDEVSSPMKKLAFRGS 233

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 26/133 (19%), Positives = 48/133 (36%), Gaps = 2/133 (1%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
            +  LD+  N +       L    +L  L L  ++ N+   +    L  L  L+LS N L
Sbjct: 27  AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHL 86

Query: 67  SGKIPSQIASMKNLTWLDISNNKI-EGSIPGEITELSRLDYLNLSS-NKLSGPVPFSNEQ 124
           S    S    + +L +L++  N      +      L+ L  L + +    S         
Sbjct: 87  SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146

Query: 125 LSSMYIVRLSPNK 137
           L+S+  + +    
Sbjct: 147 LTSLNELEIKALS 159

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 38/143 (26%), Positives = 58/143 (40%), Gaps = 8/143 (5%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI 70
            D  S S    IPS  GL   +  LDLS N+       +L     L  L L S++++   
Sbjct: 10  CDGRSRSFTS-IPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 71  PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVPFSNEQLSSMY 129
                S+ +L  LD+S+N +          LS L YLNL  N      V      L+++ 
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126

Query: 130 IVRLSPNKGLC----GNFSALPS 148
            +R+   +        +F+ L S
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTS 149

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 19/145 (13%), Positives = 49/145 (33%), Gaps = 1/145 (0%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
              NL NL  L +G+      I       LT L+ L++      +     L  +  +  L
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHL 177

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            L  ++ +  +      + ++ +L++ +  +       +        +   + + S    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 120 FSNEQLSSMYIVRLSPNKGLCGNFS 144
            S  +L  +    L  ++    + +
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCT 262

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 32/128 (25%), Positives = 50/128 (39%), Gaps = 20/128 (15%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ---FNSSIPNELTWL------- 53
            LKNL  LD+  N+   P+P +      + +L+LS        + IP  L  L       
Sbjct: 385 TLKNLTSLDISRNT-FHPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNL 443

Query: 54  -------TGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDY 106
                    L  L +S NKL   +P   +    L  + IS N+++    G    L+ L  
Sbjct: 444 DSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQK 501

Query: 107 LNLSSNKL 114
           + L +N  
Sbjct: 502 IWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 22/158 (13%), Positives = 56/158 (35%), Gaps = 16/158 (10%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTG--------LLG 58
               L   S + +  +   +  L+++ + D + N      P+E   ++         +  
Sbjct: 231 RGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRR 290

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L++    L   + +  + ++ +  + + N+K+          L  L++L+LS N +    
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 119 PFSNE---QLSSMYIVRLSPNK-----GLCGNFSALPS 148
             ++       S+  + LS N              L +
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN 388

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 78.9 bits (195), Expect = 1e-16
 Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 35/161 (21%)

Query: 227 IGTGGYGSVYKA-QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G  G V +       + FALK L              R E ++  +     +IV++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIV 77

Query: 285 GFC----LHRKCMFLIYEYMERGSLF------CNLHNNE-DAVELDWAKRVNIVKAMAHA 333
                    RKC+ ++ E ++ G LF       +    E +A E        I+K++  A
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE--------IMKSIGEA 129

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTA 371
           + YLH   S +I HRD+   N+L  SK       + DFG A
Sbjct: 130 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 35/139 (25%), Positives = 51/139 (36%), Gaps = 9/139 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
            L  L +LD+  N+ +  +   T   L  L  L L R      +       L  L  L L
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYL 136

Query: 62  SSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS--GPV 118
             N L   +P      + NLT L +  N+I          L  LD L L  N+++   P 
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 119 PFSNEQLSSMYIVRLSPNK 137
            F +  L  +  + L  N 
Sbjct: 196 AFRD--LGRLMTLYLFANN 212

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 29/115 (25%), Positives = 50/115 (43%), Gaps = 5/115 (4%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
             +NL  L + SN L     +    L  L  LDLS N    S+       L  L  L+L 
Sbjct: 54  ACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
              L  ++   +   +  L +L + +N ++ ++P +   +L  L +L L  N++S
Sbjct: 114 RCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 3/111 (2%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
               + +  N +     ++     +L+ L L  N          T L  L  L+LS N  
Sbjct: 33  ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
              +       +  L  L +    ++  +   +   L+ L YL L  N L 
Sbjct: 93  LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 35/135 (25%), Positives = 56/135 (41%), Gaps = 4/135 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
            L  L  L +    L    P     L  L YL L  N    ++P++    L  L  L L 
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLH 161

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            N++S  +P +    + +L  L +  N++    P    +L RL  L L +N LS     +
Sbjct: 162 GNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 122 NEQLSSMYIVRLSPN 136
              L ++  +RL+ N
Sbjct: 221 LAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 23/96 (23%), Positives = 36/96 (37%), Gaps = 5/96 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P   G+      + L  N+ +            L  L L SN L+ +I +     +  L
Sbjct: 26  VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
             LD+S+N    S+       L RL  L+L    L 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ 118

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 20/106 (18%), Positives = 39/106 (36%), Gaps = 8/106 (7%)

Query: 35  LDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSI 94
               +     ++P  +        + L  N++S    +   + +NLT L + +N +    
Sbjct: 16  TSCPQQGL-QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72

Query: 95  PGEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSPNK 137
               T L+ L+ L+LS N     V    F    L  ++ + L    
Sbjct: 73  AAAFTGLALLEQLDLSDNAQLRSVDPATFHG--LGRLHTLHLDRCG 116

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 43/198 (21%)

Query: 206 DGRIVYEDLIEATEGF--DIKYC----IGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL 259
             +++     +   G   +I Y     IG G +G V++A+L      A+KK+   +  + 
Sbjct: 21  PNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN 80

Query: 260 AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KCMFLIYEYMERGSLFCNLHNNE 313
                 R E Q++  V H N+V L  F            + L+ EY+        ++   
Sbjct: 81  ------R-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYR-- 126

Query: 314 DAVELDWAKRVNIVKAMAH----------ALAYLHHDCSPSIIHRDISSNNILLNSKFEA 363
                    ++     M            +LAY+H   S  I HRDI   N+LL+     
Sbjct: 127 ---ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGV 180

Query: 364 F-VADFGTARLLHADSSN 380
             + DFG+A++L A   N
Sbjct: 181 LKLIDFGSAKILIAGEPN 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.1 bits (195), Expect = 4e-16
 Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 14/178 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F     +G GG+G V   Q+   GK++A KKL     ++        NE Q+L +V  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 280 IVKLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAV--ELDWAKRVNIVKA-MAHALA 335
           +V L  +    K  + L+   M  G L  ++++   A   E     R     A +   L 
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPE----ARAVFYAAEICCGLE 300

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            LH      I++RD+   NILL+      ++D G A  +    + +    GT GY+AP
Sbjct: 301 DLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAP 354

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 79.2 bits (195), Expect = 5e-16
 Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 16/179 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---L 276
           F +   IG GG+G VY  +    GK++A+K L     +         NE  +LS V    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 277 HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
              IV + Y F    K +  I + M  G L  +L  +    E      +    A +   L
Sbjct: 251 CPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGL 305

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            ++H   +  +++RD+   NILL+      ++D G A        +     GT+GY+AP
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SVGTHGYMAP 359

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.2 bits (193), Expect = 5e-16
 Identities = 34/134 (25%), Positives = 53/134 (39%), Gaps = 3/134 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            + +L+ LD+G    +  I       L +L YL+L        +P  LT L GL  L +S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI-KDMP-NLTPLVGLEELEMS 226

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
            N      P     + +L  L + N+++          L+ L  LNL+ N LS       
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLF 286

Query: 123 EQLSSMYIVRLSPN 136
             L  +  + L  N
Sbjct: 287 TPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 36/138 (26%), Positives = 57/138 (41%), Gaps = 9/138 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
           +L +L  L +G NS+          L  L+ L+L  N   + IP+    +L+ L  L L 
Sbjct: 97  HLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL-TVIPSGAFEYLSKLRELWLR 155

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDIS-NNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP 119
           +N +   IPS     + +L  LD+    K+E  I       L  L YLNL    +     
Sbjct: 156 NNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDMPN 213

Query: 120 FSNEQLSSMYIVRLSPNK 137
            +   L  +  + +S N 
Sbjct: 214 LTP--LVGLEELEMSGNH 229

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 34/136 (25%), Positives = 56/136 (41%), Gaps = 5/136 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
            L +L  L++  N L          L+ L  L L  N    SIP+     +  L+ L+L 
Sbjct: 121 GLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLG 179

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             K    I       + NL +L++    I+  +P  +T L  L+ L +S N      P S
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGS 237

Query: 122 NEQLSSMYIVRLSPNK 137
              LSS+  + +  ++
Sbjct: 238 FHGLSSLKKLWVMNSQ 253

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 23/96 (23%), Positives = 40/96 (41%), Gaps = 6/96 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P   G+ ++  YL+L  N       +    L  L  L L  N +  +I       + +L
Sbjct: 69  VPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
             L++ +N +   IP      LS+L  L L +N + 
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE 160

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 33/112 (29%), Positives = 42/112 (37%), Gaps = 5/112 (4%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           N   L++  N++      T   L  L  L L RN            L  L  L L  N L
Sbjct: 76  NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSS-NKLS 115
           +  IPS     +  L  L + NN IE SIP      +  L  L+L    KL 
Sbjct: 136 T-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE 185

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 35/135 (25%), Positives = 55/135 (40%), Gaps = 5/135 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            + +L  LD+G    +  I       L++L YL+L+       IP  LT L  L  L+LS
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLS 215

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            N LS  I       + +L  L +  ++I+         L  L  +NL+ N L+      
Sbjct: 216 GNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274

Query: 122 NEQLSSMYIVRLSPN 136
              L  +  + L  N
Sbjct: 275 FTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.6 bits (168), Expect = 8e-13
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 9/138 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
           +L++L  L +  N +          L +L+ L+L  N+  ++IPN    +L+ L  L L 
Sbjct: 86  HLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLR 144

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDIS-NNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP 119
           +N +   IPS     + +L  LD+    ++   I       LS L YLNL+   L     
Sbjct: 145 NNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLREIPN 202

Query: 120 FSNEQLSSMYIVRLSPNK 137
            +   L  +  + LS N 
Sbjct: 203 LTP--LIKLDELDLSGNH 218

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 5/136 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
            L NL  L++  N L          L+ L  L L  N    SIP+     +  L  L+L 
Sbjct: 110 GLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLG 168

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             K    I       + NL +L+++   +   IP  +T L +LD L+LS N LS   P S
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGS 226

Query: 122 NEQLSSMYIVRLSPNK 137
            + L  +  + +  ++
Sbjct: 227 FQGLMHLQKLWMIQSQ 242

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 27/96 (28%), Positives = 42/96 (43%), Gaps = 6/96 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P   G+ T+   L+L  NQ      N    L  L  L LS N +   I       + NL
Sbjct: 58  VPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
             L++ +N++  +IP      LS+L  L L +N + 
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE 149

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 32/112 (28%), Positives = 46/112 (41%), Gaps = 5/112 (4%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           N   L++  N +     ++   L  L  L LSRN   +        L  L  L L  N+L
Sbjct: 65  NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSS-NKLS 115
           +  IP+     +  L  L + NN IE SIP      +  L  L+L    +LS
Sbjct: 125 T-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 16/79 (20%), Positives = 33/79 (41%), Gaps = 3/79 (3%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +      L  ++P  I++  N   L++  N+I+         L  L+ L LS N +    
Sbjct: 48  VICVRKNLR-EVPDGIST--NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104

Query: 119 PFSNEQLSSMYIVRLSPNK 137
             +   L+++  + L  N+
Sbjct: 105 IGAFNGLANLNTLELFDNR 123

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 7/176 (3%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F     +G GG+G V+  Q+   GK++A KKL+    ++    +    E ++L++V  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 280 IVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHALAYL 337
           IV L  +    K  + L+   M  G +  +++N ++        R     A +   L +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H     +II+RD+   N+LL+      ++D G A  L A  +     AGT G++AP
Sbjct: 306 H---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 30/184 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NED-----AVELDWAKRVNIVKAM 330
           +VKL         ++++ EY+  G +F +L      +E      A ++            
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQI------------ 150

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYG 389
                YLH   S  +I+RD+   N+L++ +    V DFG A+ +      RT  L GT  
Sbjct: 151 VLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPE 203

Query: 390 YIAP 393
            +AP
Sbjct: 204 ALAP 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 38/187 (20%), Positives = 68/187 (36%), Gaps = 40/187 (21%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKK--LHTSETE-ELAFIKSFRNEAQV 271
           +  + F ++   G G +G+V   +    G   A+KK          EL  ++        
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQ-------D 72

Query: 272 LSQVLHRNIVKLYGFCLHRK-------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           L+ + H NIV+L  +             + ++ EY+        LH            R 
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHR-----CCRNYYRR 122

Query: 325 NIVKAMAH----------ALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARL 373
            +                ++  LH   S ++ HRDI  +N+L+N +     + DFG+A+ 
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181

Query: 374 LHADSSN 380
           L     N
Sbjct: 182 LSPSEPN 188

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 39/116 (33%), Positives = 57/116 (49%), Gaps = 6/116 (5%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT-WLTGLLG 58
              LK L  L +  N L     +      ++ L  LD+S N  NS   +    W   +L 
Sbjct: 373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV 432

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           LNLSSN L+G +   +     +  LD+ NN+I  SIP ++T L  L  LN++SN+L
Sbjct: 433 LNLSSNMLTGSVFRCLPP--KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 29/120 (24%), Positives = 57/120 (47%), Gaps = 12/120 (10%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P    L      L LS+N  +     ++++L+ L  L LS N++   +   +    ++L
Sbjct: 46  VPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDL 102

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS---GPVPFSNEQLSSMYIVRLSPNK 137
            +LD+S+N+++ +I      ++ L +L+LS N          F N  L+ +  + LS  K
Sbjct: 103 EYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGN--LTKLTFLGLSAAK 157

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 25/150 (16%), Positives = 49/150 (32%), Gaps = 7/150 (4%)

Query: 4   NLKNLIELDVGSNSLIGPIP-----STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
             + +  L++ + ++   I       +   L  L    +    F  S     +    +  
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS--G 116
             LS +           S  + T+L+ + N    S+    + L RL  L L  N L    
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFF 393

Query: 117 PVPFSNEQLSSMYIVRLSPNKGLCGNFSAL 146
            V    + +SS+  + +S N      +   
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRT 423

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 3/115 (2%)

Query: 3   GNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL-TGLLGLN 60
             + +L  LD+  N     P+    G LT L++L LS  +F       +  L    + L+
Sbjct: 118 CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           L S  + G   ++   + N T L +  +            ++ L +L LS+ KL+
Sbjct: 178 LVSYHIKG-GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 36/148 (24%), Positives = 62/148 (41%), Gaps = 8/148 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS-SIPNELTWLTGLLGLNLS 62
             ++L  LDV  N L   I      +  L +LDLS N F+   +  E   LT L  L LS
Sbjct: 98  FNQDLEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLS 154

Query: 63  SNKLSGKIPSQIASMKNLTW--LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           + K   ++     +  +L+   LD+ +  I+G     +   +    L+L  +  S     
Sbjct: 155 AAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-TTVLHLVFHPNSLFSVQ 212

Query: 121 SNEQLSSMYIVRLSPNKGLCGNFSALPS 148
            N  ++++  ++LS  K    N   L +
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMT 240

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 4/138 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
            L     L +  N +     S+   L  L  L+L       +I  E    L  L  L+L 
Sbjct: 22  VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSI--PGEITELSRLDYLNLSSNKLSG-PVP 119
           S+K+    P     + +L  L +    +  ++   G    L  L  L+LS N++    + 
Sbjct: 82  SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141

Query: 120 FSNEQLSSMYIVRLSPNK 137
            S  +L+S+  +  S N+
Sbjct: 142 PSFGKLNSLKSIDFSSNQ 159

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 5/131 (3%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           ++  LD+    +          L DL  L+L+ N+ N         L  L  LNLS N L
Sbjct: 267 SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326

Query: 67  SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLS 126
                S    +  + ++D+  N I          L +L  L+L  N L+     +   + 
Sbjct: 327 GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIP 381

Query: 127 SMYIVRLSPNK 137
           S+  + LS NK
Sbjct: 382 SIPDIFLSGNK 392

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 34/145 (23%), Positives = 59/145 (40%), Gaps = 11/145 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI--PNELTWLTGLLGLNL 61
           NL NL  LD+GS+ +    P     L  L  L L     + ++        L  L  L+L
Sbjct: 71  NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

Query: 62  SSNKLSG-KIPSQIASMKNLTWLDISNNKIEGSIPGEITELS--RLDYLNLSSNKLSGPV 118
           S N++    +      + +L  +D S+N+I      E+  L    L + +L++N L   V
Sbjct: 131 SKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRV 190

Query: 119 P------FSNEQLSSMYIVRLSPNK 137
                   +  +   + I+ +S N 
Sbjct: 191 SVDWGKCMNPFRNMVLEILDVSGNG 215

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 72.9 bits (179), Expect = 5e-14
 Identities = 34/129 (26%), Positives = 48/129 (37%), Gaps = 11/129 (8%)

Query: 29  LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNLTWLDISN 87
           L     L LS N   +   +   +L  L  L L S      I  +   ++ NL  LD+ +
Sbjct: 23  LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82

Query: 88  NKIEGSIPGEITELSRLDYLNLSSNKLSG----PVPFSNEQLSSMYIVRLSPNK----GL 139
           +KI    P     L  L  L L    LS        F N  L ++  + LS N+     L
Sbjct: 83  SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN--LKALTRLDLSKNQIRSLYL 140

Query: 140 CGNFSALPS 148
             +F  L S
Sbjct: 141 HPSFGKLNS 149

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 28/126 (22%), Positives = 57/126 (45%), Gaps = 14/126 (11%)

Query: 4   NLKNLIELDVGSNSLI--------GPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLT 54
            L  L ++++ +N +           I   L  +  L  L L++N+F+S   ++  +   
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451

Query: 55  GLLGLNLSSNKLSGKIPSQI-----ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNL 109
            L  L L  N L     +++       + +L  L +++N +    PG  + L+ L  L+L
Sbjct: 452 SLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSL 511

Query: 110 SSNKLS 115
           +SN+L+
Sbjct: 512 NSNRLT 517

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 28/137 (20%), Positives = 47/137 (34%), Gaps = 2/137 (1%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL--TGLLGLN 60
           GN   +      SN++      +L L   +       +       N    L  + +  L+
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLD 272

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           LS   +         ++K+L  L+++ NKI          L  L  LNLS N L      
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332

Query: 121 SNEQLSSMYIVRLSPNK 137
           +   L  +  + L  N 
Sbjct: 333 NFYGLPKVAYIDLQKNH 349

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 45/193 (23%), Positives = 72/193 (37%), Gaps = 20/193 (10%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGL-----LTDLSYLDLSRNQFNSSIPNELTWLTGLL 57
               +L +L +G N L     + L       L+ L  L L+ N  NS  P   + LT L 
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507

Query: 58  GLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS-- 115
           GL+L+SN+L+  +        NL  LDIS N++    P        L  L+++ NK    
Sbjct: 508 GLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPD---VFVSLSVLDITHNKFICE 562

Query: 116 -GPVPFSNEQLSSMYIVRLSPNKGLCGNFSALP-------SCDATKPATLFVEIFLPLAI 167
                F N    +   +   P    C    +         S +      +   +   L I
Sbjct: 563 CELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFI 622

Query: 168 VPSVIVFACLLVV 180
           V +V +   L+ +
Sbjct: 623 VCTVTLTLFLMTI 635

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 36/159 (22%), Positives = 55/159 (34%), Gaps = 23/159 (14%)

Query: 2   IGNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTG--LLG 58
             NLK L  LD+  N +    +  + G L  L  +D S NQ      +EL  L G  L  
Sbjct: 119 FRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178

Query: 59  LNLSSNKLSGKIPSQIASMKN------LTWLDISNNKIEGSIPG------------EITE 100
            +L++N L  ++        N      L  LD+S N     I G             +  
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238

Query: 101 LSRLDYLNLSSNKLSGPVP--FSNEQLSSMYIVRLSPNK 137
              +       + +  P    F+    SS+  + LS   
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 30/135 (22%), Positives = 59/135 (43%), Gaps = 10/135 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L NL  L++  N L     S    L  ++Y+DL +N           +L  L  L+L  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVPFSN 122
           N L     + I  + ++  + +S NK+  ++P         + ++LS N+L    + +  
Sbjct: 372 NAL-----TTIHFIPSIPDIFLSGNKLV-TLP---KINLTANLIHLSENRLENLDILYFL 422

Query: 123 EQLSSMYIVRLSPNK 137
            ++  + I+ L+ N+
Sbjct: 423 LRVPHLQILILNQNR 437

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 28/157 (17%), Positives = 52/157 (33%), Gaps = 22/157 (14%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLT--DLSYLDLSRNQFNSSIPNELTWLTGLLG-- 58
           G L +L  +D  SN +       L  L    LS+  L+ N   S +  +           
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204

Query: 59  ----LNLSSNKLSGKIPS------------QIASMKNLTWLDISNNKIEGSIPGEITELS 102
               L++S N  +  I               +    ++       + I+         L+
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264

Query: 103 R--LDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           R  + +L+LS   +        E L  + ++ L+ NK
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK 301

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 34/134 (25%), Positives = 55/134 (41%), Gaps = 13/134 (9%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           E+ N   L  +DV +NSL   +P    L   L ++    NQ    +P EL  L  L  + 
Sbjct: 148 ELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQL-EELP-ELQNLPFLTAIY 201

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
             +N L  K+P       +L  +   NN +E  +P E+  L  L  +   +N L   +P 
Sbjct: 202 ADNNSLK-KLPDLPL---SLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPD 254

Query: 121 SNEQLSSMYIVRLS 134
               L ++ +    
Sbjct: 255 LPPSLEALNVRDNY 268

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 74.3 bits (183), Expect = 1e-14
 Identities = 29/115 (25%), Positives = 51/115 (44%), Gaps = 15/115 (13%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
              +LK+L+  +    +L    P        L YL +S NQ    +P EL   + L  ++
Sbjct: 109 LPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQL-EKLP-ELQNSSFLKIID 159

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           + +N L  K+P       +L ++   NN++E  +P E+  L  L  +   +N L 
Sbjct: 160 VDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 29/158 (18%), Positives = 50/158 (31%), Gaps = 34/158 (21%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLG-------------LLTDLSYLDLSRNQFNSSIP 47
           E  N+K+  E     +      P   G             L      L+L+     SS+P
Sbjct: 29  EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSLP 87

Query: 48  NELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG----------- 96
                L     L  S N L+ ++P    S+K+L   + +   +    P            
Sbjct: 88  ELPPHLE---SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQL 143

Query: 97  ----EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYI 130
               E+   S L  +++ +N L   +P     L  +  
Sbjct: 144 EKLPELQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAA 180

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 21/129 (16%), Positives = 39/129 (30%), Gaps = 19/129 (14%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT--------- 51
              +   L E    S++L   +P     +   +    + +++  + P             
Sbjct: 6   RNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 52  ----WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYL 107
                      L L++  LS  +P       +L  L  S N +   +P     L  L   
Sbjct: 65  LRDCLDRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVD 119

Query: 108 NLSSNKLSG 116
           N +   LS 
Sbjct: 120 NNNLKALSD 128

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 68.9 bits (169), Expect = 6e-13
 Identities = 31/128 (24%), Positives = 47/128 (36%), Gaps = 22/128 (17%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP---------NELT 51
           E+ NL  L  +   +N L   +P     L  L+  D                    N  +
Sbjct: 232 ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFS 290

Query: 52  WLTGLLG----LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYL 107
            L+ L      LN SSN++   +        +L  L++SNNK+   +P     L RL   
Sbjct: 291 GLSELPPNLYYLNASSNEIR-SLCDL---PPSLEELNVSNNKLI-ELPALPPRLERLI-- 343

Query: 108 NLSSNKLS 115
             S N L+
Sbjct: 344 -ASFNHLA 350

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 29/152 (19%), Positives = 52/152 (34%), Gaps = 29/152 (19%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
                +L EL+V +N LI  +P+    L     L  S N   + +P     L  L   ++
Sbjct: 313 CDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHL-AEVPELPQNLKQL---HV 364

Query: 62  SSNKLSGKIPSQIASMK----------------NLTWLDISNNKIEGSIPGEITELSRLD 105
             N L  + P    S++                NL  L +  N +    P     +  L 
Sbjct: 365 EYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDLR 422

Query: 106 YLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
              ++S ++  P  F++E    +       + 
Sbjct: 423 ---MNSERVVDPYEFAHETTDKLEDDVFEHHH 451

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 27/115 (23%), Positives = 44/115 (38%), Gaps = 19/115 (16%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
              +L  L   +   + L         L  +L YL+ S N+   S+ +    L     LN
Sbjct: 275 LPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR-SLCDLPPSLE---ELN 323

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           +S+NKL  ++P+       L  L  S N +   +P     L +L    +  N L 
Sbjct: 324 VSNNKLI-ELPALP---PRLERLIASFNHLA-EVPELPQNLKQLH---VEYNPLR 370

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 17/127 (13%), Positives = 37/127 (29%), Gaps = 25/127 (19%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLG------ 58
              L  L    N L   +P    L  +L  L +  N      P+    +  L        
Sbjct: 336 PPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPL-REFPDIPESVEDLRMNSHLAE 390

Query: 59  ----------LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLN 108
                     L++ +N L  + P      +++  L +++ ++            +L+   
Sbjct: 391 VPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDV 446

Query: 109 LSSNKLS 115
              +   
Sbjct: 447 FEHHHHH 453

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 48/180 (26%), Positives = 72/180 (40%), Gaps = 14/180 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALK-----KLHTSETEELAFIKSFRNEAQVLSQ 274
           +     +G+G +G V+ A      K   +K     K+      E   +     E  +LS+
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGS-LFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           V H NI+K+     ++    L+ E    G  LF  +  +    E   A    I + +  A
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-PLASY--IFRQLVSA 142

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           + YL       IIHRDI   NI++   F   + DFG+A  L       T   GT  Y AP
Sbjct: 143 VGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAP 198

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 2/135 (1%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L +L +L +   +L       L  L  L  L L     N+        L  L  L +S 
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFSN 122
                 +        NLT L I++  +  ++P   +  L  L +LNLS N +S       
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSML 268

Query: 123 EQLSSMYIVRLSPNK 137
            +L  +  ++L   +
Sbjct: 269 HELLRLQEIQLVGGQ 283

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 38/135 (28%), Positives = 54/135 (40%), Gaps = 8/135 (5%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
               LD+G N +             L  L+L+ N  ++  P     L  L  L L SN+L
Sbjct: 33  ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS--GPVPFSN 122
              IP  +   + NLT LDIS NKI   +   +  +L  L  L +  N L       FS 
Sbjct: 93  K-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150

Query: 123 EQLSSMYIVRLSPNK 137
             L+S+  + L    
Sbjct: 151 --LNSLEQLTLEKCN 163

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 26/135 (19%), Positives = 53/135 (39%), Gaps = 4/135 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
            L  L  L++     +  +        +L+ L ++     +++P   +  L  L  LNLS
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLS 256

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            N +S  I   +   +  L  + +   ++    P     L+ L  LN+S N+L+      
Sbjct: 257 YNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315

Query: 122 NEQLSSMYIVRLSPN 136
              + ++  + L  N
Sbjct: 316 FHSVGNLETLILDSN 330

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 6/137 (4%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
           +  +L EL++  N +    P     L +L  L L  N+    IP    T L+ L  L++S
Sbjct: 54  SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDIS 112

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPF 120
            NK+   +   +   + NL  L++ +N +   I     + L+ L+ L L    L+     
Sbjct: 113 ENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTE 170

Query: 121 SNEQLSSMYIVRLSPNK 137
           +   L  + ++RL    
Sbjct: 171 ALSHLHGLIVLRLRHLN 187

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 34/140 (24%), Positives = 55/140 (39%), Gaps = 8/140 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           NL NL  L + SN L          L++L+ LD+S N+    +      L  L  L +  
Sbjct: 78  NLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGD 137

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS--GPVP 119
           N L   I  +  + + +L  L +    +  SIP E  + L  L  L L    ++      
Sbjct: 138 NDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYS 195

Query: 120 FSNEQLSSMYIVRLSPNKGL 139
           F    L  + ++ +S    L
Sbjct: 196 FKR--LYRLKVLEISHWPYL 213

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 29/118 (24%), Positives = 57/118 (48%), Gaps = 6/118 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P   G+ T+   LDL +N+  +   +E      L  L L+ N +S  +      ++ NL
Sbjct: 26  VPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
             L + +N+++  IP  + T LS L  L++S NK+   + +  + L ++  + +  N 
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 25/114 (21%), Positives = 48/114 (42%), Gaps = 4/114 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
              NL  L +   +L       +  L  L +L+LS N  ++   + L  L  L  + L  
Sbjct: 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
            +L+  +       +  L  L++S N++  ++   +   +  L+ L L SN L+
Sbjct: 282 GQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 21/81 (25%), Positives = 36/81 (44%), Gaps = 3/81 (3%)

Query: 35  LDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSI 94
           +   R +F  ++P  +   T    L+L  N++      + AS  +L  L+++ N +    
Sbjct: 16  VLCHRKRF-VAVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 95  PGEITELSRLDYLNLSSNKLS 115
           PG    L  L  L L SN+L 
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLK 93

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 27/183 (14%), Positives = 61/183 (33%), Gaps = 15/183 (8%)

Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           I             K Q    +++   +         + + +   + + +     +N V 
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCS 342
                  +  +++  +   + +L   ++      + +    ++I   +A A+ +LH   S
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---S 182

Query: 343 PSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS------------NRTLLAGTYGY 390
             ++HRD+  +NI         V DFG    +  D                T   GT  Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 391 IAP 393
           ++P
Sbjct: 243 MSP 245

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 76.7 bits (188), Expect = 3e-15
 Identities = 29/134 (21%), Positives = 58/134 (43%), Gaps = 10/134 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
                I+ ++   S+   +      L  +  +  + +    S+   + +L  +  L L+ 
Sbjct: 19  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNG 74

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE 123
           NKL+  I   + ++KNL WL +  NKI+  +   + +L +L  L+L  N +S      + 
Sbjct: 75  NKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH- 129

Query: 124 QLSSMYIVRLSPNK 137
            L  +  + L  NK
Sbjct: 130 -LPQLESLYLGNNK 142

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 73.6 bits (180), Expect = 3e-14
 Identities = 33/138 (23%), Positives = 63/138 (45%), Gaps = 14/138 (10%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
              L ++ ++   ++ +  +  I      L +++ L L+ N+  + I   LT L  L  L
Sbjct: 39  QNELNSIDQIIANNSDIKSVQGIQY----LPNVTKLFLNGNK-LTDIKP-LTNLKNLGWL 92

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            L  NK+   + S +  +K L  L + +N I   I G +  L +L+ L L +NK++    
Sbjct: 93  FLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV 148

Query: 120 FSNEQLSSMYIVRLSPNK 137
            S   L+ +  + L  N+
Sbjct: 149 LSR--LTKLDTLSLEDNQ 164

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.4 bits (169), Expect = 6e-13
 Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 6/123 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + +L  L  L +G+N +     + L  LT L  L L  NQ  S I   L  LT L  L L
Sbjct: 127 LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYL 182

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S N +S      +A +KNL  L++ + +         + L   + +  +   L  P   S
Sbjct: 183 SKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

Query: 122 NEQ 124
           ++ 
Sbjct: 241 DDG 243

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 69.0 bits (168), Expect = 7e-13
 Identities = 35/138 (25%), Positives = 54/138 (39%), Gaps = 12/138 (8%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           + +LK L  L +  N +  I  +      L  L  L L  N+  + I   L+ LT L  L
Sbjct: 105 LKDLKKLKSLSLEHNGISDINGLVH----LPQLESLYLGNNKI-TDITV-LSRLTKLDTL 158

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
           +L  N++S  I   +A +  L  L +S N I   +   +  L  LD L L S +      
Sbjct: 159 SLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPI 214

Query: 120 FSNEQLSSMYIVRLSPNK 137
                L     V+ +   
Sbjct: 215 NHQSNLVVPNTVKNTDGS 232

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.8 bits (139), Expect = 3e-09
 Identities = 19/114 (16%), Positives = 42/114 (36%), Gaps = 8/114 (7%)

Query: 24  STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL 83
                  +    +L +     ++      L  +  +  +++ +   +   I  + N+T L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70

Query: 84  DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
            ++ NK+   I   +T L  L +L L  NK+       +  L  +  + L  N 
Sbjct: 71  FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLKD--LKKLKSLSLEHNG 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 10/136 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + NL  + EL++  N L     S +  L  +  LDL+  Q     P  L  L+ L  L L
Sbjct: 81  LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             N+++  I   +A + NL +L I N ++   +   +  LS+L  L    NK+S   P +
Sbjct: 137 DLNQIT-NISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISPLA 192

Query: 122 NEQLSSMYIVRLSPNK 137
           +  L ++  V L  N+
Sbjct: 193 S--LPNLIEVHLKNNQ 206

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 37/137 (27%), Positives = 69/137 (50%), Gaps = 10/137 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +  L NLI L++  N +    P  L  LT ++ L+LS N    ++   +  L  +  L+
Sbjct: 58  GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL-KNVSA-IAGLQSIKTLD 113

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           L+S +++   P  +A + NL  L +  N+I  +I   +  L+ L YL++ + ++S   P 
Sbjct: 114 LTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPL 169

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N  LS +  ++   NK
Sbjct: 170 AN--LSKLTTLKADDNK 184

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.0 bits (182), Expect = 6e-15
 Identities = 39/137 (28%), Positives = 69/137 (50%), Gaps = 10/137 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            I  L+++  LD+ S  +    P  L  L++L  L L  NQ  ++I   L  LT L  L+
Sbjct: 102 AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQI-TNISP-LAGLTNLQYLS 157

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
           + + ++S  +   +A++  LT L   +NKI   I   +  L  L  ++L +N++S   P 
Sbjct: 158 IGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSPL 213

Query: 121 SNEQLSSMYIVRLSPNK 137
           +N   S+++IV L+   
Sbjct: 214 AN--TSNLFIVTLTNQT 228

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 28/134 (20%), Positives = 66/134 (49%), Gaps = 10/134 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L N I++  G +++      T   L  ++ L        ++I   + +L  L+GL L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKD 72

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE 123
           N+++  +   + ++  +T L++S N ++ ++   I  L  +  L+L+S +++   P +  
Sbjct: 73  NQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAG- 127

Query: 124 QLSSMYIVRLSPNK 137
            LS++ ++ L  N+
Sbjct: 128 -LSNLQVLYLDLNQ 140

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 8/131 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  L NL  L +  N +    P  L  LT+L YL +   Q  S +   L  L+ L  L  
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV-SDLTP-LANLSKLTTLKA 180

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             NK+S  I   +AS+ NL  + + NN+I   +   +   S L  + L++  ++    F 
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFY 236

Query: 122 NEQLSSMYIVR 132
           N  L    +V+
Sbjct: 237 NNNLVVPNVVK 247

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 31/136 (22%), Positives = 61/136 (44%), Gaps = 10/136 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             +L  +  L       +  I   +  L +L  L+L  NQ  + +   L  LT +  L L
Sbjct: 37  QADLDGITTLSAFGT-GVTTIEG-VQYLNNLIGLELKDNQI-TDLAP-LKNLTKITELEL 92

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S N L   + + IA ++++  LD+++ +I    P  +  LS L  L L  N+++   P +
Sbjct: 93  SGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA 148

Query: 122 NEQLSSMYIVRLSPNK 137
              L+++  + +   +
Sbjct: 149 G--LTNLQYLSIGNAQ 162

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 29/121 (23%), Positives = 50/121 (41%), Gaps = 6/121 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  L NL  L +G+  +    P  L  L+ L+ L    N+  S I   L  L  L+ ++L
Sbjct: 147 LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI-SDISP-LASLPNLIEVHL 202

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            +N++S   P  +A+  NL  + ++N  I          L   + +   S     P   S
Sbjct: 203 KNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260

Query: 122 N 122
           +
Sbjct: 261 D 261

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 19/114 (16%), Positives = 45/114 (39%), Gaps = 8/114 (7%)

Query: 24  STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL 83
                L +   +   ++    ++      L G+  L+     ++  I   +  + NL  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 84  DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           ++ +N+I   +   +  L+++  L LS N L      +   L S+  + L+  +
Sbjct: 69  ELKDNQIT-DLAP-LKNLTKITELELSGNPLKNVSAIAG--LQSIKTLDLTSTQ 118

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 36/185 (19%), Positives = 73/185 (39%), Gaps = 25/185 (13%)

Query: 210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRN-- 267
           +  +L      + ++  I +G YG+V       G   A+K++  + ++    +    +  
Sbjct: 13  LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG-RTVNILSDSF 71

Query: 268 -------EAQVLSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHN--NE 313
                  E ++L+   H NI+ L    +H +      ++L+ E M       +L    ++
Sbjct: 72  LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-----TDLAQVIHD 126

Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
             + +        +  +   L  LH      ++HRD+   NILL    +  + DF  AR 
Sbjct: 127 QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLARE 183

Query: 374 LHADS 378
             AD+
Sbjct: 184 DTADA 188

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 35/141 (24%), Positives = 60/141 (42%), Gaps = 12/141 (8%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLS 62
            +K L  + +   ++   IP   GL   L+ L L  N+  + +    L  L  L  L LS
Sbjct: 169 GMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLS 224

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG------ 116
            N +S      +A+  +L  L ++NNK+   +PG + +   +  + L +N +S       
Sbjct: 225 FNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDF 283

Query: 117 PVPFSNEQLSSMYIVRLSPNK 137
             P  N + +S   V L  N 
Sbjct: 284 CPPGYNTKKASYSGVSLFSNP 304

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 13/145 (8%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           G   +L EL +  N +     ++L  L +L+ L LS N  ++     L     L  L+L+
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEG------SIPGEITELSRLDYLNLSSNKLSG 116
           +NKL  K+P  +A  K +  + + NN I          PG  T+ +    ++L SN +  
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307

Query: 117 ----PVPFSNEQLSSMYIVRLSPNK 137
               P  F    +     V+L   K
Sbjct: 308 WEIQPSTFRC--VYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 12/138 (8%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L  L  L +  N L   +P    +   L  L +  N+      +    L  ++ + L +
Sbjct: 98  PLVKLERLYLSKNQLKE-LPE--KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 154

Query: 64  NKL-SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS--GPVP 119
           N L S  I +     MK L+++ I++  I  +IP  +     L  L+L  NK++      
Sbjct: 155 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAAS 211

Query: 120 FSNEQLSSMYIVRLSPNK 137
                L+++  + LS N 
Sbjct: 212 LKG--LNNLAKLGLSFNS 227

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 25/115 (21%), Positives = 52/115 (45%), Gaps = 7/115 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           NLKNL  L + +N +    P     L  L  L LS+NQ    +P ++     L  L +  
Sbjct: 74  NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHE 130

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSI--PGEITELSRLDYLNLSSNKLS 115
           N+++ K+   +   +  +  +++  N ++ S    G    + +L Y+ ++   ++
Sbjct: 131 NEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 7/117 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P    L  D + LDL  N+       +   L  L  L L +NK+S KI     A +  L
Sbjct: 46  VPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKL 102

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
             L +S N+++  +P ++     L  L +  N+++         L+ M +V L  N 
Sbjct: 103 ERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP 156

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 25/85 (29%), Positives = 38/85 (44%), Gaps = 3/85 (3%)

Query: 31  DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI 90
            L  +  S       +P +L        L+L +NK++        ++KNL  L + NNKI
Sbjct: 32  HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 91  EGSIPGEITELSRLDYLNLSSNKLS 115
               PG    L +L+ L LS N+L 
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK 113

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 74.3 bits (183), Expect = 5e-15
 Identities = 46/168 (27%), Positives = 76/168 (45%), Gaps = 9/168 (5%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG G +  V  A+ +  G+  A+K +  ++    +  K FR E +++  + H NIVKL+ 
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFE 81

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSI 345
                K ++LI EY   G +F  L  +    E   A+     + +  A+ Y H      I
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-KEARS--KFRQIVSAVQYCHQKR---I 135

Query: 346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +HRD+ + N+LL++     +ADFG +              G   Y AP
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAP 182

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 73.6 bits (181), Expect = 7e-15
 Identities = 38/136 (27%), Positives = 53/136 (38%), Gaps = 6/136 (4%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           G L  L  LD+  N L   +P     L  L+ LD+S N+  S     L  L  L  L L 
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPF 120
            N+L   +P  +      L  L ++NN +   +P  +   L  LD L L  N L   +P 
Sbjct: 133 GNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK 189

Query: 121 SNEQLSSMYIVRLSPN 136
                  +    L  N
Sbjct: 190 GFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 68.2 bits (167), Expect = 4e-13
 Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 6/112 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            + + +E++    +L   +P    L  D + L LS N   +     L   T L  LNL  
Sbjct: 8   KVASHLEVNCDKRNL-TALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            +L+ K+     ++  L  LD+S+N+++ S+P     L  L  L++S N+L+
Sbjct: 65  AELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT 113

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 19/90 (21%), Positives = 34/90 (37%), Gaps = 10/90 (11%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           +N     L+  +P  +    + T L +S N +       +   +RL  LNL   +L+   
Sbjct: 15  VNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71

Query: 119 PFSNEQLSSMYIVRLSPNKGLCGNFSALPS 148
                 L  +  + LS N+       +LP 
Sbjct: 72  VDGT--LPVLGTLDLSHNQ-----LQSLPL 94

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 19/195 (9%)

Query: 208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR 266
            +V   + +    +     IG G YG V  A    N    A+KK+   E +     ++ R
Sbjct: 16  EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC-QRTLR 74

Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKC-----MFLIYEYMERGSLFCNLHNNEDAVELDWA 321
            E ++L +  H NI+ +              ++++ + ME      +L+       L   
Sbjct: 75  -EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYKLLKTQHLSND 128

Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR 381
                +  +   L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+   D  + 
Sbjct: 129 HICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 382 TLLAG---TYGYIAP 393
             L     T  Y AP
Sbjct: 186 GFLTEYVATRWYRAP 200

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 32/115 (27%), Positives = 50/115 (43%), Gaps = 6/115 (5%)

Query: 4   NLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
            L  L +L + SN L   G    +    T L YLDLS N    ++ +    L  L  L+ 
Sbjct: 50  KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDF 108

Query: 62  SSNKLSGKIPSQIA--SMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
             + L  ++       S++NL +LDIS+     +  G    LS L+ L ++ N  
Sbjct: 109 QHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 30/116 (25%), Positives = 47/116 (40%), Gaps = 6/116 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
            L +L  L +  NS            L +L++LDLS+ Q    +       L+ L  LN+
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNM 206

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE--LSRLDYLNLSSNKLS 115
           S N            + +L  LD S N I  +   +  +   S L +LNL+ N  +
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 68.5 bits (168), Expect = 4e-13
 Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 5/96 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIA--SMKN 79
           +P+  G+ +  + L+L  N+  S        LT L  L+LSSN LS K     +     +
Sbjct: 22  VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79

Query: 80  LTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           L +LD+S N +  ++      L +L++L+   + L 
Sbjct: 80  LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK 114

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 16/179 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+    +G G +G V   +    G+ +A   LKK      +E+A   +   E +VL    
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNSR 206

Query: 277 HRNIVKLYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  +  L  +       +  + EY   G LF +L       E     R     A +  AL
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 261

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            YLH + +  +++RD+   N++L+      + DFG  +    D +      GT  Y+AP
Sbjct: 262 DYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 56/184 (30%), Positives = 84/184 (45%), Gaps = 30/184 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           F I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN----NED-----AVELDWAKRVNIVKAM 330
           I++++G     + +F+I +Y+E G LF  L              A E+            
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------------ 115

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYG 389
             AL YLH   S  II+RD+   NILL+      + DFG A+ +     + T  L GT  
Sbjct: 116 CLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPD 168

Query: 390 YIAP 393
           YIAP
Sbjct: 169 YIAP 172

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V   +    G   A+K L+  +   L  +   + E Q L    H +I+KLY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 339
                   F++ EY+  G LF  +  +          RV  ++A      +  A+ Y H 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKH---------GRVEEMEARRLFQQILSAVDYCH- 128

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                ++HRD+   N+LL++   A +ADFG + ++      RT   G+  Y AP
Sbjct: 129 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 179

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 34/148 (22%), Positives = 60/148 (40%), Gaps = 19/148 (12%)

Query: 3   GNLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLN 60
              + L EL +  N  I  I    L   + L  L L  NQ    I N  L++L  L  L+
Sbjct: 190 DLPETLNELHLDHNK-IQAIELEDLLRYSKLYRLGLGHNQI-RMIENGSLSFLPTLRELH 247

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIP-------GEITELSRLDYLNLSSNK 113
           L +NKLS ++P+ +  +K L  + +  N I   +        G   + +  + ++L +N 
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305

Query: 114 LS----GPVPFSNEQLSSMYIVRLSPNK 137
           +      P  F    ++    ++    K
Sbjct: 306 VPYWEVQPATFRC--VTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 25/114 (21%), Positives = 52/114 (45%), Gaps = 6/114 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L++L  L + +N +          L  L  L +S+N     IP  L   + L+ L +  
Sbjct: 76  GLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHD 132

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKI-EGSIPGEITELSRLDYLNLSSNKLS 115
           N++  K+P  + + ++N+  +++  N +          +  +L+YL +S  KL+
Sbjct: 133 NRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 30/135 (22%), Positives = 53/135 (39%), Gaps = 7/135 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L+ L +L +  N L+  IP    L + L  L +  N+         + L  +  + +  
Sbjct: 100 PLRKLQKLYISKNHLVE-IPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGG 156

Query: 64  NKL-SGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           N L +            L +L IS  K+   IP ++     L+ L+L  NK+        
Sbjct: 157 NPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDL 213

Query: 123 EQLSSMYIVRLSPNK 137
            + S +Y + L  N+
Sbjct: 214 LRYSKLYRLGLGHNQ 228

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 29/117 (24%), Positives = 49/117 (41%), Gaps = 7/117 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P    +  D + LDL  N  +    ++   L  L  L L +NK+S KI  +  + ++ L
Sbjct: 48  VPK--EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKL 104

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
             L IS N +   IP  +   S L  L +  N++          L +M  + +  N 
Sbjct: 105 QKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 31  DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI 90
            L  +  S      ++P E++       L+L +N +S         +++L  L + NNKI
Sbjct: 34  HLRVVQCSDLGL-KAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 91  EGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
                   + L +L  L +S N L           SS+  +R+  N+
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLVE---IPPNLPSSLVELRIHDNR 134

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 24/115 (20%), Positives = 47/115 (40%), Gaps = 13/115 (11%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
                +         N  +  +     L+   S L L+R    SS+P+ L     +  L 
Sbjct: 32  AWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNL-SSLPDNL--PPQITVLE 86

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           ++ N L   +P   A   +L +LD  +N++  ++P     L     L++ +N+L+
Sbjct: 87  ITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKH---LDVDNNQLT 133

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 29/128 (22%), Positives = 50/128 (39%), Gaps = 20/128 (15%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
              +L+    LD   N L   +P     L    +LD+  NQ  + +P     L  +   N
Sbjct: 98  LPASLE---YLDACDNRLST-LPELPASLK---HLDVDNNQL-TMLPELPALLEYI---N 146

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
             +N+L+  +P       +L  L + NN++   +P     L  LD   +S+N L   +P 
Sbjct: 147 ADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPELPESLEALD---VSTNLLES-LPA 197

Query: 121 SNEQLSSM 128
              +    
Sbjct: 198 VPVRNHHS 205

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 10/122 (8%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL----LGLN 60
             +L  L V +N L   +P     L  L   D+S N    S+P             +   
Sbjct: 159 PTSLEVLSVRNNQLTF-LPELPESLEAL---DVSTNLL-ESLPAVPVRNHHSEETEIFFR 213

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
              N+++  IP  I S+     + + +N +   I   +++ +     +      S     
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272

Query: 121 SN 122
            N
Sbjct: 273 QN 274

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 20/131 (15%), Positives = 33/131 (25%), Gaps = 10/131 (7%)

Query: 1   EIGNLKNL----IELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL 56
                 +     I      N +   IP  +  L     + L  N  +S I   L+  T  
Sbjct: 198 VPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQ 256

Query: 57  LGLNLSSNKLSGKIPSQIASMKNL-----TWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
              +      S     Q    + L      W   +       I          +  +   
Sbjct: 257 PDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFL 316

Query: 112 NKLSGPVPFSN 122
           ++LS  V   N
Sbjct: 317 DRLSDTVSARN 327

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 24/186 (12%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
             +  F +K  +G G YG V  A   P G++ A+KK+   +    A +++ R E ++L  
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA-LRTLR-EIKILKH 65

Query: 275 VLHRNIVKLY---------GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVN 325
             H NI+ ++          F      +++I E M+      +LH       L       
Sbjct: 66  FKHENIITIFNIQRPDSFENF----NEVYIIQELMQ-----TDLHRVISTQMLSDDHIQY 116

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA 385
            +     A+  LH     ++IHRD+  +N+L+NS  +  V DFG AR++   +++ +   
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 386 GTYGYI 391
           G    +
Sbjct: 174 GQQSGM 179

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 72.1 bits (176), Expect = 7e-14
 Identities = 27/122 (22%), Positives = 51/122 (41%), Gaps = 13/122 (10%)

Query: 2   IGNLKNLIELD--------VGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL 53
           +     L  +D           +  +           D+  L L+     + + + L  L
Sbjct: 405 LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL-TVLCH-LEQL 462

Query: 54  TGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNK 113
             +  L+LS N+L   +P  +A+++ L  L  S+N +E ++ G +  L RL  L L +N+
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 519

Query: 114 LS 115
           L 
Sbjct: 520 LQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 69.4 bits (169), Expect = 6e-13
 Identities = 30/128 (23%), Positives = 52/128 (40%), Gaps = 12/128 (9%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
            L +    L   +   L  L  +++LDLS N+   ++P  L  L  L  L  S N L   
Sbjct: 445 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALE-N 500

Query: 70  IPSQIASMKNLTWLDISNNKIEG-SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSM 128
           +   +A++  L  L + NN+++  +    +    RL  LNL  N          E+    
Sbjct: 501 VDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN------SLCQEEGIQE 553

Query: 129 YIVRLSPN 136
            +  + P+
Sbjct: 554 RLAEMLPS 561

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.8 bits (157), Expect = 2e-11
 Identities = 24/105 (22%), Positives = 39/105 (37%), Gaps = 5/105 (4%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            +  L  +  LD+  N L   +P  L  L  L  L  S N    ++   +  L  L  L 
Sbjct: 458 HLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL-ENVDG-VANLPRLQELL 514

Query: 61  LSSNKLSG-KIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRL 104
           L +N+L        + S   L  L++  N +     G    L+ +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 46/203 (22%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIK-SFRNEAQVLS 273
           +  + ++I++ IGTG YG V +A      +V A+KK+     E+L   K   R E  +L+
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILR-EIAILN 107

Query: 274 QVLHRNIVKLY-----GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           ++ H ++VK+              ++++ E  +      +                 + +
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-----SDFKK--------------LFR 148

Query: 329 A-----MAH----------ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
                   H           + Y+H   S  I+HRD+   N L+N      V DFG AR 
Sbjct: 149 TPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART 205

Query: 374 LHADSSNRTLLAGTYGYIAPGLP 396
           +    +  + L  +       L 
Sbjct: 206 VDYPENGNSQLPISPREDDMNLV 228

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 40/177 (22%), Positives = 71/177 (40%), Gaps = 18/177 (10%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQV----LHR 278
           +G GG+G+V+    L +    A+K   +        L+   +   E  +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGS-LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            +++L  +   ++   L+ E       LF  +       E   ++       +  A+ + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE-GPSRC--FFGQVVAAIQHC 155

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  ++HRDI   NIL++ +     + DFG+  LLH D        GT  Y  P
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTD-FDGTRVYSPP 207

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 32/147 (21%), Positives = 61/147 (41%), Gaps = 2/147 (1%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
           +L +L  LD+  N L     S    L+ L++L+L  N + +     L + LT L  L + 
Sbjct: 98  SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           +     KI  +  A +  L  L+I  + ++   P  +  +  + +L L   +    +   
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIF 217

Query: 122 NEQLSSMYIVRLSPNKGLCGNFSALPS 148
            +  SS+  + L        +FS L +
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELST 244

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 29/144 (20%), Positives = 58/144 (40%), Gaps = 15/144 (10%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L  L EL++ ++ L    P +L  + ++S+L L   Q    +   +   + +  L L  
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRD 231

Query: 64  NKLSGKIPSQIAS--------MKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
             L     S++++              + I++  +   +   + ++S L  L  S N+L 
Sbjct: 232 TDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK 290

Query: 116 GPVP---FSNEQLSSMYIVRLSPN 136
             VP   F    L+S+  + L  N
Sbjct: 291 S-VPDGIFDR--LTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 36/134 (26%), Positives = 57/134 (42%), Gaps = 11/134 (8%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           IPS  GL   +  LDLS N+      ++L     L  L L+SN ++  I     +S+ +L
Sbjct: 46  IPS--GLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFSN-EQLSSMYIVRLSPNKG 138
             LD+S N +  ++       LS L +LNL  N        S    L+ + I+R+     
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161

Query: 139 L----CGNFSALPS 148
                  +F+ L  
Sbjct: 162 FTKIQRKDFAGLTF 175

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 21/145 (14%), Positives = 47/145 (32%), Gaps = 14/145 (9%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           +L  L  L VG+      I       LT L  L++  +   S  P  L  +  +  L L 
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITE--------LSRLDYLNLSSNK 113
             +    +         ++  L++ +  ++     E++               + ++   
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265

Query: 114 L-SGPVPFSNEQLSSMYIVRLSPNK 137
           L       +   +S +  +  S N+
Sbjct: 266 LFQVMKLLNQ--ISGLLELEFSRNQ 288

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 19/120 (15%), Positives = 48/120 (40%), Gaps = 11/120 (9%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL--------TWLTG 55
           +++N+  L +     I  +   + + + +  L+L     ++   +EL             
Sbjct: 196 SIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFT 255

Query: 56  LLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKL 114
              + ++   L  ++   +  +  L  L+ S N+++ S+P  I   L+ L  + L +N  
Sbjct: 256 FRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 26/119 (21%), Positives = 53/119 (44%), Gaps = 8/119 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
                I+ ++   S+      T   L  +  +  + +    S+   + +L  +  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNG 77

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           NKL+  I   +A++KNL WL +  NK++  +   + +L +L  L+L  N +S      +
Sbjct: 78  NKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH 132

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 32/136 (23%), Positives = 62/136 (45%), Gaps = 10/136 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L ++ ++   ++  I  +   +  L +++ L L+ N+  + I   L  L  L  L L
Sbjct: 42  QNELNSIDQIIANNSD-IKSV-QGIQYLPNVTKLFLNGNK-LTDIKP-LANLKNLGWLFL 97

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             NK+   + S +  +K L  L + +N I   I G +  L +L+ L L +NK++     S
Sbjct: 98  DENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITVLS 153

Query: 122 NEQLSSMYIVRLSPNK 137
              L+ +  + L  N+
Sbjct: 154 R--LTKLDTLSLEDNQ 167

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 35/136 (25%), Positives = 54/136 (39%), Gaps = 8/136 (5%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + +LK L  L +  N +     + L  L  L  L L  N+  + I   L+ LT L  L+L
Sbjct: 108 LKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKI-TDITV-LSRLTKLDTLSL 163

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             N++S  I   +A +  L  L +S N I   +   +  L  LD L L S +        
Sbjct: 164 EDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINH 219

Query: 122 NEQLSSMYIVRLSPNK 137
              L     V+ +   
Sbjct: 220 QSNLVVPNTVKNTDGS 235

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 6/122 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + +L  L  L +G+N +     + L  LT L  L L  NQ  S I   L  LT L  L L
Sbjct: 130 LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI-SDIVP-LAGLTKLQNLYL 185

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S N +S  +   +A +KNL  L++ + +         + L   + +  +   L  P   S
Sbjct: 186 SKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243

Query: 122 NE 123
           ++
Sbjct: 244 DD 245

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 15/99 (15%), Positives = 37/99 (37%), Gaps = 6/99 (6%)

Query: 24  STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL 83
            +     +    +L +     ++      L  +  +  +++ +   +   I  + N+T L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73

Query: 84  DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
            ++ NK+   I   +  L  L +L L  NK+       +
Sbjct: 74  FLNGNKLT-DIKP-LANLKNLGWLFLDENKVKDLSSLKD 110

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 45/175 (25%), Positives = 73/175 (41%), Gaps = 16/175 (9%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALK---KLHTSETEELAFIKSFRNEAQVLSQVLHR--NI 280
           +G+GG+GSVY    + +    A+K   K   S+  EL        E  +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 281 VKLYGFCLHRKCMFLIYEYME-RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           ++L  +        LI E  E    LF  +       E + A+       +  A+ + H 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE-ELARS--FFWQVLEAVRHCH- 166

Query: 340 DCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             +  ++HRDI   NIL++  + E  + DFG+  LL  D+       GT  Y  P
Sbjct: 167 --NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTD-FDGTRVYSPP 217

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 27/136 (19%), Positives = 61/136 (44%), Gaps = 11/136 (8%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L N ++ ++G  S+      +   L+ +   +   +    S+   + + T L  L+L
Sbjct: 15  DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHL 70

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
           S N++S  + S +  +  L  L ++ N+++ ++ G     + L  L L +N+L       
Sbjct: 71  SHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDSLI 125

Query: 122 NEQLSSMYIVRLSPNK 137
           +  L ++ I+ +  NK
Sbjct: 126 H--LKNLEILSIRNNK 139

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.3 bits (144), Expect = 3e-10
 Identities = 18/107 (16%), Positives = 46/107 (42%), Gaps = 6/107 (5%)

Query: 24  STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL 83
                L +    +L +      +      L+G+   N  ++ +   +   +    NL  L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68

Query: 84  DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYI 130
            +S+N+I   +   + +L++L+ L+++ N+L       +  LS +++
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL 113

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 57.0 bits (138), Expect = 2e-09
 Identities = 26/119 (21%), Positives = 47/119 (39%), Gaps = 6/119 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
               L  L + +N L      +L  L +L  L +  N+   SI   L +L+ L  L+L  
Sbjct: 104 PSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKL-KSIVM-LGFLSKLEVLDLHG 159

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN 122
           N+++      +  +K + W+D++  K          EL   + +     +   P   SN
Sbjct: 160 NEITNT--GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYISN 216

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 33/130 (25%), Positives = 62/130 (47%), Gaps = 11/130 (8%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++ +   L ELD   N  I  +   +   T L+ LD S N+       +++    L  LN
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLN 197

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
             +N ++ K+   +     LT+LD S+NK+   I   +T L++L Y + S N L+     
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLTELDVS 251

Query: 121 SNEQLSSMYI 130
           +  +L++++ 
Sbjct: 252 TLSKLTTLHC 261

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 29/127 (22%), Positives = 56/127 (44%), Gaps = 11/127 (8%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           N  + +       +       +   L  L+ LD   +   + +   +  LTGL  L  +S
Sbjct: 19  NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTS 73

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE 123
           N ++  +   ++   NLT+L   +NK+  ++   +T L++L YLN  +NKL+      N 
Sbjct: 74  NNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNP 127

Query: 124 QLSSMYI 130
            L+ +  
Sbjct: 128 LLTYLNC 134

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 31/136 (22%), Positives = 56/136 (41%), Gaps = 14/136 (10%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  L  L  L+  +N L       +     L+YL+ +RN        +++  T L  L+ 
Sbjct: 102 VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLTE---IDVSHNTQLTELDC 155

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             NK   K+   +     LT LD S NKI   +   +++   L+ LN  +N ++  +  +
Sbjct: 156 HLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITK-LDLN 209

Query: 122 NEQLSSMYIVRLSPNK 137
                 +  +  S NK
Sbjct: 210 Q--NIQLTFLDCSSNK 223

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 24/137 (17%), Positives = 49/137 (35%), Gaps = 14/137 (10%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++  L  L   D   N L     ST   L+ L+ L   +         +LT  T L+   
Sbjct: 228 DVTPLTQLTYFDCSVNPLTELDVST---LSKLTTLHCIQTDLLE---IDLTHNTQLIYFQ 281

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
               +   ++   +     L  LD     I   +   +++  +L YL L++ +L+  +  
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LDV 335

Query: 121 SNEQLSSMYIVRLSPNK 137
           S+   + +  +      
Sbjct: 336 SH--NTKLKSLSCVNAH 350

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 34/137 (24%), Positives = 64/137 (46%), Gaps = 14/137 (10%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
            I  L  L +L   SN++   +   L   T+L+YL    N+  +++   +T LT L  LN
Sbjct: 59  GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLN 112

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPF 120
             +NKL+ K+   ++    LT+L+ + N +   I   ++  ++L  L+   NK    +  
Sbjct: 113 CDTNKLT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDV 166

Query: 121 SNEQLSSMYIVRLSPNK 137
           +    + +  +  S NK
Sbjct: 167 TP--QTQLTTLDCSFNK 181

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L  L  LD  ++S+     + +  LT L+ L  + N   +++   L+  T L  L  
Sbjct: 38  EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLAC 92

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            SNKL+  +   +  +  LT+L+   NK+   +   +++   L YLN + N L+
Sbjct: 93  DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 18/120 (15%), Positives = 41/120 (34%), Gaps = 13/120 (10%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
           ++ +   L  LD  +  +   +   L     L YL L+  +  + +   ++  T L  L+
Sbjct: 292 DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLS 345

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELS-----RLDYLNLSSNKLS 115
             +  +     S +  +  L     +  +        +T  S       D L+   N ++
Sbjct: 346 CVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)

Query: 40  NQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEIT 99
             FN   P++       +                   +  LT LD  N+ I   + G I 
Sbjct: 9   QSFNDWFPDDN--FASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-IE 61

Query: 100 ELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           +L+ L  L  +SN ++  +  S    +++  +    NK
Sbjct: 62  KLTGLTKLICTSNNITT-LDLSQ--NTNLTYLACDSNK 96

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 36/164 (21%), Positives = 59/164 (35%), Gaps = 19/164 (11%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
            L++L  L V   +    I + T   L+ L  L L  NQF   +       L  L  L L
Sbjct: 52  RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTL 110

Query: 62  SSNKL-SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS--- 115
           +   L    +       + +L  L + +N I+   P      + R   L+L+ NK+    
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170

Query: 116 -------GPVPFSNEQLSSMYIVRLSPNK---GLCGNFSALPSC 149
                      F+  +LSS+ +  ++        CGN     S 
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI 214

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 27/117 (23%), Positives = 53/117 (45%), Gaps = 8/117 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLL--TDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLN 60
           +    +    G  +   P   T   L  + +   DLS+++   ++   + +  T L  L 
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLT 305

Query: 61  LSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
           L+ N+++ KI       + +L  L++S N + GSI   +   L +L+ L+LS N + 
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR 360

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 30/112 (26%), Positives = 52/112 (46%), Gaps = 6/112 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
           +  +L +L +  N +     +    LT L  L+LS+N    SI + +   L  L  L+LS
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLS 355

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSN 112
            N +   +  Q    + NL  L +  N+++ S+P  I   L+ L  + L +N
Sbjct: 356 YNHIRA-LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 26/122 (21%), Positives = 45/122 (36%), Gaps = 12/122 (9%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P    L   ++Y+DLS N          + L  L  L +        I +     + +L
Sbjct: 25  VPE---LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPV----PFSNEQLSSMYIVRLSP 135
             L +  N+    +       L+ L+ L L+   L G V     F    L+S+ ++ L  
Sbjct: 82  IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP--LTSLEMLVLRD 138

Query: 136 NK 137
           N 
Sbjct: 139 NN 140

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 32/168 (19%), Positives = 56/168 (33%), Gaps = 23/168 (13%)

Query: 4   NLKNLIELDVGSNSLIGPI--PSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLN 60
            L NL  L +   +L G +   +    LT L  L L  N      P      +     L+
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160

Query: 61  LSSNKLSGKIPSQI---ASMKNLTWL--------DISNNKIEGSIPGEITELSRLDYLNL 109
           L+ NK+   I  +       K+ T L        D++   +     G   + + +  L+L
Sbjct: 161 LTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDL 219

Query: 110 SSNKLSGPVP---FSNEQLSSMYIVRLSPNKGL-----CGNFSALPSC 149
           S N     +    F     + +  + LS +  +       NF    + 
Sbjct: 220 SGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 45/174 (25%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V   +    G   A+K L+  +   L  +   R E Q L    H +I+KLY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 339
                  +F++ EY+  G LF  +  N          R++  ++      +   + Y H 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKN---------GRLDEKESRRLFQQILSGVDYCH- 133

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                ++HRD+   N+LL++   A +ADFG + ++      RT   G+  Y AP
Sbjct: 134 --RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAP 184

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 40/189 (21%), Positives = 67/189 (35%), Gaps = 46/189 (24%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 273
              + + IK+ IG G YG VY A      K  A+KK++   E       +  R E  +L+
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC-KRILR-EITILN 80

Query: 274 QVLHRNIVKLYGFCL--HRKCM---FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           ++    I++LY   +          +++ E  +      +L                + K
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-----SDLKK--------------LFK 121

Query: 329 AMAH---------------ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
                                 ++H      IIHRD+   N LLN      V DFG AR 
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178

Query: 374 LHADSSNRT 382
           ++++     
Sbjct: 179 INSEKDTNI 187

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 18/165 (10%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 273
           E    +     +G+G YG+V  A     G   A+KKL+   ++E  A  +++R E ++L 
Sbjct: 22  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA-KRAYR-ELRLLK 79

Query: 274 QVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 327
            + H N++ L       + +      +L+  +M       +L       +L   +   +V
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHEKLGEDRIQFLV 134

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR
Sbjct: 135 YQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 29/174 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETE------ELAFIKSFRNEAQ 270
           +++   +G G YG V+K+     G+V A+KK+     + T+      E+  +        
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG--- 67

Query: 271 VLSQVLHRNIVKLYGFCL--HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
                 H NIV L       + + ++L+++YME      +LH    A  L+   +  +V 
Sbjct: 68  ------HENIVNLLNVLRADNDRDVYLVFDYME-----TDLHAVIRANILEPVHKQYVVY 116

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT 382
            +   + YLH   S  ++HRD+  +NILLN++    VADFG +R          
Sbjct: 117 QLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 43/201 (21%), Positives = 80/201 (39%), Gaps = 48/201 (23%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN---------EAQ 270
           +     +G GG G V+ A      K  A+KK+               +         E +
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------------VLTDPQSVKHALREIK 60

Query: 271 VLSQVLHRNIVKLY--------------GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAV 316
           ++ ++ H NIVK++              G       ++++ EYME      +L N  +  
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-----TDLANVLEQG 115

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLH 375
            L        +  +   L Y+H   S +++HRD+   N+ +N++     + DFG AR++ 
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 376 ADSSNRTLLAG---TYGYIAP 393
              S++  L+    T  Y +P
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSP 193

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 10/117 (8%)

Query: 3   GNLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNE----LTWLTGL- 56
           G+LK L EL+V  N +    +P     LT+L +LDLS N+   SI       L  +  L 
Sbjct: 121 GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMPLLN 179

Query: 57  LGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSN 112
           L L+LS N ++  I         L  L +  N+++ S+P  I   L+ L  + L +N
Sbjct: 180 LSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 30/117 (25%), Positives = 52/117 (44%), Gaps = 9/117 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNL 61
           +   L  LD+     I  I       L+ LS L L+ N    S+     + L+ L  L  
Sbjct: 50  SFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107

Query: 62  SSNKLSGKIPSQIAS-MKNLTWLDISNNKIEGSIP--GEITELSRLDYLNLSSNKLS 115
               L+  + +     +K L  L++++N I+ S       + L+ L++L+LSSNK+ 
Sbjct: 108 VETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 62.3 bits (152), Expect = 3e-11
 Identities = 27/120 (22%), Positives = 45/120 (37%), Gaps = 10/120 (8%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           IP    L      LDLS N               L  L+LS  ++   I      S+ +L
Sbjct: 22  IPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSG--PVPFSNEQLSSMYIVRLSPNK 137
           + L ++ N I+ S+     + LS L  L      L+     P  +  L ++  + ++ N 
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGH--LKTLKELNVAHNL 135

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 61.1 bits (149), Expect = 9e-11
 Identities = 36/139 (25%), Positives = 58/139 (41%), Gaps = 8/139 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
            L +L +L     +L       +G L  L  L+++ N   S    E  + LT L  L+LS
Sbjct: 98  GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 63  SNKLSGKIPSQI-ASMKNLTW----LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
           SNK+   I       +  +      LD+S N +   I     +  RL  L L +N+L   
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSV 215

Query: 118 VPFSNEQLSSMYIVRLSPN 136
                ++L+S+  + L  N
Sbjct: 216 PDGIFDRLTSLQKIWLHTN 234

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 38/142 (26%), Positives = 55/142 (38%), Gaps = 13/142 (9%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
            L NL  L +  N  +  I S     + +L YLDLS N    ++     + L  L  L L
Sbjct: 62  RLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLL 119

Query: 62  SSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI----TELSRLDYLNLSSNKLSG 116
            +N +   +       M  L  L +S N+I    P E+     +L +L  L+LSSNKL  
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177

Query: 117 --PVPFSNEQLSSMYIVRLSPN 136
                           + L  N
Sbjct: 178 LPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 14/137 (10%)

Query: 10  ELDVGSNSLIGPIPS--TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLSSNKL 66
            LD+  N+ +  + +  T   LT+L  L LS N   + I +E    +  L  L+LSSN L
Sbjct: 43  LLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHL 100

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP---FS 121
              +   + + ++ L  L + NN I   +      ++++L  L LS N++S   P     
Sbjct: 101 H-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIK 157

Query: 122 N-EQLSSMYIVRLSPNK 137
           +  +L  + ++ LS NK
Sbjct: 158 DGNKLPKLMLLDLSSNK 174

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 61.4 bits (149), Expect = 1e-10
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 9/98 (9%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNE--LTWLTGLLGLNLSSNKLSGKIPSQI-ASMK 78
           +P    L +  + LDLS N   S +  E   T LT L  L LS N L+  I S+    + 
Sbjct: 33  VPQ--SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88

Query: 79  NLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
           NL +LD+S+N +  ++   + ++L  L+ L L +N + 
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.3 bits (165), Expect = 7e-13
 Identities = 32/116 (27%), Positives = 58/116 (50%), Gaps = 8/116 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNL 61
            L  L  L +  N L   +P+ +   L +L  L ++ N+   ++P  +   L  L  L L
Sbjct: 59  RLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRL 116

Query: 62  SSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLS 115
             N+L   +P ++  S+  LT+L +  N+++ S+P G   +L+ L  L L +N+L 
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 64.2 bits (157), Expect = 8e-12
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 6/136 (4%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
            LKNL  L V  N L          L +L+ L L RNQ   S+P  +   LT L  L+L 
Sbjct: 83  ELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLG 141

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPF 120
            N+L   +P  +   + +L  L + NN+++  +P G   +L+ L  L L +N+L      
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEG 199

Query: 121 SNEQLSSMYIVRLSPN 136
           + + L  + +++L  N
Sbjct: 200 AFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 7/111 (6%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKL 66
           N   +D  S  L   IPS   +  D   LDL  N+ +S        LT L  L L+ NKL
Sbjct: 17  NKNSVDCSSKKLTA-IPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
              +P+ I   +KNL  L +++NK++ ++P  +  +L  L  L L  N+L 
Sbjct: 74  Q-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK 122

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 43/177 (24%), Positives = 78/177 (44%), Gaps = 31/177 (17%)

Query: 210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRN 267
           V +   E  + +     +G+G YGSV  A    +G+  A+KKL    ++E  A  +++R 
Sbjct: 15  VNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFA-KRAYR- 72

Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHN------NEDA 315
           E  +L  + H N++ L         +      +L+  +M+      +L        +E+ 
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIMGLKFSEEK 127

Query: 316 VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           ++        +V  M   L Y+H   S  ++HRD+   N+ +N   E  + DFG AR
Sbjct: 128 IQY-------LVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 18/165 (10%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 273
           E  E +     +G+G YGSV  A     G   A+KKL    ++   A  +++R E ++L 
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYR-ELRLLK 83

Query: 274 QVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 327
            + H N++ L       + +      +L+   M       +L+N     +L       ++
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQFLI 138

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
             +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR
Sbjct: 139 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 19/180 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           FD    +G G +G V   +    G+ +A   L+K      +E+A   +   E++VL    
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNTR 63

Query: 277 HRNIVKLYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHAL 334
           H  +  L  +       +  + EY   G LF +L       E    +R     A +  AL
Sbjct: 64  HPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTE----ERARFYGAEIVSAL 118

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIAP 393
            YLH   S  +++RDI   N++L+      + DFG  +  +   ++ +T   GT  Y+AP
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAP 174

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 43/204 (21%), Positives = 71/204 (34%), Gaps = 56/204 (27%)

Query: 222 DIKYC----IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRN-EAQVLSQV 275
             KY     +GTG +G V +   + +GK FALKK+             ++N E  ++  +
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVL 57

Query: 276 LHRNIVKLYGF---CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR----VNIV- 327
            H NI+KL  +       +                N   N     +         +N++ 
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 328 --------KAMAH----------------------ALAYLHHDCSPSIIHRDISSNNILL 357
                   K +                        A+ ++H   S  I HRDI   N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLV 174

Query: 358 NSKFEAF-VADFGTARLLHADSSN 380
           NSK     + DFG+A+ L     +
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEPS 198

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 25/168 (14%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRNEAQVLS 273
              + +     IG+G  G V  A      +  A+KKL    + +  A  +++R E  ++ 
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA-KRAYR-ELVLMK 79

Query: 274 QVLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAV---ELDWAKRV 324
            V H+NI+ L      +K +      +++ E M+      NL      V   ELD  +  
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-----ANLCQ----VIQMELDHERMS 130

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
            ++  M   + +LH   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 131 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 64.5 bits (158), Expect = 6e-12
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 23/176 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V  A      +  A+K +      +    ++ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 339
                   +L  EY   G LF  +  +           +    A      +   + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
                I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 41/174 (23%), Positives = 69/174 (39%), Gaps = 21/174 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G +G V  A      +  ALK +     ++         E   L  + H +I+KLY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 339
                  + ++ EY   G LF  +            KR+   +       +  A+ Y H 
Sbjct: 77  VITTPTDIVMVIEYAG-GELFDYIVEK---------KRMTEDEGRRFFQQIICAIEYCH- 125

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
                I+HRD+   N+LL+      +ADFG + ++   +  +T   G+  Y AP
Sbjct: 126 --RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAP 176

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 64.2 bits (157), Expect = 9e-12
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 27/181 (14%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKS-FRNEAQVLSQVLHRNIVKLY 284
           +G G YG V +          A+K L   +   +   ++  + E Q+L ++ H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 285 GFCLH--RKCMFLIYEYMERGS--LFCNLHNNEDAVELDWAKRVNIVKA------MAHAL 334
               +  ++ M+++ EY   G   +        D+V     KR  + +A      +   L
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEML-------DSVP---EKRFPVCQAHGYFCQLIDGL 122

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIA 392
            YLH   S  I+H+DI   N+LL +     ++  G A  LH  +++ T     G+  +  
Sbjct: 123 EYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 393 P 393
           P
Sbjct: 180 P 180

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 40/199 (20%), Positives = 73/199 (36%), Gaps = 45/199 (22%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALK-----------------------KLHTSETEELAFI 262
           IG G YG V  A    +   +A+K                              +    I
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 263 KSFRNEAQVLSQVLHRNIVKLYG--FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDW 320
           +    E  +L ++ H N+VKL       +   +++++E + +G +        +      
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-------EVPT--- 130

Query: 321 AKRVNIVKA------MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL 374
            K ++  +A      +   + YLH      IIHRDI  +N+L+       +ADFG +   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187

Query: 375 HADSSNRTLLAGTYGYIAP 393
               +  +   GT  ++AP
Sbjct: 188 KGSDALLSNTVGTPAFMAP 206

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 59/184 (32%), Positives = 84/184 (45%), Gaps = 21/184 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP----NGKVFA---LKKLHTSETEELAFIKSFRNEAQVLS 273
           F++   +GTG YG V+  +       GK++A   LKK    +  +    +  R E QVL 
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT--TEHTRTERQVLE 113

Query: 274 QVLHRN-IVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-M 330
            +     +V L Y F    K + LI +Y+  G LF +L   E   E      V I    +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEI 168

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYG 389
             AL +LH      II+RDI   NILL+S     + DFG ++   AD + R     GT  
Sbjct: 169 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 390 YIAP 393
           Y+AP
Sbjct: 226 YMAP 229

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 63.7 bits (156), Expect = 2e-11
 Identities = 56/184 (30%), Positives = 85/184 (46%), Gaps = 23/184 (12%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGK----VFALKKLH----TSETEELAFIKSFRNEAQVL 272
           F++   +G GGYG V++ +   G     +FA+K L         ++ A  K+   E  +L
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNIL 75

Query: 273 SQVLHRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-M 330
            +V H  IV L Y F    K ++LI EY+  G LF  L      +E           A +
Sbjct: 76  EEVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME----DTACFYLAEI 130

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYG 389
           + AL +LH      II+RD+   NI+LN +    + DFG  +  +H  +   T   GT  
Sbjct: 131 SMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIE 186

Query: 390 YIAP 393
           Y+AP
Sbjct: 187 YMAP 190

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 19/171 (11%)

Query: 210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTS-ETEELAFIKSFRN 267
           V +      + +     IG+G  G V  A      +  A+KKL    + +  A  +++R 
Sbjct: 53  VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYR- 110

Query: 268 EAQVLSQVLHRNIVKLY------GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWA 321
           E  ++  V H+NI+ L             + ++L+ E M+      NL       ELD  
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-----ANLCQVIQM-ELDHE 164

Query: 322 KRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR 372
           +   ++  M   + +LH   S  IIHRD+  +NI++ S     + DFG AR
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.4 bits (153), Expect = 2e-11
 Identities = 28/218 (12%), Positives = 54/218 (24%), Gaps = 51/218 (23%)

Query: 217 ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLH-----TSETEELAFIKSFRNEAQV 271
            TE       IG G +G V++    +  V A+K +                +    E  +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 272 LSQVL---------HRNIVKLYGFCLHRKC------------------------------ 292
             ++              + L      +                                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS 352
           +F++ E+   G     +           A   +I+  +  +LA      S    HRD+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 353 NNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
            N+LL       +      +     S    +    Y  
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 23/176 (13%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           +G G YG V  A      +  A+K +      +    ++ + E  +   + H N+VK YG
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLNHENVVKFYG 72

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA------MAHALAYLHH 339
                   +L  EY   G LF  +  +           +    A      +   + YLH 
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPD---------IGMPEPDAQRFFHQLMAGVVYLH- 122

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
                I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 123 --GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 39/191 (20%)

Query: 221 FDIKYCIGTGGYGSVY----KAQLPNGKVFALKKL-----------HTSETEELAFIKSF 265
           F++   +G G +G V+     +     +++A+K L            T            
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT------------ 73

Query: 266 RNEAQVLSQVLHRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
           + E  +L +V H  IVKL Y F    K ++LI +++  G LF  L       E    + V
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE----EDV 128

Query: 325 NIVKA-MAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRT 382
               A +A AL +LH   S  II+RD+   NILL+ +    + DFG ++  +  +    +
Sbjct: 129 KFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185

Query: 383 LLAGTYGYIAP 393
              GT  Y+AP
Sbjct: 186 FC-GTVEYMAP 195

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.8 bits (148), Expect = 5e-11
 Identities = 27/133 (20%), Positives = 55/133 (41%), Gaps = 11/133 (8%)

Query: 10  ELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG 68
           EL + +N             L  L  ++ S N+            +G+  + L+SN+L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 69  KIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP---FSNE 123
            +  ++   +++L  L + +N+I   +  +    LS +  L+L  N+++  V    F   
Sbjct: 96  -VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT- 151

Query: 124 QLSSMYIVRLSPN 136
            L S+  + L  N
Sbjct: 152 -LHSLSTLNLLAN 163

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 61.2 bits (149), Expect = 7e-11
 Identities = 32/108 (29%), Positives = 56/108 (51%), Gaps = 4/108 (3%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
           +LD+ S  L     +T   LT L++L+L  NQ  +        LT L  L L++N+L+  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 70  IPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLS 115
           +P  +   +  L  L +  N+++ S+P G    L++L  L L++N+L 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.9 bits (135), Expect = 4e-09
 Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 6/95 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +PS  G+  D   LDL      +        LT L  LNL  N+L   + + +   +  L
Sbjct: 29  VPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKL 114
             L ++NN++  S+P  +   L++LD L L  N+L
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL 119

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 35/111 (31%), Positives = 52/111 (46%), Gaps = 6/111 (5%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLSS 63
           L  L  L + +N L          LT L  L L  NQ   S+P+ +   LT L  L L++
Sbjct: 82  LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNT 140

Query: 64  NKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSN 112
           N+L   IP+     + NL  L +S N+++ S+P G    L +L  + L  N
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 26/86 (30%), Positives = 36/86 (41%), Gaps = 2/86 (2%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
           +L  L +L +G N L          LT L  L L+ NQ   SIP      LT L  L+LS
Sbjct: 105 HLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLS 163

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNN 88
           +N+L          +  L  + +  N
Sbjct: 164 TNQLQSVPHGAFDRLGKLQTITLFGN 189

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 31/186 (16%), Positives = 71/186 (38%), Gaps = 31/186 (16%)

Query: 203 WNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE---- 257
           W+Y+    +       + + +   +G G Y  V++A  + N +   +K L   + +    
Sbjct: 23  WDYE---SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR 79

Query: 258 ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF---LIYEYMERGSLFCNLHNNED 314
           E+  +++ R            NI+ L    +         L++E++       +      
Sbjct: 80  EIKILENLRG---------GPNIITLAD-IVKDPVSRTPALVFEHVNN----TDFKQLYQ 125

Query: 315 AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARL 373
            +     +    +  +  AL Y H   S  I+HRD+  +N++++ +  +  + D+G A  
Sbjct: 126 TLTDYDIRF--YMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180

Query: 374 LHADSS 379
            H    
Sbjct: 181 YHPGQE 186

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.6 bits (145), Expect = 9e-11
 Identities = 36/120 (30%), Positives = 63/120 (52%), Gaps = 13/120 (10%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P   G+  D++ L L  NQF + +P EL+    L  ++LS+N++S  + +Q  ++M  L
Sbjct: 25  LPK--GIPRDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 81  TWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSPN 136
             L +S N++   IP      L  L  L+L  N +S  VP   F++  LS++  + +  N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFND--LSALSHLAIGAN 136

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 60.8 bits (148), Expect = 1e-10
 Identities = 37/117 (31%), Positives = 59/117 (50%), Gaps = 10/117 (8%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGL---LTDLSYLDLSRNQFNSSIPNELTWLTGLLG 58
           I  L N+  L +G N L       +     LT+L+YL L+ NQ  S        LT L  
Sbjct: 59  IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKE 113

Query: 59  LNLSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           L L  N+L   +P  +   + NLT+L++++N+++    G   +L+ L  L+LS N+L
Sbjct: 114 LVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQL 169

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 47/139 (33%), Positives = 69/139 (49%), Gaps = 12/139 (8%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
            L NL  L +  N L   +P+ +   LT+L  L L  NQ  S        LT L  LNL+
Sbjct: 83  ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLA 141

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP- 119
            N+L   +P  +   + NLT LD+S N+++ S+P G   +L++L  L L  N+L   VP 
Sbjct: 142 HNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPD 198

Query: 120 --FSNEQLSSMYIVRLSPN 136
             F    L+S+  + L  N
Sbjct: 199 GVFDR--LTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 17/94 (18%), Positives = 38/94 (40%), Gaps = 8/94 (8%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
            P       +    +L +     ++      L  +  +  +++ +   +   I  + N+ 
Sbjct: 13  FPD--DAFAETIKANLKKKSVTDAVTQNE--LNSIDQIIANNSDIK-SVQG-IQYLPNVR 66

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
           +L +  NK+   I   + EL+ L YL L+ N+L 
Sbjct: 67  YLALGGNKLH-DI-SALKELTNLTYLILTGNQLQ 98

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 38/124 (30%), Positives = 57/124 (45%), Gaps = 8/124 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           +  LK    L + +N  I  I S+L  + +L  L L RN     I N       L  L +
Sbjct: 44  LSTLKACKHLALSTN-NIEKI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWI 100

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIE--GSIPGEITELSRLDYLNLSSNKLSGPVP 119
           S N+++  + S I  + NL  L +SNNKI   G I  ++  L +L+ L L+ N L     
Sbjct: 101 SYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLYNDYK 157

Query: 120 FSNE 123
            +N 
Sbjct: 158 ENNA 161

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 6/108 (5%)

Query: 8   LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS 67
            +EL       I  + +TL  L    +L LS N     I + L+ +  L  L+L  N + 
Sbjct: 27  KVELHGMIPP-IEKMDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIK 83

Query: 68  GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS 115
            KI +  A    L  L IS N+I  S+ G I +L  L  L +S+NK++
Sbjct: 84  -KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKIT 128

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.3 bits (144), Expect = 2e-10
 Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 4/129 (3%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
           E+ +  N++    P        L  +DLS NQ +   P+    L  L  L L  NK++ +
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 70  IPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFSNEQLSS 127
           +P  +   + +L  L ++ NKI   +      +L  L+ L+L  NKL      +   L +
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 128 MYIVRLSPN 136
           +  + L+ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.5 bits (142), Expect = 4e-10
 Identities = 27/111 (24%), Positives = 50/111 (45%), Gaps = 4/111 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLS 62
             K L  +D+ +N +    P     L  L+ L L  N+  + +P  L   L  L  L L+
Sbjct: 54  PYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLN 112

Query: 63  SNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           +NK++  +       + NL  L + +NK++    G  + L  +  ++L+ N
Sbjct: 113 ANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 28/121 (23%), Positives = 57/121 (47%), Gaps = 12/121 (9%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           IP+   L   ++ + L +N      P   +    L  ++LS+N++S ++       +++L
Sbjct: 26  IPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82

Query: 81  TWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSPN 136
             L +  NKI   +P  +   L  L  L L++NK++  +    F +  L ++ ++ L  N
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQD--LHNLNLLSLYDN 138

Query: 137 K 137
           K
Sbjct: 139 K 139

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 59.2 bits (144), Expect = 2e-10
 Identities = 24/115 (20%), Positives = 43/115 (37%), Gaps = 7/115 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE--LTWLTGLLGLN 60
           NL  +  +++ +   +  I    L  L  L +L +         P+   +        L 
Sbjct: 78  NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILE 136

Query: 61  LSSNKLSGKIPSQI-ASMKNLT-WLDISNNKIEGSIPGEITELSRLDYLNLSSNK 113
           ++ N     IP      + N T  L + NN    S+ G     ++LD + L+ NK
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.9 bits (143), Expect = 4e-10
 Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 18/158 (11%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
           NL N+  + V  +  +  + S +   L+ ++++++   +  + I  + L  L  L  L +
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112

Query: 62  SSNKLSGKIP--SQIASMKNLTWLDISNNKIEGSIP-GEITEL-SRLDYLNLSSNKLSGP 117
            +  L    P  +++ S      L+I++N    SIP      L +    L L +N  +  
Sbjct: 113 FNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTS- 170

Query: 118 VP---FSNEQLSSMYIVRLSPNKGLC----GNFSALPS 148
           V    F+  +L ++Y   L+ NK L       F  + S
Sbjct: 171 VQGYAFNGTKLDAVY---LNKNKYLTVIDKDAFGGVYS 205

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.1 bits (141), Expect = 6e-10
 Identities = 24/115 (20%), Positives = 41/115 (35%), Gaps = 8/115 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTL--GLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
           + +      L++  N  +  IP     GL  +   L L  N F +S+       T L  +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAV 184

Query: 60  NLSSNKLSGKIPSQIAS--MKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
            L+ NK    I            + LD+S   +  ++P +   L  L  L   + 
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 17/92 (18%), Positives = 36/92 (39%), Gaps = 4/92 (4%)

Query: 27  GLLTDLSYLDLSRNQFNSSIP-NELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNLTWLD 84
            L      L L       +IP +  + L  +  + +S +    ++ S    ++  +T ++
Sbjct: 28  SLPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIE 86

Query: 85  ISNNKIEGSIPGEI-TELSRLDYLNLSSNKLS 115
           I N +    I  +   EL  L +L + +  L 
Sbjct: 87  IRNTRNLTYIDPDALKELPLLKFLGIFNTGLK 118

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 6/117 (5%)

Query: 4   NLKNLIELDVGSNSLIG-PIPSTLGLLTDLSYLDLSRNQFNSSIP-NELTWLTGLLG-LN 60
            L  L  L + +  L   P  + +        L+++ N + +SIP N    L      L 
Sbjct: 103 ELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162

Query: 61  LSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE--LSRLDYLNLSSNKLS 115
           L +N  +  +     +   L  + ++ NK    I  +      S    L++S   ++
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 49/181 (27%), Positives = 83/181 (45%), Gaps = 20/181 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           FD+   IG G Y  V   +L    +++A   +KK   ++ E++ ++++   E  V  Q  
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT---EKHVFEQAS 67

Query: 277 -HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
            H  +V L   F    + +F + EY+  G L  ++       E    +      A ++ A
Sbjct: 68  NHPFLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLA 122

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIA 392
           L YLH      II+RD+  +N+LL+S+    + D+G  +  L    +  T   GT  YIA
Sbjct: 123 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 178

Query: 393 P 393
           P
Sbjct: 179 P 179

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.9 bits (146), Expect = 3e-10
 Identities = 48/183 (26%), Positives = 79/183 (43%), Gaps = 24/183 (13%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F +   +G G +G V+ A+     + FA   LKK      +++        E +VLS   
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMV---EKRVLSLAW 75

Query: 277 -HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
            H  +  +   F      +F + EY+  G L  ++ +     +L  A       A +   
Sbjct: 76  EHPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQS-CHKFDLSRAT---FYAAEIILG 130

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARL-LHADSSNRTLLAGTYGY 390
           L +LH   S  I++RD+  +NILL+   +  +  ADFG  +  +  D+   T   GT  Y
Sbjct: 131 LQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDAKTNT-FCGTPDY 184

Query: 391 IAP 393
           IAP
Sbjct: 185 IAP 187

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 20/181 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           FD+   IG G Y  V   +L    +++A   +KK   ++ E++ ++++   E  V  Q  
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQT---EKHVFEQAS 110

Query: 277 -HRNIVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
            H  +V L+  C   +  +F + EY+  G L  ++       E    +      A ++ A
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE----EHARFYSAEISLA 165

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIA 392
           L YLH      II+RD+  +N+LL+S+    + D+G  +  L    +  T   GT  YIA
Sbjct: 166 LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221

Query: 393 P 393
           P
Sbjct: 222 P 222

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.5 bits (144), Expect = 6e-10
 Identities = 20/121 (16%), Positives = 40/121 (33%), Gaps = 6/121 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           IPS   L  +   L     +         +    L  + +S N +   I + + +++  L
Sbjct: 24  IPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81

Query: 81  TWLDISN-NKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG 138
             + I   N +   I  E    L  L YL +S+  +               ++ +  N  
Sbjct: 82  HEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140

Query: 139 L 139
           +
Sbjct: 141 I 141

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 29/150 (19%), Positives = 52/150 (34%), Gaps = 9/150 (6%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGL-LTDLSYLDLSRNQFNSSIP-NELTWLTGLLG-LN 60
           NL NL  L + +   I  +P    +       LD+  N    +I  N    L+     L 
Sbjct: 102 NLPNLQYLLISNTG-IKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160

Query: 61  LSSNKLSGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPV 118
           L+ N +  +I +      +        NN +E  +P ++    S    L++S  ++    
Sbjct: 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLP 218

Query: 119 PFSNEQLSSMYIVRLSPNKGLCGNFSALPS 148
            +  E L  +        K L      L +
Sbjct: 219 SYGLENLKKLRARSTYNLKKL-PTLEKLVA 247

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 50.2 bits (120), Expect = 5e-07
 Identities = 22/117 (18%), Positives = 39/117 (33%), Gaps = 6/117 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNL 61
              +L ++++  N ++  I +     L  L  + + +      I  E    L  L  L +
Sbjct: 52  GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLI 111

Query: 62  SSNKLSGKIPSQI-ASMKNLTWLDIS-NNKIEGSIPGEITELS-RLDYLNLSSNKLS 115
           S+  +   +P            LDI  N  I          LS     L L+ N + 
Sbjct: 112 SNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 43.7 bits (103), Expect = 7e-05
 Identities = 18/86 (20%), Positives = 36/86 (41%), Gaps = 5/86 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           N   L EL++  N+ +  +P+      +    LD+SR + +S     L  L  L   +  
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNN 88
           + K   K+P+ +  +  L    ++  
Sbjct: 235 NLK---KLPT-LEKLVALMEASLTYP 256

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 42/183 (22%), Positives = 79/183 (43%), Gaps = 20/183 (10%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQ 274
             F+    +G G +G V  ++     +++A   LKK    + +++        E +VL+ 
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLAL 397

Query: 275 VL-HRNIVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MA 331
                 + +L+  C      ++ + EY+  G L  ++       E           A +A
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE----PHAVFYAAEIA 452

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGY 390
             L +L    S  II+RD+  +N++L+S+    +ADFG  +  +    + +T   GT  Y
Sbjct: 453 IGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDY 508

Query: 391 IAP 393
           IAP
Sbjct: 509 IAP 511

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.2 bits (144), Expect = 7e-10
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F     IG G +G V  A+       +A   L+K    + +E   I S RN   VL + +
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN---VLLKNV 96

Query: 277 -HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
            H  +V L + F    K ++ + +Y+  G LF +L      +E     R     A +A A
Sbjct: 97  KHPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLE----PRARFYAAEIASA 151

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIA 392
           L YLH   S +I++RD+   NILL+S+    + DFG  +  +  +S+  T   GT  Y+A
Sbjct: 152 LGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLA 207

Query: 393 P 393
           P
Sbjct: 208 P 208

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 8e-10
 Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 20/181 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+    +G G +G V  A++   G ++A   LKK    + +++    +   E ++LS   
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMT---EKRILSLAR 81

Query: 277 -HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
            H  + +L   F    + +F + E++  G L  ++  +    E     R     A +  A
Sbjct: 82  NHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEIISA 136

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIA 392
           L +LH      II+RD+  +N+LL+ +    +ADFG  +  +    +  T   GT  YIA
Sbjct: 137 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIA 192

Query: 393 P 393
           P
Sbjct: 193 P 193

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 58.8 bits (143), Expect = 9e-10
 Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 20/181 (11%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFA---LKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           F+    +G G +G V  ++     +++A   LKK    + +++        E +VL+   
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV---EKRVLALPG 78

Query: 277 -HRNIVKL-YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKA-MAHA 333
               + +L   F    + ++ + EY+  G L  ++       +   A       A +A  
Sbjct: 79  KPPFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAV---FYAAEIAIG 133

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL-LHADSSNRTLLAGTYGYIA 392
           L +L    S  II+RD+  +N++L+S+    +ADFG  +  +    + +T   GT  YIA
Sbjct: 134 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIA 189

Query: 393 P 393
           P
Sbjct: 190 P 190

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 40/176 (22%), Positives = 69/176 (39%), Gaps = 26/176 (14%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG 285
           IG+G +G     +     ++ A+K +      +    ++ + E      + H NIV+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKE 83

Query: 286 FCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA------HALAYLHH 339
             L    + +I EY   G L+  + N           R +  +A          ++Y H 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNA---------GRFSEDEARFFFQQLLSGVSYCH- 133

Query: 340 DCSPSIIHRDISSNNILLNSKFEAF--VADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S  I HRD+   N LL+        + DFG ++     S  ++ + GT  YIAP
Sbjct: 134 --SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAP 186

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 2e-09
 Identities = 29/113 (25%), Positives = 46/113 (40%), Gaps = 8/113 (7%)

Query: 4   NLKNLIELDV-GSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
               + EL +    S  G I        +L +L L       S+ N L  L  L  L LS
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELS 79

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSR---LDYLNLSSN 112
            N++ G +      + NLT L++S NK++      +  L +   L  L+L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 54.4 bits (131), Expect = 4e-09
 Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 29  LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN 88
           + +L  LD  ++  +  I         L  L+L +  L   + S +  +  L  L++S N
Sbjct: 26  VREL-VLDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSEN 81

Query: 89  KIEGSIPGEITELSRLDYLNLSSNKLS 115
           +I G +     +L  L +LNLS NKL 
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLK 108

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 24/92 (26%), Positives = 37/92 (40%), Gaps = 7/92 (7%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
                NL  L + +  L  +  +P     L  L  L+LS N+    +      L  L  L
Sbjct: 45  TAEFVNLEFLSLINVGLISVSNLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100

Query: 60  NLSSNKLSG-KIPSQIASMKNLTWLDISNNKI 90
           NLS NKL        +  ++ L  LD+ N ++
Sbjct: 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 1e-05
 Identities = 25/91 (27%), Positives = 42/91 (46%), Gaps = 7/91 (7%)

Query: 47  PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDY 106
           P  +  L     L+   +   GKI    A   NL +L + N  +  S+   + +L +L  
Sbjct: 23  PAAVRELV----LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKK 75

Query: 107 LNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           L LS N++ G +    E+L ++  + LS NK
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNK 106

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.0 bits (133), Expect = 3e-09
 Identities = 25/112 (22%), Positives = 45/112 (40%), Gaps = 8/112 (7%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           N     ELD+     I  I +    L     +D S N+    +      L  L  L +++
Sbjct: 17  NAVRDRELDLRGY-KIPVIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKTLLVNN 73

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELS---RLDYLNLSSN 112
           N++         ++ +LT L ++NN +     G++  L+    L YL +  N
Sbjct: 74  NRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.9 bits (130), Expect = 6e-09
 Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 3/87 (3%)

Query: 29  LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN 88
                 LDL   +    I N    L     ++ S N++  K+      ++ L  L ++NN
Sbjct: 18  AVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNN 74

Query: 89  KIEGSIPGEITELSRLDYLNLSSNKLS 115
           +I     G    L  L  L L++N L 
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNSLV 101

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 18/85 (21%), Positives = 37/85 (43%), Gaps = 3/85 (3%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
                 L+L   K+   I +  A++     +D S+N+I   + G    L RL  L +++N
Sbjct: 18  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 74

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
           ++       ++ L  +  + L+ N 
Sbjct: 75  RICRIGEGLDQALPDLTELILTNNS 99

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.1 bits (102), Expect = 3e-05
 Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 3/88 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
            L     +D   N  I  +     LL  L  L ++ N+           L  L  L L++
Sbjct: 40  TLDQFDAIDFSDNE-IRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97

Query: 64  NKLSG-KIPSQIASMKNLTWLDISNNKI 90
           N L        +AS+K+LT+L I  N +
Sbjct: 98  NSLVELGDLDPLASLKSLTYLCILRNPV 125

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 15/134 (11%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS---SIPNELTWLTGLLGLNLSSNKL 66
            L +  N +    P     L +L  L L  NQ  +    + + LT LT    L+L +N+L
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLT---VLDLGTNQL 100

Query: 67  SGKIPSQI-ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP---FSN 122
           +  +PS +   + +L  L +  NK+   +P  I  L+ L +L L  N+L   +P   F  
Sbjct: 101 T-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDR 157

Query: 123 EQLSSMYIVRLSPN 136
             LSS+    L  N
Sbjct: 158 --LSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.1 bits (133), Expect = 6e-09
 Identities = 33/117 (28%), Positives = 52/117 (44%), Gaps = 5/117 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P+  G+ T+   L L  NQ     P     L  L  L L SN+L   +P  +  S+  L
Sbjct: 34  VPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           T LD+  N++          L  L  L +  NKL+  +P   E+L+ +  + L  N+
Sbjct: 91  TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQ 146

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 5e-09
 Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 2/94 (2%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGLNLSSNKLSGKIPSQIASMKNL 80
               L    +L+ L +   Q    +    L  L  L  L +  + L    P        L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           + L++S N +E S+  +  +   L  L LS N L
Sbjct: 83  SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 7e-09
 Identities = 19/100 (19%), Positives = 32/100 (32%), Gaps = 8/100 (8%)

Query: 45  SIPNELTWLTGLLGLNLSSNKLSGKIPSQ-IASMKNLTWLDISNNKIEGSIPGEI-TELS 102
              + L     L  L + + +    +  + +  +  L  L I  + +   +  +      
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 103 RLDYLNLSSNKLSG--PVPFSNEQLSSMYIVRLSPNKGLC 140
           RL  LNLS N L            L  +    LS N   C
Sbjct: 81  RLSRLNLSFNALESLSWKTVQGLSLQELV---LSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 2e-08
 Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 4/89 (4%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNE-LTWLTGLLGL 59
           +   +NL EL + +   +  +    L  L +L  L + ++     +  +   +   L  L
Sbjct: 27  LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLSRL 85

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNN 88
           NLS N L   +  +     +L  L +S N
Sbjct: 86  NLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 14/76 (18%), Positives = 27/76 (35%), Gaps = 1/76 (1%)

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFS 121
           +   +      +   +NLT L I N +    +   ++  L  L  L +  + L    P +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75

Query: 122 NEQLSSMYIVRLSPNK 137
                 +  + LS N 
Sbjct: 76  FHFTPRLSRLNLSFNA 91

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 5e-09
 Identities = 21/87 (24%), Positives = 40/87 (45%), Gaps = 4/87 (4%)

Query: 29  LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN 88
           + +L  LD SR+     +         L  L+  +  L+  I + +  +  L  L++S+N
Sbjct: 19  VKEL-VLDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDN 74

Query: 89  KIEGSIPGEITELSRLDYLNLSSNKLS 115
           ++ G +     +   L +LNLS NK+ 
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIK 101

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 23/92 (25%), Positives = 37/92 (40%), Gaps = 7/92 (7%)

Query: 2   IGNLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGL 59
               + L  L   +  L  I  +P     L  L  L+LS N+ +  +         L  L
Sbjct: 38  TDEFEELEFLSTINVGLTSIANLPK----LNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93

Query: 60  NLSSNKLSG-KIPSQIASMKNLTWLDISNNKI 90
           NLS NK+        +  ++NL  LD+ N ++
Sbjct: 94  NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 22/80 (27%), Positives = 41/80 (51%), Gaps = 3/80 (3%)

Query: 59  LNLSSNKLS-GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGP 117
           L L +++ + GK+       + L +L   N  +  SI   + +L++L  L LS N++SG 
Sbjct: 22  LVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNRVSGG 79

Query: 118 VPFSNEQLSSMYIVRLSPNK 137
           +    E+  ++  + LS NK
Sbjct: 80  LEVLAEKCPNLTHLNLSGNK 99

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 7e-09
 Identities = 22/94 (23%), Positives = 40/94 (42%), Gaps = 10/94 (10%)

Query: 227 IGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRN 279
           +G G +G V +A           +  A+K L    T      ++  +E ++L  +  H N
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLN 87

Query: 280 IVKLYGFCLHRKC-MFLIYEYMERGSLFCNLHNN 312
           +V L G C      + +I E+ + G+L   L + 
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P+  G+    +YLDL  N   S        LT L  L L  NKL   +P+ +   + +L
Sbjct: 22  VPT--GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           T+L++S N+++    G   +L++L  L L++N+L
Sbjct: 79  TYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL 112

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
            LD+ +NSL          LT L+ L L  N+  S        LT L  LNLS+N+L   
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 70  IPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP---FSNEQ 124
           +P+ +   +  L  L ++ N+++ S+P G   +L++L  L L  N+L   VP   F    
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDR-- 146

Query: 125 LSSMYIVRLSPN 136
           L+S+  + L  N
Sbjct: 147 LTSLQYIWLHDN 158

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 31/121 (25%), Positives = 51/121 (42%), Gaps = 13/121 (10%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLSSNKLSGKIPSQI-ASMKN 79
           IP    +    + L L+ N+      + L   L  L+ L L  N+L+  I         +
Sbjct: 23  IPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79

Query: 80  LTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSP 135
           +  L +  NKI+  I       L +L  LNL  N++S  V    F +  L+S+  + L+ 
Sbjct: 80  IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEH--LNSLTSLNLAS 135

Query: 136 N 136
           N
Sbjct: 136 N 136

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 6/95 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P+  G+ +  + L+L  N+  S        LT L  L+LS N++   +P  +   +  L
Sbjct: 22  VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKL 78

Query: 81  TWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKL 114
           T L +  NK++ S+P G   +L++L  L L +N+L
Sbjct: 79  TILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 51.9 bits (123), Expect = 2e-07
 Identities = 22/129 (17%), Positives = 43/129 (33%), Gaps = 18/129 (13%)

Query: 5   LKNLIELDVGSNSLIGPIPSTLG--LLTDLSYLDLSRNQFNSSIPNELTWLTGLLG---- 58
             NL  L++ S  L   +   +    L +L  L L     +     ++     L      
Sbjct: 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 59  -----LNLSSNKLSGKIPSQIAS---MKNLTWLDISNNKI--EG--SIPGEITELSRLDY 106
                L +   +    +         +  L  +DIS   +  EG   +   + ++  L +
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 107 LNLSSNKLS 115
           +N+  N LS
Sbjct: 312 INMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 42.2 bits (98), Expect = 2e-04
 Identities = 15/101 (14%), Positives = 38/101 (37%), Gaps = 15/101 (14%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTL-------GLLTDLSYLDLSRNQFNSSIPNEL---TWL 53
           NL+ L  L VG           +           +L +L +   +  + +         L
Sbjct: 220 NLEKL-VLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 54  TGLLGLNLSSNKLSGK----IPSQIASMKNLTWLDISNNKI 90
             L  +++S+  L+ +    +   +  +K+L ++++  N +
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 40.7 bits (94), Expect = 6e-04
 Identities = 12/82 (14%), Positives = 27/82 (32%), Gaps = 7/82 (8%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLG---LLTDLSYLDLSRNQFNSS----IPNELTWLTG 55
               NL  L +        +        +L  L  +D+S           + + +  +  
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308

Query: 56  LLGLNLSSNKLSGKIPSQIASM 77
           L  +N+  N LS ++  ++   
Sbjct: 309 LKFINMKYNYLSDEMKKELQKS 330

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 34/177 (19%), Positives = 69/177 (38%), Gaps = 42/177 (23%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---------- 275
           +G G + +V+ A+ + N    A+K +   +     + ++  +E ++L +V          
Sbjct: 27  LGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDS 82

Query: 276 -LHRNIVKLYGFCLHRKC----MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI--VK 328
               +I+KL     H+      + +++E +   +L   +   E        + + +  VK
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-------RGIPLIYVK 134

Query: 329 AMAH----ALAYLHHDCSPSIIHRDISSNNILLNSKFEAF------VADFGTARLLH 375
            ++      L Y+H  C   IIH DI   N+L+             +AD G A    
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 20/145 (13%), Positives = 39/145 (26%), Gaps = 33/145 (22%)

Query: 2   IGNLKNLIELDVGSNSLIGP-----IPSTLGLLTDLSYLDLSRNQFN----------SSI 46
           +    ++ E+ +  N+ IG      +   +    DL   + S                 +
Sbjct: 28  LLEDDSVKEIVLSGNT-IGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLL 86

Query: 47  PNELTWLTGLLGLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKI------------ 90
              L     L  + LS N         +         L  L + NN +            
Sbjct: 87  LQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL 146

Query: 91  -EGSIPGEITELSRLDYLNLSSNKL 114
            E ++  +      L  +    N+L
Sbjct: 147 QELAVNKKAKNAPPLRSIICGRNRL 171

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 21/141 (14%), Positives = 41/141 (29%), Gaps = 28/141 (19%)

Query: 2   IGNLKNLIELDVGSNSLIGP--------------IPSTLGLLTDLSYLDLSRNQFN---- 43
           +     L  L + +N  +GP              +         L  +   RN+      
Sbjct: 118 LSKHTPLEHLYLHNNG-LGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176

Query: 44  SSIPNELTWLTGLLGLNLSSNKLSGK-----IPSQIASMKNLTWLDISNNKI--EG--SI 94
                       L  + +  N +  +     +   +A  + L  LD+ +N     G  ++
Sbjct: 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 236

Query: 95  PGEITELSRLDYLNLSSNKLS 115
              +     L  L L+   LS
Sbjct: 237 AIALKSWPNLRELGLNDCLLS 257

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 40.5 bits (95), Expect = 6e-04
 Identities = 24/132 (18%), Positives = 50/132 (37%), Gaps = 23/132 (17%)

Query: 6   KNLIELDVGSNSLIGP-----IPSTLGLLTDLSYLDLSRNQFNS----SIPNELTWL--T 54
           + L  LD+  N+         +   L    +L  L L+    ++    ++ +  + L   
Sbjct: 216 QELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI 274

Query: 55  GLLGLNLSSNKLSGKIPSQIAS-----MKNLTWLDISNNKI--EGSIPGEITEL----SR 103
           GL  L L  N++       + +     M +L +L+++ N+   E  +  EI E+     R
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGR 334

Query: 104 LDYLNLSSNKLS 115
            +   L   +  
Sbjct: 335 GELDELDDMEEL 346

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 49.7 bits (119), Expect = 9e-07
 Identities = 36/169 (21%), Positives = 61/169 (36%), Gaps = 36/169 (21%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR- 278
           +++   IG G +G V KA      +  ALK +           K F  +A    ++L   
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN--------EKRFHRQAAEEIRILEHL 150

Query: 279 ---------NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-----NNEDAVELDWAKRV 324
                    N++ +      R  + + +E +       NL+     N      L   ++ 
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRNHICMTFELLS-----MNLYELIKKNKFQGFSLPLVRK- 204

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KFEAFVADFGTA 371
               ++   L  LH      IIH D+   NILL    +    V DFG++
Sbjct: 205 -FAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 35/163 (21%)

Query: 219 EGFDIKYCI----GTGGYGSVYKAQ-LPNGKVFALK--KLHTSETEELAFIKSFRNEAQV 271
           + F+ +Y +    G G + +V+ +  +   K  A+K  K     TE         +E ++
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA------LDEIRL 86

Query: 272 LSQVL--------HRNIVKLYG-FCLHRK-----CMFLIYEYMERGSLFCNLHNNED-AV 316
           L  V            +V+L   F +        CM  ++E +    L   +  +    +
Sbjct: 87  LKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM--VFEVL-GHHLLKWIIKSNYQGL 143

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS 359
            L   K+  I++ +   L YLH  C   IIH DI   NILL+ 
Sbjct: 144 PLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSV 182

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 47/185 (25%), Positives = 78/185 (42%), Gaps = 34/185 (18%)

Query: 204 NYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFI 262
           NYD  +   +     + ++I   IG G +G V KA      +  A+K            I
Sbjct: 41  NYDYIVKNGEKW--MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK-----------II 87

Query: 263 KS---FRNEAQVLSQVLHR----------NIVKLYGFCLHRKCMFLIYEYMERGSLFCNL 309
           K+   F N+AQ+  ++L             IV L    + R  + L++E +   +L+  L
Sbjct: 88  KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLL 146

Query: 310 -HNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKFEAFVA 366
            + N   V L+  ++    + M  AL +L      SIIH D+   NILL    +    + 
Sbjct: 147 RNTNFRGVSLNLTRK--FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203

Query: 367 DFGTA 371
           DFG++
Sbjct: 204 DFGSS 208

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 29/127 (22%), Positives = 46/127 (36%), Gaps = 18/127 (14%)

Query: 7   NLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSS-----IPNELTWLTGLL 57
            + +L + +  L     G + STL  L  L  L LS N    +         L     L 
Sbjct: 86  KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145

Query: 58  GLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKIEGSIPGEITEL-----SRLDYLN 108
            L L    LS      +AS+     +   L +SNN I  +    + +       +L+ L 
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205

Query: 109 LSSNKLS 115
           L S  ++
Sbjct: 206 LESCGVT 212

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 27/127 (21%), Positives = 45/127 (35%), Gaps = 18/127 (14%)

Query: 7   NLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSS----IPNELTWLT-GLL 57
            L +L +   SL      P+ S L    D   L +S N  N +    +   L      L 
Sbjct: 143 RLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLE 202

Query: 58  GLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKIEGS-----IPGEITELSRLDYLN 108
            L L S  ++      +  +     +L  L + +NK+         PG +   SRL  L 
Sbjct: 203 ALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262

Query: 109 LSSNKLS 115
           +    ++
Sbjct: 263 IWECGIT 269

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 18/129 (13%)

Query: 5   LKNLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWL-----TG 55
           L+    + +    L       I S L +   L+ L+L  N+      + +          
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 56  LLGLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKIEGSIPGEITEL-----SRLDY 106
           +  L+L +  L+G     ++S       L  L +S+N +  +    + E       RL+ 
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 107 LNLSSNKLS 115
           L L    LS
Sbjct: 147 LQLEYCSLS 155

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 26/124 (20%), Positives = 39/124 (31%), Gaps = 14/124 (11%)

Query: 6   KNLIELDVGSNSLIGP-IPSTLGLLTDLSYLDLSRNQFN----SSIPNELTWLTGLLGLN 60
            ++  LD+    L        L LL     + L            I + L     L  LN
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 61  LSSNKLSGKIPSQIASM-----KNLTWLDISNNKI--EG--SIPGEITELSRLDYLNLSS 111
           L SN+L       +          +  L + N  +   G   +   +  L  L  L+LS 
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 112 NKLS 115
           N L 
Sbjct: 123 NLLG 126

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/128 (21%), Positives = 45/128 (35%), Gaps = 18/128 (14%)

Query: 6   KNLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSS----IPNELTW-LTGL 56
             L  L +    +     G +   L     L  L L+ N+        +   L      L
Sbjct: 256 SRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQL 315

Query: 57  LGLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKIEGSIPGEITEL-----SRLDYL 107
             L + S   +    S  +S+    + L  L ISNN++E +   E+ +      S L  L
Sbjct: 316 ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVL 375

Query: 108 NLSSNKLS 115
            L+   +S
Sbjct: 376 WLADCDVS 383

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.9 bits (107), Expect = 8e-06
 Identities = 31/105 (29%), Positives = 52/105 (49%), Gaps = 7/105 (6%)

Query: 10  ELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK 69
            +D    SL   +P+  G+ T    L L  NQ     P     LT L  L+L +N+L+  
Sbjct: 13  TVDCSGKSL-ASVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-V 68

Query: 70  IPSQI-ASMKNLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSN 112
           +P+ +   +  LT L +++N+++ SIP G    L  L ++ L +N
Sbjct: 69  LPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.6 bits (106), Expect = 1e-05
 Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI-ASMKNL 80
           +P+  G+ TD   L L+ NQ     P     L  L  L  +SNKL+  IP+ +   +  L
Sbjct: 27  VPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQL 83

Query: 81  TWLDISNNKIEGSIP-GEITELSRLDYLNLSSN 112
           T LD+++N ++ SIP G    L  L ++ L +N
Sbjct: 84  TQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 40/173 (23%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALK-----KLHTSET----EELAFIKSFRNEAQVLSQVLH 277
           IG GG+G +Y A + + +          K+  S+      EL F +      Q+   +  
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 278 RN-----IVKLYGFCLHRKCM----FLIYEYMERGSLFCNLHNNEDAVELDWAKR----- 323
           R      + K +G  LH K      F+I   M+R     +L   +     +   +     
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDR--FGSDL---QKI--YEANAKRFSRK 152

Query: 324 --VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--AFVADFGTAR 372
             + +   +   L Y+H       +H DI ++N+LLN K     ++ D+G A 
Sbjct: 153 TVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.9 bits (104), Expect = 4e-05
 Identities = 30/156 (19%), Positives = 57/156 (36%), Gaps = 26/156 (16%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLY 284
           IG+G +G +Y    +  G+  A+K                  E+++   +     I  + 
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIR 71

Query: 285 GFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
                     ++ E +   SL     FC+   +   V       + +   M   + Y+H 
Sbjct: 72  WCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTV-------LLLADQMISRIEYIH- 122

Query: 340 DCSPSIIHRDISSNNILL---NSKFEAFVADFGTAR 372
             S + IHRD+  +N L+         ++ DFG A+
Sbjct: 123 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 35/182 (19%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKL 283
           IG+G +G +Y    +   +  A+K  +               E+++  ++L     I  +
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIY-RILQGGTGIPNV 68

Query: 284 YGFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
             F +      L+ + +   SL     FC+   +   V       + +   M + + ++H
Sbjct: 69  RWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTV-------LMLADQMINRVEFVH 120

Query: 339 HDCSPSIIHRDISSNNILLNSKFEA---FVADFGTARL-------LHADSSNRTLLAGTY 388
              S S +HRDI  +N L+     A   ++ DFG A+         H        L GT 
Sbjct: 121 ---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177

Query: 389 GY 390
            Y
Sbjct: 178 RY 179

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 31/158 (19%), Positives = 54/158 (34%), Gaps = 28/158 (17%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLY 284
           IG G +G +++   L N +  A+K                R+E +    +     I  +Y
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVY 72

Query: 285 GFCLHRKCMFLIYEYMERGSL-----FCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
            F        L+ + +   SL      C    +   V           K M   +  +H 
Sbjct: 73  YFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTV-------AMAAKQMLARVQSIH- 123

Query: 340 DCSPSIIHRDISSNNILLNSKFEA-----FVADFGTAR 372
               S+++RDI  +N L+           +V DFG  +
Sbjct: 124 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 33/166 (19%), Positives = 59/166 (35%), Gaps = 32/166 (19%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-R 278
           F +   IG G +G +   + L   +  A+K                  E +   Q+    
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGD 65

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR-------VNIVKAMA 331
            I ++Y F    K   ++ E +   SL       ED    D   R       + I   + 
Sbjct: 66  GIPQVYYFGPCGKYNAMVLELLGP-SL-------EDL--FDLCDRTFSLKTVLMIAIQLI 115

Query: 332 HALAYLHHDCSPSIIHRDISSNNILL-----NSKFEAFVADFGTAR 372
             + Y+H   S ++I+RD+   N L+      ++    + DF  A+
Sbjct: 116 SRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 34/173 (19%), Positives = 63/173 (36%), Gaps = 40/173 (23%)

Query: 227 IGTGGYGSVYKAQ---------LPNGKVFALK--KLHTSETEELAFIKSFRNEAQV---- 271
                 G +Y+A           P  + F+LK          E  F +      QV    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 272 -LSQVLHRNIVKLYGFCLHR-KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------ 323
            L       I    GF +H+ K  FL+   +    L  +L   + A  LD + +      
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPS--LGRSL---QSA--LDVSPKHVLSER 159

Query: 324 --VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA--FVADFGTAR 372
             + +   +  AL +LH       +H ++++ NI ++ + ++   +A +G A 
Sbjct: 160 SVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.9 bits (100), Expect = 2e-04
 Identities = 60/424 (14%), Positives = 112/424 (26%), Gaps = 158/424 (37%)

Query: 51  TWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLS 110
           TW+   +     S K+  K+  +I       WL++ N     ++   +  L +L    + 
Sbjct: 164 TWVALDV---CLSYKVQCKMDFKIF------WLNLKNCNSPETV---LEMLQKL-LYQID 210

Query: 111 SNKLSGPVPFSN---------EQLSSMYIVRLSPNKGL------------------C--- 140
            N  S     SN          +L  +   +   N  L                  C   
Sbjct: 211 PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN-CLLVLLNVQNAKAWNAFNLSCKIL 269

Query: 141 ------GNFSALPSCDA------------TKPATLFVEIF----------LP---LAIVP 169
                      L +               T        +           LP   L   P
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK--SLLLKYLDCRPQDLPREVLTTNP 327

Query: 170 SVI-VFACLLVVK-------RKYKKPKLKANATNSIGV------------FSIWNYDGRI 209
             + + A  +          +     KL     +S+ V             S++     I
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHI 387

Query: 210 -------VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFI 262
                  ++ D+I++     +        Y  V K   P     ++  ++      L   
Sbjct: 388 PTILLSLIWFDVIKSDVMVVVNKLHK---YSLVEKQ--PKESTISIPSIY------LELK 436

Query: 263 KSFRNEAQVLSQVLHRNIVKLY----GFCLHRK---------CMFLIY-----EYMERGS 304
               NE       LHR+IV  Y     F                 + +     E+ ER +
Sbjct: 437 VKLENEYA-----LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT 491

Query: 305 LFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEA 363
           LF  +  +       + ++    K        + HD +    +   S  N L     ++ 
Sbjct: 492 LFRMVFLD-----FRFLEQ----K--------IRHDSTA--WNASGSILNTLQQLKFYKP 532

Query: 364 FVAD 367
           ++ D
Sbjct: 533 YICD 536

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 38/170 (22%), Positives = 62/170 (36%), Gaps = 37/170 (21%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETE------ELAFIKSFRNEAQV-----LSQ 274
           IG+GG+G +Y A      +  A   +     E      EL F +    +  +       Q
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 275 VLHRNIVKLYGFCLH----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------V 324
           + +  I   YG  L     R   F++   MER  L  +L   +                +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMV---MER--LGIDL---QKI--SGQNGTFKKSTVL 154

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--AFVADFGTAR 372
            +   M   L Y+H       +H DI + N+LL  K     ++AD+G + 
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 28/132 (21%), Positives = 51/132 (38%), Gaps = 20/132 (15%)

Query: 4   NLKNLIELDVGSNSL----IGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNEL-----TWL 53
              N+  L++  N L       +  TL  +   ++ LDL  N F+S   +E         
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 54  TGLLGLNLSSNKLSGKIPSQIASM-----KNLTWLDISNNKIEGSIPGEITEL-----SR 103
             +  LNL  N L  K   ++  +      N+  L++  N +      E+ +      + 
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 104 LDYLNLSSNKLS 115
           +  L+LS+N L 
Sbjct: 198 VTSLDLSANLLG 209

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	397
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	99.98
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.98
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.98
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.98
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.98
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.98
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.98
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.98
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.98
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.98
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.98
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.98
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.97
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.97
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.97
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.97
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.97
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.97
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.97
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.97
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.97
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.97
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.97
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.97
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.97
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.97
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.97
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.97
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.97
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
3bhy_A	283	Death-associated protein kinase 3; death associate	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.96
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.96
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.96
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.96
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.96
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.86
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.85
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.84
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.84
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.84
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.83
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.82
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.82
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.81
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.81
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.81
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.8
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.8
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.8
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.8
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.79
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.79
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.79
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.79
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.79
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.78
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.78
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.78
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.77
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.77
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.77
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.76
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.76
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.76
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.76
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.75
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.75
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.75
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.75
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.74
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.74
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.73
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.73
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.73
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.73
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.73
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.72
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.72
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.72
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.72
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.71
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.71
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.71
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.71
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.7
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.7
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.7
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.7
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.7
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.69
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.69
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.69
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.69
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.69
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.69
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.69
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.69
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.69
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.68
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.68
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.68
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.68
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.68
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.68
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.67
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.67
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.67
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.67
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.67
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.66
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.66
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.66
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.66
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.66
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.65
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.65
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.65
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.65
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.64
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.64
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.64
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.64
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.64
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.64
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.64
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.64
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.63
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.62
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.62
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.61
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.61
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.61
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.61
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.61
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.6
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.59
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.58
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.56
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.56
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.56
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.55
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.54
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.54
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.53
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.49
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.49
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.48
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.48
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.47
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.47
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.46
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.46
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.45
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.45
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.44
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.38
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.36
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.36
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.35
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.3
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.23
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.23
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.23
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.19
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.11
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.03
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.91
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.91
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.9
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.89
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.86
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.81
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.73
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.65
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.63
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.58
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.56
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.54
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.49
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.41
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.33
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.21
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.02
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	98.01
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.94
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.94
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.91
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	97.89
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.87
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.86
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.84
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.84
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	97.81
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	97.75
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.74
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.73
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.7
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.66
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.65
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.47
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.38
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.32
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.18
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.04
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.01
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.11
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.71
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.64
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	83.58

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.2e-43  Score=321.59  Aligned_cols=172  Identities=28%  Similarity=0.434  Sum_probs=151.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|+. .+++.||||++......+....+.+.+|++++++++|||||++++++++++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999986 478999999998655443334577899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+||+|.+++.+.+   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999997643   4889999999999999999999   569999999999999999999999999999987543


Q ss_pred             C--CCeeeccccccccCCCCC
Q 043586          378 S--SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~--~~~~~~~gt~~y~APE~~  396 (397)
                      .  ......+||+.|||||++
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl  206 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELL  206 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHH
T ss_pred             CCcccccCcccCcccCCHHHH
Confidence            3  234457899999999974

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.3e-43  Score=326.74  Aligned_cols=173  Identities=25%  Similarity=0.404  Sum_probs=144.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|++. +|+.||||++....... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            57999999999999999999864 78999999997654332 23578999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+||+|.+++...+. ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       103 Ey~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999975432 34788899999999999999999   569999999999999999999999999999976543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ....+..+||+.|||||++
T Consensus       179 ~~~~~~~~GT~~YmAPE~l  197 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEIC  197 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHH
T ss_pred             cccccccCCCccccCHHHH
Confidence            3333456899999999974

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-42  Score=321.88  Aligned_cols=168  Identities=28%  Similarity=0.425  Sum_probs=150.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||+||+|++. +|+.||||++.......   .+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56899999999999999999865 79999999997554332   256788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+||+|.+++...    .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       151 Ey~~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          151 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CCCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999988753    4889999999999999999999   569999999999999999999999999999988766


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ....+..+||+.|||||++
T Consensus       224 ~~~~~~~~GTp~YmAPEvl  242 (346)
T 4fih_A          224 VPRRKSLVGTPYWMAPELI  242 (346)
T ss_dssp             SCCBCCCCSCGGGCCHHHH
T ss_pred             CCcccccccCcCcCCHHHH
Confidence            5556667899999999974

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-41  Score=307.60  Aligned_cols=170  Identities=23%  Similarity=0.412  Sum_probs=134.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++......+....+++.+|++++++++||||+++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999999864 78999999998765544444578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+ +|+|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 679999887643   4899999999999999999999   569999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      . .....+||+.|||||++
T Consensus       166 ~-~~~~~~GT~~Y~APE~~  183 (275)
T 3hyh_A          166 N-FLKTSCGSPNYAAPEVI  183 (275)
T ss_dssp             ----------CTTSCHHHH
T ss_pred             C-ccCCeeECcccCChhhh
Confidence            3 23446899999999974

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=323.49  Aligned_cols=168  Identities=28%  Similarity=0.425  Sum_probs=150.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|++. +|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++..|+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            56999999999999999999864 68999999997654332   256789999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||+||+|.+++...    .+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       228 Ey~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          228 EFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             ECCTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             eCCCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999988653    4889999999999999999999   569999999999999999999999999999988766


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .......+||+.|||||++
T Consensus       301 ~~~~~~~~GTp~YmAPEvl  319 (423)
T 4fie_A          301 VPRRKSLVGTPYWMAPELI  319 (423)
T ss_dssp             CCCBCCCEECTTTCCHHHH
T ss_pred             CccccccccCcCcCCHHHH
Confidence            5556667899999999974

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.2e-41  Score=310.53  Aligned_cols=174  Identities=23%  Similarity=0.406  Sum_probs=138.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  291 (397)
                      .++|++.+.||+|+||+||+|++. +++.||||+++......  ..+.+.+|++++++++|||||++++++.+.+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            346999999999999999999864 78999999997654332  2467899999999999999999999987544     


Q ss_pred             -------EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeE
Q 043586          292 -------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF  364 (397)
Q Consensus       292 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~k  364 (397)
                             ..|+|||||++|+|.+++.........++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEE
Confidence                   37999999999999999987655555667778899999999999999   56999999999999999999999


Q ss_pred             EeccccccccCCCCCC------------eeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSSN------------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~~------------~~~~~gt~~y~APE~~  396 (397)
                      |+|||+|+........            .+..+||+.|||||++
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~  202 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQI  202 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHH
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHH
Confidence            9999999977543221            2335799999999974

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=308.09  Aligned_cols=170  Identities=29%  Similarity=0.487  Sum_probs=140.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+++++.+.||+|+||+||+|++.+  .||||+++...... ...++|.+|++++++++|||||++++++.. +..|+||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~-~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTP-EQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            3578889999999999999999753  69999987544332 335789999999999999999999998865 5689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.++++...  ..+++.++..|+.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+.....
T Consensus       111 Ey~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            9999999999997543  24899999999999999999999   568999999999999999999999999999876432


Q ss_pred             C--CCeeeccccccccCCCCC
Q 043586          378 S--SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~--~~~~~~~gt~~y~APE~~  396 (397)
                      .  ......+||+.|||||++
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l  206 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVI  206 (307)
T ss_dssp             --------CCCCTTSCCHHHH
T ss_pred             CcceeecccccCCCccCHHHh
Confidence            2  223456899999999964

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-41  Score=310.39  Aligned_cols=172  Identities=26%  Similarity=0.476  Sum_probs=145.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|.+.+.||+|+||.||+|++.      ++..||||+++.....   ..++|.+|++++++++|||||+++|+|.+++.
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChH---HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            46788899999999999999863      4778999999865432   24789999999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCC----------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNE----------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                      .|+|||||++|+|.++++...          ....++|.++..|+.||+.||+|||   +++|+||||||+|||++.++.
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCc
Confidence            999999999999999997642          2346899999999999999999999   568999999999999999999


Q ss_pred             eEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      +||+|||+|+.........  ....||+.|||||++
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~  202 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESI  202 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHH
Confidence            9999999998765433222  224699999999964

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-40  Score=302.62  Aligned_cols=168  Identities=27%  Similarity=0.435  Sum_probs=141.1

Q ss_pred             CccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEeeEE
Q 043586          222 DIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLI  296 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  296 (397)
                      ++.+.||+|+||+||+|++. +++.||+|++....... ...++|.+|++++++++|||||+++++|.+    +...|+|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            56678999999999999864 68899999997654332 234789999999999999999999999875    3468999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEeccccccccC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLLH  375 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~~~  375 (397)
                      ||||++|+|.+++.+..   .+++..+..++.||+.||+|||+. .++|+||||||+|||++. ++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999997543   478999999999999999999943 123999999999999984 7999999999998643


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .  ......+|||.|||||++
T Consensus       184 ~--~~~~~~~GTp~YmAPE~~  202 (290)
T 3fpq_A          184 A--SFAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             T--TSBEESCSSCCCCCGGGG
T ss_pred             C--CccCCcccCccccCHHHc
Confidence            3  334557899999999974

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=9.8e-41  Score=310.97  Aligned_cols=172  Identities=22%  Similarity=0.440  Sum_probs=139.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|.+.+.||+|+||+||+|++.      +++.||||+++.....   ..++|.+|++++++++|||||+++|+|.+++.
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~  117 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTEGRP  117 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            45777889999999999999864      4788999999865432   34789999999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCC------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNED------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      .|+|||||++|+|.++++....            ...++|.+++.|+.||+.||+|||   +++|+||||||+|||++.+
T Consensus       118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~  194 (329)
T 4aoj_A          118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQG  194 (329)
T ss_dssp             EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCC
Confidence            9999999999999999876432            235899999999999999999999   5689999999999999999


Q ss_pred             CCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      +.+||+|||+|+.......  ......||+.|||||++
T Consensus       195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~  232 (329)
T 4aoj_A          195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESI  232 (329)
T ss_dssp             TEEEECCCC----------------CCCCGGGCCHHHH
T ss_pred             CcEEEcccccceeccCCCcceecCcccccccccChhhh
Confidence            9999999999997644332  22345799999999974

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-42  Score=314.24  Aligned_cols=171  Identities=26%  Similarity=0.369  Sum_probs=140.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||+||+|+..    +++.||||+++........ ..++.+|++++++++|||||++++++.+++..|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            56999999999999999999752    4788999999764322111 135778999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|||||+||+|.+++.+..   .+++.++..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            9999999999999997643   4889999999999999999999   569999999999999999999999999999976


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........+||+.|||||++
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~  198 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVV  198 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHH
T ss_pred             cCCCccccccccCcccCCHHHh
Confidence            5555555567899999999964

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=6.4e-41  Score=309.39  Aligned_cols=172  Identities=24%  Similarity=0.365  Sum_probs=144.7

Q ss_pred             CCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++++.+.||+|+||+||+|++.      +++.||||+++......  ..++|.+|+.++++++|||||+++|+|.+++..
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~--~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP--LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChH--HHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            4667889999999999999863      46789999997653322  236899999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          294 FLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      ++|||||++|+|.+++.....             ...++|.++..|+.|||.||+|||   +++||||||||+|||++++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCC
Confidence            999999999999999965321             235899999999999999999999   5689999999999999999


Q ss_pred             CCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          361 FEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      +.+||+|||+|+.......  ......||+.|||||++
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l  219 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAI  219 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHH
Confidence            9999999999987644322  23345799999999964

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-40  Score=309.96  Aligned_cols=164  Identities=26%  Similarity=0.322  Sum_probs=140.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|++. +|+.||||+++....        ..+|+.++++++|||||++++++.+++..|+||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45788889999999999999864 689999999976432        246999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~~~~  376 (397)
                      |||+||+|.++++...   .+++.++..++.||+.||+|||   +++|+||||||+|||++.+| .+||+|||+|+.+..
T Consensus       130 Ey~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~  203 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP  203 (336)
T ss_dssp             CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred             eccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence            9999999999997643   4899999999999999999999   67999999999999999988 699999999998754


Q ss_pred             CCCC-----eeeccccccccCCCCC
Q 043586          377 DSSN-----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~-----~~~~~gt~~y~APE~~  396 (397)
                      +...     ....+||+.|||||++
T Consensus       204 ~~~~~~~~~~~~~~GT~~YmAPE~~  228 (336)
T 4g3f_A          204 DGLGKSLLTGDYIPGTETHMAPEVV  228 (336)
T ss_dssp             ----------CCCCCCGGGCCHHHH
T ss_pred             CCcccceecCCccccCccccCHHHH
Confidence            3321     2235799999999975

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-39  Score=300.07  Aligned_cols=169  Identities=26%  Similarity=0.384  Sum_probs=138.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Eee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  294 (397)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++.......    ..+..|+..+.+++|||||++++++..++    ..|
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            4577889999999999999998 58899999997654321    23345777778899999999999998753    589


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      +|||||++|+|.++++..    .++|..+.+++.|++.||+|||+.     +.++|+||||||+|||+|.++++||+|||
T Consensus        78 lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999999754    478999999999999999999954     23489999999999999999999999999


Q ss_pred             cccccCCCCCC----eeeccccccccCCCCC
Q 043586          370 TARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      +|+........    ....+||+.|||||++
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l  184 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHH
T ss_pred             CCccccCCCCceeeecccccccccccCHHHh
Confidence            99877544322    2235799999999974

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6.7e-39  Score=301.02  Aligned_cols=180  Identities=24%  Similarity=0.340  Sum_probs=150.1

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc-CCcccee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLY  284 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~  284 (397)
                      .+++...++|++.+.||+|+||.||+|++.      .++.||||+++.......  .+.|.+|++++++++| ||||+++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~--~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHH--HHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345555678999999999999999999753      246899999987554432  4779999999999975 8999999


Q ss_pred             eEEeeC-CEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043586          285 GFCLHR-KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  350 (397)
Q Consensus       285 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  350 (397)
                      |+|..+ +..++|||||++|+|.++++....             ...+++.++..++.|||.||+|||   +++||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCcc
Confidence            999764 568999999999999999975321             234889999999999999999999   568999999


Q ss_pred             CCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          351 SSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       351 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ||+|||++.++.+||+|||+|+.+..+...  ....+||+.|||||++
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l  259 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  259 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence            999999999999999999999977554432  2345799999999964

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=297.92  Aligned_cols=170  Identities=28%  Similarity=0.412  Sum_probs=143.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee------CC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------RK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  291 (397)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++...... ...+++.+|+++|++++|||||++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            5799999999999999999986 479999999997654322 224678899999999999999999998764      35


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+|||||+ |+|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 68998887543   5899999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCC----CCeeeccccccccCCCCC
Q 043586          372 RLLHADS----SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~----~~~~~~~gt~~y~APE~~  396 (397)
                      +.+....    ......+||+.|||||++
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             eecccCccccccccccceeChHhcCHHHh
Confidence            8764322    223456899999999974

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.6e-37  Score=293.35  Aligned_cols=169  Identities=25%  Similarity=0.337  Sum_probs=142.5

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      +.+..+.|++.+.||+|+||+||+|+.+    +++.||+|++......     .++.+|+++++.+ .||||+++++++.
T Consensus        16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-----~~~~~E~~~l~~~~~h~nIv~l~~~~~   90 (361)
T 4f9c_A           16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP-----IRIAAELQCLTVAGGQDNVMGVKYCFR   90 (361)
T ss_dssp             SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH-----HHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred             cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH-----HHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence            3345678999999999999999999742    4688999998765432     4567899999998 6999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEec
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVAD  367 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~D  367 (397)
                      +.+..|+||||+++|+|.+++.      .+++.++..++.|++.||+|||   ++||+||||||+|||++.+ +.+||+|
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECc
Confidence            9999999999999999999884      3788999999999999999999   5699999999999999876 8999999


Q ss_pred             cccccccCCCCC----------------------------CeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSS----------------------------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~----------------------------~~~~~~gt~~y~APE~~  396 (397)
                      ||+|+.......                            ..+..+||+.|||||++
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l  218 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL  218 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            999986543211                            12335799999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-37  Score=309.50  Aligned_cols=170  Identities=24%  Similarity=0.315  Sum_probs=144.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++.+......   ......+.++.+++.++|||||+++++|.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            57999999999999999999865 689999999976443221   11223344567777889999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|||||+||+|.+++....   .+++..+..++.||+.||+|||   +++||||||||+|||++.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999997643   4889999999999999999999   779999999999999999999999999999976


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ....  ....+||+.|||||++
T Consensus       343 ~~~~--~~t~~GTp~YmAPEvl  362 (689)
T 3v5w_A          343 SKKK--PHASVGTHGYMAPEVL  362 (689)
T ss_dssp             SSCC--CCSCCSCGGGCCHHHH
T ss_pred             CCCC--CCCccCCcCccCHHHH
Confidence            5433  3446899999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.4e-36  Score=298.80  Aligned_cols=170  Identities=26%  Similarity=0.441  Sum_probs=148.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++......+   .+.+.+|+++|+.++||||+++++++.+++..|+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999864 78999999997765433   35788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC--CCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK--FEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~DFG~a~~~  374 (397)
                      ||||+||+|.+++....  ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999886433  24889999999999999999999   5699999999999999854  89999999999987


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... .....+||+.|||||++
T Consensus       308 ~~~~-~~~~~~GT~~y~APEv~  328 (573)
T 3uto_A          308 DPKQ-SVKVTTGTAEFAAPEVA  328 (573)
T ss_dssp             CTTS-EEEEECSSGGGCCHHHH
T ss_pred             cCCC-ceeeeEECccccCHHHh
Confidence            6543 33456899999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4e-34  Score=268.50  Aligned_cols=172  Identities=24%  Similarity=0.351  Sum_probs=149.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|+++++.++||||+++++++...+..|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            57899999999999999999865 68999999997654332233467888999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++.....
T Consensus        85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999998887532   4788999999999999999999   569999999999999999999999999999875544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .......+||+.|+|||++
T Consensus       159 ~~~~~~~~gt~~y~aPE~~  177 (337)
T 1o6l_A          159 GATMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGG
T ss_pred             CCcccccccChhhCChhhh
Confidence            4445567899999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.1e-34  Score=270.91  Aligned_cols=173  Identities=24%  Similarity=0.422  Sum_probs=145.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  295 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|.++++.+ +||||+++++++.+.+..|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            468999999999999999999865 6899999999875444434456788899999998 69999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       102 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999887543   4789999999999999999999   5699999999999999999999999999998655


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+||+.|+|||++
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~  196 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEIL  196 (353)
T ss_dssp             C---------CCGGGCCHHHH
T ss_pred             cCCccccccCCCcCeEChhhc
Confidence            444445567899999999963

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.2e-34  Score=278.87  Aligned_cols=180  Identities=29%  Similarity=0.373  Sum_probs=152.3

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      .++....++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|..++..++||||+++++++.+.
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  146 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD  146 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence            344445688999999999999999999876 5789999999764433222234478899999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      +..|+||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       147 ~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          147 NNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             SEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            99999999999999999997632  24889999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCC-eeeccccccccCCCCC
Q 043586          371 ARLLHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      |+........ ....+||+.|+|||++
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l  248 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEIL  248 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHH
T ss_pred             hhhcccCCCcccccccCCcCeeChHHH
Confidence            9876544332 2345799999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=5.1e-34  Score=272.86  Aligned_cols=172  Identities=25%  Similarity=0.410  Sum_probs=148.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++.++ +||||+++++++.+.+..|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            57999999999999999999865 6789999999876544433445678899999887 899999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       132 ~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            99999999999887543   4889999999999999999999   56999999999999999999999999999987544


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+||+.|+|||++
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l  225 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEIL  225 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHH
T ss_pred             CCCccccccCCcccCCchhh
Confidence            44445567899999999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-34  Score=275.15  Aligned_cols=180  Identities=25%  Similarity=0.377  Sum_probs=152.8

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      .+.....++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++..++||||+++++++.+.
T Consensus        54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            344445678999999999999999999875 7899999999765433333335678899999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      +..|+||||+++|+|.+++.....  .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFGl  208 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGS  208 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeechh
Confidence            999999999999999999975432  4788999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCC-eeeccccccccCCCCC
Q 043586          371 ARLLHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ++........ ....+||+.|+|||++
T Consensus       209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l  235 (412)
T 2vd5_A          209 CLKLRADGTVRSLVAVGTPDYLSPEIL  235 (412)
T ss_dssp             CEECCTTSCEECSSCCSCGGGCCHHHH
T ss_pred             heeccCCCccccceeccccCcCCHHHH
Confidence            9877554332 2345799999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.5e-33  Score=265.59  Aligned_cols=172  Identities=26%  Similarity=0.411  Sum_probs=149.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..+++++ +||||+++++++.+.+..|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            56899999999999999999865 6889999999876544344456788999999988 899999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999887542   4788999999999999999999   56999999999999999999999999999986544


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+||+.|+|||++
T Consensus       163 ~~~~~~~~~gt~~y~aPE~~  182 (345)
T 3a8x_A          163 PGDTTSTFCGTPNYIAPEIL  182 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHH
T ss_pred             CCCcccccCCCccccCcccc
Confidence            44444556899999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.1e-33  Score=266.19  Aligned_cols=174  Identities=25%  Similarity=0.423  Sum_probs=149.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            4578999999999999999999875 6899999999765432222245677899999887 8999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+++..
T Consensus        95 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            9999999999999987532   4788999999999999999999   569999999999999999999999999999875


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........+||+.|+|||++
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~  190 (345)
T 1xjd_A          169 MLGDAKTNTFCGTPDYIAPEIL  190 (345)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHH
T ss_pred             ccCCCcccCCCCCcccCChhhh
Confidence            5444445567899999999964

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=267.24  Aligned_cols=171  Identities=27%  Similarity=0.438  Sum_probs=149.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56999999999999999999865 68899999997654433333567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.+|+|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.+|.+||+|||+++.....
T Consensus        95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999987543   4788999999999999999999   569999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      . .....+||+.|+|||++
T Consensus       169 ~-~~~~~~gt~~Y~aPE~~  186 (384)
T 4fr4_A          169 T-QITTMAGTKPYMAPEMF  186 (384)
T ss_dssp             C-CBCCCCSCGGGCCGGGT
T ss_pred             C-ceeccCCCccccCCeee
Confidence            3 33456799999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3e-34  Score=275.81  Aligned_cols=177  Identities=25%  Similarity=0.365  Sum_probs=150.1

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ++....++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~  142 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  142 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence            34445678999999999999999999875 68899999997643332222245778999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999988753    3788899999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCC-CeeeccccccccCCCCC
Q 043586          372 RLLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      +....... .....+||+.|+|||++
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l  241 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVL  241 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHH
T ss_pred             EeeccCCcccccCCcCCccccCHHHh
Confidence            87654432 22356799999999964

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7e-33  Score=255.74  Aligned_cols=169  Identities=27%  Similarity=0.414  Sum_probs=149.4

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.......   .+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            36799999999999999999986 478999999987554332   25678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999998754    3788999999999999999999   56999999999999999999999999999988766


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........||+.|+|||++
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~  188 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVV  188 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHH
T ss_pred             cccccCCccCCcCccChhhh
Confidence            55555566899999999963

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-33  Score=262.66  Aligned_cols=171  Identities=25%  Similarity=0.432  Sum_probs=148.7

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|++ .+++.||||++....... ...+++.+|+++++.++||||+++++++...+..|+|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            35799999999999999999986 578999999997654322 2346788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            99999999999986543   4788999999999999999999   56999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ....+||+.|+|||++
T Consensus       167 ~~~-~~~~~gt~~y~aPE~~  185 (328)
T 3fe3_A          167 GGK-LDAFCGAPPYAAPELF  185 (328)
T ss_dssp             SCG-GGTTSSSGGGCCHHHH
T ss_pred             CCc-cccccCCcceeCcccc
Confidence            432 3446799999999963

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.7e-33  Score=259.36  Aligned_cols=175  Identities=22%  Similarity=0.388  Sum_probs=145.7

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----  291 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  291 (397)
                      ..++|++.+.||+|+||.||+|++. +++.||||+++......  ..+.+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTT--HHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            4467999999999999999999875 78999999997544322  2367889999999999999999999986543    


Q ss_pred             -----------------------------------------------------EeeEEEeeccCCCchhhcccCCCcccc
Q 043586          292 -----------------------------------------------------CMFLIYEYMERGSLFCNLHNNEDAVEL  318 (397)
Q Consensus       292 -----------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~  318 (397)
                                                                           ..++||||+++++|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 379999999999999999877665566


Q ss_pred             ChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC------------Ceeeccc
Q 043586          319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS------------NRTLLAG  386 (397)
Q Consensus       319 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~------------~~~~~~g  386 (397)
                      ++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......            ......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77788999999999999999   56999999999999999999999999999997765421            1233569


Q ss_pred             cccccCCCCC
Q 043586          387 TYGYIAPGLP  396 (397)
Q Consensus       387 t~~y~APE~~  396 (397)
                      |+.|+|||++
T Consensus       239 t~~y~aPE~~  248 (332)
T 3qd2_B          239 TKLYMSPEQI  248 (332)
T ss_dssp             CGGGSCHHHH
T ss_pred             CcCccChHHh
Confidence            9999999963

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-33  Score=259.84  Aligned_cols=169  Identities=31%  Similarity=0.488  Sum_probs=147.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..+++.++||||+++++++.+....|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            56899999999999999999865 68999999997654333233467788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+|.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            9999999999997643   4788999999999999999999   679999999999999999999999999999875432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         ....+||+.|+|||++
T Consensus       160 ---~~~~~gt~~y~aPE~~  175 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVV  175 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHH
T ss_pred             ---cccccCCccccCHhHh
Confidence               2345799999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.4e-33  Score=259.76  Aligned_cols=187  Identities=40%  Similarity=0.721  Sum_probs=158.9

Q ss_pred             cccHHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEE
Q 043586          208 RIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC  287 (397)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  287 (397)
                      .+++.++....++|++.+.||+|+||.||+|+..+++.||||++........  ...+.+|+++++.++||||+++++++
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG--ELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C--CCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH--HHHHHHHHHHHHhccCCCccceEEEE
Confidence            4678899999999999999999999999999988899999999976543221  13688999999999999999999999


Q ss_pred             eeCCEeeEEEeeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          288 LHRKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       288 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      ...+..++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            999999999999999999999986543 3348899999999999999999996544499999999999999999999999


Q ss_pred             ccccccccCCCCCC-eeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      |||+++........ .....||+.|+|||++
T Consensus       177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (326)
T 3uim_A          177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYL  207 (326)
T ss_dssp             CCSSCEECCSSSSCEECCCCSCGGGCCHHHH
T ss_pred             cCccccccCcccccccccccCCcCccCHHHh
Confidence            99999877544332 3345699999999963

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.9e-33  Score=265.39  Aligned_cols=173  Identities=23%  Similarity=0.342  Sum_probs=149.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  295 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..++..+ +||||+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            467999999999999999999876 4789999999865433333346778899999988 79999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++....   .+++..++.++.|++.||+|||   +.+|+||||||+|||++.+|.+||+|||+++...
T Consensus        99 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            999999999999987543   4788999999999999999999   5699999999999999999999999999998754


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........+||+.|+|||++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~  193 (353)
T 2i0e_A          173 WDGVTTKTFCGTPDYIAPEII  193 (353)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHH
T ss_pred             cCCcccccccCCccccChhhh
Confidence            444445567899999999964

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.2e-33  Score=258.06  Aligned_cols=176  Identities=30%  Similarity=0.489  Sum_probs=141.3

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ...++|++.+.||+|+||.||+|++ +++.||||++....... ...+++.+|++++++++||||+++++++...+..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3456799999999999999999987 57889999997654332 234678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ||||+++|+|.+++........+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++.
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            9999999999999987554445889999999999999999999   557  99999999999999999999999999986


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ............||+.|+|||++
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~  211 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVL  211 (309)
T ss_dssp             -------------CCTTSCHHHH
T ss_pred             ccccccccccCCCCccccChhhh
Confidence            65544444456799999999964

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-32  Score=256.39  Aligned_cols=180  Identities=28%  Similarity=0.411  Sum_probs=154.7

Q ss_pred             CcccHHHHHHHhcC----------CCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc
Q 043586          207 GRIVYEDLIEATEG----------FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV  275 (397)
Q Consensus       207 ~~~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l  275 (397)
                      +.++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++.......   .+.+.+|+.+++++
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l   99 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDY   99 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS---HHHHHHHHHHHTTC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH---HHHHHHHHHHHHhC
Confidence            45677888777764          667789999999999999875 79999999997654332   25678999999999


Q ss_pred             ccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       276 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      +||||+++++++...+..++||||+++++|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  172 (321)
T 2c30_A          100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI  172 (321)
T ss_dssp             CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence            9999999999999999999999999999999988643    4789999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++.++.+||+|||+++.............||+.|+|||++
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  213 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI  213 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence            99999999999999998776554444556799999999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.98  E-value=7.4e-33  Score=257.27  Aligned_cols=172  Identities=29%  Similarity=0.420  Sum_probs=144.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++.+++.||+|++...... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            3679999999999999999999988999999999765332 223467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++ ++.+.+....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99975 7877776543  24788999999999999999999   569999999999999999999999999999987655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       173 ~~~~~~~~~t~~y~aPE~~  191 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVL  191 (311)
T ss_dssp             CC---CCCCCCTTCCHHHH
T ss_pred             cccccCCcccCCcCCHHHh
Confidence            5445556799999999964

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.98  E-value=2.5e-32  Score=253.49  Aligned_cols=170  Identities=30%  Similarity=0.512  Sum_probs=145.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|++. +++.||+|++......   ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHH---HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            56888999999999999999864 6899999988654332   2467899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.....  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  161 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE  161 (310)
T ss_dssp             ECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred             EecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence            99999999999976432  4889999999999999999999   568999999999999999999999999999876443


Q ss_pred             CCCe--------------eeccccccccCCCCC
Q 043586          378 SSNR--------------TLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~--------------~~~~gt~~y~APE~~  396 (397)
                      ....              ....||+.|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (310)
T 3s95_A          162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI  194 (310)
T ss_dssp             ------------------CCCCSCGGGCCHHHH
T ss_pred             cccccccccccccccccccccCCCcceeCHHHh
Confidence            2211              145799999999963

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.98  E-value=1.9e-32  Score=252.88  Aligned_cols=171  Identities=24%  Similarity=0.362  Sum_probs=141.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHH-----------------------HHHHHHHHHHHHHHhh
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEE-----------------------LAFIKSFRNEAQVLSQ  274 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~  274 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++.......                       ....+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57999999999999999999864 68899999997654221                       1123568899999999


Q ss_pred             cccCCccceeeEEee--CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043586          275 VLHRNIVKLYGFCLH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISS  352 (397)
Q Consensus       275 l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp  352 (397)
                      ++||||+++++++.+  .+..++||||+++++|.+++..    ..+++.++..++.|++.||+|||   +.+|+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCH
Confidence            999999999999987  5689999999999999886543    24889999999999999999999   56999999999


Q ss_pred             CCEEeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          353 NNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       353 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +||+++.++.+||+|||+++.............||+.|+|||++
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~  209 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL  209 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGC
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhh
Confidence            99999999999999999998776544444456799999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.98  E-value=6.1e-33  Score=261.88  Aligned_cols=169  Identities=26%  Similarity=0.387  Sum_probs=147.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999865 68999999997654433333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            9999999999987543   4788999999999999999999   569999999999999999999999999999876433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         ....+||+.|+|||++
T Consensus       195 ---~~~~~gt~~y~aPE~~  210 (350)
T 1rdq_E          195 ---TWTLCGTPEALAPEII  210 (350)
T ss_dssp             ---BCCCEECGGGCCHHHH
T ss_pred             ---cccccCCccccCHHHh
Confidence               2345799999999964

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.98  E-value=1e-32  Score=254.21  Aligned_cols=171  Identities=28%  Similarity=0.426  Sum_probs=143.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            57999999999999999999864 68899999986654444445678999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        91 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999987543   4788999999999999999999   568999999999999999999999999999876543


Q ss_pred             CC-CeeeccccccccCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~  395 (397)
                      .. ......||+.|+|||+
T Consensus       165 ~~~~~~~~~gt~~y~aPE~  183 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQ  183 (294)
T ss_dssp             ----------CCSSCCHHH
T ss_pred             cccccCccccCccccCHhH
Confidence            32 2234569999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.98  E-value=9.8e-33  Score=273.23  Aligned_cols=175  Identities=26%  Similarity=0.376  Sum_probs=152.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+....|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            57888999999999999999875 68999999997654433333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||++||+|.+++..... ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence            99999999998875432 335889999999999999999999   56999999999999999999999999999998765


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+||+.|+|||++
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l  361 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELL  361 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHH
T ss_pred             CCcccccccCCccccChhhh
Confidence            55444556899999999974

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.98  E-value=1.4e-32  Score=267.04  Aligned_cols=174  Identities=23%  Similarity=0.350  Sum_probs=149.0

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++........ ..+.+.+|+++++.++||||+++++++.+.+..|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~-~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSAR-DHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHH-HHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHH-HHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            3457799999999999999999975 4789999999987654332 2467889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC---CCCCeEEeccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKFEAFVADFGTA  371 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DFG~a  371 (397)
                      +||||+++|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            9999999999999887643   4788999999999999999999   56999999999999998   4688999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.............||+.|+|||++
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l  185 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVL  185 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHH
T ss_pred             EEecCCCceeecccCCcccCCHHHh
Confidence            8776555444556899999999964

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.98  E-value=3.6e-33  Score=265.43  Aligned_cols=172  Identities=27%  Similarity=0.390  Sum_probs=139.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHH-HhhcccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQV-LSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56999999999999999999875 588999999987654333334556677776 5778999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++....
T Consensus       118 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          118 LDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            99999999999887533   4788889999999999999999   56999999999999999999999999999987554


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+||+.|+|||++
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~  211 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVL  211 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHH
T ss_pred             CCCccccccCCccccCHHHh
Confidence            44445567899999999964

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.98  E-value=1.1e-32  Score=257.13  Aligned_cols=182  Identities=39%  Similarity=0.643  Sum_probs=154.1

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL  288 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  288 (397)
                      +.+.++...+++|++.+.||+|+||.||+|++.+++.||+|++.......   .+.+.+|+++++.++||||+++++++.
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQG---IEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSH---HHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHH---HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34445556778999999999999999999998889999999987654332   367889999999999999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                      ..+..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence            99999999999999999999875432 235889999999999999999999   56999999999999999999999999


Q ss_pred             cccccccCCCCC--CeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ||+++.......  ......||+.|+|||++
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  213 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYF  213 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHH
T ss_pred             cccccccccccccccccccCCCccccCHHHh
Confidence            999986543221  22345689999999963

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.98  E-value=1.1e-32  Score=258.52  Aligned_cols=170  Identities=23%  Similarity=0.386  Sum_probs=146.4

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|++ .+++.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999986 578999999997654333223357889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+ +|+|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        89 E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 688988886543   4788999999999999999999   558999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .. ....+||+.|+|||++
T Consensus       162 ~~-~~~~~gt~~y~aPE~~  179 (336)
T 3h4j_B          162 NF-LKTSCGSPNYAAPEVI  179 (336)
T ss_dssp             BT-TCCCTTSTTTSCGGGS
T ss_pred             cc-cccccCCcCcCCHHHH
Confidence            32 3345799999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.98  E-value=8.3e-33  Score=261.30  Aligned_cols=176  Identities=22%  Similarity=0.350  Sum_probs=146.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH--HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++........  ...+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            457999999999999999999864 689999999865432110  01367889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC---eEEecccc
Q 043586          295 LIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE---AFVADFGT  370 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DFG~  370 (397)
                      +||||+++++|.+.+.... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 2234788999999999999999999   569999999999999986654   99999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++.............||+.|+|||++
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~  205 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVV  205 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHH
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHH
Confidence            98876554444456799999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.1e-32  Score=258.05  Aligned_cols=172  Identities=29%  Similarity=0.442  Sum_probs=136.6

Q ss_pred             cCCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|+.    .+++.||+|+++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            5799999999999999999986    47899999999865422 122235678899999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           97 YLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            99999999999999887532   3788899999999999999999   56999999999999999999999999999986


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ............||+.|+|||++
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~  193 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEIL  193 (327)
T ss_dssp             --------CTTSSCCTTSCHHHH
T ss_pred             cccCCccccccCCCcCccCHhhC
Confidence            54444334456799999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.97  E-value=2.5e-32  Score=251.26  Aligned_cols=171  Identities=26%  Similarity=0.383  Sum_probs=145.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST-THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC-CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            57899999999999999999865 68999999997654322 22366788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++ ++.+.+....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99976 5655554432  24889999999999999999999   569999999999999999999999999999987655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       155 ~~~~~~~~~t~~y~aPE~~  173 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVL  173 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHH
T ss_pred             cccccCCccccCCcChHHH
Confidence            5555556799999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=2.1e-32  Score=255.64  Aligned_cols=171  Identities=26%  Similarity=0.437  Sum_probs=144.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999865 78999999997654332  235688999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            99999999999987542   4789999999999999999999   56999999999999999999999999999986643


Q ss_pred             CCC--CeeeccccccccCCCCC
Q 043586          377 DSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ...  ......||+.|+|||++
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~  179 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELL  179 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHH
T ss_pred             CCcccccCCCccCcCccCcHHh
Confidence            221  22345799999999963

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=4.2e-33  Score=271.79  Aligned_cols=174  Identities=22%  Similarity=0.333  Sum_probs=138.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++.............+.+|+++++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            357999999999999999999864 6899999999765433333346778899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||+.  .+|+||||||+|||++.++.+||+|||+|+....
T Consensus       227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999998886543   478899999999999999999941  5899999999999999999999999999987554


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+||+.|+|||++
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~  321 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVL  321 (446)
T ss_dssp             -----CCSSSCGGGCCHHHH
T ss_pred             CCcccccccCCccccCHhhc
Confidence            44444557899999999963

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=2.4e-32  Score=259.92  Aligned_cols=174  Identities=25%  Similarity=0.390  Sum_probs=146.2

Q ss_pred             hcCCCccceeecCCcccEEEEEc--------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL--------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|++.+.||+|+||.||+|++        .++..||||+++.....  ...+++.+|+++++++ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBH--HHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCH--HHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            36789999999999999999975        23567999999765433  2346789999999999 8999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      ..+..|+||||+++|+|.+++.....             ...+++.+++.++.||+.||+|||   +.+|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhE
Confidence            99999999999999999999876432             124788999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |++.++.+||+|||+++........  .....||+.|+|||++
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  277 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL  277 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence            9999999999999999876543321  2234578899999963

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=7.9e-32  Score=251.42  Aligned_cols=169  Identities=27%  Similarity=0.380  Sum_probs=147.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|.+......    .+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCccc----HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            467999999999999999999865 6889999999765432    25678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC--CCCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KFEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DFG~a~~~  374 (397)
                      |||+++++|.+++....  ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.  ++.+||+|||+++..
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            99999999999987543  24889999999999999999999   569999999999999987  789999999999877


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... ......||+.|+|||++
T Consensus       155 ~~~~-~~~~~~gt~~y~aPE~~  175 (321)
T 1tki_A          155 KPGD-NFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CTTC-EEEEEESCGGGSCHHHH
T ss_pred             CCCC-ccccccCChhhcCcHHh
Confidence            5443 23446799999999964

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=3.6e-32  Score=266.04  Aligned_cols=171  Identities=26%  Similarity=0.452  Sum_probs=149.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++...........+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56899999999999999999865 78999999997654433333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999987543   4889999999999999999999   679999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      . .....+||+.|+|||++
T Consensus       170 ~-~~~~~~gt~~y~aPE~~  187 (476)
T 2y94_A          170 E-FLRTSCGSPNYAAPEVI  187 (476)
T ss_dssp             C-CBCCCCSCSTTCCHHHH
T ss_pred             c-cccccCCCcCeEChhhc
Confidence            3 23445799999999964

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=2.2e-32  Score=271.45  Aligned_cols=174  Identities=26%  Similarity=0.353  Sum_probs=149.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            356889999999999999999865 7899999999765433333345678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||++||+|.+++..... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.+|.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999998876432 34889999999999999999999   56999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ....+||+.|+|||++
T Consensus       339 ~~~-~~~~~GT~~Y~APEvl  357 (576)
T 2acx_A          339 GQT-IKGRVGTVGYMAPEVV  357 (576)
T ss_dssp             TCC-EECCCSCGGGCCHHHH
T ss_pred             Ccc-ccccCCCccccCHHHH
Confidence            432 3445799999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=2.5e-32  Score=258.56  Aligned_cols=172  Identities=27%  Similarity=0.403  Sum_probs=147.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .+.|++.+.||+|+||.||+|+.. +|+.||+|++........   ...+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999865 689999999976543210   0135788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEeccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFG  369 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG  369 (397)
                      |+||||+++|+|.+++....   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999986542   4889999999999999999999   56999999999999998776    79999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       165 ~a~~~~~~~~-~~~~~gt~~y~aPE~~  190 (361)
T 2yab_A          165 LAHEIEDGVE-FKNIFGTPEFVAPEIV  190 (361)
T ss_dssp             SCEECCTTCC-CCCCCSCGGGCCHHHH
T ss_pred             CceEcCCCCc-cccCCCCccEECchHH
Confidence            9987755432 3345799999999964

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=4.5e-32  Score=257.22  Aligned_cols=173  Identities=27%  Similarity=0.448  Sum_probs=147.5

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..|
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34567999999999999999999864 68999999997654332 22467889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC---CCeEEeccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---FEAFVADFGTA  371 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DFG~a  371 (397)
                      +||||+++|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.+   +.+||+|||++
T Consensus       105 lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999998886543   4788999999999999999999   5699999999999999865   45999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +....... .....||+.|+|||++
T Consensus       179 ~~~~~~~~-~~~~~gt~~y~aPE~~  202 (362)
T 2bdw_A          179 IEVNDSEA-WHGFAGTPGYLSPEVL  202 (362)
T ss_dssp             BCCTTCCS-CCCSCSCTTTCCHHHH
T ss_pred             eEecCCcc-cccCCCCccccCHHHH
Confidence            87654332 3346799999999964

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=4.1e-32  Score=253.51  Aligned_cols=166  Identities=33%  Similarity=0.467  Sum_probs=142.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Eee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  294 (397)
                      ++|++.+.||+|+||.||+|++. ++.||||++.......    ..+.+|+.++++++||||+++++++....    ..+
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   98 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW   98 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchHH----HHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence            67999999999999999999875 7899999997654332    34566999999999999999999998743    479


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCC----------CeEEcCCCCCCEEeCCCCCeE
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP----------SIIHRDISSNNILLNSKFEAF  364 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dlkp~NIll~~~~~~k  364 (397)
                      +||||+++|+|.+++...    .+++..+..++.|++.||.|||   +.          +|+||||||+|||++.++.+|
T Consensus        99 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           99 LITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             EEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence            999999999999999753    3789999999999999999999   56          999999999999999999999


Q ss_pred             EeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |+|||+++........  .....||+.|+|||++
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  205 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL  205 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhc
Confidence            9999999876543332  2335799999999964

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=5.7e-32  Score=247.00  Aligned_cols=174  Identities=26%  Similarity=0.482  Sum_probs=135.6

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35799999999999999999986 47899999999765443333346788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            99999999999987543  24788999999999999999999   56999999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........||+.|+|||++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~  184 (278)
T 3cok_A          165 PHEKHYTLCGTPNYISPEIA  184 (278)
T ss_dssp             --------------------
T ss_pred             CCCcceeccCCCCcCCcchh
Confidence            44434446799999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=3.8e-32  Score=253.16  Aligned_cols=173  Identities=25%  Similarity=0.366  Sum_probs=132.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|+++......  ..+.+.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC--SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc--cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence            467999999999999999999865 68999999997654221  125677899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCC---CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |||++ ++|.+++....   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            99998 58988876432   1234788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ............||+.|+|||++
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~  180 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVL  180 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHH
T ss_pred             cCCCcccCCCCcccccccCchHh
Confidence            76544444456799999999964

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=3.2e-32  Score=258.71  Aligned_cols=170  Identities=19%  Similarity=0.256  Sum_probs=141.8

Q ss_pred             hcCCCccceeecCCcccEEEEE------cCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc---cCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQ------LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  288 (397)
                      .++|.+.+.||+|+||.||+|.      ..+++.||+|++.....      .++.+|++++++++   |+||+++++++.
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP------WEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH------HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh------hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3678899999999999999994      34688999999986543      34566777777776   999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCC--CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-------
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNE--DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-------  359 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-------  359 (397)
                      ..+..|+||||+++|+|.+++....  ....+++..++.++.|++.||+|||   +.+|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence            9999999999999999999997422  2235899999999999999999999   679999999999999998       


Q ss_pred             ----CCCeEEeccccccccCCC--CCCeeeccccccccCCCCC
Q 043586          360 ----KFEAFVADFGTARLLHAD--SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ----~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~APE~~  396 (397)
                          ++.+||+|||+|+.+...  .......+||+.|+|||++
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  257 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEML  257 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHH
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHh
Confidence                899999999999765422  2233456799999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=2.3e-32  Score=251.07  Aligned_cols=171  Identities=32%  Similarity=0.447  Sum_probs=142.0

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|+..+++.||+|++....... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5788999999999999999998889999999997654321 112567789999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9975 8888887543  24788899999999999999999   5699999999999999999999999999998765444


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......||+.|+|||++
T Consensus       155 ~~~~~~~~t~~y~aPE~~  172 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVL  172 (288)
T ss_dssp             -------CCCTTCCHHHH
T ss_pred             cccccccccccccCchhe
Confidence            444445799999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=2.1e-31  Score=246.72  Aligned_cols=184  Identities=34%  Similarity=0.570  Sum_probs=156.9

Q ss_pred             cccHHHHHHHhcCCCcc------ceeecCCcccEEEEEcCCCcEEEEEEecccch-HHHHHHHHHHHHHHHHhhcccCCc
Q 043586          208 RIVYEDLIEATEGFDIK------YCIGTGGYGSVYKAQLPNGKVFALKKLHTSET-EELAFIKSFRNEAQVLSQVLHRNI  280 (397)
Q Consensus       208 ~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni  280 (397)
                      .+.+.++..++++|...      +.||+|+||.||+|+. +++.||+|++..... ......+.+.+|+.++++++||||
T Consensus        14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            46789999999998877      8999999999999997 578999999875421 112234678899999999999999


Q ss_pred             cceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC
Q 043586          281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK  360 (397)
Q Consensus       281 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~  360 (397)
                      +++++++...+..++||||+++++|.+++........+++..+..++.|++.||.|||   +.+++||||||+||+++.+
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~  169 (307)
T 2nru_A           93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEA  169 (307)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTT
T ss_pred             EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcCC
Confidence            9999999999999999999999999999876544446889999999999999999999   5699999999999999999


Q ss_pred             CCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          361 FEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       361 ~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      +.+||+|||+++........  .....||+.|+|||+
T Consensus       170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  206 (307)
T 2nru_A          170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA  206 (307)
T ss_dssp             CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred             CcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence            99999999999876543322  223469999999995

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=250.35  Aligned_cols=171  Identities=28%  Similarity=0.439  Sum_probs=142.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++.    .+..||||+++......  ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            56888999999999999999874    34569999998654332  2467899999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++.....  .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999875432  4889999999999999999999   569999999999999999999999999999977


Q ss_pred             CCCCCCe---eeccccccccCCCCC
Q 043586          375 HADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      .......   ....+|+.|+|||++
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~  226 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAI  226 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHH
T ss_pred             ccCccceeeccCCCCcccccCHhHh
Confidence            5543221   223467889999963

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=5e-32  Score=276.21  Aligned_cols=174  Identities=22%  Similarity=0.339  Sum_probs=150.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++..........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            3467999999999999999999865 6889999999865433333346678899999988 6999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....   .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999997643   4789999999999999999999   569999999999999999999999999999975


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........+||+.|+|||++
T Consensus       493 ~~~~~~~~~~~GT~~Y~APE~l  514 (674)
T 3pfq_A          493 IWDGVTTKTFCGTPDYIAPEII  514 (674)
T ss_dssp             CCTTCCBCCCCSCSSSCCHHHH
T ss_pred             ccCCcccccccCCCcccCHhhh
Confidence            5544455567899999999974

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=249.01  Aligned_cols=170  Identities=24%  Similarity=0.289  Sum_probs=139.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|++. +++.||||++......... ...+..|+..+.++ +||||+++++++.+++..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            57999999999999999999876 7899999998764433222 23444566666555 899999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+ +++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 678988876543  24899999999999999999999   55899999999999999999999999999987654


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ... .....||+.|+|||++
T Consensus       210 ~~~-~~~~~gt~~y~aPE~~  228 (311)
T 3p1a_A          210 AGA-GEVQEGDPRYMAPELL  228 (311)
T ss_dssp             ------CCCCCGGGCCGGGG
T ss_pred             CCC-CcccCCCccccCHhHh
Confidence            332 3345699999999974

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.2e-31  Score=249.91  Aligned_cols=171  Identities=26%  Similarity=0.399  Sum_probs=146.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC--EeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  295 (397)
                      ++|++.+.||+|+||.||+|++. +++.||||++........  .+.+.+|++++++++||||+++++++....  ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            56889999999999999999875 589999999976543322  356778999999999999999999998755  7899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe----CCCCCeEEeccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVADFGTA  371 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DFG~a  371 (397)
                      ||||+++++|.+++........+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            9999999999999987554445899999999999999999999   5699999999999999    78888999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      +........ ....||+.|+|||+
T Consensus       164 ~~~~~~~~~-~~~~gt~~y~aPE~  186 (319)
T 4euu_A          164 RELEDDEQF-VSLYGTEEYLHPDM  186 (319)
T ss_dssp             EECCTTCCB-CCCCSCGGGCCHHH
T ss_pred             eecCCCCce-eecccCCCccCHHH
Confidence            877554432 33569999999996

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=4.9e-33  Score=261.30  Aligned_cols=166  Identities=17%  Similarity=0.206  Sum_probs=134.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchH-----HHHHHHHHHHHHHHHhhcc---------cCCccce
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVL---------HRNIVKL  283 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~niv~l  283 (397)
                      .++|++.+.||+|+||.||+|++ +++.||||++......     .....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688999999999999999998 6899999999865321     1111256778999998886         6666666


Q ss_pred             eeE-----------------Eee-------------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHH
Q 043586          284 YGF-----------------CLH-------------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA  333 (397)
Q Consensus       284 ~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~  333 (397)
                      .+.                 +.+             .+..|+||||+++|++.+.+..    ..+++..+..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999987777643    247889999999999999


Q ss_pred             HHHHH-hCCCCCeEEcCCCCCCEEeCCCC--------------------CeEEeccccccccCCCCCCeeeccccccccC
Q 043586          334 LAYLH-HDCSPSIIHRDISSNNILLNSKF--------------------EAFVADFGTARLLHADSSNRTLLAGTYGYIA  392 (397)
Q Consensus       334 l~~LH-~~~~~~ivH~dlkp~NIll~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~A  392 (397)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....     ..+||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 54   899999999999999887                    8999999999876532     3479999999


Q ss_pred             CCCC
Q 043586          393 PGLP  396 (397)
Q Consensus       393 PE~~  396 (397)
                      ||++
T Consensus       246 PE~~  249 (336)
T 2vuw_A          246 EDLF  249 (336)
T ss_dssp             SGGG
T ss_pred             hhhh
Confidence            9985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=2.6e-31  Score=253.85  Aligned_cols=170  Identities=25%  Similarity=0.416  Sum_probs=146.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|... +++.||+|++......+   ...+.+|+++++.++||||+++++++.+....++|
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999865 68899999997654332   25688999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC--CCCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KFEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DFG~a~~~  374 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.  ++.+||+|||+++..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999887543  24889999999999999999999   569999999999999974  578999999999977


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..... .....||+.|+|||++
T Consensus       202 ~~~~~-~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          202 NPDEI-VKVTTATAEFAAPEIV  222 (387)
T ss_dssp             CTTSC-EEEECSSGGGCCHHHH
T ss_pred             CCCcc-eeeeccCCCccCchhc
Confidence            54432 3445799999999964

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=7.6e-32  Score=263.85  Aligned_cols=170  Identities=26%  Similarity=0.373  Sum_probs=131.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----CE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----KC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  292 (397)
                      ++|++.+.||+|+||.||+|++. +++.||||++...... ....+++.+|++++++++||||+++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcC-HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            67999999999999999999865 7899999999754322 22346788999999999999999999998543     56


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .|+||||+ +++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 46898888654   24889999999999999999999   5699999999999999999999999999998


Q ss_pred             ccCCCCC---------------------------CeeeccccccccCCCCC
Q 043586          373 LLHADSS---------------------------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~---------------------------~~~~~~gt~~y~APE~~  396 (397)
                      .......                           ..+..+||+.|+|||++
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            7643221                           12345789999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.2e-31  Score=248.96  Aligned_cols=172  Identities=24%  Similarity=0.375  Sum_probs=146.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++........   ...+.+.+|+.++++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999865 689999999976432210   0135788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEeccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFG  369 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG  369 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999986532   4889999999999999999999   56999999999999999887    89999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       164 ~a~~~~~~~~-~~~~~gt~~y~aPE~~  189 (326)
T 2y0a_A          164 LAHKIDFGNE-FKNIFGTPEFVAPEIV  189 (326)
T ss_dssp             TCEECCTTSC-CCCCCSCTTTCCHHHH
T ss_pred             CCeECCCCCc-cccccCCcCcCCceee
Confidence            9987754332 2345799999999963

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=3.9e-32  Score=252.35  Aligned_cols=172  Identities=24%  Similarity=0.409  Sum_probs=139.9

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Ee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  293 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++...........+.+.+|++++++++||||+++++++....    ..
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~   91 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   91 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence            5799999999999999999986 578999999998765554555678899999999999999999999987654    34


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+++++|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           92 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             EEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence            99999999999999987543   4788999999999999999999   56899999999999999999999999999987


Q ss_pred             cCCCCC---CeeeccccccccCCCCC
Q 043586          374 LHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      ......   ......||+.|+|||++
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             ----------------CCTTCCHHHH
T ss_pred             ccccccccccccccCcCcccCCHHHh
Confidence            654322   22335699999999963

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=1e-31  Score=254.67  Aligned_cols=168  Identities=23%  Similarity=0.350  Sum_probs=136.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.......    +.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   94 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII   94 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence            357999999999999999999875 78999999997654332    4577899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC--eEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--AFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DFG~a~~~  374 (397)
                      |||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.  +||+|||+++..
T Consensus        95 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~  168 (361)
T 3uc3_A           95 MEYASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS  168 (361)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence            99999999999886533   4789999999999999999999   569999999999999987765  999999999854


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..... .....||+.|+|||++
T Consensus       169 ~~~~~-~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          169 VLHSQ-PKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             -------------CTTSCHHHH
T ss_pred             cccCC-CCCCcCCCCcCChhhh
Confidence            33222 2345699999999964

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=2.6e-31  Score=248.34  Aligned_cols=161  Identities=25%  Similarity=0.385  Sum_probs=124.1

Q ss_pred             cceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeEEEeecc
Q 043586          224 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      .+.||+|+||.||+|++. +++.||||++.....      ..+.+|+.+++.+. ||||+++++++.+....|+||||++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~   89 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN   89 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhh------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence            377999999999999865 689999999975432      45678999999997 9999999999999999999999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC---CeEEeccccccccCCCC
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF---EAFVADFGTARLLHADS  378 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~DFG~a~~~~~~~  378 (397)
                      +|+|.+++....   .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||+++......
T Consensus        90 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           90 GGELFERIKKKK---HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             SCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999997643   4889999999999999999999   56999999999999998765   89999999998766555


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......||+.|+|||++
T Consensus       164 ~~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             ------------------
T ss_pred             CcccccCCCcCccCHHHh
Confidence            444556799999999975

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=9.8e-32  Score=244.31  Aligned_cols=168  Identities=26%  Similarity=0.444  Sum_probs=145.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++.+++.||+|++.......    +++.+|++++++++||||+++++++.+.+..++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            5688999999999999999998888999999998765432    568899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999975432  4788999999999999999999   5689999999999999999999999999998664322


Q ss_pred             C-CeeeccccccccCCCC
Q 043586          379 S-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       379 ~-~~~~~~gt~~y~APE~  395 (397)
                      . ......||+.|+|||+
T Consensus       161 ~~~~~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEV  178 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHH
T ss_pred             cccccCcccccccCCHHH
Confidence            1 1223457888999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.97  E-value=1.3e-31  Score=252.08  Aligned_cols=168  Identities=24%  Similarity=0.396  Sum_probs=143.2

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEe
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  293 (397)
                      ...++|++.+.||+|+||.||+|+.. +++.||+|++.....       ...+|++++.++ +||||+++++++.+.+..
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~   91 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV   91 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence            34567999999999999999999865 688999999976542       234688888888 799999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC----CCeEEeccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK----FEAFVADFG  369 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~DFG  369 (397)
                      |+||||+++|+|.+.+....   .+++..+..++.|++.||+|||   +.+|+||||||+||++..+    +.+||+|||
T Consensus        92 ~lv~E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            99999999999999887543   4789999999999999999999   5699999999999998533    359999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++............+||+.|+|||++
T Consensus       166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          166 FAKQLRAENGLLMTPCYTANFVAPEVL  192 (342)
T ss_dssp             TCEECBCTTCCBCCSSCCSSCCCHHHH
T ss_pred             CcccCcCCCCceeccCCCccccCHHHh
Confidence            999776554444556799999999963

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=1.8e-31  Score=254.17  Aligned_cols=171  Identities=29%  Similarity=0.460  Sum_probs=134.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++.    ++..||||+++.....  ...+++.+|+.++++++||||+++++++...+..+
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            57999999999999999999864    5678999999765432  22468999999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....  ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999997543  24788999999999999999999   568999999999999999999999999999876


Q ss_pred             CCCCCCe---eeccccccccCCCCC
Q 043586          375 HADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      .......   ....+|+.|+|||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~  222 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAI  222 (373)
T ss_dssp             ----------------CTTSCHHHH
T ss_pred             ccCCccceeccCCCcCCCccChhhh
Confidence            5433211   122357789999963

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=2.2e-31  Score=241.73  Aligned_cols=169  Identities=24%  Similarity=0.416  Sum_probs=146.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++.++..||+|++.......    +++.+|++++++++||||+++++++...+..++||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            35788999999999999999999888899999998765432    56788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             ECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999987542  24889999999999999999999   569999999999999999999999999999876543


Q ss_pred             CCC-eeeccccccccCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~  395 (397)
                      ... .....+|+.|+|||+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~  176 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEV  176 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHH
T ss_pred             hhhcccCCCcCcccCCHHH
Confidence            322 122346778999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=4.2e-31  Score=243.27  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=149.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            56889999999999999999875 57899999987654333344577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        95 e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           95 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             ECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999886532   4788999999999999999999   569999999999999999999999999999877654


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       169 ~~~~~~~~~~~~y~aPE~~  187 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVL  187 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHH
T ss_pred             ccccccccCCCCcCCcchh
Confidence            4444556799999999963

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=4.5e-31  Score=245.01  Aligned_cols=171  Identities=28%  Similarity=0.372  Sum_probs=141.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            57999999999999999999875 5899999998765433 233467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999988776442   4788999999999999999999   569999999999999999999999999999887655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~y~aPE~~  174 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELL  174 (311)
T ss_dssp             ----------GGGCCHHHH
T ss_pred             ccccCCCcCCccccChHHH
Confidence            4444556799999999963

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.97  E-value=4e-31  Score=248.17  Aligned_cols=172  Identities=24%  Similarity=0.389  Sum_probs=149.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||++++. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            57889999999999999999875 57899999987654333344577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       121 e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          121 ELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             CCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             ecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999886532   4788999999999999999999   569999999999999999999999999999987655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       195 ~~~~~~~~gt~~y~aPE~~  213 (335)
T 2owb_A          195 GERKKVLCGTPNYIAPEVL  213 (335)
T ss_dssp             TCCBCCCCSCCSSCCHHHH
T ss_pred             cccccccCCCccccCHHHh
Confidence            4444556799999999963

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=1e-31  Score=254.49  Aligned_cols=181  Identities=24%  Similarity=0.346  Sum_probs=149.0

Q ss_pred             HHHHHHHhcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccce
Q 043586          211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKL  283 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l  283 (397)
                      ..++....++|++.+.||+|+||.||+|++      .+++.||||+++.......  .+.+.+|+++++++ +||||+++
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHH--HHHHHHHHHHHHhhcCCcceeee
Confidence            445555678899999999999999999973      3568999999986543322  36789999999999 79999999


Q ss_pred             eeEEeeCC-EeeEEEeeccCCCchhhcccCCC------------------------------------------------
Q 043586          284 YGFCLHRK-CMFLIYEYMERGSLFCNLHNNED------------------------------------------------  314 (397)
Q Consensus       284 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------  314 (397)
                      ++++...+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998755 48999999999999999876432                                                


Q ss_pred             ---------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          315 ---------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       315 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                                     ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           112888999999999999999999   56999999999999999999999999999987644332


Q ss_pred             C--eeeccccccccCCCCC
Q 043586          380 N--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~--~~~~~gt~~y~APE~~  396 (397)
                      .  .....||+.|+|||++
T Consensus       249 ~~~~~~~~~t~~y~aPE~~  267 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETI  267 (359)
T ss_dssp             CEEC--CEECGGGCCHHHH
T ss_pred             chhccccCCCceeEChhhh
Confidence            2  2345689999999963

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=2.4e-31  Score=258.23  Aligned_cols=171  Identities=27%  Similarity=0.380  Sum_probs=141.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|++.+.||+|+||.||+|++. +++.||||++...... ....+++.+|++++++++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFED-LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcC-hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            367999999999999999999864 6889999999764322 22346788999999999999999999999876     5


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+. ++|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            6899999996 5999988754   24889999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCC----------------------CeeeccccccccCCCCC
Q 043586          372 RLLHADSS----------------------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~----------------------~~~~~~gt~~y~APE~~  396 (397)
                      +.......                      ..+..+||+.|+|||++
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  223 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI  223 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHH
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHH
Confidence            97654321                      12456799999999964

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=3.3e-31  Score=253.83  Aligned_cols=173  Identities=14%  Similarity=0.257  Sum_probs=147.4

Q ss_pred             cCCCccceeecC--CcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          219 EGFDIKYCIGTG--GYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ++|++.+.||+|  +||.||+|+.. +++.||||++....... ...+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            579999999999  99999999875 78999999997654332 335778899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+....
T Consensus       104 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFM-DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            9999999999999876422 24889999999999999999999   5699999999999999999999999999987543


Q ss_pred             CCCC-------CeeeccccccccCCCCC
Q 043586          376 ADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      ....       ......||+.|+|||++
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             cccccccccccccccccccccccCHHHH
Confidence            2211       11224689999999964

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.97  E-value=8.7e-31  Score=248.73  Aligned_cols=181  Identities=29%  Similarity=0.455  Sum_probs=154.1

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccc-----hHHHHHHHHHHHHHHHHhhc-ccCCcc
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE-----TEELAFIKSFRNEAQVLSQV-LHRNIV  281 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~h~niv  281 (397)
                      ..+.......++|++.+.||+|+||.||+|++. +|+.||||+++...     .......+.+.+|+++++++ +||||+
T Consensus        84 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv  163 (365)
T 2y7j_A           84 PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII  163 (365)
T ss_dssp             CHHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             ccchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            344555667788999999999999999999875 79999999987643     22233456788999999999 799999


Q ss_pred             ceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          282 KLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       282 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      ++++++......++||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.||+||||||+||+++.++
T Consensus       164 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~  237 (365)
T 2y7j_A          164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNM  237 (365)
T ss_dssp             CEEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTC
T ss_pred             EEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCC
Confidence            9999999999999999999999999988753   24788999999999999999999   56999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||++........ .....||+.|+|||++
T Consensus       238 ~ikl~DfG~~~~~~~~~~-~~~~~gt~~y~aPE~~  271 (365)
T 2y7j_A          238 QIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEIL  271 (365)
T ss_dssp             CEEECCCTTCEECCTTCC-BCCCCSCGGGCCHHHH
T ss_pred             CEEEEecCcccccCCCcc-cccCCCCCCccChhhc
Confidence            999999999987754433 3346799999999963

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=2e-31  Score=250.69  Aligned_cols=175  Identities=27%  Similarity=0.441  Sum_probs=146.8

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ...++|++.+.||+|+||.||+|++.      +++.||+|+++......  ..+.+.+|+.++++++||||+++++++..
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHH--HHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            34578999999999999999999864      34789999998654332  34678999999999999999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCC---------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  348 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  348 (397)
                      .+..++||||+++++|.+++.....                     ...+++.+++.++.|++.||.|||   +.+|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            9999999999999999999876421                     135889999999999999999999   5699999


Q ss_pred             CCCCCCEEeCCCCCeEEeccccccccCCCC--CCeeeccccccccCCCC
Q 043586          349 DISSNNILLNSKFEAFVADFGTARLLHADS--SNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       349 dlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~APE~  395 (397)
                      ||||+||+++.++.+||+|||+++......  .......||+.|+|||+
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            999999999999999999999998764322  12233568999999996

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.97  E-value=3.7e-31  Score=249.63  Aligned_cols=168  Identities=29%  Similarity=0.412  Sum_probs=144.4

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|+. .+++.||||++...........+++.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999985 578999999997654444444578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+. |++.+.+....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       134 e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 57877775432  24789999999999999999999   568999999999999999999999999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                          ....||+.|+|||++
T Consensus       208 ----~~~~gt~~y~aPE~~  222 (348)
T 1u5q_A          208 ----NSFVGTPYWMAPEVI  222 (348)
T ss_dssp             ----CCCCSCGGGCCHHHH
T ss_pred             ----CcccCCcceeCHhhh
Confidence                235799999999963

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=8.5e-31  Score=253.29  Aligned_cols=173  Identities=28%  Similarity=0.396  Sum_probs=136.6

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH-----HHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ...++|.+.+.||+|+||.||+|... +++.||+|++......     .......+.+|++++++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45678999999999999999999764 6899999999764321     11223457899999999999999999999754


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC---CCeEEe
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---FEAFVA  366 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~  366 (397)
                       +..|+||||+++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+
T Consensus       212 -~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          212 -EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             -SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEe
Confidence             55799999999999998886543   4789999999999999999999   5689999999999999754   459999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||+++...... .....+||+.|+|||++
T Consensus       285 DFG~a~~~~~~~-~~~~~~gt~~y~aPE~~  313 (419)
T 3i6u_A          285 DFGHSKILGETS-LMRTLCGTPTYLAPEVL  313 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTT
T ss_pred             ecccceecCCCc-cccccCCCCCccCceee
Confidence            999998765432 23346799999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=250.90  Aligned_cols=164  Identities=25%  Similarity=0.414  Sum_probs=136.3

Q ss_pred             cceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeeccC
Q 043586          224 KYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .+.||+|+||.||+|+. .+++.||+|+++......   .+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~  170 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG  170 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence            56799999999999986 468999999998765432   36788999999999999999999999999999999999999


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe--CCCCCeEEeccccccccCCCCCC
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL--NSKFEAFVADFGTARLLHADSSN  380 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll--~~~~~~kl~DFG~a~~~~~~~~~  380 (397)
                      ++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++....... 
T Consensus       171 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-  244 (373)
T 2x4f_A          171 GELFDRIIDES--YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-  244 (373)
T ss_dssp             CEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred             CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence            99998886532  34788999999999999999999   5689999999999999  5678999999999997754433 


Q ss_pred             eeeccccccccCCCCC
Q 043586          381 RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 ~~~~~gt~~y~APE~~  396 (397)
                      .....||+.|+|||++
T Consensus       245 ~~~~~gt~~y~aPE~~  260 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVV  260 (373)
T ss_dssp             CCCCCSSCTTCCHHHH
T ss_pred             cccccCCCcEeChhhc
Confidence            2335699999999963

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=4.4e-31  Score=247.36  Aligned_cols=167  Identities=19%  Similarity=0.247  Sum_probs=143.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||||++......     +.+.+|+++++++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv   83 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV   83 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence            5789999999999999999985 57899999998755432     4577899999999 899999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC-----eEEeccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE-----AFVADFGTA  371 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~DFG~a  371 (397)
                      |||+ +++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||++
T Consensus        84 ~e~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           84 LELL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             EECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EEeC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            9999 999999987642  25889999999999999999999   569999999999999998887     999999999


Q ss_pred             cccCCCCCC-------eeeccccccccCCCCC
Q 043586          372 RLLHADSSN-------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~-------~~~~~gt~~y~APE~~  396 (397)
                      +.+......       .....||+.|+|||++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  189 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTH  189 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHH
Confidence            976543321       2346799999999964

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=2.4e-31  Score=250.41  Aligned_cols=176  Identities=25%  Similarity=0.394  Sum_probs=145.1

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      ...++|++.+.||+|+||.||+|++      .++..||+|++......  ...+.+.+|+.+++++ +||||+++++++.
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3457899999999999999999985      24568999999754322  2246788999999999 8999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCCc--------------------cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNEDA--------------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  348 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  348 (397)
                      ..+..++||||+++|+|.+++......                    ..+++..+..++.|++.||+|||   +.+|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence            999999999999999999999764321                    23788999999999999999999   5699999


Q ss_pred             CCCCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          349 DISSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       349 dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ||||+||+++.++.+||+|||+++........  .....||+.|+|||++
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  246 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  246 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHh
Confidence            99999999999999999999999876544332  2234578899999953

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=6.2e-31  Score=251.34  Aligned_cols=173  Identities=26%  Similarity=0.384  Sum_probs=146.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  289 (397)
                      ++|.+.+.||+|+||.||+|++.        ++..||+|+++......  ..+++.+|+++++++ +||||+++++++..
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHH--HHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            57889999999999999999752        34679999998654332  246788999999999 89999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                      ++..++||||+++|+|.+++.....             ...+++..++.++.|++.||+|||   +.+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            9999999999999999999876432             134889999999999999999999   569999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ++.++.+||+|||+++.......  ......||+.|+|||++
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  265 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  265 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHh
Confidence            99999999999999987654332  22334578999999963

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.6e-31  Score=253.96  Aligned_cols=173  Identities=26%  Similarity=0.361  Sum_probs=143.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++|++.+.||+|+||.||+|++.      +++.||||+++.......  ..++.+|+.++++++||||+++++++.....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHH--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhh--HHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            56889999999999999999843      467899999976543322  3578889999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCC----ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC---CeEE
Q 043586          293 MFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF---EAFV  365 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl  365 (397)
                      .++||||+++|+|.+++.....    ...+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence            9999999999999999875431    235888999999999999999999   56999999999999999555   5999


Q ss_pred             eccccccccCCCC--CCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADS--SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~--~~~~~~~gt~~y~APE~~  396 (397)
                      +|||+++......  .......||+.|+|||++
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  258 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAF  258 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHh
Confidence            9999998653221  222335689999999963

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=1.8e-31  Score=254.56  Aligned_cols=172  Identities=26%  Similarity=0.420  Sum_probs=144.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|.+.+.||+|+||.||+|++. +++.||||.++.....  ...+++.+|++++++++||||+++++++...+..++|
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPP--DLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCH--HHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCH--HHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            457889999999999999999876 7899999998765332  2236788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999987532  24788999999999999999999   56899999999999999999999999999986543


Q ss_pred             CCCCe--eeccccccccCCCCC
Q 043586          377 DSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~--~~~~gt~~y~APE~~  396 (397)
                      .....  ....+++.|+|||++
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~  287 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEAL  287 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHH
T ss_pred             CceeecCCCCCCCcCcCCHhHh
Confidence            21111  112357789999963

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5e-31  Score=248.33  Aligned_cols=181  Identities=26%  Similarity=0.373  Sum_probs=145.7

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH--HHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE--ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ++.+..++|++.+.||+|+||.||+|+.. +++.||+|++......  .....+.+.+|++++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45567788999999999999999999864 6889999998764321  12234678999999999999999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCC-------------------------------------CccccChHHHHHHHHHHHH
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNE-------------------------------------DAVELDWAKRVNIVKAMAH  332 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~~~~~~~~~i~~~i~~  332 (397)
                      .+..++||||+++|+|.+++....                                     ....+++..+..++.|++.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999885210                                     0112466778899999999


Q ss_pred             HHHHHHhCCCCCeEEcCCCCCCEEeCCCC--CeEEeccccccccCCCCC----CeeeccccccccCCCCC
Q 043586          333 ALAYLHHDCSPSIIHRDISSNNILLNSKF--EAFVADFGTARLLHADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       333 ~l~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      ||+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||++
T Consensus       180 ~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          180 ALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            999999   56899999999999998776  899999999987643221    12345799999999964

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=6.5e-31  Score=240.15  Aligned_cols=170  Identities=34%  Similarity=0.559  Sum_probs=143.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            57899999999999999999765 57799999997655444334567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            9999999999887542   4788999999999999999999   679999999999999999999999999998654332


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....||+.|+|||++
T Consensus       163 ~--~~~~~~~~~y~aPE~~  179 (279)
T 3fdn_A          163 R--RTDLCGTLDYLPPEMI  179 (279)
T ss_dssp             -------CCCCTTCCHHHH
T ss_pred             c--ccccCCCCCccCHhHh
Confidence            2  2345799999999963

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.97  E-value=1.3e-31  Score=251.55  Aligned_cols=174  Identities=27%  Similarity=0.395  Sum_probs=147.0

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHH-----HHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL-----AFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      +..++|++.+.||+|+||.||+|++ .+++.||||++........     ...+.+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4567899999999999999999985 4788999999976532110     012356779999999999999999999999


Q ss_pred             CCEeeEEEeeccCC-CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          290 RKCMFLIYEYMERG-SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       290 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                      .+..++||||+.+| +|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999776 9988887543   4789999999999999999999   569999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++....... .....||+.|+|||++
T Consensus       175 g~a~~~~~~~~-~~~~~gt~~y~aPE~~  201 (335)
T 3dls_A          175 GSAAYLERGKL-FYTFCGTIEYCAPEVL  201 (335)
T ss_dssp             TTCEECCTTCC-BCEECSCGGGCCHHHH
T ss_pred             ccceECCCCCc-eeccCCCccccChhhh
Confidence            99987755433 2345799999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.97  E-value=8.8e-31  Score=243.05  Aligned_cols=174  Identities=23%  Similarity=0.352  Sum_probs=143.4

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++......+....+.+.+|+.++++++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            3478999999999999999999865 688999999987655555556789999999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus       112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            999999999999987542   4788999999999999999999   5689999999999999999999999999998765


Q ss_pred             CCCC-CeeeccccccccCCCCC
Q 043586          376 ADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      .... ......||+.|+|||++
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~  207 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERF  207 (309)
T ss_dssp             -----------CCGGGCCGGGT
T ss_pred             ccccccccccCCCcCccCHHHH
Confidence            4322 22345699999999975

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=4.4e-31  Score=253.55  Aligned_cols=172  Identities=26%  Similarity=0.391  Sum_probs=145.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC--EeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--CMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l  295 (397)
                      ++|.+.+.||+|+||.||+|++. +++.||||++........  .+.+.+|++++++++||||+++++++...+  ..++
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            56889999999999999999875 589999999976443322  356778999999999999999999998755  6899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe----CCCCCeEEeccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFEAFVADFGTA  371 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~DFG~a  371 (397)
                      ||||+++|+|.+++........+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            9999999999999986544444899999999999999999999   5689999999999999    77888999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +....... .....||+.|+|||++
T Consensus       164 ~~~~~~~~-~~~~~gt~~y~aPE~~  187 (396)
T 4eut_A          164 RELEDDEQ-FVSLYGTEEYLHPDMY  187 (396)
T ss_dssp             EECCCGGG-SSCSSSCCTTCCHHHH
T ss_pred             eEccCCCc-cccccCCccccCHHHh
Confidence            87654332 2335699999999963

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=5.5e-31  Score=252.25  Aligned_cols=172  Identities=28%  Similarity=0.436  Sum_probs=133.2

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCC--
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK--  291 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--  291 (397)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++....... ...+++.+|+.+++++. ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            3457899999999999999999986 478999999986543222 22366778999999997 999999999997644  


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||++ ++|.+.+...    .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            6899999997 5888888653    4788889999999999999999   569999999999999999999999999999


Q ss_pred             cccCCC---------------------CCCeeeccccccccCCCCC
Q 043586          372 RLLHAD---------------------SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~---------------------~~~~~~~~gt~~y~APE~~  396 (397)
                      +.+...                     ....+..+||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL  202 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence            875431                     1112345799999999964

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=5.3e-31  Score=248.48  Aligned_cols=176  Identities=26%  Similarity=0.375  Sum_probs=140.7

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHH--HHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ....++|++.+.||+|+||.||+|++. +++.||+|++.......  ....+.+.+|++++++++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            345678999999999999999999875 58999999997643321  112246788999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++ +|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999986 8888776543  24788899999999999999999   568999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.............||+.|+|||++
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~  184 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELL  184 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHH
T ss_pred             eeccCCcccCCcccccccccCchHh
Confidence            8776554444556799999999964

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=8.6e-31  Score=243.27  Aligned_cols=173  Identities=25%  Similarity=0.395  Sum_probs=146.3

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .++|.+.+.||+|+||.||+|++      .+++.||+|++......  ...+.+.+|++++++++||||+++++++...+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP--SELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH--HHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            46789999999999999999975      24578999999765433  22477889999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCC---------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED---------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  350 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  350 (397)
                      ..++||||+++++|.+++.....                     ...+++.++..++.|++.||.|||   +.+|+||||
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~di  176 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDL  176 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCccccc
Confidence            99999999999999999876432                     134788999999999999999999   568999999


Q ss_pred             CCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          351 SSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       351 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      ||+||+++.++.+||+|||+++........  .....+|+.|+|||+
T Consensus       177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            999999999999999999999876543322  223457889999995

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=3.2e-31  Score=242.70  Aligned_cols=169  Identities=26%  Similarity=0.443  Sum_probs=143.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++.++..||+|++.......    +++.+|++++++++||||+++++++.+.+..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            45789999999999999999999888899999998765432    56788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....  ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           99 EYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999987532  24889999999999999999999   569999999999999999999999999999866432


Q ss_pred             CC-CeeeccccccccCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~  395 (397)
                      .. ......+|+.|+|||+
T Consensus       174 ~~~~~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEV  192 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHH
T ss_pred             ccccccCCccCcccCCHHH
Confidence            21 1122347888999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=3.5e-31  Score=243.91  Aligned_cols=170  Identities=29%  Similarity=0.491  Sum_probs=139.7

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--C
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--K  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  291 (397)
                      ++|++.+.||+|+||.||+|++     .+++.||||++.......   .+.+.+|++++++++||||+++++++...  .
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHH---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            5789999999999999999984     368899999998654332   46788999999999999999999998653  4


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             ceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            58999999999999999976532  4888999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCC---CeeeccccccccCCCCC
Q 043586          372 RLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      +.......   ......||+.|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESL  189 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHh
Confidence            87654332   12234578889999963

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=1.8e-30  Score=239.61  Aligned_cols=168  Identities=30%  Similarity=0.495  Sum_probs=138.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhh--cccCCccceeeEEee----CC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCLH----RK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~  291 (397)
                      .++|++.+.||+|+||.||+|++ +++.||||++.....      +.+.+|.+++..  ++||||+++++++..    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            46799999999999999999988 688999999876432      344556666666  789999999998765    34


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      ..++||||+++|+|.++++..    .+++..+..++.|++.||+|||..     ++++|+||||||+|||++.++.+||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            689999999999999999643    488999999999999999999932     14589999999999999999999999


Q ss_pred             ccccccccCCCCCC----eeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      |||+++........    .....||+.|+|||++
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  189 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL  189 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHH
T ss_pred             eCCCeeecccccccccccccccccccceeChhhh
Confidence            99999876544332    1234799999999964

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=5.1e-31  Score=248.81  Aligned_cols=167  Identities=29%  Similarity=0.442  Sum_probs=129.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.....     .+.+.+|++++++++||||+++++++...+..++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            467999999999999999999876 578999999976532     25678899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~~  373 (397)
                      |||+++++|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+|||+++.
T Consensus       127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999999887543   4788999999999999999999   568999999999999975   89999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..... ......||+.|+|||++
T Consensus       201 ~~~~~-~~~~~~gt~~y~aPE~~  222 (349)
T 2w4o_A          201 VEHQV-LMKTVCGTPGYCAPEIL  222 (349)
T ss_dssp             -------------CGGGSCHHHH
T ss_pred             cCccc-ccccccCCCCccCHHHh
Confidence            64432 22345799999999964

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.97  E-value=2.1e-30  Score=236.24  Aligned_cols=172  Identities=26%  Similarity=0.441  Sum_probs=147.4

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.......  ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT--HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh--hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence            3467999999999999999999865 68999999987554322  23678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.+....
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  156 (276)
T 2yex_A           83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (276)
T ss_dssp             EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence            99999999999988653   24788999999999999999999   5699999999999999999999999999998654


Q ss_pred             CCCC--CeeeccccccccCCCCC
Q 043586          376 ADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ....  ......||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~  179 (276)
T 2yex_A          157 YNNRERLLNKMCGTLPYVAPELL  179 (276)
T ss_dssp             ETTEECCBCCCCSCGGGCCGGGG
T ss_pred             CCcchhcccCCccccCccChHHH
Confidence            3221  12345699999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.97  E-value=1.1e-31  Score=250.84  Aligned_cols=170  Identities=26%  Similarity=0.366  Sum_probs=136.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|++........  ...+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc--chhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence            57899999999999999999875 789999999976443211  124557999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++ ++|.+++.....  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           80 EYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             ECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            9997 588888875433  4788999999999999999999   569999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       154 ~~~~~~~~~t~~y~aPE~~  172 (324)
T 3mtl_A          154 TKTYDNEVVTLWYRPPDIL  172 (324)
T ss_dssp             ---------CGGGCCHHHH
T ss_pred             ccccccccCcccccChhhh
Confidence            4444456789999999964

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.97  E-value=7e-31  Score=239.44  Aligned_cols=171  Identities=24%  Similarity=0.438  Sum_probs=140.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57899999999999999999875 78999999997654333333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           91 EYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             ECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             eccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            9999999999987543   4788999999999999999999   558999999999999999999999999999876543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .. .....||+.|+|||++
T Consensus       165 ~~-~~~~~~~~~y~aPE~~  182 (276)
T 2h6d_A          165 EF-LRTSCGSPNYAAPEVI  182 (276)
T ss_dssp             -------------CCTGGG
T ss_pred             cc-eecccCCccccCHHHH
Confidence            32 2335699999999974

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.97  E-value=2.6e-31  Score=248.85  Aligned_cols=172  Identities=26%  Similarity=0.380  Sum_probs=136.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|+++...... ...+.+.+|++++++++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE-GVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc-ccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            4467999999999999999999754 78999999997654332 234567789999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-----CCCCeEEecccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-----SKFEAFVADFGT  370 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-----~~~~~kl~DFG~  370 (397)
                      ||||++ ++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            999997 49998887643   3788999999999999999999   56999999999999994     455699999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++.............||+.|+|||++
T Consensus       184 a~~~~~~~~~~~~~~~t~~y~aPE~~  209 (329)
T 3gbz_A          184 ARAFGIPIRQFTHEIITLWYRPPEIL  209 (329)
T ss_dssp             HHHHC-----------CCTTCCHHHH
T ss_pred             ccccCCcccccCCCcCCccccCHHHh
Confidence            98776554444556789999999964

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.97  E-value=5.9e-31  Score=247.83  Aligned_cols=169  Identities=24%  Similarity=0.414  Sum_probs=140.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--CCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  296 (397)
                      +.|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++++++|  |||+++++++..++..++|
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            468899999999999999999888999999999765432 2334778899999999987  9999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+ .+++|.+++....   .+++.++..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e~-~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             EeC-CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            995 5789999987643   4788999999999999999999   56899999999999997 67899999999987654


Q ss_pred             CCCC--eeeccccccccCCCCC
Q 043586          377 DSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ....  .....||+.|+|||++
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             ----------CCCCSSCCHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHH
Confidence            3322  2345799999999963

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=6.5e-31  Score=249.10  Aligned_cols=176  Identities=26%  Similarity=0.327  Sum_probs=148.0

Q ss_pred             ccHHHHHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-----cCCccc
Q 043586          209 IVYEDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----HRNIVK  282 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~  282 (397)
                      +.+.+.....++|++.+.||+|+||.||+|++ .+++.||||+++.....    .+.+..|+.+++.++     ||||++
T Consensus        25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY----TRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHH----HHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhh----hhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34444445567899999999999999999986 46889999999754322    256677999999997     999999


Q ss_pred             eeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---
Q 043586          283 LYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---  359 (397)
Q Consensus       283 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---  359 (397)
                      +++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.   
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~  175 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYF  175 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccc
Confidence            999999999999999999 8999999876532 24788999999999999999999   569999999999999975   


Q ss_pred             ----------------------CCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          360 ----------------------KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ----------------------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                                            ++.+||+|||+++......   ....||+.|+|||++
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~---~~~~gt~~y~aPE~~  231 (360)
T 3llt_A          176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH---GSIINTRQYRAPEVI  231 (360)
T ss_dssp             CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC---CSCCSCGGGCCHHHH
T ss_pred             cccccchhcccccccccccccCCCCEEEEeccCceecCCCC---cCccCcccccCcHHH
Confidence                                  7899999999998654322   335799999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.97  E-value=1.1e-30  Score=250.03  Aligned_cols=169  Identities=23%  Similarity=0.406  Sum_probs=141.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc--cCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|...+++.||||++...... ....+.+.+|+.++++++  ||||+++++++...+..|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            459999999999999999999888999999999765432 233577899999999997  59999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      || +.+++|.+++....   .+++.++..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 56789999987643   4788889999999999999999   67999999999999996 58999999999987654


Q ss_pred             CCCC--eeeccccccccCCCCC
Q 043586          377 DSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ....  ....+||+.|+|||++
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             -------CCSCCCGGGCCHHHH
T ss_pred             CCccccCCCCCcCCCccChHHh
Confidence            3321  2345799999999963

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=1.8e-30  Score=236.91  Aligned_cols=170  Identities=24%  Similarity=0.382  Sum_probs=146.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. ++..+|+|++.......   .+.+.+|++++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            3467999999999999999999865 57789999987654332   3578899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~  372 (397)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999998886532   4788999999999999999999   5689999999999999   788999999999998


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ....... .....||+.|+|||++
T Consensus       158 ~~~~~~~-~~~~~~t~~y~aPE~~  180 (277)
T 3f3z_A          158 RFKPGKM-MRTKVGTPYYVSPQVL  180 (277)
T ss_dssp             ECCTTSC-BCCCCSCTTTCCHHHH
T ss_pred             eccCccc-hhccCCCCCccChHHh
Confidence            7654433 3345699999999963

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.97  E-value=2.3e-31  Score=249.41  Aligned_cols=176  Identities=26%  Similarity=0.376  Sum_probs=146.2

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEcCC------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEE
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFC  287 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  287 (397)
                      ....++|++.+.||+|+||.||+|++..      ...||+|.+.......  ..+.+.+|+.+++++ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChH--HHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3345789999999999999999998642      2479999997654332  246788999999999 899999999999


Q ss_pred             eeCCEeeEEEeeccCCCchhhcccCCC-----------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          288 LHRKCMFLIYEYMERGSLFCNLHNNED-----------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       288 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                      ...+..++||||+++|+|.+++.....           ...+++..+..++.|++.||.|||   +.+|+||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            999999999999999999998875321           124688999999999999999999   569999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      ++.++.+||+|||+++........  .....||+.|+|||+
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  237 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES  237 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHH
Confidence            999999999999999876543332  223457889999995

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.97  E-value=2.3e-30  Score=242.86  Aligned_cols=174  Identities=25%  Similarity=0.396  Sum_probs=145.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|++.+.||+|+||.||+|++.        ++..||+|+++......  ..+.+.+|+++++++ +||||+++++++.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHH--HHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            467999999999999999999853        46789999998654332  246788999999999 8999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      ..+..++||||+++++|.+++.....             ...+++..++.++.|++.||.|||   +.+|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence            99999999999999999999876432             124788999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +++.++.+||+|||+++........  .....+|+.|+|||++
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  231 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL  231 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHh
Confidence            9999999999999999876543321  2234578899999963

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=2.1e-30  Score=249.02  Aligned_cols=165  Identities=27%  Similarity=0.432  Sum_probs=131.2

Q ss_pred             cCCCcc-ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee----CC
Q 043586          219 EGFDIK-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----RK  291 (397)
Q Consensus       219 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  291 (397)
                      ++|.+. +.||+|+||.||+|++. +++.||||+++..        ..+.+|+.++.+. +||||+++++++..    ..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            457666 68999999999999865 6889999999743        2455688887554 89999999999876    56


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DF  368 (397)
                      ..|+||||+++|+|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+||
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence            78999999999999999976432 35889999999999999999999   569999999999999997   789999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++...... .....+||+.|+|||++
T Consensus       209 G~a~~~~~~~-~~~~~~gt~~y~aPE~~  235 (400)
T 1nxk_A          209 GFAKETTSHN-SLTTPCYTPYYVAPEVL  235 (400)
T ss_dssp             TTCEECC------------CTTCCGGGS
T ss_pred             ccccccCCCC-ccccCCCCCCccCHhhc
Confidence            9998765332 23446799999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=9e-31  Score=258.09  Aligned_cols=172  Identities=24%  Similarity=0.441  Sum_probs=144.4

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++....... ...+.+.+|++++++++||||+++++++.+....|+
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            4467999999999999999999865 78999999986533211 113578899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC---CCCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DFG~a~  372 (397)
                      ||||+++++|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            999999999998886543   4788999999999999999999   56999999999999995   46689999999998


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ....... ....+||+.|+|||++
T Consensus       173 ~~~~~~~-~~~~~gt~~y~aPE~~  195 (486)
T 3mwu_A          173 CFQQNTK-MKDRIGTAYYIAPEVL  195 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGG
T ss_pred             ECCCCCc-cCCCcCCCCCCCHHHh
Confidence            7654332 3345799999999974

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.97  E-value=1.4e-30  Score=241.39  Aligned_cols=167  Identities=34%  Similarity=0.495  Sum_probs=135.8

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++. ++.||+|++.....     .+.+.+|++++++++||||+++++++.+  ..++|||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e   79 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE-----RKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME   79 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTTH-----HHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChhH-----HHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence            46888999999999999999885 78899999875432     2678899999999999999999998874  4789999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC-eEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE-AFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+++........+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            9999999999987655445788899999999999999999643378999999999999998886 799999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .   ....||+.|+|||++
T Consensus       160 ~---~~~~gt~~y~aPE~~  175 (307)
T 2eva_A          160 M---TNNKGSAAWMAPEVF  175 (307)
T ss_dssp             --------CCTTSSCHHHH
T ss_pred             c---ccCCCCCceEChhhh
Confidence            2   234699999999963

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.97  E-value=1.7e-30  Score=243.50  Aligned_cols=171  Identities=29%  Similarity=0.406  Sum_probs=140.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            57999999999999999999875 5899999998665432 223466789999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.++.....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999988887765432   4788999999999999999999   569999999999999999999999999999876554


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       178 ~~~~~~~~~t~~y~aPE~~  196 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELL  196 (331)
T ss_dssp             ------CCCCCTTCCHHHH
T ss_pred             ccccCCCcCCccccCcccc
Confidence            4444456799999999963

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=3.4e-30  Score=235.87  Aligned_cols=171  Identities=27%  Similarity=0.457  Sum_probs=146.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            468999999999999999999864 68999999997654332 2246788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC---eEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE---AFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DFG~a~~  373 (397)
                      |||+++++|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            99999999988886542   4788999999999999999999   568999999999999986655   99999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... .....||+.|+|||++
T Consensus       158 ~~~~~~-~~~~~~~~~y~aPE~~  179 (284)
T 3kk8_A          158 VNDSEA-WHGFAGTPGYLSPEVL  179 (284)
T ss_dssp             CCSSCB-CCCSCSCGGGCCHHHH
T ss_pred             cccCcc-ccCCCCCcCCcCchhh
Confidence            654333 2345799999999963

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.97  E-value=2e-30  Score=237.48  Aligned_cols=172  Identities=22%  Similarity=0.343  Sum_probs=144.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++......... ..++.+|+..+..+ +||||+++++++.+++..+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHH-HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHH-HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence            3467999999999999999999875 7899999999865333222 35677899999999 8999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCC-ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-------------
Q 043586          295 LIYEYMERGSLFCNLHNNED-AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-------------  360 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-------------  360 (397)
                      +||||+++++|.+++..... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.+             
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~  164 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDED  164 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC---------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence            99999999999999875321 134789999999999999999999   5699999999999999844             


Q ss_pred             ------CCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          361 ------FEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       361 ------~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                            ..+||+|||.+.......    ...||+.|+|||++
T Consensus       165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~  202 (289)
T 1x8b_A          165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVL  202 (289)
T ss_dssp             -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHH
T ss_pred             cccCCceEEEEcccccccccCCcc----ccCCCccccChhHh
Confidence                  479999999998765432    23599999999964

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=1.3e-30  Score=240.77  Aligned_cols=171  Identities=24%  Similarity=0.429  Sum_probs=141.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--C
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--K  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  291 (397)
                      +.|++.+.||+|+||.||+|++     .+++.||+|++.......  ..+.+.+|++++++++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----C--CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccch--hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            4588899999999999999983     368899999997654221  236788999999999999999999999876  5


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence            68999999999999999865432  4788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      +........   .....||+.|+|||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECL  201 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeee
Confidence            877654422   2334688899999963

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.97  E-value=1.8e-30  Score=257.01  Aligned_cols=172  Identities=31%  Similarity=0.476  Sum_probs=143.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH----------HHHHHHHHHHHHHhhcccCCccceeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL----------AFIKSFRNEAQVLSQVLHRNIVKLYGF  286 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~  286 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........          ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            468999999999999999999865 678999999976543211          224678899999999999999999999


Q ss_pred             EeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC---Ce
Q 043586          287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF---EA  363 (397)
Q Consensus       287 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~---~~  363 (397)
                      +.+....|+||||+++|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccE
Confidence            999999999999999999998886542   4789999999999999999999   56999999999999998775   69


Q ss_pred             EEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+|||+++....... .....||+.|+|||++
T Consensus       189 kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~  220 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVL  220 (504)
T ss_dssp             EECCCTTCEECCTTSC-BCCCCSCTTTCCHHHH
T ss_pred             EEEECCCCEEcCCCCc-cccccCCcCCCCHHHh
Confidence            9999999987654432 3345799999999963

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.3e-30  Score=241.70  Aligned_cols=173  Identities=27%  Similarity=0.434  Sum_probs=139.1

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhh--cccCCccceeeEEeeC
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCLHR  290 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  290 (397)
                      ......++|++.+.||+|+||.||+|++. ++.||||++.....      ..+.+|.+++..  ++||||+++++++...
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33445678999999999999999999985 89999999865442      233345555554  4899999999999887


Q ss_pred             ----CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCEEeCCCC
Q 043586          291 ----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----SPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       291 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlkp~NIll~~~~  361 (397)
                          ...++||||+++|+|.++++..    .+++..+..++.|++.||.|||+.+     .++|+||||||+||+++.++
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence                7899999999999999999653    4788999999999999999999320     12999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCe----eeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNR----TLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~----~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++.........    ....||+.|+|||++
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  218 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL  218 (337)
T ss_dssp             CEEECCCTTCEECC---------CCSSCSCGGGCCHHHH
T ss_pred             CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhc
Confidence            99999999998765433221    235799999999964

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.1e-30  Score=237.40  Aligned_cols=170  Identities=32%  Similarity=0.557  Sum_probs=146.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            56899999999999999999865 67889999997654333333467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            9999999999887543   4788999999999999999999   679999999999999999999999999999765432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....||+.|+|||++
T Consensus       168 ~--~~~~~~~~~y~aPE~~  184 (284)
T 2vgo_A          168 R--RRTMCGTLDYLPPEMI  184 (284)
T ss_dssp             C--BCCCCSCGGGCCHHHH
T ss_pred             c--cccccCCCCcCCHHHh
Confidence            2  2345799999999963

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.97  E-value=9.4e-31  Score=255.96  Aligned_cols=168  Identities=27%  Similarity=0.324  Sum_probs=135.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  290 (397)
                      .++|++.+.||+|+||.||+|++. +++.||||++...... ....+++.+|+.+++.++||||+++++++...      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccC-hHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            467999999999999999999754 6899999999765322 22346788999999999999999999999654      


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ...|+||||+++ ++.+.+..     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~  210 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  210 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence            357999999976 46555543     2788899999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+...... ..+..+||+.|+|||++
T Consensus       211 a~~~~~~~-~~~~~~gt~~y~aPE~~  235 (464)
T 3ttj_A          211 ARTAGTSF-MMTPYVVTRYYRAPEVI  235 (464)
T ss_dssp             C-----CC-CC----CCCTTCCHHHH
T ss_pred             eeecCCCc-ccCCCcccccccCHHHH
Confidence            98765432 23446799999999974

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.97  E-value=5e-30  Score=235.95  Aligned_cols=171  Identities=25%  Similarity=0.375  Sum_probs=142.9

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      +|.....||+|+||.||+|++ .+++.||+|.+.......   .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY---SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHH---HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            355566899999999999986 468899999987654322   3678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEeccccccccCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGTARLLHAD  377 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~a~~~~~~  377 (397)
                      |+++++|.+++........+++..+..++.|++.||.|||   +.+++||||||+||+++. ++.+||+|||+++.....
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9999999999986544445678889999999999999999   569999999999999987 899999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       177 ~~~~~~~~~~~~y~aPE~~  195 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEII  195 (295)
T ss_dssp             ----CCCCCCGGGCCHHHH
T ss_pred             CCcccccCCCccccChhhh
Confidence            3334456799999999963

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.97  E-value=1.4e-30  Score=241.79  Aligned_cols=173  Identities=29%  Similarity=0.394  Sum_probs=146.9

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++.......  ..+.+.+|+.+++++ +||||+++++++..+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--HHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            35789999999999999999974      356889999998654332  236788999999999 899999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCc---------------cccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDA---------------VELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      +..++||||+++|+|.+++......               ..+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            9999999999999999998764321               24789999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      +++.++.+||+|||+++........  .....||+.|+|||+
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  218 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence            9999999999999999877554432  123457889999995

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.97  E-value=9.6e-31  Score=239.92  Aligned_cols=171  Identities=27%  Similarity=0.452  Sum_probs=140.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|.+.+.||+|+||.||+|+.. +++.+|+|++........  .+.+.+|++++++++||||+++++++.+....++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchh--HHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            57999999999999999999864 688999999876543211  367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEeccccccc
Q 043586          298 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTARL  373 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~~  373 (397)
                      ||+++++|.+.+.... ....+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            9999999998885431 1235888999999999999999999   5699999999999999   4568899999999987


Q ss_pred             cCCCCCCeeeccccccccCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ...... .....||+.|+|||+
T Consensus       177 ~~~~~~-~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          177 FKSDEH-STNAAGTALYMAPEV  197 (285)
T ss_dssp             -----------CTTGGGCCHHH
T ss_pred             cCCccc-CcCcccccCcCChHH
Confidence            654332 334569999999996

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=5.5e-31  Score=259.90  Aligned_cols=172  Identities=27%  Similarity=0.453  Sum_probs=146.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|++. ++..||||.++.....    .++|.+|+.++++++||||+++++++...+..++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3467889999999999999999876 4789999999865433    3678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++..... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            9999999999999976432 34788999999999999999999   5699999999999999999999999999998764


Q ss_pred             CCCCC-eeeccccccccCCCCC
Q 043586          376 ADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ..... .....+++.|+|||++
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~  391 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESL  391 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHH
T ss_pred             CCceeecCCCcCCcceeCHhHH
Confidence            33211 1223467889999963

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.97  E-value=4.3e-30  Score=235.62  Aligned_cols=168  Identities=30%  Similarity=0.535  Sum_probs=141.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHH----HHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELA----FIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++.........    ..+.+.+|++++++++||||+++++++.+..  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            5789999999999999999986 47899999998654332111    1257889999999999999999999987665  


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeCCCCC-----eEEe
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKFE-----AFVA  366 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl~  366 (397)
                      ++||||+++++|.+.+.....  .+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.     +||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            699999999999888865432  5889999999999999999999   557  999999999999988776     9999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||+++....   ......||+.|+|||++
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETI  198 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGS
T ss_pred             CCCccccccc---cccccCCCccccCchhh
Confidence            9999985433   23446799999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=3.4e-31  Score=258.78  Aligned_cols=171  Identities=25%  Similarity=0.454  Sum_probs=144.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..++|++.+.||+|+||.||+|++.++..||||+++.....    .+.|.+|++++++++||||+++++++. .+..++|
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv  260 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII  260 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence            45678999999999999999999988899999999865433    367889999999999999999999986 5678999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++.... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       261 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          261 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  336 (454)
T ss_dssp             ECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence            99999999999997532 124788899999999999999999   56899999999999999999999999999987643


Q ss_pred             CCC-CeeeccccccccCCCCC
Q 043586          377 DSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ... ......+|+.|+|||++
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~  357 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAI  357 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHH
T ss_pred             CceeccCCCcccccccCHHHh
Confidence            211 11223467889999963

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=1.9e-30  Score=242.05  Aligned_cols=172  Identities=27%  Similarity=0.401  Sum_probs=146.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........   ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456999999999999999999865 689999999976432210   0135788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEeccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFG  369 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG  369 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            99999999999999997542   4788999999999999999999   56999999999999999887    79999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       165 ~~~~~~~~~~-~~~~~gt~~y~aPE~~  190 (321)
T 2a2a_A          165 LAHEIEDGVE-FKNIFGTPEFVAPEIV  190 (321)
T ss_dssp             TCEECCTTCC-CCCCCSCGGGCCHHHH
T ss_pred             cceecCcccc-ccccCCCCCccCcccc
Confidence            9987655432 2345699999999963

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.97  E-value=3.9e-30  Score=237.86  Aligned_cols=169  Identities=34%  Similarity=0.476  Sum_probs=147.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++.......  ..+.+.+|+.+++.++||||+++++++......++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST--THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH--HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            5689999999999999999975 468999999997654322  2367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus       100 e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999988642    4788999999999999999999   569999999999999999999999999999877654


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       173 ~~~~~~~~~~~~y~aPE~~  191 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVI  191 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHH
T ss_pred             ccccCccCCCcCccCHHHH
Confidence            4444556799999999963

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.97  E-value=2.9e-31  Score=243.46  Aligned_cols=172  Identities=27%  Similarity=0.458  Sum_probs=147.6

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++......    .+.+.+|++++++++||||+++++++.+.+..+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            34567999999999999999999875 4889999999865543    367889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999999999976432 35888999999999999999999   558999999999999999999999999999876


Q ss_pred             CCCCCC-eeeccccccccCCCC
Q 043586          375 HADSSN-RTLLAGTYGYIAPGL  395 (397)
Q Consensus       375 ~~~~~~-~~~~~gt~~y~APE~  395 (397)
                      ...... .....+|+.|+|||+
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~  183 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPES  183 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHH
T ss_pred             cCCccccccCCccccCcCChhh
Confidence            544322 223457889999996

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.97  E-value=2e-30  Score=240.52  Aligned_cols=175  Identities=23%  Similarity=0.346  Sum_probs=136.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++......+....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5699999999999999999986 478999999998643333344577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          298 EYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      ||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            9999999999886421 1234788999999999999999999   56999999999999999999999999999987655


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .........||+.|+|||++
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~  208 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERI  208 (310)
T ss_dssp             ----------CCSSCCHHHH
T ss_pred             CCccccccCCCeeEeChHHh
Confidence            44434445799999999963

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.97  E-value=1.2e-30  Score=245.88  Aligned_cols=172  Identities=24%  Similarity=0.424  Sum_probs=146.5

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHH--------------HHHHHHHHHHHHhhcccCCcccee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELA--------------FIKSFRNEAQVLSQVLHRNIVKLY  284 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~l~  284 (397)
                      ++|++.+.||+|+||.||+|+. +++.||+|++.........              ..+.+.+|+.++++++||||++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            5799999999999999999998 8999999998754322110              115788999999999999999999


Q ss_pred             eEEeeCCEeeEEEeeccCCCchhh------cccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC
Q 043586          285 GFCLHRKCMFLIYEYMERGSLFCN------LHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  358 (397)
Q Consensus       285 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~  358 (397)
                      +++...+..++||||+++++|.++      +.... ...+++..+..++.|++.||.|||+  ..+++||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence            999999999999999999999998      54321 3458899999999999999999994  16999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          359 SKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       359 ~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .++.+||+|||.+......  ......||+.|+|||++
T Consensus       187 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~  222 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFF  222 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGG
T ss_pred             CCCcEEEeccccccccccc--cccCCCCCcCccCchhh
Confidence            9999999999999876443  23345799999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.97  E-value=1.2e-30  Score=257.55  Aligned_cols=171  Identities=26%  Similarity=0.409  Sum_probs=140.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. ++..||+|++........ ..+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----C-TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCch-HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            456999999999999999999875 688999999976543221 135688999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~~  373 (397)
                      |||+++|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999998886542   4788999999999999999999   569999999999999976   45699999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..... ......||+.|+|||++
T Consensus       189 ~~~~~-~~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          189 FENQK-KMKERLGTAYYIAPEVL  210 (494)
T ss_dssp             CBTTB-CBCCCCSCTTTCCHHHH
T ss_pred             CCCCc-cccccCCCcCeeCHHHH
Confidence            65433 23345799999999963

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.6e-31  Score=263.68  Aligned_cols=161  Identities=19%  Similarity=0.154  Sum_probs=125.9

Q ss_pred             eecCCcccEEEEEc-CCCcEEEEEEecccc-------hHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEE
Q 043586          227 IGTGGYGSVYKAQL-PNGKVFALKKLHTSE-------TEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       227 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+.|+.|.+..++. -.|+.||+|++....       .......++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566665555432 258899999997542       12233457899999999999 6999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++|++|.+.+.....   ++.   .+|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+....+
T Consensus       322 Eyv~G~~L~d~i~~~~~---l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGEE---IDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             ECCCSEEHHHHHHTTCC---CCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             ecCCCCcHHHHHHhCCC---CCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            99999999999986532   443   358999999999999   669999999999999999999999999999987666


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .......+||++|||||++
T Consensus       393 ~~~~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          393 CSWPTNLVQSFFVFVNELF  411 (569)
T ss_dssp             -CCSHHHHHHHHHHHHHHC
T ss_pred             CccccCceechhhccHHHh
Confidence            5555667899999999975

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=2.2e-30  Score=240.16  Aligned_cols=174  Identities=29%  Similarity=0.414  Sum_probs=138.6

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHH--HHHHHHHHHHHHHHhhcc---cCCccceeeEEeeC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHR  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  290 (397)
                      ..++|++.+.||+|+||.||+|++ .+++.||+|++.......  ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457899999999999999999986 478999999987432110  000134556777776665   99999999999875


Q ss_pred             C-----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEE
Q 043586          291 K-----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV  365 (397)
Q Consensus       291 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl  365 (397)
                      .     ..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            4     5899999997 599998876533 24889999999999999999999   568999999999999999999999


Q ss_pred             eccccccccCCCCCCeeeccccccccCCCCC
Q 043586          366 ADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       366 ~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +|||+++....... .....||+.|+|||++
T Consensus       162 ~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          162 ADFGLARIYSYQMA-LTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             CSCSCTTTSTTCCC-SGGGGCCCSSCCHHHH
T ss_pred             eeCccccccCCCcc-cCCccccccccCchHH
Confidence            99999987654332 3446799999999963

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.96  E-value=8.1e-31  Score=258.31  Aligned_cols=171  Identities=26%  Similarity=0.444  Sum_probs=146.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||||++...........+.+.+|+.++++++||||+++++++...+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            457999999999999999999875 7899999998654322111236788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~~  373 (397)
                      |||+.+|+|.+.+....   .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999887543   4788999999999999999999   5699999999999999   4678999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ...... .....||+.|+|||+
T Consensus       179 ~~~~~~-~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          179 FEASKK-MKDKIGTAYYIAPEV  199 (484)
T ss_dssp             BCCCCS-HHHHTTGGGTCCHHH
T ss_pred             cccccc-cccCCCCccccCcee
Confidence            754433 334579999999996

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=1.6e-30  Score=242.58  Aligned_cols=175  Identities=26%  Similarity=0.396  Sum_probs=129.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcCCC----cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ..++|++.+.||+|+||.||+|++...    ..||+|+++...... ...+++.+|++++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            346799999999999999999987543    279999997653322 224778999999999999999999999987665


Q ss_pred             e------eEEEeeccCCCchhhcccCC---CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          293 M------FLIYEYMERGSLFCNLHNNE---DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       293 ~------~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                      .      ++||||+++|+|.+++....   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence            4      99999999999999886432   1224888999999999999999999   5699999999999999999999


Q ss_pred             EEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          364 FVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      ||+|||+++........  .....+|+.|+|||+
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchh
Confidence            99999999876443321  223457889999996

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=1.9e-30  Score=237.31  Aligned_cols=170  Identities=27%  Similarity=0.398  Sum_probs=131.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|++..    +..||+|++......  ...+.+.+|+.++++++||||+++++++. .+..
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            3578999999999999999998642    457999998764432  23467899999999999999999999984 4568


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999987543  24788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCC-eeeccccccccCCCC
Q 043586          374 LHADSSN-RTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~~-~~~~~gt~~y~APE~  395 (397)
                      ....... .....+|+.|+|||+
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~  188 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPES  188 (281)
T ss_dssp             -------------CCGGGCCHHH
T ss_pred             cCcccccccccCCCcccccChhh
Confidence            6543321 223457889999996

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.3e-30  Score=246.02  Aligned_cols=167  Identities=27%  Similarity=0.357  Sum_probs=136.1

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  291 (397)
                      .++|++.+.||+|+||.||+|.+ .+|+.||||++...... ....+++.+|+++++.++||||+++++++....     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            35799999999999999999986 47899999999654322 233467889999999999999999999998753     


Q ss_pred             -EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          292 -CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       292 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                       ..|+||||+ +++|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~  174 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  174 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence             469999999 78999888752    4788999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++.....   ....+||+.|+|||++
T Consensus       175 a~~~~~~---~~~~~~t~~y~aPE~~  197 (367)
T 1cm8_A          175 ARQADSE---MTGYVVTRWYRAPEVI  197 (367)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHH
T ss_pred             ccccccc---cCcCcCCCCcCCHHHH
Confidence            9875432   2345799999999963

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=3.3e-31  Score=247.15  Aligned_cols=179  Identities=22%  Similarity=0.349  Sum_probs=148.1

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG  285 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  285 (397)
                      +++....++|++.+.||+|+||.||+|++.      +++.||+|.+.......  ....+.+|+.+++.++||||+++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHH--HHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            344455678999999999999999999754      36789999997654332  2367889999999999999999999


Q ss_pred             EEeeCCEeeEEEeeccCCCchhhcccCCC-------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC
Q 043586          286 FCLHRKCMFLIYEYMERGSLFCNLHNNED-------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN  358 (397)
Q Consensus       286 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~  358 (397)
                      ++...+..++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +.+|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEc
Confidence            99999999999999999999998875321       134688899999999999999999   56999999999999999


Q ss_pred             CCCCeEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          359 SKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       359 ~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      .++.+||+|||+++........  .....||+.|+|||+
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            9999999999999866433221  122357889999996

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=3.4e-30  Score=251.36  Aligned_cols=166  Identities=26%  Similarity=0.421  Sum_probs=140.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-EeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-CMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|++. ++.||||+++....     .+.|.+|++++++++||||+++++++.... ..++|
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCTT-----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCchH-----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            467888999999999999999985 77999999986542     267889999999999999999999987755 79999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++..... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       266 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999986432 23688899999999999999999   56899999999999999999999999999986433


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..   ....+++.|+|||++
T Consensus       342 ~~---~~~~~~~~y~aPE~~  358 (450)
T 1k9a_A          342 TQ---DTGKLPVKWTAPEAL  358 (450)
T ss_dssp             --------CCCTTTSCHHHH
T ss_pred             cc---cCCCCCcceeCHHHh
Confidence            22   223578899999963

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=3e-30  Score=236.02  Aligned_cols=167  Identities=28%  Similarity=0.513  Sum_probs=143.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee------
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  289 (397)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++....       +.+.+|++++++++||||+++++++..      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE   81 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence            4467999999999999999999875 78999999997654       345679999999999999999998864      


Q ss_pred             ----------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC
Q 043586          290 ----------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       290 ----------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~  359 (397)
                                ....++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~  157 (284)
T 2a19_B           82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVD  157 (284)
T ss_dssp             -------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEE
T ss_pred             cccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcC
Confidence                      445899999999999999997542 235788999999999999999999   569999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCCeeeccccccccCCCC
Q 043586          360 KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ++.+||+|||+++....... .....||+.|+|||+
T Consensus       158 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~  192 (284)
T 2a19_B          158 TKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQ  192 (284)
T ss_dssp             TTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHH
T ss_pred             CCCEEECcchhheecccccc-ccccCCcccccChhh
Confidence            99999999999987655432 233569999999996

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=2.7e-30  Score=245.03  Aligned_cols=180  Identities=24%  Similarity=0.368  Sum_probs=142.4

Q ss_pred             cHHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccch--------HHHHHHHHHHHHHHHHhhcccCCcc
Q 043586          210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET--------EELAFIKSFRNEAQVLSQVLHRNIV  281 (397)
Q Consensus       210 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv  281 (397)
                      ...++....++|++.+.||+|+||.||+|...+++.||||++.....        .+....+.+.+|++++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677888899999999999999999999988899999999865321        1223347889999999999999999


Q ss_pred             ceeeEEee-----CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          282 KLYGFCLH-----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       282 ~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                      ++++++..     ....|+||||++ |+|.+.+....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEE
Confidence            99999854     336899999997 58888877543  34889999999999999999999   568999999999999


Q ss_pred             eCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          357 LNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++.++.+||+|||+++....... .....||+.|+|||++
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~t~~y~aPE~~  205 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN-KTHYVTHRWYRAPELV  205 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHH
T ss_pred             EcCCCCEEEEecCcccccccccc-cceecccceecCcHHh
Confidence            99999999999999986543332 3345799999999963

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.3e-31  Score=251.80  Aligned_cols=172  Identities=31%  Similarity=0.454  Sum_probs=144.2

Q ss_pred             cCCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  292 (397)
                      ++|++.+.||+|+||.||+|+.    .+++.||||+++..... .....+.+.+|+++++++ .||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            5799999999999999999986    36899999998753210 001124567799999999 59999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            999999999999999987543   4788999999999999999999   5689999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccccccccCCCCC
Q 043586          373 LLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ....... ......||+.|+|||++
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~  232 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIV  232 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred             ecccCCCCcccCcccCcCccChhhh
Confidence            7643322 22345799999999964

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=1.1e-29  Score=236.55  Aligned_cols=167  Identities=25%  Similarity=0.396  Sum_probs=141.7

Q ss_pred             CCccceeecCCcccEEEEEcC-----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEe
Q 043586          221 FDIKYCIGTGGYGSVYKAQLP-----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCM  293 (397)
Q Consensus       221 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  293 (397)
                      |++.+.||+|+||.||++.+.     +++.||||++......  ...+.+.+|++++++++||||+++++++.+.  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccCh--HHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            488999999999999988642     6789999999865433  2246789999999999999999999999884  678


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++...    .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999999754    3788999999999999999999   56899999999999999999999999999998


Q ss_pred             cCCCCCC---eeeccccccccCCCCC
Q 043586          374 LHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      .......   .....||+.|+|||++
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~  209 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECL  209 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHh
Confidence            7654322   2334588899999963

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=2.2e-30  Score=244.65  Aligned_cols=171  Identities=27%  Similarity=0.435  Sum_probs=140.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--------  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  289 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++....... .....+.+|+++++.++||||+++++++..        
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            5799999999999999999987 478999999986543221 112456789999999999999999999987        


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      .+..++||||+++ ++.+.+.....  .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccch
Confidence            3468999999975 77777664332  4889999999999999999999   5699999999999999999999999999


Q ss_pred             cccccCCCC----CCeeeccccccccCCCCC
Q 043586          370 TARLLHADS----SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~----~~~~~~~gt~~y~APE~~  396 (397)
                      +++.+....    .......||+.|+|||++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL  200 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHH
T ss_pred             hcccccccccccccccCCcccccCccCchhh
Confidence            998765322    122345689999999964

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=4.6e-30  Score=236.84  Aligned_cols=171  Identities=27%  Similarity=0.505  Sum_probs=139.2

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee------
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  289 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++.....    ..+.+.+|+.++++++||||+++++++.+      
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK   79 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH----HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence            4567999999999999999999864 789999999975432    23678899999999999999999998865      


Q ss_pred             -------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          290 -------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       290 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                             .+..|+||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSC
T ss_pred             hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCC
Confidence                   456899999999999999997543  34678889999999999999999   568999999999999999999


Q ss_pred             eEEeccccccccCCCC--------------CCeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADS--------------SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~--------------~~~~~~~gt~~y~APE~~  396 (397)
                      +||+|||+++......              .......||+.|+|||++
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  202 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL  202 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHHH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccc
Confidence            9999999998764321              112345699999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=1.2e-29  Score=233.77  Aligned_cols=172  Identities=26%  Similarity=0.420  Sum_probs=147.8

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccc------hHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEe
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSE------TEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCL  288 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  288 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++....      .......+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999875 68999999997543      122233567889999999996 999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecc
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADF  368 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DF  368 (397)
                      ..+..++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecc
Confidence            9999999999999999999987532   4788999999999999999999   569999999999999999999999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      |++........ .....||+.|+|||+
T Consensus       169 g~~~~~~~~~~-~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          169 GFSCQLDPGEK-LREVCGTPSYLAPEI  194 (298)
T ss_dssp             TTCEECCTTCC-BCCCCSCGGGCCHHH
T ss_pred             cchhhcCCCcc-cccccCCccccCHHH
Confidence            99987654332 234569999999996

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=2.6e-30  Score=235.05  Aligned_cols=170  Identities=32%  Similarity=0.518  Sum_probs=131.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHH-HHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. ++.||+|+++...... ....+.+.+|+++++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            57889999999999999999975 8899999987654332 223467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC--------CCCeEEeccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--------KFEAFVADFG  369 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--------~~~~kl~DFG  369 (397)
                      ||+++++|.+++...    .+++..+..++.|++.||.|||+....+|+||||||+||+++.        ++.+||+|||
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             ECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999888632    4788999999999999999999542223999999999999986        6789999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      +++.......  ....||+.|+|||+
T Consensus       162 ~~~~~~~~~~--~~~~~~~~y~aPE~  185 (271)
T 3dtc_A          162 LAREWHRTTK--MSAAGAYAWMAPEV  185 (271)
T ss_dssp             C---------------CCGGGSCHHH
T ss_pred             cccccccccc--cCCCCccceeCHHH
Confidence            9986654332  23469999999995

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=2.5e-31  Score=253.67  Aligned_cols=171  Identities=17%  Similarity=0.189  Sum_probs=135.6

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHH---HHHhhcccCCcccee-------eE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEA---QVLSQVLHRNIVKLY-------GF  286 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  286 (397)
                      .++|++.+.||+|+||.||+|++ .+++.||||++...........+.+.+|+   +.+++++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            36788899999999999999996 46899999999754332223346788999   555666899999998       66


Q ss_pred             EeeCC-----------------EeeEEEeeccCCCchhhcccCCC----ccccChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 043586          287 CLHRK-----------------CMFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSI  345 (397)
Q Consensus       287 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~i  345 (397)
                      +..++                 ..|+||||+ +|+|.+++.....    ...+++..+..++.|++.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            65543                 278999999 6899999875321    123446788889999999999999   5689


Q ss_pred             EEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       346 vH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +||||||+|||++.++.+||+|||+|+....   ......| +.|+|||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELE  274 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhh
Confidence            9999999999999999999999999986332   3344567 999999964

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=5.6e-30  Score=239.48  Aligned_cols=169  Identities=28%  Similarity=0.432  Sum_probs=144.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe--eCC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--HRK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~  291 (397)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++.......   .+.+.+|++++++++||||+++++++.  ...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH---HHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence            5789999999999999999983     368899999998764332   367889999999999999999999887  456


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             eEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccc
Confidence            7899999999999999987532  24889999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGL  395 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~  395 (397)
                      +........   .....||+.|+|||+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPES  201 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHH
T ss_pred             eecccCCccceeeccCCccccccCHHH
Confidence            877544332   223458889999996

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.96  E-value=1.2e-30  Score=239.45  Aligned_cols=166  Identities=23%  Similarity=0.397  Sum_probs=141.7

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-C-------cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-G-------KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ++|++.+.||+|+||.||+|++.. +       ..||+|++.......   .+.+.+|++++++++||||+++++++..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY---SESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGG---HHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHH---HHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            568899999999999999997642 3       479999987654332   36788999999999999999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC--------
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--------  362 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--------  362 (397)
                      +..++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.        
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccce
Confidence            99999999999999999997643  23788999999999999999999   568999999999999998887        


Q ss_pred             eEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +||+|||++.....    .....||+.|+|||++
T Consensus       160 ~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~  189 (289)
T 4fvq_A          160 IKLSDPGISITVLP----KDILQERIPWVPPECI  189 (289)
T ss_dssp             EEECCCCSCTTTSC----HHHHHHTTTTSCHHHH
T ss_pred             eeeccCcccccccC----ccccCCcCcccCHHHh
Confidence            99999999975432    2234689999999963

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=9.9e-30  Score=234.34  Aligned_cols=167  Identities=20%  Similarity=0.286  Sum_probs=143.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++......     +.+.+|+++++.+ +|+|++++++++......++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            5799999999999999999985 57899999998754432     4577899999999 799999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC-----eEEeccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE-----AFVADFGTA  371 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~DFG~a  371 (397)
                      |||+ +++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||++
T Consensus        85 ~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            9999 9999999976432  4889999999999999999999   679999999999999987776     999999999


Q ss_pred             cccCCCCC-------CeeeccccccccCCCCC
Q 043586          372 RLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      +.......       ......||+.|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  190 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTH  190 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhh
Confidence            87754332       12345799999999963

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.8e-30  Score=235.51  Aligned_cols=168  Identities=26%  Similarity=0.430  Sum_probs=145.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++.+++.||+|++.......    +.+.+|++++++++||||+++++++..++..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            5688899999999999999998888999999998765432    568889999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++++|.+++.....  .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999876432  4788999999999999999999   5689999999999999999999999999998654321


Q ss_pred             C-CeeeccccccccCCCC
Q 043586          379 S-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       379 ~-~~~~~~gt~~y~APE~  395 (397)
                      . ......||+.|+|||+
T Consensus       159 ~~~~~~~~~~~~y~aPE~  176 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEV  176 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHH
T ss_pred             ccccccccccccccChhh
Confidence            1 1122457889999996

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=6.5e-30  Score=237.50  Aligned_cols=170  Identities=31%  Similarity=0.472  Sum_probs=142.6

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|.+.....     .+.+.+|+.++++++||||+++++++...+..++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            4568999999999999999999865 589999999976542     2567889999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus       102 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  176 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT  176 (314)
T ss_dssp             EEECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECB
T ss_pred             EeecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhh
Confidence            999999999999886432  24788999999999999999999   5699999999999999999999999999998776


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........||+.|+|||++
T Consensus       177 ~~~~~~~~~~~~~~y~aPE~~  197 (314)
T 3com_A          177 DTMAKRNTVIGTPFWMAPEVI  197 (314)
T ss_dssp             TTBSCBCCCCSCGGGCCHHHH
T ss_pred             hhccccCccCCCCCccChhhc
Confidence            544444456799999999963

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=4e-30  Score=234.87  Aligned_cols=169  Identities=27%  Similarity=0.476  Sum_probs=143.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|+..+++.||+|++......    .+.+.+|++++++++||||+++++++.. +..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            3678999999999999999999888889999999765433    2578899999999999999999999864 4589999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            9999999999987532 124788999999999999999999   569999999999999999999999999999876543


Q ss_pred             CCC-eeeccccccccCCCC
Q 043586          378 SSN-RTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~~-~~~~~gt~~y~APE~  395 (397)
                      ... .....+|+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEA  181 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHH
T ss_pred             ccccccCCCCccCccChhh
Confidence            321 122347889999996

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.96  E-value=1.7e-29  Score=232.02  Aligned_cols=168  Identities=26%  Similarity=0.412  Sum_probs=141.3

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMF  294 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  294 (397)
                      .|.+.+.||+|+||.||+|.+. ++..||+|++....... ...+.+.+|+.++++++||||+++++++..    ....+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3677888999999999999864 67899999987654332 224778899999999999999999999875    45689


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeC-CCCCeEEeccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLN-SKFEAFVADFGTA  371 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~DFG~a  371 (397)
                      +||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+  |+||||||+||+++ .++.+||+|||++
T Consensus       106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999997532   4788999999999999999999   556  99999999999998 7899999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ......  ......||+.|+|||++
T Consensus       180 ~~~~~~--~~~~~~~t~~y~aPE~~  202 (290)
T 1t4h_A          180 TLKRAS--FAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             GGCCTT--SBEESCSSCCCCCGGGG
T ss_pred             cccccc--ccccccCCcCcCCHHHH
Confidence            754432  23445799999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.5e-30  Score=243.10  Aligned_cols=177  Identities=28%  Similarity=0.474  Sum_probs=142.8

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH  289 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  289 (397)
                      .++....++|++.+.||+|+||.||+|++ .+++.||+|++.......    +.+.+|+.+++++ +||||+++++++..
T Consensus        17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE----EEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTT----HHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccH----HHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33444567899999999999999999986 478999999997654332    5678899999999 79999999999987


Q ss_pred             ------CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          290 ------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       290 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                            .+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence                  467899999999999999987643 235788899999999999999999   5689999999999999999999


Q ss_pred             EEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+|||++..............||+.|+|||++
T Consensus       169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  201 (326)
T ss_dssp             EECCCTTTC-------------CCGGGCCHHHH
T ss_pred             EEeeCcCceecCcCccccccccCCccccChhhh
Confidence            999999998765443334456799999999964

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=4.9e-30  Score=232.90  Aligned_cols=167  Identities=19%  Similarity=0.301  Sum_probs=143.2

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC--CEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR--KCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|++. ++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            56899999999999999999985 8889999998654332 2246789999999999999999999999887  778999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      |||+++|+|.+++..... ..+++..+..++.|++.||.|||   +.+  ++||||||+||+++.++.++|+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~  163 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF  163 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred             ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence            999999999999986432 24889999999999999999999   557  999999999999999999999999987653


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...     ...||+.|+|||++
T Consensus       164 ~~~-----~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          164 QSP-----GRMYAPAWVAPEAL  180 (271)
T ss_dssp             SCT-----TCBSCGGGSCHHHH
T ss_pred             ccc-----CccCCccccChhhh
Confidence            322     24689999999963

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=6.4e-30  Score=236.57  Aligned_cols=169  Identities=26%  Similarity=0.453  Sum_probs=143.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|.+.+.||+|+||.||+|+.. +++.||+|++.......   .+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            3467999999999999999999865 78999999998654322   2567889999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~  372 (397)
                      ||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus        84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            999999999999886543   4788999999999999999999   5699999999999999   788999999999997


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .....  ......||+.|+|||++
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~  179 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVL  179 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTB
T ss_pred             ecCCC--ccccccCCCCccChHHh
Confidence            54332  22335699999999975

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=3e-30  Score=241.42  Aligned_cols=170  Identities=25%  Similarity=0.419  Sum_probs=135.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++. +++    .||+|.++.....  ...+++.+|+.++++++||||+++++++.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            56889999999999999999864 344    3588887644322  22467889999999999999999999998765 7


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++|+||+.+|+|.+++.....  .+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            789999999999999876433  4788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCC--eeeccccccccCCCCC
Q 043586          374 LHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      .......  .....||+.|+|||++
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~  191 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHH
T ss_pred             ccCCcccccccCCCccccccChHHh
Confidence            6544332  2234578899999963

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=8.1e-30  Score=237.09  Aligned_cols=169  Identities=22%  Similarity=0.389  Sum_probs=137.5

Q ss_pred             cCCCcc-ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeE
Q 043586          219 EGFDIK-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       219 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  295 (397)
                      +.|++. +.||+|+||.||+|+.. +++.||||++.......   .+.+.+|++++.++ +||||+++++++.+.+..|+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCC---HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchh---HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            568774 77999999999999864 78999999997654322   25678899999985 79999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC---eEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE---AFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~DFG~a~  372 (397)
                      ||||+++++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+++
T Consensus        89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999987542   4788999999999999999999   569999999999999998776   9999999998


Q ss_pred             ccCCCCC-------CeeeccccccccCCCCC
Q 043586          373 LLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      .......       ......||+.|+|||++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  193 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVV  193 (316)
T ss_dssp             -------------------CCSGGGCCHHHH
T ss_pred             ccccCCccccccccccccccCCcCccChHHh
Confidence            6543211       11234699999999963

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=1.8e-30  Score=253.51  Aligned_cols=171  Identities=27%  Similarity=0.461  Sum_probs=139.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ..++|++.+.||+|+||.||+|++.++..||||+++.....    .+.|.+|++++++++||||+++++++.. +..++|
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv  256 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV  256 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence            34678899999999999999999988888999999865433    2578899999999999999999999876 668999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++.... ...+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       257 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          257 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED  332 (452)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             ehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence            99999999999997432 124788999999999999999999   56899999999999999999999999999987654


Q ss_pred             CCC-CeeeccccccccCCCCC
Q 043586          377 DSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ... ......+|+.|+|||++
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~  353 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAA  353 (452)
T ss_dssp             ----------CCGGGSCHHHH
T ss_pred             CceecccCCcccccccCHhHH
Confidence            322 12234578899999963

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=5.8e-30  Score=240.12  Aligned_cols=167  Identities=27%  Similarity=0.430  Sum_probs=134.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-----CCE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----RKC  292 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  292 (397)
                      .++|++.+.||+|+||.||+|+. +++.||||++.......    .....|+..+..++||||+++++.+..     ...
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN----FINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchhh----HHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            36799999999999999999987 58899999997654321    112234444556899999999986543     336


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCC---------CeEEcCCCCCCEEeCCCCCe
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP---------SIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dlkp~NIll~~~~~~  363 (397)
                      .++||||+++|+|.+++....    .++..+..++.|++.||.|||   +.         +|+||||||+|||++.++.+
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcE
Confidence            789999999999999997542    478889999999999999999   55         99999999999999999999


Q ss_pred             EEeccccccccCCCCC--------CeeeccccccccCCCCC
Q 043586          364 FVADFGTARLLHADSS--------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~--------~~~~~~gt~~y~APE~~  396 (397)
                      ||+|||+++.+.....        ......||+.|+|||++
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL  200 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhh
Confidence            9999999987653221        12235699999999964

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.96  E-value=4.2e-30  Score=237.00  Aligned_cols=172  Identities=29%  Similarity=0.406  Sum_probs=142.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccch-hhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEE
Confidence            57899999999999999999875 78999999987644221 12356788999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++ ++|.+++..... ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        82 e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  156 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  156 (299)
T ss_dssp             ECCS-EEHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             Eccc-CCHHHHHHhhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCC
Confidence            9997 599988876432 24788899999999999999999   569999999999999999999999999999876544


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~y~aPE~~  175 (299)
T 2r3i_A          157 VRTYTHEVVTLWYRAPEIL  175 (299)
T ss_dssp             SBCTTSCBCCCTTCCHHHH
T ss_pred             ccccCcccccccccCcHHh
Confidence            3333445689999999963

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.96  E-value=6.7e-30  Score=233.77  Aligned_cols=172  Identities=26%  Similarity=0.397  Sum_probs=142.7

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++........   ...+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356899999999999999999875 689999999876532210   0136788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEeccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFG  369 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG  369 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999986532   4788999999999999999999   56999999999999998877    89999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++........ .....||+.|+|||++
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~y~aPE~~  183 (283)
T 3bhy_A          158 IAHKIEAGNE-FKNIFGTPEFVAPEIV  183 (283)
T ss_dssp             TCEECC---------CCCGGGCCHHHH
T ss_pred             cceeccCCCc-ccccCCCcCccCccee
Confidence            9987654332 2335699999999963

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=4.2e-30  Score=238.85  Aligned_cols=180  Identities=24%  Similarity=0.350  Sum_probs=148.3

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCcccee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLY  284 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~  284 (397)
                      .++....++|++.+.||+|+||.||+|++      .+++.||+|++.......  ..+.+.+|+.+++++ +||||++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcH--HHHHHHHHHHHHHhcccCCCeeeEE
Confidence            34444567899999999999999999973      356899999998654332  236788999999999 699999999


Q ss_pred             eEEeeCC-EeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043586          285 GFCLHRK-CMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  350 (397)
Q Consensus       285 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  350 (397)
                      +++...+ ..++||||+++++|.+++.....             ...+++..+..++.|++.||.|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9988754 58999999999999999976532             112788999999999999999999   569999999


Q ss_pred             CCCCEEeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          351 SSNNILLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       351 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      ||+||+++.++.+||+|||+++........  .....||+.|+|||++
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  222 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhh
Confidence            999999999999999999999876544332  2234588999999963

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=4.3e-30  Score=243.92  Aligned_cols=173  Identities=18%  Similarity=0.284  Sum_probs=138.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC------CcEEEEEEecccchHHHHH--------HHHHHHHHHHHhhcccCCccce
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAF--------IKSFRNEAQVLSQVLHRNIVKL  283 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l  283 (397)
                      .++|++.+.||+|+||.||+|++.+      ++.||||++..........        ...+.+|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            3579999999999999999998754      4789999987654321111        1234456677788899999999


Q ss_pred             eeEEeeC----CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-
Q 043586          284 YGFCLHR----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-  358 (397)
Q Consensus       284 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-  358 (397)
                      ++++...    ...++||||+ +++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEec
Confidence            9998774    4589999999 999999987642  34899999999999999999999   56999999999999999 


Q ss_pred             -CCCCeEEeccccccccCCCCC-------CeeeccccccccCCCCC
Q 043586          359 -SKFEAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       359 -~~~~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                       .++.+||+|||+++.+.....       ......||+.|+|||++
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  233 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH  233 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence             889999999999987644321       11334599999999964

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.96  E-value=3.2e-30  Score=244.37  Aligned_cols=169  Identities=28%  Similarity=0.367  Sum_probs=144.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++......  ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCH--HHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            56899999999999999999875 6899999999865433  23467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....   .+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||+++.....
T Consensus       111 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             ECCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999999987543   478899999999999999999952  28999999999999999999999999999765332


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .  .....||+.|+|||++
T Consensus       186 ~--~~~~~gt~~y~aPE~~  202 (360)
T 3eqc_A          186 M--ANSFVGTRSYMSPERL  202 (360)
T ss_dssp             C------CCCCTTCCHHHH
T ss_pred             c--ccCCCCCCCeECHHHH
Confidence            2  2335799999999964

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=1.6e-30  Score=237.34  Aligned_cols=177  Identities=28%  Similarity=0.495  Sum_probs=143.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMF  294 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  294 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|+.++++++||||+++++++..  ....+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            367899999999999999999865 68999999997654322 224678899999999999999999998854  56899


Q ss_pred             EEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          295 LIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      +||||+++++|.+++.... ....+++..+..++.|++.||+|||+..  ..+++||||||+||+++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999987532 1234889999999999999999999541  012999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      +.............||+.|+|||+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~  187 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQ  187 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHH
T ss_pred             eeeccccccccccCCCccccChHH
Confidence            876544333334569999999996

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=1.9e-30  Score=239.72  Aligned_cols=172  Identities=28%  Similarity=0.434  Sum_probs=140.3

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+++++.++||||+++++++...+..++
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CC---HHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHH---HHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            3467999999999999999999875 58899999987543222   3678889999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++.....  .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999988765322  4788999999999999999999   5699999999999999999999999999986432


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..........||+.|+|||++
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~  189 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVV  189 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHH
T ss_pred             ccccccccccCChhhcCCeee
Confidence            222222335699999999963

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=5.6e-30  Score=235.29  Aligned_cols=170  Identities=30%  Similarity=0.500  Sum_probs=132.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++.  ..||+|+++...... ...+.+.+|++++++++||||+++++++ .....++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCH-HHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            367999999999999999999874  359999997654332 2347789999999999999999999965 455689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        99 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A           99 QWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW  173 (289)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred             EecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence            9999999999886543  34888999999999999999999   568999999999999999999999999999865432


Q ss_pred             C--CCeeeccccccccCCCCC
Q 043586          378 S--SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~--~~~~~~~gt~~y~APE~~  396 (397)
                      .  .......||+.|+|||++
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~  194 (289)
T 3og7_A          174 SGSHQFEQLSGSILWMAPEVI  194 (289)
T ss_dssp             ----------CCCTTCCHHHH
T ss_pred             cccccccccCCCccccCchhh
Confidence            2  222345699999999963

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=2.7e-30  Score=241.47  Aligned_cols=170  Identities=23%  Similarity=0.367  Sum_probs=136.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcE----EEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+.......  ..+.+.+|+.++++++||||+++++++. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQ--SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCS--CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHH--HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            46888999999999999999864 4443    7888775432211  1245678999999999999999999986 4568


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            89999999999999987542  35788999999999999999999   56899999999999999999999999999997


Q ss_pred             cCCCCC--CeeeccccccccCCCCC
Q 043586          374 LHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ......  ......||+.|+|||++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~  189 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESI  189 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHH
T ss_pred             cCcccccccccCCCCcccccChHHh
Confidence            754432  22345688899999963

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.96  E-value=1.5e-30  Score=249.59  Aligned_cols=167  Identities=28%  Similarity=0.366  Sum_probs=134.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC------E
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------C  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  292 (397)
                      .+|++.+.||+|+||.||+|++..+..+|+|++.....       ...+|+++++.++||||+++++++...+      .
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            46899999999999999999987777799998865432       2236999999999999999999996533      3


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEeccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTA  371 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a  371 (397)
                      .++||||++++.+............+++..+..++.|++.||+|||   +.+|+||||||+|||++ .++.+||+|||+|
T Consensus       113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            8899999987544333322222335888999999999999999999   56999999999999999 7999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +........ ....||+.|+|||++
T Consensus       190 ~~~~~~~~~-~~~~~t~~y~aPE~~  213 (394)
T 4e7w_A          190 KILIAGEPN-VSYICSRYYRAPELI  213 (394)
T ss_dssp             EECCTTCCC-CSSCSCGGGCCHHHH
T ss_pred             ccccCCCCC-cccccCcCccCHHHH
Confidence            876544332 345789999999964

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=1.1e-29  Score=234.26  Aligned_cols=170  Identities=26%  Similarity=0.389  Sum_probs=139.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe-eCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL-HRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  293 (397)
                      ..|++.+.||+|+||.||+|++.+    ...+|+|.+.......  ..+.+.+|+.++++++||||+++++++. .++..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHH--HHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHH--HHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            457888999999999999998542    2358999987644332  2467889999999999999999999865 45678


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999997543  34788899999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCC----CeeeccccccccCCCC
Q 043586          374 LHADSS----NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~----~~~~~~gt~~y~APE~  395 (397)
                      ......    ......||+.|+|||.
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALES  203 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHH
T ss_pred             ccccchhccccccCCCCCccccChHH
Confidence            644221    2233467889999995

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=237.99  Aligned_cols=171  Identities=25%  Similarity=0.364  Sum_probs=129.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEe--------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCL--------  288 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------  288 (397)
                      .+|++.+.||+|+||.||+|++. +++.||+|++.......   .+.+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHH---HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHH---HHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            47899999999999999999864 78999999986654332   367889999999996 999999999984        


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEeCCCCCeEEe
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPS--IIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      .....++||||+. |+|.+++........+++..++.++.|++.||.|||   +.+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEe
Confidence            3446899999996 689888865333345899999999999999999999   557  9999999999999999999999


Q ss_pred             ccccccccCCCCCC------------eeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSN------------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~------------~~~~~gt~~y~APE~~  396 (397)
                      |||+++........            .....||+.|+|||++
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             CCTTCBCCSSCC------------------------------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            99999876543221            1134699999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2e-29  Score=231.27  Aligned_cols=170  Identities=26%  Similarity=0.403  Sum_probs=141.2

Q ss_pred             cCCCccc-eeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||+|+++.....  ...+.+.+|++++++++||||+++++++ ..+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            4566666 8999999999999753   5788999999875432  2347788999999999999999999999 455689


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999986432  34889999999999999999999   569999999999999999999999999999877


Q ss_pred             CCCCCC---eeeccccccccCCCCC
Q 043586          375 HADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      ......   .....||+.|+|||++
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~  185 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECI  185 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred             ccCcceeeccccccccccccCHHHh
Confidence            543322   1223468999999963

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=7.7e-30  Score=237.34  Aligned_cols=172  Identities=22%  Similarity=0.368  Sum_probs=141.2

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  293 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++......   ..+.+.+|+++++.++||||+++++++..    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ---DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH---HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH---HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            5799999999999999999986 57899999998764432   24678899999999999999999999873    3478


Q ss_pred             eEEEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      ++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            99999999999999887521 1235889999999999999999999   5699999999999999999999999999988


Q ss_pred             ccCCCCCC---------eeeccccccccCCCCC
Q 043586          373 LLHADSSN---------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~---------~~~~~gt~~y~APE~~  396 (397)
                      ........         .....||+.|+|||++
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELF  215 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred             hcccccccccccccccccccccCCcccCCHhHh
Confidence            65422111         1123579999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=9.1e-30  Score=238.11  Aligned_cols=183  Identities=21%  Similarity=0.324  Sum_probs=148.0

Q ss_pred             cccHHHHHHHhcCCCcc-ceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCcccee
Q 043586          208 RIVYEDLIEATEGFDIK-YCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY  284 (397)
Q Consensus       208 ~~~~~~~~~~~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  284 (397)
                      .+.+.......+.|.+. +.||+|+||.||+|+.. +++.||+|++....... .....+.+|+.+++.++ ||||++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            34455566677788887 88999999999999865 68999999997654322 11356788999999995 69999999


Q ss_pred             eEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CC
Q 043586          285 GFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KF  361 (397)
Q Consensus       285 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~  361 (397)
                      +++...+..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence            99999999999999999999999886532 235889999999999999999999   569999999999999997   78


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++....... .....||+.|+|||++
T Consensus       172 ~~kL~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~  205 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEIL  205 (327)
T ss_dssp             CEEECCGGGCEEC----------CCCGGGCCHHHH
T ss_pred             cEEEeeCccccccCCccc-cccccCCcCccCCeee
Confidence            999999999987654332 2335799999999963

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=232.35  Aligned_cols=174  Identities=21%  Similarity=0.323  Sum_probs=141.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHH-HHHHHHHHHHHHHHhhcccCCccceeeEEe--eCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEE-LAFIKSFRNEAQVLSQVLHRNIVKLYGFCL--HRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|++++++++||||+++++++.  .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999874 68899999997654321 123467889999999999999999999984  45578


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||++++ +.+.+..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 6666654332 35889999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCC--CeeeccccccccCCCCC
Q 043586          374 LHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ......  ......||+.|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~  183 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIA  183 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred             cCccccccccccCCCCCCCcChhhc
Confidence            653222  22345699999999963

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=9.3e-30  Score=242.22  Aligned_cols=167  Identities=28%  Similarity=0.325  Sum_probs=131.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK------  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  291 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+.+|+.+++.++||||+++++++...+      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            57999999999999999999764 6889999999764322 223467889999999999999999999997654      


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+++ +|.+.+..     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 78777753     3788899999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +...... ......||+.|+|||++
T Consensus       175 ~~~~~~~-~~~~~~gt~~y~aPE~~  198 (371)
T 2xrw_A          175 RTAGTSF-MMTPYVVTRYYRAPEVI  198 (371)
T ss_dssp             ----------------CTTCCHHHH
T ss_pred             ccccccc-ccCCceecCCccCHHHh
Confidence            8664332 22345799999999964

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.1e-29  Score=238.17  Aligned_cols=170  Identities=32%  Similarity=0.463  Sum_probs=136.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCC-----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN-----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++..     +..||+|+++......  ....+.+|++++++++||||+++++++...+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            457778999999999999997542     2469999997654332  236788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....  ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999987543  24788999999999999999999   56899999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccccccccCCCC
Q 043586          374 LHADSSN---RTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~~---~~~~~gt~~y~APE~  395 (397)
                      .......   .....+|+.|+|||+
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~  221 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEA  221 (333)
T ss_dssp             --------------CCCGGGSCHHH
T ss_pred             hccccccccccCCCCccccccCchh
Confidence            6543221   122346889999996

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=5.6e-30  Score=243.19  Aligned_cols=166  Identities=27%  Similarity=0.357  Sum_probs=124.1

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------C
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  291 (397)
                      ++|++.+.||+|+||.||+|.+ .+++.||||++...... ....+++.+|+++++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            6799999999999999999985 47899999999754322 22346788999999999999999999998754      5


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+ +++|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 68998888642    4888999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.....   .....||+.|+|||++
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~  201 (367)
T 2fst_X          180 RHTADE---MTGYVATRWYRAPEIM  201 (367)
T ss_dssp             --------------CCCTTCCHHHH
T ss_pred             cccccc---CCCcCcCcCccChHHH
Confidence            865432   2345799999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=4.4e-30  Score=245.56  Aligned_cols=169  Identities=26%  Similarity=0.378  Sum_probs=136.9

Q ss_pred             HHhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-----
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-----  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----  289 (397)
                      ...++|++.+.||+|+||.||+|+. .+++.||+|++.....       ...+|+++++.++||||+++++++..     
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            3457899999999999999999975 5789999999876532       23469999999999999999999854     


Q ss_pred             ---------------------------------CCEeeEEEeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHH
Q 043586          290 ---------------------------------RKCMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALA  335 (397)
Q Consensus       290 ---------------------------------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~  335 (397)
                                                       ....++||||++ ++|.+.+... .....+++..+..++.|++.||.
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~  155 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG  155 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence                                             334889999998 5777666531 12235889999999999999999


Q ss_pred             HHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          336 YLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       336 ~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||   +.+|+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++
T Consensus       156 ~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~  213 (383)
T 3eb0_A          156 FIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELM  213 (383)
T ss_dssp             HHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHH
T ss_pred             HHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHh
Confidence            999   67999999999999998 689999999999987654433 2345689999999964

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.96  E-value=9.6e-30  Score=237.36  Aligned_cols=171  Identities=29%  Similarity=0.418  Sum_probs=138.8

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchH-----HHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETE-----ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++......     .......+.+|++++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999864 6889999998764321     112234688999999999999999999998766


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC---eEEec
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE---AFVAD  367 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D  367 (397)
                      . .|+||||+++++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999999886542   4788999999999999999999   569999999999999987654   99999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ||+++...... ......||+.|+|||+
T Consensus       161 fg~~~~~~~~~-~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          161 FGHSKILGETS-LMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             CTTCEECCCCH-HHHHHHSCCTTCCHHH
T ss_pred             Cccceeccccc-ccccccCCcCccCchh
Confidence            99998764322 1233569999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=1.3e-29  Score=236.89  Aligned_cols=171  Identities=28%  Similarity=0.474  Sum_probs=139.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcE--EEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKV--FALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++. ++..  +|+|.+......  ...+.+.+|+++++++ +||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch--HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            57999999999999999999864 4554  499988754322  2236788999999999 8999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCC-------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          295 LIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      +||||+++++|.+++....             ....+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCC
Confidence            9999999999999987643             1235889999999999999999999   56999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~  395 (397)
                      .+||+|||+++...... ......+|+.|+|||+
T Consensus       180 ~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~  212 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIES  212 (327)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHHH
T ss_pred             eEEEcccCcCccccccc-cccCCCCCccccChhh
Confidence            99999999997543222 1233457889999996

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.96  E-value=3.8e-30  Score=244.95  Aligned_cols=169  Identities=9%  Similarity=0.056  Sum_probs=126.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc--ccCCcccee-------eEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV--LHRNIVKLY-------GFCL  288 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~  288 (397)
                      ..|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999864 7899999999886654444457788886655555  599988755       4443


Q ss_pred             eC-----------------CEeeEEEeeccCCCchhhcccCCCccccChHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 043586          289 HR-----------------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKR------VNIVKAMAHALAYLHHDCSPSI  345 (397)
Q Consensus       289 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~~~~~~i  345 (397)
                      .+                 ...|+||||++ |+|.+++.....  .+++..+      ..++.|++.||+|||   +.+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            32                 34799999998 899999976422  2344445      677899999999999   5689


Q ss_pred             EEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          346 IHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       346 vH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +||||||+|||++.++.+||+|||+|+....   ......||+.|+|||++
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~  263 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFL  263 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHH
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhc
Confidence            9999999999999999999999999986532   22234678999999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=3.7e-29  Score=234.04  Aligned_cols=162  Identities=20%  Similarity=0.342  Sum_probs=140.4

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEee--CCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLH--RKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++.....      +.+.+|+.++++++ ||||+++++++..  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            5799999999999999999975 5789999999976442      56788999999997 9999999999988  56789


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARL  373 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~  373 (397)
                      +||||+++++|.+++..      +++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++.
T Consensus       110 lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            99999999999888752      678889999999999999999   56899999999999999776 899999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... .....||+.|+|||++
T Consensus       181 ~~~~~~-~~~~~~~~~y~aPE~~  202 (330)
T 3nsz_A          181 YHPGQE-YNVRVASRYFKGPELL  202 (330)
T ss_dssp             CCTTCC-CCSCCSCGGGCCHHHH
T ss_pred             cCCCCc-cccccccccccChhhh
Confidence            654433 2345799999999963

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=2.1e-29  Score=239.22  Aligned_cols=168  Identities=27%  Similarity=0.416  Sum_probs=142.1

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++......  ...+.+.+|++++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCc--HHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            457999999999999999999864 6889999999754433  2246788999999999999999999999765     3


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+. ++|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence            6899999997 5898888653    4788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGL  395 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~  395 (397)
                      +........   .....||+.|+|||+
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~  202 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEI  202 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred             EecCCCCCccccccccccccCCCCCHH
Confidence            876543221   234579999999996

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=5e-30  Score=236.79  Aligned_cols=174  Identities=25%  Similarity=0.426  Sum_probs=128.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++......  ...+++.+|+.++++++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            3468999999999999999999864 6889999998764332  224678899999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccC-----CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          296 IYEYMERGSLFCNLHNN-----EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      ||||+++++|.+++...     .....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999988641     11234889999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCC-----CeeeccccccccCCCC
Q 043586          371 ARLLHADSS-----NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       371 a~~~~~~~~-----~~~~~~gt~~y~APE~  395 (397)
                      +........     ......||+.|+|||+
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEV  197 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHH
Confidence            987643321     1234569999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.8e-30  Score=243.54  Aligned_cols=170  Identities=25%  Similarity=0.392  Sum_probs=130.2

Q ss_pred             CCCccceeecCCcccEEEEEcC--C--CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CCEee
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP--N--GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMF  294 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  294 (397)
                      .|++.+.||+|+||.||+|++.  +  +..||+|.++.....  ...+++.+|+.++++++||||+++++++.. .+..+
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCS--HHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence            3667789999999999999753  2  246899988754322  224788999999999999999999998754 56789


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       168 lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccc
Confidence            99999999999999975432  4788899999999999999999   569999999999999999999999999999866


Q ss_pred             CCCCC----CeeeccccccccCCCCC
Q 043586          375 HADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      .....    ......+|+.|+|||++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             ---------------CCGGGSCHHHH
T ss_pred             cccccccccccCCCCCcccccChHHh
Confidence            43321    12234578899999963

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=5.2e-29  Score=234.11  Aligned_cols=175  Identities=26%  Similarity=0.407  Sum_probs=146.1

Q ss_pred             HHHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhh--cccCCccceeeEEe
Q 043586          211 YEDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ--VLHRNIVKLYGFCL  288 (397)
Q Consensus       211 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  288 (397)
                      ........++|++.+.||+|+||.||+|++ +++.||+|++.....      +.+.+|.+++..  ++||||+++++++.
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            333445567899999999999999999998 489999999975432      456678888887  78999999999998


Q ss_pred             eCC----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEeCC
Q 043586          289 HRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNS  359 (397)
Q Consensus       289 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~  359 (397)
                      ...    ..++||||+++|+|.+++...    .+++.+++.++.|++.||.|||..     ++.+|+||||||+||+++.
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence            875    789999999999999999753    478899999999999999999932     1358999999999999999


Q ss_pred             CCCeEEeccccccccCCCCCC----eeeccccccccCCCCC
Q 043586          360 KFEAFVADFGTARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 ~~~~kl~DFG~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      ++.+||+|||+++........    .....||+.|+|||++
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  223 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL  223 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhh
Confidence            999999999999876544322    2334699999999964

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=1.8e-29  Score=234.55  Aligned_cols=176  Identities=21%  Similarity=0.376  Sum_probs=133.9

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ...++|.+.+.||+|+||.||+|++.    ++..||+|++....... ...+.+.+|+.++++++||||+++++++...+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            34567889999999999999999753    34589999997653322 22467889999999999999999999998754


Q ss_pred             -----EeeEEEeeccCCCchhhcccC---CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCe
Q 043586          292 -----CMFLIYEYMERGSLFCNLHNN---EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEA  363 (397)
Q Consensus       292 -----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~  363 (397)
                           ..++||||+++++|.+++...   .....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence                 359999999999999988532   12345889999999999999999999   6799999999999999999999


Q ss_pred             EEeccccccccCCCCC--CeeeccccccccCCCC
Q 043586          364 FVADFGTARLLHADSS--NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       364 kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~  395 (397)
                      ||+|||+++.......  ......+++.|+|||+
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  220 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIES  220 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchh
Confidence            9999999987654322  2233457889999996

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.96  E-value=4.1e-30  Score=248.59  Aligned_cols=166  Identities=27%  Similarity=0.389  Sum_probs=133.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------C
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------K  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  291 (397)
                      .+|++.+.||+|+||.||+|++. +++.||||++.....       ...+|++++++++||||+++++++...      .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            35888999999999999999875 689999999876432       234699999999999999999998542      2


Q ss_pred             EeeEEEeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-CCeEEeccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFG  369 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~DFG  369 (397)
                      ..++||||+++ ++.+.+... .....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccch
Confidence            46799999975 565554321 12235888999999999999999999   6799999999999999965 678999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++....... .....||+.|+|||++
T Consensus       203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~  228 (420)
T 1j1b_A          203 SAKQLVRGEP-NVSYICSRYYRAPELI  228 (420)
T ss_dssp             TCEECCTTCC-CCSCCSCTTSCCHHHH
T ss_pred             hhhhcccCCC-ceeeeeCCCcCCHHHH
Confidence            9997654333 2335799999999964

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.96  E-value=2.1e-29  Score=258.03  Aligned_cols=163  Identities=29%  Similarity=0.451  Sum_probs=138.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC--CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC----  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  292 (397)
                      ++|++.+.||+|+||.||+|++.  +++.||||++......  ...+.+.+|++++++++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA--EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCH--HHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCH--HHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            67999999999999999999865  6899999998754332  224678899999999999999999999987654    


Q ss_pred             -eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          293 -MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       293 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                       .|+||||+++++|.+++..     .+++.+++.++.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccc
Confidence             7999999999999887653     4889999999999999999999   5689999999999999986 8999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.....    ....||+.|+|||++
T Consensus       229 ~~~~~~----~~~~gt~~y~aPE~~  249 (681)
T 2pzi_A          229 SRINSF----GYLYGTPGFQAPEIV  249 (681)
T ss_dssp             EETTCC----SCCCCCTTTSCTTHH
T ss_pred             hhcccC----CccCCCccccCHHHH
Confidence            876543    335699999999963

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.1e-29  Score=232.16  Aligned_cols=170  Identities=22%  Similarity=0.327  Sum_probs=139.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-C---CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe-e
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-N---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM-F  294 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~  294 (397)
                      .|+..+.||+|+||.||+|++. +   +..||+|++......  ...+.+.+|+.++++++||||+++++++...+.. +
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   99 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM--QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH   99 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSH--HHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence            3556688999999999999753 2   337999998764433  2347888999999999999999999999876654 9


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+.+++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus       100 ~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          100 VLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             EEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999997633  34788999999999999999999   568999999999999999999999999999865


Q ss_pred             CCCC----CCeeeccccccccCCCCC
Q 043586          375 HADS----SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~----~~~~~~~gt~~y~APE~~  396 (397)
                      ....    .......||+.|+|||.+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESL  200 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHH
T ss_pred             cCCcccccccCcCCCCCccccChhhh
Confidence            4321    122335689999999963

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=234.87  Aligned_cols=170  Identities=29%  Similarity=0.485  Sum_probs=142.8

Q ss_pred             cCCCccceeecCCcccEEEEEc-----CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC--
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-----PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK--  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  291 (397)
                      ++|++.+.||+|+||.||+|++     .+++.||+|++.......   .+.+.+|++++++++||||+++++++...+  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH---LRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHH---HHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHH---HHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            5688999999999999999983     368899999997654332   367889999999999999999999987654  


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+++++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            68999999999999999976532  4788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC---eeeccccccccCCCCC
Q 043586          372 RLLHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      +........   .....++..|+|||++
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  220 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESL  220 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhh
Confidence            877554332   1223577889999963

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=1.4e-29  Score=236.82  Aligned_cols=174  Identities=27%  Similarity=0.375  Sum_probs=140.3

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      .++|++.+.||+|+||.||+|++      .+++.||+|++........  ..++.+|+.++++++||||+++++++...+
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD--ELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHH--HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhh--HHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            36799999999999999999984      2567899999975443322  367889999999999999999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCC----ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeE
Q 043586          292 CMFLIYEYMERGSLFCNLHNNED----AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAF  364 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~k  364 (397)
                      ..|+||||+++++|.+++.....    ...+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999976532    134788999999999999999999   569999999999999984   45699


Q ss_pred             EeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          365 VADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       365 l~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      |+|||+++.......  ......||+.|+|||++
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  217 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAF  217 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHH
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHh
Confidence            999999986543322  12334689999999963

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.96  E-value=1.1e-29  Score=239.22  Aligned_cols=171  Identities=21%  Similarity=0.255  Sum_probs=135.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHH--------HHHHHHHHHHHHhhcccCCccceeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELA--------FIKSFRNEAQVLSQVLHRNIVKLYGF  286 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~  286 (397)
                      ++|++.+.||+|+||.||+|++.    ++..+|+|++.........        ..+.+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            56899999999999999999875    5788999998765322111        11346688899999999999999999


Q ss_pred             Eee----CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-
Q 043586          287 CLH----RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-  361 (397)
Q Consensus       287 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-  361 (397)
                      +..    ....|+||||+ +++|.+++....   .+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++ 
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSST
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCC
Confidence            988    77899999999 999999987643   5889999999999999999999   56999999999999999877 


Q ss_pred             -CeEEeccccccccCCCCC-------CeeeccccccccCCCCC
Q 043586          362 -EAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 -~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                       .+||+|||+++.+.....       ......||+.|+|||++
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  232 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH  232 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence             999999999987643221       11345799999999963

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=4.2e-30  Score=255.89  Aligned_cols=172  Identities=27%  Similarity=0.453  Sum_probs=144.2

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ...++|++.+.||+|+||.||+|++.++..||||+++.....    .++|.+|++++++++||||+++++++.. +..|+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            345678889999999999999999988888999999865433    2578899999999999999999999876 67899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++|+|.+++.... ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999999997432 124788999999999999999999   5689999999999999999999999999998764


Q ss_pred             CCCC-CeeeccccccccCCCCC
Q 043586          376 ADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      .... ......++..|+|||++
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~  436 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAA  436 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHH
T ss_pred             CCceecccCCcCcccccCHHHh
Confidence            3211 11223467889999963

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=2e-29  Score=230.46  Aligned_cols=170  Identities=26%  Similarity=0.349  Sum_probs=138.6

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|++.+    +..||+|.+.......  ..+.+.+|+.++++++||||+++++++.++ ..
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHH--HHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SC
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCch--HHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CC
Confidence            3578899999999999999997532    3469999998654332  247789999999999999999999998754 56


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            89999999999999987543  24788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCC-CeeeccccccccCCCC
Q 043586          374 LHADSS-NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       374 ~~~~~~-~~~~~~gt~~y~APE~  395 (397)
                      ...... ......+|+.|+|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~  185 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPES  185 (281)
T ss_dssp             C---------CCCCCGGGCCHHH
T ss_pred             cccccccccccCCCCcceeCchh
Confidence            654332 1233457889999995

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.96  E-value=4.3e-30  Score=247.44  Aligned_cols=169  Identities=27%  Similarity=0.457  Sum_probs=125.5

Q ss_pred             cCCCc-cceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCE
Q 043586          219 EGFDI-KYCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKC  292 (397)
Q Consensus       219 ~~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  292 (397)
                      +.|++ .+.||+|+||.||+|++.   +++.||+|++......     +.+.+|+.++++++||||+++++++..  ...
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34655 457999999999999864   5789999999765433     456789999999999999999999965  678


Q ss_pred             eeEEEeeccCCCchhhcccCC------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe----CCCCC
Q 043586          293 MFLIYEYMERGSLFCNLHNNE------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL----NSKFE  362 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~  362 (397)
                      .|+||||+. ++|.+++....      ....+++..++.++.|++.||.|||   +.+|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCc
Confidence            999999996 47877765321      1224889999999999999999999   5689999999999999    67899


Q ss_pred             eEEeccccccccCCCCC---CeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      +||+|||+|+.......   .....+||+.|+|||++
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  207 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHH
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhh
Confidence            99999999987654321   22346799999999964

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.96  E-value=3.8e-29  Score=242.37  Aligned_cols=166  Identities=22%  Similarity=0.292  Sum_probs=140.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc------ccCCccceeeEEeeCC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV------LHRNIVKLYGFCLHRK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~  291 (397)
                      .+|++.+.||+|+||.||+|+.. +++.||||+++.....    .+.+.+|+++++.+      .|+||+++++++...+
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF----HRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccch----HHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            56999999999999999999764 6899999999865432    25667788888887      4679999999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC--eEEeccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE--AFVADFG  369 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~DFG  369 (397)
                      ..++||||+. ++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.  +||+|||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKF-QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             eEEEEEeccC-CCHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999996 689888876432 24889999999999999999999   558999999999999999887  9999999


Q ss_pred             cccccCCCCCCeeeccccccccCCCCC
Q 043586          370 TARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +++.....   ....+||+.|+|||++
T Consensus       248 ~a~~~~~~---~~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          248 SSCYEHQR---VYTYIQSRFYRAPEVI  271 (429)
T ss_dssp             TCEETTCC---CCSSCSCGGGCCHHHH
T ss_pred             cceecCCc---ccccCCCCCccChHHH
Confidence            99765432   2335799999999964

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.96  E-value=1.6e-29  Score=239.46  Aligned_cols=178  Identities=23%  Similarity=0.283  Sum_probs=131.8

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ++.....++|++.+.||+|+||.||+|++. +++.||||++.......    ..+.+|++.++.++||||+++++++...
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~   91 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTL   91 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence            456677889999999999999999999874 68999999986543322    3456788888999999999999999763


Q ss_pred             C-------EeeEEEeeccCCCchhhccc-CCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CC
Q 043586          291 K-------CMFLIYEYMERGSLFCNLHN-NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KF  361 (397)
Q Consensus       291 ~-------~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~  361 (397)
                      +       ..++||||+++ ++.+.+.. ......+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++
T Consensus        92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred             ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence            3       38899999986 44433322 12233578888999999999999999943 458999999999999996 89


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++....... .....||+.|+|||++
T Consensus       170 ~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~  203 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELI  203 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHH
T ss_pred             cEEEeeCCCceecCCCCC-cccccCCcceeCHHHH
Confidence            999999999987654333 2345689999999964

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.96  E-value=1.4e-29  Score=232.57  Aligned_cols=172  Identities=24%  Similarity=0.407  Sum_probs=133.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC--CCc--EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++.  +++  .||+|+++..........+.+.+|++++++++||||+++++++..+. .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            57899999999999999999753  333  68999987654433344578899999999999999999999998765 88


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus        97 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            9999999999999887542  34788999999999999999999   569999999999999999999999999999877


Q ss_pred             CCCCCC---eeeccccccccCCCCC
Q 043586          375 HADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      ......   .....+|+.|+|||++
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~  196 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESL  196 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHH
T ss_pred             cccccchhhhccCCCCceeeCchhh
Confidence            544322   1234578899999963

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=1.5e-29  Score=232.20  Aligned_cols=172  Identities=24%  Similarity=0.362  Sum_probs=130.7

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++....... ..+.+.++...++.++||||+++++++..++..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE-QKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH-HHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            36789999999999999999986 4789999999976543322 234455566668888999999999999999999999


Q ss_pred             EeeccCCCchhhcccC-CCccccChHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNN-EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      |||++ |+|.+++... .....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99997 4887766531 12235889999999999999999999   44 8999999999999999999999999999876


Q ss_pred             CCCCCCeeeccccccccCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~  395 (397)
                      ..... .....||+.|+|||+
T Consensus       161 ~~~~~-~~~~~~t~~y~aPE~  180 (290)
T 3fme_A          161 VDDVA-KDIDAGCKPYMAPER  180 (290)
T ss_dssp             ----------CCCCCCSCHHH
T ss_pred             ccccc-ccccCCCccccChhh
Confidence            54332 233469999999997

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=256.74  Aligned_cols=168  Identities=25%  Similarity=0.386  Sum_probs=134.4

Q ss_pred             CCccc-eeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          221 FDIKY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       221 ~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      +.+.+ .||+|+||.||+|.+.   ++..||||+++......  ..+++.+|++++++++||||+++++++.. +..++|
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv  413 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV  413 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSST--THHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChH--HHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence            33344 7999999999999763   45679999998653221  23678899999999999999999999976 558999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       414 ~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          414 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999987543  35889999999999999999999   56999999999999999999999999999987654


Q ss_pred             CCCC---eeeccccccccCCCCC
Q 043586          377 DSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~---~~~~~gt~~y~APE~~  396 (397)
                      ....   .....+|+.|+|||++
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~  511 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECI  511 (613)
T ss_dssp             -------------CCTTSCHHHH
T ss_pred             CCceeeeccCCCCccceeCHhhh
Confidence            3321   1223457899999963

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=5e-29  Score=235.34  Aligned_cols=168  Identities=26%  Similarity=0.446  Sum_probs=139.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|++.+.||+|+||.||+|++. +++.||||++......  ....++.+|++++++++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP--LFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSH--HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccc--hHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            367999999999999999999865 6899999999754332  2236778999999999999999999988764     6


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..++||||+. ++|.+++...    .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            7899999997 5898888652    4788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC----------eeeccccccccCCCC
Q 043586          372 RLLHADSSN----------RTLLAGTYGYIAPGL  395 (397)
Q Consensus       372 ~~~~~~~~~----------~~~~~gt~~y~APE~  395 (397)
                      +........          .....||+.|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCee
Confidence            876532211          123468999999995

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.96  E-value=2.6e-29  Score=239.19  Aligned_cols=165  Identities=28%  Similarity=0.392  Sum_probs=136.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM----  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  293 (397)
                      ++|.+.+.||+|+||.||+|++. +++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            57899999999999999999864 6899999999764332 23346788999999999999999999999876654    


Q ss_pred             --eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          294 --FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       294 --~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                        ++||||+. ++|.+.+..     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 588777643     3788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.....   .....||+.|+|||++
T Consensus       192 ~~~~~~---~~~~~~t~~y~aPE~~  213 (371)
T 4exu_A          192 RHADAE---MTGYVVTRWYRAPEVI  213 (371)
T ss_dssp             -----------CTTCCCTTSCHHHH
T ss_pred             cccccC---cCCcccCccccCHHHh
Confidence            865432   2345789999999964

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=5.1e-29  Score=229.02  Aligned_cols=171  Identities=26%  Similarity=0.401  Sum_probs=139.4

Q ss_pred             hcCCCccc-eeecCCcccEEEEEc---CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKY-CIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~-~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+ .||+|+||.||+|.+   .+++.||||+++..... ....+++.+|+++++.++||||+++++++ ..+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            35678877 999999999999954   34688999999765432 22347789999999999999999999999 56678


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+++++|.+++....   .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            99999999999999997643   3788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCCe---eeccccccccCCCCC
Q 043586          374 LHADSSNR---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~---~~~~gt~~y~APE~~  396 (397)
                      ........   ....||+.|+|||++
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~  192 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECI  192 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHH
T ss_pred             eccCCCcccccccCCCCceeeChHHh
Confidence            65443321   223467899999963

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=2.3e-29  Score=235.39  Aligned_cols=170  Identities=25%  Similarity=0.422  Sum_probs=132.9

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcE----EEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKV----FALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||.||+|++. +++.    ||+|.+.......  ..+.+.+|+.++++++||||+++++++.... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCC--CHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHH--HHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            57999999999999999999864 4443    5777775433221  1367889999999999999999999998765 7


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++|+||+.+|+|.+++.....  .+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            889999999999999876433  4788999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCCC--eeeccccccccCCCCC
Q 043586          374 LHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      .......  .....||+.|+|||++
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~  191 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESI  191 (327)
T ss_dssp             -------------CCCGGGSCHHHH
T ss_pred             ccCccccccccCCCccccccCHHHH
Confidence            6443322  2234578899999963

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.96  E-value=7.7e-29  Score=232.29  Aligned_cols=166  Identities=22%  Similarity=0.376  Sum_probs=141.3

Q ss_pred             cCCCccceeecCCcccEEEEEc--CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC------ccceeeEEeeC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN------IVKLYGFCLHR  290 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~  290 (397)
                      ++|++.+.||+|+||.||+|.+  .+++.||+|+++....    ..+.+.+|+++++.++|++      ++++++++...
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR----YCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH----HHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc----hhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            5799999999999999999975  3688999999976432    2367788999999998765      99999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-----------
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----------  359 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----------  359 (397)
                      +..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.           
T Consensus        90 ~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           90 GHICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CcEEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence            9999999999 8899998876532 34788999999999999999999   569999999999999987           


Q ss_pred             --------CCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          360 --------KFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       360 --------~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                              ++.+||+|||+++......   ....||+.|+|||++
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~  206 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEHH---STLVSTRHYRAPEVI  206 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSCC---CSSCSCGGGCCHHHH
T ss_pred             ccccccccCCCceEeeCcccccCcccc---ccccCCccccChHHh
Confidence                    6789999999998654322   335799999999964

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.96  E-value=4.8e-29  Score=239.04  Aligned_cols=167  Identities=22%  Similarity=0.292  Sum_probs=137.9

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc--------cCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--------HRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~  288 (397)
                      .++|++.+.||+|+||.||+|+. .+++.||+|+++.....    .+.+.+|+++++.++        ||||+++++++.
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY----TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcc----hHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            36799999999999999999975 46889999999765322    367788999999996        788999999987


Q ss_pred             ----eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEeCCCC--
Q 043586          289 ----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKF--  361 (397)
Q Consensus       289 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~--  361 (397)
                          .....++||||+ ++++.+.+.... ...+++..+..++.||+.||.|||   ++ +|+||||||+|||++.++  
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence                456799999999 556666665432 234889999999999999999999   55 899999999999999775  


Q ss_pred             -----------------------------------------------CeEEeccccccccCCCCCCeeeccccccccCCC
Q 043586          362 -----------------------------------------------EAFVADFGTARLLHADSSNRTLLAGTYGYIAPG  394 (397)
Q Consensus       362 -----------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE  394 (397)
                                                                     .+||+|||+++......   ....||+.|+|||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~gt~~y~aPE  263 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS---CSCCSCGGGCCHH
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC---ccCCCCCcccCCh
Confidence                                                           79999999998765432   3346999999999


Q ss_pred             CC
Q 043586          395 LP  396 (397)
Q Consensus       395 ~~  396 (397)
                      ++
T Consensus       264 ~~  265 (397)
T 1wak_A          264 VL  265 (397)
T ss_dssp             HH
T ss_pred             hh
Confidence            64

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=1.6e-29  Score=230.79  Aligned_cols=165  Identities=25%  Similarity=0.419  Sum_probs=133.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-CEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-KCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv  296 (397)
                      .++|++.+.||+|+||.||+|++. ++.||+|+++....     .+.+.+|++++++++||||+++++++... +..++|
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv   93 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   93 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchhH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence            357899999999999999999874 88999999976542     26788999999999999999999997654 478999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++.... ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            99999999999987532 123788889999999999999999   56899999999999999999999999999986543


Q ss_pred             CCCCeeeccccccccCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~  395 (397)
                      ..   ....+++.|+|||+
T Consensus       170 ~~---~~~~~~~~y~aPE~  185 (278)
T 1byg_A          170 TQ---DTGKLPVKWTAPEA  185 (278)
T ss_dssp             ---------CCTTTSCHHH
T ss_pred             cc---cCCCccccccCHHH
Confidence            22   22357899999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=9.2e-29  Score=227.51  Aligned_cols=169  Identities=18%  Similarity=0.316  Sum_probs=136.9

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEE-eeCCEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC-LHRKCMF  294 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~  294 (397)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++......     +.+.+|+.+++.++|++++..++++ ...+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence            457899999999999999999985 57899999987654322     3577899999999988877766655 6678899


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEeccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTA  371 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a  371 (397)
                      +||||+ +++|.+++.....  .+++..+..++.|++.||.|||   +.+|+||||||+||++   +.++.+||+|||++
T Consensus        82 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           82 MVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            999999 8999999875332  4889999999999999999999   5689999999999999   78899999999999


Q ss_pred             cccCCCCC-------CeeeccccccccCCCCC
Q 043586          372 RLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      +.......       ......||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  187 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTH  187 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHh
Confidence            87654332       12345799999999963

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=2.3e-29  Score=254.82  Aligned_cols=164  Identities=27%  Similarity=0.418  Sum_probs=133.0

Q ss_pred             ceeecCCcccEEEEEc---CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          225 YCIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      +.||+|+||.||+|.+   ..++.||||+++...... ...+++.+|++++++++||||+++++++.. +..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCG-GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999954   246789999997653321 224678999999999999999999999965 45789999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCC-
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN-  380 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~-  380 (397)
                      +|+|.+++....   .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus       453 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999997543   4788999999999999999999   568999999999999999999999999999877544321 


Q ss_pred             --eeeccccccccCCCCC
Q 043586          381 --RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       381 --~~~~~gt~~y~APE~~  396 (397)
                        .....||+.|+|||++
T Consensus       527 ~~~~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECI  544 (635)
T ss_dssp             --------CGGGSCHHHH
T ss_pred             ccccCCCCceeeeChhhh
Confidence              2234578899999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=6.1e-29  Score=249.44  Aligned_cols=173  Identities=28%  Similarity=0.380  Sum_probs=144.8

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee------C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------R  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~  290 (397)
                      .++|++.+.||+|+||.||+|.+. +++.||||+++.....  ...+.+.+|++++++++||||+++++++..      .
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~--~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCH--HHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            368999999999999999999864 6899999998765332  224678899999999999999999998765      6


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC---eEEec
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE---AFVAD  367 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~D  367 (397)
                      +..++||||+++|+|.+++........+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            678999999999999999987655446888999999999999999999   569999999999999997765   89999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+++....... .....||+.|+|||++
T Consensus       168 FG~a~~~~~~~~-~~~~~gt~~Y~APE~l  195 (676)
T 3qa8_A          168 LGYAKELDQGEL-CTEFVGTLQYLAPELL  195 (676)
T ss_dssp             CCCCCBTTSCCC-CCCCCSCCTTCSSCSS
T ss_pred             cccccccccccc-cccccCCcccCChHHh
Confidence            999987654433 2345799999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=2.1e-29  Score=238.06  Aligned_cols=165  Identities=21%  Similarity=0.297  Sum_probs=138.1

Q ss_pred             cCCCccceeecCCcccEEEEEcCC---------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccc-------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK-------  282 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------  282 (397)
                      ++|++.+.||+|+||.||+|++..         ++.||+|++...        +.+.+|++++++++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            578999999999999999998753         789999998754        35678999999999999988       


Q ss_pred             --------eeeEEee-CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043586          283 --------LYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  353 (397)
Q Consensus       283 --------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  353 (397)
                              +++++.. ....++||||+ +++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~  188 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAE  188 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGG
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHH
Confidence                    6777776 67899999999 999999998642 235899999999999999999999   569999999999


Q ss_pred             CEEeCCCC--CeEEeccccccccCCCCC-------CeeeccccccccCCCCC
Q 043586          354 NILLNSKF--EAFVADFGTARLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       354 NIll~~~~--~~kl~DFG~a~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      ||+++.++  .+||+|||+++.+.....       ......||+.|+|||++
T Consensus       189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  240 (352)
T 2jii_A          189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH  240 (352)
T ss_dssp             GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred             HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence            99999998  999999999987654321       12334799999999963

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.95  E-value=6.6e-29  Score=227.82  Aligned_cols=174  Identities=25%  Similarity=0.437  Sum_probs=145.9

Q ss_pred             HHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          215 IEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       215 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ....++|++.+.||+|+||.||+|+.. +++.||+|++....... ...+.+.+|++++++++||||+++++++...+..
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            445678999999999999999999875 68999999986543221 1135788999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC---CCeEEecccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK---FEAFVADFGT  370 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~DFG~  370 (397)
                      ++||||+++++|.+.+....   .+++..+..++.|++.||.|||   +.+++||||||+||+++.+   +.+||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            99999999999988876532   4788999999999999999999   5699999999999999754   4799999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ++....... .....||+.|+|||++
T Consensus       171 ~~~~~~~~~-~~~~~~~~~y~aPE~~  195 (287)
T 2wei_A          171 STCFQQNTK-MKDRIGTAYYIAPEVL  195 (287)
T ss_dssp             GGTBCCCSS-CSCHHHHHTTCCHHHH
T ss_pred             ceeecCCCc-cccccCcccccChHHh
Confidence            987654332 2334689999999963

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.95  E-value=1.6e-28  Score=225.94  Aligned_cols=168  Identities=18%  Similarity=0.318  Sum_probs=140.0

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEE-eeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFC-LHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  295 (397)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++......     +++.+|+.+++.++|++++..+.++ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            36799999999999999999986 57899999998765432     3577899999999988866666555 56778899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~  372 (397)
                      ||||+ +++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++
T Consensus        83 v~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            99999 8999999874332  4889999999999999999999   5699999999999999   488999999999998


Q ss_pred             ccCCCCCC-------eeeccccccccCCCCC
Q 043586          373 LLHADSSN-------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~-------~~~~~gt~~y~APE~~  396 (397)
                      ........       .....||+.|+|||++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  187 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTH  187 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHH
T ss_pred             cccccccccccccccccccccccccCChhhh
Confidence            76554321       2345799999999963

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=2.2e-28  Score=229.54  Aligned_cols=166  Identities=25%  Similarity=0.387  Sum_probs=120.3

Q ss_pred             hcCCCccc-eeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CC
Q 043586          218 TEGFDIKY-CIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RK  291 (397)
Q Consensus       218 ~~~~~~~~-~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~  291 (397)
                      .++|.+.+ .||+|+||.||+|++. +++.||+|++......       ..+....++.++||||+++++++..    ..
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            46788855 6999999999999875 6899999999764322       1122234566789999999999976    45


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DF  368 (397)
                      ..++||||+++|+|.+++..... ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Df  175 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDF  175 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEecc
Confidence            68999999999999999986533 35889999999999999999999   569999999999999976   456999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++......  .....||+.|+|||++
T Consensus       176 g~~~~~~~~~--~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          176 GFAKETTQNA--LQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             TTCEEC----------------------
T ss_pred             ccceeccccc--cccCCCCcCccChhhh
Confidence            9998654322  2345689999999975

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=228.57  Aligned_cols=166  Identities=26%  Similarity=0.379  Sum_probs=132.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEe---------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCL---------  288 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------  288 (397)
                      ++|++.+.||+|+||.||+|+.. +++.||+|++......   ..+.+.+|++++++++||||+++++++.         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHH---HHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChH---HHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            57899999999999999999876 5899999998765432   2467889999999999999999999874         


Q ss_pred             -----eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCC
Q 043586          289 -----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFE  362 (397)
Q Consensus       289 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~  362 (397)
                           .....++||||++ |+|.+++...    .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCe
Confidence                 3467899999997 6999888642    4788899999999999999999   56999999999999997 5679


Q ss_pred             eEEeccccccccCCCCC---CeeeccccccccCCCC
Q 043586          363 AFVADFGTARLLHADSS---NRTLLAGTYGYIAPGL  395 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~---~~~~~~gt~~y~APE~  395 (397)
                      +||+|||+++.......   ......||+.|+|||+
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL  195 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHH
Confidence            99999999987643221   1233457999999995

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=1.2e-28  Score=230.39  Aligned_cols=171  Identities=27%  Similarity=0.294  Sum_probs=124.1

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHH-HHhhcccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQ-VLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|... +++.||||++........  ..++.+|+. +++.++||||+++++++...+..++|
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH--HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH--HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            67889999999999999999874 789999999976543322  244555655 77778999999999999999999999


Q ss_pred             EeeccCCCchhhcccC--CCccccChHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNN--EDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |||+++ +|.+++...  .....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++.
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999985 777766531  11235788999999999999999999   55 899999999999999999999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... .....||+.|+|||++
T Consensus       176 ~~~~~~-~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          176 LVDSIA-KTRDAGCRPYMAPERI  197 (327)
T ss_dssp             -----------------------
T ss_pred             cccccc-cccCCCCccccCceee
Confidence            654332 2334699999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=1.3e-28  Score=232.65  Aligned_cols=165  Identities=28%  Similarity=0.383  Sum_probs=136.4

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE-----
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC-----  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  292 (397)
                      ++|.+.+.||+|+||.||+|++. +|+.||||++...... ....+++.+|+.+++.++||||+++++++...+.     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            57889999999999999999864 6899999999764322 2234678899999999999999999999987653     


Q ss_pred             -eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          293 -MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       293 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                       .|+||||+. ++|.+.+..     .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 588877643     3788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +.....   .....||+.|+|||++
T Consensus       174 ~~~~~~---~~~~~~t~~y~aPE~~  195 (353)
T 3coi_A          174 RHADAE---MTGYVVTRWYRAPEVI  195 (353)
T ss_dssp             TC-----------CCSBCCSCHHHH
T ss_pred             cCCCCC---ccccccCcCcCCHHHH
Confidence            865432   2335789999999963

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=1.5e-28  Score=228.36  Aligned_cols=170  Identities=24%  Similarity=0.413  Sum_probs=138.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc--cCCccceeeEEeeCCEeeE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  295 (397)
                      .++|++.+.||+|+||.||+|+..+++.||+|++....... ...+.+.+|++++++++  ||||+++++++...+..++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCH-HHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccc-cchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            46799999999999999999998889999999997654322 23477889999999997  4999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||| +.+++|.+++....   .+++..+..++.|++.||.|||   +.+|+||||||+||++++ +.+||+|||+++...
T Consensus       106 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 55789999987643   4788899999999999999999   569999999999999964 899999999998765


Q ss_pred             CCCCC--eeeccccccccCCCCC
Q 043586          376 ADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      .....  .....||+.|+|||++
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~  200 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAI  200 (313)
T ss_dssp             ------------CCGGGCCHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHH
Confidence            43321  2345699999999963

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=1.5e-28  Score=240.77  Aligned_cols=167  Identities=20%  Similarity=0.334  Sum_probs=140.2

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc-CCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||||++......     +++.+|+++++.++| +++..+..++...+..++|
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            6799999999999999999986 57899999988765432     356789999999987 5566677777788899999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe---CCCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL---NSKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~DFG~a~~  373 (397)
                      |||+ +++|.+++.....  .+++..++.++.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++.
T Consensus        82 me~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             EECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            9999 8999999875332  4889999999999999999999   5699999999999999   6889999999999997


Q ss_pred             cCCCCCC-------eeeccccccccCCCCC
Q 043586          374 LHADSSN-------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~-------~~~~~gt~~y~APE~~  396 (397)
                      +......       .....||+.|+|||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  185 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTH  185 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             ccCCccccccccccccccCCCccccCHHHh
Confidence            7554321       1246799999999964

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=8.4e-29  Score=240.40  Aligned_cols=167  Identities=23%  Similarity=0.326  Sum_probs=128.1

Q ss_pred             CCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEEe
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      .|...+.||+|+||+||.+...+|+.||||++.....      +.+.+|+.+++++ +||||+++++++.+.+..|+|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            3445678999999999877666799999999876432      3567899999987 89999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccc----cChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCC-------------C
Q 043586          299 YMERGSLFCNLHNNEDAVE----LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-------------F  361 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~-------------~  361 (397)
                      |+. |+|.+++........    .++..++.++.||+.||+|||   +.+|+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCce
Confidence            996 699999876432211    133456789999999999999   5699999999999999754             4


Q ss_pred             CeEEeccccccccCCCCCC----eeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+++........    .....||+.|+|||++
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  204 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL  204 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence            8999999999987654321    2245799999999964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=1.4e-28  Score=250.03  Aligned_cols=173  Identities=27%  Similarity=0.381  Sum_probs=140.5

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC----CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK  291 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  291 (397)
                      ...++|++.+.||+|+||.||+|.+.    .+..||+|.++.....  ...+.+.+|+.++++++||||+++++++. .+
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCH--HHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            34567888999999999999999864    2467999998764433  23467899999999999999999999985 45


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+++|+|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCC
Confidence            6899999999999999997543  24788999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCC-eeeccccccccCCCCC
Q 043586          372 RLLHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      +........ .....||+.|+|||++
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~  564 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESI  564 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHH
T ss_pred             eecCCCcceeccCCCCCcceeCHHHh
Confidence            876543322 2234578899999963

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.95  E-value=3.4e-28  Score=232.33  Aligned_cols=170  Identities=24%  Similarity=0.325  Sum_probs=141.1

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cC-----CccceeeEEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HR-----NIVKLYGFCLH  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~  289 (397)
                      ..++|++.+.||+|+||.||+|+.. +++.||||+++.....    .+++.+|+++++.++ |+     +|+++++++..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHH----HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHH----HHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3468999999999999999999865 6889999999764322    356777889988885 44     49999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC--CCCCeEEec
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKFEAFVAD  367 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~D  367 (397)
                      .+..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999996 599998876432 2478999999999999999999953 46899999999999995  578899999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+++......   ....||+.|+|||++
T Consensus       205 FG~a~~~~~~~---~~~~~t~~y~aPE~~  230 (382)
T 2vx3_A          205 FGSSCQLGQRI---YQYIQSRFYRSPEVL  230 (382)
T ss_dssp             CTTCEETTCCC---CSSCSCGGGCCHHHH
T ss_pred             ccCceeccccc---ccccCCccccChHHH
Confidence            99998764332   335799999999964

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=7.8e-29  Score=240.19  Aligned_cols=166  Identities=25%  Similarity=0.378  Sum_probs=131.2

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .+|++.+.||+|+||.||.....+++.||||++......      .+.+|+++++.+ +||||+++++++.+....|+||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            458888999999999966555557899999999764322      345799999999 7999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-----CCCeEEecccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KFEAFVADFGTAR  372 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DFG~a~  372 (397)
                      ||+. |+|.+++.....  ...+..+..++.|++.||.|||   +.+|+||||||+|||++.     ...+||+|||+|+
T Consensus        98 E~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~  171 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK  171 (432)
T ss_dssp             ECCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred             ECCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence            9996 599998876532  2444567789999999999999   568999999999999953     3367899999998


Q ss_pred             ccCCCC---CCeeeccccccccCCCCC
Q 043586          373 LLHADS---SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~---~~~~~~~gt~~y~APE~~  396 (397)
                      ......   .......||+.|+|||++
T Consensus       172 ~~~~~~~~~~~~~~~~gt~~y~APE~l  198 (432)
T 3p23_A          172 KLAVGRHSFSRRSGVPGTEGWIAPEML  198 (432)
T ss_dssp             CC------------CCSCTTSCCGGGT
T ss_pred             eccCCCcceeeccccCCCcCccChhhh
Confidence            765432   223345799999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=8e-29  Score=231.29  Aligned_cols=173  Identities=29%  Similarity=0.434  Sum_probs=139.5

Q ss_pred             HhcCCCccceeecCCcccEEEEEc--CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEe---
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL--PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCL---  288 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---  288 (397)
                      ..++|++.+.||+|+||.||+|++  .+++.||+|++........ ....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-CCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            346899999999999999999987  4688999999875432210 012455677777666   7999999999987   


Q ss_pred             --eCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          289 --HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       289 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                        .....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEe
Confidence              4567899999997 699998876432 24788999999999999999999   5699999999999999999999999


Q ss_pred             ccccccccCCCCCCeeeccccccccCCCCC
Q 043586          367 DFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       367 DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |||+++...... ......||+.|+|||++
T Consensus       163 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~  191 (326)
T 1blx_A          163 DFGLARIYSFQM-ALTSVVVTLWYRAPEVL  191 (326)
T ss_dssp             SCCSCCCCCGGG-GGCCCCCCCTTCCHHHH
T ss_pred             cCcccccccCCC-CccccccccceeCHHHH
Confidence            999998654322 22345689999999963

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=4.9e-28  Score=228.40  Aligned_cols=167  Identities=25%  Similarity=0.355  Sum_probs=139.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CC-cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC------ccceeeEEee
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NG-KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN------IVKLYGFCLH  289 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~  289 (397)
                      .++|++.+.||+|+||.||+|... ++ +.||+|+++.....    .+.+.+|+.++++++|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccc----hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            367999999999999999999864 34 68999999764322    356788999999998776      8999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEe------------
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILL------------  357 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll------------  357 (397)
                      .+..++||||+ ++++.+.+..... ..+++..+..++.|++.||+|||   +.+|+||||||+|||+            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence            99999999999 5677777665432 34889999999999999999999   6799999999999999            


Q ss_pred             -------CCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          358 -------NSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       358 -------~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                             +.++.+||+|||+++......   ....||+.|+|||++
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~  211 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH---TTIVATRHYRPPEVI  211 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC---CSSCSCGGGCCHHHH
T ss_pred             ccccccccCCCcEEEeecCccccccccc---cCCcCCCcccCCeee
Confidence                   567899999999998654332   335799999999964

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.95  E-value=8.3e-29  Score=229.87  Aligned_cols=176  Identities=23%  Similarity=0.329  Sum_probs=136.9

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhc----ccCCcccee
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQV----LHRNIVKLY  284 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~  284 (397)
                      +.....++|++.+.||+|+||.||+|+.. +++.||+|++........   .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            44456678999999999999999999864 688999999976543211   1123466799999999    899999999


Q ss_pred             eEEeeCCEeeEEEee-ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCC
Q 043586          285 GFCLHRKCMFLIYEY-MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFE  362 (397)
Q Consensus       285 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~  362 (397)
                      +++...+..++|||| +.+++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence            999999999999999 78999999987533   4789999999999999999999   55899999999999999 8899


Q ss_pred             eEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          363 AFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +||+|||+++......  .....||+.|+|||++
T Consensus       179 ~kl~dfg~~~~~~~~~--~~~~~~~~~y~aPE~~  210 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEP--YTDFDGTRVYSPPEWI  210 (312)
T ss_dssp             EEECCCSSCEECCSSC--BCCCCSCTTTSCHHHH
T ss_pred             EEEEEcchhhhcccCc--ccccCCcccccCceee
Confidence            9999999998765432  2345699999999963

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=5.8e-28  Score=229.74  Aligned_cols=166  Identities=22%  Similarity=0.334  Sum_probs=138.9

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-----------cCCccceeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRNIVKLYGF  286 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~  286 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||||++......    .+.+.+|++++++++           ||||++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            5799999999999999999986 47899999999865432    356778999999887           8999999999


Q ss_pred             EeeCC----EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCC-CeEEcCCCCCCEEeC---
Q 043586          287 CLHRK----CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP-SIIHRDISSNNILLN---  358 (397)
Q Consensus       287 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlkp~NIll~---  358 (397)
                      +...+    ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||   +. +|+||||||+|||++   
T Consensus        95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEE
T ss_pred             hhccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccC
Confidence            98654    789999999 8899998876432 24788999999999999999999   55 899999999999994   


Q ss_pred             ---CCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          359 ---SKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       359 ---~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                         ..+.+||+|||+++......   ....||+.|+|||++
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVL  207 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHH
T ss_pred             CCcCcceEEEcccccccccCCCC---CCCCCCccccCcHHH
Confidence               44589999999998765432   234699999999963

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=1e-28  Score=230.34  Aligned_cols=172  Identities=23%  Similarity=0.337  Sum_probs=143.0

Q ss_pred             HhcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHH---HHHHHHHHHHHHHhhcc--cCCccceeeEEeeC
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEEL---AFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHR  290 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  290 (397)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++........   ...+.+.+|+.++++++  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            456799999999999999999975 4789999999976432110   01134667999999996  59999999999999


Q ss_pred             CEeeEEEeeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEecc
Q 043586          291 KCMFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADF  368 (397)
Q Consensus       291 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DF  368 (397)
                      +..++||||+.+ ++|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++ .++.+||+||
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Df  194 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDF  194 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence            999999999976 89999887532   4788999999999999999999   56999999999999999 7899999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+++......  .....||+.|+|||++
T Consensus       195 g~~~~~~~~~--~~~~~gt~~y~aPE~~  220 (320)
T 3a99_A          195 GSGALLKDTV--YTDFDGTRVYSPPEWI  220 (320)
T ss_dssp             TTCEECCSSC--BCCCCSCGGGSCHHHH
T ss_pred             cccccccccc--ccCCCCCccCCChHHh
Confidence            9998765432  2335699999999963

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.95  E-value=6.1e-29  Score=231.36  Aligned_cols=172  Identities=23%  Similarity=0.427  Sum_probs=138.2

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeE
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  295 (397)
                      ...++|++.+.||+|+||.||+|++.+  .+|+|++....... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            345679999999999999999998753  58999987543221 112456789999999999999999999999999999


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccC
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~  375 (397)
                      ||||+++++|.+++....  ..+++..+..++.|++.||+|||   +.+++||||||+||+++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999999997643  34788999999999999999999   56999999999999998 6799999999987653


Q ss_pred             CC-----CCCeeeccccccccCCCCC
Q 043586          376 AD-----SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~-----~~~~~~~~gt~~y~APE~~  396 (397)
                      ..     ........||+.|+|||++
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~  206 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEII  206 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHH
T ss_pred             cccccccccccccCCCcccccChHHh
Confidence            21     1122334699999999963

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.95  E-value=7.9e-28  Score=223.66  Aligned_cols=171  Identities=25%  Similarity=0.320  Sum_probs=124.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||||++........ ..+.+.++..+++.++||||+++++++...+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHH-HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchH-HHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            56889999999999999999875 789999999976543322 2344555566788889999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+ ++.+..+.....  ..+++..+..++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||+++.....
T Consensus       104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            999 445544443221  2478899999999999999999942  28999999999999999999999999999866543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .. .....||+.|+|||++
T Consensus       179 ~~-~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          179 KA-KDRSAGCAAYMAPERI  196 (318)
T ss_dssp             ---------CCTTCCHHHH
T ss_pred             cc-ccccCCCccccChhhc
Confidence            32 2335699999999964

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=1.9e-28  Score=243.45  Aligned_cols=158  Identities=16%  Similarity=0.203  Sum_probs=122.1

Q ss_pred             CccceeecCCcccEEEEEcCCCcEEEEEEecccch-----HHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSET-----EELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ...+.||+|+||.||+|++ .++.+++|+......     ......+++.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3456899999999999965 467888887654321     2222346789999999999999999776666677788999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++++|.+++..           +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+|+....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998864           4578999999999999   568999999999999999  999999999998754


Q ss_pred             CCCC-------eeeccccccccCCCCC
Q 043586          377 DSSN-------RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~-------~~~~~gt~~y~APE~~  396 (397)
                      ....       .....||+.|||||++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~  508 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIW  508 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHH
Confidence            3221       1346799999999963

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=3.6e-27  Score=216.18  Aligned_cols=146  Identities=11%  Similarity=0.051  Sum_probs=128.8

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.++++++||||+++++++...+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56999999999999999999875 58999999998765544445578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      ||++|++|.+++...     ....++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+++|...
T Consensus       111 e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999998542     244568889999999999999   5699999999999999999999999887654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=1.1e-25  Score=207.51  Aligned_cols=146  Identities=27%  Similarity=0.462  Sum_probs=125.5

Q ss_pred             cCCCcc-ceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHH-hhcccCCccceeeEEee----CC
Q 043586          219 EGFDIK-YCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVL-SQVLHRNIVKLYGFCLH----RK  291 (397)
Q Consensus       219 ~~~~~~-~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~  291 (397)
                      ++|.+. +.||+|+||.||+|.. .+++.||+|+++..        ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            567776 7799999999999986 47899999999753        2455788887 55589999999999987    67


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DF  368 (397)
                      ..++||||+++++|.+++..... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.   ++.+||+||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            79999999999999999986432 25889999999999999999999   568999999999999998   789999999


Q ss_pred             ccccccCC
Q 043586          369 GTARLLHA  376 (397)
Q Consensus       369 G~a~~~~~  376 (397)
                      |++.....
T Consensus       165 g~a~~~~~  172 (299)
T 3m2w_A          165 GFAKETTG  172 (299)
T ss_dssp             TTCEECTT
T ss_pred             cccccccc
Confidence            99987654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=4.3e-26  Score=208.33  Aligned_cols=145  Identities=17%  Similarity=0.206  Sum_probs=115.1

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHH---------------HHHHHHHHHHHHHhhcc
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEEL---------------AFIKSFRNEAQVLSQVL  276 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~  276 (397)
                      ..+......|.+.+.||+|+||.||+|++.+|+.||+|.++.......               .....+.+|++++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344555667778899999999999999987799999999975332110               23467889999999999


Q ss_pred             cCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043586          277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNIL  356 (397)
Q Consensus       277 h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIl  356 (397)
                        | +++.+++.. +..|+||||++|++|.+ +..         .....++.|++.||.|||   +.+|+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEE
Confidence              4 666665543 55799999999999987 421         224469999999999999   569999999999999


Q ss_pred             eCCCCCeEEecccccccc
Q 043586          357 LNSKFEAFVADFGTARLL  374 (397)
Q Consensus       357 l~~~~~~kl~DFG~a~~~  374 (397)
                      ++ ++.+||+|||+|+..
T Consensus       226 l~-~~~vkl~DFG~a~~~  242 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVEV  242 (282)
T ss_dssp             EE-TTEEEECCCTTCEET
T ss_pred             EE-CCcEEEEECCCCeEC
Confidence            99 999999999999744

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.93  E-value=1.6e-26  Score=222.88  Aligned_cols=170  Identities=18%  Similarity=0.190  Sum_probs=125.3

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc-CCccce---------e---
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKL---------Y---  284 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l---------~---  284 (397)
                      ..|...+.||+|+||.||+|++ .+|+.||||++...........+.+.+|+.+++.++| +|....         .   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            3467778999999999999985 5789999999985544433335778899999999977 322111         1   


Q ss_pred             ---------eEEee-----CCEeeEEEeeccCCCchhhccc----CCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 043586          285 ---------GFCLH-----RKCMFLIYEYMERGSLFCNLHN----NEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSII  346 (397)
Q Consensus       285 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~iv  346 (397)
                               .++..     ....+++|+++ +++|.+++..    ......+++..+..++.|++.||+|||   +.+|+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence                     11111     12356777765 6799888741    112335788899999999999999999   56999


Q ss_pred             EcCCCCCCEEeCCCCCeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          347 HRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       347 H~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhh
Confidence            9999999999999999999999999865433   334568 999999964

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=7.1e-22  Score=178.09  Aligned_cols=144  Identities=19%  Similarity=0.225  Sum_probs=108.0

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcE--EEEEEecccchH---------------------HHHHHHHHHHHHHHHhhc
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKV--FALKKLHTSETE---------------------ELAFIKSFRNEAQVLSQV  275 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~E~~~l~~l  275 (397)
                      -|++.+.||+|+||.||+|.+ .+|+.  ||||+++.....                     .......+.+|++++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367788999999999999987 67888  999987654211                     011124678899999999


Q ss_pred             ccCCc--cceeeEEeeCCEeeEEEeeccC-C----CchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043586          276 LHRNI--VKLYGFCLHRKCMFLIYEYMER-G----SLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHR  348 (397)
Q Consensus       276 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  348 (397)
                      .|+++  +.++++    +..++||||+.+ |    +|.+....      .++..+..++.|++.||.|||.  ..+|+||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence            98864  344432    356899999942 4    44443321      2345678899999999999993  2389999


Q ss_pred             CCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          349 DISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       349 dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||||+|||++.  .++|+|||+|.....+
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~~~  222 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLRHP  222 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence            99999999998  9999999999876443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.86  E-value=4.6e-21  Score=172.12  Aligned_cols=138  Identities=25%  Similarity=0.280  Sum_probs=75.2

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      +++++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.
T Consensus        56 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  135 (251)
T 3m19_A           56 RGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKE  135 (251)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccE
Confidence            44555555555555555555555555555555555555555444445555555555555555555444444555555555


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      |++++|.|++..+..|..+++|+.|++++|++++.++..+..+++|+.+++++|+..|
T Consensus       136 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          136 LRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             EECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            5555555554444455555555555555555555555555555555555555555444

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.85  E-value=3.5e-21  Score=169.37  Aligned_cols=136  Identities=24%  Similarity=0.300  Sum_probs=128.1

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            57999999999999888889999999999999999999888999999999999999999999766667899999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      ++|+|++..|..|..+++|+.|+|++|++++..+..+..+++|+.+++++|+..|.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  167 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD  167 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence            99999999999999999999999999999999888899999999999999998884

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.84  E-value=9.3e-21  Score=166.63  Aligned_cols=136  Identities=20%  Similarity=0.233  Sum_probs=126.7

Q ss_pred             CCCCEEEcCCCcccccCC-ccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      ..+++|+|++|++++..| ..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|+.|+
T Consensus        32 ~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  111 (220)
T 2v70_A           32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM  111 (220)
T ss_dssp             TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEE
T ss_pred             CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEE
Confidence            367999999999997755 4689999999999999999988888999999999999999999988888899999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      |++|+|++..|..|..+++|+.|+|++|++++..|..+..+++|+.+++++|+..|.
T Consensus       112 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  168 (220)
T 2v70_A          112 LRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN  168 (220)
T ss_dssp             CTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred             CCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence            999999998899999999999999999999999999999999999999999988874

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.84  E-value=2.4e-20  Score=165.01  Aligned_cols=136  Identities=26%  Similarity=0.230  Sum_probs=126.1

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      .++|++|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus        39 ~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~  118 (229)
T 3e6j_A           39 PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELF  118 (229)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEe
Confidence            36799999999999998899999999999999999999866667789999999999999999987777789999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +++|+|+ .+|..+..+++|+.|++++|++++.++..+..+++|+.+++++|+..|.
T Consensus       119 Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  174 (229)
T 3e6j_A          119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE  174 (229)
T ss_dssp             CCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred             ccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence            9999999 6788999999999999999999988888899999999999999988774

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.84  E-value=2.7e-20  Score=169.08  Aligned_cols=138  Identities=30%  Similarity=0.290  Sum_probs=74.6

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      +++++|++|+|++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.
T Consensus        82 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  161 (272)
T 3rfs_A           82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE  161 (272)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence            34455555555555555444444555555555555555555444444555555555555555555444444555555555


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      |++++|.+++..+..++.+++|+.|++++|++++.++..+..+++|+.+++++|+..|
T Consensus       162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  219 (272)
T 3rfs_A          162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  219 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence            5555555555444445555555555555555555555555555555555555554443

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.83  E-value=1.6e-20  Score=194.94  Aligned_cols=136  Identities=42%  Similarity=0.619  Sum_probs=82.1

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhh-----------------------------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW-----------------------------   52 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~-----------------------------   52 (397)
                      ++++++|++|+|++|++++.+|..++.+++|+.|++++|+++|.+|..+..                             
T Consensus       510 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  589 (768)
T 3rgz_A          510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHG  589 (768)
T ss_dssp             GGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCS
T ss_pred             HhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccc
Confidence            345666666666666666666666666666666666666665555543321                             


Q ss_pred             -----------------------------------------cccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccc
Q 043586           53 -----------------------------------------LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIE   91 (397)
Q Consensus        53 -----------------------------------------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~   91 (397)
                                                               +++|+.|+|++|+++|.+|..++++++|+.|+|++|.++
T Consensus       590 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~  669 (768)
T 3rgz_A          590 AGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS  669 (768)
T ss_dssp             SEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             cccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccC
Confidence                                                     244556666666666666666666666666666666666


Q ss_pred             cCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           92 GSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        92 ~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |.+|..++.+++|+.|||++|+++|.+|..+..+++|+.+++++|+
T Consensus       670 g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~  715 (768)
T 3rgz_A          670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN  715 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred             CCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence            6666666666666666666666666666666555555555555443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.82  E-value=9.8e-20  Score=165.21  Aligned_cols=138  Identities=22%  Similarity=0.256  Sum_probs=108.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|+++...+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|..+++|+
T Consensus        57 ~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  136 (270)
T 2o6q_A           57 FHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLT  136 (270)
T ss_dssp             SSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCC
Confidence            56778888888888888866666678888888888888888866666777888888888888888877777778888888


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      .|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.+++++|...
T Consensus       137 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (270)
T 2o6q_A          137 YLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK  194 (270)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             EEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCC
Confidence            8888888888766666788888888888888888777777777888888888877544

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.82  E-value=1.1e-19  Score=158.20  Aligned_cols=137  Identities=26%  Similarity=0.261  Sum_probs=125.4

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      .++|++|+|++|++++..+..|..+++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|+.|+
T Consensus        27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  106 (208)
T 2o6s_A           27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA  106 (208)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence            46799999999999987777899999999999999999977777789999999999999999977777789999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +++|.+++..+..+..+++|+.|++++|++++.++..+..+++|+.+++++|+..|.
T Consensus       107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  163 (208)
T 2o6s_A          107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  163 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred             cCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence            999999988888899999999999999999988888889999999999999987663

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.81  E-value=3.1e-19  Score=160.12  Aligned_cols=135  Identities=24%  Similarity=0.280  Sum_probs=126.1

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..+..|..+++|+.|++
T Consensus        35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  114 (251)
T 3m19_A           35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL  114 (251)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence            56999999999999888889999999999999999999888888999999999999999999878888999999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++|.|++..+..|..+++|+.|++++|.+++.++..+..+++|+.+++++|....
T Consensus       115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  169 (251)
T 3m19_A          115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS  169 (251)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence            9999998888888999999999999999998888889999999999999997553

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.81  E-value=4.3e-20  Score=171.26  Aligned_cols=139  Identities=34%  Similarity=0.543  Sum_probs=85.3

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCC-CCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhh------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLT-DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQI------   74 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~------   74 (397)
                      ++++++|++|+|++|++++.+|..+..++ +|+.|++++|++++.+|..+..+. |++|+|++|++++..|..|      
T Consensus       145 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L  223 (313)
T 1ogq_A          145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNT  223 (313)
T ss_dssp             GGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCC
T ss_pred             HhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCC
Confidence            44567777777777777766777777766 677777777766666665555554 5555555555554444444      


Q ss_pred             -----------------cCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           75 -----------------ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        75 -----------------~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                                       ..+++|+.|++++|.+++.+|..+..+++|+.|++++|++++.+|.. ..+++|+.+++++|+
T Consensus       224 ~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          224 QKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             SEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             CEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence                             44555555555555555555666666666666666666666555554 555666666666666


Q ss_pred             CcCCC
Q 043586          138 GLCGN  142 (397)
Q Consensus       138 ~~c~~  142 (397)
                      ..|+.
T Consensus       303 ~lc~~  307 (313)
T 1ogq_A          303 CLCGS  307 (313)
T ss_dssp             EEEST
T ss_pred             CccCC
Confidence            66654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.81  E-value=8.8e-20  Score=166.81  Aligned_cols=139  Identities=26%  Similarity=0.256  Sum_probs=115.2

Q ss_pred             CCCCCCCCEEEcCCCc-ccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNS-LIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   80 (397)
                      ++++++|++|+|++|. +....|..|..+++|+.|++++|.+++..|..|..+++|++|+|++|++++..+..|..+++|
T Consensus        76 ~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  155 (285)
T 1ozn_A           76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL  155 (285)
T ss_dssp             TTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred             cCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCc
Confidence            5678888888888887 776667888888888888888888887777788888888888888888887666678888888


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      +.|++++|.+++..+..+..+++|+.|++++|.+++..|..+..+++|+.+++++|....
T Consensus       156 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  215 (285)
T 1ozn_A          156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA  215 (285)
T ss_dssp             CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             cEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence            888888888887666778888888888888888888878888888888888888886543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.80  E-value=7e-20  Score=190.05  Aligned_cols=142  Identities=35%  Similarity=0.493  Sum_probs=116.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhc------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIA------   75 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~------   75 (397)
                      ++++++|++|+|++|++++.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++|.++|.+|..+.      
T Consensus       486 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~  565 (768)
T 3rgz_A          486 LSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI  565 (768)
T ss_dssp             GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCB
T ss_pred             HhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchh
Confidence            45678888888888888888888888888888888888888888888888888888888888888877776543      


Q ss_pred             ----------------------------------------------------------------CCCCCcEEEccCcccc
Q 043586           76 ----------------------------------------------------------------SMKNLTWLDISNNKIE   91 (397)
Q Consensus        76 ----------------------------------------------------------------~l~~L~~L~l~~N~~~   91 (397)
                                                                                      .+++|+.|++++|+++
T Consensus       566 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~  645 (768)
T 3rgz_A          566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLS  645 (768)
T ss_dssp             CCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCB
T ss_pred             hhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCccc
Confidence                                                                            2466788888888888


Q ss_pred             cCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCC
Q 043586           92 GSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNF  143 (397)
Q Consensus        92 ~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~  143 (397)
                      |.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|++++|......+
T Consensus       646 g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip  697 (768)
T 3rgz_A          646 GYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIP  697 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCC
T ss_pred             ccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCC
Confidence            8888888888888888888888888888888888888888888887655443

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.80  E-value=5.7e-19  Score=160.15  Aligned_cols=136  Identities=25%  Similarity=0.247  Sum_probs=111.4

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|.++++|+.|++
T Consensus        37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l  116 (270)
T 2o6q_A           37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL  116 (270)
T ss_dssp             TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred             CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence            45888888888888776678888888888888888888655556678888888888888888766677788888888888


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      ++|.+++..+..|..+++|+.|++++|.+++.++..+..+++|+.+++++|.....
T Consensus       117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  172 (270)
T 2o6q_A          117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV  172 (270)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence            88888887777888888888888888888877777788888888888888865443

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.80  E-value=4.4e-20  Score=171.18  Aligned_cols=137  Identities=34%  Similarity=0.566  Sum_probs=118.0

Q ss_pred             CCCCCCCCEEEcCC-CcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGS-NSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   80 (397)
                      ++++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..|..+++|++|+|++|.+++.+|..+..+++|
T Consensus        72 l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  151 (313)
T 1ogq_A           72 LANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL  151 (313)
T ss_dssp             GGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred             HhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCC
Confidence            56788899999984 88888888888889999999999999988888888888999999999999888888888888899


Q ss_pred             cEEEccCcccccCCchhhccCC-CCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           81 TWLDISNNKIEGSIPGEITELS-RLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~-~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +.|++++|.+++.+|..++.++ .|+.|++++|.+++..|..+..+. |+.+++++|...
T Consensus       152 ~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~  210 (313)
T 1ogq_A          152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE  210 (313)
T ss_dssp             CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred             CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence            9999999998888888888887 888999998888888888887776 888888887644

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.80  E-value=5.8e-19  Score=161.80  Aligned_cols=135  Identities=25%  Similarity=0.265  Sum_probs=99.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|++++..+.  +.+++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..|..|.++++|+
T Consensus        51 ~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~  127 (290)
T 1p9a_G           51 LMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ  127 (290)
T ss_dssp             GTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC
T ss_pred             hhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCC
Confidence            45677788888888887754332  67777777777777776 5666777777777777777777766667777777777


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      .|++++|++++..+..|..+++|+.|++++|++++.++..+..+++|+.+++++|...
T Consensus       128 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY  185 (290)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             EEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence            7777777777766666777777777777777777766666777777777777777544

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.79  E-value=3.6e-19  Score=153.02  Aligned_cols=131  Identities=27%  Similarity=0.327  Sum_probs=119.0

Q ss_pred             CCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCch-hhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            8 LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPN-ELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         8 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      -++|++++|+++ .+|..+..  +|+.|++++|.+++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus        10 ~~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls   86 (192)
T 1w8a_A           10 GTTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence            378999999997 67776643  999999999999876664 48999999999999999998889999999999999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+|++..|..|..+++|+.|++++|++++..|..+..+++|+.+++++|+..|.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            9999998888899999999999999999999999999999999999999987764

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.79  E-value=1e-18  Score=158.74  Aligned_cols=137  Identities=31%  Similarity=0.355  Sum_probs=122.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|++|+|++|.+++ + ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+
T Consensus        59 l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  136 (272)
T 3rfs_A           59 IQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT  136 (272)
T ss_dssp             GGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred             cccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence            5678999999999999986 3 4789999999999999999987777889999999999999999987777889999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|++++|.+++..+..++.+++|+.|++++|++++.++..+..+++|+.+++++|....
T Consensus       137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  195 (272)
T 3rfs_A          137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKS  195 (272)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCc
Confidence            99999999998888888999999999999999998888888899999999999987554

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.79  E-value=6.9e-20  Score=180.09  Aligned_cols=28  Identities=21%  Similarity=0.050  Sum_probs=25.2

Q ss_pred             HHHHHHHHHHhhcccCCccceeeEEeeC
Q 043586          263 KSFRNEAQVLSQVLHRNIVKLYGFCLHR  290 (397)
Q Consensus       263 ~~~~~E~~~l~~l~h~niv~l~~~~~~~  290 (397)
                      ++|..|++.+.+++|+|+|+++|||...
T Consensus       324 ~eF~~Eve~L~~i~HrNLV~L~gyC~s~  351 (487)
T 3oja_A          324 ETERLECERENQARQREIDALKEQYRTV  351 (487)
T ss_dssp             -CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHhcccccchhhHHHHhcCh
Confidence            6799999999999999999999999764

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.79  E-value=4.6e-19  Score=163.68  Aligned_cols=139  Identities=27%  Similarity=0.346  Sum_probs=98.3

Q ss_pred             CCCCCCCEEEcCCCcccccCC-ccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCC-cCChhhcCCCCC
Q 043586            3 GNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG-KIPSQIASMKNL   80 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L   80 (397)
                      .++++|++|+|++|++++..+ ..+..+++|+.|++++|.+++..|..+..+++|++|+|++|.+++ .+|..+..+++|
T Consensus        98 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  177 (306)
T 2z66_A           98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  177 (306)
T ss_dssp             ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCC
Confidence            456777777777777765444 467777777777777777776666677777777777777777765 466777777777


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +.|++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.+++++|.....
T Consensus       178 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  238 (306)
T 2z66_A          178 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS  238 (306)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred             CEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence            7777777777766677777777777777777777766666666777777777777765443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.79  E-value=9.7e-19  Score=150.41  Aligned_cols=130  Identities=25%  Similarity=0.303  Sum_probs=119.8

Q ss_pred             CCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccC
Q 043586            8 LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISN   87 (397)
Q Consensus         8 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~   87 (397)
                      -+++++++|.++ .+|..+.  ++|+.|+|++|.++ .+|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~   87 (193)
T 2wfh_A           12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY   87 (193)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence            368999999998 6776553  79999999999998 7889999999999999999999988888999999999999999


Q ss_pred             cccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           88 NKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        88 N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      |+|++..|..|..+++|+.|+|++|+++..++..+..+++|..+++++|+..|.
T Consensus        88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            999998889999999999999999999988888899999999999999998874

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.78  E-value=1.2e-18  Score=159.15  Aligned_cols=134  Identities=21%  Similarity=0.178  Sum_probs=99.5

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCcc-CCCcCChhhcCCCCCcEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK-LSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L   83 (397)
                      .++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|. +++..|..+..+++|+.|
T Consensus        31 ~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L  110 (285)
T 1ozn_A           31 PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (285)
T ss_dssp             CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence            3567777777777776666677777777777777777776667777777777777777776 665557777777777777


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++++|.+++..|..+..+++|+.|++++|.+++..+..+..+++|+.+++++|..
T Consensus       111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  165 (285)
T 1ozn_A          111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI  165 (285)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcc
Confidence            7777777776677777777777777777777766666677777777777777754

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.78  E-value=4.7e-19  Score=165.35  Aligned_cols=135  Identities=22%  Similarity=0.308  Sum_probs=101.2

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhh---------cccCCeEeccCccCCCcCCh
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW---------LTGLLGLNLSSNKLSGKIPS   72 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~p~   72 (397)
                      ++++++|++|+|++|+++ .+|..++.+++|+.|+|++|.+.+.+|..+..         +++|++|+|++|+++ .+|.
T Consensus       123 ~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~  200 (328)
T 4fcg_A          123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA  200 (328)
T ss_dssp             GGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCG
T ss_pred             HhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchH
Confidence            456778888888888887 67777888888888888887777777766554         777777777777777 6777


Q ss_pred             hhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           73 QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        73 ~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      .++.+++|+.|++++|.+++ +|..++.+++|+.|++++|.+.+.+|..+..+++|+.+++++|...
T Consensus       201 ~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~  266 (328)
T 4fcg_A          201 SIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL  266 (328)
T ss_dssp             GGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTC
T ss_pred             hhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCch
Confidence            77777777777777777774 5556777777777777777777777777777777777777776543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.78  E-value=4.4e-19  Score=167.81  Aligned_cols=134  Identities=26%  Similarity=0.186  Sum_probs=104.4

Q ss_pred             CCCCEEEcCCCcccccCCcccc-CCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLG-LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +.++.|+|++|+|++..+..|. .+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|+.|+
T Consensus        39 ~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  118 (361)
T 2xot_A           39 SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL  118 (361)
T ss_dssp             TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEE
Confidence            3477888888888877777776 788888888888888877777788888888888888888866666788888888888


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCc---ccccccceeccCCCCCc
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN---EQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~~l~l~~n~~~  139 (397)
                      |++|+|++..|..|..+++|+.|+|++|++++.++..+   ..+++|+.|++++|...
T Consensus       119 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~  176 (361)
T 2xot_A          119 LYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK  176 (361)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred             CCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence            88888887777888888888888888888887655555   45777888888887643

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.3e-18  Score=163.21  Aligned_cols=150  Identities=11%  Similarity=0.081  Sum_probs=105.4

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchH-----------------H--HHHHHHHHHHHHHHh
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE-----------------E--LAFIKSFRNEAQVLS  273 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~--~~~~~~~~~E~~~l~  273 (397)
                      .+....--|++..+||+|++|.||+|...+|+.||||+++.....                 .  ........+|...|.
T Consensus        89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            334444459999999999999999999989999999987642110                 0  000112245667777


Q ss_pred             hcccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043586          274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSN  353 (397)
Q Consensus       274 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~  353 (397)
                      ++.+.++....-+...  ..++||||++|++|..+...         .....++.|++.+|.|||   ..|||||||||.
T Consensus       169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~  234 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLA---KHGLIHGDFNEF  234 (397)
T ss_dssp             HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTT
T ss_pred             HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHH
Confidence            7765544322222122  24799999999888654321         234568899999999999   558999999999


Q ss_pred             CEEeCCCC----------CeEEeccccccccCC
Q 043586          354 NILLNSKF----------EAFVADFGTARLLHA  376 (397)
Q Consensus       354 NIll~~~~----------~~kl~DFG~a~~~~~  376 (397)
                      |||+++++          .+.|+||+-+.....
T Consensus       235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             SEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             HEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence            99998776          388999998765443

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.77  E-value=1e-18  Score=170.28  Aligned_cols=136  Identities=27%  Similarity=0.290  Sum_probs=129.9

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|+.|++
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            68999999999999999999999999999999999999888999999999999999999999888999999999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      ++|.+++..|..|..+++|+.|++++|++++.++..+..+++|+.+++++|+..|.
T Consensus       355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~  410 (455)
T 3v47_A          355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  410 (455)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence            99999998899999999999999999999998888889999999999999988775

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.77  E-value=5.9e-19  Score=145.16  Aligned_cols=130  Identities=22%  Similarity=0.229  Sum_probs=117.3

Q ss_pred             CCCCCCEEEcCCCccc-ccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLI-GPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ..++|+.|++++|.++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|+.
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            4578999999999998 78999999999999999999999865  77899999999999999999879998989999999


Q ss_pred             EEccCcccccC-CchhhccCCCCceeeccCCcCCCCCC---CCcccccccceeccCC
Q 043586           83 LDISNNKIEGS-IPGEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSP  135 (397)
Q Consensus        83 L~l~~N~~~~~-~p~~~~~~~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~l~l~~  135 (397)
                      |++++|.+++. .+..+..+++|+.|++++|++++.++   ..+..+++|+.+++++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            99999999874 34889999999999999999998766   5788899999988763

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.77  E-value=2.5e-18  Score=157.51  Aligned_cols=131  Identities=27%  Similarity=0.237  Sum_probs=85.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..+ . ..+++|++|+|++|+++ .+|..+..+++|+.|++
T Consensus        31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l  107 (290)
T 1p9a_G           31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV  107 (290)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence            456666777666666666666666677777777766664322 2 55666667777766666 56666666666667777


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      ++|+|++..|..|..+++|+.|++++|++++.++..+..+++|+.+++++|...
T Consensus       108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  161 (290)
T 1p9a_G          108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (290)
T ss_dssp             CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC
Confidence            777666655566666666777777777666666666666666666666666543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.76  E-value=1e-18  Score=162.97  Aligned_cols=140  Identities=21%  Similarity=0.250  Sum_probs=126.2

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccC---------CCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCCh
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGL---------LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPS   72 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~---------l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~   72 (397)
                      ++++++|++|+|++|++.+.+|..+..         +++|+.|+|++|.++ .+|..+..+++|++|+|++|+++ .+|+
T Consensus       146 l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~  223 (328)
T 4fcg_A          146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGP  223 (328)
T ss_dssp             GGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCG
T ss_pred             HhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCch
Confidence            567899999999999888889987765         999999999999998 78889999999999999999999 4777


Q ss_pred             hhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCC
Q 043586           73 QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNF  143 (397)
Q Consensus        73 ~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~  143 (397)
                      .+..+++|+.|++++|.+.+.+|..++.+++|+.|++++|++.+.+|..+..+++|+.+++++|+....-+
T Consensus       224 ~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP  294 (328)
T 4fcg_A          224 AIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLP  294 (328)
T ss_dssp             GGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCC
T ss_pred             hhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhcc
Confidence            89999999999999999999999999999999999999999999999999999999999999987655443

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.76  E-value=1e-18  Score=146.76  Aligned_cols=133  Identities=21%  Similarity=0.219  Sum_probs=120.2

Q ss_pred             CCCCCCEEEcCCCccc-ccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLI-GPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ..++|+.|+|++|+++ +.+|..+..+++|+.|++++|.+++.  ..+..+++|++|+|++|++++.+|..+..+++|+.
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   99 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH   99 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence            4588999999999998 78899899999999999999999865  67899999999999999999878998888999999


Q ss_pred             EEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCC---CCcccccccceeccCCCCC
Q 043586           83 LDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        83 L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~l~l~~n~~  138 (397)
                      |++++|.+++..+ ..+..+++|+.|++++|++++.++   ..+..+++|+.+++++|..
T Consensus       100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~  159 (168)
T 2ell_A          100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRED  159 (168)
T ss_dssp             EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred             EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCCh
Confidence            9999999987432 789999999999999999997765   4788899999999999864

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.76  E-value=2e-18  Score=151.63  Aligned_cols=118  Identities=19%  Similarity=0.243  Sum_probs=111.3

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|+
T Consensus        53 ~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  132 (220)
T 2v70_A           53 FKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVR  132 (220)
T ss_dssp             GGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCS
T ss_pred             hccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCC
Confidence            56789999999999999988888999999999999999999988888899999999999999999988899999999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      .|+|++|+|++..|..|..+++|+.|++++|++.+..+
T Consensus       133 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             EEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             EEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            99999999999889999999999999999999987644

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.76  E-value=3.3e-18  Score=155.53  Aligned_cols=125  Identities=24%  Similarity=0.232  Sum_probs=93.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..|..|.++++|++|++++|.+++..+..+..+++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  127 (276)
T 2z62_A           48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK  127 (276)
T ss_dssp             TTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred             hccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCC
Confidence            55677888888888888776667788888888888888888777777777888888888888888766565677777888


Q ss_pred             EEEccCcccccC-CchhhccCCCCceeeccCCcCCCCCCCCccccc
Q 043586           82 WLDISNNKIEGS-IPGEITELSRLDYLNLSSNKLSGPVPFSNEQLS  126 (397)
Q Consensus        82 ~L~l~~N~~~~~-~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~  126 (397)
                      .|++++|.+.+. +|..+..+++|+.|++++|++++..+..+..+.
T Consensus       128 ~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  173 (276)
T 2z62_A          128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH  173 (276)
T ss_dssp             EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHH
T ss_pred             EEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhh
Confidence            888888877653 477777777888888887777765554444333

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.75  E-value=2.2e-18  Score=174.58  Aligned_cols=135  Identities=21%  Similarity=0.168  Sum_probs=122.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      +++++|||++|+|++..|..|.++++|++|+|++|+|++..|+.|.++++|++|+|++|+|++..|..|.++++|+.|++
T Consensus        52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L  131 (635)
T 4g8a_A           52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  131 (635)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence            37999999999999888889999999999999999999888888999999999999999999777778999999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCC-CCCCcccccccceeccCCCCCcC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGP-VPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~-~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++|++++..+..|+.+++|+.|++++|.+++. .|..+..+++|+.+++++|....
T Consensus       132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~  187 (635)
T 4g8a_A          132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  187 (635)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence            99999988788899999999999999999864 57778889999999999997543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=1.7e-18  Score=148.74  Aligned_cols=139  Identities=25%  Similarity=0.300  Sum_probs=116.3

Q ss_pred             CCCCEEEcCCCcccccCCc-cccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPS-TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      .+|++|+|++|++++..+. .|..+++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        29 ~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  108 (192)
T 1w8a_A           29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEE
Confidence            3899999999999976664 589999999999999999998899999999999999999999988888899999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCCcC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSA  145 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~~~  145 (397)
                      +++|+|++..|..+..+++|+.|++++|++++..+... -...+....+..+...|..+..
T Consensus       109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~-~~~~l~~~~~~~~~~~C~~P~~  168 (192)
T 1w8a_A          109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSK  168 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSSTT
T ss_pred             CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchH-HHHHHHHcCCCCCCCCCCCChH
Confidence            99999999999999999999999999999997654211 1111222344455556665433

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.75  E-value=4e-18  Score=157.37  Aligned_cols=135  Identities=24%  Similarity=0.315  Sum_probs=83.2

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCc-hhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP-NELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ++++|++|+|++|.+. .+|..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+++..|..+..+++|+.
T Consensus        76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  154 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV  154 (306)
T ss_dssp             SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCE
T ss_pred             cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCE
Confidence            3556666666666665 345556666666666666666654433 35566666666666666666556666666666666


Q ss_pred             EEccCccccc-CCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           83 LDISNNKIEG-SIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        83 L~l~~N~~~~-~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      |++++|.+.+ ..|..+..+++|+.|++++|.+++..|..+..+++|+.+++++|...
T Consensus       155 L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  212 (306)
T 2z66_A          155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF  212 (306)
T ss_dssp             EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCS
T ss_pred             EECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccC
Confidence            6666666654 45556666666666666666666655666666666666666666543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.75  E-value=3.3e-18  Score=161.80  Aligned_cols=138  Identities=28%  Similarity=0.208  Sum_probs=118.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|+.|
T Consensus        62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  141 (361)
T 2xot_A           62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL  141 (361)
T ss_dssp             CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence            78899999999999998788889999999999999999987777788999999999999999998788899999999999


Q ss_pred             EccCcccccCCchhh---ccCCCCceeeccCCcCCCCCCCCccccccc--ceeccCCCCCcCC
Q 043586           84 DISNNKIEGSIPGEI---TELSRLDYLNLSSNKLSGPVPFSNEQLSSM--YIVRLSPNKGLCG  141 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~---~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l--~~l~l~~n~~~c~  141 (397)
                      +|++|+|++..+..|   ..+++|+.|+|++|+|++.++..+..++.+  ..+++++|+..|.
T Consensus       142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~  204 (361)
T 2xot_A          142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECD  204 (361)
T ss_dssp             ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred             ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCC
Confidence            999999987555555   678999999999999997766677777763  7789999988874

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.75  E-value=4.2e-18  Score=154.84  Aligned_cols=134  Identities=22%  Similarity=0.169  Sum_probs=124.0

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|+.|++
T Consensus        28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            46999999999999887879999999999999999999888888999999999999999999888899999999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCC-CCCCcccccccceeccCCCCCc
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGP-VPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~-~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      ++|.+.+..+..++.+++|+.|++++|.+++. +|..+..+++|+.+++++|...
T Consensus       108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~  162 (276)
T 2z62_A          108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ  162 (276)
T ss_dssp             TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence            99999987777899999999999999999874 5889999999999999999654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.75  E-value=1.3e-17  Score=141.24  Aligned_cols=132  Identities=24%  Similarity=0.302  Sum_probs=115.7

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      +.+.+++++|+++ .+|..+  .++|+.|++++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+.|+++
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            3578999999988 466544  4799999999999997777778999999999999999997777778999999999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|.+++..+..+..+++|+.|++++|.+++.++..+..+++|+.+++++|+..|.
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            9999988788889999999999999999988887788899999999999986663

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.74  E-value=5.8e-18  Score=171.44  Aligned_cols=140  Identities=25%  Similarity=0.291  Sum_probs=129.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcc-cccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQF-NSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l-~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   80 (397)
                      +.++++++.++++.|.+.+..|..+..+++|+.|+|++|.+ .+..|..|..+++|++|+|++|+|++..|..|.++++|
T Consensus       441 ~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L  520 (635)
T 4g8a_A          441 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  520 (635)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCC
Confidence            45678899999999999999999999999999999999985 44678889999999999999999999889999999999


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccc-cccceeccCCCCCcCC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQL-SSMYIVRLSPNKGLCG  141 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l-~~l~~l~l~~n~~~c~  141 (397)
                      +.|+|++|+|++..|..|..+++|+.|++++|++++.+|..+..+ ++|+.+++++|+..|.
T Consensus       521 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          521 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             CEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            999999999999989999999999999999999999999999887 6899999999998884

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.74  E-value=6e-18  Score=170.90  Aligned_cols=136  Identities=29%  Similarity=0.301  Sum_probs=79.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCC-ccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCC-cCChhhcCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG-KIPSQIASMKN   79 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~   79 (397)
                      +.++++|+.|+|++|++.+..| ..|..+++|+.|++++|.+++..|..+..+++|++|++++|.+++ .+|..+..+++
T Consensus       395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  474 (606)
T 3vq2_A          395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN  474 (606)
T ss_dssp             CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence            3455666666666666655554 455566666666666666655555555556666666666666554 24555555666


Q ss_pred             CcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           80 LTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        80 L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |+.|++++|++++..|..+..+++|+.|++++|++++..|..+..+++|+.+++++|.
T Consensus       475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~  532 (606)
T 3vq2_A          475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR  532 (606)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSC
T ss_pred             CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCc
Confidence            6666666666655555555556666666666666655555555555555555655554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.73  E-value=2.4e-17  Score=144.71  Aligned_cols=130  Identities=22%  Similarity=0.249  Sum_probs=119.2

Q ss_pred             CEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCc
Q 043586            9 IELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN   88 (397)
Q Consensus         9 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   88 (397)
                      +.+++++|.++ .+|..+.  ++|+.|+|++|.+++..+..|..+++|++|+|++|++++..|..|.++++|+.|+|++|
T Consensus        14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N   90 (220)
T 2v9t_B           14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN   90 (220)
T ss_dssp             TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence            67899999998 5777664  79999999999999887889999999999999999999888999999999999999999


Q ss_pred             ccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           89 KIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        89 ~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      .|+...+..|..+++|+.|+|++|++++..|..+..+++|+.+++++|.....
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  143 (220)
T 2v9t_B           91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI  143 (220)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE
Confidence            99987777889999999999999999999999999999999999999975543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.73  E-value=1.3e-17  Score=145.16  Aligned_cols=129  Identities=27%  Similarity=0.336  Sum_probs=113.2

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|+|++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  127 (208)
T 2o6s_A           48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK  127 (208)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence            56889999999999999977777889999999999999999977777789999999999999999987777789999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .|++++|.+++..+..+..+++|+.|++++|.+.+..|       .++.++++.|.
T Consensus       128 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-------~l~~L~~~~n~  176 (208)
T 2o6s_A          128 DLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-------GIRYLSEWINK  176 (208)
T ss_dssp             EEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT-------TTHHHHHHHHH
T ss_pred             EEECCCCccceeCHHHhccCCCccEEEecCCCeecCCC-------CHHHHHHHHHh
Confidence            99999999998777789999999999999999886543       45555555554

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.73  E-value=8.6e-18  Score=144.96  Aligned_cols=127  Identities=16%  Similarity=0.267  Sum_probs=76.0

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++|+.|++++|.++ .+| .+..+++|+.|++++|.++  .+..+..+++|++|++++|++++..|..++.+++|+.|+
T Consensus        43 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           43 MNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             cCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            445666666666665 344 4566666666666666554  223556666666666666666655566666666666666


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCc-CCCCCCCCcccccccceeccCCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNK-LSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~-l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +++|.+++..|..++.+++|+.|++++|+ ++. +| .+..+++|+.+++++|.
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~  170 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDG  170 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBC
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCC
Confidence            66666665556666666666666666665 443 23 45556666666666654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.73  E-value=1.1e-17  Score=162.47  Aligned_cols=139  Identities=21%  Similarity=0.171  Sum_probs=73.3

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccC-CcccccCchhhhhcccCCeEeccCccCC-------------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSR-NQFNSSIPNELTWLTGLLGLNLSSNKLS-------------   67 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~-------------   67 (397)
                      +.++++|++|+|++|.+++..+..|..+++|+.|+|++ |.++...+..|.++++|++|+|++|+++             
T Consensus       132 ~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~  211 (440)
T 3zyj_A          132 FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDE  211 (440)
T ss_dssp             SCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCCCCTTCSSCCE
T ss_pred             hhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccccccCCCcccCE
Confidence            45667777777777777655555555555555555555 3333222234455555555555555544             


Q ss_pred             ---------CcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           68 ---------GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        68 ---------~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                               +..|..|.++++|+.|++++|++++..+..|..+++|+.|+|++|++++.++..+..+++|+.+++++|+.
T Consensus       212 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~  291 (440)
T 3zyj_A          212 LDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW  291 (440)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCE
T ss_pred             EECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCc
Confidence                     44444444555555555555555444444455555555555555555544444444455555555555544


Q ss_pred             cC
Q 043586          139 LC  140 (397)
Q Consensus       139 ~c  140 (397)
                      .|
T Consensus       292 ~C  293 (440)
T 3zyj_A          292 NC  293 (440)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.73  E-value=1.4e-17  Score=162.18  Aligned_cols=66  Identities=23%  Similarity=0.228  Sum_probs=47.8

Q ss_pred             hcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           74 IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        74 ~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..+..+..+++|+.+++++|...
T Consensus       214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  279 (452)
T 3zyi_A          214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS  279 (452)
T ss_dssp             CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred             ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC
Confidence            444556666666667776666777777888888888888887777777777777777787777544

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.72  E-value=9.8e-18  Score=164.45  Aligned_cols=132  Identities=26%  Similarity=0.228  Sum_probs=83.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|+.|+|++|++++..|..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|++
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  111 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI  111 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence            35666666666666555666666666666666666666555666666666666666666666444445566666666666


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ++|.+.+..|..|..+++|+.|++++|.+++..+..+..+++|+.+++++|.
T Consensus       112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~  163 (477)
T 2id5_A          112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN  163 (477)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCC
T ss_pred             CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCc
Confidence            6666666566666666666666666666665555566666666666666554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.72  E-value=1.5e-17  Score=168.02  Aligned_cols=136  Identities=29%  Similarity=0.284  Sum_probs=67.8

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCccccc---CchhhhhcccCCeEeccCccCCCcCChhhcCCCCC
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSS---IPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL   80 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   80 (397)
                      ++++|++|+|++|.+.+..|..|..+++|+.|++++|.+++.   .+..+..+++|+.|+|++|++++..|..|..+++|
T Consensus       423 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  502 (606)
T 3t6q_A          423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM  502 (606)
T ss_dssp             TCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             CcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCC
Confidence            444444555554444444444444455555555555554431   12334445555555555555554444555555555


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      +.|++++|++++..|..+..++.| .|++++|++++.+|..+..+++++.+++++|+..|
T Consensus       503 ~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  561 (606)
T 3t6q_A          503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC  561 (606)
T ss_dssp             CEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred             CEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence            555555555555555555555555 55555555555444444555555555555555444

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.72  E-value=1.4e-17  Score=166.76  Aligned_cols=139  Identities=27%  Similarity=0.351  Sum_probs=103.1

Q ss_pred             CCCCCCCEEEcCCCcccccCC-ccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCC-CcCChhhcCCCCC
Q 043586            3 GNLKNLIELDVGSNSLIGPIP-STLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLS-GKIPSQIASMKNL   80 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~~~l~~L   80 (397)
                      .++++|+.|+|++|.+.+..| ..+..+++|+.|++++|.+++..|..+..+++|+.|+|++|.++ +.+|..+..+++|
T Consensus       393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L  472 (570)
T 2z63_A          393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  472 (570)
T ss_dssp             ETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence            456677777777777765555 45677777777777777777777777777777777777777776 4677777777777


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +.|++++|++++..|..+..+++|+.|++++|++++.+|..+..+++|+.+++++|+..|.
T Consensus       473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  533 (570)
T 2z63_A          473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  533 (570)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence            7777777777777777777777777888877777777777777777777777777776653

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.72  E-value=1.2e-17  Score=157.42  Aligned_cols=135  Identities=20%  Similarity=0.184  Sum_probs=112.8

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++..+..|..+++|+.|++++|.+++..|..|.++++|++|+|++|++++..+..|.++++|+.|++
T Consensus        52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred             ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence            47899999999998776778899999999999999998877888999999999999999999655555888999999999


Q ss_pred             cCcccccCCc-hhhccCCCCceeeccCC-cCCCCCCCCcccccccceeccCCCCCcC
Q 043586           86 SNNKIEGSIP-GEITELSRLDYLNLSSN-KLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        86 ~~N~~~~~~p-~~~~~~~~L~~l~l~~n-~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++|++++..+ ..+..+++|+.|++++| .++...+..+..+++|+.+++++|....
T Consensus       132 ~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~  188 (353)
T 2z80_A          132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS  188 (353)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred             CCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence            9999986444 47888999999999998 4776667788888899999998886443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.71  E-value=3.6e-18  Score=173.41  Aligned_cols=134  Identities=19%  Similarity=0.333  Sum_probs=90.9

Q ss_pred             CCCCCCCCEEEcCCCccccc-----------------CCcccc--CCCCCCEEeccCCcccccCchhhhhcccCCeEecc
Q 043586            2 IGNLKNLIELDVGSNSLIGP-----------------IPSTLG--LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS   62 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   62 (397)
                      ++++++|++|+|++|.+++.                 +|..++  .+++|++|+|++|.+.+.+|..|.++++|++|+|+
T Consensus       202 l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls  281 (636)
T 4eco_A          202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVA  281 (636)
T ss_dssp             GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECT
T ss_pred             HhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECc
Confidence            45666777777777777664                 666666  77777777777777766777777777777777777


Q ss_pred             Ccc-CCC-cCChhhcCC------CCCcEEEccCcccccCCch--hhccCCCCceeeccCCcCCCCCCCCcccccccceec
Q 043586           63 SNK-LSG-KIPSQIASM------KNLTWLDISNNKIEGSIPG--EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVR  132 (397)
Q Consensus        63 ~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~~~~~~p~--~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~  132 (397)
                      +|+ ++| .+|..++.+      ++|+.|++++|.++ .+|.  .++.+++|+.|++++|.++|.+| .+..+++|+.++
T Consensus       282 ~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~  359 (636)
T 4eco_A          282 CNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLN  359 (636)
T ss_dssp             TCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEE
T ss_pred             CCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEE
Confidence            776 666 666666655      66777777777766 5665  66667777777777777766666 666666666666


Q ss_pred             cCCCC
Q 043586          133 LSPNK  137 (397)
Q Consensus       133 l~~n~  137 (397)
                      +++|.
T Consensus       360 L~~N~  364 (636)
T 4eco_A          360 LAYNQ  364 (636)
T ss_dssp             CCSSE
T ss_pred             CCCCc
Confidence            66654

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.71  E-value=2.7e-17  Score=166.06  Aligned_cols=132  Identities=23%  Similarity=0.240  Sum_probs=76.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++..+..|.++++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|+.|++
T Consensus        32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  111 (606)
T 3vq2_A           32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA  111 (606)
T ss_dssp             TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred             CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence            34556666666665555555666666666666666665555555555666666666666665555555666666666666


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCC-CCCCCcccccccceeccCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ++|.+++..+..++.+++|+.|++++|.+++ .+|..+..+++|+.+++++|.
T Consensus       112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A          112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            6666655554555556666666666665554 335555555555555555554

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.71  E-value=4.8e-17  Score=143.70  Aligned_cols=117  Identities=30%  Similarity=0.342  Sum_probs=108.1

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+
T Consensus        60 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  138 (229)
T 3e6j_A           60 FDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT  138 (229)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCS
T ss_pred             hhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCC
Confidence            578899999999999998777778899999999999999999777777899999999999999999 7899999999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      .|++++|+|++..+..|..+++|+.|++++|++....+
T Consensus       139 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A          139 HLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             EEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             EEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            99999999998877889999999999999999986643

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.71  E-value=6.5e-17  Score=157.56  Aligned_cols=138  Identities=23%  Similarity=0.245  Sum_probs=85.6

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChh--------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQ--------   73 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--------   73 (397)
                      +.++++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..        
T Consensus        95 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  174 (452)
T 3zyi_A           95 FRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLM  174 (452)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCC
T ss_pred             cCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCccc
Confidence            445666666666666666555566666666666666666666544445556666666666666655333323        


Q ss_pred             -----------------hcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           74 -----------------IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        74 -----------------~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                                       |.++++|+.|++++|.+++. | .+..+++|+.|++++|.+++..|..+..+++|+.+++++|
T Consensus       175 ~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n  252 (452)
T 3zyi_A          175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNS  252 (452)
T ss_dssp             EEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTS
T ss_pred             EEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCC
Confidence                             33444455555555555432 2 3555666777777777777777778888899999999988


Q ss_pred             CCcCC
Q 043586          137 KGLCG  141 (397)
Q Consensus       137 ~~~c~  141 (397)
                      .....
T Consensus       253 ~l~~~  257 (452)
T 3zyi_A          253 QVSLI  257 (452)
T ss_dssp             CCCEE
T ss_pred             cCceE
Confidence            76543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.70  E-value=3.2e-17  Score=160.76  Aligned_cols=139  Identities=21%  Similarity=0.236  Sum_probs=129.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+
T Consensus        52 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~  131 (477)
T 2id5_A           52 FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK  131 (477)
T ss_dssp             TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCC
Confidence            67899999999999999988899999999999999999999976666789999999999999999988899999999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|++++|.+.+..|..|..+++|+.|++++|.+++.++..+..+++|+.+++++|....
T Consensus       132 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             EEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            99999999999889999999999999999999998877788999999999999987543

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.70  E-value=6.6e-17  Score=136.87  Aligned_cols=115  Identities=26%  Similarity=0.269  Sum_probs=105.1

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      .++|++|+|++|++++..+..|..+++|+.|++++|.+++..+..|..+++|++|+|++|++++..+..+..+++|+.|+
T Consensus        27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  106 (177)
T 2o6r_A           27 PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELA  106 (177)
T ss_dssp             CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEE
Confidence            47899999999999987777899999999999999999977777789999999999999999987777789999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      +++|.+++..+..+..+++|+.|++++|++++..|
T Consensus       107 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A          107 LDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            99999998777778999999999999999997655

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.70  E-value=3.5e-17  Score=167.54  Aligned_cols=139  Identities=22%  Similarity=0.187  Sum_probs=75.2

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCc--------hhhhhcccCCeEeccCccCCCcCChhh
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP--------NELTWLTGLLGLNLSSNKLSGKIPSQI   74 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~~~~p~~~   74 (397)
                      .++++|++|+|++|++++..|..|..+++|+.|+|++|++++..+        ..|.++++|+.|+|++|+++...+..|
T Consensus       477 ~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~  556 (680)
T 1ziw_A          477 QPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF  556 (680)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             ccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHc
Confidence            344555555555555554444455555555555555555543211        124455555555555555553333345


Q ss_pred             cCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcc-cccccceeccCCCCCcCC
Q 043586           75 ASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE-QLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        75 ~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~-~l~~l~~l~l~~n~~~c~  141 (397)
                      .++++|+.|++++|++++..+..|..+++|+.|++++|++++..+..+. .+++++.+++++|+..|.
T Consensus       557 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             ccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            5555666666666666554445555555666666666666555544444 455566666666665553

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.70  E-value=6.1e-17  Score=139.11  Aligned_cols=111  Identities=28%  Similarity=0.391  Sum_probs=104.2

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|+++ .+|..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            57999999999998 68899999999999999999999888889999999999999999999888889999999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      ++|.|++..+..|..+++|+.|++++|++...
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A          110 HGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             CCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            99999987777899999999999999998754

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.70  E-value=5.7e-17  Score=157.93  Aligned_cols=135  Identities=21%  Similarity=0.277  Sum_probs=116.6

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccC-chhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      ++|++|+|++|.+++..|..|+.+++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus        30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~  109 (455)
T 3v47_A           30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT  109 (455)
T ss_dssp             TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred             CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence            57899999999999888889999999999999999987555 56788999999999999999988889999999999999


Q ss_pred             ccCcccccCCchh--hccCCCCceeeccCCcCCCCCCCC-cccccccceeccCCCCCcC
Q 043586           85 ISNNKIEGSIPGE--ITELSRLDYLNLSSNKLSGPVPFS-NEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        85 l~~N~~~~~~p~~--~~~~~~L~~l~l~~n~l~~~~~~~-~~~l~~l~~l~l~~n~~~c  140 (397)
                      +++|.+++..|..  +..+++|+.|++++|.+++..|.. +..+++|+.+++++|....
T Consensus       110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~  168 (455)
T 3v47_A          110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS  168 (455)
T ss_dssp             CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred             CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence            9999998755554  888999999999999999887776 7888999999999887543

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.69  E-value=1.2e-16  Score=155.11  Aligned_cols=136  Identities=26%  Similarity=0.289  Sum_probs=110.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccC-ccCCCcCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS-NKLSGKIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L   80 (397)
                      +.++++|++|+|++|++++..+..|..+++|+.|+|++|.+++..+..|..+++|+.|+|++ |.++...+..|.++++|
T Consensus       108 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L  187 (440)
T 3zyj_A          108 FNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL  187 (440)
T ss_dssp             GTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSC
T ss_pred             ccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhccccc
Confidence            56899999999999999977777899999999999999999987777999999999999999 55664455578888888


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +.|++++|.++. +| .+..+++|+.|++++|++++..|..+..+++|+.+++++|...
T Consensus       188 ~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  244 (440)
T 3zyj_A          188 RYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ  244 (440)
T ss_dssp             CEEECTTSCCSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCC
T ss_pred             CeecCCCCcCcc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCcee
Confidence            888888888874 44 3677777777777777777777777777777777777776543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.69  E-value=6e-17  Score=160.58  Aligned_cols=134  Identities=25%  Similarity=0.320  Sum_probs=109.8

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccc--cCchhhhhcccCCeEeccCccCCCcCChh-hcCCCC
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS--SIPNELTWLTGLLGLNLSSNKLSGKIPSQ-IASMKN   79 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~   79 (397)
                      ..+++|++|+|++|++++..|..++.+++|+.|++++|++++  .+|..+..+++|++|+|++|.+++.+|.. +..+++
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            578899999999999998889999999999999999999986  56678899999999999999999756654 778888


Q ss_pred             CcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           80 LTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        80 L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      |+.|++++|++++..|..+.  ++|+.|++++|+++ .+|..+..+++|+.+++++|...
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  457 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK  457 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence            88888888888776666554  67888888888887 45555557778888888877644

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.69  E-value=1.3e-17  Score=154.37  Aligned_cols=136  Identities=21%  Similarity=0.228  Sum_probs=116.3

Q ss_pred             CCCCCCEEEcCCCcccccCCccc--cCCCCCCEEeccCCcccccCchhhhhc-----ccCCeEeccCccCCCcCChhhcC
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTL--GLLTDLSYLDLSRNQFNSSIPNELTWL-----TGLLGLNLSSNKLSGKIPSQIAS   76 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~   76 (397)
                      ++++|++|+|++|++++.+|..+  ..+++|+.|+|++|++++. |..+..+     ++|++|+|++|++++..|..|++
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            58899999999999999899876  8999999999999999976 8888888     89999999999999888899999


Q ss_pred             CCCCcEEEccCcccccC--Cchhh--ccCCCCceeeccCCcCCCCC---CCCcccccccceeccCCCCCcC
Q 043586           77 MKNLTWLDISNNKIEGS--IPGEI--TELSRLDYLNLSSNKLSGPV---PFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        77 l~~L~~L~l~~N~~~~~--~p~~~--~~~~~L~~l~l~~n~l~~~~---~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      +++|+.|++++|++.+.  .|..+  ..+++|+.|++++|++++..   ...+..+++|+.+++++|....
T Consensus       172 l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~  242 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD  242 (312)
T ss_dssp             CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCS
T ss_pred             CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCc
Confidence            99999999999998765  34444  88999999999999998432   2333567899999999986443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.69  E-value=2e-17  Score=167.89  Aligned_cols=133  Identities=22%  Similarity=0.370  Sum_probs=125.2

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCc-ccc-cCchhhhhc------ccCCeEeccCccCCCcCCh--h
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ-FNS-SIPNELTWL------TGLLGLNLSSNKLSGKIPS--Q   73 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~   73 (397)
                      ++++|++|+|++|++.+.+|..|+.+++|+.|+|++|+ ++| .+|..++.+      ++|++|+|++|+++ .+|.  .
T Consensus       247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~  325 (636)
T 4eco_A          247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS  325 (636)
T ss_dssp             GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred             ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence            89999999999999999999999999999999999998 998 899999887      99999999999999 8998  9


Q ss_pred             hcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccc-cceeccCCCCCc
Q 043586           74 IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS-MYIVRLSPNKGL  139 (397)
Q Consensus        74 ~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~-l~~l~l~~n~~~  139 (397)
                      ++++++|+.|++++|.++|.+| .++.+++|+.|++++|.++ .+|..+..+++ |+.+++++|...
T Consensus       326 l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~  390 (636)
T 4eco_A          326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK  390 (636)
T ss_dssp             HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS
T ss_pred             hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc
Confidence            9999999999999999998899 8999999999999999999 77788899998 999999998754

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.69  E-value=3.1e-17  Score=145.83  Aligned_cols=132  Identities=15%  Similarity=0.159  Sum_probs=106.0

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCc-ccccCchhhhhcccCCeEeccC-ccCCCcCChhhcCCCCCcEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ-FNSSIPNELTWLTGLLGLNLSS-NKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ++|++|+|++|++++..+..|..+++|+.|++++|. +++..+..|.++++|++|+|++ |++++..+..|.++++|+.|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            368888888888887777788888888888888886 7766666788888888888887 88886666778888888888


Q ss_pred             EccCcccccCCchhhccCCCCc---eeeccCC-cCCCCCCCCcccccccc-eeccCCCCCc
Q 043586           84 DISNNKIEGSIPGEITELSRLD---YLNLSSN-KLSGPVPFSNEQLSSMY-IVRLSPNKGL  139 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~---~l~l~~n-~l~~~~~~~~~~l~~l~-~l~l~~n~~~  139 (397)
                      ++++|.+++ +|. +..+++|+   .|++++| .+++..+..+..+++|+ .+++++|...
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~  169 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT  169 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence            888888876 555 77777787   8888888 88877777788888888 8888887543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.69  E-value=1.9e-17  Score=172.03  Aligned_cols=135  Identities=19%  Similarity=0.248  Sum_probs=100.4

Q ss_pred             CCCCCCCCEEEcCCCcccc-----------------cCCcccc--CCCCCCEEeccCCcccccCchhhhhcccCCeEecc
Q 043586            2 IGNLKNLIELDVGSNSLIG-----------------PIPSTLG--LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS   62 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   62 (397)
                      +++|++|++|+|++|+|++                 .+|..++  .+++|+.|+|++|.+.+.+|..|.++++|+.|+|+
T Consensus       444 l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls  523 (876)
T 4ecn_A          444 IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA  523 (876)
T ss_dssp             GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECT
T ss_pred             HhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECc
Confidence            4567778888888888776                 3777766  77888888888887777777777778888888888


Q ss_pred             Ccc-CCC-cCChhhcCCC-------CCcEEEccCcccccCCch--hhccCCCCceeeccCCcCCCCCCCCccccccccee
Q 043586           63 SNK-LSG-KIPSQIASMK-------NLTWLDISNNKIEGSIPG--EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIV  131 (397)
Q Consensus        63 ~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~~~~~~p~--~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l  131 (397)
                      +|+ ++| .+|..++.++       +|+.|++++|.++ .+|.  .++.+++|+.|++++|.++ .+| .+..+++|+.|
T Consensus       524 ~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L  600 (876)
T 4ecn_A          524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDL  600 (876)
T ss_dssp             TCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEE
T ss_pred             CCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEE
Confidence            877 776 6777666655       7777777777777 5666  7777777777777777777 555 66777777777


Q ss_pred             ccCCCCCc
Q 043586          132 RLSPNKGL  139 (397)
Q Consensus       132 ~l~~n~~~  139 (397)
                      ++++|...
T Consensus       601 ~Ls~N~l~  608 (876)
T 4ecn_A          601 KLDYNQIE  608 (876)
T ss_dssp             ECCSSCCS
T ss_pred             ECcCCccc
Confidence            77777543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.69  E-value=3.7e-17  Score=145.36  Aligned_cols=133  Identities=18%  Similarity=0.207  Sum_probs=110.5

Q ss_pred             CCCCCCCCEEEcCCCc-ccccCCccccCCCCCCEEeccC-CcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCC
Q 043586            2 IGNLKNLIELDVGSNS-LIGPIPSTLGLLTDLSYLDLSR-NQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKN   79 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~   79 (397)
                      ++++++|++|+|++|+ +++..+..|..+++|+.|++++ |.+++..+..|.++++|++|++++|++++ +|. +..+++
T Consensus        51 ~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~  128 (239)
T 2xwt_C           51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYS  128 (239)
T ss_dssp             TTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCB
T ss_pred             ccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccc
Confidence            5678899999999997 8866667889999999999998 99987777788889999999999999985 666 888888


Q ss_pred             Cc---EEEccCc-ccccCCchhhccCCCCc-eeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           80 LT---WLDISNN-KIEGSIPGEITELSRLD-YLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        80 L~---~L~l~~N-~~~~~~p~~~~~~~~L~-~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |+   .|++++| .+++..+..|..+++|+ .|++++|.++..++..+.. ++|+.+++++|+
T Consensus       129 L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~  190 (239)
T 2xwt_C          129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNK  190 (239)
T ss_dssp             CCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCT
T ss_pred             cccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCC
Confidence            87   8999998 88877777788888898 8999888888555555555 788888888884

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.69  E-value=1.2e-16  Score=161.06  Aligned_cols=89  Identities=21%  Similarity=0.217  Sum_probs=43.6

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      +++++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+.+++|+.
T Consensus        96 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  175 (597)
T 3oja_B           96 AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQN  175 (597)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcE
Confidence            34445555555555555444444455555555555555554333333444555555555555555444444555555555


Q ss_pred             EEccCcccc
Q 043586           83 LDISNNKIE   91 (397)
Q Consensus        83 L~l~~N~~~   91 (397)
                      |++++|.++
T Consensus       176 L~L~~N~l~  184 (597)
T 3oja_B          176 LQLSSNRLT  184 (597)
T ss_dssp             EECTTSCCS
T ss_pred             EECcCCCCC
Confidence            555554444

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.69  E-value=6.7e-17  Score=152.27  Aligned_cols=136  Identities=21%  Similarity=0.180  Sum_probs=96.5

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCC-hhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIP-SQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L   80 (397)
                      +.++++|++|+|++|++++..|..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++++..+ ..+..+++|
T Consensus        72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L  151 (353)
T 2z80_A           72 LQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL  151 (353)
T ss_dssp             TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTC
T ss_pred             hccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCC
Confidence            4567777777777777776666677777777777777777775444457777777777777777774332 367777777


Q ss_pred             cEEEccCc-ccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           81 TWLDISNN-KIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        81 ~~L~l~~N-~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +.|++++| .+.+..+..+..+++|+.|++++|.+++..|..+..+++|+.+++++|.
T Consensus       152 ~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~  209 (353)
T 2z80_A          152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ  209 (353)
T ss_dssp             CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred             cEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence            77777777 3665556677777777777777777777767777777777777777664

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.68  E-value=3e-17  Score=138.92  Aligned_cols=130  Identities=18%  Similarity=0.212  Sum_probs=110.9

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++++|+.|+|++|+++. +|......++|+.|++++|.+++.  ..|..+++|++|+|++|++++..|..+..+++|+.
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            467899999999999994 565444445999999999999965  57899999999999999999655566699999999


Q ss_pred             EEccCcccccCCch--hhccCCCCceeeccCCcCCCCCCC----CcccccccceeccCCCC
Q 043586           83 LDISNNKIEGSIPG--EITELSRLDYLNLSSNKLSGPVPF----SNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        83 L~l~~N~~~~~~p~--~~~~~~~L~~l~l~~n~l~~~~~~----~~~~l~~l~~l~l~~n~  137 (397)
                      |++++|.|.. +|.  .+..+++|+.|++++|+++.. |.    .+..+++|+.+++++|.
T Consensus        93 L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~  151 (176)
T 1a9n_A           93 LILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVK  151 (176)
T ss_dssp             EECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECC
T ss_pred             EECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCC
Confidence            9999999974 565  899999999999999999854 54    47889999999999885

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.68  E-value=8.5e-17  Score=162.22  Aligned_cols=132  Identities=17%  Similarity=0.166  Sum_probs=61.4

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      .+++.|++++|.+....+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..|+++++|+.|+|
T Consensus        51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  130 (597)
T 3oja_B           51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL  130 (597)
T ss_dssp             CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence            34444444444444333333444444444444444444444444444444444444444444444444444444444444


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ++|.+++..+..|+.+++|+.|++++|.+++.+|..+..+++|..|++++|.
T Consensus       131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  182 (597)
T 3oja_B          131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR  182 (597)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSC
T ss_pred             eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCC
Confidence            4444443333334444444444444444444444444444444444444443

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.68  E-value=9e-17  Score=153.45  Aligned_cols=135  Identities=17%  Similarity=0.158  Sum_probs=103.0

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++|++|++++|.+....+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|.+++..|..|.++++|+.|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            46778888888877755555567788888888888888766666778888888888888888876677778888888888


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +++|.++...+..|..+++|+.|++++|.+++..|..+..+++|+.+++++|...
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  178 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT  178 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCS
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCC
Confidence            8888887555555677888888888888887777777777888888888877643

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.68  E-value=5.4e-17  Score=161.91  Aligned_cols=133  Identities=19%  Similarity=0.201  Sum_probs=95.6

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|+.|++
T Consensus        26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  105 (549)
T 2z81_A           26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL  105 (549)
T ss_dssp             TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred             CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence            46777777777777766777777777777777777777766677777777777777777777666666777777777777


Q ss_pred             cCcccccC-CchhhccCCCCceeeccCCcCCCCC-CCCcccccccceeccCCCCC
Q 043586           86 SNNKIEGS-IPGEITELSRLDYLNLSSNKLSGPV-PFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        86 ~~N~~~~~-~p~~~~~~~~L~~l~l~~n~l~~~~-~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++|.+++. .|..++.+++|+.|++++|.+.+.+ +..+..+++|+.+++++|..
T Consensus       106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l  160 (549)
T 2z81_A          106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL  160 (549)
T ss_dssp             TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred             CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence            77777652 4566777777777777777743333 35667777777777776654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.68  E-value=1.1e-16  Score=160.31  Aligned_cols=132  Identities=22%  Similarity=0.192  Sum_probs=84.7

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      +++.|+|++|++++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|+.|+++
T Consensus        29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  108 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (570)
T ss_dssp             SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence            46666666666666556666666666666666666665555666666666666666666665555666666666666666


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCC-CCCCCcccccccceeccCCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSG-PVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~-~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +|.+++..+..++.+++|+.|++++|.+++ .+|..+..+++|+.+++++|..
T Consensus       109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l  161 (570)
T 2z63_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI  161 (570)
T ss_dssp             TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCC
T ss_pred             ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCcc
Confidence            666665444456666666666666666665 2456666666666666666643

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.68  E-value=2.3e-17  Score=152.79  Aligned_cols=136  Identities=21%  Similarity=0.145  Sum_probs=113.0

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCC-----CCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCc--CChhh-
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLL-----TDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK--IPSQI-   74 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~-   74 (397)
                      +++++|++|+|++|++++. |..++.+     ++|++|+|++|++++..|..|..+++|++|+|++|++++.  .|..+ 
T Consensus       118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  196 (312)
T 1wwl_A          118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC  196 (312)
T ss_dssp             CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred             hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence            6789999999999999976 8878777     8999999999999988888999999999999999998765  34455 


Q ss_pred             -cCCCCCcEEEccCcccccC---CchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCc
Q 043586           75 -ASMKNLTWLDISNNKIEGS---IPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        75 -~~l~~L~~L~l~~N~~~~~---~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~  139 (397)
                       ..+++|+.|++++|.+++.   ....+..+++|+.|++++|++++.+| ..+..+++|+.+++++|...
T Consensus       197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence             7889999999999999832   22445678899999999999998775 45566889999999998644

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.68  E-value=1.7e-16  Score=160.26  Aligned_cols=136  Identities=26%  Similarity=0.220  Sum_probs=72.5

Q ss_pred             CCCCCCCCEEEcCCCcccccC--CccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChh-hcCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPI--PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQ-IASMK   78 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~--p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~   78 (397)
                      +.++++|++|+|++|.+++..  |..+..+++|+.|++++|.+++..|..|..+++|+.|++++|++++..|.. +..++
T Consensus       346 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  425 (606)
T 3t6q_A          346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH  425 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCT
T ss_pred             hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcc
Confidence            344555555666555555443  445555555555555555555555555555555555555555555443332 55555


Q ss_pred             CCcEEEccCcccccCCchhhccCCCCceeeccCCcCCC---CCCCCcccccccceeccCCCC
Q 043586           79 NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG---PVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~---~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +|+.|++++|.+.+..|..+..+++|+.|++++|++++   ..+..+..+++|+.+++++|.
T Consensus       426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~  487 (606)
T 3t6q_A          426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD  487 (606)
T ss_dssp             TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred             cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence            55555555555555555555555555555555555544   122344555555555555554

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.68  E-value=1.8e-16  Score=162.24  Aligned_cols=133  Identities=28%  Similarity=0.215  Sum_probs=114.5

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|++++..+..|+++++|+.|++
T Consensus        25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L  104 (680)
T 1ziw_A           25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL  104 (680)
T ss_dssp             TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence            57889999999988777778888999999999999998888888889999999999999998655557888999999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++|.+++..|..|+.+++|+.|++++|.+++..|..+..+++|+.+++++|..
T Consensus       105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l  157 (680)
T 1ziw_A          105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI  157 (680)
T ss_dssp             CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCC
T ss_pred             CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcc
Confidence            99998877778888899999999999999888888888888888888888754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.67  E-value=1.5e-16  Score=159.37  Aligned_cols=134  Identities=19%  Similarity=0.236  Sum_probs=105.6

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCccccc--CchhhhhcccCCeEeccCccCCCcCCh-hhcCCCC
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSS--IPNELTWLTGLLGLNLSSNKLSGKIPS-QIASMKN   79 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~   79 (397)
                      +.+++|++|+|++|++++..|..+..+++|+.|+|++|++++.  +|..+..+++|++|+|++|++++.+|. .+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            5788999999999999988899999999999999999999863  346788899999999999999974554 4777888


Q ss_pred             CcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           80 LTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        80 L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      |+.|++++|++++..|..+.  ++|+.|++++|+++. +|..+..+++|+.+++++|...
T Consensus       430 L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~  486 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLK  486 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCC
T ss_pred             CCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCC
Confidence            88888888888766655443  577778888887774 4444447777777777777644

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.67  E-value=1.9e-16  Score=151.14  Aligned_cols=132  Identities=20%  Similarity=0.183  Sum_probs=117.7

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|+++...+..|.++++|+.
T Consensus        66 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~  145 (390)
T 3o6n_A           66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTT  145 (390)
T ss_dssp             HHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcE
Confidence            45789999999999999888889999999999999999999888888999999999999999999555555799999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |++++|.+.+..|..+..+++|+.|++++|.+++.   .+..+++++.+++++|.
T Consensus       146 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~  197 (390)
T 3o6n_A          146 LSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNL  197 (390)
T ss_dssp             EECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSC
T ss_pred             EECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccc
Confidence            99999999988888999999999999999999865   24566777778887774

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.67  E-value=1.1e-16  Score=159.55  Aligned_cols=136  Identities=22%  Similarity=0.167  Sum_probs=122.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCC-cCChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSG-KIPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L   80 (397)
                      ++++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..|.++++|++|+|++|.+++ ..|..++++++|
T Consensus        46 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L  125 (549)
T 2z81_A           46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL  125 (549)
T ss_dssp             TSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTC
T ss_pred             hhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCc
Confidence            6789999999999999998888999999999999999999998777789999999999999999996 367889999999


Q ss_pred             cEEEccCccc-ccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           81 TWLDISNNKI-EGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        81 ~~L~l~~N~~-~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +.|++++|.+ ....+..+..+++|+.|++++|.+++..|..+..+++++.++++.|.
T Consensus       126 ~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~  183 (549)
T 2z81_A          126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE  183 (549)
T ss_dssp             CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSB
T ss_pred             cEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCc
Confidence            9999999984 44444689999999999999999999899999999999999999875

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.67  E-value=8.9e-17  Score=167.06  Aligned_cols=132  Identities=22%  Similarity=0.314  Sum_probs=124.3

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCc-ccc-cCchhhhhcc-------cCCeEeccCccCCCcCCh--
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ-FNS-SIPNELTWLT-------GLLGLNLSSNKLSGKIPS--   72 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--   72 (397)
                      +|++|++|+|++|++.+.+|..|+.+++|+.|+|++|+ ++| .+|..++.++       +|+.|+|++|+++ .+|.  
T Consensus       489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~  567 (876)
T 4ecn_A          489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA  567 (876)
T ss_dssp             GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred             cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence            89999999999999999999999999999999999998 998 8999998887       9999999999999 8998  


Q ss_pred             hhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccc-cceeccCCCCCc
Q 043586           73 QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS-MYIVRLSPNKGL  139 (397)
Q Consensus        73 ~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~-l~~l~l~~n~~~  139 (397)
                      .++++++|+.|++++|.++ .+| .++.+++|+.|++++|.++ .+|..+..+++ |+.|++++|...
T Consensus       568 ~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~  632 (876)
T 4ecn_A          568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK  632 (876)
T ss_dssp             HHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred             hhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence            9999999999999999999 778 8999999999999999999 77888999998 999999999754

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.67  E-value=1.2e-16  Score=137.81  Aligned_cols=130  Identities=19%  Similarity=0.222  Sum_probs=116.6

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|++|++++|.++  .+..+..+++|+.|++++|.+++..|..+..+++|++|+|++|++++..|..+..+++|+
T Consensus        62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~  139 (197)
T 4ezg_A           62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN  139 (197)
T ss_dssp             GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred             HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence            457899999999999776  334799999999999999999987888999999999999999999988899999999999


Q ss_pred             EEEccCcc-cccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           82 WLDISNNK-IEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        82 ~L~l~~N~-~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .|++++|. +. .+| .+..+++|+.|++++|++++..  .+..+++|+.+++++|+
T Consensus       140 ~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          140 SIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred             EEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence            99999998 65 455 6999999999999999999753  78889999999999986

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.66  E-value=3.4e-16  Score=131.59  Aligned_cols=110  Identities=24%  Similarity=0.293  Sum_probs=97.2

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      ..+.|++++|.++ .+|..+  .++|+.|+|++|.|++..|..|..+++|++|+|++|+|++..|..|.++++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            4578999999998 477666  3899999999999998888899999999999999999997777778999999999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~  119 (397)
                      +|+|++..+..|..+++|+.|+|++|+++...+
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            999998777789999999999999999986643

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.66  E-value=2.7e-16  Score=164.73  Aligned_cols=136  Identities=26%  Similarity=0.286  Sum_probs=68.4

Q ss_pred             CCCCCCCCEEEcCCCcccccC-CccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChh--hcCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPI-PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQ--IASMK   78 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~   78 (397)
                      ++++++|++|+|++|.+.+.+ |..|..+++|+.|+|++|.+++..|..|.++++|++|+|++|.+++.+|..  |.+++
T Consensus        44 ~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~  123 (844)
T 3j0a_A           44 FPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK  123 (844)
T ss_dssp             CSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCS
T ss_pred             CcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccC
Confidence            344555555555555333333 445555555555555555555444555555555555555555555444433  55555


Q ss_pred             CCcEEEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCCCCcccc--cccceeccCCCC
Q 043586           79 NLTWLDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFSNEQL--SSMYIVRLSPNK  137 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l--~~l~~l~l~~n~  137 (397)
                      +|+.|++++|.+++..+ ..|+.+++|+.|++++|.+++..+..+..+  ++|+.++++.|.
T Consensus       124 ~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~  185 (844)
T 3j0a_A          124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS  185 (844)
T ss_dssp             SCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSB
T ss_pred             CCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCc
Confidence            55555555555544332 345555555555555555555444444444  444444444443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.66  E-value=5e-16  Score=144.83  Aligned_cols=132  Identities=26%  Similarity=0.286  Sum_probs=69.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccc--cCchhhhhccc---------------------CCeEecc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNS--SIPNELTWLTG---------------------LLGLNLS   62 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~---------------------L~~L~l~   62 (397)
                      ++|++|++++|++++..+..|..+++|+.|++++|.++.  ..+..+..+++                     |++|+++
T Consensus       121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~  200 (330)
T 1xku_A          121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLD  200 (330)
T ss_dssp             TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECT
T ss_pred             ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECC
Confidence            345555555555554444445555555555555555532  34444444444                     4455555


Q ss_pred             CccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           63 SNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        63 ~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|+++ .+|..+..+++|+.+++++|..
T Consensus       201 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i  275 (330)
T 1xku_A          201 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI  275 (330)
T ss_dssp             TSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCC
T ss_pred             CCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcC
Confidence            55555444555555555555555555555554555555555555555555555 3444455555555555555543

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.66  E-value=5.1e-16  Score=142.24  Aligned_cols=125  Identities=31%  Similarity=0.411  Sum_probs=78.5

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      ..+++|++|+|++|++++..+  +..+++|+.|++++|.+++ +| .+..+++|++|+|++|++++ + +.+..+++|+.
T Consensus        65 ~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~  138 (291)
T 1h6t_A           65 QYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLES  138 (291)
T ss_dssp             GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCE
T ss_pred             hcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCE
Confidence            445666666666666664333  6666666666666666653 33 36666666666666666664 2 34666666666


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |++++|.+++.  ..+..+++|+.|++++|++++..+  +..+++|+.+++++|.
T Consensus       139 L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~  189 (291)
T 1h6t_A          139 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNH  189 (291)
T ss_dssp             EECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCc
Confidence            66666666643  456666666666666666665544  5566666666666664

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.66  E-value=1.5e-16  Score=147.56  Aligned_cols=132  Identities=21%  Similarity=0.171  Sum_probs=78.6

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhh-hcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT-WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      +++|++|+|++|++++..|..+..+++|+.|+|++|.+++..|..+. .+++|++|+|++|.+++. |. ...+++|+.|
T Consensus       119 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L  196 (317)
T 3o53_A          119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTL  196 (317)
T ss_dssp             CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEE
T ss_pred             cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEE
Confidence            44556666666666555555666666666666666666655555543 456666666666666633 22 2235666666


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++++|.+++. |..+..+++|+.|++++|+++. +|..+..+++|+.+++++|+..|
T Consensus       197 ~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~  251 (317)
T 3o53_A          197 DLSSNKLAFM-GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC  251 (317)
T ss_dssp             ECCSSCCCEE-CGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBH
T ss_pred             ECCCCcCCcc-hhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccC
Confidence            6666666643 3336666666666666666663 34555666666666666666554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.65  E-value=8.2e-16  Score=143.52  Aligned_cols=107  Identities=23%  Similarity=0.301  Sum_probs=71.5

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|.+++..|..|..+++|+.|+|++|.+++..|..|..+++|++|+|++|+++ .+|..+.  ++|++|++
T Consensus        54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l  130 (332)
T 2ft3_A           54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI  130 (332)
T ss_dssp             TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence            45677777777777666666777777777777777777666667777777777777777776 4554443  56666666


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      ++|.+.+..+..+..+++|+.|++++|.++
T Consensus       131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~  160 (332)
T 2ft3_A          131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLE  160 (332)
T ss_dssp             CSSCCCCCCSGGGSSCSSCCEEECCSCCCB
T ss_pred             CCCccCccCHhHhCCCccCCEEECCCCccc
Confidence            666666555555666666666666666664

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.65  E-value=3.5e-16  Score=131.14  Aligned_cols=114  Identities=26%  Similarity=0.240  Sum_probs=102.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcC-ChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI-PSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L   80 (397)
                      +..+++|++|+|++|.+++.  ..+..+++|+.|+|++|++++.+|..+..+++|++|+|++|++++.. +..+..+++|
T Consensus        45 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L  122 (168)
T 2ell_A           45 TAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECL  122 (168)
T ss_dssp             CGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCC
T ss_pred             HHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCC
Confidence            45789999999999999965  78999999999999999999878988888999999999999999632 2789999999


Q ss_pred             cEEEccCcccccCCc---hhhccCCCCceeeccCCcCCCC
Q 043586           81 TWLDISNNKIEGSIP---GEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p---~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      +.|++++|++++..+   ..+..+++|+.|++++|.+...
T Consensus       123 ~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A          123 KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred             CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence            999999999997665   5899999999999999998744

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.65  E-value=7.2e-17  Score=165.84  Aligned_cols=135  Identities=23%  Similarity=0.293  Sum_probs=106.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|+.|+|++|.+. .+|..+..+++|+.|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|++|++|+
T Consensus       220 ~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  296 (727)
T 4b8c_D          220 KYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK  296 (727)
T ss_dssp             --CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCS
T ss_pred             hccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCC
Confidence            456788888999988888 67777778889999999999888 78888888889999999999988 7788888888899


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCccccccc-ceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSM-YIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l-~~l~l~~n~~~c  140 (397)
                      .|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|..+..+... ..+++++|....
T Consensus       297 ~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~  355 (727)
T 4b8c_D          297 YFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI  355 (727)
T ss_dssp             EEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred             EEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence            9999999887 567778888899999999999888877766543221 235566665443

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.65  E-value=7.6e-16  Score=152.60  Aligned_cols=137  Identities=31%  Similarity=0.408  Sum_probs=107.3

Q ss_pred             CCCCCCCCEEEcCCCcccc--cCCccccCCCCCCEEeccCCcccccCch-hhhhcccCCeEeccCccCCCcCChhhcCCC
Q 043586            2 IGNLKNLIELDVGSNSLIG--PIPSTLGLLTDLSYLDLSRNQFNSSIPN-ELTWLTGLLGLNLSSNKLSGKIPSQIASMK   78 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~   78 (397)
                      ++++++|++|+|++|++++  .+|..+..+++|+.|++++|.+++.+|. .+..+++|++|+|++|++++..|..+.  +
T Consensus       344 ~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~  421 (520)
T 2z7x_B          344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--P  421 (520)
T ss_dssp             CCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--T
T ss_pred             hccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--c
Confidence            5677888888888888875  4567788888888888888888864555 377788888888888888877776664  6


Q ss_pred             CCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           79 NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+.|++++|+++ .+|..+..+++|+.|++++|+++..++..+..+++|+.+++++|+..|.
T Consensus       422 ~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  483 (520)
T 2z7x_B          422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  483 (520)
T ss_dssp             TCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCccc
Confidence            7888888888887 5777777888888888888888865555577888888888888877663

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.65  E-value=7.8e-16  Score=129.86  Aligned_cols=108  Identities=24%  Similarity=0.297  Sum_probs=89.2

Q ss_pred             CCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccC
Q 043586            8 LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISN   87 (397)
Q Consensus         8 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~   87 (397)
                      -+.+++++|+++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            367889988886 6776664  8899999999999887788888899999999999999876666678888999999999


Q ss_pred             cccccCCchhhccCCCCceeeccCCcCCCCC
Q 043586           88 NKIEGSIPGEITELSRLDYLNLSSNKLSGPV  118 (397)
Q Consensus        88 N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~  118 (397)
                      |+|++..+..|..+++|+.|+|++|++....
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~  121 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCEC  121 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCccccc
Confidence            9988766667888889999999998887543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.64  E-value=5e-16  Score=154.96  Aligned_cols=121  Identities=27%  Similarity=0.316  Sum_probs=104.1

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      .|+.|+|++|+|++ +|. |+.+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            58899999999986 676 999999999999999998 788899999999999999999996 67 89999999999999


Q ss_pred             CcccccCC-chhhccCCCCceeeccCCcCCCCCCCCc---ccccccceec
Q 043586           87 NNKIEGSI-PGEITELSRLDYLNLSSNKLSGPVPFSN---EQLSSMYIVR  132 (397)
Q Consensus        87 ~N~~~~~~-p~~~~~~~~L~~l~l~~n~l~~~~~~~~---~~l~~l~~l~  132 (397)
                      +|+|++.. |..++.+++|+.|++++|++++.+|...   ..+++|+.|+
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence            99999876 8999999999999999999998766432   2356666654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.64  E-value=3e-16  Score=164.41  Aligned_cols=136  Identities=21%  Similarity=0.197  Sum_probs=123.7

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccC-chhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .++|++|||++|.+++..|..|..+++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|..|.++++|+.|
T Consensus        23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  102 (844)
T 3j0a_A           23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL  102 (844)
T ss_dssp             CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred             CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence            478999999999999989999999999999999999665565 7889999999999999999998889999999999999


Q ss_pred             EccCcccccCCchh--hccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCcC
Q 043586           84 DISNNKIEGSIPGE--ITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        84 ~l~~N~~~~~~p~~--~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      +|++|.+++..|..  ++.+++|+.|++++|.+++..+ ..+.++++|+.|++++|....
T Consensus       103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~  162 (844)
T 3j0a_A          103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL  162 (844)
T ss_dssp             ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred             eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence            99999999866665  9999999999999999998765 578999999999999997543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.64  E-value=8.2e-16  Score=143.36  Aligned_cols=131  Identities=21%  Similarity=0.244  Sum_probs=114.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++..+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|+++ .+|..+.  ++|+.|++
T Consensus        52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l  128 (330)
T 1xku_A           52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV  128 (330)
T ss_dssp             TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred             CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence            57899999999999877778999999999999999999877889999999999999999998 6776665  68999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCC--CCCCCcccccccceeccCCCCCc
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSG--PVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~--~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      ++|.+.+..+..+..+++|+.|++++|.++.  ..+..+..+++|+.+++++|...
T Consensus       129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~  184 (330)
T 1xku_A          129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  184 (330)
T ss_dssp             CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc
Confidence            9999998888889999999999999999863  66778888999999999988643

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.64  E-value=5.1e-16  Score=140.06  Aligned_cols=126  Identities=24%  Similarity=0.318  Sum_probs=84.1

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+++|++|++++|.++ .+| .+..+++|+.|+|++|++++..|  +..+++|++|+|++|++++ +|....  ++|+.|
T Consensus        39 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L  111 (263)
T 1xeu_A           39 ELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRL  111 (263)
T ss_dssp             HHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEE
T ss_pred             hcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEE
Confidence            4567777777777776 344 57777777777777777774433  7777777777777777774 443222  667777


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++++|++++. + .+..+++|+.|++++|++++. + .+..+++|+.+++++|....
T Consensus       112 ~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~  164 (263)
T 1xeu_A          112 FLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN  164 (263)
T ss_dssp             ECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred             EccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence            7777777653 2 466777777777777777654 2 46666777777777765443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.64  E-value=5.6e-16  Score=127.20  Aligned_cols=108  Identities=24%  Similarity=0.244  Sum_probs=97.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCc-CChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK-IPSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L   80 (397)
                      +..+++|++|+|++|.+++.  ..+..+++|+.|++++|.+++.+|..+..+++|++|++++|++++. .|..+..+++|
T Consensus        38 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L  115 (149)
T 2je0_A           38 TDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENL  115 (149)
T ss_dssp             CTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTC
T ss_pred             HhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCC
Confidence            46789999999999999965  7799999999999999999987898888999999999999999963 34889999999


Q ss_pred             cEEEccCcccccCCc---hhhccCCCCceeeccC
Q 043586           81 TWLDISNNKIEGSIP---GEITELSRLDYLNLSS  111 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p---~~~~~~~~L~~l~l~~  111 (397)
                      +.|++++|++++..+   ..+..+++|+.|++++
T Consensus       116 ~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A          116 KSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             CEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             CEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            999999999998766   5899999999999874

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.64  E-value=4.7e-16  Score=145.20  Aligned_cols=133  Identities=22%  Similarity=0.260  Sum_probs=114.0

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++ +|++|++++|++++ +|..+.  ++|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..+..+++|+.
T Consensus       170 ~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  245 (332)
T 2ft3_A          170 DGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRE  245 (332)
T ss_dssp             CSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCE
T ss_pred             cCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCE
Confidence            344 89999999999985 666554  79999999999999888888999999999999999999877888999999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccc------cccceeccCCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQL------SSMYIVRLSPNKGLC  140 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l------~~l~~l~l~~n~~~c  140 (397)
                      |++++|+++ .+|..+..+++|+.|++++|++++..+..+...      .++..+++++|+..+
T Consensus       246 L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~  308 (332)
T 2ft3_A          246 LHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPY  308 (332)
T ss_dssp             EECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred             EECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccc
Confidence            999999998 678889999999999999999998777766543      567889999998763

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.64  E-value=1.2e-15  Score=140.82  Aligned_cols=127  Identities=28%  Similarity=0.455  Sum_probs=92.1

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|++|+|++|++++..+  +..+++|+.|+|++|.+++ +| .+..+++|++|+|++|++++ +|. +..+++|+
T Consensus        59 ~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~  132 (308)
T 1h6u_A           59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQ  132 (308)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCC
T ss_pred             hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCC
Confidence            4457788888888888875433  7788888888888888874 33 57777888888888888874 443 77777888


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      .|++++|.+++..+  +..+++|+.|++++|.+++..+  +..+++|+.+++++|..
T Consensus       133 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  185 (308)
T 1h6u_A          133 VLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI  185 (308)
T ss_dssp             EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence            88888887775433  7777777778887777776544  66677777777777754

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.64  E-value=1.2e-15  Score=141.01  Aligned_cols=126  Identities=24%  Similarity=0.337  Sum_probs=91.9

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ++++|+.|++++|.+.. +| .+..+++|+.|+|++|.+++. +. +..+++|++|+|++|++++ +| .+..+++|+.|
T Consensus        39 ~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEE
Confidence            35677888888887773 44 477788888888888888743 33 7778888888888888774 33 57778888888


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      ++++|.+++. +. +..+++|+.|++++|.+++..+  +..+++|+.+++++|...
T Consensus       113 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~  164 (308)
T 1h6u_A          113 DLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS  164 (308)
T ss_dssp             ECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCC
Confidence            8888887753 32 7777888888888888876654  667777888888777543

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.64  E-value=2.3e-16  Score=145.87  Aligned_cols=129  Identities=21%  Similarity=0.181  Sum_probs=56.5

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCccccc--C--chhhhhcccCCeEeccCccCCCcCCh----hhcC
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSS--I--PNELTWLTGLLGLNLSSNKLSGKIPS----QIAS   76 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~--~--p~~~~~l~~L~~L~l~~N~l~~~~p~----~~~~   76 (397)
                      +++|++|+|++|++.+..|..|+.+++|+.|+|++|++.+.  +  +..+..+++|++|+|++|+++ .+|.    .+..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence            44444555555544444444444455555555555544321  1  111234444444555554444 2222    1234


Q ss_pred             CCCCcEEEccCcccccCCchhhccC---CCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           77 MKNLTWLDISNNKIEGSIPGEITEL---SRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        77 l~~L~~L~l~~N~~~~~~p~~~~~~---~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +++|+.|++++|++.+..|..+..+   ++|+.|++++|+++. +|..+.  ++|+.+++++|.
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~  283 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNR  283 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCC
T ss_pred             CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCc
Confidence            4445555555555544444444443   345555555555542 232221  344445554443

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.63  E-value=9.4e-16  Score=140.46  Aligned_cols=129  Identities=29%  Similarity=0.395  Sum_probs=113.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|+|++|++++ +| .+..+++|+.|++++|++++ + +.+..+++|+.|++++|++++.  +.+..+++|+
T Consensus        86 l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~  159 (291)
T 1h6t_A           86 LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD  159 (291)
T ss_dssp             GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCC
Confidence            4678999999999999985 44 49999999999999999986 3 4688999999999999999964  6899999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|++++|++++..|  +..+++|+.|++++|.+++. + .+..+++|..+++++|+..+
T Consensus       160 ~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred             EEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence            99999999997655  99999999999999999975 3 47889999999999986444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.62  E-value=1.4e-15  Score=142.72  Aligned_cols=126  Identities=31%  Similarity=0.404  Sum_probs=66.5

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+++|++|+|++|.+++..+  +..+++|+.|++++|.+++ + +.+..+++|++|++++|++++ + +.+..+++|+.|
T Consensus       219 ~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L  292 (347)
T 4fmz_A          219 NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSL  292 (347)
T ss_dssp             GCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEE
T ss_pred             cCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEE
Confidence            34555555555555553222  5555555555555555543 2 235555555555555555553 2 235555555555


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ++++|++.+..|..+..+++|+.|++++|++++..|  +..+++|+.+++++|+
T Consensus       293 ~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~  344 (347)
T 4fmz_A          293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV  344 (347)
T ss_dssp             ECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC-
T ss_pred             ECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhc
Confidence            555555555555555555555555555555555444  4455555555555553

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.62  E-value=1.4e-15  Score=127.79  Aligned_cols=108  Identities=25%  Similarity=0.303  Sum_probs=99.2

Q ss_pred             CCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeecc
Q 043586           31 DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLS  110 (397)
Q Consensus        31 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~  110 (397)
                      ..+.|++++|.++ .+|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|+
T Consensus        10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            3579999999998 5776664  889999999999998889999999999999999999998888889999999999999


Q ss_pred             CCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586          111 SNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus       111 ~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+|++.++..+..+++|+.+++++|+..|.
T Consensus        87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence            9999998888899999999999999988775

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.61  E-value=3e-15  Score=149.83  Aligned_cols=137  Identities=32%  Similarity=0.408  Sum_probs=108.7

Q ss_pred             CCCCCCCCEEEcCCCcccc--cCCccccCCCCCCEEeccCCcccccCch-hhhhcccCCeEeccCccCCCcCChhhcCCC
Q 043586            2 IGNLKNLIELDVGSNSLIG--PIPSTLGLLTDLSYLDLSRNQFNSSIPN-ELTWLTGLLGLNLSSNKLSGKIPSQIASMK   78 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~   78 (397)
                      ++++++|++|+|++|++++  .+|..|..+++|+.|++++|.+++.+|. .+..+++|++|+|++|++++..|..+.  +
T Consensus       373 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~  450 (562)
T 3a79_B          373 CSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P  450 (562)
T ss_dssp             CCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--T
T ss_pred             hcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--C
Confidence            5678888888998888886  3346788888889999998888874554 477888888889988888877776554  6


Q ss_pred             CCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           79 NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+.|++++|+++ .+|..+..+++|+.|++++|+++..++..+..+++|+.+++++|+..|.
T Consensus       451 ~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~  512 (562)
T 3a79_B          451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT  512 (562)
T ss_dssp             TCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCC
T ss_pred             cCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCC
Confidence            7888889888888 5666666888888899988888865555578888888888888887763

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.61  E-value=3.1e-16  Score=154.07  Aligned_cols=131  Identities=24%  Similarity=0.205  Sum_probs=74.1

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCCh------------
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPS------------   72 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~------------   72 (397)
                      +++|++|+|++|.+++..|..|+.+++|+.|+|++|.+++..|  +..+++|++|+|++|.|++..+.            
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~  110 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNN  110 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSC
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCc
Confidence            3467777777777776666777777777777777777765554  66666666666666555532111            


Q ss_pred             ----hhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcc-cccccceeccCCCC
Q 043586           73 ----QIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE-QLSSMYIVRLSPNK  137 (397)
Q Consensus        73 ----~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~-~l~~l~~l~l~~n~  137 (397)
                          ....+++|+.|++++|.+++..|..++.+++|+.|++++|.+++.+|..+. .+++|..|++++|.
T Consensus       111 l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~  180 (487)
T 3oja_A          111 ISRVSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF  180 (487)
T ss_dssp             CCCEEECCCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred             CCCCCccccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence                001234455555555555554455555555555555555555554444433 34455555555443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.61  E-value=1.8e-15  Score=151.83  Aligned_cols=127  Identities=31%  Similarity=0.402  Sum_probs=88.2

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.+|++|+.|+|++|+|++..|  +..+++|+.|+|++|.+++ +| .+..+++|+.|+|++|++++ + +.+..+++|+
T Consensus        61 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~  134 (605)
T 1m9s_A           61 IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLE  134 (605)
T ss_dssp             GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCS
T ss_pred             HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccC
Confidence            4556777777777777775444  7777777777777777764 33 56777777777777777774 3 3467777777


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      .|+|++|.+++.  ..+..+++|+.|+|++|.+++..|  +..+++|+.|++++|..
T Consensus       135 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i  187 (605)
T 1m9s_A          135 SLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  187 (605)
T ss_dssp             EEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             EEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence            777777777654  456777777777777777776655  66677777777777653

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.61  E-value=1.7e-15  Score=136.70  Aligned_cols=129  Identities=27%  Similarity=0.355  Sum_probs=112.1

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|++|+|++|++++..|  +..+++|+.|+|++|++++ +|. +.. ++|++|+|++|++++ +| .+..+++|+
T Consensus        59 l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~  131 (263)
T 1xeu_A           59 MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLE  131 (263)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCC
T ss_pred             HhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCc-ccc-CcccEEEccCCccCC-Ch-hhcCccccc
Confidence            5678999999999999996544  9999999999999999985 454 333 899999999999995 44 699999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      .|++++|++++. + .+..+++|+.|++++|++++.  ..+..+++|+.+++++|+..|.
T Consensus       132 ~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          132 ILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             EEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             EEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            999999999875 4 689999999999999999977  6678899999999999976554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.61  E-value=5e-16  Score=143.58  Aligned_cols=137  Identities=19%  Similarity=0.145  Sum_probs=105.4

Q ss_pred             CCCCCEEEcCCCcccccCCccc--cCCCCCCEEeccCCcccccCc----hhhhhcccCCeEeccCccCCCcCChhhcCCC
Q 043586            5 LKNLIELDVGSNSLIGPIPSTL--GLLTDLSYLDLSRNQFNSSIP----NELTWLTGLLGLNLSSNKLSGKIPSQIASMK   78 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~   78 (397)
                      +++|++|+|++|.+++..|..+  ..+++|+.|+|++|.+++..|    ..+..+++|++|+|++|++++..|..|+.++
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~  169 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFP  169 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCT
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCC
Confidence            3568999999999988888887  889999999999999987655    3445688999999999999888888888999


Q ss_pred             CCcEEEccCcccccC--C--chhhccCCCCceeeccCCcCCCCCCC---CcccccccceeccCCCCCcCC
Q 043586           79 NLTWLDISNNKIEGS--I--PGEITELSRLDYLNLSSNKLSGPVPF---SNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~--~--p~~~~~~~~L~~l~l~~n~l~~~~~~---~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+.|++++|++.+.  +  +..++.+++|+.|++++|+++...+.   .+..+++|+.+++++|.....
T Consensus       170 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~  239 (310)
T 4glp_A          170 ALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRAT  239 (310)
T ss_dssp             TCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCC
T ss_pred             CCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCcc
Confidence            999999999987642  2  22346778888888888888643221   235667888888888865443

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.60  E-value=3.1e-15  Score=126.15  Aligned_cols=107  Identities=22%  Similarity=0.282  Sum_probs=98.0

Q ss_pred             CCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccC
Q 043586           32 LSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS  111 (397)
Q Consensus        32 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~  111 (397)
                      -+.+++++|.++ .+|..+.  ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            478999999997 6787664  8999999999999988899999999999999999999987777789999999999999


Q ss_pred             CcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586          112 NKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus       112 n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      |+|++.++..+..+++|+.+++++|+..|.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            999988888899999999999999987774

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.59  E-value=5.2e-15  Score=148.55  Aligned_cols=129  Identities=29%  Similarity=0.393  Sum_probs=114.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.+|++|+.|+|++|+|++ +| .+..+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++.  +.+..+++|+
T Consensus        83 l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~  156 (605)
T 1m9s_A           83 LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLD  156 (605)
T ss_dssp             GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCS
T ss_pred             hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCC
Confidence            4678999999999999985 44 69999999999999999985 4 4599999999999999999964  7899999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|+|++|.|.+..|  +..+++|+.|+|++|++++. | .+..+++|..|++++|+...
T Consensus       157 ~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          157 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEEC
T ss_pred             EEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCcC
Confidence            99999999998766  99999999999999999975 3 57889999999999986443

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.58  E-value=4e-15  Score=152.86  Aligned_cols=129  Identities=23%  Similarity=0.270  Sum_probs=102.1

Q ss_pred             CCEEEcCCCcccc---------cCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCC
Q 043586            8 LIELDVGSNSLIG---------PIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMK   78 (397)
Q Consensus         8 L~~L~L~~n~l~~---------~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~   78 (397)
                      |+.++|+.|.|.+         ..|..|..+++|+.|+|++|.+. .+|..+..+++|++|+|++|.|+ .+|..|++++
T Consensus       193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~  270 (727)
T 4b8c_D          193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS  270 (727)
T ss_dssp             -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred             hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence            3445555554433         45788999999999999999998 78888889999999999999999 8999999999


Q ss_pred             CCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           79 NLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      +|+.|+|++|.|+ .+|..|+.|++|+.|+|++|.|+ .+|..+..+++|..|+|++|....
T Consensus       271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~  330 (727)
T 4b8c_D          271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEK  330 (727)
T ss_dssp             TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCS
T ss_pred             CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCC
Confidence            9999999999999 67999999999999999999998 567779999999999999998653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.56  E-value=4.6e-15  Score=139.25  Aligned_cols=133  Identities=20%  Similarity=0.135  Sum_probs=107.2

Q ss_pred             CEEEcCCC-cccccCCccccCCCCCCEEeccC-CcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            9 IELDVGSN-SLIGPIPSTLGLLTDLSYLDLSR-NQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         9 ~~L~L~~n-~l~~~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      ..++++++ +|+ .+|. |..+++|+.|+|++ |.|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            46799998 888 5788 99999999999996 99998888899999999999999999999889999999999999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCcCCCCc
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGLCGNFS  144 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~c~~~~  144 (397)
                      +|+|++..+..+..++ |+.|+|++|++..... .++..+.......+..+...|..+.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            9999987777777666 9999999999985432 1222222222334445666776544

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.56  E-value=9.2e-15  Score=142.88  Aligned_cols=128  Identities=34%  Similarity=0.457  Sum_probs=88.0

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|+.|+|++|.+++..|  +..+++|+.|++++|.+++..|  +..+++|+.|+|++|++++..|  +..+++|+
T Consensus       239 l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~  312 (466)
T 1o6v_A          239 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLT  312 (466)
T ss_dssp             GGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCS
T ss_pred             hhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCC
Confidence            3456777888888887775444  7777777777777777775433  6677777777777777775333  66777777


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      .|++++|++++..|  +..+++|+.|++++|++++.  ..+..+++|+.+++++|...
T Consensus       313 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~  366 (466)
T 1o6v_A          313 YLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQIS  366 (466)
T ss_dssp             EEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred             EEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccC
Confidence            77777777776554  56677777777777777755  24566667777777766543

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.56  E-value=1.9e-15  Score=140.10  Aligned_cols=125  Identities=23%  Similarity=0.214  Sum_probs=99.8

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+++|++|+|++|++++..|..|..+++|+.|+|++|.+++..|  +..+++|++|+|++|++++ +|    .+++|+.|
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L  104 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETL  104 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEE
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEE
Confidence            45689999999999998777889999999999999999986655  8889999999999999984 33    23678888


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++++|.+++..+..   +++|+.|++++|++++..+..+..+++|+.+++++|..
T Consensus       105 ~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  156 (317)
T 3o53_A          105 HAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEI  156 (317)
T ss_dssp             ECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCC
T ss_pred             ECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCC
Confidence            88888887655433   56788888888888877777777777888888877753

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.56  E-value=7.9e-15  Score=123.91  Aligned_cols=106  Identities=24%  Similarity=0.259  Sum_probs=94.9

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCCh--hhcCCCCCcEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPS--QIASMKNLTWL   83 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L   83 (397)
                      ++|++|+|++|.+++.  ..|..+++|+.|+|++|++++..|..+..+++|++|+|++|+++ .+|.  .+..+++|+.|
T Consensus        42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L  118 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL  118 (176)
T ss_dssp             TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred             CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence            4999999999999965  67999999999999999999766666799999999999999998 5776  89999999999


Q ss_pred             EccCcccccCCch----hhccCCCCceeeccCCcCC
Q 043586           84 DISNNKIEGSIPG----EITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        84 ~l~~N~~~~~~p~----~~~~~~~L~~l~l~~n~l~  115 (397)
                      ++++|++.. .|.    .+..+++|+.|+++.|.+.
T Consensus       119 ~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          119 CILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             ECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            999999985 565    4899999999999999765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.55  E-value=9.4e-17  Score=138.52  Aligned_cols=132  Identities=28%  Similarity=0.259  Sum_probs=112.3

Q ss_pred             CCCCCCEEEcCCCcccccCCc------cccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCC
Q 043586            4 NLKNLIELDVGSNSLIGPIPS------TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASM   77 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~------~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l   77 (397)
                      ...+++.++++.|.+++..|.      .|..+++|+.|+|++|.+++ +| .+..+++|++|+|++|.++ .+|..+..+
T Consensus        16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~   92 (198)
T 1ds9_A           16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVA   92 (198)
T ss_dssp             HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred             hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence            346778888888888888776      89999999999999999986 67 8999999999999999999 688888888


Q ss_pred             CCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCcC
Q 043586           78 KNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        78 ~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      ++|+.|++++|++++ +| .+..+++|+.|++++|++++..+ ..+..+++|+.+++++|+..|
T Consensus        93 ~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~  154 (198)
T 1ds9_A           93 DTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred             CcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccc
Confidence            999999999999986 45 68889999999999999986543 467788899999999986443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.54  E-value=2.2e-14  Score=140.16  Aligned_cols=128  Identities=36%  Similarity=0.460  Sum_probs=109.1

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      +.+++|+.|+|++|++.+.  +.+..+++|+.|++++|.+++..|  +..+++|+.|++++|.+++. |. +..+++|+.
T Consensus       218 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~  291 (466)
T 1o6v_A          218 GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTN  291 (466)
T ss_dssp             GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSE
T ss_pred             cccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCe
Confidence            5678999999999998853  468889999999999999986554  88899999999999999964 44 889999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      |++++|++.+..+  +..+++|+.|++++|++++..|  +..+++|+.+++++|....
T Consensus       292 L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~  345 (466)
T 1o6v_A          292 LELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD  345 (466)
T ss_dssp             EECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             EEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence            9999999987554  8889999999999999998776  6788999999999986544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=8.6e-17  Score=138.79  Aligned_cols=125  Identities=26%  Similarity=0.296  Sum_probs=109.4

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      +++++|++|+|++|++++ +| .+..+++|+.|++++|.++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.
T Consensus        45 ~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~  119 (198)
T 1ds9_A           45 STLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRV  119 (198)
T ss_dssp             HHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSE
T ss_pred             hcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCE
Confidence            457899999999999996 77 8999999999999999998 688888889999999999999996 55 6899999999


Q ss_pred             EEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCCCC----------cccccccceec
Q 043586           83 LDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVPFS----------NEQLSSMYIVR  132 (397)
Q Consensus        83 L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~~~----------~~~l~~l~~l~  132 (397)
                      |++++|++++..+ ..+..+++|+.|++++|++++.+|..          +..+++|+.++
T Consensus       120 L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld  180 (198)
T 1ds9_A          120 LYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             EEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred             EECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence            9999999986433 57899999999999999998776653          66777887765

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.54  E-value=1.5e-14  Score=135.63  Aligned_cols=125  Identities=30%  Similarity=0.490  Sum_probs=68.6

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++++|++|++++|.+.+..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++ +|. +..+++|+.
T Consensus       174 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~  247 (347)
T 4fmz_A          174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTW  247 (347)
T ss_dssp             GGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCE
T ss_pred             ccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCE
Confidence            456677777777777664322  5556666666666666653322  5555556666666665553 222 555555555


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      |++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|+.+++++|.
T Consensus       248 L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~  298 (347)
T 4fmz_A          248 LEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ  298 (347)
T ss_dssp             EECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             EECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence            55555555532  2355555555555555555543  234445555555555554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.53  E-value=2.4e-15  Score=140.36  Aligned_cols=134  Identities=19%  Similarity=0.219  Sum_probs=80.1

Q ss_pred             CCCCCCEEEcCCCccccc-CCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCc-cCCCc-CChhhcCCCCC
Q 043586            4 NLKNLIELDVGSNSLIGP-IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN-KLSGK-IPSQIASMKNL   80 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L   80 (397)
                      ++++|++|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+..+++|
T Consensus        91 ~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L  170 (336)
T 2ast_B           91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  170 (336)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCC
Confidence            456666666666666544 5666666666666666666666556666666666666666666 45542 45556666666


Q ss_pred             cEEEccCc-ccccC-CchhhccCC-CCceeeccCC--cCC-CCCCCCcccccccceeccCCCC
Q 043586           81 TWLDISNN-KIEGS-IPGEITELS-RLDYLNLSSN--KLS-GPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        81 ~~L~l~~N-~~~~~-~p~~~~~~~-~L~~l~l~~n--~l~-~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +.|++++| .+++. ++..+..++ +|+.|++++|  .++ +.+|..+..+++|+.+++++|.
T Consensus       171 ~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~  233 (336)
T 2ast_B          171 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV  233 (336)
T ss_dssp             CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred             CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence            66666666 55543 355556666 6666666666  333 2233444455566666666554

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.49  E-value=2.5e-15  Score=140.25  Aligned_cols=131  Identities=23%  Similarity=0.246  Sum_probs=106.4

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCccccc-CchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSS-IPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      ++++.|++++|.+.+..+. +..+++|+.|++++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|+.|+
T Consensus        70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~  148 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN  148 (336)
T ss_dssp             TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred             ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence            6788899999888876665 55788999999999988765 777888888999999999988877888888888999999


Q ss_pred             ccCc-ccccC-CchhhccCCCCceeeccCC-cCCCC-CCCCccccc-ccceeccCCCC
Q 043586           85 ISNN-KIEGS-IPGEITELSRLDYLNLSSN-KLSGP-VPFSNEQLS-SMYIVRLSPNK  137 (397)
Q Consensus        85 l~~N-~~~~~-~p~~~~~~~~L~~l~l~~n-~l~~~-~~~~~~~l~-~l~~l~l~~n~  137 (397)
                      +++| .+++. ++..+..+++|+.|++++| .+++. ++..+..++ +|+.+++++|.
T Consensus       149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~  206 (336)
T 2ast_B          149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYR  206 (336)
T ss_dssp             CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCG
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCc
Confidence            9988 57652 6667888889999999988 88753 455567788 88888888874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=1.3e-13  Score=124.13  Aligned_cols=149  Identities=14%  Similarity=0.079  Sum_probs=115.6

Q ss_pred             HHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCC
Q 043586          213 DLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRK  291 (397)
Q Consensus       213 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  291 (397)
                      .+....++|++....+.|+.+.||++... ++.+++|.........   ...+.+|+++++.+. +..+.++++++...+
T Consensus         8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~   83 (263)
T 3tm0_A            8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG   83 (263)
T ss_dssp             HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred             HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence            34456678988888888889999999864 6789999987532111   135778999999985 677889999999999


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------------------------------  340 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------  340 (397)
                      ..|+||||++|.++.+.+..        ......++.++++++..||..                               
T Consensus        84 ~~~lv~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             ceEEEEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            99999999999988765321        122346788999999999971                               


Q ss_pred             -------------------------CCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          341 -------------------------CSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       341 -------------------------~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                                               ....++|+|++|.||+++++..+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                     014589999999999998766667999998864

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.49  E-value=3.4e-15  Score=142.29  Aligned_cols=137  Identities=22%  Similarity=0.221  Sum_probs=96.4

Q ss_pred             CCCCCCCCEEEcCCC---cccccCCccc-------cCCCCCCEEeccCCcccc----cCchhhhhcccCCeEeccCccCC
Q 043586            2 IGNLKNLIELDVGSN---SLIGPIPSTL-------GLLTDLSYLDLSRNQFNS----SIPNELTWLTGLLGLNLSSNKLS   67 (397)
Q Consensus         2 l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~   67 (397)
                      +.++++|++|+|++|   ++++.+|..+       ..+++|+.|+|++|.+++    .+|..+..+++|++|+|++|.++
T Consensus        56 l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~  135 (386)
T 2ca6_A           56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG  135 (386)
T ss_dssp             TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCC
Confidence            557788888888885   4445556544       677888888888888876    46777778888888888888876


Q ss_pred             CcCChhhcC----C---------CCCcEEEccCcccc-cCCc---hhhccCCCCceeeccCCcCC--C---CCCCCcccc
Q 043586           68 GKIPSQIAS----M---------KNLTWLDISNNKIE-GSIP---GEITELSRLDYLNLSSNKLS--G---PVPFSNEQL  125 (397)
Q Consensus        68 ~~~p~~~~~----l---------~~L~~L~l~~N~~~-~~~p---~~~~~~~~L~~l~l~~n~l~--~---~~~~~~~~l  125 (397)
                      +..+..+..    +         ++|+.|++++|++. +..|   ..+..+++|+.|++++|.++  |   ..|..+..+
T Consensus       136 ~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~  215 (386)
T 2ca6_A          136 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC  215 (386)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred             HHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence            444433333    3         77888888888876 3344   45667778888888888776  2   344466677


Q ss_pred             cccceeccCCCCC
Q 043586          126 SSMYIVRLSPNKG  138 (397)
Q Consensus       126 ~~l~~l~l~~n~~  138 (397)
                      ++|+.|++++|..
T Consensus       216 ~~L~~L~Ls~n~l  228 (386)
T 2ca6_A          216 QELKVLDLQDNTF  228 (386)
T ss_dssp             TTCCEEECCSSCC
T ss_pred             CCccEEECcCCCC
Confidence            7778888877764

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.48  E-value=2.3e-13  Score=132.41  Aligned_cols=125  Identities=25%  Similarity=0.231  Sum_probs=92.5

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|+|++|++++. +  ++.+++|+.|++++|...+.+  .+..+++|++|++++|++++ +|  +..+++|+
T Consensus       123 ~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~  194 (457)
T 3bz5_A          123 VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLN  194 (457)
T ss_dssp             CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCC
T ss_pred             CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCC
Confidence            56788888899988888863 3  777888888888888554455  36677888888888888885 45  67777788


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|++++|.+++.   .++.+++|+.|++++|++++. |  +..+++|+.+++++|....
T Consensus       195 ~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~i-p--~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          195 RLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEI-D--VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             EEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC
T ss_pred             EEECcCCcCCee---ccccCCCCCEEECcCCccccc-C--ccccCCCCEEEeeCCcCCC
Confidence            888888887764   367777788888888887763 4  5667777777777776443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.48  E-value=8e-14  Score=139.02  Aligned_cols=105  Identities=22%  Similarity=0.245  Sum_probs=94.6

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcC-ChhhcCCCCC
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI-PSQIASMKNL   80 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L   80 (397)
                      +++|++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .++.+++|+.|+|++|+|++.. |..++.+++|
T Consensus       459 ~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L  535 (567)
T 1dce_A          459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL  535 (567)
T ss_dssp             GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCC
Confidence            567889999999999999 789999999999999999999996 77 8999999999999999999876 9999999999


Q ss_pred             cEEEccCcccccCCch---hhccCCCCceeec
Q 043586           81 TWLDISNNKIEGSIPG---EITELSRLDYLNL  109 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~---~~~~~~~L~~l~l  109 (397)
                      +.|+|++|++++.+|.   .+..+++|+.|++
T Consensus       536 ~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          536 VLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             CEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            9999999999987653   2455899999864

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.47  E-value=3.4e-13  Score=131.27  Aligned_cols=125  Identities=26%  Similarity=0.292  Sum_probs=106.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|+|++|++++ +|  ++.+++|+.|++++|++++ +|  +..+++|++|++++|...+.+  .+..+++|+
T Consensus       102 ~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~  173 (457)
T 3bz5_A          102 VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT  173 (457)
T ss_dssp             CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred             cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence            5788999999999999986 44  8899999999999999986 44  888999999999999655566  478899999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      .|++++|.+++ +|  ++.+++|+.|++++|.+++.   .+..+++|+.+++++|....
T Consensus       174 ~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~  226 (457)
T 3bz5_A          174 TLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE  226 (457)
T ss_dssp             EEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred             EEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence            99999999987 45  88899999999999999976   37788999999999987554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.47  E-value=8.7e-14  Score=130.53  Aligned_cols=106  Identities=25%  Similarity=0.218  Sum_probs=96.9

Q ss_pred             CEEeccCC-cccccCchhhhhcccCCeEeccC-ccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeecc
Q 043586           33 SYLDLSRN-QFNSSIPNELTWLTGLLGLNLSS-NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLS  110 (397)
Q Consensus        33 ~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~  110 (397)
                      ..+++++| .|+ .+|. +..+++|+.|+|++ |+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35799998 898 5787 99999999999996 99998777899999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586          111 SNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus       111 ~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+|++.++..+..+. |+.|++.+|+..|.
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~  118 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHCS  118 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccCC
Confidence            9999988888887776 99999999998874

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.46  E-value=2.1e-14  Score=136.77  Aligned_cols=137  Identities=18%  Similarity=0.201  Sum_probs=106.4

Q ss_pred             CCCCCCCEEEcCCCccccc----CCccccCCCCCCEEeccCC---cccccCchhh-------hhcccCCeEeccCccCCC
Q 043586            3 GNLKNLIELDVGSNSLIGP----IPSTLGLLTDLSYLDLSRN---QFNSSIPNEL-------TWLTGLLGLNLSSNKLSG   68 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N---~l~~~~p~~~-------~~l~~L~~L~l~~N~l~~   68 (397)
                      ..+++|+.|+|++|.+++.    ++..|..+++|+.|+|++|   ++++.+|..+       ..+++|++|+|++|.+++
T Consensus        29 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~  108 (386)
T 2ca6_A           29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP  108 (386)
T ss_dssp             HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred             hcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence            3568899999999998765    3445778999999999985   4555666655       578899999999999997


Q ss_pred             ----cCChhhcCCCCCcEEEccCcccccCCchhhc----cC---------CCCceeeccCCcCC-CCCC---CCcccccc
Q 043586           69 ----KIPSQIASMKNLTWLDISNNKIEGSIPGEIT----EL---------SRLDYLNLSSNKLS-GPVP---FSNEQLSS  127 (397)
Q Consensus        69 ----~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~----~~---------~~L~~l~l~~n~l~-~~~~---~~~~~l~~  127 (397)
                          .+|..+..+++|+.|+|++|.+....+..+.    .+         ++|+.|++++|+++ +.++   ..+..+++
T Consensus       109 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~  188 (386)
T 2ca6_A          109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL  188 (386)
T ss_dssp             TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred             HHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC
Confidence                4788888999999999999998754444443    33         89999999999987 3344   35567788


Q ss_pred             cceeccCCCCCc
Q 043586          128 MYIVRLSPNKGL  139 (397)
Q Consensus       128 l~~l~l~~n~~~  139 (397)
                      |+.+++++|...
T Consensus       189 L~~L~L~~n~l~  200 (386)
T 2ca6_A          189 LHTVKMVQNGIR  200 (386)
T ss_dssp             CCEEECCSSCCC
T ss_pred             cCEEECcCCCCC
Confidence            999999988643

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.46  E-value=1.7e-13  Score=136.22  Aligned_cols=95  Identities=29%  Similarity=0.404  Sum_probs=46.9

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++|++|+|++|+|++ +|. +..  +|+.|+|++|.|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+
T Consensus        99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  166 (571)
T 3cvr_A           99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS  166 (571)
T ss_dssp             CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence            4566666666666664 444 433  55566666655554 333   34455555555555553 333   334444444


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      +++|.|++ +|. +.  ++|+.|++++|.|+
T Consensus       167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLE  193 (571)
T ss_dssp             CCSSCCSC-CCC-CC--TTCCEEECCSSCCS
T ss_pred             CCCCCCCC-cch-hh--CCCCEEECcCCCCC
Confidence            44444443 333 22  34444444444444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.45  E-value=1.5e-14  Score=136.72  Aligned_cols=136  Identities=22%  Similarity=0.221  Sum_probs=107.0

Q ss_pred             CCCCCCEEEcCCCcccccCC----ccccCCC-CCCEEeccCCcccccCchhhhhc-----ccCCeEeccCccCCCcCChh
Q 043586            4 NLKNLIELDVGSNSLIGPIP----STLGLLT-DLSYLDLSRNQFNSSIPNELTWL-----TGLLGLNLSSNKLSGKIPSQ   73 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~p~~   73 (397)
                      ..++|++|+|++|.+++..+    ..|..++ +|+.|+|++|.+++..+..+..+     ++|++|+|++|++++..+..
T Consensus        20 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~   99 (362)
T 3goz_A           20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDE   99 (362)
T ss_dssp             SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH
T ss_pred             CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHH
Confidence            34569999999999987666    7788888 89999999999988878888876     89999999999999777765


Q ss_pred             hcCC-----CCCcEEEccCcccccCCchhhcc-----CCCCceeeccCCcCCCCCCC----Cccccc-ccceeccCCCCC
Q 043586           74 IASM-----KNLTWLDISNNKIEGSIPGEITE-----LSRLDYLNLSSNKLSGPVPF----SNEQLS-SMYIVRLSPNKG  138 (397)
Q Consensus        74 ~~~l-----~~L~~L~l~~N~~~~~~p~~~~~-----~~~L~~l~l~~n~l~~~~~~----~~~~l~-~l~~l~l~~n~~  138 (397)
                      +...     ++|+.|++++|.+++..+..+..     .++|+.|++++|.++.....    .+..+. +|+.+++++|..
T Consensus       100 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l  179 (362)
T 3goz_A          100 LVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL  179 (362)
T ss_dssp             HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCG
T ss_pred             HHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCC
Confidence            5443     88999999999998777666544     36899999999998853322    223343 788899988864


Q ss_pred             c
Q 043586          139 L  139 (397)
Q Consensus       139 ~  139 (397)
                      .
T Consensus       180 ~  180 (362)
T 3goz_A          180 A  180 (362)
T ss_dssp             G
T ss_pred             c
Confidence            3

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.45  E-value=2.7e-14  Score=134.93  Aligned_cols=127  Identities=22%  Similarity=0.231  Sum_probs=64.2

Q ss_pred             EEcCCCcccccCCccccCCCCCCEEeccCCcccccCc----hhhhhcc-cCCeEeccCccCCCcCChhhcCC-----CCC
Q 043586           11 LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP----NELTWLT-GLLGLNLSSNKLSGKIPSQIASM-----KNL   80 (397)
Q Consensus        11 L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~L   80 (397)
                      ++|+.|++++.+|..+...++|+.|+|++|.+++..+    ..+..++ +|++|+|++|++++..+..+..+     ++|
T Consensus         3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            4555555555555555444455555555555554444    4444454 55555555555554445444443     555


Q ss_pred             cEEEccCcccccCCchhhccC-----CCCceeeccCCcCCCCCCCCccc-----ccccceeccCCCC
Q 043586           81 TWLDISNNKIEGSIPGEITEL-----SRLDYLNLSSNKLSGPVPFSNEQ-----LSSMYIVRLSPNK  137 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~-----~~L~~l~l~~n~l~~~~~~~~~~-----l~~l~~l~l~~n~  137 (397)
                      +.|++++|.+++..+..+...     ++|+.|++++|.+++..+..+..     .++|+.+++++|.
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~  149 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGND  149 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSC
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCc
Confidence            555555555554444433332     45555555555555443322221     1355555555554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.44  E-value=4.1e-13  Score=133.53  Aligned_cols=112  Identities=27%  Similarity=0.443  Sum_probs=57.1

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|+|+ .+|   ..+++|+.|+|++|.|++ +|. +..  +|++|+|++|+|++ +|.   .+++|+.|++
T Consensus        80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L  147 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA  147 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred             CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence            34555555555555 344   334555555555555554 444 433  55555555555553 444   3455555555


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      ++|.|++ +|.   .+++|+.|++++|++++. |. +.  ++|..|++++|.
T Consensus       148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~l-p~-l~--~~L~~L~Ls~N~  191 (571)
T 3cvr_A          148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFL-PE-LP--ESLEALDVSTNL  191 (571)
T ss_dssp             CSSCCSC-CCC---CCTTCCEEECCSSCCSCC-CC-CC--TTCCEEECCSSC
T ss_pred             CCCccCc-CCC---cCCCcCEEECCCCCCCCc-ch-hh--CCCCEEECcCCC
Confidence            5555554 333   345555555555555542 22 22  445555555543

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.43  E-value=1.8e-13  Score=128.56  Aligned_cols=132  Identities=22%  Similarity=0.139  Sum_probs=89.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCc-hhhhhcccCCe-EeccCccCCCcCChhhcCCCCCcEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP-NELTWLTGLLG-LNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      +++++|+|++|+|+...+..|.++++|+.|+|++|++.+.+| ..|.++++|++ +.++.|++++..|..|..+++|+.|
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            467778888888775555567778888888888887755554 35667777664 5556677776667777777778888


Q ss_pred             EccCcccccCCchhhccCCCCceeeccC-CcCCCCCCCCccccc-ccceeccCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSS-NKLSGPVPFSNEQLS-SMYIVRLSPNK  137 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~-n~l~~~~~~~~~~l~-~l~~l~l~~n~  137 (397)
                      ++++|++....+..+....++..|++.+ |.+....+..+..+. .+..+++++|.
T Consensus       110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~  165 (350)
T 4ay9_X          110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG  165 (350)
T ss_dssp             EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred             cccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccc
Confidence            8888877766666666666667777754 455555555555553 45667777764

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.38  E-value=1.8e-12  Score=125.98  Aligned_cols=119  Identities=22%  Similarity=0.278  Sum_probs=70.6

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|++++ +| .|+.+++|+.|++++|++++ +|..+   .+|++|++++|++++ +| .++++++|+.|++
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            456666666666664 55 36666666666666666653 44322   356666666666664 44 4666666666666


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++|.+++ +|..   .++|+.|++++|.++ .+| .+..+++|+.+++++|..
T Consensus       203 ~~N~l~~-l~~~---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l  249 (454)
T 1jl5_A          203 DNNSLKK-LPDL---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLL  249 (454)
T ss_dssp             CSSCCSS-CCCC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCC
T ss_pred             CCCcCCc-CCCC---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcC
Confidence            6666664 3322   135666666666666 334 256666677777776643

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.36  E-value=3.2e-12  Score=124.26  Aligned_cols=122  Identities=26%  Similarity=0.316  Sum_probs=97.8

Q ss_pred             CCCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCC
Q 043586            1 EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL   80 (397)
Q Consensus         1 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   80 (397)
                      +++++++|++|++++|++++ +|..+   .+|+.|++++|.+++ +| .+..+++|++|++++|++++ +|...   ++|
T Consensus       148 ~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L  217 (454)
T 1jl5_A          148 ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSL  217 (454)
T ss_dssp             CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTC
T ss_pred             ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---Ccc
Confidence            36788999999999999985 66543   589999999999986 66 58899999999999999995 55533   578


Q ss_pred             cEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           81 TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        81 ~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +.|++++|.++ .+|. ++.+++|+.|++++|++++. |..   +++++.+++++|..
T Consensus       218 ~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l  269 (454)
T 1jl5_A          218 ESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYL  269 (454)
T ss_dssp             CEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCC
T ss_pred             cEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcc
Confidence            99999999988 5664 88899999999999998864 332   36777788887753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.36  E-value=2.4e-12  Score=129.49  Aligned_cols=77  Identities=32%  Similarity=0.330  Sum_probs=53.1

Q ss_pred             ccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceecc
Q 043586           54 TGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRL  133 (397)
Q Consensus        54 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l  133 (397)
                      ++|+.|+|++|+|++ +|   ..+++|+.|++++|.|+. +|.   .+++|+.|++++|+|+ .+|..+..+++|..+++
T Consensus       221 ~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L  291 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  291 (622)
T ss_dssp             TTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEEC
T ss_pred             CCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEe
Confidence            556666666666663 44   344667777777777764 443   4567788888888887 45667777888888888


Q ss_pred             CCCCCc
Q 043586          134 SPNKGL  139 (397)
Q Consensus       134 ~~n~~~  139 (397)
                      ++|+..
T Consensus       292 ~~N~l~  297 (622)
T 3g06_A          292 EGNPLS  297 (622)
T ss_dssp             CSCCCC
T ss_pred             cCCCCC
Confidence            887654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.35  E-value=6.8e-14  Score=136.27  Aligned_cols=111  Identities=22%  Similarity=0.172  Sum_probs=52.9

Q ss_pred             CCCCCEEEcCCCcccccC-----CccccCCCCCCEEeccCCccccc----CchhhhhcccCCeEeccCccCCCcCChhhc
Q 043586            5 LKNLIELDVGSNSLIGPI-----PSTLGLLTDLSYLDLSRNQFNSS----IPNELTWLTGLLGLNLSSNKLSGKIPSQIA   75 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~-----p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~   75 (397)
                      +++|++|+|++|.+++..     +..+..+++|+.|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+.
T Consensus       226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  305 (461)
T 1z7x_W          226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC  305 (461)
T ss_dssp             CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred             CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence            455566666666554321     22222455555555555555532    344444555555555555555433333332


Q ss_pred             CC-----CCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCC
Q 043586           76 SM-----KNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        76 ~l-----~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      ..     ++|+.|++++|.+++.    ++..+..+++|+.|++++|.++
T Consensus       306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~  354 (461)
T 1z7x_W          306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLE  354 (461)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCH
T ss_pred             HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccc
Confidence            21     3455555555554433    2333444455555555555444

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=3.2e-12  Score=114.48  Aligned_cols=139  Identities=17%  Similarity=0.143  Sum_probs=101.9

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC--ccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv  296 (397)
                      .+|.+....+.|..+.||++...+|+.+++|.......      ..+.+|+.+++.+.+.+  +.+++++...++..++|
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            34544333345666999999887788899999765421      35677999999996544  56688888888889999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------------  341 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------------  341 (397)
                      |||++|.++.  ...      .+   ...++.++++.+..||...                                   
T Consensus        94 ~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           94 LGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999998883  211      11   1246778888888888531                                   


Q ss_pred             --------------------CCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          342 --------------------SPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       342 --------------------~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                                          ...++|+|++|.||+++.++.+.|+|||.+...
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                123999999999999988766779999998643

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.35  E-value=1.1e-12  Score=123.23  Aligned_cols=135  Identities=20%  Similarity=0.135  Sum_probs=71.1

Q ss_pred             CCCCCCCCE-EEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccC-ccCCCcCChhhcCCC-
Q 043586            2 IGNLKNLIE-LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS-NKLSGKIPSQIASMK-   78 (397)
Q Consensus         2 l~~l~~L~~-L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~-   78 (397)
                      +.++++|.. +++++|+|+...|..|..+++|+.|++++|.+++..+..+....++..|++.+ |+++...+..|..+. 
T Consensus        75 f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~  154 (350)
T 4ay9_X           75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF  154 (350)
T ss_dssp             BCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBS
T ss_pred             hhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcch
Confidence            356666654 56677888877778888888888888888888755554444444444444433 334433333333332 


Q ss_pred             CCcEEEccCcccccCCchhhccCCCCceeeccC-CcCCCCCCCCcccccccceeccCCCC
Q 043586           79 NLTWLDISNNKIEGSIPGEITELSRLDYLNLSS-NKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        79 ~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~-n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .++.|++++|+|+.+.+ ......+|+.|++++ |.++..++.+|..+++|+.+++++|.
T Consensus       155 ~l~~L~L~~N~i~~i~~-~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~  213 (350)
T 4ay9_X          155 ESVILWLNKNGIQEIHN-SAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR  213 (350)
T ss_dssp             SCEEEECCSSCCCEECT-TSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSC
T ss_pred             hhhhhccccccccCCCh-hhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCC
Confidence            24445555555443222 222233444444432 33433333344444444444444443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.30  E-value=1.3e-11  Score=116.20  Aligned_cols=143  Identities=19%  Similarity=0.277  Sum_probs=106.3

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEec--ccchHHHHHHHHHHHHHHHHhhcc--cCCccceeeEEeeC---CEeeE
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLH--TSETEELAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHR---KCMFL  295 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~l  295 (397)
                      ..+.++.|.++.||+.+..+ ..+++|+..  ......  ....+.+|..+++.+.  +..+++++.++.+.   +..|+
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~--~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLP--SAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCC--cHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            35678999999999998764 678889876  332111  1246778999999997  45678899988776   45899


Q ss_pred             EEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 043586          296 IYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC----------------------------------  341 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  341 (397)
                      ||||++|..+.+...     ..++..+...++.++++.|..||...                                  
T Consensus       119 vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          119 IMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             EEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             EEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            999999987754221     13567778889999999999999620                                  


Q ss_pred             ---------------------CCCeEEcCCCCCCEEeCCCCC--eEEeccccccc
Q 043586          342 ---------------------SPSIIHRDISSNNILLNSKFE--AFVADFGTARL  373 (397)
Q Consensus       342 ---------------------~~~ivH~dlkp~NIll~~~~~--~kl~DFG~a~~  373 (397)
                                           ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 257999999999999997753  68999999874

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.23  E-value=1.4e-12  Score=126.91  Aligned_cols=111  Identities=20%  Similarity=0.177  Sum_probs=48.7

Q ss_pred             CCCCCEEEcCCCcccccCCccc-cCCC----CCCEEeccCCcccc----cCchhhhhcccCCeEeccCccCCCcCChhhc
Q 043586            5 LKNLIELDVGSNSLIGPIPSTL-GLLT----DLSYLDLSRNQFNS----SIPNELTWLTGLLGLNLSSNKLSGKIPSQIA   75 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l-~~l~----~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~   75 (397)
                      +++|++|+|++|.+++..+..+ ..++    +|+.|+|++|.++.    .+|..+..+++|++|+|++|.+++..+..+.
T Consensus        55 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~  134 (461)
T 1z7x_W           55 NPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC  134 (461)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH
T ss_pred             CCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHH
Confidence            4555555555555543222211 2222    35555555555542    2344445555555555555554432222222


Q ss_pred             C-----CCCCcEEEccCcccccCC----chhhccCCCCceeeccCCcCC
Q 043586           76 S-----MKNLTWLDISNNKIEGSI----PGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        76 ~-----l~~L~~L~l~~N~~~~~~----p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      .     .++|+.|++++|.+++..    +..+..+++|+.|++++|.++
T Consensus       135 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  183 (461)
T 1z7x_W          135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN  183 (461)
T ss_dssp             HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcc
Confidence            1     233555555555444322    333334444444444444443

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.23  E-value=3.5e-11  Score=120.98  Aligned_cols=94  Identities=32%  Similarity=0.450  Sum_probs=45.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      ++|++|+|++|+|+ .+|.   .+++|+.|+|++|+++ .+|.   .+++|++|+|++|++++ +|.   .+++|+.|++
T Consensus        61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L  128 (622)
T 3g06_A           61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWI  128 (622)
T ss_dssp             TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEEC
T ss_pred             CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEEC
Confidence            34566666666655 3343   3455666666666655 2333   34555555555555553 333   2334444444


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      ++|++++ +|..   +++|+.|++++|+++
T Consensus       129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~  154 (622)
T 3g06_A          129 FGNQLTS-LPVL---PPGLQELSVSDNQLA  154 (622)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred             CCCCCCc-CCCC---CCCCCEEECcCCcCC
Confidence            4444443 2221   244444444444444

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.23  E-value=2.5e-11  Score=112.92  Aligned_cols=141  Identities=12%  Similarity=0.093  Sum_probs=108.8

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhh---------------------------------
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELT---------------------------------   51 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~---------------------------------   51 (397)
                      +++|+.|+|.+ +++...+.+|.++++|+.|++++|.+....+..|.                                 
T Consensus       100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            78899999988 78766777899999999999988875321111110                                 


Q ss_pred             ---------------------------------------------hcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586           52 ---------------------------------------------WLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus        52 ---------------------------------------------~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                                                                   .+++|+.|+|++|+++...+.+|.+|++|+.+++.
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~  258 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP  258 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence                                                         26789999999999997677789999999999999


Q ss_pred             CcccccCCchhhccCCCCc-eeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCCcCCCC
Q 043586           87 NNKIEGSIPGEITELSRLD-YLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPS  148 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~-~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~~~~~~  148 (397)
                      +| +..+.+.+|..|.+|+ .+++.+ .++...+.+|.++++|+.+++++|........+...
T Consensus       259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~  319 (329)
T 3sb4_A          259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGN  319 (329)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCT
T ss_pred             cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcC
Confidence            98 7777788899999999 999988 777777889999999999999877654444333333

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.19  E-value=5.8e-11  Score=110.40  Aligned_cols=102  Identities=15%  Similarity=0.115  Sum_probs=92.7

Q ss_pred             CCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc-EEEccCcccccCCchhhccCCCCcee
Q 043586           29 LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT-WLDISNNKIEGSIPGEITELSRLDYL  107 (397)
Q Consensus        29 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~-~L~l~~N~~~~~~p~~~~~~~~L~~l  107 (397)
                      +++|+.|+|++|.++...+..|.++.+|+.|+|++| ++.+.+.+|.+|++|+ .+++.+ .++.+.+.+|..|++|+.+
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            679999999999999777778999999999999999 8867788899999999 999999 7877788999999999999


Q ss_pred             eccCCcCCCCCCCCcccccccceec
Q 043586          108 NLSSNKLSGPVPFSNEQLSSMYIVR  132 (397)
Q Consensus       108 ~l~~n~l~~~~~~~~~~l~~l~~l~  132 (397)
                      +++.|.++...+.+|.++++|+.+.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             EeCCCccCccchhhhcCCcchhhhc
Confidence            9999999988888999998888765

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.11  E-value=2.8e-12  Score=121.24  Aligned_cols=132  Identities=19%  Similarity=0.205  Sum_probs=61.4

Q ss_pred             CCCCEEEcCCCcccccCCccc-cCCCCCCEEeccCCcccccCchhhh-----hcccCCeEeccCccCCC----cCChhhc
Q 043586            6 KNLIELDVGSNSLIGPIPSTL-GLLTDLSYLDLSRNQFNSSIPNELT-----WLTGLLGLNLSSNKLSG----KIPSQIA   75 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~----~~p~~~~   75 (397)
                      ++|++|+|++|.++......+ ..+++|+.|+|++|.++......+.     ..++|++|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            345555555555542211111 2234555555555555433222221     23455555555555542    1233334


Q ss_pred             CCCCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCCC----CCCCcccccccceeccCCCC
Q 043586           76 SMKNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSGP----VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        76 ~l~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .+++|+.|+|++|.|...    ++..+..+++|+.|+|++|.++..    +...+...++|..+++++|.
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~  250 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNE  250 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSS
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCC
Confidence            455566666666655432    133444555566666666655432    11222234555556666553

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.03  E-value=9.2e-12  Score=117.69  Aligned_cols=133  Identities=15%  Similarity=0.150  Sum_probs=101.5

Q ss_pred             CCCCCEEEcCCCcccccCCccccC-----CCCCCEEeccCCcccccCchhh-hhcccCCeEeccCccCCCcCChhhc---
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGL-----LTDLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLSSNKLSGKIPSQIA---   75 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~-----l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~~~---   75 (397)
                      +++|+.|+|++|.++......+..     .++|+.|+|++|.++......+ ..+.+|+.|+|++|.++......+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            367999999999997644443333     3799999999999975433344 3578999999999999865444443   


Q ss_pred             --CCCCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCCC----CCCCcccccccceeccCCCC
Q 043586           76 --SMKNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSGP----VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        76 --~l~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~l~l~~n~  137 (397)
                        ..++|+.|+|++|.|+..    ++..+..+++|+.|+|++|.++..    +...+...++|+.|++++|.
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~  222 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNG  222 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSC
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCC
Confidence              457899999999999753    345567889999999999998743    23455667789999999985

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.91  E-value=8.9e-10  Score=110.55  Aligned_cols=131  Identities=11%  Similarity=0.026  Sum_probs=58.3

Q ss_pred             CCCCCEEEcCCCccccc----CCccccCCCCCCEEeccCCccc----ccCchhhhhcccCCeEeccCccCCCcCChhhcC
Q 043586            5 LKNLIELDVGSNSLIGP----IPSTLGLLTDLSYLDLSRNQFN----SSIPNELTWLTGLLGLNLSSNKLSGKIPSQIAS   76 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~   76 (397)
                      +++|++|+|++|.+++.    ++..+..+++|+.|++++|.++    +.++..+.++++|+.|+|++|.+++ +|..+.+
T Consensus       163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~  241 (592)
T 3ogk_B          163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA  241 (592)
T ss_dssp             CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred             CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence            34445555555444333    2223334444555555555443    1222233344445555555544442 4444444


Q ss_pred             CCCCcEEEccCcccc---cCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           77 MKNLTWLDISNNKIE---GSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        77 l~~L~~L~l~~N~~~---~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +++|+.|+++++...   ...+..+..+++|+.|+++++.. +.+|..+..+++|+.|++++|.
T Consensus       242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~  304 (592)
T 3ogk_B          242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYAL  304 (592)
T ss_dssp             CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCC
T ss_pred             hhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCc
Confidence            444444444432211   11222334444444444444322 2334445556667777777664

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.91  E-value=7.8e-11  Score=118.29  Aligned_cols=133  Identities=14%  Similarity=0.120  Sum_probs=64.0

Q ss_pred             CCCCCEEEcCCCcccccCCccccC-CCCCCEEecc----CCccccc-----CchhhhhcccCCeEeccCc--cCCCcCCh
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGL-LTDLSYLDLS----RNQFNSS-----IPNELTWLTGLLGLNLSSN--KLSGKIPS   72 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~l~~L~~L~l~~N--~l~~~~p~   72 (397)
                      +++|++|+|+.|++++..+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|+|+.+  .+++..+.
T Consensus       377 ~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~  456 (592)
T 3ogk_B          377 CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS  456 (592)
T ss_dssp             CTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred             CccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence            344444444444444433333333 4455555553    4444432     2222444555555555422  24433333


Q ss_pred             hhcC-CCCCcEEEccCccccc-CCchhhccCCCCceeeccCCcCCCC-CCCCcccccccceeccCCCC
Q 043586           73 QIAS-MKNLTWLDISNNKIEG-SIPGEITELSRLDYLNLSSNKLSGP-VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        73 ~~~~-l~~L~~L~l~~N~~~~-~~p~~~~~~~~L~~l~l~~n~l~~~-~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .+.. +++|+.|++++|.+++ .++..+..+++|+.|++++|.+++. ++.....+++|+.+++++|+
T Consensus       457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~  524 (592)
T 3ogk_B          457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR  524 (592)
T ss_dssp             HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred             HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence            3332 5566666666666554 2333445566666666666665432 22223445666666666664

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.90  E-value=2.7e-10  Score=101.77  Aligned_cols=67  Identities=30%  Similarity=0.453  Sum_probs=37.3

Q ss_pred             hhcccCCeEeccCccCCC--cCChhhcCCCCCcEEEccCcccccCCchhhccCC--CCceeeccCCcCCCCCC
Q 043586           51 TWLTGLLGLNLSSNKLSG--KIPSQIASMKNLTWLDISNNKIEGSIPGEITELS--RLDYLNLSSNKLSGPVP  119 (397)
Q Consensus        51 ~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~--~L~~l~l~~n~l~~~~~  119 (397)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|++++..|
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence            345566666666666665  3345555666666666666666543  2233333  56666666666655443

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.89  E-value=5.6e-10  Score=94.70  Aligned_cols=112  Identities=18%  Similarity=0.178  Sum_probs=60.2

Q ss_pred             CCCCCCEEEcCCC-cccc----cCCccccCCCCCCEEeccCCccccc----CchhhhhcccCCeEeccCccCCCc----C
Q 043586            4 NLKNLIELDVGSN-SLIG----PIPSTLGLLTDLSYLDLSRNQFNSS----IPNELTWLTGLLGLNLSSNKLSGK----I   70 (397)
Q Consensus         4 ~l~~L~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~   70 (397)
                      +.++|++|+|++| .+..    .+...+...++|+.|+|++|.++..    +...+...++|++|+|++|.|+..    +
T Consensus        34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l  113 (185)
T 1io0_A           34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL  113 (185)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence            4456666666666 5542    1334455556666666666666432    223334445666666666666532    2


Q ss_pred             ChhhcCCCCCcEEEc--cCcccccC----CchhhccCCCCceeeccCCcCC
Q 043586           71 PSQIASMKNLTWLDI--SNNKIEGS----IPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        71 p~~~~~l~~L~~L~l--~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      ...+...++|+.|+|  ++|.|...    +...+...+.|+.|++++|.+.
T Consensus       114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            344455556666666  55666432    2233444456666666666543

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.86  E-value=9e-09  Score=94.37  Aligned_cols=137  Identities=23%  Similarity=0.244  Sum_probs=97.7

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCC--ccceeeEEeeCC---EeeEEE
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRN--IVKLYGFCLHRK---CMFLIY  297 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~  297 (397)
                      .+.++.|....||+..    ..+++|+....     .....+.+|.++++.+. +..  +.+++......+   ..|+||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            3568999999999864    46888986543     11356888999999884 333  445555543333   358999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-------------------------------------  340 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------------  340 (397)
                      |+++|.++.+....     .++..+...++.+++..+..||..                                     
T Consensus        96 ~~i~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             ECCCCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cccCCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            99999888643221     255666777888888888888851                                     


Q ss_pred             ------------------CCCCeEEcCCCCCCEEeCC--CCCeEEecccccccc
Q 043586          341 ------------------CSPSIIHRDISSNNILLNS--KFEAFVADFGTARLL  374 (397)
Q Consensus       341 ------------------~~~~ivH~dlkp~NIll~~--~~~~kl~DFG~a~~~  374 (397)
                                        ....++|+|++|.||+++.  +..+.++||+.+...
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                              1245899999999999998  456789999998754

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.81  E-value=8.8e-10  Score=98.44  Aligned_cols=96  Identities=22%  Similarity=0.237  Sum_probs=73.1

Q ss_pred             EEcCCCccc---ccCCccccCCCCCCEEeccCCcccc--cCchhhhhcccCCeEeccCccCCCcCChhhcCCC--CCcEE
Q 043586           11 LDVGSNSLI---GPIPSTLGLLTDLSYLDLSRNQFNS--SIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMK--NLTWL   83 (397)
Q Consensus        11 L~L~~n~l~---~~~p~~l~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~L   83 (397)
                      ++++.|+..   ..++.....+++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|+.|
T Consensus       148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L  225 (267)
T 3rw6_A          148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL  225 (267)
T ss_dssp             CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred             ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence            566667432   2222233568999999999999997  4567788999999999999999964  4455555  89999


Q ss_pred             EccCcccccCCc-------hhhccCCCCceee
Q 043586           84 DISNNKIEGSIP-------GEITELSRLDYLN  108 (397)
Q Consensus        84 ~l~~N~~~~~~p-------~~~~~~~~L~~l~  108 (397)
                      +|++|++.+..|       ..+..+++|+.||
T Consensus       226 ~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD  257 (267)
T 3rw6_A          226 WLDGNSLCDTFRDQSTYISAIRERFPKLLRLD  257 (267)
T ss_dssp             ECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred             EccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence            999999987665       2477888888875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=8.3e-08  Score=88.05  Aligned_cols=137  Identities=18%  Similarity=0.142  Sum_probs=92.5

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccC---CccceeeEEe-eCCEeeEEEee
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR---NIVKLYGFCL-HRKCMFLIYEY  299 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~  299 (397)
                      .+.++.|....||+.    +..+++|+....     .....+.+|.++++.+.+.   .+.+++.++. ..+..++||||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            355788888899988    567888885332     1235788999999999752   3567777764 35567899999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD---------------------------------------  340 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~---------------------------------------  340 (397)
                      ++|..+.+....     .++..+...++.++++.|..||..                                       
T Consensus        95 i~G~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           95 VQGQILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             CCSEECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             cCCeECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            999887652211     123333444444444444444431                                       


Q ss_pred             ------------------CCCCeEEcCCCCCCEEeCC---CCCe-EEecccccccc
Q 043586          341 ------------------CSPSIIHRDISSNNILLNS---KFEA-FVADFGTARLL  374 (397)
Q Consensus       341 ------------------~~~~ivH~dlkp~NIll~~---~~~~-kl~DFG~a~~~  374 (397)
                                        ....++|+|++|.||+++.   ++.+ .|+||+.+...
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                              2346799999999999987   4554 79999988753

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.74  E-value=3.5e-08  Score=93.97  Aligned_cols=130  Identities=11%  Similarity=0.065  Sum_probs=76.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|+.++|++|+++......|. .++|+.+.|..| ++..-+..|.++++|+.+++..| ++..-..+|.+ .+|+
T Consensus       176 F~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~  251 (401)
T 4fdw_A          176 FYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGIT  251 (401)
T ss_dssp             TTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCS
T ss_pred             hhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCcc
Confidence            34556666666666666544344444 355666666533 44344456666666666666654 34333444444 4566


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCC-----CCCCCCcccccccceeccCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS-----GPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~-----~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      .+.+ .|.++.+.+.+|..|++|+.+++.+|.+.     ...+.+|.++.+|+.+.+.++
T Consensus       252 ~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~~  310 (401)
T 4fdw_A          252 TVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPES  310 (401)
T ss_dssp             EEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCTT
T ss_pred             EEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCCc
Confidence            6666 33455455667777778888877777654     345567777777777777643

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.73  E-value=5.3e-08  Score=92.74  Aligned_cols=127  Identities=10%  Similarity=0.080  Sum_probs=65.2

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCC---------------------cccccCchhhhhcccCCeEeccCc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRN---------------------QFNSSIPNELTWLTGLLGLNLSSN   64 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N---------------------~l~~~~p~~~~~l~~L~~L~l~~N   64 (397)
                      ++|+.+.|.++ +...-..+|.++++|+.++++.|                     .++...+..|.++++|+.+++.+|
T Consensus       203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~l~~I~~~aF~~~~L~~i~lp~~i~~I~~~aF~~c~~L~~l~l~~~  281 (401)
T 4fdw_A          203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPENVSTIGQEAFRESGITTVKLPNGVTNIASRAFYYCPELAEVTTYGS  281 (401)
T ss_dssp             CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTTCCEECTTTTTTCCCSEEEEETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred             cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCCccCccccccccCCccEEEeCCCccEEChhHhhCCCCCCEEEeCCc
Confidence            45555555532 44444445555555555555543                     233233445555555555555555


Q ss_pred             cCC-----CcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           65 KLS-----GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        65 ~l~-----~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      .+.     ...+.+|.+|++|+.+.+.+ .++.+...+|..|.+|+.+.+..| ++...+.+|.++ +|+.+.+++|
T Consensus       282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n  355 (401)
T 4fdw_A          282 TFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGT  355 (401)
T ss_dssp             CCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCS
T ss_pred             cccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCC
Confidence            443     23444555555555555552 344444455555555665555433 444444555555 5555666555

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.70  E-value=1e-09  Score=110.12  Aligned_cols=85  Identities=16%  Similarity=0.143  Sum_probs=38.1

Q ss_pred             hhcccCCeEeccCccCCCcCChhhcC-CCCCcEEEccCcccccCCchhh-ccCCCCceeeccCCcCCCCCC-CCcccccc
Q 043586           51 TWLTGLLGLNLSSNKLSGKIPSQIAS-MKNLTWLDISNNKIEGSIPGEI-TELSRLDYLNLSSNKLSGPVP-FSNEQLSS  127 (397)
Q Consensus        51 ~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~~~~~~p~~~-~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~  127 (397)
                      ..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+++... .....+++
T Consensus       429 ~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~  507 (594)
T 2p1m_B          429 EHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLET  507 (594)
T ss_dssp             HHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGG
T ss_pred             hhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCC
Confidence            3344455555543 333333333333 4555555555555543333333 445555555555555532211 12233455


Q ss_pred             cceeccCCC
Q 043586          128 MYIVRLSPN  136 (397)
Q Consensus       128 l~~l~l~~n  136 (397)
                      |+.+++++|
T Consensus       508 L~~L~l~~~  516 (594)
T 2p1m_B          508 MRSLWMSSC  516 (594)
T ss_dssp             SSEEEEESS
T ss_pred             CCEEeeeCC
Confidence            555555554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.69  E-value=3.2e-07  Score=82.35  Aligned_cols=144  Identities=19%  Similarity=0.172  Sum_probs=101.4

Q ss_pred             HHhcCCCccceeecCCcc-cEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCE
Q 043586          216 EATEGFDIKYCIGTGGYG-SVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKC  292 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  292 (397)
                      ....+|+. +.+..|..| .||+.... ++..+++|+-....      ...+.+|...|+.+. +--+.++++++.+.+.
T Consensus        22 ~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~   94 (272)
T 4gkh_A           22 ADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD   94 (272)
T ss_dssp             HHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             ccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCe
Confidence            34445554 345556665 68988765 46678999865432      245778999998884 3347788999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC-------------------------------
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-------------------------------  341 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-------------------------------  341 (397)
                      .|+|||+++|.++.+.....       ......++.+++..+.-||...                               
T Consensus        95 ~~lvme~l~G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (272)
T 4gkh_A           95 AWLLTTAIPGKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDF  167 (272)
T ss_dssp             EEEEEECCCSEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGC
T ss_pred             EEEEEEeeCCccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhc
Confidence            99999999998776544321       1223446666777777777410                               


Q ss_pred             ------------------------CCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          342 ------------------------SPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       342 ------------------------~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                                              ...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       168 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          168 DDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                    12379999999999999887777999998874

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.58  E-value=6.9e-09  Score=104.03  Aligned_cols=86  Identities=21%  Similarity=0.177  Sum_probs=48.0

Q ss_pred             CCCCCCEEeccCCcccccCchhhh-hcccCCeEeccCc-cCCCc-CChhhcCCCCCcEEEccCcccccCCchhhc----c
Q 043586           28 LLTDLSYLDLSRNQFNSSIPNELT-WLTGLLGLNLSSN-KLSGK-IPSQIASMKNLTWLDISNNKIEGSIPGEIT----E  100 (397)
Q Consensus        28 ~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~----~  100 (397)
                      .+++|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++..+..+++|+.|++++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            455666666666666555555554 4666666666666 34321 333344566666666666665544433333    3


Q ss_pred             CCCCceeeccCCc
Q 043586          101 LSRLDYLNLSSNK  113 (397)
Q Consensus       101 ~~~L~~l~l~~n~  113 (397)
                      +++|+.|++++|.
T Consensus       183 ~~~L~~L~l~~~~  195 (594)
T 2p1m_B          183 YTSLVSLNISCLA  195 (594)
T ss_dssp             CCCCCEEECTTCC
T ss_pred             CCcCcEEEecccC
Confidence            4466666666664

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.56  E-value=2.2e-08  Score=93.84  Aligned_cols=60  Identities=17%  Similarity=0.340  Sum_probs=29.5

Q ss_pred             CCCCcEEEccCcccccCCchhhc---cCCCCceeeccCCcCCCC----CCCCcccccccceeccCCC
Q 043586           77 MKNLTWLDISNNKIEGSIPGEIT---ELSRLDYLNLSSNKLSGP----VPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        77 l~~L~~L~l~~N~~~~~~p~~~~---~~~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~l~l~~n  136 (397)
                      +++|+.|+|++|.+....+..+.   .+++|+.|+|+.|.++..    ++..+..+++|+.|+++.|
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n  317 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN  317 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence            45566666665555433222222   345566666666655432    2223344555555555544

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.54  E-value=1.6e-08  Score=85.67  Aligned_cols=116  Identities=14%  Similarity=0.135  Sum_probs=88.6

Q ss_pred             CCccccCCCCCCEEeccCC-ccccc----CchhhhhcccCCeEeccCccCCCc----CChhhcCCCCCcEEEccCccccc
Q 043586           22 IPSTLGLLTDLSYLDLSRN-QFNSS----IPNELTWLTGLLGLNLSSNKLSGK----IPSQIASMKNLTWLDISNNKIEG   92 (397)
Q Consensus        22 ~p~~l~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~~~~   92 (397)
                      +...+...++|+.|+|++| .+...    +...+...++|++|+|++|.|+..    +...+...++|+.|+|++|.|..
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~  107 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG  107 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCH
Confidence            4456777899999999999 88643    344556678999999999999843    34455666899999999999975


Q ss_pred             C----CchhhccCCCCceeec--cCCcCCCC----CCCCcccccccceeccCCCC
Q 043586           93 S----IPGEITELSRLDYLNL--SSNKLSGP----VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        93 ~----~p~~~~~~~~L~~l~l--~~n~l~~~----~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .    +...+...+.|+.|+|  ++|.++..    +...+...++|+.+++++|.
T Consensus       108 ~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~  162 (185)
T 1io0_A          108 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  162 (185)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCC
Confidence            4    3566788889999999  88998743    22334455788999998874

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.49  E-value=3.8e-07  Score=85.38  Aligned_cols=80  Identities=10%  Similarity=-0.005  Sum_probs=55.8

Q ss_pred             cee-ecCCcccEEEEEcC-------CCcEEEEEEecccc---hHHHHHHHHHHHHHHHHhhcc-c--CCccceeeEEeeC
Q 043586          225 YCI-GTGGYGSVYKAQLP-------NGKVFALKKLHTSE---TEELAFIKSFRNEAQVLSQVL-H--RNIVKLYGFCLHR  290 (397)
Q Consensus       225 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~  290 (397)
                      +.| +.|....+|+....       +++.+++|+.....   ...   ...+.+|+.+++.+. +  -.+.+++.++.+.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            456 78888999998754       26788999875432   000   134567888888885 3  3577788887665


Q ss_pred             ---CEeeEEEeeccCCCchh
Q 043586          291 ---KCMFLIYEYMERGSLFC  307 (397)
Q Consensus       291 ---~~~~lv~e~~~~g~L~~  307 (397)
                         +..|+||||++|..+.+
T Consensus       103 ~~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCCB
T ss_pred             CccCCceEEEEecCCCChhh
Confidence               35789999999877654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.41  E-value=1e-06  Score=81.74  Aligned_cols=140  Identities=19%  Similarity=0.320  Sum_probs=80.0

Q ss_pred             eeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--CCccceee------EEeeCCEeeEEE
Q 043586          226 CIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYG------FCLHRKCMFLIY  297 (397)
Q Consensus       226 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~  297 (397)
                      .++.|..+.||+....++ .+++|+.....       .++..|..+++.+..  -.+.+++.      +....+..+++|
T Consensus        39 ~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           39 VIQGNQMALVWKVHTDSG-AVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             ECC----CEEEEEEETTE-EEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eccccccCcEEEEEeCCC-CEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            455567889999987655 58999987632       223345555555532  12334443      123466789999


Q ss_pred             eeccCCCch--------------hhcccCCC----c-------cccChHH------------------------------
Q 043586          298 EYMERGSLF--------------CNLHNNED----A-------VELDWAK------------------------------  322 (397)
Q Consensus       298 e~~~~g~L~--------------~~l~~~~~----~-------~~~~~~~------------------------------  322 (397)
                      +|++|..+.              ..+|....    .       ....|..                              
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999986552              01111000    0       0011211                              


Q ss_pred             -HHHHHHHHHHHHHHHHh----------CCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          323 -RVNIVKAMAHALAYLHH----------DCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       323 -~~~i~~~i~~~l~~LH~----------~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                       ...+..++..++++|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             00111223445666653          0256899999999999998888999999998863

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.33  E-value=1.2e-07  Score=88.96  Aligned_cols=129  Identities=17%  Similarity=0.250  Sum_probs=77.8

Q ss_pred             CCCCEEEcCCCcccccCCcccc--CCCCCCEEeccC--Cccccc-----Cchhh--hhcccCCeEeccCccCCCcCChhh
Q 043586            6 KNLIELDVGSNSLIGPIPSTLG--LLTDLSYLDLSR--NQFNSS-----IPNEL--TWLTGLLGLNLSSNKLSGKIPSQI   74 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~p~~~   74 (397)
                      ++|+.|+|..|.++......+.  .+++|+.|+|+.  |...+.     +...+  ..+++|+.|+|++|.++...+..+
T Consensus       193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l  272 (362)
T 2ra8_A          193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF  272 (362)
T ss_dssp             TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred             CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence            4444444444444322222232  578888888753  222111     11122  246889999999888875444444


Q ss_pred             c---CCCCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCCCCCCCcccccc-c-ceeccCCCC
Q 043586           75 A---SMKNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSS-M-YIVRLSPNK  137 (397)
Q Consensus        75 ~---~l~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~-l-~~l~l~~n~  137 (397)
                      .   .+++|+.|+|+.|.+.+.    ++..+..+++|+.|++++|.++...   ...+.. + ..++++.|.
T Consensus       273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~---~~~l~~alg~~~~~~~~~  341 (362)
T 2ra8_A          273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM---KKELQKSLPMKIDVSDSQ  341 (362)
T ss_dssp             HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH---HHHHHHHCCSEEECCSBC
T ss_pred             HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH---HHHHHHHcCCEEEecCCc
Confidence            3   478999999999999764    3444567899999999999887322   222222 1 336777664

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=5.2e-06  Score=78.83  Aligned_cols=78  Identities=13%  Similarity=0.083  Sum_probs=49.3

Q ss_pred             cceeecCCcccEEEEEcC-CCcEEEEEEecccch-HHH---HHHHHHHHHHHHHhhccc--C-CccceeeEEeeCCEeeE
Q 043586          224 KYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSET-EEL---AFIKSFRNEAQVLSQVLH--R-NIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l  295 (397)
                      .+.+|.|.++.||+++.. +++.+++|....... ...   ...+++..|.++++.+..  | .+.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            456899999999999764 467899998654321 000   012355678888888753  3 34456544  3445689


Q ss_pred             EEeeccCC
Q 043586          296 IYEYMERG  303 (397)
Q Consensus       296 v~e~~~~g  303 (397)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.21  E-value=1.8e-05  Score=72.47  Aligned_cols=138  Identities=21%  Similarity=0.238  Sum_probs=91.4

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc---cCCccceeeEEeeCCEeeEEEeec
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL---HRNIVKLYGFCLHRKCMFLIYEYM  300 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~  300 (397)
                      .+.|+.|....+|+... ++..+++|+.....      ...+..|.+.|+.+.   ...+++++.++...+..++||||+
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            45688999999999986 46788899876432      256778999998885   256888999988888999999999


Q ss_pred             cCCCchh-----------hcccCCC--c-----------------cccChHHHH---HHHH----------------HHH
Q 043586          301 ERGSLFC-----------NLHNNED--A-----------------VELDWAKRV---NIVK----------------AMA  331 (397)
Q Consensus       301 ~~g~L~~-----------~l~~~~~--~-----------------~~~~~~~~~---~i~~----------------~i~  331 (397)
                      ++..+..           .+|....  .                 ..-+|....   ++..                .++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9876521           1222111  0                 011343221   1111                111


Q ss_pred             HH-HHHHHh-CCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          332 HA-LAYLHH-DCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       332 ~~-l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      .. ...|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11 123321 2256899999999999999887 8899984

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.02  E-value=3.7e-05  Score=70.61  Aligned_cols=159  Identities=13%  Similarity=0.088  Sum_probs=90.1

Q ss_pred             ccHHHHHHHhcCCCcc-----ceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC--cc
Q 043586          209 IVYEDLIEATEGFDIK-----YCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IV  281 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  281 (397)
                      ++.+++....+.|.+.     +.++.|....+|+....++ .+++|.......     .+.+..|..++..+....  +.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~-----~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCC-----HHHHHHHHHHHHHHHHCCCCCC
Confidence            4456676776777652     3456677789999987655 688998876311     134556778877775322  33


Q ss_pred             ceeeE------EeeCCEeeEEEeeccCCCchh--------------hcccC----CCcc----c-cChHHHHH-------
Q 043586          282 KLYGF------CLHRKCMFLIYEYMERGSLFC--------------NLHNN----EDAV----E-LDWAKRVN-------  325 (397)
Q Consensus       282 ~l~~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~~~----~-~~~~~~~~-------  325 (397)
                      +++..      ....+..+++|+|++|..+..              .+|..    ....    . ..|.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            34321      123456789999999865421              01110    0000    0 11211000       


Q ss_pred             -----HHHHHHHHHHHHHhC----CCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          326 -----IVKAMAHALAYLHHD----CSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       326 -----i~~~i~~~l~~LH~~----~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                           +...+...++++...    ...+++|+|+.+.||+++.++.+.++||+.+..
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence                 011234445555431    245799999999999999876668999988763

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=98.01  E-value=1.4e-05  Score=75.70  Aligned_cols=126  Identities=10%  Similarity=0.112  Sum_probs=85.1

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      .+..+.+. +.+...-..+|.++++|+.+.+..+..+ .-...|.++.+|+.+.+. +.++.....+|.+|.+|+.+.+.
T Consensus       243 ~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp  319 (394)
T 4gt6_A          243 EDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIP  319 (394)
T ss_dssp             CCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECC
T ss_pred             ccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeC
Confidence            34444443 2344445567777888888888766553 455667778888888775 44554556677788888888887


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +| ++.+...+|..|.+|+.+.+..+ ++..-..+|.++++|+.+++.+|.
T Consensus       320 ~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~  368 (394)
T 4gt6_A          320 EG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR  368 (394)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred             Cc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence            54 55555667888888888888654 554556677777888877777664

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.94  E-value=4.2e-05  Score=72.00  Aligned_cols=129  Identities=17%  Similarity=0.124  Sum_probs=94.3

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ...+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++......|.++++|+.+
T Consensus       215 ~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i  291 (379)
T 4h09_A          215 YGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKV  291 (379)
T ss_dssp             TCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEE
T ss_pred             cccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccc
Confidence            4456777777654 44455567788888888888776 44455567778888888888655 554556678888888888


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      .+.++.++.+...+|.+|.+|+.+.+..+ ++..-..+|.++.+|+.+.+..+
T Consensus       292 ~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          292 VMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             EECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred             cccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence            88888887777778888888888888754 55555677888888887777554

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.94  E-value=4e-05  Score=73.29  Aligned_cols=32  Identities=16%  Similarity=0.231  Sum_probs=28.2

Q ss_pred             CCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       342 ~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ...++|+|++|.||+++.++ ++++||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            56899999999999999876 999999988743

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.91  E-value=4e-06  Score=69.49  Aligned_cols=84  Identities=13%  Similarity=0.116  Sum_probs=54.6

Q ss_pred             CCCCEEeccCCcccccCchhhhhcccCCeEeccCcc-CCCcCChhhcCC----CCCcEEEccCcc-cccCCchhhccCCC
Q 043586           30 TDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK-LSGKIPSQIASM----KNLTWLDISNNK-IEGSIPGEITELSR  103 (397)
Q Consensus        30 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-~~~~~p~~~~~~~~  103 (397)
                      .+|+.||++++.++..--..+.++++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++. |+..--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            467788888777764433456677778888887774 654333334443    357788887764 65444445667778


Q ss_pred             CceeeccCCc
Q 043586          104 LDYLNLSSNK  113 (397)
Q Consensus       104 L~~l~l~~n~  113 (397)
                      |+.|+++++.
T Consensus       141 L~~L~L~~c~  150 (176)
T 3e4g_A          141 LKYLFLSDLP  150 (176)
T ss_dssp             CCEEEEESCT
T ss_pred             CCEEECCCCC
Confidence            8888887764

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=97.89  E-value=4.1e-05  Score=72.01  Aligned_cols=120  Identities=11%  Similarity=0.021  Sum_probs=96.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.+..+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.++.+|+.+.+.++.++..-..+|.+|.+|+
T Consensus       236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~  313 (379)
T 4h09_A          236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS  313 (379)
T ss_dssp             TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred             ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence            346788999999876 66566778999999999999866 5545566899999999999999999867778899999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccc
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQL  125 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l  125 (397)
                      .+.|.++ ++.+...+|.+|.+|+.+.+..+ ++..-..+|.+.
T Consensus       314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c  355 (379)
T 4h09_A          314 SVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS  355 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred             EEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence            9999765 66666788999999999998765 554445566544

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.87  E-value=0.0002  Score=65.84  Aligned_cols=158  Identities=16%  Similarity=0.208  Sum_probs=88.8

Q ss_pred             ccHHHHHHHhcCCCc-----cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC--cc
Q 043586          209 IVYEDLIEATEGFDI-----KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN--IV  281 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv  281 (397)
                      .+.+++....+.|.+     ...++ |....||+....+|+.+++|.........    ..+..|..+++.+....  ++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeec
Confidence            344555555454433     23455 77789999987778789999987432211    34556888887775322  34


Q ss_pred             ceeeE-----EeeCCEeeEEEeeccCCCchh----h----------ccc----CC--CccccChHHH----HHH------
Q 043586          282 KLYGF-----CLHRKCMFLIYEYMERGSLFC----N----------LHN----NE--DAVELDWAKR----VNI------  326 (397)
Q Consensus       282 ~l~~~-----~~~~~~~~lv~e~~~~g~L~~----~----------l~~----~~--~~~~~~~~~~----~~i------  326 (397)
                      +++..     ....+..+++|+|++|..+..    .          +|.    ..  .....++...    ..+      
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            44443     223456788999998855421    0          111    00  0011111110    000      


Q ss_pred             ---------HHHHHHHHHHHHh----CCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          327 ---------VKAMAHALAYLHH----DCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       327 ---------~~~i~~~l~~LH~----~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                               ...+...++.+..    .....++|+|+++.||+++ + .+.++||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     1111122233321    1245689999999999999 4 889999988764

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.86  E-value=5.5e-06  Score=68.66  Aligned_cols=83  Identities=14%  Similarity=0.198  Sum_probs=65.5

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCc-ccccCchhhhhc----ccCCeEeccCcc-CCCcCChhhcCCCCC
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ-FNSSIPNELTWL----TGLLGLNLSSNK-LSGKIPSQIASMKNL   80 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L   80 (397)
                      .|+.|||+++.++..--..+.++++|+.|+|+++. +++.-=..+..+    ++|++|+|+++. +|..-=..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            58999999999876555668899999999999995 664322344443    479999999974 885444567889999


Q ss_pred             cEEEccCcc
Q 043586           81 TWLDISNNK   89 (397)
Q Consensus        81 ~~L~l~~N~   89 (397)
                      +.|++++++
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            999999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.84  E-value=3.9e-05  Score=69.37  Aligned_cols=76  Identities=18%  Similarity=0.172  Sum_probs=54.1

Q ss_pred             ccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc---CCccceeeEEeeCCEeeEEEee
Q 043586          223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH---RNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      -.+.+|.|..+.||+.+..+|+.|++|+........   ...|..|++.|+.+.-   --+.+++++.    ..++||||
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            346689999999999999999999999875443211   1356789999988842   1345555542    24789999


Q ss_pred             ccCCCc
Q 043586          300 MERGSL  305 (397)
Q Consensus       300 ~~~g~L  305 (397)
                      ++++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.84  E-value=5e-05  Score=71.94  Aligned_cols=125  Identities=13%  Similarity=0.047  Sum_probs=61.3

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCch---------------------hhhhcccCCeEeccCc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPN---------------------ELTWLTGLLGLNLSSN   64 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~---------------------~~~~l~~L~~L~l~~N   64 (397)
                      .+|+.+.+..+ +...-...|..+.+|+.+.+..|... ....                     .|..+.+|+.+.+..+
T Consensus       230 ~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F~~~~~L~~i~l~~~  307 (394)
T 4fs7_A          230 TGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTFYGCSSLTEVKLLDS  307 (394)
T ss_dssp             CCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTTTTCTTCCEEEECTT
T ss_pred             CCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccccccccccccccccc
Confidence            34555555432 23233344555555555555554432 2233                     3444555555555443


Q ss_pred             cCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCC
Q 043586           65 KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSP  135 (397)
Q Consensus        65 ~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~  135 (397)
                       ++..-..+|.++++|+.+++.++ ++.+...+|.+|.+|+.+++..| ++.....+|.++.+|+.+.+..
T Consensus       308 -i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~  375 (394)
T 4fs7_A          308 -VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK  375 (394)
T ss_dssp             -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred             -cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence             33333445555555555555433 44344455555555555555544 4434445555555555555543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=97.81  E-value=5e-05  Score=71.95  Aligned_cols=129  Identities=9%  Similarity=-0.026  Sum_probs=70.6

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|+.+.|.. .++..-..+|.++++|+.++++.| ++..-...|.++.+|+.+.+..+ ++..-..+|.++..+.
T Consensus        67 F~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~  143 (394)
T 4fs7_A           67 FQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKE  143 (394)
T ss_dssp             TTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSE
T ss_pred             hhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccccc
Confidence            45678888888874 466556678888899999998766 54445567888888887776654 2223333344433222


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      .......  ......+|..|.+|+.+.+.++. ......+|..+.+|+.+.+..|
T Consensus       144 ~~~~~~~--~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~  195 (394)
T 4fs7_A          144 ITIPEGV--TVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN  195 (394)
T ss_dssp             EECCTTC--CEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT
T ss_pred             cccCccc--cccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC
Confidence            2111111  11223345555555555554332 2133344444444544444433

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=97.75  E-value=6.9e-05  Score=70.97  Aligned_cols=109  Identities=8%  Similarity=0.127  Sum_probs=68.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++.+|+.+.+..+... .-...|.++++|+.+.++. .++......|.++.+|+.+.|..| ++..-..+|.+|.+|+
T Consensus       261 F~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~~-~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~  337 (394)
T 4gt6_A          261 FDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFSS-RITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLE  337 (394)
T ss_dssp             TTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred             eeecccccEEecccccce-ecCcccccccccccccCCC-cccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCC
Confidence            345566777777654332 4555677777777777753 344344556777777777777654 5544556677777777


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKL  114 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l  114 (397)
                      .+.+..+ ++.+-..+|.+|.+|+.+++.+|..
T Consensus       338 ~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~  369 (394)
T 4gt6_A          338 RIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS  369 (394)
T ss_dssp             EEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred             EEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence            7777544 5545566777777777777776643

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.74  E-value=9.5e-05  Score=68.24  Aligned_cols=142  Identities=17%  Similarity=0.158  Sum_probs=73.5

Q ss_pred             ceeecCCccc-EEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccC--CccceeeEEeeCCEeeEEEeecc
Q 043586          225 YCIGTGGYGS-VYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR--NIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       225 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      +.++.|.... +|+....++..+++|.......      +.+..|+.+++.+...  .+.+++.+....+  +++||++.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~   95 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG   95 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence            3455555444 6777764467788876544321      1234567777777432  3556776643333  78999997


Q ss_pred             CCCchhhcccCC---------------------C--ccccChHHHH-------H-------------HHHHHHHHHHHHH
Q 043586          302 RGSLFCNLHNNE---------------------D--AVELDWAKRV-------N-------------IVKAMAHALAYLH  338 (397)
Q Consensus       302 ~g~L~~~l~~~~---------------------~--~~~~~~~~~~-------~-------------i~~~i~~~l~~LH  338 (397)
                      +..+.+.+....                     .  ...++.....       .             ....+...++.+-
T Consensus        96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~  175 (333)
T 3csv_A           96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL  175 (333)
T ss_dssp             SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred             CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence            765543322100                     0  0001110000       0             0011112222221


Q ss_pred             ---hCCCCCeEEcCCCCCCEEeCCC----CCeEEecccccccc
Q 043586          339 ---HDCSPSIIHRDISSNNILLNSK----FEAFVADFGTARLL  374 (397)
Q Consensus       339 ---~~~~~~ivH~dlkp~NIll~~~----~~~kl~DFG~a~~~  374 (397)
                         ......++|+|+.+.||+++.+    +.+.++||+.+..-
T Consensus       176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence               1125689999999999999875    67899999988743

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.73  E-value=1.7e-05  Score=67.03  Aligned_cols=38  Identities=8%  Similarity=0.154  Sum_probs=16.7

Q ss_pred             CCCCEEEcCCC-cccc----cCCccccCCCCCCEEeccCCccc
Q 043586            6 KNLIELDVGSN-SLIG----PIPSTLGLLTDLSYLDLSRNQFN   43 (397)
Q Consensus         6 ~~L~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~l~~N~l~   43 (397)
                      +.|+.|+|++| +|..    .+.+.+..-+.|+.|+|++|.+.
T Consensus        41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig   83 (197)
T 1pgv_A           41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS   83 (197)
T ss_dssp             SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred             CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC
Confidence            34555555543 4321    12333444444555555555543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.70  E-value=0.00016  Score=69.30  Aligned_cols=72  Identities=22%  Similarity=0.299  Sum_probs=48.8

Q ss_pred             ceeecCCcccEEEEEcCC--------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc-cceeeEEeeCCEeeE
Q 043586          225 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI-VKLYGFCLHRKCMFL  295 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l  295 (397)
                      +.|+.|-...+|++...+        ++.+++|+.......     +.+.+|..+++.+...++ .++++.+.+    .+
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~-----~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~  149 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG----GR  149 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcH-----HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence            457778889999998653        578999988542110     234468888888854444 566766542    28


Q ss_pred             EEeeccCCCc
Q 043586          296 IYEYMERGSL  305 (397)
Q Consensus       296 v~e~~~~g~L  305 (397)
                      |+||++|.++
T Consensus       150 v~e~l~G~~l  159 (429)
T 1nw1_A          150 LEEYIPSRPL  159 (429)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeCCccc
Confidence            9999987555

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.66  E-value=0.00022  Score=66.93  Aligned_cols=141  Identities=20%  Similarity=0.247  Sum_probs=81.5

Q ss_pred             ceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeCCEeeE
Q 043586          225 YCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHRKCMFL  295 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  295 (397)
                      +.+..|-...+|++...        +++.+++|+.......    ...+.+|.++++.+. +.-..++++++.+    .+
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~----~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~  127 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG----VDSLVLESVMFAILAERSLGPQLYGVFPE----GR  127 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC----HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch----HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence            45667878899999874        2478999986432111    244557999998885 3333566666543    28


Q ss_pred             EEeeccCCCchhh-c----------------ccCCC--cccc--ChHHHHHHHHHHHH-------------------HHH
Q 043586          296 IYEYMERGSLFCN-L----------------HNNED--AVEL--DWAKRVNIVKAMAH-------------------ALA  335 (397)
Q Consensus       296 v~e~~~~g~L~~~-l----------------~~~~~--~~~~--~~~~~~~i~~~i~~-------------------~l~  335 (397)
                      ||||++|.++..- +                |....  ....  -+.++.++..++..                   .+.
T Consensus       128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~  207 (379)
T 3feg_A          128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG  207 (379)
T ss_dssp             EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred             EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence            9999998665321 1                11100  0111  13344444433321                   233


Q ss_pred             HHHh-----CCCCCeEEcCCCCCCEEeCCC----CCeEEeccccccc
Q 043586          336 YLHH-----DCSPSIIHRDISSNNILLNSK----FEAFVADFGTARL  373 (397)
Q Consensus       336 ~LH~-----~~~~~ivH~dlkp~NIll~~~----~~~kl~DFG~a~~  373 (397)
                      +|..     .....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3321     123468999999999999876    7899999998874

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.65  E-value=0.00023  Score=64.59  Aligned_cols=71  Identities=13%  Similarity=0.084  Sum_probs=45.4

Q ss_pred             cceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc-cceeeEEeeCCEeeEEEeec-c
Q 043586          224 KYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI-VKLYGFCLHRKCMFLIYEYM-E  301 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~  301 (397)
                      .+.++.|....+|+.     +.+++|+.......    .....+|..+++.+....+ .+++++.  .+..++++||+ +
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence            577888999999999     56888987653211    0122458888887753333 4555543  33457899999 6


Q ss_pred             CCCc
Q 043586          302 RGSL  305 (397)
Q Consensus       302 ~g~L  305 (397)
                      |.++
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            6555

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.47  E-value=0.00016  Score=57.00  Aligned_cols=35  Identities=20%  Similarity=0.248  Sum_probs=15.5

Q ss_pred             CCeEeccCccCCCcCChhhcCCCCCcEEEccCccc
Q 043586           56 LLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI   90 (397)
Q Consensus        56 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~   90 (397)
                      |+.|+|++|+|+...+..|..+++|+.|+|++|++
T Consensus        33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            44444444444433333344444444444444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.38  E-value=0.00027  Score=55.61  Aligned_cols=56  Identities=20%  Similarity=0.302  Sum_probs=37.0

Q ss_pred             eEeccCccCC-CcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCC
Q 043586           58 GLNLSSNKLS-GKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLS  115 (397)
Q Consensus        58 ~L~l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~  115 (397)
                      .++.+++.|+ ..+|..+.  ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5666777665 23554332  25777777777777666667777777777777777654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.36  E-value=0.00042  Score=64.86  Aligned_cols=73  Identities=14%  Similarity=0.039  Sum_probs=44.2

Q ss_pred             ceeecCCcccEEEEEcCC---------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC-ccceeeEEeeCCEee
Q 043586          225 YCIGTGGYGSVYKAQLPN---------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRKCMF  294 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~  294 (397)
                      ..++.|....+|+....+         ++.+++|+.......-    .....|.++++.+...+ ..++++..  .  -+
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~  110 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----YNTISEFEVYKTMSKYKIAPQLLNTF--N--GG  110 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----ecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence            346778788999998653         2688889876532110    12346888888885434 44666544  2  36


Q ss_pred             EEEeeccCCCc
Q 043586          295 LIYEYMERGSL  305 (397)
Q Consensus       295 lv~e~~~~g~L  305 (397)
                      +||||++|..+
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999988654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.32  E-value=0.00085  Score=62.06  Aligned_cols=33  Identities=21%  Similarity=0.418  Sum_probs=28.6

Q ss_pred             CCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       342 ~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      ...++|+|+.+.||+++.++.+.++||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            357999999999999998888999999877643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.18  E-value=0.0017  Score=62.48  Aligned_cols=73  Identities=19%  Similarity=0.191  Sum_probs=46.9

Q ss_pred             ceeecCCcccEEEEEcCC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCc-cceeeEEeeCCEeeEEEeeccC
Q 043586          225 YCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI-VKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      +.|+.|-...+|++...+ +..+++|+.......-    -...+|..+++.+...++ .++++.+.  +  .+||||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            457778889999998765 4788899875432110    011468888988865444 56777663  2  259999998


Q ss_pred             CCc
Q 043586          303 GSL  305 (397)
Q Consensus       303 g~L  305 (397)
                      .++
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            655

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.04  E-value=0.0002  Score=60.37  Aligned_cols=112  Identities=12%  Similarity=0.089  Sum_probs=71.8

Q ss_pred             cccCCCCCCEEeccCC-ccccc----CchhhhhcccCCeEeccCccCCCcCC----hhhcCCCCCcEEEccCcccccCC-
Q 043586           25 TLGLLTDLSYLDLSRN-QFNSS----IPNELTWLTGLLGLNLSSNKLSGKIP----SQIASMKNLTWLDISNNKIEGSI-   94 (397)
Q Consensus        25 ~l~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~~~~~~-   94 (397)
                      .+..-+.|+.|+|++| .+...    +...+..-+.|+.|+|++|+|...--    ..+..=+.|++|+|+.|.|...- 
T Consensus        36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            3455678999999985 77532    33445556789999999999884332    33444578999999999986532 


Q ss_pred             ---chhhccCCCCceeeccCCcC---CCC----CCCCcccccccceeccCCC
Q 043586           95 ---PGEITELSRLDYLNLSSNKL---SGP----VPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        95 ---p~~~~~~~~L~~l~l~~n~l---~~~----~~~~~~~l~~l~~l~l~~n  136 (397)
                         -+.+..-..|+.|+|++|..   ...    +-..+..-++|..++++.|
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~  167 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA  167 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCC
Confidence               34455566799999986533   211    1122333455666666544

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.61  E-value=0.0045  Score=58.86  Aligned_cols=73  Identities=12%  Similarity=0.054  Sum_probs=47.0

Q ss_pred             ceeecCCcccEEEEEcCC--------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC-ccceeeEEeeCCEeeE
Q 043586          225 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRKCMFL  295 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  295 (397)
                      +.+..|-...+|+....+        ++.+++++.......    .-+..+|.++++.+.-.+ ..++++.+  .  -+.
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~  147 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADF--P--EGR  147 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCE
Confidence            456667788999998653        578999987543211    012246888888885333 44566533  2  368


Q ss_pred             EEeeccCCCc
Q 043586          296 IYEYMERGSL  305 (397)
Q Consensus       296 v~e~~~~g~L  305 (397)
                      ||||++|.++
T Consensus       148 I~efI~G~~l  157 (424)
T 3mes_A          148 IEEFIDGEPL  157 (424)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEeCCccC
Confidence            9999998665

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.01  E-value=0.18  Score=47.38  Aligned_cols=30  Identities=30%  Similarity=0.441  Sum_probs=25.3

Q ss_pred             CeEEcCCCCCCEEe------CCCCCeEEeccccccc
Q 043586          344 SIIHRDISSNNILL------NSKFEAFVADFGTARL  373 (397)
Q Consensus       344 ~ivH~dlkp~NIll------~~~~~~kl~DFG~a~~  373 (397)
                      .++|+|+.+.||++      +.+..++++||-.|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567799999998874

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.11  E-value=1.1  Score=37.88  Aligned_cols=89  Identities=6%  Similarity=0.095  Sum_probs=61.8

Q ss_pred             ccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       276 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      .||+++.. .+-...+.+.+.++.-+.+.-...++      ..+....++++..|+....+++     .=+|--+.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceE
Confidence            47888866 45555665555544433221112222      3567888899999988887666     347889999999


Q ss_pred             EeCCCCCeEEeccccccccCC
Q 043586          356 LLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~  376 (397)
                      +++.++.+++.-.|+-..+.+
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P  131 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDP  131 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSC
T ss_pred             EEcCCCCEEEEEccCccCCCC
Confidence            999999999999998665543

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.71  E-value=1.5  Score=37.21  Aligned_cols=87  Identities=10%  Similarity=0.125  Sum_probs=60.2

Q ss_pred             ccCCccceeeEEeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHH-HHHhCCCCCeEEcCCCCCC
Q 043586          276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA-YLHHDCSPSIIHRDISSNN  354 (397)
Q Consensus       276 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlkp~N  354 (397)
                      .||++  -...-.+.+...+.++.-+++.-...++      ..+...+++++..++.... +++     .-+|--+.|+|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCce
Confidence            47777  3444456666666655543332233332      3566788888888877666 555     45888999999


Q ss_pred             EEeCCCCCeEEeccccccccC
Q 043586          355 ILLNSKFEAFVADFGTARLLH  375 (397)
Q Consensus       355 Ill~~~~~~kl~DFG~a~~~~  375 (397)
                      |++|.++.+++.-.|+-..+.
T Consensus       115 L~f~~~~~p~i~hRGi~~~lp  135 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLP  135 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBS
T ss_pred             EEEeCCCcEEEEEcCCcccCC
Confidence            999999999999999866553

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.64  E-value=0.064  Score=51.59  Aligned_cols=63  Identities=14%  Similarity=0.117  Sum_probs=17.8

Q ss_pred             ccceeecCCcccEEEEEcCC-CcEEEE------EEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          223 IKYCIGTGGYGSVYKAQLPN-GKVFAL------KKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      +.+.+|   ||.||+|.+.. ..+|||      |..+...... +....+.+|..+++..+|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~-e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSE-KRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccc-cccccccccccccccccccccCCCcceEEe
Confidence            345565   99999998754 357888      6665433222 223567889999999999999999887653

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=83.58  E-value=1.6  Score=26.51  Aligned_cols=28  Identities=7%  Similarity=-0.117  Sum_probs=15.1

Q ss_pred             hhhhhhhHhhHhhhhhhhhhhhhccccc
Q 043586          161 IFLPLAIVPSVIVFACLLVVKRKYKKPK  188 (397)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (397)
                      .+.+++.++.++++...++...|+++.+
T Consensus        14 A~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           14 ATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            3344444444445556667777766544

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	397
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-46
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-45
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-45
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-45
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-42
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	7e-42
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-41
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-41
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-41
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-40
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-39
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-39
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-39
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-38
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-37
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-36
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-36
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	9e-36
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-34
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-33
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-33
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-31
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-30
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-30
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-28
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-26
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	7e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-16
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-05
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-07
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-06
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-10
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-07
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	6e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	7e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	4e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.003
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	7e-04
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.001

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 1e-46
 Identities = 49/178 (27%), Positives = 73/178 (41%), Gaps = 10/178 (5%)

Query: 217 ATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV 275
             + F+    +G G  G V+K    P+G V A K +H               E QVL + 
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHEC 61

Query: 276 LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
               IV  YG       + +  E+M+ GSL   L        +       +  A+   L 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLT 118

Query: 336 YLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           YL       I+HRD+  +NIL+NS+ E  + DFG +  L    +N     GT  Y++P
Sbjct: 119 YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF--VGTRSYMSP 172

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-46
 Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 11/175 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
             +   IG+G +G+VYK +       A+K L+ +       +++F+NE  VL +  H NI
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNI 66

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           +   G+      + ++ ++ E  SL+ +LH  E   + +  K ++I +  A  + YLH  
Sbjct: 67  LLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHA- 122

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
              SIIHRD+ SNNI L+      + DFG A +    S +     L+G+  ++AP
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 61/176 (34%), Positives = 93/176 (52%), Gaps = 9/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F+I   +G G +G+VY A+   +  + ALK L  ++ E+       R E ++ S + H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NI++LYG+      ++LI EY   G+++  L       + D  +    +  +A+AL+Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +IHRDI   N+LL S  E  +ADFG +   HA SS RT L GT  Y+ P
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTTLCGTLDYLPP 173

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 52/181 (28%), Positives = 88/181 (48%), Gaps = 7/181 (3%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +++ Y IGTG YG   K +   +GK+   K+L      E A  +   +E  +L ++ H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 62

Query: 278 RNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAVE-LDWAKRVNIVKAMAHAL 334
            NIV+ Y   + R    ++++ EY E G L   +       + LD    + ++  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 335 AYLH--HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
              H   D   +++HRD+   N+ L+ K    + DFG AR+L+ D+S      GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 393 P 393
           P
Sbjct: 183 P 183

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-45
 Identities = 46/176 (26%), Positives = 78/176 (44%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   +   +G G +G V+          A+K L            +F  EA ++ Q+ H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY        +++I EYME GSL   L      ++L   K +++   +A  +A++ 
Sbjct: 69  RLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIE 126

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN-RTLLAGTYGYIAP 393
                  IHRD+ + NIL++      +ADFG ARL+  +    R        + AP
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 6e-45
 Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + F     IG G +G+VY A+ + N +V A+KK+  S  +     +    E + L ++ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N ++  G  L     +L+ EY    +      + +    L   +   +       LAY
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   S ++IHRD+ + NILL+      + DFG+A ++   +S      GT  ++AP
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAP 180

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (373), Expect = 1e-42
 Identities = 43/174 (24%), Positives = 74/174 (42%), Gaps = 10/174 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
                 +GTG +G V   +       A+K +      E      F  EA+V+  + H  +
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKL 61

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V+LYG C  ++ +F+I EYM  G L   L            + + + K +  A+ YL   
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESK 119

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAP 393
                +HRD+++ N L+N +    V+DFG +R +  D    ++       +  P
Sbjct: 120 Q---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (376), Expect = 1e-42
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 12/187 (6%)

Query: 211 YEDL---IEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFR 266
           YE +   +   + ++I   +G G +G VYKAQ      + A K + T   EE   ++ + 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYM 57

Query: 267 NEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNI 326
            E  +L+   H NIVKL     +   ++++ E+   G++   +   E    L  ++   +
Sbjct: 58  VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 327 VKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAG 386
            K    AL YLH      IIHRD+ + NIL     +  +ADFG +         R    G
Sbjct: 116 CKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 387 TYGYIAP 393
           T  ++AP
Sbjct: 173 TPYWMAP 179

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  148 bits (374), Expect = 2e-42
 Identities = 57/201 (28%), Positives = 91/201 (45%), Gaps = 25/201 (12%)

Query: 211 YEDLIEATEGFD---------IKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETE 257
           +ED  EA   F          I+  IG G +G V    L          A+K L +  TE
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 258 ELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVE 317
           +    + F +EA ++ Q  H N++ L G       + +I E+ME GSL   L  N+   +
Sbjct: 69  K--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124

Query: 318 LDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD 377
               + V +++ +A  + YL        +HRD+++ NIL+NS     V+DFG +R L  D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 378 SSNRTLLA-----GTYGYIAP 393
           +S+ T  +         + AP
Sbjct: 182 TSDPTYTSALGGKIPIRWTAP 202

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 7e-42
 Identities = 45/178 (25%), Positives = 74/178 (41%), Gaps = 11/178 (6%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E +D+   +G G YG V  A      +  A+K +      +    ++ + E  +   + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNH 62

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            N+VK YG        +L  EY   G LF  +  +     +           +   + YL
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYL 119

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
           H      I HRDI   N+LL+ +    ++DFG A +   ++  R L  + GT  Y+AP
Sbjct: 120 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-41
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 14/174 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
             +   IG G +G V       G   A+K +    T +     +F  EA V++Q+ H N+
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ-----AFLAEASVMTQLRHSNL 62

Query: 281 VKLYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           V+L G  +  K  ++++ EYM +GSL   L +   +V L     +     +  A+ YL  
Sbjct: 63  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE- 120

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               + +HRD+++ N+L++    A V+DFG  +     SS +        + AP
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAP 169

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 6e-41
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E   ++  +G G +G V+          A+K L           ++F  EAQV+ ++ H 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +V+LY      + ++++ EYM +GSL  +    E    L   + V++   +A  +AY+ 
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD-SSNRTLLAGTYGYIAP 393
                  +HRD+ + NIL+       VADFG ARL+  +  + R        + AP
Sbjct: 131 RMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 9e-41
 Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 15/189 (7%)

Query: 212 EDLIEATEGFDI-KYCIGTGGYGSVYKAQL---PNGKVFALKKLHTSETEELAFIKSFRN 267
           + L    +   I    +G G +GSV +            A+K L     +     +    
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMR 58

Query: 268 EAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 327
           EAQ++ Q+ +  IV+L G C   + + L+ E    G L   L    +  E+  +    ++
Sbjct: 59  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELL 115

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN---RTLL 384
             ++  + YL      + +HRD+++ N+LL ++  A ++DFG ++ L AD S    R+  
Sbjct: 116 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 385 AGTYGYIAP 393
                + AP
Sbjct: 173 KWPLKWYAP 181

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-40
 Identities = 39/174 (22%), Positives = 72/174 (41%), Gaps = 10/174 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNI 280
                 IG+G +G V+     N    A+K +      E    + F  EA+V+ ++ H  +
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKL 62

Query: 281 VKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
           V+LYG CL +  + L++E+ME G L    +             + +   +      + + 
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEG---MAYL 117

Query: 341 CSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL-LAGTYGYIAP 393
               +IHRD+++ N L+       V+DFG  R +  D    +        + +P
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 15/179 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FDI+  IG G + +VYK          A  +L   +  + +  + F+ EA++L  + H N
Sbjct: 13  FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69

Query: 280 IVKLYGFCL----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALA 335
           IV+ Y         +KC+ L+ E M  G+L   L   +    +      +  + +   L 
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126

Query: 336 YLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +LH    P IIHRD+  +NI +        + D G A L  A  +    + GT  ++AP
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA--VIGTPEFMAP 182

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 3e-40
 Identities = 48/178 (26%), Positives = 73/178 (41%), Gaps = 9/178 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     +G G + +V  A+ L   + +A+K L      +   +     E  V+S++ H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
              VKLY      + ++    Y + G L   +         D          +  AL YL
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAGTYGYIAP 393
           H      IIHRD+   NILLN      + DFGTA++L  +S         GT  Y++P
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 8e-40
 Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 11/177 (6%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
            + +     IG G  G+VY A  +  G+  A+++++  +  +    +   NE  V+ +  
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENK 75

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           + NIV      L    ++++ EY+  GSL   +         D  +   + +    AL +
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEF 131

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           LH   S  +IHRDI S+NILL       + DFG    +  + S R+ + GT  ++AP
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (354), Expect = 1e-39
 Identities = 47/175 (26%), Positives = 78/175 (44%), Gaps = 10/175 (5%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
             +K+ +G G YG VY+          A+K L     E    ++ F  EA V+ ++ H N
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPN 74

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           +V+L G C      ++I E+M  G+L   L       E+     + +   ++ A+ YL  
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE- 132

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGTYGYIAP 393
               + IHRD+++ N L+       VADFG +RL+  D+            + AP
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 14/173 (8%)

Query: 227 IGTGGYGSVYKAQLPN---GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKL 283
           +G+G +G+V K         K  A+K L     +  A       EA V+ Q+ +  IV++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPYIVRM 73

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
            G C   +   L+ E  E G L   L  N     +     + +V  ++  + YL      
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEE---S 126

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN---RTLLAGTYGYIAP 393
           + +HRD+++ N+LL ++  A ++DFG ++ L AD +    +T       + AP
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 44/202 (21%), Positives = 78/202 (38%), Gaps = 34/202 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
            +    +G+G +G V  A              A+K L           ++  +E ++++Q
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMMTQ 96

Query: 275 VL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN--------------------E 313
           +  H NIV L G C     ++LI+EY   G L   L +                     E
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
           D   L +   +     +A  + +L      S +HRD+++ N+L+       + DFG AR 
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 374 LHADSSNRTL--LAGTYGYIAP 393
           + +DS+            ++AP
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAP 235

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 50/197 (25%), Positives = 77/197 (39%), Gaps = 29/197 (14%)

Query: 221 FDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
                 +G G +G V +A              A+K L  S        ++  +E +VLS 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVLSY 82

Query: 275 VL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN---------------EDAVEL 318
           +  H NIV L G C       +I EY   G L   L                  +D + L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 319 DWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS 378
           D    ++    +A  +A+L    S + IHRD+++ NILL       + DFG AR +  DS
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 379 SN--RTLLAGTYGYIAP 393
           +   +        ++AP
Sbjct: 200 NYVVKGNARLPVKWMAP 216

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  140 bits (355), Expect = 5e-39
 Identities = 45/178 (25%), Positives = 85/178 (47%), Gaps = 12/178 (6%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + +DI   +G+G +G V++      G+VF  K ++T    +     + +NE  +++Q+ H
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             ++ L+     +  M LI E++  G LF  +   +   ++  A+ +N ++     L ++
Sbjct: 86  PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHM 143

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H     SI+H DI   NI+  +K  + V   DFG A  L+ D   +     T  + AP
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAP 197

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 8e-39
 Identities = 42/180 (23%), Positives = 73/180 (40%), Gaps = 13/180 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP----NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
             +   +G G +G V + +           A+K L      +   +  F  E   +  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           HRN+++LYG  L    M ++ E    GSL   L  ++    L    R      +A  + Y
Sbjct: 70  HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGY 126

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN---RTLLAGTYGYIAP 393
           L    S   IHRD+++ N+LL ++    + DFG  R L  +  +   +      + + AP
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-38
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 22/184 (11%)

Query: 223 IKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           ++  IG G +G V++ +   G+  A+K   + E            E      + H NI+ 
Sbjct: 7   LQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFR----EAEIYQTVMLRHENILG 61

Query: 283 LYGFCLHR----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
                         ++L+ +Y E GSLF  L+       +     + +  + A  LA+LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLH 117

Query: 339 HDC-----SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSN----RTLLAGTYG 389
            +       P+I HRD+ S NIL+       +AD G A    + +           GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 390 YIAP 393
           Y+AP
Sbjct: 178 YMAP 181

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  138 bits (349), Expect = 4e-38
 Identities = 49/202 (24%), Positives = 87/202 (43%), Gaps = 19/202 (9%)

Query: 199 VFSIWNYD----GRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHT 253
           VF IW         I ++ +++    +DI   +GTG +G V++      G  FA K + T
Sbjct: 5   VFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 61

Query: 254 SETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNE 313
               +    ++ R E Q +S + H  +V L+        M +IYE+M  G LF  + +  
Sbjct: 62  PHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 118

Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTA 371
           +   +   + V  ++ +   L ++H +     +H D+   NI+  +K    +   DFG  
Sbjct: 119 NK--MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLT 173

Query: 372 RLLHADSSNRTLLAGTYGYIAP 393
             L    S +    GT  + AP
Sbjct: 174 AHLDPKQSVKV-TTGTAEFAAP 194

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  134 bits (337), Expect = 5e-37
 Identities = 48/202 (23%), Positives = 85/202 (42%), Gaps = 34/202 (16%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
            +    IG G +G V++A+ P         + A+K L    + +      F+ EA ++++
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAE 72

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN---------------------E 313
             + NIVKL G C   K M L++EYM  G L   L +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 314 DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL 373
               L  A+++ I + +A  +AYL        +HRD+++ N L+       +ADFG +R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 374 LHADSSNR--TLLAGTYGYIAP 393
           +++    +     A    ++ P
Sbjct: 190 IYSADYYKADGNDAIPIRWMPP 211

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  134 bits (338), Expect = 7e-37
 Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + F I   +GTG +G V+  +   NG+ +A+K L       L  ++   +E  +LS V H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             I++++G     + +F+I +Y+E G LF  L  ++                 A     L
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------AAEVCLAL 117

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +  S  II+RD+   NILL+      + DFG A+ +         L GT  YIAP
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP---DVTYTLCGTPDYIAP 170

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 8e-37
 Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 8/177 (4%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
           E F +   +G G +G V+ A+     + FA+K L          ++    E +VLS    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H  +  ++     ++ +F + EY+  G L  ++ +     + D ++       +   L +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           L    S  I++RD+  +NILL+      +ADFG  +      +      GT  YIAP
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 4e-36
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 13/179 (7%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  ++  CIG G +G V++    +        A+K      ++     + F  EA  + Q
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 64

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
             H +IVKL G       +++I E    G L            LD A  +     ++ AL
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTAL 121

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR-TLLAGTYGYIA 392
           AYL    S   +HRDI++ N+L++S     + DFG +R +   +  + +       ++A
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  132 bits (332), Expect = 4e-36
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 16/186 (8%)

Query: 212 EDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQ 270
           ED+    + +D +  +GTG +  V  A+     K+ A+K +     E      S  NE  
Sbjct: 5   EDI---RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIA 59

Query: 271 VLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           VL ++ H NIV L         ++LI + +  G LF  +                ++  +
Sbjct: 60  VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQV 116

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAF---VADFGTARLLHADSSNRTLLAGT 387
             A+ YLH      I+HRD+   N+L  S  E     ++DFG +++    S   T   GT
Sbjct: 117 LDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGT 172

Query: 388 YGYIAP 393
            GY+AP
Sbjct: 173 PGYVAP 178

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 8e-36
 Identities = 46/181 (25%), Positives = 84/181 (46%), Gaps = 13/181 (7%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E  E + I   +G G +G V++     + K +  K +    T++       + E  +L+ 
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57

Query: 275 VLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
             HRNI+ L+      + + +I+E++    +F  ++ +  A EL+  + V+ V  +  AL
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEAL 115

Query: 335 AYLHHDCSPSIIHRDISSNNILLNSKFEAFV--ADFGTARLLHADSSNRTLLAGTYGYIA 392
            +LH   S +I H DI   NI+  ++  + +   +FG AR L    + R  L     Y A
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYA 171

Query: 393 P 393
           P
Sbjct: 172 P 172

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (327), Expect = 9e-36
 Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 14/184 (7%)

Query: 218 TEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL 276
           ++ +++   +G GG   V+ A+ L   +  A+K L      + +F   FR EAQ  + + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 277 HRNIVKLYGFCLHR----KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
           H  IV +Y             +++ EY++  +L   +H       +   + + ++     
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL---LAGTYG 389
           AL +        IIHRD+   NI++++     V DFG AR +    ++ T    + GT  
Sbjct: 123 ALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 390 YIAP 393
           Y++P
Sbjct: 180 YLSP 183

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-35
 Identities = 48/190 (25%), Positives = 82/190 (43%), Gaps = 23/190 (12%)

Query: 221 FDIKYCIGTGGYGSVYKAQLPNG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVL- 276
              +  IG G +G V KA++         A+K++    +++    + F  E +VL ++  
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGH 69

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHN-------------NEDAVELDWAKR 323
           H NI+ L G C HR  ++L  EY   G+L   L               N  A  L   + 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
           ++    +A  + YL        IHRD+++ NIL+   + A +ADFG +R        +T+
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTM 185

Query: 384 LAGTYGYIAP 393
                 ++A 
Sbjct: 186 GRLPVRWMAI 195

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 12/176 (6%)

Query: 221 FDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVL 276
           F +   IG GG+G VY  +    GK++A+K L        +      + R    ++S   
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
              IV +         +  I + M  G L  +L  +    E D          +   L +
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF---YAAEIILGLEH 122

Query: 337 LHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           +H   +  +++RD+   NILL+      ++D G A        + +   GT+GY+A
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMA 173

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 4e-35
 Identities = 51/183 (27%), Positives = 81/183 (44%), Gaps = 15/183 (8%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSETEELAFIKSFRNEAQVLS 273
                +  IG G +G VYK  L           A+K L    TE+      F  EA ++ 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMG 64

Query: 274 QVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           Q  H NI++L G     K M +I EYME G+   +    E   E    + V +++ +A  
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAG 122

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLA---GTYGY 390
           +    +  + + +HRD+++ NIL+NS     V+DFG +R+L  D       +       +
Sbjct: 123 M---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 391 IAP 393
            AP
Sbjct: 180 TAP 182

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 41/181 (22%), Positives = 73/181 (40%), Gaps = 15/181 (8%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQVL 276
           +D    +G+G +  V K +    G  +A K +    T  +      +    E  +L ++ 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 277 HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAY 336
           H N++ L+    ++  + LI E +  G LF  L   E   E + A        +   L  
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE-EEATEF-----LKQILNG 125

Query: 337 LHHDCSPSIIHRDISSNNILLNS----KFEAFVADFGTARLLHADSSNRTLLAGTYGYIA 392
           +++  S  I H D+   NI+L      K    + DFG A  +   +     + GT  ++A
Sbjct: 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVA 184

Query: 393 P 393
           P
Sbjct: 185 P 185

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 43/170 (25%), Positives = 74/170 (43%), Gaps = 9/170 (5%)

Query: 227 IGTGGYGSVYKAQLPN-GKVFALKKLHTSETEEL--AFIKSFRNEAQVLSQVLHRNIVKL 283
           +G G + +VYKA+  N  ++ A+KK+      E      ++   E ++L ++ H NI+ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 284 YGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSP 343
                H+  + L++++ME         N+                 M   L  L +    
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY------MLMTLQGLEYLHQH 119

Query: 344 SIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            I+HRD+  NN+LL+      +ADFG A+   + +   T    T  Y AP
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  126 bits (317), Expect = 3e-34
 Identities = 46/183 (25%), Positives = 79/183 (43%), Gaps = 15/183 (8%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELA------FIKSFRNEAQV 271
           E ++ K  +G G    V +    P  K +A+K +  +     +        ++   E  +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 272 LSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAM 330
           L +V  H NI++L          FL+++ M++G LF  L        L   +   I++A+
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119

Query: 331 AHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGY 390
              +  LH     +I+HRD+   NILL+      + DFG +  L      R  + GT  Y
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE-VCGTPSY 175

Query: 391 IAP 393
           +AP
Sbjct: 176 LAP 178

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (313), Expect = 9e-34
 Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 7/175 (4%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR 278
           E +     IG G YG VYKAQ   G+ FALKK+   + +E     +   E  +L ++ H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
           NIVKLY     +K + L++E++    L   L   E  +E   AK       +   L  + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSF-----LLQLLNGIA 114

Query: 339 HDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           +     ++HRD+   N+L+N + E  +ADFG AR         T    T  Y AP
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 1e-33
 Identities = 46/187 (24%), Positives = 89/187 (47%), Gaps = 16/187 (8%)

Query: 214 LIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVF----ALKKLHTSETEELAFIKSFRNE 268
           +++ TE F     +G+G +G+VYK   +P G+      A+K+L  + + +    K   +E
Sbjct: 5   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK--ANKEILDE 61

Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           A V++ V + ++ +L G CL    + LI + M  G L   +  ++D   +     +N   
Sbjct: 62  AYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCV 118

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL--LAG 386
            +A  + YL       ++HRD+++ N+L+ +     + DFG A+LL A+           
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 387 TYGYIAP 393
              ++A 
Sbjct: 176 PIKWMAL 182

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-33
 Identities = 42/176 (23%), Positives = 70/176 (39%), Gaps = 16/176 (9%)

Query: 227 IGTGGYGSVYKAQLPNGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVK 282
           IG G +G VY   L +        A+K L+         +  F  E  ++    H N++ 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLS 92

Query: 283 LYGFCLHRK-CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC 341
           L G CL  +    ++  YM+ G L   + N      +       +  A       +    
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 342 SPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS----SNRTLLAGTYGYIAP 393
           S   +HRD+++ N +L+ KF   VADFG AR ++        N+T       ++A 
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-33
 Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 7/176 (3%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           FD    +G G +G V   +    G+ +A+K L          +     E++VL    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           +  L         +  + EY   G LF +L       E             A  ++ L +
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAEIVSALEY 120

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAPGL 395
             S  +++RDI   N++L+      + DFG  +   +D +      GT  Y+AP +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-33
 Identities = 41/190 (21%), Positives = 75/190 (39%), Gaps = 20/190 (10%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVL 272
           E   +   +G G +G VY+               A+K ++ + +        F NEA V+
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77

Query: 273 SQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLH-------NNEDAVELDWAKRVN 325
            +    ++V+L G     +   +I E M RG L   L        NN        +K + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 326 IVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR--TL 383
           +   +A  +AYL    +   +HRD+++ N ++   F   + DFG  R ++     R    
Sbjct: 138 MAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 384 LAGTYGYIAP 393
                 +++P
Sbjct: 195 GLLPVRWMSP 204

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 2e-32
 Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 9/184 (4%)

Query: 214 LIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVL 272
           + +    +     IG G YG V  A    N    A+KK+   E +   + +    E ++L
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQT--YCQRTLREIKIL 60

Query: 273 SQVLHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
            +  H NI+ +           +   Y+    +  +L+       L        +  +  
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILR 120

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL---LAGTYG 389
            L Y+H   S +++HRD+  +N+LLN+  +  + DFG AR+   D  +         T  
Sbjct: 121 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 390 YIAP 393
           Y AP
Sbjct: 178 YRAP 181

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-32
 Identities = 51/176 (28%), Positives = 77/176 (43%), Gaps = 7/176 (3%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           E F     IG G YG VYKA+    G+V ALKK+   +TE      +   E  +L ++ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNH 60

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
            NIVKL         ++L++E++ +        +    + L   K       +   L  L
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSY-----LFQLLQGL 115

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
               S  ++HRD+   N+L+N++    +ADFG AR         T    T  Y AP
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 1e-31
 Identities = 41/180 (22%), Positives = 72/180 (40%), Gaps = 14/180 (7%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLH---TSETEELAFIKSFRNEAQVLSQV- 275
           + +   +G+GG+GSVY    + +    A+K +     S+  EL        E  +L +V 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 276 -LHRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHAL 334
                +++L  +        LI E  E      +      A  L      +    +  A+
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAV 123

Query: 335 AYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            +     +  ++HRDI   NIL++ ++ E  + DFG+  LL    +  T   GT  Y  P
Sbjct: 124 RHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPP 178

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 3e-31
 Identities = 46/176 (26%), Positives = 75/176 (42%), Gaps = 22/176 (12%)

Query: 227 IGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLY 284
           +G G  G V +       + FALK L              R E ++  +     +IV++ 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIV 71

Query: 285 GFC----LHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD 340
                    RKC+ ++ E ++ G LF  + +  D       +   I+K++  A+ YLH  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAIQYLH-- 128

Query: 341 CSPSIIHRDISSNNILLNSKFE---AFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
            S +I HRD+   N+L  SK       + DFG A+   + +S  T    T  Y+AP
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAP 182

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 3e-31
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 10/176 (5%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH 277
           + FD    +GTG +G V   +   +G  +A+K L   +  +L  I+   NE ++L  V  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 278 RNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYL 337
             +VKL         ++++ EY+  G +F +L                    +     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157

Query: 338 HHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           H   S  +I+RD+   N+L++ +    V DFG A+ +         L GT   +AP
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEALAP 207

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-31
 Identities = 44/199 (22%), Positives = 79/199 (39%), Gaps = 29/199 (14%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQ 270
           +   +   +G G +G V  A+               A+K L +  TE+   +    +E +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70

Query: 271 VLSQVL-HRNIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNN-------------EDAV 316
           ++  +  H+NI+ L G C     +++I EY  +G+L   L                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA 376
           +L     V+    +A  + YL    S   IHRD+++ N+L+       +ADFG AR +H 
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187

Query: 377 DSSNRTLLA--GTYGYIAP 393
               +          ++AP
Sbjct: 188 IDYYKKTTNGRLPVKWMAP 206

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 47/181 (25%), Positives = 79/181 (43%), Gaps = 19/181 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +     IG G +G VY+A+L  +G++ A+KK+   +       +    E Q++ ++ H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74

Query: 280 IVKLYGFCLH------RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           IV+L  F            + L+ +Y+         H +     L        +  +  +
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAF-VADFGTARLLHADSSNRTLLAGTYGYIA 392
           LAY+H   S  I HRDI   N+LL+       + DFG+A+ L     N + +   Y Y A
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRA 190

Query: 393 P 393
           P
Sbjct: 191 P 191

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 2e-30
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 8/174 (4%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           ++    IG G YG+V+KA+     ++ ALK++   + +E     S   E  +L ++ H+N
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKN 62

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           IV+L+      K + L++E+ ++         N D               +   L  L  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK------SFLFQLLKGLGF 116

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
             S +++HRD+   N+L+N   E  +A+FG AR         +    T  Y  P
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 4e-30
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 20/188 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           ++    IG G +G V+KA+    G+  ALKK+     +E  F  +   E ++L  + H N
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHEN 70

Query: 280 IVKLYGFCLHRK--------CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMA 331
           +V L   C  +          ++L++++ E        +       L   KRV     M 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRV-----MQ 124

Query: 332 HALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS----NRTLLAGT 387
             L  L++     I+HRD+ + N+L+       +ADFG AR      +      T    T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184

Query: 388 YGYIAPGL 395
             Y  P L
Sbjct: 185 LWYRPPEL 192

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 4e-30
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 13/181 (7%)

Query: 219 EGFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSE-TEELAFIKSFRNEAQVLS 273
           E F++   +GTG YG V+  +       GK++A+K L  +   ++    +  R E QVL 
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 274 QVLHR-NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAH 332
            +     +V L+        + LI +Y+  G LF +L   E   E +          +  
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY------VGE 137

Query: 333 ALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRT-LLAGTYGYI 391
            +  L H     II+RDI   NILL+S     + DFG ++   AD + R     GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 392 A 392
           A
Sbjct: 198 A 198

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 43/196 (21%), Positives = 78/196 (39%), Gaps = 28/196 (14%)

Query: 221 FDIKYCIGTGGYGSVYKA------QLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
             +   +G G +G V +A      +    +  A+K L    T      ++  +E ++L  
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIH 72

Query: 275 VLHR-NIVKLYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVE-------------LD 319
           + H  N+V L G C      + +I E+ + G+L   L +  +                L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 320 WAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS 379
               +     +A  + +L    S   IHRD+++ NILL+ K    + DFG AR ++ D  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 380 N--RTLLAGTYGYIAP 393
              +        ++AP
Sbjct: 190 YVRKGDARLPLKWMAP 205

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (283), Expect = 2e-29
 Identities = 29/185 (15%), Positives = 62/185 (33%), Gaps = 23/185 (12%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + +   IG+G +G +Y    +  G+  A+K                  E+++   +    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGV 63

Query: 280 IVKLYGFCLH-RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            +    +C        ++ E +           +    +      + +   M   + Y+H
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 120

Query: 339 HDCSPSIIHRDISSNNILLNSK---FEAFVADFGTARLLHADSSN-------RTLLAGTY 388
              S + IHRD+  +N L+         ++ DFG A+      ++          L GT 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 389 GYIAP 393
            Y + 
Sbjct: 178 RYASI 182

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 5e-28
 Identities = 45/186 (24%), Positives = 82/186 (44%), Gaps = 15/186 (8%)

Query: 217 ATEGFDIKYCIGTGGYGSVYKAQ--LPNGKVFALKKLHTSETEELAFIKSFR--NEAQVL 272
           A + ++    IG G YG V+KA+     G+  ALK++     EE   + + R     + L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 273 SQVLHRNIVKLYGFCL-----HRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIV 327
               H N+V+L+  C          + L++E++++          E    +      +++
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMM 122

Query: 328 KAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGT 387
             +   L +LH      ++HRD+   NIL+ S  +  +ADFG AR+     +  + +  T
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVT 178

Query: 388 YGYIAP 393
             Y AP
Sbjct: 179 LWYRAP 184

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  104 bits (261), Expect = 3e-26
 Identities = 31/187 (16%), Positives = 61/187 (32%), Gaps = 25/187 (13%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHR- 278
           + +   IG G +G +++   L N +  A+K                R+E +    +    
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAGCT 61

Query: 279 NIVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLH 338
            I  +Y F        L+ + +                +          K M   +  +H
Sbjct: 62  GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 118

Query: 339 HDCSPSIIHRDISSNNILLNSKF-----EAFVADFGTARLLHADSSN-------RTLLAG 386
                S+++RDI  +N L+           +V DFG  +      +        +  L+G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175

Query: 387 TYGYIAP 393
           T  Y++ 
Sbjct: 176 TARYMSI 182

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  105 bits (262), Expect = 4e-26
 Identities = 33/198 (16%), Positives = 74/198 (37%), Gaps = 24/198 (12%)

Query: 201 SIWNYDGRIVYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEEL 259
             W+Y+  +V     +    + +   +G G Y  V++A  + N +   +K L   + ++ 
Sbjct: 20  EYWDYESHVVEWGNQD---DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK- 75

Query: 260 AFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR--KCMFLIYEYMERGSLFCNLHNNEDAV 316
                 + E ++L  +    NI+ L         +   L++E++                
Sbjct: 76  -----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----- 125

Query: 317 ELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARLLH 375
            L        +  +  AL Y H      I+HRD+  +N++++ +  +  + D+G A   H
Sbjct: 126 -LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

Query: 376 ADSSNRTLLAGTYGYIAP 393
                  +   +  +  P
Sbjct: 182 PGQEY-NVRVASRYFKGP 198

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-26
 Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 19/189 (10%)

Query: 216 EATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQ 274
           E    +     +G+G YG+V  A     G   A+KKL+     EL F K    E ++L  
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKH 73

Query: 275 VLHRNIVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVK 328
           + H N++ L       + +      +L+  +M  G+    L  +E   +L   +   +V 
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVY 128

Query: 329 AMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTY 388
            M   L Y+H   +  IIHRD+   N+ +N   E  + DFG AR      S  T    T 
Sbjct: 129 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTR 182

Query: 389 GYIAPGLPL 397
            Y AP + L
Sbjct: 183 WYRAPEVIL 191

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 5e-25
 Identities = 44/180 (24%), Positives = 68/180 (37%), Gaps = 18/180 (10%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           +     IG+G  G V  A      +  A+KKL      +    K    E  ++  V H+N
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKN 77

Query: 280 IVKLYGFCLHRKCM------FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHA 333
           I+ L      +K +      +L+ E M+                 D  +   ++  M   
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCG 131

Query: 334 LAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTLLAGTYGYIAP 393
           + +LH      IIHRD+  +NI++ S     + DFG AR     S   T    T  Y AP
Sbjct: 132 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAP 187

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.2 bits (228), Expect = 1e-22
 Identities = 25/164 (15%), Positives = 56/164 (34%), Gaps = 17/164 (10%)

Query: 227 IGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFI-------KSFRNEAQVLSQVLHRN 279
           +G G   +V+           +K      T               F   A   ++   R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 280 IVKLYGFCLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH 339
           + KL G  + +   +      E  ++   L + ++   +       ++  +   +A  +H
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 340 DCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
                I+H D+S  N+L+ S+   ++ DF  +  +  +     L
Sbjct: 122 RG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREIL 161

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 1e-22
 Identities = 42/190 (22%), Positives = 74/190 (38%), Gaps = 16/190 (8%)

Query: 210 VYEDLIEATEGFDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNE 268
           + + + E  E +     +G+G YGSV  A     G   A+KKL     + +   K    E
Sbjct: 9   LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRE 67

Query: 269 AQVLSQVLHRNIVKLYGFCLHRKCM-----FLIYEYMERGSLFCNLHNNEDAVELDWAKR 323
            ++L  + H N++ L       + +       +  ++    L   +       +L     
Sbjct: 68  LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHV 123

Query: 324 VNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNRTL 383
             ++  +   L Y+H   S  IIHRD+  +N+ +N   E  + DFG AR  H D      
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGY 178

Query: 384 LAGTYGYIAP 393
           +A  +     
Sbjct: 179 VATRWYRAPE 188

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.5 bits (210), Expect = 4e-19
 Identities = 34/192 (17%), Positives = 70/192 (36%), Gaps = 27/192 (14%)

Query: 221 FDIKYCIGTGGYGSVYKAQ-LPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN 279
           + +   +G G + +V+ A+ + N    A+K +   +     + ++  +E ++L +V   +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDAD 70

Query: 280 IVKLYGFCLHR---------------KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRV 324
             K      +                  + +++E +    L          + L + K+ 
Sbjct: 71  NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ- 129

Query: 325 NIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSK-FEAFVADFGTARLLHADSSNRT- 382
            I K +   L Y+H  C   IIH DI   N+L+        +     A L +A   +   
Sbjct: 130 -ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186

Query: 383 -LLAGTYGYIAP 393
                T  Y +P
Sbjct: 187 TNSIQTREYRSP 198

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 78.9 bits (193), Expect = 1e-16
 Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 28/156 (17%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP------------- 47
            + +L NL +LD+ +N +    P  L  LT L+ L L  NQ ++  P             
Sbjct: 236 TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293

Query: 48  -------NELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE 100
                  + ++ L  L  L L  N +S   P  ++S+  L  L  +NNK+       +  
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349

Query: 101 LSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN 136
           L+ +++L+   N++S   P +N  L+ +  + L+  
Sbjct: 350 LTNINWLSAGHNQISDLTPLAN--LTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 66.2 bits (160), Expect = 1e-12
 Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 28/152 (18%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK 65
            NL EL +  N L      TL  LT+L+ LDL+ NQ ++  P  L+ LT L  L L +N+
Sbjct: 219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQ 274

Query: 66  LSGKIP--------------------SQIASMKNLTWLDISNNKIEGSIPGEITELSRLD 105
           +S   P                    S I+++KNLT+L +  N I    P  ++ L++L 
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQ 332

Query: 106 YLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
            L  ++NK+S     +N  L+++  +    N+
Sbjct: 333 RLFFANNKVSDVSSLAN--LTNINWLSAGHNQ 362

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.3 bits (111), Expect = 1e-06
 Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 4/70 (5%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           L   +   L    ++  +      +  +T L      I+ SI G +  L+ L  +N S+N
Sbjct: 21  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76

Query: 113 KLSGPVPFSN 122
           +L+   P  N
Sbjct: 77  QLTDITPLKN 86

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 1e-05
 Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 10/88 (11%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV 118
           L  ++N++S   P  I  + NL  L ++ N+++    G +  L+ L  L+L++N++S   
Sbjct: 202 LIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257

Query: 119 PFSNEQ------LSSMYIVRLSPNKGLC 140
           P S         L +  I  +SP  GL 
Sbjct: 258 PLSGLTKLTELKLGANQISNISPLAGLT 285

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.5 bits (101), Expect = 3e-05
 Identities = 17/85 (20%), Positives = 38/85 (44%), Gaps = 6/85 (7%)

Query: 4  NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           L   ++  +G  ++   +  +   L  ++ L   R    S I   + +L  L  +N S+
Sbjct: 20 ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSN 75

Query: 64 NKLSGKIPSQIASMKNLTWLDISNN 88
          N+L+   P  + ++  L  + ++NN
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNN 98

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.8 bits (169), Expect = 6e-14
 Identities = 30/73 (41%), Positives = 41/73 (56%), Gaps = 3/73 (4%)

Query: 77  MKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN 136
            KNL  LD+ NN+I G++P  +T+L  L  LN+S N L G +P     L    +   + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANN 301

Query: 137 KGLCGNFSALPSC 149
           K LCG  S LP+C
Sbjct: 302 KCLCG--SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.5 bits (145), Expect = 8e-11
 Identities = 21/63 (33%), Positives = 31/63 (49%), Gaps = 1/63 (1%)

Query: 33  SYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEG 92
           + LDL  N+   ++P  LT L  L  LN+S N L G+IP    +++       +NNK   
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLC 305

Query: 93  SIP 95
             P
Sbjct: 306 GSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.4 bits (124), Expect = 3e-08
 Identities = 20/66 (30%), Positives = 29/66 (43%), Gaps = 1/66 (1%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK 65
           KNL  LD+ +N + G +P  L  L  L  L++S N     IP +   L        ++NK
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302

Query: 66  LSGKIP 71
                P
Sbjct: 303 CLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 48.6 bits (114), Expect = 5e-07
 Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 3/141 (2%)

Query: 3   GNLKNLIELDVGSNSLIG--PIPSTLGLLTDLSYLDLSRN-QFNSSIPNELTWLTGLLGL 59
                +  LD+   +L    PIPS+L  L  L++L +         IP  +  LT L  L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
            ++   +SG IP  ++ +K L  LD S N + G++P  I+ L  L  +    N++SG +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 120 FSNEQLSSMYIVRLSPNKGLC 140
            S    S ++         L 
Sbjct: 167 DSYGSFSKLFTSMTISRNRLT 187

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 46.7 bits (109), Expect = 2e-06
 Identities = 14/47 (29%), Positives = 19/47 (40%), Gaps = 1/47 (2%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP 47
            +  LK L  L+V  N+L G IP   G L        + N+     P
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 59.7 bits (143), Expect = 1e-10
 Identities = 26/143 (18%), Positives = 53/143 (37%), Gaps = 1/143 (0%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNK 65
            +   LD+ +N +          L +L  L L  N+ +   P     L  L  L LS N+
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 66  LSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQL 125
           L         +++ L   +    K+  S+   + ++  ++ L  +  K SG    + + +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149

Query: 126 SSMYIVRLSPNKGLCGNFSALPS 148
             +  +R++            PS
Sbjct: 150 KKLSYIRIADTNITTIPQGLPPS 172

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 1e-09
 Identities = 29/119 (24%), Positives = 46/119 (38%), Gaps = 3/119 (2%)

Query: 31  DLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKI 90
            L  +  S       +P +L        L+L +NK++        ++KNL  L + NNKI
Sbjct: 11  HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 91  EGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
               PG    L +L+ L LS N+L        + L  + +      K     F+ L   
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 1e-09
 Identities = 32/119 (26%), Positives = 54/119 (45%), Gaps = 7/119 (5%)

Query: 3   GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLS 62
           G   +L EL +  N +     ++L  L +L+ L LS N  ++     L     L  L+L+
Sbjct: 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227

Query: 63  SNKLSGKIPSQIASMKNLTWLDISNNKIEG------SIPGEITELSRLDYLNLSSNKLS 115
           +NKL  K+P  +A  K +  + + NN I          PG  T+ +    ++L SN + 
Sbjct: 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 56.6 bits (135), Expect = 1e-09
 Identities = 36/158 (22%), Positives = 62/158 (39%), Gaps = 28/158 (17%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW-------- 52
           +  NLKNL  L + +N +    P     L  L  L LS+NQ    +P ++          
Sbjct: 50  DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVH 108

Query: 53  ----------------LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG 96
                              ++ L  +  K SG        MK L+++ I++  I  +IP 
Sbjct: 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 167

Query: 97  EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLS 134
            +     L  L+L  NK++     S + L+++  + LS
Sbjct: 168 GL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 55.0 bits (131), Expect = 4e-09
 Identities = 27/129 (20%), Positives = 44/129 (34%), Gaps = 4/129 (3%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT 81
           +P    L  D + LDL  N+       +   L  L  L L +NK+S   P   A +  L 
Sbjct: 25  VPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 82  WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV--PFSNEQLSSMYIVRLSPNKGL 139
            L +S N+++         L  L        K+   V    +   +  +    L  +   
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142

Query: 140 CGNFSALPS 148
            G F  +  
Sbjct: 143 NGAFQGMKK 151

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 54.7 bits (130), Expect = 5e-09
 Identities = 35/142 (24%), Positives = 58/142 (40%), Gaps = 10/142 (7%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              +K L  + +   ++   IP   GL   L+ L L  N+        L  L  L  L L
Sbjct: 146 FQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 202

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG----- 116
           S N +S      +A+  +L  L ++NNK+   +PG + +   +  + L +N +S      
Sbjct: 203 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSND 261

Query: 117 -PVPFSNEQLSSMYIVRLSPNK 137
              P  N + +S   V L  N 
Sbjct: 262 FCPPGYNTKKASYSGVSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 9/154 (5%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           N   ++EL        G        +  LSY+ ++     ++IP  L     L  L+L  
Sbjct: 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDG 180

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNE 123
           NK++    + +  + NL  L +S N I     G +     L  L+L++NKL   VP    
Sbjct: 181 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 239

Query: 124 QLSSMYIVRLSPNKGLCGNFSALPSCDATKPATL 157
               + +V L  N     N SA+ S D   P   
Sbjct: 240 DHKYIQVVYLHNN-----NISAIGSNDFCPPGYN 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.4 bits (134), Expect = 1e-09
 Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 4/135 (2%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
             +L NL  L +  N +          L  L  L L +N+     P+    L  L+ L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
            +N LS      +A ++ L +L +++N             + L     SS+++   +P  
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP-- 265

Query: 122 NEQLSSMYIVRLSPN 136
            ++L+   + RL+ N
Sbjct: 266 -QRLAGRDLKRLAAN 279

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.2 bits (118), Expect = 1e-07
 Identities = 30/118 (25%), Positives = 40/118 (33%)

Query: 23  PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW 82
           P+T   L  L  L L R       P     L  L  L L  N L          + NLT 
Sbjct: 98  PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157

Query: 83  LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC 140
           L +  N+I          L  LD L L  N+++   P +   L  +  + L  N    
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (110), Expect = 1e-06
 Identities = 34/139 (24%), Positives = 52/139 (37%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
              L  L  L +    L    P     L  L YL L  N   +   +    L  L  L L
Sbjct: 101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFL 160

Query: 62  SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS 121
             N++S         + +L  L +  N++    P    +L RL  L L +N LS     +
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEA 220

Query: 122 NEQLSSMYIVRLSPNKGLC 140
              L ++  +RL+ N  +C
Sbjct: 221 LAPLRALQYLRLNDNPWVC 239

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.6 bits (106), Expect = 5e-06
 Identities = 26/169 (15%), Positives = 49/169 (28%), Gaps = 25/169 (14%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI------------------- 46
                + +  N +     ++     +L+ L L  N                         
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 47  ------PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE 100
                 P     L  L  L+L    L    P     +  L +L + +N ++        +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 101 LSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
           L  L +L L  N++S     +   L S+  + L  N+    +  A    
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 54.1 bits (128), Expect = 1e-08
 Identities = 18/80 (22%), Positives = 30/80 (37%), Gaps = 10/80 (12%)

Query: 29  LTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN 88
              L  L++S N+    +P     L  L     S N L+ ++P      +NL  L +  N
Sbjct: 283 PPSLEELNVSNNKL-IELPALPPRLERL---IASFNHLA-EVPE---LPQNLKQLHVEYN 334

Query: 89  KIEGSIPGEITELSRLDYLN 108
            +    P     +  L  +N
Sbjct: 335 PLR-EFPDIPESVEDL-RMN 352

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 2e-08
 Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 9/94 (9%)

Query: 37  LSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG 96
              N  ++ I +       L  LN+S+NKL  ++P   A    L  L  S N +   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPE 321

Query: 97  EITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYI 130
               L +L    +  N L    P   E +  + +
Sbjct: 322 LPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 43.3 bits (100), Expect = 3e-05
 Identities = 20/71 (28%), Positives = 31/71 (43%), Gaps = 5/71 (7%)

Query: 60  NLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP 119
               N  S +I S      +L  L++SNNK+   +P     L RL     S N L+  VP
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLAE-VP 320

Query: 120 FSNEQLSSMYI 130
              + L  +++
Sbjct: 321 ELPQNLKQLHV 331

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.001
 Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 8/65 (12%)

Query: 28 LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISN 87
          L      L+L+     SS+P     L     L  S N L+ ++P      ++L  L + N
Sbjct: 36 LDRQAHELELNNLGL-SSLPELPPHLE---SLVASCNSLT-ELPELP---QSLKSLLVDN 87

Query: 88 NKIEG 92
          N ++ 
Sbjct: 88 NNLKA 92

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.9 bits (86), Expect = 0.001
 Identities = 14/56 (25%), Positives = 21/56 (37%), Gaps = 5/56 (8%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           L L++  LS  +P       +L  L  S N +   +P     L  L   N +   L
Sbjct: 43  LELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 36.7 bits (83), Expect = 0.003
 Identities = 14/73 (19%), Positives = 26/73 (35%), Gaps = 6/73 (8%)

Query: 78  KNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK 137
           +    L+++N  +  S+P     L  L     S N L+  +P   + L S+ +   +   
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLK- 91

Query: 138 GLCGNFSALPSCD 150
            L      L    
Sbjct: 92  ALSDLPPLLEYLG 104

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 2e-08
 Identities = 14/91 (15%), Positives = 31/91 (34%), Gaps = 5/91 (5%)

Query: 31  DLSYLDLSRNQFNSSIPNEL-TWLTGLLGLNLSSNKLSGKIPSQIASM----KNLTWLDI 85
           D+  LD+   + + +   EL   L     + L    L+      I+S       L  L++
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 86  SNNKIEGSIPGEITELSRLDYLNLSSNKLSG 116
            +N++       + +  +     +    L  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 2e-06
 Identities = 18/92 (19%), Positives = 27/92 (29%), Gaps = 10/92 (10%)

Query: 7  NLIELDVGSNSLI-GPIPSTLGLLTDLSYLDLSRNQFN----SSIPNELTWLTGLLGLNL 61
          ++  LD+    L        L LL     + L            I + L     L  LNL
Sbjct: 3  DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 62 SSNKLSGKIPSQIASM-----KNLTWLDISNN 88
           SN+L       +          +  L + N 
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.5 bits (108), Expect = 4e-06
 Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 9/93 (9%)

Query: 42  FNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASM----KNLTWLDISNNKIEGSIPGE 97
                       + L  L L+   +S    S +A+      +L  LD+SNN +  +   +
Sbjct: 357 VRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQ 416

Query: 98  ITE-----LSRLDYLNLSSNKLSGPVPFSNEQL 125
           + E        L+ L L     S  +    + L
Sbjct: 417 LVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 4e-05
 Identities = 17/92 (18%), Positives = 31/92 (33%), Gaps = 10/92 (10%)

Query: 4   NLKNLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNEL-----TWLT 54
               L  L +    +       + +TL     L  LDLS N    +   +L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 55  GLLGLNLSSNKLSGKIPSQIASM-KNLTWLDI 85
            L  L L     S ++  ++ ++ K+   L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 4e-04
 Identities = 10/71 (14%), Positives = 21/71 (29%), Gaps = 4/71 (5%)

Query: 2  IGNLKNLIELDVGSNSL----IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLL 57
          +  L+    + +    L       I S L +   L+ L+L  N+      + +       
Sbjct: 23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 58 GLNLSSNKLSG 68
             +    L  
Sbjct: 83 SCKIQKLSLQN 93

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 4e-08
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 6/107 (5%)

Query: 11  LDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKI 70
           L +    L   +   L  L  +++LDLS N+   ++P  L  L  L  L  S N    + 
Sbjct: 3   LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNA--LEN 57

Query: 71  PSQIASMKNLTWLDISNNKIEG-SIPGEITELSRLDYLNLSSNKLSG 116
              +A++  L  L + NN+++  +    +    RL  LNL  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.1 bits (80), Expect = 0.003
 Identities = 19/108 (17%), Positives = 32/108 (29%), Gaps = 25/108 (23%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGL---------------------LTDLSYLDLSR 39
            +  L  +  LD+  N L    P+   L                     L  L  L L  
Sbjct: 15  HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCN 74

Query: 40  NQFNS-SIPNELTWLTGLLGLNLSSNKLSGK---IPSQIASMKNLTWL 83
           N+    +    L     L+ LNL  N L  +          + +++ +
Sbjct: 75  NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 1e-07
 Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 3/65 (4%)

Query: 49  ELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLN 108
           E++ +   L +N     L+  +P  +   K+ T L +S N +       +   +RL  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 109 LSSNK 113
           L   +
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 7e-06
 Identities = 37/180 (20%), Positives = 51/180 (28%), Gaps = 46/180 (25%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ------------------------ 41
           K+   L +  N L     +TL   T L+ L+L R +                        
Sbjct: 31  KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ 90

Query: 42  ---------------------FNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNL 80
                                  S     L  L  L  L L  N+L    P  +     L
Sbjct: 91  SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150

Query: 81  TWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC 140
             L ++NN +     G +  L  LD L L  N L   +P        +    L  N  LC
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.8 bits (99), Expect = 3e-05
 Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 3/65 (4%)

Query: 1  EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLN 60
          E+  + + +E++    +L   +P    L  D + L LS N   +     L   T L  LN
Sbjct: 5  EVSKVASHLEVNCDKRNLTA-LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 61 LSSNK 65
          L   +
Sbjct: 62 LDRAE 66

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 1e-06
 Identities = 17/80 (21%), Positives = 35/80 (43%), Gaps = 2/80 (2%)

Query: 6   KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFN-SSIPNELTWLTGLLGLNLSSN 64
           + +I      + +  P+         + ++DLS +    S++   L+  + L  L+L   
Sbjct: 23  QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL 81

Query: 65  KLSGKIPSQIASMKNLTWLD 84
           +LS  I + +A   NL  L+
Sbjct: 82  RLSDPIVNTLAKNSNLVRLN 101

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 9e-04
 Identities = 11/92 (11%), Positives = 35/92 (38%), Gaps = 3/92 (3%)

Query: 59  LNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSG-P 117
           L+L+   L   +  ++ S + +       + ++  +    +   R+ +++LS++ +    
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62

Query: 118 VPFSNEQLSSMYIVRLSPNKGLCGNFSALPSC 149
           +     Q S +  + L   +      + L   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKN 94

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.6 bits (104), Expect = 7e-06
 Identities = 19/64 (29%), Positives = 35/64 (54%), Gaps = 4/64 (6%)

Query: 71  PSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYI 130
            + +A++  LT L   +NKI    P  +  L  L  ++L +N++S   P +N   S+++I
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLAN--TSNLFI 221

Query: 131 VRLS 134
           V L+
Sbjct: 222 VTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 6e-04
 Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 4/70 (5%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           L   + +    + ++  +    A +  +T L      +  +I G +  L+ L  L L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73

Query: 113 KLSGPVPFSN 122
           +++   P  N
Sbjct: 74  QITDLAPLKN 83

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 12/41 (29%), Positives = 22/41 (53%), Gaps = 3/41 (7%)

Query: 1   EIGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQ 41
            + +L NLIE+ + +N +    P  L   ++L  + L+ NQ
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 16/61 (26%), Positives = 24/61 (39%), Gaps = 4/61 (6%)

Query: 2   IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           + NL  L  L    N +    P  L  L +L  + L  NQ +   P  L   + L  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 62  S 62
           +
Sbjct: 225 T 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.003
 Identities = 14/63 (22%), Positives = 29/63 (46%), Gaps = 4/63 (6%)

Query: 4  NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           L N I++  G +++   +  T   L  ++ L        ++I   + +L  L+GL L  
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKD 72

Query: 64 NKL 66
          N++
Sbjct: 73 NQI 75

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 3e-05
 Identities = 13/70 (18%), Positives = 28/70 (40%), Gaps = 4/70 (5%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
               +  NL    ++  +      + ++  +  +N+ I+      I  L  +  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 113 KLSGPVPFSN 122
           KL+   P +N
Sbjct: 79  KLTDIKPLAN 88

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 6e-04
 Identities = 11/65 (16%), Positives = 25/65 (38%), Gaps = 4/65 (6%)

Query: 4  NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
               I+ ++   S+   +  T   L  +  +  + +   S     + +L  +  L L+ 
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 64 NKLSG 68
          NKL+ 
Sbjct: 78 NKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.5 bits (83), Expect = 0.002
 Identities = 12/38 (31%), Positives = 17/38 (44%), Gaps = 2/38 (5%)

Query: 74  IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSS 111
           +A +  L  L +S N I   +   +  L  LD L L S
Sbjct: 174 LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.3 bits (96), Expect = 5e-05
 Identities = 26/120 (21%), Positives = 48/120 (40%), Gaps = 9/120 (7%)

Query: 24  STLGLLTDLSYLDL-----SRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK--IPSQIAS 76
             L    DL   ++      R+   +++      +  LL LNLS+N+L     + S +  
Sbjct: 30  KGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQK 89

Query: 77  MKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN 136
             NL  L++S N+++     +  +  +L+ L L  N LS      ++      I    P 
Sbjct: 90  APNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR--DQSTYISAIRERFPK 147

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 2e-04
 Identities = 22/90 (24%), Positives = 34/90 (37%), Gaps = 9/90 (10%)

Query: 4   NLKNLIELDVGSNSL--IGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNL 61
           N+  L+ L++ +N L  +  + S +    +L  L+LS N+  S    +      L  L L
Sbjct: 63  NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWL 122

Query: 62  SSNKLSGKIPSQ-------IASMKNLTWLD 84
             N LS     Q             L  LD
Sbjct: 123 DGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (94), Expect = 7e-05
 Identities = 18/85 (21%), Positives = 37/85 (43%), Gaps = 3/85 (3%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
                 L+L   K+   I +  A++     +D S+N+I   + G    L RL  L +++N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNNN 73

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNK 137
           ++       ++ L  +  + L+ N 
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNS 98

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (91), Expect = 2e-04
 Identities = 14/53 (26%), Positives = 23/53 (43%), Gaps = 4/53 (7%)

Query: 65  KLSGKIPSQIASMKNLT---WLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           KL+ ++  Q A   N      LD+   KI   I      L + D ++ S N++
Sbjct: 2   KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 0.002
 Identities = 19/88 (21%), Positives = 34/88 (38%), Gaps = 3/88 (3%)

Query: 4   NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSS 63
           N     ELD+     I  I +    L     +D S N+           L  L  L +++
Sbjct: 16  NAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72

Query: 64  NKLSGKIPSQIASMKNLTWLDISNNKIE 91
           N++         ++ +LT L ++NN + 
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLV 100

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 2e-04
 Identities = 13/80 (16%), Positives = 21/80 (26%)

Query: 34  YLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGS 93
            L L++N                      +N L                LDIS  +I   
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216

Query: 94  IPGEITELSRLDYLNLSSNK 113
               +  L +L   +  + K
Sbjct: 217 PSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.001
 Identities = 8/58 (13%), Positives = 18/58 (31%)

Query: 32  LSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNK 89
                   N       +     +G + L++S  ++       + ++K L      N K
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.4 bits (82), Expect = 0.003
 Identities = 11/51 (21%), Positives = 19/51 (37%), Gaps = 3/51 (5%)

Query: 22  IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPS 72
                   +    LD+SR + +S     L  L  L   +  + K   K+P+
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 2e-04
 Identities = 13/57 (22%), Positives = 25/57 (43%), Gaps = 7/57 (12%)

Query: 52  WLTGLLGLNLSSNKLSGKIPSQIAS-----MKNLTWLDISNNKI--EGSIPGEITEL 101
              GL  L L  N++       + +     M +L +L+++ N+   E  +  EI E+
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 3e-04
 Identities = 13/67 (19%), Positives = 24/67 (35%), Gaps = 11/67 (16%)

Query: 60  NLSSNKLSGKIPSQIASM------KNLTWLDISNNKIEGSIPGEITE-----LSRLDYLN 108
            L+   LS +  + +           L  L +  N+IE      +       +  L +L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 109 LSSNKLS 115
           L+ N+ S
Sbjct: 309 LNGNRFS 315

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 4e-04
 Identities = 17/88 (19%), Positives = 28/88 (31%), Gaps = 2/88 (2%)

Query: 54  TGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITE-LSRLDYLNLSSN 112
            G  GL  + +         +   +NLT L I N +    +       L  L  L +  +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 113 KLSGPVPFSNEQLSSMYIVRLSPNKGLC 140
            L    P +      +  + LS N    
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALES 94

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.9 bits (81), Expect = 0.003
 Identities = 22/109 (20%), Positives = 37/109 (33%), Gaps = 3/109 (2%)

Query: 7   NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTW-LTGLLGLNLSSNK 65
               L    +  +      L    +L+ L +   Q    +       L  L  L +  + 
Sbjct: 9   GSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 66  LSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKL 114
           L    P        L+ L++S N +E S+  +  +   L  L LS N L
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 7e-04
 Identities = 16/70 (22%), Positives = 29/70 (41%), Gaps = 4/70 (5%)

Query: 53  LTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN 112
           L   +   L    ++  +      +  +T L      I+ SI G +  L+ L  +N S+N
Sbjct: 17  LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 72

Query: 113 KLSGPVPFSN 122
           +L+   P  N
Sbjct: 73  QLTDITPLKN 82

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.4 bits (85), Expect = 0.001
 Identities = 14/75 (18%), Positives = 31/75 (41%), Gaps = 11/75 (14%)

Query: 43  NSSIPNELTWL---TGLLGLNLSSNKLSGKIP------SQIASMKNLTWLDISNNKIEGS 93
            ++I + +        ++       +L G IP      + ++++K    L +S N IE  
Sbjct: 4   ATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-K 62

Query: 94  IPGEITELSRLDYLN 108
           I   ++ +  L  L+
Sbjct: 63  ISS-LSGMENLRILS 76

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	397
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.98
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.98
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.98
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.78
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.76
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.76
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.75
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.69
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.68
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.68
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.66
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.64
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.56
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.55
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.55
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.54
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.52
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.51
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.51
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.5
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.48
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.46
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.46
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.43
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.41
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.37
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.31
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.3
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.19
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.14
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.92
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.91
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.89
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.79
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.77
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.75
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.63
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.58
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.55
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.42
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.31
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.88
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.81
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.72
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.69
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.59
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.22
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.93

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=303.08  Aligned_cols=171  Identities=26%  Similarity=0.437  Sum_probs=146.3

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||+||+|++. +++.||||++......+  ..+++.+|++++++++||||+++++++.+++..|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            357999999999999999999864 78999999997654332  236788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999987543   5889999999999999999999   56999999999999999999999999999997644


Q ss_pred             CCC--CeeeccccccccCCCCC
Q 043586          377 DSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~--~~~~~~gt~~y~APE~~  396 (397)
                      ...  ..+..+||+.|||||++
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~  177 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELL  177 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHH
T ss_pred             CCccccccceeeCcCccCHhHh
Confidence            322  23456799999999964

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-40  Score=300.82  Aligned_cols=168  Identities=27%  Similarity=0.416  Sum_probs=149.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.......   .+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4699999999999999999986 478999999987654332   257889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.+++...    .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            999999999887643    4889999999999999999999   569999999999999999999999999999987665


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .......+||+.|||||++
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~  188 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVV  188 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHH
T ss_pred             cccccccccCCCccChhhh
Confidence            5555667899999999974

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=297.35  Aligned_cols=170  Identities=34%  Similarity=0.565  Sum_probs=149.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|++. +++.||+|++......+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            56999999999999999999875 68899999997655444444577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            9999999999987543   4889999999999999999999   569999999999999999999999999999866433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                        ......||+.|||||++
T Consensus       160 --~~~~~~Gt~~Y~APE~~  176 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMI  176 (263)
T ss_dssp             --CCEETTEEGGGCCHHHH
T ss_pred             --cccccCCCCcccCHHHH
Confidence              23456799999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=298.55  Aligned_cols=172  Identities=28%  Similarity=0.427  Sum_probs=147.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|+.. +++.||||++......+....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56999999999999999999864 78999999997654433334567899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++...+   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccC
Confidence            9999999999887543   4889999999999999999999   569999999999999999999999999999977543


Q ss_pred             CC--CeeeccccccccCCCCC
Q 043586          378 SS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~--~~~~~~gt~~y~APE~~  396 (397)
                      ..  .....+||+.|||||++
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~  182 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELL  182 (288)
T ss_dssp             --------CCCCGGGCCHHHH
T ss_pred             CcccccccccCCccccCceee
Confidence            22  23446799999999964

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=302.09  Aligned_cols=172  Identities=24%  Similarity=0.353  Sum_probs=152.4

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+. .+++.||||+++..........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5699999999999999999986 478999999998654433334577889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.+++....   .+++..+..++.|++.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            9999999999887643   4788899999999999999999   669999999999999999999999999999977655


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .......+||+.|||||++
T Consensus       159 ~~~~~~~~GT~~Y~aPE~~  177 (337)
T d1o6la_         159 GATMKTFCGTPEYLAPEVL  177 (337)
T ss_dssp             TCCBCCCEECGGGCCGGGG
T ss_pred             CcccccceeCHHHhhhhhc
Confidence            5555667899999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-40  Score=300.44  Aligned_cols=170  Identities=29%  Similarity=0.405  Sum_probs=147.2

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|++.+.||+|+||.||+|++. +++.||||+++......   .+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE---LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG---GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH---HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            46899999999999999999864 68999999997654332   367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|+|.+++....  ..+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             ecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            9999999999876532  24889999999999999999999   569999999999999999999999999999865433


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........||+.|||||++
T Consensus       164 ~~~~~~~~Gt~~y~APE~l  182 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVV  182 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHH
T ss_pred             cccccccccccccCCHHHH
Confidence            3233446799999999974

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-40  Score=297.53  Aligned_cols=177  Identities=28%  Similarity=0.490  Sum_probs=136.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--CCEeeE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--RKCMFL  295 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  295 (397)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++......+ ...+.+.+|++++++++||||+++++++.+  .+..|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            67999999999999999999864 78999999997765433 234678999999999999999999999865  456899


Q ss_pred             EEeeccCCCchhhcccCC-CccccChHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          296 IYEYMERGSLFCNLHNNE-DAVELDWAKRVNIVKAMAHALAYLHHDC--SPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       296 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      |||||++|+|.+++.... ....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999886432 2235899999999999999999999642  2359999999999999999999999999999


Q ss_pred             ccCCCCCCeeeccccccccCCCCC
Q 043586          373 LLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+..........+||+.|||||++
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l  186 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQM  186 (269)
T ss_dssp             HC-----------CCCSCCCHHHH
T ss_pred             ecccCCCccccCCCCcccCCHHHH
Confidence            876655555567899999999964

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-39  Score=298.96  Aligned_cols=168  Identities=27%  Similarity=0.379  Sum_probs=147.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      +.|+..+.||+|+||.||+|++ .+++.||||++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4588999999999999999985 478899999998765544455678999999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |||++|++..++...   ..+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            999999987665543   24899999999999999999999   569999999999999999999999999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                          ....||+.|||||++
T Consensus       169 ----~~~~GT~~Y~APE~~  183 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVI  183 (309)
T ss_dssp             ----CCCCSCGGGCCHHHH
T ss_pred             ----CccccCccccCHHHH
Confidence                335799999999974

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-40  Score=299.29  Aligned_cols=175  Identities=27%  Similarity=0.440  Sum_probs=149.6

Q ss_pred             HHHHhcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCE
Q 043586          214 LIEATEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKC  292 (397)
Q Consensus       214 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  292 (397)
                      ++...++|++.+.||+|+||+||+|++. +++.||||+++.....    .++|.+|++++++++|||||++++++.+++.
T Consensus        12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            3334567899999999999999999875 5889999999765443    2578899999999999999999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .++||||+++|+|.+++..... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~  163 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR  163 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred             eEEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEcccccee
Confidence            9999999999999999875432 35889999999999999999999   5689999999999999999999999999999


Q ss_pred             ccCCCCCC-eeeccccccccCCCCC
Q 043586          373 LLHADSSN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~~-~~~~~gt~~y~APE~~  396 (397)
                      ....+... .....||+.|||||++
T Consensus       164 ~~~~~~~~~~~~~~g~~~y~aPE~~  188 (287)
T d1opja_         164 LMTGDTYTAHAGAKFPIKWTAPESL  188 (287)
T ss_dssp             TCCSSSSEEETTEEECGGGCCHHHH
T ss_pred             ecCCCCceeeccccccccccChHHH
Confidence            76554332 2234588999999964

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=291.79  Aligned_cols=169  Identities=26%  Similarity=0.426  Sum_probs=138.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++.+++.||||+++......    ++|.+|++++++++||||++++|++..++..++|||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E   80 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   80 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence            4688899999999999999999888999999998655443    578899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|+|.+++....  ..+++..+..++.|++.||+|||   +++|+||||||+|||+|.++.+||+|||+|+......
T Consensus        81 ~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          81 FMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             CCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             ecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999999887543  34788999999999999999999   5689999999999999999999999999998765433


Q ss_pred             CC-eeeccccccccCCCCC
Q 043586          379 SN-RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~-~~~~~gt~~y~APE~~  396 (397)
                      .. .....||+.|||||++
T Consensus       156 ~~~~~~~~gt~~y~aPE~l  174 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVF  174 (263)
T ss_dssp             ---------CTTSCCHHHH
T ss_pred             ceeecceecCcccCChHHh
Confidence            22 2335689999999964

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-39  Score=295.28  Aligned_cols=170  Identities=30%  Similarity=0.506  Sum_probs=140.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++.  ..||||+++...... ...+.|.+|++++++++||||+++++++.. +..++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence            467999999999999999999875  369999997553322 235789999999999999999999998754 4689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.....  .+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        83 Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~  157 (276)
T d1uwha_          83 QWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW  157 (276)
T ss_dssp             ECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred             ecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence            99999999999975433  4889999999999999999999   569999999999999999999999999999876543


Q ss_pred             CC--CeeeccccccccCCCCC
Q 043586          378 SS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~--~~~~~~gt~~y~APE~~  396 (397)
                      ..  ......||+.|||||++
T Consensus       158 ~~~~~~~~~~gt~~y~APE~l  178 (276)
T d1uwha_         158 SGSHQFEQLSGSILWMAPEVI  178 (276)
T ss_dssp             --------CCCCGGGCCHHHH
T ss_pred             CCcccccccccCcccCCHHHH
Confidence            22  23446799999999974

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-39  Score=302.25  Aligned_cols=170  Identities=28%  Similarity=0.360  Sum_probs=146.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||+||+|++. +|+.||+|+++......  ..+++.+|+.++++++|||||+++++|.+++..|+|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--HHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999864 78999999997653322  236788999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++.+..   .+++..+..++.|++.||.|||+.  ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            99999999999997543   478999999999999999999952  3899999999999999999999999999997643


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..  ....+||+.|||||++
T Consensus       158 ~~--~~~~~GT~~Y~APEvl  175 (322)
T d1s9ja_         158 SM--ANSFVGTRSYMSPERL  175 (322)
T ss_dssp             HT--C---CCSSCCCCHHHH
T ss_pred             Cc--cccccCCccccCchHH
Confidence            22  2346899999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-39  Score=295.22  Aligned_cols=169  Identities=31%  Similarity=0.487  Sum_probs=148.5

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5699999999999999999986 468999999997655444344578899999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||++||++.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            9999999998887543   3677888899999999999999   679999999999999999999999999999976543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         ....+||+.|||||++
T Consensus       158 ---~~~~~Gt~~Y~APE~l  173 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVV  173 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHH
T ss_pred             ---cccccCcccccCHHHH
Confidence               2346799999999974

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=293.45  Aligned_cols=170  Identities=27%  Similarity=0.471  Sum_probs=145.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      .++|++.+.||+|+||.||+|++++++.||||+++......    +.|.+|++++++++|||||++++++.+ +..++||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~   86 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence            45788999999999999999999888899999997654432    578999999999999999999998765 5579999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.... ...+++.++..|+.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            9999999998776432 234899999999999999999999   568999999999999999999999999999987543


Q ss_pred             CC-CeeeccccccccCCCCC
Q 043586          378 SS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~-~~~~~~gt~~y~APE~~  396 (397)
                      .. ......||+.|||||++
T Consensus       163 ~~~~~~~~~gt~~y~APE~~  182 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAI  182 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHH
T ss_pred             ccccccccCCcccccChHHH
Confidence            32 22335689999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=283.39  Aligned_cols=168  Identities=27%  Similarity=0.431  Sum_probs=140.3

Q ss_pred             CccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee----CCEeeEE
Q 043586          222 DIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH----RKCMFLI  296 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  296 (397)
                      ++.+.||+|+||+||+|++. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+    ....|+|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            55678999999999999865 68899999987654332 224678999999999999999999999875    3568999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC-CCCCeEEeccccccccC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN-SKFEAFVADFGTARLLH  375 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~DFG~a~~~~  375 (397)
                      |||+++|+|.+++.+..   .+++..+..++.||+.||+|||+. ..+|+||||||+|||++ .++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999987543   478899999999999999999943 22399999999999996 57999999999998643


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..  .....+||+.|||||++
T Consensus       167 ~~--~~~~~~GT~~Y~aPE~~  185 (270)
T d1t4ha_         167 AS--FAKAVIGTPEFMAPEMY  185 (270)
T ss_dssp             TT--SBEESCSSCCCCCGGGG
T ss_pred             CC--ccCCcccCccccCHHHh
Confidence            32  33456899999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.3e-38  Score=293.80  Aligned_cols=169  Identities=25%  Similarity=0.439  Sum_probs=147.8

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++......+   .+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999986 478999999997765433   367889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC--CCCCeEEeccccccccC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKFEAFVADFGTARLLH  375 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DFG~a~~~~  375 (397)
                      |||++|+|.+++....  ..+++..+..++.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       103 E~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~  177 (350)
T d1koaa2         103 EFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD  177 (350)
T ss_dssp             CCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred             EcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecc
Confidence            9999999999886433  24899999999999999999999   56999999999999996  46889999999999775


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ... ......||+.|||||++
T Consensus       178 ~~~-~~~~~~gT~~Y~aPEv~  197 (350)
T d1koaa2         178 PKQ-SVKVTTGTAEFAAPEVA  197 (350)
T ss_dssp             TTS-CEEEECSCTTTCCHHHH
T ss_pred             ccc-ccceecCcccccCHHHH
Confidence            443 34456799999999964

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-38  Score=290.53  Aligned_cols=171  Identities=30%  Similarity=0.477  Sum_probs=133.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CC---cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NG---KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||+||+|++. ++   ..||||.+.......  ..++|.+|++++++++|||||+++|++..++..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHH--HHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHH--HHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            34666789999999999999864 23   358899887654432  2468999999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +|||||++|+|.+++.....  .+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999998875433  4899999999999999999999   569999999999999999999999999999977


Q ss_pred             CCCCCCe-----eeccccccccCCCCC
Q 043586          375 HADSSNR-----TLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~-----~~~~gt~~y~APE~~  396 (397)
                      .......     ....||+.|||||++
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~  205 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAI  205 (299)
T ss_dssp             -----------------CGGGSCHHHH
T ss_pred             cCCCCcceeeecccccCCccccCHHHH
Confidence            5433221     223579999999963

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-38  Score=291.81  Aligned_cols=170  Identities=26%  Similarity=0.421  Sum_probs=131.0

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .+.|++.+.||+|+||+||+|+.. +++.||||++........  .+.+.+|++++++++||||+++++++.+++..|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999865 689999999986554332  35688999999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC---CCCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN---SKFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~DFG~a~~  373 (397)
                      ||||+||+|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+||++.   .++.+||+|||+|+.
T Consensus        86 mE~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             EeccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999997543   4899999999999999999999   56999999999999994   578999999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... ....+||+.|||||++
T Consensus       160 ~~~~~~-~~~~~GT~~y~APE~~  181 (307)
T d1a06a_         160 EDPGSV-LSTACGTPGYVAPEVL  181 (307)
T ss_dssp             --------------CTTSCHHHH
T ss_pred             ccCCCe-eeeeeeCccccCcHHH
Confidence            654332 3346799999999974

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.5e-38  Score=291.99  Aligned_cols=169  Identities=25%  Similarity=0.421  Sum_probs=147.9

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+. .+|+.||||+++.....+   .+.+.+|++++++++||||+++++++.+++..|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            5799999999999999999986 479999999998765433   257889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeC--CCCCeEEeccccccccC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLN--SKFEAFVADFGTARLLH  375 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~DFG~a~~~~  375 (397)
                      |||+||+|.+.+....  ..+++.+++.++.||+.||.|||   +++|+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            9999999988776543  24899999999999999999999   56999999999999998  67899999999999876


Q ss_pred             CCCCCeeeccccccccCCCCC
Q 043586          376 ADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       376 ~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .... .....||+.|||||++
T Consensus       181 ~~~~-~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         181 PDEI-VKVTTATAEFAAPEIV  200 (352)
T ss_dssp             TTSC-EEEECSSGGGCCHHHH
T ss_pred             CCCc-eeeccCcccccCHHHH
Confidence            5433 4456799999999974

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-38  Score=281.62  Aligned_cols=169  Identities=26%  Similarity=0.439  Sum_probs=148.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||+||+|++++++.||||+++.....+    ++|.+|+.++++++||||++++|++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence            5799999999999999999999888899999998765443    578899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|++.+++....  ..+++..+.+++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             ccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999998876543  34788999999999999999999   5699999999999999999999999999998765443


Q ss_pred             C-CeeeccccccccCCCCC
Q 043586          379 S-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~-~~~~~~gt~~y~APE~~  396 (397)
                      . ......||+.|+|||++
T Consensus       155 ~~~~~~~~~t~~y~aPE~~  173 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVL  173 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHH
T ss_pred             ceeecccCCCCCcCCcHHh
Confidence            3 23345699999999964

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-38  Score=292.63  Aligned_cols=169  Identities=26%  Similarity=0.387  Sum_probs=149.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++. +|+.||||++......+....+.+.+|+++++.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999999864 79999999997654444344567889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.+|+|.+++....   .+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+.....
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999887543   4889999999999999999999   569999999999999999999999999999976543


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                         .....||+.|||||++
T Consensus       195 ---~~~~~Gt~~Y~APE~~  210 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEII  210 (350)
T ss_dssp             ---BCCCEECGGGCCHHHH
T ss_pred             ---cccccCccccCCHHHH
Confidence               2346799999999974

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-37  Score=280.75  Aligned_cols=170  Identities=25%  Similarity=0.391  Sum_probs=141.3

Q ss_pred             cCCCccc-eeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKY-CIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|.+.+ .||+|+||.||+|.+.   ++..||||+++......  ..++|.+|++++++++|||||+++|++.++ ..|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHH--HHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            4456666 4999999999999754   35579999997654332  347899999999999999999999998754 578


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....  ..+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+.+
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999876433  35899999999999999999999   569999999999999999999999999999977


Q ss_pred             CCCCCC---eeeccccccccCCCCC
Q 043586          375 HADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      ......   .....||+.|||||++
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~  184 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECI  184 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred             cccccccccccccccCccccChHHH
Confidence            554322   2234689999999963

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=286.48  Aligned_cols=172  Identities=25%  Similarity=0.428  Sum_probs=148.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHh-hcccCCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLS-QVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||+||+|+.. +++.||||+++..........+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999999865 78999999997654333233456667777765 67999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCC
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHA  376 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~  376 (397)
                      |||+++|+|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999997543   4788899999999999999999   56899999999999999999999999999997766


Q ss_pred             CCCCeeeccccccccCCCCC
Q 043586          377 DSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       377 ~~~~~~~~~gt~~y~APE~~  396 (397)
                      .....+...||+.|+|||++
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~  175 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEIL  175 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHH
T ss_pred             ccccccccCCCCCcCCHHHH
Confidence            55555667899999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=283.38  Aligned_cols=171  Identities=25%  Similarity=0.374  Sum_probs=146.9

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHH---HHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.......   ....+.+.+|++++++++||||+++++++.+++..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5799999999999999999986 478999999987543221   112367889999999999999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----CeEEecccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----EAFVADFGT  370 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~DFG~  370 (397)
                      +|||||++|+|.+++....   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999987543   4889999999999999999999   56999999999999998776    499999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+....... .....||+.|+|||++
T Consensus       164 a~~~~~~~~-~~~~~~t~~y~APE~~  188 (293)
T d1jksa_         164 AHKIDFGNE-FKNIFGTPEFVAPEIV  188 (293)
T ss_dssp             CEECTTSCB-CSCCCCCGGGCCHHHH
T ss_pred             hhhcCCCcc-ccccCCCCcccCHHHH
Confidence            988755433 3345799999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.4e-37  Score=277.35  Aligned_cols=171  Identities=27%  Similarity=0.440  Sum_probs=149.3

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccch------HHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSET------EELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR  290 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  290 (397)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++....      ......+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999986 4789999999876432      12334567889999999997 99999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                      +..|+||||+++|+|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999997543   4899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+....... .+...||+.|+|||++
T Consensus       157 a~~~~~~~~-~~~~~gt~~y~~PE~~  181 (277)
T d1phka_         157 SCQLDPGEK-LREVCGTPSYLAPEII  181 (277)
T ss_dssp             CEECCTTCC-BCCCCSCGGGCCHHHH
T ss_pred             eeEccCCCc-eeeeeccCCCCCHHHh
Confidence            998765443 3446799999999963

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-37  Score=281.92  Aligned_cols=171  Identities=32%  Similarity=0.459  Sum_probs=137.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCC-----cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNG-----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      +.|+..+.||+|+||.||+|.+.+.     ..||||++........  .++|.+|++++++++|||||+++|++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHH--HHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            4577889999999999999986532     4699999976544332  36789999999999999999999999999999


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      ++||||+.++++.+.+....  ..+++.++..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhc
Confidence            99999999999988776543  24889999999999999999999   56899999999999999999999999999997


Q ss_pred             cCCCCCC---eeeccccccccCCCCC
Q 043586          374 LHADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      .......   .....||+.|||||++
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l  185 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAI  185 (283)
T ss_dssp             --------------CCCGGGSCHHHH
T ss_pred             ccCCCccceEeccCCCCccccCHHHH
Confidence            6543322   2234689999999963

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-37  Score=287.41  Aligned_cols=174  Identities=25%  Similarity=0.393  Sum_probs=143.2

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||+||+|++..      ...||+|.+......  ...+.+.+|+.+++++ +|||||++++++.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH--HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            3678999999999999999998642      236899998764432  2236788999999998 899999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCCC--------------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNED--------------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDI  350 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  350 (397)
                      +..|+|||||++|+|.++++....                    ...+++..++.++.||++||+|||   +++|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence            999999999999999999976432                    134788999999999999999999   569999999


Q ss_pred             CCCCEEeCCCCCeEEeccccccccCCCCCCe--eeccccccccCCCCC
Q 043586          351 SSNNILLNSKFEAFVADFGTARLLHADSSNR--TLLAGTYGYIAPGLP  396 (397)
Q Consensus       351 kp~NIll~~~~~~kl~DFG~a~~~~~~~~~~--~~~~gt~~y~APE~~  396 (397)
                      ||+||+++.++.+||+|||+|+.........  ....||+.|||||++
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l  238 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  238 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence            9999999999999999999998765544332  235689999999964

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.6e-37  Score=290.14  Aligned_cols=170  Identities=24%  Similarity=0.300  Sum_probs=143.3

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHH---HHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIK---SFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|+.. +|+.||||++............   ...+|+++++.++||||+++++++.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999865 6899999999754433222122   3334577777888999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|+|.+++....   .+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            9999999999999987543   4788899999999999999999   569999999999999999999999999999976


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ....  ....+||+.|||||++
T Consensus       158 ~~~~--~~~~~GT~~y~APE~~  177 (364)
T d1omwa3         158 SKKK--PHASVGTHGYMAPEVL  177 (364)
T ss_dssp             SSSC--CCSCCSCGGGCCHHHH
T ss_pred             CCCc--ccccccccccchhHHh
Confidence            5433  3345799999999974

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-37  Score=282.86  Aligned_cols=169  Identities=27%  Similarity=0.470  Sum_probs=139.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++++++.||||+++......    +.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E   91 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   91 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence            5799999999999999999999888899999997655432    578999999999999999999999854 55799999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+++|++.+++.... ...+++.+++.++.||+.||+|||   +++|+||||||+|||+|.++++||+|||+|+......
T Consensus        92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            999999988876532 224899999999999999999999   5689999999999999999999999999998765433


Q ss_pred             C-CeeeccccccccCCCCC
Q 043586          379 S-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~-~~~~~~gt~~y~APE~~  396 (397)
                      . ......||+.|+|||++
T Consensus       168 ~~~~~~~~gt~~y~aPE~~  186 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAA  186 (285)
T ss_dssp             --------CCGGGSCHHHH
T ss_pred             ceeeccccccccccChHHH
Confidence            2 23345699999999964

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-37  Score=276.48  Aligned_cols=164  Identities=27%  Similarity=0.407  Sum_probs=135.2

Q ss_pred             ceeecCCcccEEEEEcC---CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEeecc
Q 043586          225 YCIGTGGYGSVYKAQLP---NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEYME  301 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  301 (397)
                      +.||+|+||.||+|.+.   .++.||||+++..... ....++|.+|++++++++|||||++++++..+ ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCC-HHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            46999999999999754   3568999999754432 23357899999999999999999999998654 5789999999


Q ss_pred             CCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCCCe
Q 043586          302 RGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSSNR  381 (397)
Q Consensus       302 ~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  381 (397)
                      +|+|.+++....   .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999987643   4889999999999999999999   5689999999999999999999999999999775543322


Q ss_pred             ---eeccccccccCCCCC
Q 043586          382 ---TLLAGTYGYIAPGLP  396 (397)
Q Consensus       382 ---~~~~gt~~y~APE~~  396 (397)
                         ....||+.|||||++
T Consensus       165 ~~~~~~~gt~~y~APE~l  182 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECI  182 (277)
T ss_dssp             EC----CCCGGGCCHHHH
T ss_pred             ccccccCCCceecCchhh
Confidence               234689999999963

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-37  Score=280.93  Aligned_cols=168  Identities=27%  Similarity=0.355  Sum_probs=139.3

Q ss_pred             ccceeecCCcccEEEEEcC-CCcEEEEEEecccchHH--HHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEee
Q 043586          223 IKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEE--LAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYEY  299 (397)
Q Consensus       223 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  299 (397)
                      ..+.||+|+||+||+|++. +|+.||||+++......  ....+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            3578999999999999875 68999999997654332  12235688999999999999999999999999999999999


Q ss_pred             ccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC
Q 043586          300 MERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADSS  379 (397)
Q Consensus       300 ~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  379 (397)
                      +.++++.......   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9988777665432   34788899999999999999999   56999999999999999999999999999988766555


Q ss_pred             CeeeccccccccCCCCC
Q 043586          380 NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       380 ~~~~~~gt~~y~APE~~  396 (397)
                      .....+||+.|+|||++
T Consensus       156 ~~~~~~gt~~y~aPE~~  172 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELL  172 (299)
T ss_dssp             CCCCSCCCCTTCCHHHH
T ss_pred             cccceecChhhccHHHH
Confidence            55556899999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-36  Score=277.57  Aligned_cols=169  Identities=26%  Similarity=0.382  Sum_probs=146.4

Q ss_pred             hcCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEE
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  296 (397)
                      .++|++.+.||+|+||+||+|.+. +++.||||+++......    ..+.+|++++++++||||+++++++.+++..|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            367999999999999999999865 68899999998765432    4578899999999999999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC--CCCeEEecccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS--KFEAFVADFGTARLL  374 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~DFG~a~~~  374 (397)
                      ||||+||+|.+++....  ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.  .+.+||+|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999997543  24899999999999999999999   569999999999999985  458999999999876


Q ss_pred             CCCCCCeeeccccccccCCCCC
Q 043586          375 HADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ..... .....||+.|+|||..
T Consensus       155 ~~~~~-~~~~~~t~~y~ape~~  175 (321)
T d1tkia_         155 KPGDN-FRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             CTTCE-EEEEESCGGGSCHHHH
T ss_pred             ccCCc-ccccccccccccchhc
Confidence            54433 3445799999999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.7e-37  Score=276.47  Aligned_cols=172  Identities=24%  Similarity=0.399  Sum_probs=141.2

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Ee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  293 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||||+++.....+....+++.+|++++++++||||+++++++...+    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            5799999999999999999986 478999999998765555555678999999999999999999999987643    48


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||++|++|.+++....   .+++.++..++.||+.||+|||   +++|+||||||+|||++.++..+++|||.++.
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhh
Confidence            99999999999998886543   4889999999999999999999   56999999999999999999999999999886


Q ss_pred             cCCCCC---CeeeccccccccCCCCC
Q 043586          374 LHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      ......   .....+||+.|||||++
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~  186 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQA  186 (277)
T ss_dssp             CC----------------TTCCHHHH
T ss_pred             hccccccccccccccCcccccCHHHH
Confidence            544322   23445799999999974

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-36  Score=276.51  Aligned_cols=165  Identities=27%  Similarity=0.433  Sum_probs=139.7

Q ss_pred             cCCCccc-eeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee----CC
Q 043586          219 EGFDIKY-CIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH----RK  291 (397)
Q Consensus       219 ~~~~~~~-~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~  291 (397)
                      ++|++.. .||+|+||.||+|++ .+++.||||+++..        +.+.+|+.++.++ +||||++++++|.+    ..
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~   82 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   82 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence            5788875 599999999999986 57899999999753        3456799887665 79999999999876    45


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEecc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADF  368 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DF  368 (397)
                      ..|+|||||+||+|.+++..... ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+||
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DF  158 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  158 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred             EEEEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccc
Confidence            68999999999999999976432 35899999999999999999999   569999999999999985   567999999


Q ss_pred             ccccccCCCCCCeeeccccccccCCCCC
Q 043586          369 GTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       369 G~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+|+....... ....+||+.|||||++
T Consensus       159 G~a~~~~~~~~-~~~~~gt~~y~aPE~~  185 (335)
T d2ozaa1         159 GFAKETTSHNS-LTTPCYTPYYVAPEVL  185 (335)
T ss_dssp             TTCEECCCCCC-CCCCSCCCSSCCCCCC
T ss_pred             ceeeeccCCCc-cccccCCcccCCcHHH
Confidence            99997765443 3446799999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-36  Score=276.12  Aligned_cols=171  Identities=28%  Similarity=0.397  Sum_probs=143.0

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||||+++..... ....+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            5799999999999999999986 57899999999754322 223467889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+.++.+ +.+.... ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        81 e~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99976444 4443322 235899999999999999999999   568999999999999999999999999999987665


Q ss_pred             CCCeeeccccccccCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGL  395 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~  395 (397)
                      ........||+.|+|||+
T Consensus       156 ~~~~~~~~gt~~y~apE~  173 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEI  173 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHH
T ss_pred             cccceeecccceeeehhh
Confidence            555555689999999996

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-36  Score=279.31  Aligned_cols=180  Identities=27%  Similarity=0.420  Sum_probs=149.0

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceee
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYG  285 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~  285 (397)
                      .+++...++|++.+.||+|+||.||+|++.      +++.||||+++.....+  ..++|.+|++++++++||||+++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~E~~il~~l~h~niv~~~~   83 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALMAEFDNPNIVKLLG   83 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH--HHHHHHHHHHHHHhcCCCCccccee
Confidence            344445678999999999999999999853      45789999997654432  3478999999999999999999999


Q ss_pred             EEeeCCEeeEEEeeccCCCchhhcccCC---------------------CccccChHHHHHHHHHHHHHHHHHHhCCCCC
Q 043586          286 FCLHRKCMFLIYEYMERGSLFCNLHNNE---------------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPS  344 (397)
Q Consensus       286 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~  344 (397)
                      ++...+..++||||+++|+|.+++....                     ....+++..+..|+.|++.||+|||   +++
T Consensus        84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~  160 (301)
T d1lufa_          84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK  160 (301)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCC
Confidence            9999999999999999999999886432                     1234788999999999999999999   569


Q ss_pred             eEEcCCCCCCEEeCCCCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          345 IIHRDISSNNILLNSKFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       345 ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      |+||||||+|||+|.++.+||+|||+|+.......  ......||+.|+|||++
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESI  214 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHH
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHH
Confidence            99999999999999999999999999987644322  22345789999999963

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-35  Score=270.57  Aligned_cols=169  Identities=26%  Similarity=0.384  Sum_probs=138.6

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Eee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  294 (397)
                      ++|.+.+.||+|+||.||+|++ +|+.||||+++......    ...+.|+..+..++||||+++++++.+.+    ..|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            4577788999999999999997 58899999997654321    22334666667889999999999998653    689


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHD-----CSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      +||||+++|+|.+++++.    .++|.++..++.|++.||+|+|+.     +.++|+||||||+|||++.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999999754    478999999999999999999953     24699999999999999999999999999


Q ss_pred             cccccCCCCCC----eeeccccccccCCCCC
Q 043586          370 TARLLHADSSN----RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~~----~~~~~gt~~y~APE~~  396 (397)
                      +++........    .....||+.|||||++
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHH
T ss_pred             ccccccCCCcceeccccceecccCcCChhhc
Confidence            99977544322    2345799999999963

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-36  Score=274.33  Aligned_cols=175  Identities=25%  Similarity=0.370  Sum_probs=135.4

Q ss_pred             HhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEee
Q 043586          217 ATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLH  289 (397)
Q Consensus       217 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  289 (397)
                      ..++|++.+.||+|+||.||+|++.      +++.||||+++.......  .+.+.+|...+.++ +|+||+.+++++..
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~--~~~~~~e~~~l~~~~~h~~iv~~~~~~~~   88 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHHLNVVNLLGACTK   88 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHH--HHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence            3467999999999999999999753      356899999976543322  36778888888887 68999999999876


Q ss_pred             C-CEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          290 R-KCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       290 ~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      . ...++|||||++|+|.++++....             ...+++.+++.++.||+.||+|||   +++|+||||||+||
T Consensus        89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NI  165 (299)
T d1ywna1          89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNI  165 (299)
T ss_dssp             TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGE
T ss_pred             CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccce
Confidence            4 468999999999999999875421             234889999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCC--CeeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSS--NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~APE~~  396 (397)
                      |++.++.+||+|||+|+.......  ......||+.|||||++
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l  208 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  208 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence            999999999999999987654333  22345799999999964

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-36  Score=269.93  Aligned_cols=171  Identities=27%  Similarity=0.395  Sum_probs=132.5

Q ss_pred             hcCCCccceeecCCcccEEEEEcCC----CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLPN----GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      .++|++.+.||+|+||.||+|++..    +..||||.++.....  ...+.|.+|++++++++||||+++++++. .+..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSH--HHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            3579999999999999999998642    356889988654433  23478999999999999999999999986 4678


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      |+||||+++|++.+++....  ..+++..++.++.||++||.|||   +++|+||||||+||+++.++.+||+|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhee
Confidence            99999999999998876543  24789999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCC-CeeeccccccccCCCCC
Q 043586          374 LHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      ...... ......||+.|+|||++
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l  181 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESI  181 (273)
T ss_dssp             -------------CCGGGCCHHHH
T ss_pred             ccCCcceeccceecCcccchhhHh
Confidence            654332 23345689999999963

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-36  Score=270.39  Aligned_cols=172  Identities=24%  Similarity=0.393  Sum_probs=133.5

Q ss_pred             cCCCccceeecCCcccEEEEEcC--CC--cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP--NG--KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++...........++|.+|+.++++++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            56899999999999999999753  22  37899999876555555567899999999999999999999999764 678


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLL  374 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~  374 (397)
                      +||||+++|++.+.+....  ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            9999999999998876543  35899999999999999999999   568999999999999999999999999999987


Q ss_pred             CCCCCC---eeeccccccccCCCCC
Q 043586          375 HADSSN---RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       375 ~~~~~~---~~~~~gt~~y~APE~~  396 (397)
                      ......   .....||+.|+|||++
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~  186 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESL  186 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHH
T ss_pred             ccCCCcceecCccccCcccCCHHHH
Confidence            554432   2234578899999963

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.6e-36  Score=273.34  Aligned_cols=171  Identities=30%  Similarity=0.412  Sum_probs=143.2

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIYE  298 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  298 (397)
                      ++|++.+.||+|+||.||+|++++++.||||+++...... ...+++.+|+.++++++||||+++++++..++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcCh-HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            5799999999999999999999899999999997654332 223678899999999999999999999999999999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      |+.++.+..+....   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            99877666555433   35899999999999999999999   5689999999999999999999999999998876555


Q ss_pred             CCeeeccccccccCCCCC
Q 043586          379 SNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       379 ~~~~~~~gt~~y~APE~~  396 (397)
                      .......|++.|+|||.+
T Consensus       155 ~~~~~~~~~~~y~~pE~~  172 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVL  172 (286)
T ss_dssp             -------CCCTTCCHHHH
T ss_pred             cccceecccchhhhHHHH
Confidence            444556799999999964

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-36  Score=274.84  Aligned_cols=170  Identities=25%  Similarity=0.418  Sum_probs=137.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc----EEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEe
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK----VFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  293 (397)
                      ++|++.+.||+|+||+||+|++. +|+    .||+|+++.....  ...++|.+|++++++++|||||+++|++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            46999999999999999999864 343    5889988654322  2246899999999999999999999999875 46


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      +++|||+.+|+|.+.+.....  .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             eEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeecccccee
Confidence            788899999999988776433  5889999999999999999999   56999999999999999999999999999998


Q ss_pred             cCCCCCC--eeeccccccccCCCCC
Q 043586          374 LHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      .......  .....||+.|||||++
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l  185 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESI  185 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHH
T ss_pred             cccccccccccccccCccccChHHH
Confidence            7554332  2334689999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=268.86  Aligned_cols=165  Identities=25%  Similarity=0.421  Sum_probs=134.4

Q ss_pred             cCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  297 (397)
                      ++|++.+.||+|+||.||+|+++ |+.||||+++.....     +++.+|++++++++||||++++|++.+ .+..|+||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~~~-----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~   80 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA-----QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   80 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHHHH-----HHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence            46888999999999999999985 788999999765432     678899999999999999999999865 45689999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      ||+++|+|.+++.... ...+++..+++++.||+.||.|||   +++|+||||||+||+++.++.+|++|||+++.....
T Consensus        81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             eccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            9999999999987532 234889999999999999999999   569999999999999999999999999999865432


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      .   ....+|+.|+|||++
T Consensus       157 ~---~~~~~~~~y~aPE~l  172 (262)
T d1byga_         157 Q---DTGKLPVKWTAPEAL  172 (262)
T ss_dssp             --------CCTTTSCHHHH
T ss_pred             C---ccccccccCCChHHH
Confidence            2   334689999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-35  Score=267.71  Aligned_cols=172  Identities=28%  Similarity=0.466  Sum_probs=141.0

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCc--EEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeCCEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGK--VFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHRKCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  294 (397)
                      ++|++.+.||+|+||.||+|++. ++.  .||||+++.....+  ..++|.+|+++++++ +||||+++++++.+.+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH--HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            56889999999999999999875 343  47788876443322  246789999999999 7999999999999999999


Q ss_pred             EEEeeccCCCchhhcccCC-------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC
Q 043586          295 LIYEYMERGSLFCNLHNNE-------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF  361 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~  361 (397)
                      +||||+++|+|.++++...             ....+++..+..++.||+.||.|+|   +++|+||||||+|||++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCC
Confidence            9999999999999987541             2345899999999999999999999   56999999999999999999


Q ss_pred             CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 ~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      .+||+|||+|+........ ....||+.|+|||.+
T Consensus       165 ~~kl~DfG~a~~~~~~~~~-~~~~gt~~y~aPE~l  198 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVKK-TMGRLPVRWMAIESL  198 (309)
T ss_dssp             CEEECCTTCEESSCEECCC-----CCTTTCCHHHH
T ss_pred             ceEEccccccccccccccc-cceecCCcccchHHh
Confidence            9999999999865443332 335699999999964

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=268.44  Aligned_cols=170  Identities=24%  Similarity=0.344  Sum_probs=140.3

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHH---HHHHHHHHHHHHHHhhcc--cCCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEE---LAFIKSFRNEAQVLSQVL--HRNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  292 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||||+++.....+   .....++.+|+.++++++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999986 478999999987543211   001134567999999997  8999999999999999


Q ss_pred             eeEEEeeccC-CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-CCCeEEecccc
Q 043586          293 MFLIYEYMER-GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-KFEAFVADFGT  370 (397)
Q Consensus       293 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~DFG~  370 (397)
                      .|+||||+.+ +++.+++....   .+++.++..++.|++.||+|||   +++|+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 56667765432   4889999999999999999999   569999999999999985 57999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+.....  ..+...||+.|||||++
T Consensus       158 a~~~~~~--~~~~~~GT~~y~aPE~~  181 (273)
T d1xwsa_         158 GALLKDT--VYTDFDGTRVYSPPEWI  181 (273)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHH
T ss_pred             ceecccc--cccccccCCCcCCHHHH
Confidence            9875433  23446799999999963

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-34  Score=266.42  Aligned_cols=174  Identities=29%  Similarity=0.387  Sum_probs=147.5

Q ss_pred             hcCCCccceeecCCcccEEEEEc------CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEeeC
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL------PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCLHR  290 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  290 (397)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++.......  ...+.+|+.+++++ +|||||++++++.++
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHH--HHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            36789999999999999999974      3467899999986544322  36788999999999 699999999999999


Q ss_pred             CEeeEEEeeccCCCchhhcccCC---------------CccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNE---------------DAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      +..++|||||++|+|.++++...               ....+++..+..++.||++||+|||   +++++||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence            99999999999999999987543               1234888999999999999999999   56899999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      +++.++.+|++|||+++........  .....||+.|+|||++
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  219 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESI  219 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHh
Confidence            9999999999999999977654332  2345789999999963

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-35  Score=268.11  Aligned_cols=175  Identities=22%  Similarity=0.347  Sum_probs=146.6

Q ss_pred             HHhcCCCccceeecCCcccEEEEEcC------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee
Q 043586          216 EATEGFDIKYCIGTGGYGSVYKAQLP------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH  289 (397)
Q Consensus       216 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  289 (397)
                      ...++|++.+.||+|+||.||+|.+.      +++.||||+++......  ....|.+|++++++++||||+++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHH--HHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChH--HHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            33477899999999999999999763      35789999997654332  24678999999999999999999999999


Q ss_pred             CCEeeEEEeeccCCCchhhcccC-------CCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCC
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNN-------EDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFE  362 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~  362 (397)
                      .+..++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||   +++|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence            99999999999999999987643       12234688899999999999999999   568999999999999999999


Q ss_pred             eEEeccccccccCCCCCC--eeeccccccccCCCC
Q 043586          363 AFVADFGTARLLHADSSN--RTLLAGTYGYIAPGL  395 (397)
Q Consensus       363 ~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~  395 (397)
                      +||+|||+|+........  .....||+.|+|||.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            999999999876543332  223468999999995

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-34  Score=260.82  Aligned_cols=165  Identities=25%  Similarity=0.414  Sum_probs=137.6

Q ss_pred             cceeecCCcccEEEEEcCCC----cEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee-CCEeeEEEe
Q 043586          224 KYCIGTGGYGSVYKAQLPNG----KVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH-RKCMFLIYE  298 (397)
Q Consensus       224 ~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  298 (397)
                      .+.||+|+||+||+|++.++    ..||||+++.....  ...++|.+|++++++++||||++++|++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI--GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCH--HHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence            46799999999999986432    35899998754332  234789999999999999999999999876 568999999


Q ss_pred             eccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCCC
Q 043586          299 YMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHADS  378 (397)
Q Consensus       299 ~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~~  378 (397)
                      ||++|+|.+++.....  ..++..++.++.|++.||.|+|   +++|+||||||+|||+++++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EeecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999998875433  4678889999999999999999   5689999999999999999999999999999765433


Q ss_pred             CC----eeeccccccccCCCC
Q 043586          379 SN----RTLLAGTYGYIAPGL  395 (397)
Q Consensus       379 ~~----~~~~~gt~~y~APE~  395 (397)
                      ..    .....||+.|+|||+
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~  205 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALES  205 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHH
T ss_pred             cccceecccccccccccChHH
Confidence            22    223468999999996

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=263.70  Aligned_cols=174  Identities=26%  Similarity=0.379  Sum_probs=141.9

Q ss_pred             hcCCCccceeecCCcccEEEEEcC--------CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhc-ccCCccceeeEEe
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQLP--------NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQV-LHRNIVKLYGFCL  288 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  288 (397)
                      .++|++.+.||+|+||.||+|+..        ++..||||+++.......  ..++.+|...+.++ +||||+++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~--~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHH--HHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHH--HHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            357899999999999999999753        234799999977654332  46788899999888 7999999999999


Q ss_pred             eCCEeeEEEeeccCCCchhhcccCCC-------------ccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043586          289 HRKCMFLIYEYMERGSLFCNLHNNED-------------AVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNI  355 (397)
Q Consensus       289 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NI  355 (397)
                      +++..++||||+++|+|.+++.....             ...+++.+++.++.|++.||+|||   +.+|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence            99999999999999999999975432             235899999999999999999999   56999999999999


Q ss_pred             EeCCCCCeEEeccccccccCCCCCC--eeeccccccccCCCCC
Q 043586          356 LLNSKFEAFVADFGTARLLHADSSN--RTLLAGTYGYIAPGLP  396 (397)
Q Consensus       356 ll~~~~~~kl~DFG~a~~~~~~~~~--~~~~~gt~~y~APE~~  396 (397)
                      |++.++.+||+|||+++........  .....||+.|+|||++
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l  209 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  209 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence            9999999999999999977544322  2345689999999963

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=270.63  Aligned_cols=166  Identities=28%  Similarity=0.389  Sum_probs=135.8

Q ss_pred             CCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC------CE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR------KC  292 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  292 (397)
                      +|+..+.||+|+||+||+|++. +++.||||++.....       ...+|++++++++||||+++++++...      .+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence            4788899999999999999875 689999999976542       234699999999999999999998643      35


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTA  371 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a  371 (397)
                      .|+||||++++.+............+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence            7899999987644443332223345899999999999999999999   67999999999999999775 8999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +........ ...+||+.|+|||.+
T Consensus       171 ~~~~~~~~~-~~~~gt~~y~aPE~~  194 (350)
T d1q5ka_         171 KQLVRGEPN-VSYICSRYYRAPELI  194 (350)
T ss_dssp             EECCTTSCC-CSCCSCTTSCCHHHH
T ss_pred             hhccCCccc-ccccccccccChHHh
Confidence            877544333 335799999999964

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-34  Score=266.11  Aligned_cols=169  Identities=25%  Similarity=0.349  Sum_probs=138.7

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC----Ee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK----CM  293 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~  293 (397)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++.....  ...+++.+|+++|++++||||+++++++....    ..
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcCh--HHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            5699999999999999999975 58999999999765432  23467889999999999999999999997653    23


Q ss_pred             eEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          294 FLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       294 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      +++++|+.+|+|.+++...    .+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        86 ~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            4555667799999998653    4889999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCCC---CeeeccccccccCCCCC
Q 043586          374 LHADSS---NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~---~~~~~~gt~~y~APE~~  396 (397)
                      ......   .....+||+.|+|||++
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l  184 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIM  184 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred             ccCCCccceeeccccccceechHHHh
Confidence            644322   12345799999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-33  Score=262.34  Aligned_cols=162  Identities=20%  Similarity=0.339  Sum_probs=138.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeC--CEee
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR--KCMF  294 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~  294 (397)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++....      +++.+|+++|+.++ ||||+++++++...  ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            5799999999999999999986 4789999999976542      46778999999995 99999999999753  5689


Q ss_pred             EEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC-CeEEeccccccc
Q 043586          295 LIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF-EAFVADFGTARL  373 (397)
Q Consensus       295 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~DFG~a~~  373 (397)
                      +||||+.+++|....+      .+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+.
T Consensus       109 ~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999999976542      3788999999999999999999   66999999999999998655 689999999987


Q ss_pred             cCCCCCCeeeccccccccCCCCC
Q 043586          374 LHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ...... ....+||+.|+|||.+
T Consensus       180 ~~~~~~-~~~~~~t~~y~aPE~~  201 (328)
T d3bqca1         180 YHPGQE-YNVRVASRYFKGPELL  201 (328)
T ss_dssp             CCTTCC-CCSCCSCGGGCCHHHH
T ss_pred             ccCCCc-ccccccCccccCcccc
Confidence            755433 3445799999999964

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-33  Score=257.40  Aligned_cols=171  Identities=25%  Similarity=0.352  Sum_probs=148.7

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCCEeeEEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRKCMFLIY  297 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  297 (397)
                      ++|++.+.||+|+||+||+|++ .+++.||||+++..... ....+++.+|+.+++.++||||+++++++.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCC-hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            5799999999999999999986 47899999999765432 223578889999999999999999999999999999999


Q ss_pred             eeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccccccCCC
Q 043586          298 EYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTARLLHAD  377 (397)
Q Consensus       298 e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~~~~~  377 (397)
                      |++.++++..++....   .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eecccccccccccccc---ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            9999998887776443   4788899999999999999999   569999999999999999999999999999987766


Q ss_pred             CCCeeeccccccccCCCCC
Q 043586          378 SSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       378 ~~~~~~~~gt~~y~APE~~  396 (397)
                      ........+++.|+|||++
T Consensus       155 ~~~~~~~~~~~~~~~pe~~  173 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVL  173 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHH
T ss_pred             CccceeeccccchhhhhHh
Confidence            5555556788899999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=264.22  Aligned_cols=167  Identities=27%  Similarity=0.357  Sum_probs=136.1

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeCC-----
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHRK-----  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  291 (397)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++..... ....+.+.+|+++|++++||||++++++|...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            46799999999999999999986 46999999999764433 233577889999999999999999999998654     


Q ss_pred             -EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccc
Q 043586          292 -CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGT  370 (397)
Q Consensus       292 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~  370 (397)
                       ..|+||||+ +.++....+..    .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccc
Confidence             479999999 56777666532    4899999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCCCCCeeeccccccccCCCCC
Q 043586          371 ARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       371 a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      |+......   +...||+.|+|||++
T Consensus       168 a~~~~~~~---~~~~~t~~y~aPE~~  190 (346)
T d1cm8a_         168 ARQADSEM---TGYVVTRWYRAPEVI  190 (346)
T ss_dssp             CEECCSSC---CSSCSCGGGCCTHHH
T ss_pred             eeccCCcc---ccccccccccCHHHH
Confidence            98765432   346799999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=6.6e-34  Score=261.44  Aligned_cols=172  Identities=28%  Similarity=0.398  Sum_probs=135.9

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CC-CcEEEEEEecccchHHHHHHHHHHHHHHHHhhc---ccCCccceeeEEee---
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PN-GKVFALKKLHTSETEELAFIKSFRNEAQVLSQV---LHRNIVKLYGFCLH---  289 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---  289 (397)
                      .++|++.+.||+|+||+||+|++ .+ ++.||||+++.....+. ....+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            36899999999999999999986 34 56799999875432211 112345677776665   79999999999863   


Q ss_pred             --CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEec
Q 043586          290 --RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVAD  367 (397)
Q Consensus       290 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D  367 (397)
                        ....+++|||++++++.......  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             ccCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecc
Confidence              34689999999987775444332  234788999999999999999999   56899999999999999999999999


Q ss_pred             cccccccCCCCCCeeeccccccccCCCCC
Q 043586          368 FGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       368 FG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ||+++...... ......||+.|||||++
T Consensus       160 fg~~~~~~~~~-~~~~~~gT~~Y~APE~~  187 (305)
T d1blxa_         160 FGLARIYSFQM-ALTSVVVTLWYRAPEVL  187 (305)
T ss_dssp             CCSCCCCCGGG-GGCCCCCCCTTCCHHHH
T ss_pred             hhhhhhhcccc-cCCCcccChhhcCcchh
Confidence            99998654333 23456799999999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2e-33  Score=259.75  Aligned_cols=171  Identities=26%  Similarity=0.410  Sum_probs=136.6

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee--------
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH--------  289 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  289 (397)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++......+ ...+++.+|++++++++||||+++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            6799999999999999999986 479999999986543321 223567889999999999999999998865        


Q ss_pred             CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccc
Q 043586          290 RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFG  369 (397)
Q Consensus       290 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG  369 (397)
                      .+..|+||||+.++.+.......   ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence            34589999999877665444322   34788889999999999999999   5699999999999999999999999999


Q ss_pred             cccccCCCCC----CeeeccccccccCCCCC
Q 043586          370 TARLLHADSS----NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       370 ~a~~~~~~~~----~~~~~~gt~~y~APE~~  396 (397)
                      +++.......    .....+||+.|+|||++
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~  193 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELL  193 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHH
Confidence            9987653221    22335799999999964

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.98  E-value=9.5e-33  Score=251.85  Aligned_cols=167  Identities=20%  Similarity=0.288  Sum_probs=140.7

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc-CCccceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||+||+|++. +++.||||++......     +.+.+|++.++.++| +|++.+++++..+...++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence            57999999999999999999864 6899999998654322     346678899999975 8999999999999999999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC-----CCCeEEeccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS-----KFEAFVADFGTA  371 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~DFG~a  371 (397)
                      |||+ +++|.+++.....  .+++.++..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|
T Consensus        80 me~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          80 IDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             EECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             EEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEccccee
Confidence            9999 6899888875443  4788999999999999999999   779999999999999974     578999999999


Q ss_pred             cccCCCCC-------CeeeccccccccCCCCC
Q 043586          372 RLLHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      +.......       .....+||+.|||||++
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~  185 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTH  185 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHh
Confidence            97654321       22345799999999964

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.4e-33  Score=257.12  Aligned_cols=172  Identities=31%  Similarity=0.456  Sum_probs=144.1

Q ss_pred             cCCCccceeecCCcccEEEEEc----CCCcEEEEEEecccchH-HHHHHHHHHHHHHHHhhccc-CCccceeeEEeeCCE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL----PNGKVFALKKLHTSETE-ELAFIKSFRNEAQVLSQVLH-RNIVKLYGFCLHRKC  292 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  292 (397)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||+++..... +....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999974    25789999998654211 11112567789999999987 899999999999999


Q ss_pred             eeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEecccccc
Q 043586          293 MFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTAR  372 (397)
Q Consensus       293 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~  372 (397)
                      .++||||+.+|+|.+++....   .+++..+..++.|++.||+|+|   +.+|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999987654   3567888999999999999999   5689999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccccccccCCCCC
Q 043586          373 LLHADSS-NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       373 ~~~~~~~-~~~~~~gt~~y~APE~~  396 (397)
                      .+..... ......||+.|+|||.+
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~  202 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIV  202 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHH
T ss_pred             hhcccccccccccccccccchhHHh
Confidence            7654332 23445799999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-32  Score=256.32  Aligned_cols=168  Identities=26%  Similarity=0.301  Sum_probs=137.8

Q ss_pred             hcCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEeeC-----C
Q 043586          218 TEGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLHR-----K  291 (397)
Q Consensus       218 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~  291 (397)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++...... ...+++.+|++++++++||||+++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            45799999999999999999985 579999999998654332 2246788999999999999999999998643     3


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..+++|+|+.+|+|.+++...    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             ceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchh
Confidence            456777888899999988643    4889999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      ......   .....||+.|+|||+.
T Consensus       169 ~~~~~~---~~~~~g~~~y~apE~~  190 (348)
T d2gfsa1         169 RHTDDE---MTGYVATRWYRAPEIM  190 (348)
T ss_dssp             -CCTGG---GSSSCHHHHTSCHHHH
T ss_pred             cccCcc---cccccccccccCchhh
Confidence            765332   2345799999999963

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.1e-31  Score=245.73  Aligned_cols=167  Identities=18%  Similarity=0.279  Sum_probs=134.3

Q ss_pred             cCCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCcc-ceeeEEeeCCEeeEE
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV-KLYGFCLHRKCMFLI  296 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv  296 (397)
                      ++|++.+.||+|+||.||+|++ .+++.||||++......     +++.+|+++++.++|+|++ .+.+++...+..++|
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv   81 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence            4699999999999999999986 46899999998765432     3567899999999877654 555666778899999


Q ss_pred             EeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCC---CCCeEEeccccccc
Q 043586          297 YEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNS---KFEAFVADFGTARL  373 (397)
Q Consensus       297 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~DFG~a~~  373 (397)
                      |||+. +++.+.+....  ..+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||+|+.
T Consensus        82 me~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          82 MELLG-PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EECCC-CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEcC-Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99994 56666554433  24889999999999999999999   569999999999999863   56799999999998


Q ss_pred             cCCCCC-------CeeeccccccccCCCCC
Q 043586          374 LHADSS-------NRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       374 ~~~~~~-------~~~~~~gt~~y~APE~~  396 (397)
                      +.....       ......||+.|||||++
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  185 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTH  185 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHH
Confidence            754332       12345799999999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.3e-32  Score=253.16  Aligned_cols=167  Identities=27%  Similarity=0.304  Sum_probs=129.6

Q ss_pred             cCCCccceeecCCcccEEEEEcC-CCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCccceeeEEee------CC
Q 043586          219 EGFDIKYCIGTGGYGSVYKAQLP-NGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIVKLYGFCLH------RK  291 (397)
Q Consensus       219 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  291 (397)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...... ....+++.+|+.++++++||||+++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            57999999999999999999865 6999999999765433 2234678899999999999999999999964      36


Q ss_pred             EeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEeccccc
Q 043586          292 CMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVADFGTA  371 (397)
Q Consensus       292 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a  371 (397)
                      ..|+||||+.++.+ +.+..     .+++..++.++.|++.||.|||   +.||+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhh
Confidence            78999999976544 44432     3788999999999999999999   569999999999999999999999999998


Q ss_pred             cccCCCCCCeeeccccccccCCCCC
Q 043586          372 RLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       372 ~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                      +...... ......||+.|+|||++
T Consensus       167 ~~~~~~~-~~~~~~~t~~y~aPE~l  190 (355)
T d2b1pa1         167 RTAGTSF-MMTPYVVTRYYRAPEVI  190 (355)
T ss_dssp             ---------------CCTTCCHHHH
T ss_pred             hcccccc-ccccccccccccChhhh
Confidence            8655433 23445799999999974

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.94  E-value=2.9e-27  Score=221.92  Aligned_cols=168  Identities=21%  Similarity=0.272  Sum_probs=132.2

Q ss_pred             CCCccceeecCCcccEEEEEc-CCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-----------cCCccceeeEE
Q 043586          220 GFDIKYCIGTGGYGSVYKAQL-PNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-----------HRNIVKLYGFC  287 (397)
Q Consensus       220 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~  287 (397)
                      +|++++.||+|+||+||+|+. .+|+.||||+++.....    .+.+.+|+++++.++           |+||+++++++
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~----~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc----hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            499999999999999999986 47999999999876433    256677888888875           57899999988


Q ss_pred             ee--CCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCC----
Q 043586          288 LH--RKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKF----  361 (397)
Q Consensus       288 ~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~----  361 (397)
                      ..  ....+++|+++..+..............+++..+..++.||+.||+|||+.  .+|+||||||+|||++.++    
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence            64  456777787776655443333333344578889999999999999999962  5899999999999998665    


Q ss_pred             --CeEEeccccccccCCCCCCeeeccccccccCCCCC
Q 043586          362 --EAFVADFGTARLLHADSSNRTLLAGTYGYIAPGLP  396 (397)
Q Consensus       362 --~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~APE~~  396 (397)
                        .+|++|||.+.......   ...+||+.|+|||++
T Consensus       168 ~~~~kl~dfg~s~~~~~~~---~~~~gt~~y~aPE~~  201 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEHY---TNSIQTREYRSPEVL  201 (362)
T ss_dssp             EEEEEECCCTTCEETTBCC---CSCCSCGGGCCHHHH
T ss_pred             cceeeEeeccccccccccc---ccccccccccChhhc
Confidence              38999999998654332   345799999999963

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1e-24  Score=185.66  Aligned_cols=138  Identities=18%  Similarity=0.269  Sum_probs=107.4

Q ss_pred             CccceeecCCcccEEEEEcCCCcEEEEEEecccchH---------------HHHHHHHHHHHHHHHhhcccCCccceeeE
Q 043586          222 DIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETE---------------ELAFIKSFRNEAQVLSQVLHRNIVKLYGF  286 (397)
Q Consensus       222 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~~~  286 (397)
                      .+.+.||+|+||.||+|+..+|+.||||+++.....               .........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            467899999999999999888999999987642111               11123445678999999999999988766


Q ss_pred             EeeCCEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEeCCCCCeEEe
Q 043586          287 CLHRKCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDCSPSIIHRDISSNNILLNSKFEAFVA  366 (397)
Q Consensus       287 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~  366 (397)
                      ..    .+++|||+++..+.+          ++...+..++.|++.+++|||   +.+|+||||||+|||++++ .++|+
T Consensus        83 ~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             cC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            32    379999998755432          334456679999999999999   5699999999999999965 48999


Q ss_pred             ccccccccCCC
Q 043586          367 DFGTARLLHAD  377 (397)
Q Consensus       367 DFG~a~~~~~~  377 (397)
                      |||.|+....+
T Consensus       145 DFG~a~~~~~~  155 (191)
T d1zara2         145 DFPQSVEVGEE  155 (191)
T ss_dssp             CCTTCEETTST
T ss_pred             ECCCcccCCCC
Confidence            99999876433

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.80  E-value=3.6e-20  Score=169.54  Aligned_cols=74  Identities=39%  Similarity=0.643  Sum_probs=58.7

Q ss_pred             hcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCCcCCCCCC
Q 043586           74 IASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNFSALPSCD  150 (397)
Q Consensus        74 ~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~~~~~~~~  150 (397)
                      ++.+++|+.|++++|+++|.+|..++.+++|+.|+|++|+|+|.+|. +..+++|+.+++++|+.+|+.|  +|+|+
T Consensus       240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEEESTT--SSCCC
T ss_pred             cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccccCCC--CCCCC
Confidence            33456788888888888888888888888888888888888888774 4678888888888888888853  56663

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.78  E-value=4.6e-19  Score=150.31  Aligned_cols=131  Identities=26%  Similarity=0.306  Sum_probs=118.7

Q ss_pred             CCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccC-chhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            8 LIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         8 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      .++++.++|+|+ .+|..+.  ++++.|+|++|+|++.+ +..|.++++|++|+|++|.+++..+..|..+++|+.|+++
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            568999999999 6777663  78999999999998644 5678899999999999999998899999999999999999


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      +|+|+...|..|..+++|+.|+|++|+|++..+.+|..+++++.+++++|+..|.
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            9999988899999999999999999999999999999999999999999987664

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.76  E-value=1.3e-18  Score=147.38  Aligned_cols=137  Identities=25%  Similarity=0.297  Sum_probs=114.7

Q ss_pred             CCCCEEEcCCCcccccC-CccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            6 KNLIELDVGSNSLIGPI-PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++++|+|++|+|++.+ +..|..+++|+.|+|++|.+.+..+..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            57999999999998644 56789999999999999999999999999999999999999999988888999999999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCGNF  143 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~~~  143 (397)
                      |++|+|+++.|+.|..+++|+.|+|++|.+....+..+ -...+....+..|...|..+
T Consensus       109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSS
T ss_pred             cCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCC
Confidence            99999999999999999999999999999876543211 11223344455555555544

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.2e-18  Score=156.91  Aligned_cols=140  Identities=24%  Similarity=0.274  Sum_probs=128.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|+|++|.+....+..+..+++|+.+++++|.+++..+..|..+++|+.|++++|++++..|..|.++++|+
T Consensus       101 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~  180 (284)
T d1ozna_         101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD  180 (284)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccc
Confidence            56789999999999999877788899999999999999999977778898999999999999999988888999999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCcCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c~  141 (397)
                      .+++++|++++..|..|..+++|+.|++++|++++..+..+..+.+|+.+++++|+..|.
T Consensus       181 ~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             hhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            999999999998999999999999999999999998888899999999999999988773

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=5.2e-18  Score=151.31  Aligned_cols=133  Identities=26%  Similarity=0.290  Sum_probs=73.8

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +.++++|++|+|++|+|+. +| .++.+++|+.|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++
T Consensus        51 f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~  127 (266)
T d1p9ag_          51 LMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ  127 (266)
T ss_dssp             GTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC
T ss_pred             hhccccccccccccccccc-cc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccc
Confidence            4566677777777777663 33 2456667777777777665 3344555666666666666655544444444555555


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .|++++|.+....+..+..+++|+.+++++|++++..+..+..+++|+.|++++|.
T Consensus       128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  183 (266)
T d1p9ag_         128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS  183 (266)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred             cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCC
Confidence            55555555544444444445555555555555554444444445555555555443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.69  E-value=5.9e-17  Score=126.66  Aligned_cols=104  Identities=29%  Similarity=0.338  Sum_probs=91.8

Q ss_pred             CEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCc
Q 043586            9 IELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNN   88 (397)
Q Consensus         9 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N   88 (397)
                      ++|+|++|+++ .++ .+..+++|++|++++|+++ .+|+.+..+++|+.|++++|+|++ +| .+..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            58999999998 455 4899999999999999998 678889999999999999999994 55 5899999999999999


Q ss_pred             ccccCC-chhhccCCCCceeeccCCcCCCC
Q 043586           89 KIEGSI-PGEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        89 ~~~~~~-p~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      +|+... ...++.+++|+.|++++|+++..
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            998654 36789999999999999999754

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=8.3e-17  Score=143.38  Aligned_cols=130  Identities=26%  Similarity=0.230  Sum_probs=82.1

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEcc
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDIS   86 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~   86 (397)
                      +|++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+| .+..+++|++|+|++|+++ ..|..+..+++|+.|+++
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~  108 (266)
T d1p9ag_          32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS  108 (266)
T ss_dssp             TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred             CCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-cccccccccccccccccc
Confidence            5666666666666555556666666666666666665 333 2455666666666666666 355566666666666666


Q ss_pred             CcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           87 NNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        87 ~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +|.+.+..+..+..+.+++.|++++|.++...+..+..++.+..+++++|...
T Consensus       109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_         109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             ccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            66666655666666666666666666666666666666666666666666543

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.68  E-value=2e-17  Score=151.06  Aligned_cols=133  Identities=31%  Similarity=0.472  Sum_probs=122.2

Q ss_pred             CCCCEEEcCCCcccc--cCCccccCCCCCCEEeccC-CcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            6 KNLIELDVGSNSLIG--PIPSTLGLLTDLSYLDLSR-NQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .+++.|+|++|.++|  .+|..+++|++|++|+|++ |.++|.+|..|+++++|++|+|++|++++..|..+..+..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            368999999999987  5889999999999999997 8999999999999999999999999999999999999999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCccccccc-ceeccCCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSM-YIVRLSPNKG  138 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l-~~l~l~~n~~  138 (397)
                      +++++|.+.+.+|..++.++.|+.+++++|.+++.+|..+..+..+ ..++++.|..
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l  186 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL  186 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEE
T ss_pred             cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999888887776 6677777753

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.66  E-value=2.6e-17  Score=135.04  Aligned_cols=128  Identities=18%  Similarity=0.209  Sum_probs=105.4

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|.++. ++ .|..+++|++|++++|+++...+..+..+++|+.
T Consensus        15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~   91 (162)
T d1a9na_          15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   91 (162)
T ss_dssp             ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCcccccccccccc
Confidence            46678999999999998 467777889999999999999984 44 4889999999999999999655666778999999


Q ss_pred             EEccCcccccCCc-hhhccCCCCceeeccCCcCCCCCC---CCcccccccceecc
Q 043586           83 LDISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGPVP---FSNEQLSSMYIVRL  133 (397)
Q Consensus        83 L~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~~~---~~~~~l~~l~~l~l  133 (397)
                      |++++|+|+.... ..+..+++|+.|++++|+++....   ..+..+++|..+|.
T Consensus        92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~  146 (162)
T d1a9na_          92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF  146 (162)
T ss_dssp             EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred             ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence            9999999985322 468899999999999999985432   24566777777764

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=5.1e-16  Score=139.51  Aligned_cols=139  Identities=26%  Similarity=0.229  Sum_probs=100.0

Q ss_pred             CCCCCCCCEEEcCCCcccccC-------------------------CccccCCCCCCEEeccCCcccccCchhhhhcccC
Q 043586            2 IGNLKNLIELDVGSNSLIGPI-------------------------PSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGL   56 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~-------------------------p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L   56 (397)
                      +.++++|++|++++|++.+..                         |..|.++++|+.|++++|.+....+..+..+.+|
T Consensus        52 f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L  131 (284)
T d1ozna_          52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL  131 (284)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred             hhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhccc
Confidence            566777888888877765332                         3456666777777777777765556666677777


Q ss_pred             CeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCC
Q 043586           57 LGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        57 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n  136 (397)
                      +.+++++|+|++..+..|..+++|+.|++++|++++..+..|..+++|+.+++++|++++..|..|..+++++.+++++|
T Consensus       132 ~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N  211 (284)
T d1ozna_         132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (284)
T ss_dssp             CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence            77777777777655666777777777777777777766777777777777777777777777777777777777777777


Q ss_pred             CCcC
Q 043586          137 KGLC  140 (397)
Q Consensus       137 ~~~c  140 (397)
                      ....
T Consensus       212 ~i~~  215 (284)
T d1ozna_         212 NLSA  215 (284)
T ss_dssp             CCSC
T ss_pred             cccc
Confidence            6443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.56  E-value=7.9e-15  Score=114.29  Aligned_cols=101  Identities=25%  Similarity=0.357  Sum_probs=89.5

Q ss_pred             CEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCC
Q 043586           33 SYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSN  112 (397)
Q Consensus        33 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n  112 (397)
                      +.|+|++|.++ .+| .+..+++|++|++++|+|+ .+|+.++.+++|+.|++++|.|++ +| .+..+++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            57999999998 555 4899999999999999999 688899999999999999999985 44 4899999999999999


Q ss_pred             cCCCCCC-CCcccccccceeccCCCCC
Q 043586          113 KLSGPVP-FSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus       113 ~l~~~~~-~~~~~l~~l~~l~l~~n~~  138 (397)
                      +++.... ..+..+++|+.+++++|+.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i  102 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSL  102 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcC
Confidence            9996643 4678899999999999964

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.55  E-value=1.5e-14  Score=122.62  Aligned_cols=126  Identities=32%  Similarity=0.471  Sum_probs=84.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|++|+|++|++++..|  ++.+++|+.|++++|.+. .+| .+.++++|+.|++++|.+.. + ..+..+++|+
T Consensus        58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~  131 (199)
T d2omxa2          58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-I-DPLKNLTNLN  131 (199)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCS
T ss_pred             cccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-c-cccchhhhhH
Confidence            3456777777777777764322  667777777777777765 333 36667777777777777663 2 3466777777


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      .|++++|++.. + +.+..+++|+.|++++|++++..  .+.++++|+.+++++|+
T Consensus       132 ~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~  183 (199)
T d2omxa2         132 RLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNK  183 (199)
T ss_dssp             EEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSC
T ss_pred             Hhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCC
Confidence            77777777763 2 24677777777777777777543  35677777778887775

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.55  E-value=1.3e-14  Score=131.47  Aligned_cols=136  Identities=24%  Similarity=0.263  Sum_probs=117.9

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      +..+++|+++++++|.++ .+|..+  +++|+.|++++|..++..+..|..++.++.|++++|.+++..+..+.++++|+
T Consensus       146 ~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~  222 (305)
T d1xkua_         146 FQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR  222 (305)
T ss_dssp             GGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCC
T ss_pred             cccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccce
Confidence            346789999999999988 466544  68999999999999999999999999999999999999988899999999999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCc------ccccccceeccCCCCCcCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSN------EQLSSMYIVRLSPNKGLCG  141 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~------~~l~~l~~l~l~~n~~~c~  141 (397)
                      .|+|++|.|+ .+|..+..+++|+.|++++|+|+......|      ..+.++..+++++|+..+.
T Consensus       223 ~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         223 ELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             EEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             eeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            9999999998 468899999999999999999997644443      3567788999999986654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.54  E-value=1.1e-14  Score=118.28  Aligned_cols=140  Identities=16%  Similarity=0.082  Sum_probs=106.4

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCC-cccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRN-QFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .....+.++.+++++. ..|..+..+++|+.|++++| .++...++.|.++++|+.|+|++|+|+...|.+|..+++|+.
T Consensus         6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            3456778999999887 57888999999999999866 588777788999999999999999999877889999999999


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCCCcCCCCcC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNKGLCGNFSA  145 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~~~c~~~~~  145 (397)
                      |+|++|+|+...+..|.. .+|+.|+|++|++.-.-. .++..+.......+..+...|..+..
T Consensus        85 L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~  147 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGP  147 (156)
T ss_dssp             EECCSSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSC
T ss_pred             eeccCCCCcccChhhhcc-ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChH
Confidence            999999999666666655 479999999998852211 11222222233334445666766543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.52  E-value=4.4e-14  Score=120.80  Aligned_cols=126  Identities=30%  Similarity=0.379  Sum_probs=79.2

Q ss_pred             CCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcE
Q 043586            3 GNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTW   82 (397)
Q Consensus         3 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~   82 (397)
                      .++++|++|+|++|++++. + .++.+++|+.|++++|++++ +| .+..+++|+.|++++|.++ .+ +.+..+++|+.
T Consensus        65 ~~l~~L~~L~L~~n~i~~l-~-~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~  138 (210)
T d1h6ta2          65 QYLPNVTKLFLNGNKLTDI-K-PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLES  138 (210)
T ss_dssp             GGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCE
T ss_pred             hhCCCCCEEeCCCccccCc-c-ccccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccc
Confidence            3456666666666666642 2 24566666666666666653 33 3666666666666666665 22 34566666666


Q ss_pred             EEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           83 LDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        83 L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      +++++|.+++  +..+..+++|+.+++++|++++..+  +.++++|+.+++++|..
T Consensus       139 l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~~l~~L~~L~Ls~N~i  190 (210)
T d1h6ta2         139 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI  190 (210)
T ss_dssp             EECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred             cccccccccc--ccccccccccccccccccccccccc--ccCCCCCCEEECCCCCC
Confidence            6666666653  2345667777777777777775433  56677777777777753

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.51  E-value=2.5e-16  Score=133.63  Aligned_cols=109  Identities=30%  Similarity=0.340  Sum_probs=67.2

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .|++|++|+|++|+|+. ++ .|..+++|+.|+|++|+++ .+|..+..+++|++|++++|+++. + +.+..+++|+.|
T Consensus        46 ~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l~~L~~L  120 (198)
T d1m9la_          46 TLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEKLVNLRVL  120 (198)
T ss_dssp             HTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHHHHHSSEE
T ss_pred             cccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-cccccccccccc
Confidence            45666677777766663 33 3666667777777777665 445545555667777777776663 3 336666667777


Q ss_pred             EccCcccccCCc-hhhccCCCCceeeccCCcCCCC
Q 043586           84 DISNNKIEGSIP-GEITELSRLDYLNLSSNKLSGP  117 (397)
Q Consensus        84 ~l~~N~~~~~~p-~~~~~~~~L~~l~l~~n~l~~~  117 (397)
                      ++++|+|+.... ..+..+++|+.|++++|+++..
T Consensus       121 ~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~  155 (198)
T d1m9la_         121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             EESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHH
T ss_pred             ccccchhccccccccccCCCccceeecCCCccccC
Confidence            777776654221 3466666677777777666543

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.51  E-value=4.5e-14  Score=127.82  Aligned_cols=127  Identities=24%  Similarity=0.226  Sum_probs=109.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+++|+.|++++|..++..+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|++|..+++|+.|
T Consensus       169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L  247 (305)
T d1xkua_         169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV  247 (305)
T ss_dssp             CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred             cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence            4688999999999999899999999999999999999999888999999999999999999999 678999999999999


Q ss_pred             EccCcccccCCchhh------ccCCCCceeeccCCcCC--CCCCCCccccccccee
Q 043586           84 DISNNKIEGSIPGEI------TELSRLDYLNLSSNKLS--GPVPFSNEQLSSMYIV  131 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~------~~~~~L~~l~l~~n~l~--~~~~~~~~~l~~l~~l  131 (397)
                      +|++|+|+.+....|      ..+.+|+.|++++|++.  ...|.+|..+.....+
T Consensus       248 ~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~  303 (305)
T d1xkua_         248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV  303 (305)
T ss_dssp             ECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGE
T ss_pred             ECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCccc
Confidence            999999997544443      45688999999999985  3455666665544443

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.50  E-value=1.3e-14  Score=118.62  Aligned_cols=110  Identities=22%  Similarity=0.143  Sum_probs=96.1

Q ss_pred             cccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCC
Q 043586           25 TLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRL  104 (397)
Q Consensus        25 ~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L  104 (397)
                      .|.+..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|+.|++++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            3678889999999999998 56777788999999999999999 554 58999999999999999998777778889999


Q ss_pred             ceeeccCCcCCCCCC-CCcccccccceeccCCCC
Q 043586          105 DYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus       105 ~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~  137 (397)
                      +.|++++|+++.... ..+..+++|+.+++++|+
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred             ccceeccccccccccccccccccccchhhcCCCc
Confidence            999999999986533 467888999999999985

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.48  E-value=5.7e-14  Score=130.90  Aligned_cols=125  Identities=34%  Similarity=0.448  Sum_probs=62.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+++|+.|++++|.+++..+  +..+++|+.|++++|.+++..|  +..+..++.++++.|.+++  ...+..+++++.|
T Consensus       239 ~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L  312 (384)
T d2omza2         239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYL  312 (384)
T ss_dssp             GCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEE
T ss_pred             cccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--ccccccccccccccccccc--ccccchhcccCeE
Confidence            34445555555555443221  4444555555555555442211  2223333333333333331  1234555666666


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++++|++++..  .+..+++|+.|++++|++++. + .+.++++|+.+++++|+.
T Consensus       313 ~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l  363 (384)
T d2omza2         313 TLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQI  363 (384)
T ss_dssp             ECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCC
T ss_pred             ECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcC
Confidence            66666666532  256666666666666666643 2 356666666666666643

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.46  E-value=1.5e-13  Score=117.31  Aligned_cols=124  Identities=28%  Similarity=0.369  Sum_probs=106.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCc
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLT   81 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~   81 (397)
                      ++++++|++|++++|++++ +| .+..+++|+.|++++|.+. .+ ..+..+++|+.+++++|.+++  +..+..+++|+
T Consensus        86 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~  159 (210)
T d1h6ta2          86 LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD  159 (210)
T ss_dssp             GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCS
T ss_pred             cccCccccccccccccccc-cc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccccc
Confidence            4678999999999999985 55 5899999999999999987 34 368899999999999999984  44678899999


Q ss_pred             EEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCC
Q 043586           82 WLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSP  135 (397)
Q Consensus        82 ~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~  135 (397)
                      .+++++|++++. + .++++++|+.|++++|+++.. | .+..+++|+.|++++
T Consensus       160 ~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         160 TLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             EEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEE
T ss_pred             cccccccccccc-c-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEccC
Confidence            999999999864 3 388999999999999999854 4 578899999998863

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.46  E-value=1.3e-13  Score=111.82  Aligned_cols=111  Identities=23%  Similarity=0.137  Sum_probs=97.5

Q ss_pred             CCCCCCEEeccCCcccccCchhhhhcccCCeEeccCc-cCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCce
Q 043586           28 LLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN-KLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDY  106 (397)
Q Consensus        28 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~  106 (397)
                      .....+.++++++.+. ..|..+..+++|++|++++| .|+...+..|.++++|+.|++++|+|+.+.|..|..+++|+.
T Consensus         6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~   84 (156)
T d2ifga3           6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR   84 (156)
T ss_dssp             CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred             CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence            4455678999999997 57888999999999999876 599766788999999999999999999988999999999999


Q ss_pred             eeccCCcCCCCCCCCcccccccceeccCCCCCcC
Q 043586          107 LNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGLC  140 (397)
Q Consensus       107 l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~c  140 (397)
                      |+|++|+|+...+..+..+ ++..+++++|+..|
T Consensus        85 L~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~C  117 (156)
T d2ifga3          85 LNLSFNALESLSWKTVQGL-SLQELVLSGNPLHC  117 (156)
T ss_dssp             EECCSSCCSCCCSTTTCSC-CCCEEECCSSCCCC
T ss_pred             eeccCCCCcccChhhhccc-cccccccCCCcccC
Confidence            9999999997777777655 69999999998877

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.43  E-value=3.7e-13  Score=113.88  Aligned_cols=125  Identities=28%  Similarity=0.419  Sum_probs=106.0

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      .+.+|+.|++++|.+.. ++ .+..+++|++|++++|++++..|  +.++++|++|++++|.+. .++ .+.++++|+.|
T Consensus        38 ~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L  111 (199)
T d2omxa2          38 DLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGL  111 (199)
T ss_dssp             HHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             HhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccccc
Confidence            36789999999999984 44 48889999999999999986443  899999999999999998 455 48899999999


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKG  138 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~  138 (397)
                      ++++|.+...  ..+..+++|+.|++++|++... + .+..++++..+++++|..
T Consensus       112 ~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~-~l~~~~~L~~L~l~~n~l  162 (199)
T d2omxa2         112 TLFNNQITDI--DPLKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLNFSSNQV  162 (199)
T ss_dssp             ECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCC
T ss_pred             cccccccccc--cccchhhhhHHhhhhhhhhccc-c-cccccccccccccccccc
Confidence            9999998753  3578899999999999999854 2 577888999999998853

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.41  E-value=6.8e-13  Score=114.64  Aligned_cols=128  Identities=30%  Similarity=0.476  Sum_probs=80.4

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCC----------
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIP----------   71 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p----------   71 (397)
                      +.+|++|++|+|++|++++..|  +..+++|+.+++++|.++ .++ .+..+++|+.+++++|...+..+          
T Consensus        59 l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l  134 (227)
T d1h6ua2          59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL  134 (227)
T ss_dssp             GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEE
T ss_pred             HhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhh
Confidence            3456677777777777664332  666677777777777665 333 35666666666666666553221          


Q ss_pred             ----------hhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           72 ----------SQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        72 ----------~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                                ..+..+++|+.|++++|.+....  .++.+++|+.|++++|++++..+  +..+++|+.+++++|+
T Consensus       135 ~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~  206 (227)
T d1h6ua2         135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ  206 (227)
T ss_dssp             ECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSC
T ss_pred             hchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChh--hcCCCCCCEEECcCCc
Confidence                      22445566777777777765332  36677777777777777775432  5667777777777774

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.37  E-value=1.2e-14  Score=123.03  Aligned_cols=126  Identities=25%  Similarity=0.221  Sum_probs=104.4

Q ss_pred             CCCCEEEcCCC--cccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEE
Q 043586            6 KNLIELDVGSN--SLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         6 ~~L~~L~L~~n--~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      ..++.+++.++  .+. .+|..+..+++|+.|+|++|+|+ .++ .+.++++|+.|+|++|.|+ .+|..+..+++|++|
T Consensus        23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L   98 (198)
T d1m9la_          23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEEL   98 (198)
T ss_dssp             TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEE
T ss_pred             cccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccc
Confidence            34566777654  233 46678999999999999999998 455 5999999999999999999 677777777889999


Q ss_pred             EccCcccccCCchhhccCCCCceeeccCCcCCCCCC-CCcccccccceeccCCCC
Q 043586           84 DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVP-FSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        84 ~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~-~~~~~l~~l~~l~l~~n~  137 (397)
                      ++++|+++..  ..+..+++|+.|++++|+++.... ..+..+++|+.+++++|+
T Consensus        99 ~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~  151 (198)
T d1m9la_          99 WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP  151 (198)
T ss_dssp             ECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred             cccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCc
Confidence            9999999853  358889999999999999986533 457889999999999985

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.31  E-value=5e-12  Score=117.44  Aligned_cols=125  Identities=37%  Similarity=0.492  Sum_probs=81.7

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      .++|+.|++++|+++. + +.+..+++|+.|++++|.+++..|  +..+++|+.|++++|++++ ++ .+..++.++.++
T Consensus       218 ~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~-~~-~~~~~~~l~~l~  291 (384)
T d2omza2         218 LTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-IS-PLAGLTALTNLE  291 (384)
T ss_dssp             CTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred             cCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCC-CC-cccccccccccc
Confidence            3455556666555552 2 245556666666666666654322  5555666666666666653 22 245556666666


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCCCc
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +++|.+.+  ...+..+++++.|++++|++++..+  +..+++|+.+++++|...
T Consensus       292 ~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l~  342 (384)
T d2omza2         292 LNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVS  342 (384)
T ss_dssp             CCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCC
T ss_pred             cccccccc--ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCCC
Confidence            66666654  2347888999999999999998754  788999999999999643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.30  E-value=6.4e-12  Score=108.37  Aligned_cols=125  Identities=27%  Similarity=0.422  Sum_probs=95.7

Q ss_pred             CCCCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccC--------------------chhhhhcccCCeEec
Q 043586            2 IGNLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI--------------------PNELTWLTGLLGLNL   61 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~--------------------p~~~~~l~~L~~L~l   61 (397)
                      +.++++|+++++++|.++. ++ .+..+++|+.++++.|...+..                    ...+..+++|+.|++
T Consensus        81 l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l  158 (227)
T d1h6ua2          81 LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSI  158 (227)
T ss_dssp             GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEEC
T ss_pred             ccccccccccccccccccc-cc-cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccc
Confidence            4566777777777777663 33 4666777777777776655321                    123566788999999


Q ss_pred             cCccCCCcCChhhcCCCCCcEEEccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccC
Q 043586           62 SSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLS  134 (397)
Q Consensus        62 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~  134 (397)
                      ++|.+++ . ..+.++++|+.|++++|++++. + .+..+++|+.|++++|+++...|  +.++++|+.++++
T Consensus       159 ~~n~~~~-~-~~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls  225 (227)
T d1h6ua2         159 GNAQVSD-L-TPLANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT  225 (227)
T ss_dssp             CSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred             ccccccc-c-hhhcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence            9999984 3 3488999999999999999864 3 38999999999999999997654  7788999999886

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.19  E-value=4.5e-11  Score=103.80  Aligned_cols=87  Identities=25%  Similarity=0.289  Sum_probs=61.7

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccC-chhhhhcccCCeEecc-CccCCCcCChhhcCCCCCcEE
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSI-PNELTWLTGLLGLNLS-SNKLSGKIPSQIASMKNLTWL   83 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~L   83 (397)
                      +++++|+|++|+|+...+..|.++++|++|++++|.+...+ +..|..++++++|.+. .|.++...+..|.++++|+.+
T Consensus        29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l  108 (242)
T d1xwdc1          29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  108 (242)
T ss_dssp             SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred             CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence            47888899888888655667888888999998888876543 3356667777777654 356665566666677777777


Q ss_pred             EccCccccc
Q 043586           84 DISNNKIEG   92 (397)
Q Consensus        84 ~l~~N~~~~   92 (397)
                      ++++|.+..
T Consensus       109 ~l~~~~l~~  117 (242)
T d1xwdc1         109 LISNTGIKH  117 (242)
T ss_dssp             EEESCCCCS
T ss_pred             ccchhhhcc
Confidence            777666643

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.14  E-value=3.4e-11  Score=104.56  Aligned_cols=131  Identities=21%  Similarity=0.189  Sum_probs=69.9

Q ss_pred             CCCCCCCEEEcCC-CcccccCCccccCCCCCCEEeccCCcccccCc-------------------------hhhhhcc-c
Q 043586            3 GNLKNLIELDVGS-NSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIP-------------------------NELTWLT-G   55 (397)
Q Consensus         3 ~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p-------------------------~~~~~l~-~   55 (397)
                      .+++++++|++.. |++....+..|.++++|+.|++++|.+....+                         ..|..++ .
T Consensus        75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~  154 (242)
T d1xwdc1          75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE  154 (242)
T ss_dssp             ESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccccc
Confidence            3566777776543 56666666677777777777777777753222                         2222221 3


Q ss_pred             CCeEeccCccCCCcCChhhcCCCCCcEE-EccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccC
Q 043586           56 LLGLNLSSNKLSGKIPSQIASMKNLTWL-DISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLS  134 (397)
Q Consensus        56 L~~L~l~~N~l~~~~p~~~~~l~~L~~L-~l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~  134 (397)
                      ++.|++++|+++. ++.......++.++ ++++|.++...+..|..+++|+.|++++|+++..++..+.++++|+.+++.
T Consensus       155 l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~  233 (242)
T d1xwdc1         155 SVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY  233 (242)
T ss_dssp             CEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred             ceeeecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence            4445555555552 33333333333333 344455554444445555666666666666555444455555555555443

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.92  E-value=3.2e-10  Score=100.88  Aligned_cols=134  Identities=25%  Similarity=0.239  Sum_probs=75.1

Q ss_pred             CCCCCCEEEcCCCcccccCCccccCCCCCCEEeccCC-ccccc-CchhhhhcccCCeEeccCc-cCCCc-CChhhcC-CC
Q 043586            4 NLKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRN-QFNSS-IPNELTWLTGLLGLNLSSN-KLSGK-IPSQIAS-MK   78 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~-l~   78 (397)
                      ++++|++|+|+++.+++..+..+..+++|+.|+++++ .++.. +..-..++++|++|+++++ .++.. ++..+.. ++
T Consensus        69 ~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~  148 (284)
T d2astb2          69 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSE  148 (284)
T ss_dssp             TBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCT
T ss_pred             hCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccc
Confidence            4556666666666665555555666666666666663 34321 1122334566666666653 33311 1122222 34


Q ss_pred             CCcEEEccCcc--cccC-CchhhccCCCCceeeccCC-cCCCCCCCCcccccccceeccCCCC
Q 043586           79 NLTWLDISNNK--IEGS-IPGEITELSRLDYLNLSSN-KLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        79 ~L~~L~l~~N~--~~~~-~p~~~~~~~~L~~l~l~~n-~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +|+.|++++..  ++.. +......+++|+.|++++| .++......+.++++|+.++++++.
T Consensus       149 ~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~  211 (284)
T d2astb2         149 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCY  211 (284)
T ss_dssp             TCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred             ccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCC
Confidence            56666666532  2211 2233456788999999876 4665555667778888888888743

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.91  E-value=4.8e-09  Score=95.37  Aligned_cols=99  Identities=24%  Similarity=0.352  Sum_probs=81.2

Q ss_pred             CCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEc
Q 043586            6 KNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDI   85 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l   85 (397)
                      .+|++|||++|.|+ .+|+.   +++|+.|+|++|+|+ .+|..+   .+|+.|++++|+++ .++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence            36899999999998 57753   578999999999998 678654   57999999999998 55542   146999999


Q ss_pred             cCcccccCCchhhccCCCCceeeccCCcCCCCC
Q 043586           86 SNNKIEGSIPGEITELSRLDYLNLSSNKLSGPV  118 (397)
Q Consensus        86 ~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~  118 (397)
                      ++|.+.. +|. ++.+++|+.|++++|.++...
T Consensus       106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~  136 (353)
T d1jl5a_         106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLP  136 (353)
T ss_dssp             CSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCC
T ss_pred             ccccccc-ccc-hhhhccceeeccccccccccc
Confidence            9999985 554 678999999999999987543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=1.6e-10  Score=93.78  Aligned_cols=121  Identities=21%  Similarity=0.159  Sum_probs=86.3

Q ss_pred             CCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCc--CChhhcCCCCCcEEE
Q 043586            7 NLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGK--IPSQIASMKNLTWLD   84 (397)
Q Consensus         7 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~p~~~~~l~~L~~L~   84 (397)
                      ..+.|+++++...    ..+..+..+..++..+|... .++..+..+++|++|+|++|+|+..  ++..+..+++|+.|+
T Consensus        23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~   97 (162)
T d1koha1          23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN   97 (162)
T ss_dssp             SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred             hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence            4566777665422    23556666677777776664 5566667899999999999999954  245677899999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCC-------cccccccceec
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFS-------NEQLSSMYIVR  132 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~-------~~~l~~l~~l~  132 (397)
                      +++|.|+...+..+....+|+.|++++|+++......       +..+++|..||
T Consensus        98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD  152 (162)
T d1koha1          98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD  152 (162)
T ss_dssp             CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred             cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence            9999998655545555567999999999998654432       34566776654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=1.2e-09  Score=97.18  Aligned_cols=136  Identities=19%  Similarity=0.201  Sum_probs=98.4

Q ss_pred             CCCCCCEEEcCCCccccc-CCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCc-cCCCc-CChhhcCCCCC
Q 043586            4 NLKNLIELDVGSNSLIGP-IPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSN-KLSGK-IPSQIASMKNL   80 (397)
Q Consensus         4 ~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~p~~~~~l~~L   80 (397)
                      ...+|++|||+++.+++. ++..+..+++|+.|+|++|.+++..+..+..+++|++|+|+++ .++.. +...+..+++|
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence            456899999999988643 4566888999999999999998888888889999999999984 56632 23335678999


Q ss_pred             cEEEccCc-ccccC-Cchhhcc-CCCCceeeccCC--cCCCC-CCCCcccccccceeccCCCCCc
Q 043586           81 TWLDISNN-KIEGS-IPGEITE-LSRLDYLNLSSN--KLSGP-VPFSNEQLSSMYIVRLSPNKGL  139 (397)
Q Consensus        81 ~~L~l~~N-~~~~~-~p~~~~~-~~~L~~l~l~~n--~l~~~-~~~~~~~l~~l~~l~l~~n~~~  139 (397)
                      +.|+++++ .++.. +...+.. ++.|+.|++++.  .++.. +......+++|+.++++++...
T Consensus       124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~i  188 (284)
T d2astb2         124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML  188 (284)
T ss_dssp             CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC
T ss_pred             cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCC
Confidence            99999985 34322 2233433 478999999865  33321 1222345788999999986543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.77  E-value=2.5e-10  Score=92.65  Aligned_cols=92  Identities=20%  Similarity=0.149  Sum_probs=71.1

Q ss_pred             cCCccccCCCCCCEEeccCCcccccC--chhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEEccCcccccCCch--
Q 043586           21 PIPSTLGLLTDLSYLDLSRNQFNSSI--PNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLDISNNKIEGSIPG--   96 (397)
Q Consensus        21 ~~p~~l~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~~~~~~p~--   96 (397)
                      .++..+..+++|++|+|++|+++..-  +..+..+++|+.|+|++|.++...+-.+....+|+.|++++|++......  
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~  135 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQS  135 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred             hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccch
Confidence            44555567999999999999998543  45678899999999999999954443455566799999999999865542  


Q ss_pred             -----hhccCCCCceeeccCCcC
Q 043586           97 -----EITELSRLDYLNLSSNKL  114 (397)
Q Consensus        97 -----~~~~~~~L~~l~l~~n~l  114 (397)
                           .+..+|+|+.||  ++.+
T Consensus       136 ~y~~~i~~~~P~L~~LD--g~~v  156 (162)
T d1koha1         136 TYISAIRERFPKLLRLD--GHEL  156 (162)
T ss_dssp             HHHHHHHTTSTTCCEET--TEEC
T ss_pred             hHHHHHHHHCCCCCEEC--cCCC
Confidence                 366789999885  5554

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.75  E-value=3.1e-08  Score=86.39  Aligned_cols=150  Identities=14%  Similarity=0.092  Sum_probs=102.2

Q ss_pred             HHHHHHhcCCCccceeecCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcc-cCCccceeeEEeeC
Q 043586          212 EDLIEATEGFDIKYCIGTGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVL-HRNIVKLYGFCLHR  290 (397)
Q Consensus       212 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  290 (397)
                      +++....+.|+..+..+.++.+.||+... +++.+++|+........   ...+.+|...+..+. +--+.+++.+...+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecC
Confidence            56666677787666544455578999875 45667788876543221   134567888887774 43467888888888


Q ss_pred             CEeeEEEeeccCCCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHhCC-----------------------------
Q 043586          291 KCMFLIYEYMERGSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHHDC-----------------------------  341 (397)
Q Consensus       291 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----------------------------  341 (397)
                      +..++||++++|.++.+.....        .....++.++++.+..||+..                             
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CceEEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            9999999999998775443211        112234555666666666310                             


Q ss_pred             ---------------------------CCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          342 ---------------------------SPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       342 ---------------------------~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                                                 ...++|+|+.|.||++++++..-|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                       12378999999999999877677999998864

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.63  E-value=1.2e-07  Score=85.84  Aligned_cols=117  Identities=22%  Similarity=0.282  Sum_probs=83.0

Q ss_pred             CCCCCEEEcCCCcccccCCccccCCCCCCEEeccCCcccccCchhhhhcccCCeEeccCccCCCcCChhhcCCCCCcEEE
Q 043586            5 LKNLIELDVGSNSLIGPIPSTLGLLTDLSYLDLSRNQFNSSIPNELTWLTGLLGLNLSSNKLSGKIPSQIASMKNLTWLD   84 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~   84 (397)
                      +++|++|+|++|+|+ .+|+.   +.+|+.|++++|+++ .++. +  .++|++|++++|.++ .+|. ++.+++|+.|+
T Consensus        57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~  126 (353)
T d1jl5a_          57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID  126 (353)
T ss_dssp             CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred             CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence            368999999999999 67865   468999999999997 4443 2  246999999999999 5775 67899999999


Q ss_pred             ccCcccccCCchhhccCCCCceeeccCCcCCCCCCCCcccccccceeccCCCC
Q 043586           85 ISNNKIEGSIPGEITELSRLDYLNLSSNKLSGPVPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        85 l~~N~~~~~~p~~~~~~~~L~~l~l~~n~l~~~~~~~~~~l~~l~~l~l~~n~  137 (397)
                      +++|.+....+ .   ...+..+.+..+....  ...+..++.+..++++.|.
T Consensus       127 l~~~~~~~~~~-~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~  173 (353)
T d1jl5a_         127 VDNNSLKKLPD-L---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNS  173 (353)
T ss_dssp             CCSSCCSCCCC-C---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSC
T ss_pred             ccccccccccc-c---cccccchhhccccccc--cccccccccceeccccccc
Confidence            99999875332 2   3445555555554432  2334445555555555554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.58  E-value=1.9e-09  Score=101.66  Aligned_cols=111  Identities=23%  Similarity=0.309  Sum_probs=84.6

Q ss_pred             CCCCEEEcCCCccccc-CCccccCCCCCCEEeccCCcccc----cCchhhhhcccCCeEeccCccCCCc----CChhhc-
Q 043586            6 KNLIELDVGSNSLIGP-IPSTLGLLTDLSYLDLSRNQFNS----SIPNELTWLTGLLGLNLSSNKLSGK----IPSQIA-   75 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~-   75 (397)
                      .+|+.|||++|++++. +.+-+..+++|+.|+|++|.++.    .++..+..+++|++|+|++|.|+..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999753 24456678999999999999873    3445567889999999999998632    122222 


Q ss_pred             CCCCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCC
Q 043586           76 SMKNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSG  116 (397)
Q Consensus        76 ~l~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~  116 (397)
                      ...+|+.|++++|+++..    ++..+..+++|+.|++++|.++.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            224799999999998754    35667888999999999998763

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.55  E-value=4e-09  Score=96.28  Aligned_cols=132  Identities=17%  Similarity=0.205  Sum_probs=66.1

Q ss_pred             CCCCEEEcCCCcccc----cCCccccCCCCCCEEeccCCccccc-----CchhhhhcccCCeEeccCccCCCc----CCh
Q 043586            6 KNLIELDVGSNSLIG----PIPSTLGLLTDLSYLDLSRNQFNSS-----IPNELTWLTGLLGLNLSSNKLSGK----IPS   72 (397)
Q Consensus         6 ~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~l~~N~l~~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~   72 (397)
                      +.|+.|++++|.+..    .+...+...+.|+.|+|++|.++..     +...+..+++|+.|+|++|.++..    +..
T Consensus       158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~  237 (344)
T d2ca6a1         158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  237 (344)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccc
Confidence            445555555555431    1222344456666666666666421     122344556666666666665422    234


Q ss_pred             hhcCCCCCcEEEccCcccccCCchh----hcc--CCCCceeeccCCcCCCC----CCCCc-ccccccceeccCCCC
Q 043586           73 QIASMKNLTWLDISNNKIEGSIPGE----ITE--LSRLDYLNLSSNKLSGP----VPFSN-EQLSSMYIVRLSPNK  137 (397)
Q Consensus        73 ~~~~l~~L~~L~l~~N~~~~~~p~~----~~~--~~~L~~l~l~~n~l~~~----~~~~~-~~l~~l~~l~l~~n~  137 (397)
                      .+..+++|++|++++|.|.+.....    +..  .+.|+.|++++|+++..    +...+ ...+.|..+++++|.
T Consensus       238 ~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~  313 (344)
T d2ca6a1         238 ALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNR  313 (344)
T ss_dssp             HGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSB
T ss_pred             cccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCc
Confidence            4555666666666666665432222    222  24566666666665421    11111 134456666666664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.53  E-value=6.2e-09  Score=94.93  Aligned_cols=136  Identities=17%  Similarity=0.118  Sum_probs=81.8

Q ss_pred             CCCCCCCCEEEcCCCccccc----------CCccccCCCCCCEEeccCCccccc----CchhhhhcccCCeEeccCccCC
Q 043586            2 IGNLKNLIELDVGSNSLIGP----------IPSTLGLLTDLSYLDLSRNQFNSS----IPNELTWLTGLLGLNLSSNKLS   67 (397)
Q Consensus         2 l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~   67 (397)
                      +...++|+.|+++++.....          +...+...++|+.|+|++|.++..    +...+..+++|+.|++++|.++
T Consensus        55 l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~  134 (344)
T d2ca6a1          55 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG  134 (344)
T ss_dssp             TTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccc
Confidence            45567788888877654311          123355677788888888887643    2334455677888888888764


Q ss_pred             CcCChh-------------hcCCCCCcEEEccCcccccC----CchhhccCCCCceeeccCCcCCCC-----CCCCcccc
Q 043586           68 GKIPSQ-------------IASMKNLTWLDISNNKIEGS----IPGEITELSRLDYLNLSSNKLSGP-----VPFSNEQL  125 (397)
Q Consensus        68 ~~~p~~-------------~~~l~~L~~L~l~~N~~~~~----~p~~~~~~~~L~~l~l~~n~l~~~-----~~~~~~~l  125 (397)
                      ..-...             ....+.|+.+++++|.+...    +...+..++.|+.|++++|.++..     +...+...
T Consensus       135 ~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~  214 (344)
T d2ca6a1         135 PQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC  214 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred             ccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcch
Confidence            211111             12345677777777776532    233355667777777777776531     22344556


Q ss_pred             cccceeccCCCC
Q 043586          126 SSMYIVRLSPNK  137 (397)
Q Consensus       126 ~~l~~l~l~~n~  137 (397)
                      ++++.+++++|.
T Consensus       215 ~~L~~L~Ls~N~  226 (344)
T d2ca6a1         215 QELKVLDLQDNT  226 (344)
T ss_dssp             TTCCEEECCSSC
T ss_pred             hhhccccccccc
Confidence            667777777765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.42  E-value=3.2e-07  Score=79.38  Aligned_cols=131  Identities=17%  Similarity=0.135  Sum_probs=88.3

Q ss_pred             eeecCCc-ccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhccc--CCccceeeEEeeCCEeeEEEeeccC
Q 043586          226 CIGTGGY-GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLH--RNIVKLYGFCLHRKCMFLIYEYMER  302 (397)
Q Consensus       226 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~  302 (397)
                      .+..|.. +.||+....++..+++|.......      ..+..|...++.+..  -.+.+++.+..+++..++||++++|
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            3455554 678999988888899998766543      235568888877753  3366788888888889999999998


Q ss_pred             CCchhhcccCCCccccChHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 043586          303 GSLFCNLHNNEDAVELDWAKRVNIVKAMAHALAYLHH-------------------------------------------  339 (397)
Q Consensus       303 g~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------------  339 (397)
                      .++.+...        ..   ...+.++++.+.-||.                                           
T Consensus        91 ~~~~~~~~--------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSSHL--------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTSCC--------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cccccccc--------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence            76643110        10   1122333333333432                                           


Q ss_pred             --------C----CCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          340 --------D----CSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       340 --------~----~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                              .    ....++|+|+.|.||+++.+..+-|+||+.+..
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                    0    022479999999999999877778999998864

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=6.4e-08  Score=90.85  Aligned_cols=133  Identities=22%  Similarity=0.120  Sum_probs=57.5

Q ss_pred             CCCCCEEEcCCCccccc----CCccccCCCCCCEEeccCCcccccCchhhh-----hcccCCeEeccCccCCCcCChh--
Q 043586            5 LKNLIELDVGSNSLIGP----IPSTLGLLTDLSYLDLSRNQFNSSIPNELT-----WLTGLLGLNLSSNKLSGKIPSQ--   73 (397)
Q Consensus         5 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~~p~~--   73 (397)
                      ..+|+.|++++|.+...    ....+...+.++.+++++|.++......+.     ....|+.+++++|.++......  
T Consensus       254 ~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~  333 (460)
T d1z7xw1         254 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFS  333 (460)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcc
Confidence            34566666666665422    122334455555555555555422111111     1234555555555554322222  


Q ss_pred             --hcCCCCCcEEEccCcccccC----Cchhhc-cCCCCceeeccCCcCCCC----CCCCcccccccceeccCCCC
Q 043586           74 --IASMKNLTWLDISNNKIEGS----IPGEIT-ELSRLDYLNLSSNKLSGP----VPFSNEQLSSMYIVRLSPNK  137 (397)
Q Consensus        74 --~~~l~~L~~L~l~~N~~~~~----~p~~~~-~~~~L~~l~l~~n~l~~~----~~~~~~~l~~l~~l~l~~n~  137 (397)
                        +...++|++|+|++|+|...    ++..+. ..+.|+.|+|++|.++..    +...+...++|+.|++++|.
T Consensus       334 ~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~  408 (460)
T d1z7xw1         334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNC  408 (460)
T ss_dssp             HHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSS
T ss_pred             cccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCc
Confidence              22333455555555555321    122222 233455555555555421    11223334455555555553

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.22  E-value=5.5e-07  Score=72.71  Aligned_cols=109  Identities=14%  Similarity=0.103  Sum_probs=62.2

Q ss_pred             CCCCCCEEEcCCC-ccccc----CCccccCCCCCCEEeccCCccccc----CchhhhhcccCCeEeccCccCCCcC----
Q 043586            4 NLKNLIELDVGSN-SLIGP----IPSTLGLLTDLSYLDLSRNQFNSS----IPNELTWLTGLLGLNLSSNKLSGKI----   70 (397)
Q Consensus         4 ~l~~L~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----   70 (397)
                      +.++|++|+|+++ .++..    +-..+...++|+.|+|++|.+...    +...+...+.|+.|+|++|.++..-    
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l   92 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL   92 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence            4577888888764 45321    334566667788888888877532    2233445567777777777776321    


Q ss_pred             ChhhcCCCCCcEEEccCcccccC-------CchhhccCCCCceeeccCC
Q 043586           71 PSQIASMKNLTWLDISNNKIEGS-------IPGEITELSRLDYLNLSSN  112 (397)
Q Consensus        71 p~~~~~l~~L~~L~l~~N~~~~~-------~p~~~~~~~~L~~l~l~~n  112 (397)
                      -.++...++|++|++++|.+...       +...+...+.|+.|+++.+
T Consensus        93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~  141 (167)
T d1pgva_          93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA  141 (167)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred             HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence            12344455677777766654422       2233444455555555443

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.88  E-value=2e-05  Score=72.32  Aligned_cols=79  Identities=14%  Similarity=0.132  Sum_probs=47.9

Q ss_pred             ceeecCCcccEEEEEcCC-CcEEEEEEecccchHH----HHHHHHHHHHHHHHhhcc-c--CCccceeeEEeeCCEeeEE
Q 043586          225 YCIGTGGYGSVYKAQLPN-GKVFALKKLHTSETEE----LAFIKSFRNEAQVLSQVL-H--RNIVKLYGFCLHRKCMFLI  296 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv  296 (397)
                      +.||.|....||+....+ ++.+++|.-.......    ....++...|.+.++.+. +  ..+.+++.+  +++..++|
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv  109 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  109 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence            458999999999998754 6789999654311000    000133456888887763 2  345566654  44556799


Q ss_pred             EeeccCCCc
Q 043586          297 YEYMERGSL  305 (397)
Q Consensus       297 ~e~~~~g~L  305 (397)
                      ||++++..+
T Consensus       110 mE~L~~~~~  118 (392)
T d2pula1         110 MEDLSHLKI  118 (392)
T ss_dssp             ECCCTTSEE
T ss_pred             EeccCCccc
Confidence            999976543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.81  E-value=4.9e-06  Score=66.87  Aligned_cols=90  Identities=11%  Similarity=0.099  Sum_probs=66.2

Q ss_pred             cCCCCCCEEeccCC-ccccc----CchhhhhcccCCeEeccCccCCCc----CChhhcCCCCCcEEEccCcccccCC---
Q 043586           27 GLLTDLSYLDLSRN-QFNSS----IPNELTWLTGLLGLNLSSNKLSGK----IPSQIASMKNLTWLDISNNKIEGSI---   94 (397)
Q Consensus        27 ~~l~~L~~L~l~~N-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~~~~~~---   94 (397)
                      .+.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.++..    +...+...+.|+.|+|++|.|...-   
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45689999999974 56532    223455668899999999998732    2344556789999999999987532   


Q ss_pred             -chhhccCCCCceeeccCCcCCC
Q 043586           95 -PGEITELSRLDYLNLSSNKLSG  116 (397)
Q Consensus        95 -p~~~~~~~~L~~l~l~~n~l~~  116 (397)
                       -..+...+.|+.|++++|.+..
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~~  114 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQSV  114 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCC
T ss_pred             HHHHHHhCCcCCEEECCCCcCCC
Confidence             3456677889999999997663

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.72  E-value=0.00011  Score=65.48  Aligned_cols=135  Identities=17%  Similarity=0.232  Sum_probs=78.9

Q ss_pred             ccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCcc--cee-----eEEeeCCEeeEEEeeccCCCc
Q 043586          233 GSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV--KLY-----GFCLHRKCMFLIYEYMERGSL  305 (397)
Q Consensus       233 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~-----~~~~~~~~~~lv~e~~~~g~L  305 (397)
                      -.||+++.++|+.|++|+.+......    +++..|...+..+....+.  ...     ..+...+..+.++++++|..+
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            58999999999999999998754332    4566788888887633322  111     123446678899999987544


Q ss_pred             hhh----c----------cc----C--CCccccCh-------------------HHHHHHHHHHHHHHHHHHh----CCC
Q 043586          306 FCN----L----------HN----N--EDAVELDW-------------------AKRVNIVKAMAHALAYLHH----DCS  342 (397)
Q Consensus       306 ~~~----l----------~~----~--~~~~~~~~-------------------~~~~~i~~~i~~~l~~LH~----~~~  342 (397)
                      ...    .          +.    .  ......++                   .....+...+...++.+..    ...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            210    0          00    0  00001111                   1111122222223333321    224


Q ss_pred             CCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          343 PSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       343 ~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      .+++|+|+.|.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            579999999999999743  45899998864

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.69  E-value=8.9e-06  Score=65.20  Aligned_cols=110  Identities=19%  Similarity=0.208  Sum_probs=63.3

Q ss_pred             CCCCCCEEEcCC-Cccccc----CCccccCCCCCCEEeccCCcccccC----chhhhhcccCCeEeccCccCCCc----C
Q 043586            4 NLKNLIELDVGS-NSLIGP----IPSTLGLLTDLSYLDLSRNQFNSSI----PNELTWLTGLLGLNLSSNKLSGK----I   70 (397)
Q Consensus         4 ~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~l~~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~----~   70 (397)
                      +.++|++|+|++ +.++..    +-..+...++|+.|+|++|.++...    ...+...++++.|++++|.++..    +
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l   94 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL   94 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence            457788888876 445321    3345566777888888888775332    22344556777777777776522    2


Q ss_pred             ChhhcCCCCCcEEEc--cCccccc----CCchhhccCCCCceeeccCCc
Q 043586           71 PSQIASMKNLTWLDI--SNNKIEG----SIPGEITELSRLDYLNLSSNK  113 (397)
Q Consensus        71 p~~~~~l~~L~~L~l--~~N~~~~----~~p~~~~~~~~L~~l~l~~n~  113 (397)
                      -..+...++|+.++|  ++|.+..    .+...+...+.|+.|+++.+.
T Consensus        95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            234455566665444  3455532    123344556666666665543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.59  E-value=0.00022  Score=63.06  Aligned_cols=159  Identities=11%  Similarity=0.023  Sum_probs=87.0

Q ss_pred             ccHHHHHHHhcCCCccceee-----cCCcccEEEEEcCCCcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCCcc--
Q 043586          209 IVYEDLIEATEGFDIKYCIG-----TGGYGSVYKAQLPNGKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRNIV--  281 (397)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~ig-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv--  281 (397)
                      ++-+|+....++|.+++...     .|---+.|+.+..+| .+++|+.......     +++..|++++..+...++.  
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp   76 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCP   76 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCH-----HHHHHHHHHHHhhhhcccccc
Confidence            45678888889998865443     455567899987665 4899998654221     3344577777777543322  


Q ss_pred             ceee------EEeeCCEeeEEEeeccCCCchhhccc------------------C--CCcc------------------c
Q 043586          282 KLYG------FCLHRKCMFLIYEYMERGSLFCNLHN------------------N--EDAV------------------E  317 (397)
Q Consensus       282 ~l~~------~~~~~~~~~lv~e~~~~g~L~~~l~~------------------~--~~~~------------------~  317 (397)
                      ....      +....+....++.++.+......-..                  .  ....                  .
T Consensus        77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (316)
T d2ppqa1          77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  156 (316)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence            1111      12234556677777766444211000                  0  0000                  0


Q ss_pred             cChHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEeCCCCCeEEeccccccc
Q 043586          318 LDWAKRVNIVKAMAHALAYLHH-DCSPSIIHRDISSNNILLNSKFEAFVADFGTARL  373 (397)
Q Consensus       318 ~~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~DFG~a~~  373 (397)
                      .........+......+.-.+. ....|++|+|+.++||+++.+...-++||+.+..
T Consensus       157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            0001111122222222222221 2256899999999999999887778999998863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.22  E-value=0.00094  Score=60.85  Aligned_cols=72  Identities=22%  Similarity=0.265  Sum_probs=47.2

Q ss_pred             ceeecCCcccEEEEEcCC--------CcEEEEEEecccchHHHHHHHHHHHHHHHHhhcccCC-ccceeeEEeeCCEeeE
Q 043586          225 YCIGTGGYGSVYKAQLPN--------GKVFALKKLHTSETEELAFIKSFRNEAQVLSQVLHRN-IVKLYGFCLHRKCMFL  295 (397)
Q Consensus       225 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l  295 (397)
                      +.|+.|-.-.+|++...+        .+.|++++.-.....     ....+|..+++.+.-.+ ..++++++.+    .+
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~  118 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG----GR  118 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-----hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence            457778788999997643        356777776532221     22346888888885334 4567777643    58


Q ss_pred             EEeeccCCCc
Q 043586          296 IYEYMERGSL  305 (397)
Q Consensus       296 v~e~~~~g~L  305 (397)
                      |+||++|..+
T Consensus       119 I~efi~g~~l  128 (395)
T d1nw1a_         119 LEEYIPSRPL  128 (395)
T ss_dssp             EECCCCEEEC
T ss_pred             EEEEeccccC
Confidence            9999987655

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.93  E-value=0.0001  Score=58.70  Aligned_cols=115  Identities=14%  Similarity=0.135  Sum_probs=77.4

Q ss_pred             CCccccCCCCCCEEeccC-Cccccc----CchhhhhcccCCeEeccCccCCCcCC----hhhcCCCCCcEEEccCccccc
Q 043586           22 IPSTLGLLTDLSYLDLSR-NQFNSS----IPNELTWLTGLLGLNLSSNKLSGKIP----SQIASMKNLTWLDISNNKIEG   92 (397)
Q Consensus        22 ~p~~l~~l~~L~~L~l~~-N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~L~~L~l~~N~~~~   92 (397)
                      +.....+.++|+.|+|++ |.++..    +-..+...++|++|+|++|.++...-    ..+...++++.+++++|.+..
T Consensus         9 l~~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~   88 (166)
T d1io0a_           9 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG   88 (166)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred             HHHHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence            334456679999999998 556522    22344567899999999999874322    345567899999999999864


Q ss_pred             C----CchhhccCCCCceeec--cCCcCCCC----CCCCcccccccceeccCCC
Q 043586           93 S----IPGEITELSRLDYLNL--SSNKLSGP----VPFSNEQLSSMYIVRLSPN  136 (397)
Q Consensus        93 ~----~p~~~~~~~~L~~l~l--~~n~l~~~----~~~~~~~l~~l~~l~l~~n  136 (397)
                      .    +...+...++|+.++|  +.|.+...    +...+...+++..++++.+
T Consensus        89 ~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~  142 (166)
T d1io0a_          89 SGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred             hhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence            3    2356777888987555  56666421    2223345567777777654